{"subject": "phosphatase", "sub_type": "Enzyme", "rel": "ThemeOf", "object": "SHP-2", "obj_type": "Gene", "file_name": "PubMed-16371368.json", "snippet": " [CLS] SHP-2 phosphatase [CLS]  that cause hyperactivation of its catalytic activity have been identified in human leukemias, particularly juvenile myelomonocytic leukemia, which is characterized by hypersensitivity of myeloid progenitor cells to granulocyte macrophage"}
{"subject": "SHP-2", "sub_type": "Gene", "rel": "ThemeOf", "object": "interactions", "obj_type": "Interaction", "file_name": "PubMed-16371368.json", "snippet": " disease in mice, while overexpression of WT SHP-2 decreased hematopoietic potential of the transduced cells in recipient animals. The E76K mutation in the N-terminal Src homology 2 domain increased  [CLS] interactions of mutant SHP-2 [CLS]  with Grb2, Gab2, and p85, leading to hyperactivation of IL-3-induced Erk and phosphatidylinositol 3-kinase (PI3K) pathways. In addition, despite the substantial increase in the catalytic activity, dephosphorylation of STAT5"}
{"subject": "mutant", "sub_type": "Var", "rel": "ThemeOf", "object": "SHP-2", "obj_type": "Gene", "file_name": "PubMed-16371368.json", "snippet": " mice, while overexpression of WT SHP-2 decreased hematopoietic potential of the transduced cells in recipient animals. The E76K mutation in the N-terminal Src homology 2 domain increased interactions of  [CLS] mutant SHP-2 [CLS]  with Grb2, Gab2, and p85, leading to hyperactivation of IL-3-induced Erk and phosphatidylinositol 3-kinase (PI3K) pathways. In addition, despite the substantial increase in the catalytic activity, dephosphorylation of STAT5"}
{"subject": "increased", "sub_type": "PosReg", "rel": "CauseOf", "object": "hyperactivation", "obj_type": "PosReg", "file_name": "PubMed-16371368.json", "snippet": " myeloproliferative disease in mice, while overexpression of WT SHP-2 decreased hematopoietic potential of the transduced cells in recipient animals. The E76K mutation in the N-terminal Src homology 2 domain  [CLS] increased interactions of mutant SHP-2 with Grb2, Gab2, and p85, leading to hyperactivation [CLS]  of IL-3-induced Erk and phosphatidylinositol 3-kinase (PI3K) pathways. In addition, despite the substantial increase in the catalytic activity, dephosphorylation of STAT5 by SHP-2 E76K was dampened. Furthermore, catalytically inactive"}
{"subject": "IL-3-induced Erk and phosphatidylinositol 3-kinase (PI3K) pathways", "sub_type": "Pathway", "rel": "ThemeOf", "object": "hyperactivation", "obj_type": "PosReg", "file_name": "PubMed-16371368.json", "snippet": " of the transduced cells in recipient animals. The E76K mutation in the N-terminal Src homology 2 domain increased interactions of mutant SHP-2 with Grb2, Gab2, and p85, leading to  [CLS] hyperactivation of IL-3-induced Erk and phosphatidylinositol 3-kinase (PI3K) pathways [CLS] . In addition, despite the substantial increase in the catalytic activity, dephosphorylation of STAT5 by SHP-2 E76K was dampened. Furthermore, catalytically inactive SHP-2 E76K with an additional C459S mutation retained"}
{"subject": "catalytic activity", "sub_type": "MPA", "rel": "ThemeOf", "object": "increase", "obj_type": "PosReg", "file_name": "PubMed-16371368.json", "snippet": " homology 2 domain increased interactions of mutant SHP-2 with Grb2, Gab2, and p85, leading to hyperactivation of IL-3-induced Erk and phosphatidylinositol 3-kinase (PI3K) pathways. In addition, despite the substantial  [CLS] increase in the catalytic activity [CLS] , dephosphorylation of STAT5 by SHP-2 E76K was dampened. Furthermore, catalytically inactive SHP-2 E76K with an additional C459S mutation retained the capability to increase the interaction with Gab2 and to"}
{"subject": "dephosphorylation of STAT5", "sub_type": "MPA", "rel": "ThemeOf", "object": "dampened", "obj_type": "NegReg", "file_name": "PubMed-16371368.json", "snippet": " of mutant SHP-2 with Grb2, Gab2, and p85, leading to hyperactivation of IL-3-induced Erk and phosphatidylinositol 3-kinase (PI3K) pathways. In addition, despite the substantial increase in the catalytic activity,  [CLS] dephosphorylation of STAT5 by SHP-2 E76K was dampened [CLS] . Furthermore, catalytically inactive SHP-2 E76K with an additional C459S mutation retained the capability to increase the interaction with Gab2 and to enhance the activation of the PI3K pathway. Taken"}
{"subject": "E76K", "sub_type": "Var", "rel": "ThemeOf", "object": "SHP-2", "obj_type": "Gene", "file_name": "PubMed-16371368.json", "snippet": " Grb2, Gab2, and p85, leading to hyperactivation of IL-3-induced Erk and phosphatidylinositol 3-kinase (PI3K) pathways. In addition, despite the substantial increase in the catalytic activity, dephosphorylation of STAT5 by  [CLS] SHP-2 E76K [CLS]  was dampened. Furthermore, catalytically inactive SHP-2 E76K with an additional C459S mutation retained the capability to increase the interaction with Gab2 and to enhance the activation of the PI3K"}
{"subject": "SHP-2", "sub_type": "Gene", "rel": "ThemeOf", "object": "dephosphorylation of STAT5", "obj_type": "MPA", "file_name": "PubMed-16371368.json", "snippet": " of mutant SHP-2 with Grb2, Gab2, and p85, leading to hyperactivation of IL-3-induced Erk and phosphatidylinositol 3-kinase (PI3K) pathways. In addition, despite the substantial increase in the catalytic activity,  [CLS] dephosphorylation of STAT5 by SHP-2 [CLS]  E76K was dampened. Furthermore, catalytically inactive SHP-2 E76K with an additional C459S mutation retained the capability to increase the interaction with Gab2 and to enhance the activation of the"}
{"subject": "E76K", "sub_type": "Var", "rel": "CauseOf", "object": "increase", "obj_type": "PosReg", "file_name": "PubMed-16371368.json", "snippet": " IL-3-induced Erk and phosphatidylinositol 3-kinase (PI3K) pathways. In addition, despite the substantial increase in the catalytic activity, dephosphorylation of STAT5 by SHP-2 E76K was dampened. Furthermore, catalytically inactive SHP-2  [CLS] E76K with an additional C459S mutation retained the capability to increase [CLS]  the interaction with Gab2 and to enhance the activation of the PI3K pathway. Taken together, these studies suggest that in addition to the elevated catalytic activity, fundamental changes in"}
{"subject": "interaction", "sub_type": "Interaction", "rel": "ThemeOf", "object": "increase", "obj_type": "PosReg", "file_name": "PubMed-16371368.json", "snippet": " the substantial increase in the catalytic activity, dephosphorylation of STAT5 by SHP-2 E76K was dampened. Furthermore, catalytically inactive SHP-2 E76K with an additional C459S mutation retained the capability to  [CLS] increase the interaction [CLS]  with Gab2 and to enhance the activation of the PI3K pathway. Taken together, these studies suggest that in addition to the elevated catalytic activity, fundamental changes in physical and"}
{"subject": "SHP-2", "sub_type": "Gene", "rel": "ThemeOf", "object": "Mutations", "obj_type": "Var", "file_name": "PubMed-16371368.json", "snippet": " [CLS] Mutations in SHP-2 [CLS]  phosphatase that cause hyperactivation of its catalytic activity have been identified in human leukemias, particularly juvenile myelomonocytic leukemia, which is characterized by hypersensitivity of myeloid progenitor cells to granulocyte"}
{"subject": "Gab2", "sub_type": "Protein", "rel": "ThemeOf", "object": "interaction", "obj_type": "Interaction", "file_name": "PubMed-16371368.json", "snippet": " increase in the catalytic activity, dephosphorylation of STAT5 by SHP-2 E76K was dampened. Furthermore, catalytically inactive SHP-2 E76K with an additional C459S mutation retained the capability to increase the  [CLS] interaction with Gab2 [CLS]  and to enhance the activation of the PI3K pathway. Taken together, these studies suggest that in addition to the elevated catalytic activity, fundamental changes in physical and functional interactions"}
{"subject": "E76K", "sub_type": "Var", "rel": "CauseOf", "object": "enhance", "obj_type": "PosReg", "file_name": "PubMed-16371368.json", "snippet": " IL-3-induced Erk and phosphatidylinositol 3-kinase (PI3K) pathways. In addition, despite the substantial increase in the catalytic activity, dephosphorylation of STAT5 by SHP-2 E76K was dampened. Furthermore, catalytically inactive SHP-2  [CLS] E76K with an additional C459S mutation retained the capability to increase the interaction with Gab2 and to enhance [CLS]  the activation of the PI3K pathway. Taken together, these studies suggest that in addition to the elevated catalytic activity, fundamental changes in physical and functional interactions between GOF mutant"}
{"subject": "PI3K pathway", "sub_type": "Pathway", "rel": "ThemeOf", "object": "enhance", "obj_type": "PosReg", "file_name": "PubMed-16371368.json", "snippet": " dephosphorylation of STAT5 by SHP-2 E76K was dampened. Furthermore, catalytically inactive SHP-2 E76K with an additional C459S mutation retained the capability to increase the interaction with Gab2 and to  [CLS] enhance the activation of the PI3K pathway [CLS] . Taken together, these studies suggest that in addition to the elevated catalytic activity, fundamental changes in physical and functional interactions between GOF mutant SHP-2 and signaling partners also play"}
{"subject": "leukemias", "sub_type": "Disease", "rel": "ThemeOf", "object": "hyperactivation", "obj_type": "PosReg", "file_name": "PubMed-16371368.json", "snippet": " [CLS] hyperactivation of its catalytic activity have been identified in human leukemias [CLS] , particularly juvenile myelomonocytic leukemia, which is characterized by hypersensitivity of myeloid progenitor cells to granulocyte macrophage colony-stimulating factor and interleukin (IL)-3. However, the molecular mechanisms by which gain-of-function (GOF)"}
{"subject": "juvenile myelomonocytic leukemia", "sub_type": "Disease", "rel": "ThemeOf", "object": "hyperactivation", "obj_type": "PosReg", "file_name": "PubMed-16371368.json", "snippet": " [CLS] hyperactivation of its catalytic activity have been identified in human leukemias, particularly juvenile myelomonocytic leukemia [CLS] , which is characterized by hypersensitivity of myeloid progenitor cells to granulocyte macrophage colony-stimulating factor and interleukin (IL)-3. However, the molecular mechanisms by which gain-of-function (GOF) mutations of SHP-2 induce"}
{"subject": "SHP-2", "sub_type": "Gene", "rel": "ThemeOf", "object": "E76K", "obj_type": "Var", "file_name": "PubMed-16371368.json", "snippet": " of IL-3-induced Erk and phosphatidylinositol 3-kinase (PI3K) pathways. In addition, despite the substantial increase in the catalytic activity, dephosphorylation of STAT5 by SHP-2 E76K was dampened. Furthermore, catalytically inactive  [CLS] SHP-2 E76K [CLS]  with an additional C459S mutation retained the capability to increase the interaction with Gab2 and to enhance the activation of the PI3K pathway. Taken together, these studies suggest that"}
{"subject": "C459S", "sub_type": "Var", "rel": "CauseOf", "object": "increase", "obj_type": "PosReg", "file_name": "PubMed-16371368.json", "snippet": " 3-kinase (PI3K) pathways. In addition, despite the substantial increase in the catalytic activity, dephosphorylation of STAT5 by SHP-2 E76K was dampened. Furthermore, catalytically inactive SHP-2 E76K with an additional  [CLS] C459S mutation retained the capability to increase [CLS]  the interaction with Gab2 and to enhance the activation of the PI3K pathway. Taken together, these studies suggest that in addition to the elevated catalytic activity, fundamental changes in"}
{"subject": "SHP-2", "sub_type": "Gene", "rel": "ThemeOf", "object": "C459S", "obj_type": "Var", "file_name": "PubMed-16371368.json", "snippet": " of IL-3-induced Erk and phosphatidylinositol 3-kinase (PI3K) pathways. In addition, despite the substantial increase in the catalytic activity, dephosphorylation of STAT5 by SHP-2 E76K was dampened. Furthermore, catalytically inactive  [CLS] SHP-2 E76K with an additional C459S [CLS]  mutation retained the capability to increase the interaction with Gab2 and to enhance the activation of the PI3K pathway. Taken together, these studies suggest that in addition to the"}
{"subject": "C459S", "sub_type": "Var", "rel": "CauseOf", "object": "enhance", "obj_type": "PosReg", "file_name": "PubMed-16371368.json", "snippet": " 3-kinase (PI3K) pathways. In addition, despite the substantial increase in the catalytic activity, dephosphorylation of STAT5 by SHP-2 E76K was dampened. Furthermore, catalytically inactive SHP-2 E76K with an additional  [CLS] C459S mutation retained the capability to increase the interaction with Gab2 and to enhance [CLS]  the activation of the PI3K pathway. Taken together, these studies suggest that in addition to the elevated catalytic activity, fundamental changes in physical and functional interactions between GOF mutant"}
{"subject": "Mutations", "sub_type": "Var", "rel": "CauseOf", "object": "hyperactivation", "obj_type": "PosReg", "file_name": "PubMed-16371368.json", "snippet": " [CLS] Mutations in SHP-2 phosphatase that cause hyperactivation [CLS]  of its catalytic activity have been identified in human leukemias, particularly juvenile myelomonocytic leukemia, which is characterized by hypersensitivity of myeloid progenitor cells to granulocyte macrophage colony-stimulating factor and"}
{"subject": "catalytic activity", "sub_type": "MPA", "rel": "ThemeOf", "object": "hyperactivation", "obj_type": "PosReg", "file_name": "PubMed-16371368.json", "snippet": " [CLS] hyperactivation of its catalytic activity [CLS]  have been identified in human leukemias, particularly juvenile myelomonocytic leukemia, which is characterized by hypersensitivity of myeloid progenitor cells to granulocyte macrophage colony-stimulating factor and interleukin (IL)-3. However, the"}
{"subject": "SHP-2", "sub_type": "Gene", "rel": "ThemeOf", "object": "E76K mutation", "obj_type": "Var", "file_name": "PubMed-16371368.json", "snippet": " effects of a GOF mutation of SHP-2 (SHP-2 E76K) on hematopoietic cell function and IL-3 signal transduction by comparing with those of overexpressed WT SHP-2. Our results showed that  [CLS] SHP-2 E76K mutation [CLS]  caused myeloproliferative disease in mice, while overexpression of WT SHP-2 decreased hematopoietic potential of the transduced cells in recipient animals. The E76K mutation in the N-terminal Src homology 2"}
{"subject": "E76K mutation", "sub_type": "Var", "rel": "CauseOf", "object": "myeloproliferative disease", "obj_type": "Disease", "file_name": "PubMed-16371368.json", "snippet": " of a GOF mutation of SHP-2 (SHP-2 E76K) on hematopoietic cell function and IL-3 signal transduction by comparing with those of overexpressed WT SHP-2. Our results showed that SHP-2  [CLS] E76K mutation caused myeloproliferative disease [CLS]  in mice, while overexpression of WT SHP-2 decreased hematopoietic potential of the transduced cells in recipient animals. The E76K mutation in the N-terminal Src homology 2 domain increased interactions"}
{"subject": "E76K", "sub_type": "Var", "rel": "CauseOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-16371368.json", "snippet": " SHP-2. Our results showed that SHP-2 E76K mutation caused myeloproliferative disease in mice, while overexpression of WT SHP-2 decreased hematopoietic potential of the transduced cells in recipient animals. The  [CLS] E76K mutation in the N-terminal Src homology 2 domain increased [CLS]  interactions of mutant SHP-2 with Grb2, Gab2, and p85, leading to hyperactivation of IL-3-induced Erk and phosphatidylinositol 3-kinase (PI3K) pathways. In addition, despite the substantial increase in the catalytic"}
{"subject": "interactions", "sub_type": "Interaction", "rel": "ThemeOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-16371368.json", "snippet": " myeloproliferative disease in mice, while overexpression of WT SHP-2 decreased hematopoietic potential of the transduced cells in recipient animals. The E76K mutation in the N-terminal Src homology 2 domain  [CLS] increased interactions [CLS]  of mutant SHP-2 with Grb2, Gab2, and p85, leading to hyperactivation of IL-3-induced Erk and phosphatidylinositol 3-kinase (PI3K) pathways. In addition, despite the substantial increase in the catalytic activity,"}
{"subject": "Grb2", "sub_type": "Protein", "rel": "ThemeOf", "object": "interactions", "obj_type": "Interaction", "file_name": "PubMed-16371368.json", "snippet": " disease in mice, while overexpression of WT SHP-2 decreased hematopoietic potential of the transduced cells in recipient animals. The E76K mutation in the N-terminal Src homology 2 domain increased  [CLS] interactions of mutant SHP-2 with Grb2 [CLS] , Gab2, and p85, leading to hyperactivation of IL-3-induced Erk and phosphatidylinositol 3-kinase (PI3K) pathways. In addition, despite the substantial increase in the catalytic activity, dephosphorylation of STAT5 by SHP-2"}
{"subject": "bchs", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-17435236.json", "snippet": " and altered ubiquitinated-protein profiles.\nDefects in lysosomal trafficking pathways lead to decreased cell viability and are associated with progressive disorders in humans. Previously we have found that loss-of-function (LOF)  [CLS] mutations in the Drosophila gene blue cheese (bchs [CLS] ) lead to reduced adult life span, increased neuronal death, and widespread CNS degeneration that is associated with the formation of ubiquitinated-protein aggregates. To identify potential genes that participate in"}
{"subject": "ubiquitinated protein profiles", "sub_type": "MPA", "rel": "ThemeOf", "object": "changes", "obj_type": "Reg", "file_name": "PubMed-17435236.json", "snippet": " mutant alleles that produced viable adults were further examined for bchs-like phenotypes. Mutations in several lysosomal trafficking genes resulted in significantly decreased adult life spans and several mutants showed  [CLS] changes in ubiquitinated protein profiles [CLS]  as young adults. This work represents a novel approach to examine the role that lysosomal transport and function have on adult viability. The genes characterized in this study have"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "reduced", "obj_type": "NegReg", "file_name": "PubMed-17435236.json", "snippet": " and altered ubiquitinated-protein profiles.\nDefects in lysosomal trafficking pathways lead to decreased cell viability and are associated with progressive disorders in humans. Previously we have found that loss-of-function (LOF)  [CLS] mutations in the Drosophila gene blue cheese (bchs) lead to reduced [CLS]  adult life span, increased neuronal death, and widespread CNS degeneration that is associated with the formation of ubiquitinated-protein aggregates. To identify potential genes that participate in the bchs functional"}
{"subject": "adult life span", "sub_type": "CPA", "rel": "ThemeOf", "object": "reduced", "obj_type": "NegReg", "file_name": "PubMed-17435236.json", "snippet": " to decreased cell viability and are associated with progressive disorders in humans. Previously we have found that loss-of-function (LOF) mutations in the Drosophila gene blue cheese (bchs) lead to  [CLS] reduced adult life span [CLS] , increased neuronal death, and widespread CNS degeneration that is associated with the formation of ubiquitinated-protein aggregates. To identify potential genes that participate in the bchs functional pathway, we conducted"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-17435236.json", "snippet": " and altered ubiquitinated-protein profiles.\nDefects in lysosomal trafficking pathways lead to decreased cell viability and are associated with progressive disorders in humans. Previously we have found that loss-of-function (LOF)  [CLS] mutations in the Drosophila gene blue cheese (bchs) lead to reduced adult life span, increased [CLS]  neuronal death, and widespread CNS degeneration that is associated with the formation of ubiquitinated-protein aggregates. To identify potential genes that participate in the bchs functional pathway, we conducted a"}
{"subject": "neuronal death", "sub_type": "CPA", "rel": "ThemeOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-17435236.json", "snippet": " and are associated with progressive disorders in humans. Previously we have found that loss-of-function (LOF) mutations in the Drosophila gene blue cheese (bchs) lead to reduced adult life span,  [CLS] increased neuronal death [CLS] , and widespread CNS degeneration that is associated with the formation of ubiquitinated-protein aggregates. To identify potential genes that participate in the bchs functional pathway, we conducted a genetic modifier"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "degeneration", "obj_type": "NegReg", "file_name": "PubMed-17435236.json", "snippet": " and altered ubiquitinated-protein profiles.\nDefects in lysosomal trafficking pathways lead to decreased cell viability and are associated with progressive disorders in humans. Previously we have found that loss-of-function (LOF)  [CLS] mutations in the Drosophila gene blue cheese (bchs) lead to reduced adult life span, increased neuronal death, and widespread CNS degeneration [CLS]  that is associated with the formation of ubiquitinated-protein aggregates. To identify potential genes that participate in the bchs functional pathway, we conducted a genetic modifier screen based on alterations"}
{"subject": "widespread CNS", "sub_type": "CPA", "rel": "ThemeOf", "object": "degeneration", "obj_type": "NegReg", "file_name": "PubMed-17435236.json", "snippet": " progressive disorders in humans. Previously we have found that loss-of-function (LOF) mutations in the Drosophila gene blue cheese (bchs) lead to reduced adult life span, increased neuronal death, and  [CLS] widespread CNS degeneration [CLS]  that is associated with the formation of ubiquitinated-protein aggregates. To identify potential genes that participate in the bchs functional pathway, we conducted a genetic modifier screen based on alterations"}
{"subject": "lysosomal trafficking genes", "sub_type": "Gene", "rel": "ThemeOf", "object": "Mutations", "obj_type": "Var", "file_name": "PubMed-17435236.json", "snippet": " the SUMO and ubiquitin signaling pathways behave as modifiers of the Bchs gain-of-function (GOF) eye phenotype. Individual mutant alleles that produced viable adults were further examined for bchs-like phenotypes.  [CLS] Mutations in several lysosomal trafficking genes [CLS]  resulted in significantly decreased adult life spans and several mutants showed changes in ubiquitinated protein profiles as young adults. This work represents a novel approach to examine the role"}
{"subject": "Mutations", "sub_type": "Var", "rel": "CauseOf", "object": "decreased", "obj_type": "NegReg", "file_name": "PubMed-17435236.json", "snippet": " the SUMO and ubiquitin signaling pathways behave as modifiers of the Bchs gain-of-function (GOF) eye phenotype. Individual mutant alleles that produced viable adults were further examined for bchs-like phenotypes.  [CLS] Mutations in several lysosomal trafficking genes resulted in significantly decreased [CLS]  adult life spans and several mutants showed changes in ubiquitinated protein profiles as young adults. This work represents a novel approach to examine the role that lysosomal transport and"}
{"subject": "adult life spans", "sub_type": "CPA", "rel": "ThemeOf", "object": "decreased", "obj_type": "NegReg", "file_name": "PubMed-17435236.json", "snippet": " of the Bchs gain-of-function (GOF) eye phenotype. Individual mutant alleles that produced viable adults were further examined for bchs-like phenotypes. Mutations in several lysosomal trafficking genes resulted in significantly  [CLS] decreased adult life spans [CLS]  and several mutants showed changes in ubiquitinated protein profiles as young adults. This work represents a novel approach to examine the role that lysosomal transport and function have on"}
{"subject": "Mutations", "sub_type": "Var", "rel": "CauseOf", "object": "changes", "obj_type": "Reg", "file_name": "PubMed-17435236.json", "snippet": " the SUMO and ubiquitin signaling pathways behave as modifiers of the Bchs gain-of-function (GOF) eye phenotype. Individual mutant alleles that produced viable adults were further examined for bchs-like phenotypes.  [CLS] Mutations in several lysosomal trafficking genes resulted in significantly decreased adult life spans and several mutants showed changes [CLS]  in ubiquitinated protein profiles as young adults. This work represents a novel approach to examine the role that lysosomal transport and function have on adult viability. The genes characterized"}
{"subject": "heterotrimeric G proteins", "sub_type": "Protein", "rel": "CauseOf", "object": "stimulation", "obj_type": "PosReg", "file_name": "PubMed-18031991.json", "snippet": " [CLS] stimulation by G protein-coupled receptors via heterotrimeric G proteins [CLS] . Alterations in RGS function have been implicated in a wide range of disease states, leading to many researchers focusing on controlling the action of these regulatory proteins. Previous studies"}
{"subject": "RGS4", "sub_type": "Var", "rel": "CauseOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-18031991.json", "snippet": " result in GOF activity. GOF activity was retained upon transposition of the serine 30-cysteine mutation to the equivalent serine residue in human RGS16. As with previously identified GOF mutants,  [CLS] RGS4(S30C/S30F/S30K) demonstrate increased [CLS]  steady state protein levels, however these mutants also demonstrate enhanced GAP activity through an additional mechanism distinct from the increased protein content. The identification of human RGS mutants with"}
{"subject": "protein levels", "sub_type": "MPA", "rel": "ThemeOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-18031991.json", "snippet": " GOF activity. GOF activity was retained upon transposition of the serine 30-cysteine mutation to the equivalent serine residue in human RGS16. As with previously identified GOF mutants, RGS4(S30C/S30F/S30K) demonstrate  [CLS] increased steady state protein levels [CLS] , however these mutants also demonstrate enhanced GAP activity through an additional mechanism distinct from the increased protein content. The identification of human RGS mutants with GOF activity may provide"}
{"subject": "GAP activity", "sub_type": "MPA", "rel": "ThemeOf", "object": "enhanced", "obj_type": "PosReg", "file_name": "PubMed-18031991.json", "snippet": " serine 30-cysteine mutation to the equivalent serine residue in human RGS16. As with previously identified GOF mutants, RGS4(S30C/S30F/S30K) demonstrate increased steady state protein levels, however these mutants also demonstrate  [CLS] enhanced GAP activity [CLS]  through an additional mechanism distinct from the increased protein content. The identification of human RGS mutants with GOF activity may provide novel therapeutic agents for the treatment of signaling-based"}
{"subject": "RGS4 mutant", "sub_type": "Var", "rel": "CauseOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-18031991.json", "snippet": " centered on reducing or inhibiting the action of RGS proteins, utilizing inactive mutants or small molecular RGS inhibitors. Here we describe the isolation and characterization of a novel human  [CLS] RGS4 mutant which displays enhanced or gain-of-function [CLS]  (GOF) activity. RGS4(S30C) demonstrates GOF activity both in an in vivo yeast-based signalling pathway and in vitro against the Galpha(o1) subunit contained in an alpha(2A)-adrenoreceptor-Galpha(o1)(C351I) fusion protein. Mutational analysis"}
{"subject": "yeast-based signalling pathway", "sub_type": "Pathway", "rel": "ThemeOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-18031991.json", "snippet": " action of RGS proteins, utilizing inactive mutants or small molecular RGS inhibitors. Here we describe the isolation and characterization of a novel human RGS4 mutant which displays enhanced or  [CLS] gain-of-function (GOF) activity. RGS4(S30C) demonstrates GOF activity both in an in vivo yeast-based signalling pathway [CLS]  and in vitro against the Galpha(o1) subunit contained in an alpha(2A)-adrenoreceptor-Galpha(o1)(C351I) fusion protein. Mutational analysis of serine 30 identified a number of alternative substitutions that result in GOF activity."}
{"subject": "Galpha(o1) subunit contained in an alpha(2A)-adrenoreceptor-Galpha(o1)(C351I) fusion protein", "sub_type": "Protein", "rel": "ThemeOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-18031991.json", "snippet": " action of RGS proteins, utilizing inactive mutants or small molecular RGS inhibitors. Here we describe the isolation and characterization of a novel human RGS4 mutant which displays enhanced or  [CLS] gain-of-function (GOF) activity. RGS4(S30C) demonstrates GOF activity both in an in vivo yeast-based signalling pathway and in vitro against the Galpha(o1) subunit contained in an alpha(2A)-adrenoreceptor-Galpha(o1)(C351I) fusion protein [CLS] . Mutational analysis of serine 30 identified a number of alternative substitutions that result in GOF activity. GOF activity was retained upon transposition of the serine 30-cysteine mutation to the"}
{"subject": "RGS", "sub_type": "Protein", "rel": "ThemeOf", "object": "Alterations", "obj_type": "Var", "file_name": "PubMed-18031991.json", "snippet": " displaying gain-of-function activity.\nRegulator of G protein signaling (RGS) proteins play a crucial role in the adaptation of cells to stimulation by G protein-coupled receptors via heterotrimeric G proteins.  [CLS] Alterations in RGS [CLS]  function have been implicated in a wide range of disease states, leading to many researchers focusing on controlling the action of these regulatory proteins. Previous studies have centered on"}
{"subject": "RGS4", "sub_type": "Var", "rel": "CauseOf", "object": "enhanced", "obj_type": "PosReg", "file_name": "PubMed-18031991.json", "snippet": " result in GOF activity. GOF activity was retained upon transposition of the serine 30-cysteine mutation to the equivalent serine residue in human RGS16. As with previously identified GOF mutants,  [CLS] RGS4(S30C/S30F/S30K) demonstrate increased steady state protein levels, however these mutants also demonstrate enhanced [CLS]  GAP activity through an additional mechanism distinct from the increased protein content. The identification of human RGS mutants with GOF activity may provide novel therapeutic agents for the treatment"}
{"subject": "G protein-coupled receptors", "sub_type": "Protein", "rel": "ThemeOf", "object": "stimulation", "obj_type": "PosReg", "file_name": "PubMed-18031991.json", "snippet": " [CLS] stimulation by G protein-coupled receptors [CLS]  via heterotrimeric G proteins. Alterations in RGS function have been implicated in a wide range of disease states, leading to many researchers focusing on controlling the action of these"}
{"subject": "S30C", "sub_type": "Var", "rel": "ThemeOf", "object": "RGS4", "obj_type": "Var", "file_name": "PubMed-18031991.json", "snippet": " result in GOF activity. GOF activity was retained upon transposition of the serine 30-cysteine mutation to the equivalent serine residue in human RGS16. As with previously identified GOF mutants,  [CLS] RGS4(S30C [CLS] /S30F/S30K) demonstrate increased steady state protein levels, however these mutants also demonstrate enhanced GAP activity through an additional mechanism distinct from the increased protein content. The identification of human RGS"}
{"subject": "S30F", "sub_type": "Var", "rel": "ThemeOf", "object": "RGS4", "obj_type": "Var", "file_name": "PubMed-18031991.json", "snippet": " result in GOF activity. GOF activity was retained upon transposition of the serine 30-cysteine mutation to the equivalent serine residue in human RGS16. As with previously identified GOF mutants,  [CLS] RGS4(S30C/S30F [CLS] /S30K) demonstrate increased steady state protein levels, however these mutants also demonstrate enhanced GAP activity through an additional mechanism distinct from the increased protein content. The identification of human RGS"}
{"subject": "S30K", "sub_type": "Var", "rel": "ThemeOf", "object": "RGS4", "obj_type": "Var", "file_name": "PubMed-18031991.json", "snippet": " result in GOF activity. GOF activity was retained upon transposition of the serine 30-cysteine mutation to the equivalent serine residue in human RGS16. As with previously identified GOF mutants,  [CLS] RGS4(S30C/S30F/S30K [CLS] ) demonstrate increased steady state protein levels, however these mutants also demonstrate enhanced GAP activity through an additional mechanism distinct from the increased protein content. The identification of human RGS"}
{"subject": "Alterations", "sub_type": "Var", "rel": "CauseOf", "object": "implicated", "obj_type": "Reg", "file_name": "PubMed-18031991.json", "snippet": " displaying gain-of-function activity.\nRegulator of G protein signaling (RGS) proteins play a crucial role in the adaptation of cells to stimulation by G protein-coupled receptors via heterotrimeric G proteins.  [CLS] Alterations in RGS function have been implicated [CLS]  in a wide range of disease states, leading to many researchers focusing on controlling the action of these regulatory proteins. Previous studies have centered on reducing or inhibiting the"}
{"subject": "disease", "sub_type": "Disease", "rel": "ThemeOf", "object": "implicated", "obj_type": "Reg", "file_name": "PubMed-18031991.json", "snippet": " protein signaling (RGS) proteins play a crucial role in the adaptation of cells to stimulation by G protein-coupled receptors via heterotrimeric G proteins. Alterations in RGS function have been  [CLS] implicated in a wide range of disease [CLS]  states, leading to many researchers focusing on controlling the action of these regulatory proteins. Previous studies have centered on reducing or inhibiting the action of RGS proteins, utilizing inactive"}
{"subject": "RGS4 mutant", "sub_type": "Var", "rel": "CauseOf", "object": "enhanced", "obj_type": "PosReg", "file_name": "PubMed-18031991.json", "snippet": " centered on reducing or inhibiting the action of RGS proteins, utilizing inactive mutants or small molecular RGS inhibitors. Here we describe the isolation and characterization of a novel human  [CLS] RGS4 mutant which displays enhanced [CLS]  or gain-of-function (GOF) activity. RGS4(S30C) demonstrates GOF activity both in an in vivo yeast-based signalling pathway and in vitro against the Galpha(o1) subunit contained in an alpha(2A)-adrenoreceptor-Galpha(o1)(C351I) fusion protein."}
{"subject": "yeast-based signalling pathway", "sub_type": "Pathway", "rel": "ThemeOf", "object": "enhanced", "obj_type": "PosReg", "file_name": "PubMed-18031991.json", "snippet": " inhibiting the action of RGS proteins, utilizing inactive mutants or small molecular RGS inhibitors. Here we describe the isolation and characterization of a novel human RGS4 mutant which displays  [CLS] enhanced or gain-of-function (GOF) activity. RGS4(S30C) demonstrates GOF activity both in an in vivo yeast-based signalling pathway [CLS]  and in vitro against the Galpha(o1) subunit contained in an alpha(2A)-adrenoreceptor-Galpha(o1)(C351I) fusion protein. Mutational analysis of serine 30 identified a number of alternative substitutions that result in GOF activity."}
{"subject": "Galpha(o1) subunit contained in an alpha(2A)-adrenoreceptor-Galpha(o1)(C351I) fusion protein", "sub_type": "Protein", "rel": "ThemeOf", "object": "enhanced", "obj_type": "PosReg", "file_name": "PubMed-18031991.json", "snippet": " inhibiting the action of RGS proteins, utilizing inactive mutants or small molecular RGS inhibitors. Here we describe the isolation and characterization of a novel human RGS4 mutant which displays  [CLS] enhanced or gain-of-function (GOF) activity. RGS4(S30C) demonstrates GOF activity both in an in vivo yeast-based signalling pathway and in vitro against the Galpha(o1) subunit contained in an alpha(2A)-adrenoreceptor-Galpha(o1)(C351I) fusion protein [CLS] . Mutational analysis of serine 30 identified a number of alternative substitutions that result in GOF activity. GOF activity was retained upon transposition of the serine 30-cysteine mutation to the"}
{"subject": "p53", "sub_type": "Gene", "rel": "ThemeOf", "object": "proteins", "obj_type": "Protein", "file_name": "PubMed-18594199.json", "snippet": " [CLS] p53 proteins [CLS]  are thought to have acquired a \"gain of function\" (GOF) activity that mainly contributes to tumor aggressiveness. Previously we reported that constitutive downregulation of mutant p53 by RNA interference"}
{"subject": "conditional RNA interference", "sub_type": "MPA", "rel": "CauseOf", "object": "inhibiting", "obj_type": "NegReg", "file_name": "PubMed-18594199.json", "snippet": " this point, mimicking more physiological conditions, we now describe the establishment of a lentiviral-based system for conditional interference with mutant p53 expression. In vivo studies assessed the efficacy of  [CLS] conditional RNA interference in inhibiting [CLS]  gain of function activity of mutant p53 proteins by reducing tumor growth ability. Moreover by using this system, microarray data were validated in vitro and in vivo and putative"}
{"subject": "activity", "sub_type": "MPA", "rel": "ThemeOf", "object": "inhibiting", "obj_type": "NegReg", "file_name": "PubMed-18594199.json", "snippet": " physiological conditions, we now describe the establishment of a lentiviral-based system for conditional interference with mutant p53 expression. In vivo studies assessed the efficacy of conditional RNA interference in  [CLS] inhibiting gain of function activity [CLS]  of mutant p53 proteins by reducing tumor growth ability. Moreover by using this system, microarray data were validated in vitro and in vivo and putative mutant p53 target genes"}
{"subject": "p53", "sub_type": "Gene", "rel": "ThemeOf", "object": "proteins", "obj_type": "Protein", "file_name": "PubMed-18594199.json", "snippet": " of a lentiviral-based system for conditional interference with mutant p53 expression. In vivo studies assessed the efficacy of conditional RNA interference in inhibiting gain of function activity of mutant  [CLS] p53 proteins [CLS]  by reducing tumor growth ability. Moreover by using this system, microarray data were validated in vitro and in vivo and putative mutant p53 target genes that may contribute to"}
{"subject": "proteins", "sub_type": "Protein", "rel": "ThemeOf", "object": "mutant", "obj_type": "Var", "file_name": "PubMed-18594199.json", "snippet": " establishment of a lentiviral-based system for conditional interference with mutant p53 expression. In vivo studies assessed the efficacy of conditional RNA interference in inhibiting gain of function activity of  [CLS] mutant p53 proteins [CLS]  by reducing tumor growth ability. Moreover by using this system, microarray data were validated in vitro and in vivo and putative mutant p53 target genes that may contribute to"}
{"subject": "mutant", "sub_type": "Var", "rel": "ThemeOf", "object": "activity", "obj_type": "MPA", "file_name": "PubMed-18594199.json", "snippet": " describe the establishment of a lentiviral-based system for conditional interference with mutant p53 expression. In vivo studies assessed the efficacy of conditional RNA interference in inhibiting gain of function  [CLS] activity of mutant [CLS]  p53 proteins by reducing tumor growth ability. Moreover by using this system, microarray data were validated in vitro and in vivo and putative mutant p53 target genes that may"}
{"subject": "depletion", "sub_type": "MPA", "rel": "CauseOf", "object": "impacts", "obj_type": "Reg", "file_name": "PubMed-18594199.json", "snippet": " validated in vitro and in vivo and putative mutant p53 target genes that may contribute to its gain of function effects in cancer were identified. Results are confirmatory that  [CLS] depletion of mutant p53 protein impacts [CLS]  on tumor malignancy and validated the inducible lentiviral-based system as an efficient tool to study the gain of function activity of human tumor derived p53 mutants."}
{"subject": "tumor malignancy", "sub_type": "CPA", "rel": "ThemeOf", "object": "impacts", "obj_type": "Reg", "file_name": "PubMed-18594199.json", "snippet": " vivo and putative mutant p53 target genes that may contribute to its gain of function effects in cancer were identified. Results are confirmatory that depletion of mutant p53 protein  [CLS] impacts on tumor malignancy [CLS]  and validated the inducible lentiviral-based system as an efficient tool to study the gain of function activity of human tumor derived p53 mutants."}
{"subject": "mutant", "sub_type": "Var", "rel": "ThemeOf", "object": "depletion", "obj_type": "MPA", "file_name": "PubMed-18594199.json", "snippet": " validated in vitro and in vivo and putative mutant p53 target genes that may contribute to its gain of function effects in cancer were identified. Results are confirmatory that  [CLS] depletion of mutant [CLS]  p53 protein impacts on tumor malignancy and validated the inducible lentiviral-based system as an efficient tool to study the gain of function activity of human tumor derived p53 mutants."}
{"subject": "p53", "sub_type": "Gene", "rel": "ThemeOf", "object": "protein", "obj_type": "Protein", "file_name": "PubMed-18594199.json", "snippet": " and in vivo and putative mutant p53 target genes that may contribute to its gain of function effects in cancer were identified. Results are confirmatory that depletion of mutant  [CLS] p53 protein [CLS]  impacts on tumor malignancy and validated the inducible lentiviral-based system as an efficient tool to study the gain of function activity of human tumor derived p53 mutants."}
{"subject": "protein", "sub_type": "Protein", "rel": "ThemeOf", "object": "mutant", "obj_type": "Var", "file_name": "PubMed-18594199.json", "snippet": " vitro and in vivo and putative mutant p53 target genes that may contribute to its gain of function effects in cancer were identified. Results are confirmatory that depletion of  [CLS] mutant p53 protein [CLS]  impacts on tumor malignancy and validated the inducible lentiviral-based system as an efficient tool to study the gain of function activity of human tumor derived p53 mutants."}
{"subject": "proteins", "sub_type": "Protein", "rel": "ThemeOf", "object": "Mutant", "obj_type": "Var", "file_name": "PubMed-18594199.json", "snippet": " [CLS] Mutant p53 proteins [CLS]  are thought to have acquired a \"gain of function\" (GOF) activity that mainly contributes to tumor aggressiveness. Previously we reported that constitutive downregulation of mutant p53 by RNA interference"}
{"subject": "Mutant", "sub_type": "Var", "rel": "CauseOf", "object": "gain of function", "obj_type": "PosReg", "file_name": "PubMed-18594199.json", "snippet": " [CLS] Mutant p53 proteins are thought to have acquired a \"gain of function [CLS] \" (GOF) activity that mainly contributes to tumor aggressiveness. Previously we reported that constitutive downregulation of mutant p53 by RNA interference reduces the tumorigenicity of cancer cells in an animal"}
{"subject": "tumor aggressiveness", "sub_type": "CPA", "rel": "ThemeOf", "object": "gain of function", "obj_type": "PosReg", "file_name": "PubMed-18594199.json", "snippet": " [CLS] gain of function\" (GOF) activity that mainly contributes to tumor aggressiveness [CLS] . Previously we reported that constitutive downregulation of mutant p53 by RNA interference reduces the tumorigenicity of cancer cells in an animal model; however, effects of adaptation to long-term mutant"}
{"subject": "RNA interference", "sub_type": "MPA", "rel": "CauseOf", "object": "downregulation", "obj_type": "NegReg", "file_name": "PubMed-18594199.json", "snippet": " function on tumor malignancy.\nMutant p53 proteins are thought to have acquired a \"gain of function\" (GOF) activity that mainly contributes to tumor aggressiveness. Previously we reported that constitutive  [CLS] downregulation of mutant p53 by RNA interference [CLS]  reduces the tumorigenicity of cancer cells in an animal model; however, effects of adaptation to long-term mutant p53 inhibition could not be excluded. To address this point, mimicking more"}
{"subject": "downregulation", "sub_type": "NegReg", "rel": "CauseOf", "object": "reduces", "obj_type": "NegReg", "file_name": "PubMed-18594199.json", "snippet": " function on tumor malignancy.\nMutant p53 proteins are thought to have acquired a \"gain of function\" (GOF) activity that mainly contributes to tumor aggressiveness. Previously we reported that constitutive  [CLS] downregulation of mutant p53 by RNA interference reduces [CLS]  the tumorigenicity of cancer cells in an animal model; however, effects of adaptation to long-term mutant p53 inhibition could not be excluded. To address this point, mimicking more physiological"}
{"subject": "p53", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutant", "obj_type": "Var", "file_name": "PubMed-18594199.json", "snippet": " tumor malignancy.\nMutant p53 proteins are thought to have acquired a \"gain of function\" (GOF) activity that mainly contributes to tumor aggressiveness. Previously we reported that constitutive downregulation of  [CLS] mutant p53 [CLS]  by RNA interference reduces the tumorigenicity of cancer cells in an animal model; however, effects of adaptation to long-term mutant p53 inhibition could not be excluded. To address this"}
{"subject": "mutant", "sub_type": "Var", "rel": "ThemeOf", "object": "downregulation", "obj_type": "NegReg", "file_name": "PubMed-18594199.json", "snippet": " function on tumor malignancy.\nMutant p53 proteins are thought to have acquired a \"gain of function\" (GOF) activity that mainly contributes to tumor aggressiveness. Previously we reported that constitutive  [CLS] downregulation of mutant [CLS]  p53 by RNA interference reduces the tumorigenicity of cancer cells in an animal model; however, effects of adaptation to long-term mutant p53 inhibition could not be excluded. To address"}
{"subject": "tumorigenicity of cancer cells in an animal model", "sub_type": "CPA", "rel": "ThemeOf", "object": "reduces", "obj_type": "NegReg", "file_name": "PubMed-18594199.json", "snippet": " are thought to have acquired a \"gain of function\" (GOF) activity that mainly contributes to tumor aggressiveness. Previously we reported that constitutive downregulation of mutant p53 by RNA interference  [CLS] reduces the tumorigenicity of cancer cells in an animal model [CLS] ; however, effects of adaptation to long-term mutant p53 inhibition could not be excluded. To address this point, mimicking more physiological conditions, we now describe the establishment of a lentiviral-based"}
{"subject": "polymorphism", "sub_type": "MPA", "rel": "ThemeOf", "object": "silent", "obj_type": "NegReg", "file_name": "PubMed-19338054.json", "snippet": " c.865T>C, p.Cys289Arg) have never been described, and the others (c.112G>A, p.Val38Met; c.122C>T, p.Ser41Phe; c.383T>C, p.Met128Thr; and c.842A>G, p.Asn281Ser) have not been analyzed for function. p.Asn281Ser corresponds to a functionally  [CLS] silent polymorphism [CLS] . The other mutations are associated with varying degrees of loss of function (LOF), from moderate decreases in coupling to the cAMP pathway (p.Val38Met and p.Val51Ala) to nearly complete absence"}
{"subject": "p.Val38Met", "sub_type": "Var", "rel": "CauseOf", "object": "reduced", "obj_type": "NegReg", "file_name": "PubMed-19338054.json", "snippet": " of functional coupling (p.Ser41Phe, p.Met128Thr, and p.Cys289Arg). The LOF p.Met128Thr and p.Cys289Arg mutants are trafficked to the cell surface, but are unable to bind agonists efficiently. Conversely, LOF of  [CLS] p.Val38Met, p.Ser41Phe, and p.Val51Ala is due to reduced [CLS]  cell surface expression as a consequence of retention in the endoplasmic reticulum (ER). Therefore, LOF of MC1R alleles is frequently associated with aberrant forward trafficking and accumulation within the"}
{"subject": "cell surface expression", "sub_type": "CPA", "rel": "ThemeOf", "object": "reduced", "obj_type": "NegReg", "file_name": "PubMed-19338054.json", "snippet": " The LOF p.Met128Thr and p.Cys289Arg mutants are trafficked to the cell surface, but are unable to bind agonists efficiently. Conversely, LOF of p.Val38Met, p.Ser41Phe, and p.Val51Ala is due to  [CLS] reduced cell surface expression [CLS]  as a consequence of retention in the endoplasmic reticulum (ER). Therefore, LOF of MC1R alleles is frequently associated with aberrant forward trafficking and accumulation within the ER or with"}
{"subject": "coupling", "sub_type": "MPA", "rel": "ThemeOf", "object": "decreases", "obj_type": "NegReg", "file_name": "PubMed-19338054.json", "snippet": " p.Asn281Ser) have not been analyzed for function. p.Asn281Ser corresponds to a functionally silent polymorphism. The other mutations are associated with varying degrees of loss of function (LOF), from moderate  [CLS] decreases in coupling [CLS]  to the cAMP pathway (p.Val38Met and p.Val51Ala) to nearly complete absence of functional coupling (p.Ser41Phe, p.Met128Thr, and p.Cys289Arg). The LOF p.Met128Thr and p.Cys289Arg mutants are trafficked to the cell"}
{"subject": "functional coupling", "sub_type": "MPA", "rel": "ThemeOf", "object": "absence", "obj_type": "NegReg", "file_name": "PubMed-19338054.json", "snippet": " polymorphism. The other mutations are associated with varying degrees of loss of function (LOF), from moderate decreases in coupling to the cAMP pathway (p.Val38Met and p.Val51Ala) to nearly complete  [CLS] absence of functional coupling [CLS]  (p.Ser41Phe, p.Met128Thr, and p.Cys289Arg). The LOF p.Met128Thr and p.Cys289Arg mutants are trafficked to the cell surface, but are unable to bind agonists efficiently. Conversely, LOF of p.Val38Met, p.Ser41Phe, and"}
{"subject": "cAMP pathway", "sub_type": "Pathway", "rel": "ThemeOf", "object": "decreases", "obj_type": "NegReg", "file_name": "PubMed-19338054.json", "snippet": " p.Asn281Ser) have not been analyzed for function. p.Asn281Ser corresponds to a functionally silent polymorphism. The other mutations are associated with varying degrees of loss of function (LOF), from moderate  [CLS] decreases in coupling to the cAMP pathway [CLS]  (p.Val38Met and p.Val51Ala) to nearly complete absence of functional coupling (p.Ser41Phe, p.Met128Thr, and p.Cys289Arg). The LOF p.Met128Thr and p.Cys289Arg mutants are trafficked to the cell surface, but are unable"}
{"subject": "p.Val38Met", "sub_type": "Var", "rel": "CauseOf", "object": "decreases", "obj_type": "NegReg", "file_name": "PubMed-19338054.json", "snippet": " p.Asn281Ser) have not been analyzed for function. p.Asn281Ser corresponds to a functionally silent polymorphism. The other mutations are associated with varying degrees of loss of function (LOF), from moderate  [CLS] decreases in coupling to the cAMP pathway (p.Val38Met [CLS]  and p.Val51Ala) to nearly complete absence of functional coupling (p.Ser41Phe, p.Met128Thr, and p.Cys289Arg). The LOF p.Met128Thr and p.Cys289Arg mutants are trafficked to the cell surface, but are unable to"}
{"subject": "p.Val51Ala", "sub_type": "Var", "rel": "CauseOf", "object": "decreases", "obj_type": "NegReg", "file_name": "PubMed-19338054.json", "snippet": " p.Asn281Ser) have not been analyzed for function. p.Asn281Ser corresponds to a functionally silent polymorphism. The other mutations are associated with varying degrees of loss of function (LOF), from moderate  [CLS] decreases in coupling to the cAMP pathway (p.Val38Met and p.Val51Ala [CLS] ) to nearly complete absence of functional coupling (p.Ser41Phe, p.Met128Thr, and p.Cys289Arg). The LOF p.Met128Thr and p.Cys289Arg mutants are trafficked to the cell surface, but are unable to bind agonists"}
{"subject": "p.Ser41Phe", "sub_type": "Var", "rel": "CauseOf", "object": "absence", "obj_type": "NegReg", "file_name": "PubMed-19338054.json", "snippet": " polymorphism. The other mutations are associated with varying degrees of loss of function (LOF), from moderate decreases in coupling to the cAMP pathway (p.Val38Met and p.Val51Ala) to nearly complete  [CLS] absence of functional coupling (p.Ser41Phe [CLS] , p.Met128Thr, and p.Cys289Arg). The LOF p.Met128Thr and p.Cys289Arg mutants are trafficked to the cell surface, but are unable to bind agonists efficiently. Conversely, LOF of p.Val38Met, p.Ser41Phe, and p.Val51Ala"}
{"subject": "p.Met128Thr", "sub_type": "Var", "rel": "CauseOf", "object": "absence", "obj_type": "NegReg", "file_name": "PubMed-19338054.json", "snippet": " polymorphism. The other mutations are associated with varying degrees of loss of function (LOF), from moderate decreases in coupling to the cAMP pathway (p.Val38Met and p.Val51Ala) to nearly complete  [CLS] absence of functional coupling (p.Ser41Phe, p.Met128Thr [CLS] , and p.Cys289Arg). The LOF p.Met128Thr and p.Cys289Arg mutants are trafficked to the cell surface, but are unable to bind agonists efficiently. Conversely, LOF of p.Val38Met, p.Ser41Phe, and p.Val51Ala is"}
{"subject": "p.Cys289Arg", "sub_type": "Var", "rel": "CauseOf", "object": "absence", "obj_type": "NegReg", "file_name": "PubMed-19338054.json", "snippet": " polymorphism. The other mutations are associated with varying degrees of loss of function (LOF), from moderate decreases in coupling to the cAMP pathway (p.Val38Met and p.Val51Ala) to nearly complete  [CLS] absence of functional coupling (p.Ser41Phe, p.Met128Thr, and p.Cys289Arg [CLS] ). The LOF p.Met128Thr and p.Cys289Arg mutants are trafficked to the cell surface, but are unable to bind agonists efficiently. Conversely, LOF of p.Val38Met, p.Ser41Phe, and p.Val51Ala is due to"}
{"subject": "p.Cys289Arg", "sub_type": "Var", "rel": "CauseOf", "object": "unable", "obj_type": "NegReg", "file_name": "PubMed-19338054.json", "snippet": " function (LOF), from moderate decreases in coupling to the cAMP pathway (p.Val38Met and p.Val51Ala) to nearly complete absence of functional coupling (p.Ser41Phe, p.Met128Thr, and p.Cys289Arg). The LOF p.Met128Thr and  [CLS] p.Cys289Arg mutants are trafficked to the cell surface, but are unable [CLS]  to bind agonists efficiently. Conversely, LOF of p.Val38Met, p.Ser41Phe, and p.Val51Ala is due to reduced cell surface expression as a consequence of retention in the endoplasmic reticulum (ER). Therefore,"}
{"subject": "p.Met128Thr", "sub_type": "Var", "rel": "CauseOf", "object": "unable", "obj_type": "NegReg", "file_name": "PubMed-19338054.json", "snippet": " loss of function (LOF), from moderate decreases in coupling to the cAMP pathway (p.Val38Met and p.Val51Ala) to nearly complete absence of functional coupling (p.Ser41Phe, p.Met128Thr, and p.Cys289Arg). The LOF  [CLS] p.Met128Thr and p.Cys289Arg mutants are trafficked to the cell surface, but are unable [CLS]  to bind agonists efficiently. Conversely, LOF of p.Val38Met, p.Ser41Phe, and p.Val51Ala is due to reduced cell surface expression as a consequence of retention in the endoplasmic reticulum (ER). Therefore,"}
{"subject": "bind", "sub_type": "Interaction", "rel": "ThemeOf", "object": "unable", "obj_type": "NegReg", "file_name": "PubMed-19338054.json", "snippet": " pathway (p.Val38Met and p.Val51Ala) to nearly complete absence of functional coupling (p.Ser41Phe, p.Met128Thr, and p.Cys289Arg). The LOF p.Met128Thr and p.Cys289Arg mutants are trafficked to the cell surface, but are  [CLS] unable to bind [CLS]  agonists efficiently. Conversely, LOF of p.Val38Met, p.Ser41Phe, and p.Val51Ala is due to reduced cell surface expression as a consequence of retention in the endoplasmic reticulum (ER). Therefore, LOF of"}
{"subject": "p.Ser41Phe,", "sub_type": "Var", "rel": "CauseOf", "object": "reduced", "obj_type": "NegReg", "file_name": "PubMed-19338054.json", "snippet": " functional coupling (p.Ser41Phe, p.Met128Thr, and p.Cys289Arg). The LOF p.Met128Thr and p.Cys289Arg mutants are trafficked to the cell surface, but are unable to bind agonists efficiently. Conversely, LOF of p.Val38Met,  [CLS] p.Ser41Phe, and p.Val51Ala is due to reduced [CLS]  cell surface expression as a consequence of retention in the endoplasmic reticulum (ER). Therefore, LOF of MC1R alleles is frequently associated with aberrant forward trafficking and accumulation within the"}
{"subject": "p.Val51Ala", "sub_type": "Var", "rel": "CauseOf", "object": "reduced", "obj_type": "NegReg", "file_name": "PubMed-19338054.json", "snippet": " (p.Ser41Phe, p.Met128Thr, and p.Cys289Arg). The LOF p.Met128Thr and p.Cys289Arg mutants are trafficked to the cell surface, but are unable to bind agonists efficiently. Conversely, LOF of p.Val38Met, p.Ser41Phe, and  [CLS] p.Val51Ala is due to reduced [CLS]  cell surface expression as a consequence of retention in the endoplasmic reticulum (ER). Therefore, LOF of MC1R alleles is frequently associated with aberrant forward trafficking and accumulation within the"}
{"subject": "p.Asn281Ser", "sub_type": "Var", "rel": "CauseOf", "object": "silent", "obj_type": "NegReg", "file_name": "PubMed-19338054.json", "snippet": " Two variants (c.152T>C, p.Val51Ala and c.865T>C, p.Cys289Arg) have never been described, and the others (c.112G>A, p.Val38Met; c.122C>T, p.Ser41Phe; c.383T>C, p.Met128Thr; and c.842A>G, p.Asn281Ser) have not been analyzed for function.  [CLS] p.Asn281Ser corresponds to a functionally silent [CLS]  polymorphism. The other mutations are associated with varying degrees of loss of function (LOF), from moderate decreases in coupling to the cAMP pathway (p.Val38Met and p.Val51Ala) to nearly complete"}
{"subject": "p53-R175H expression vector", "sub_type": "Protein", "rel": "ThemeOf", "object": "inducing", "obj_type": "Reg", "file_name": "PubMed-19917135.json", "snippet": " expression of p53 GOF mutation (p53-R175H) and invasive potential of human endometrial cancer KLE cells, we tested the consequences of up-regulation and down-regulation of p53-R175H in KLE cells by  [CLS] inducing p53-R175H expression vector [CLS]  or suppressing the p53 gene with short hairpin RNA.\nRESULTS: We found that forced over-expression of p53-R175H significantly promoted cell migration and invasion, and induced activation of the epidermal"}
{"subject": "p53-R175H expression vector", "sub_type": "Protein", "rel": "CauseOf", "object": "tested", "obj_type": "Reg", "file_name": "PubMed-19917135.json", "snippet": " endometrial cancer progression through the GOF properties.\nMETHODS: To clarify the relationship between expression of p53 GOF mutation (p53-R175H) and invasive potential of human endometrial cancer KLE cells, we  [CLS] tested the consequences of up-regulation and down-regulation of p53-R175H in KLE cells by inducing p53-R175H expression vector [CLS]  or suppressing the p53 gene with short hairpin RNA.\nRESULTS: We found that forced over-expression of p53-R175H significantly promoted cell migration and invasion, and induced activation of the epidermal"}
{"subject": "up-regulation", "sub_type": "PosReg", "rel": "ThemeOf", "object": "tested", "obj_type": "Reg", "file_name": "PubMed-19917135.json", "snippet": " endometrial cancer progression through the GOF properties.\nMETHODS: To clarify the relationship between expression of p53 GOF mutation (p53-R175H) and invasive potential of human endometrial cancer KLE cells, we  [CLS] tested the consequences of up-regulation [CLS]  and down-regulation of p53-R175H in KLE cells by inducing p53-R175H expression vector or suppressing the p53 gene with short hairpin RNA.\nRESULTS: We found that forced over-expression of p53-R175H"}
{"subject": "down-regulation", "sub_type": "NegReg", "rel": "ThemeOf", "object": "tested", "obj_type": "Reg", "file_name": "PubMed-19917135.json", "snippet": " endometrial cancer progression through the GOF properties.\nMETHODS: To clarify the relationship between expression of p53 GOF mutation (p53-R175H) and invasive potential of human endometrial cancer KLE cells, we  [CLS] tested the consequences of up-regulation and down-regulation [CLS]  of p53-R175H in KLE cells by inducing p53-R175H expression vector or suppressing the p53 gene with short hairpin RNA.\nRESULTS: We found that forced over-expression of p53-R175H significantly promoted"}
{"subject": "p53 gene", "sub_type": "Gene", "rel": "ThemeOf", "object": "suppressing", "obj_type": "NegReg", "file_name": "PubMed-19917135.json", "snippet": " (p53-R175H) and invasive potential of human endometrial cancer KLE cells, we tested the consequences of up-regulation and down-regulation of p53-R175H in KLE cells by inducing p53-R175H expression vector or  [CLS] suppressing the p53 gene [CLS]  with short hairpin RNA.\nRESULTS: We found that forced over-expression of p53-R175H significantly promoted cell migration and invasion, and induced activation of the epidermal growth factor receptor (EGFR)/phosphatidylinositol 3-kinase"}
{"subject": "p53 gene", "sub_type": "Gene", "rel": "CauseOf", "object": "tested", "obj_type": "Reg", "file_name": "PubMed-19917135.json", "snippet": " endometrial cancer progression through the GOF properties.\nMETHODS: To clarify the relationship between expression of p53 GOF mutation (p53-R175H) and invasive potential of human endometrial cancer KLE cells, we  [CLS] tested the consequences of up-regulation and down-regulation of p53-R175H in KLE cells by inducing p53-R175H expression vector or suppressing the p53 gene [CLS]  with short hairpin RNA.\nRESULTS: We found that forced over-expression of p53-R175H significantly promoted cell migration and invasion, and induced activation of the epidermal growth factor receptor (EGFR)/phosphatidylinositol 3-kinase"}
{"subject": "epidermal growth factor receptor (EGFR)/phosphatidylinositol 3-kinase (PI3K)/AKT pathway", "sub_type": "Pathway", "rel": "ThemeOf", "object": "activation", "obj_type": "PosReg", "file_name": "PubMed-19917135.json", "snippet": " inducing p53-R175H expression vector or suppressing the p53 gene with short hairpin RNA.\nRESULTS: We found that forced over-expression of p53-R175H significantly promoted cell migration and invasion, and induced  [CLS] activation of the epidermal growth factor receptor (EGFR)/phosphatidylinositol 3-kinase (PI3K)/AKT pathway [CLS] . Conversely, suppression of p53-R175H with short hairpin RNA significantly inhibited cell migration and invasion, and resulted in attenuation of EGFR/PI3K/AKT pathway.\nCONCLUSION: These findings show for the first time"}
{"subject": "short hairpin RNA", "sub_type": "Gene", "rel": "CauseOf", "object": "suppression", "obj_type": "NegReg", "file_name": "PubMed-19917135.json", "snippet": " RNA.\nRESULTS: We found that forced over-expression of p53-R175H significantly promoted cell migration and invasion, and induced activation of the epidermal growth factor receptor (EGFR)/phosphatidylinositol 3-kinase (PI3K)/AKT pathway. Conversely,  [CLS] suppression of p53-R175H with short hairpin RNA [CLS]  significantly inhibited cell migration and invasion, and resulted in attenuation of EGFR/PI3K/AKT pathway.\nCONCLUSION: These findings show for the first time that elevated expression of p53-R175H mutant may exert"}
{"subject": "p53-R175H", "sub_type": "Protein", "rel": "ThemeOf", "object": "suppression", "obj_type": "NegReg", "file_name": "PubMed-19917135.json", "snippet": " RNA.\nRESULTS: We found that forced over-expression of p53-R175H significantly promoted cell migration and invasion, and induced activation of the epidermal growth factor receptor (EGFR)/phosphatidylinositol 3-kinase (PI3K)/AKT pathway. Conversely,  [CLS] suppression of p53-R175H [CLS]  with short hairpin RNA significantly inhibited cell migration and invasion, and resulted in attenuation of EGFR/PI3K/AKT pathway.\nCONCLUSION: These findings show for the first time that elevated expression of"}
{"subject": "p53-R175H", "sub_type": "Protein", "rel": "CauseOf", "object": "inhibited", "obj_type": "NegReg", "file_name": "PubMed-19917135.json", "snippet": " We found that forced over-expression of p53-R175H significantly promoted cell migration and invasion, and induced activation of the epidermal growth factor receptor (EGFR)/phosphatidylinositol 3-kinase (PI3K)/AKT pathway. Conversely, suppression of  [CLS] p53-R175H with short hairpin RNA significantly inhibited [CLS]  cell migration and invasion, and resulted in attenuation of EGFR/PI3K/AKT pathway.\nCONCLUSION: These findings show for the first time that elevated expression of p53-R175H mutant may exert gain-of-function activity"}
{"subject": "cell migration and invasion", "sub_type": "CPA", "rel": "ThemeOf", "object": "inhibited", "obj_type": "NegReg", "file_name": "PubMed-19917135.json", "snippet": " p53-R175H significantly promoted cell migration and invasion, and induced activation of the epidermal growth factor receptor (EGFR)/phosphatidylinositol 3-kinase (PI3K)/AKT pathway. Conversely, suppression of p53-R175H with short hairpin RNA significantly  [CLS] inhibited cell migration and invasion [CLS] , and resulted in attenuation of EGFR/PI3K/AKT pathway.\nCONCLUSION: These findings show for the first time that elevated expression of p53-R175H mutant may exert gain-of-function activity to activate the EGFR/PI3K/AKT"}
{"subject": "p53-R175H", "sub_type": "Protein", "rel": "CauseOf", "object": "attenuation", "obj_type": "NegReg", "file_name": "PubMed-19917135.json", "snippet": " We found that forced over-expression of p53-R175H significantly promoted cell migration and invasion, and induced activation of the epidermal growth factor receptor (EGFR)/phosphatidylinositol 3-kinase (PI3K)/AKT pathway. Conversely, suppression of  [CLS] p53-R175H with short hairpin RNA significantly inhibited cell migration and invasion, and resulted in attenuation [CLS]  of EGFR/PI3K/AKT pathway.\nCONCLUSION: These findings show for the first time that elevated expression of p53-R175H mutant may exert gain-of-function activity to activate the EGFR/PI3K/AKT pathway and thus may"}
{"subject": "EGFR/PI3K/AKT pathway.", "sub_type": "Pathway", "rel": "ThemeOf", "object": "attenuation", "obj_type": "NegReg", "file_name": "PubMed-19917135.json", "snippet": " induced activation of the epidermal growth factor receptor (EGFR)/phosphatidylinositol 3-kinase (PI3K)/AKT pathway. Conversely, suppression of p53-R175H with short hairpin RNA significantly inhibited cell migration and invasion, and resulted in  [CLS] attenuation of EGFR/PI3K/AKT pathway. [CLS] \nCONCLUSION: These findings show for the first time that elevated expression of p53-R175H mutant may exert gain-of-function activity to activate the EGFR/PI3K/AKT pathway and thus may contribute to the"}
{"subject": "expression", "sub_type": "MPA", "rel": "ThemeOf", "object": "elevated", "obj_type": "PosReg", "file_name": "PubMed-19917135.json", "snippet": " suppression of p53-R175H with short hairpin RNA significantly inhibited cell migration and invasion, and resulted in attenuation of EGFR/PI3K/AKT pathway.\nCONCLUSION: These findings show for the first time that  [CLS] elevated expression [CLS]  of p53-R175H mutant may exert gain-of-function activity to activate the EGFR/PI3K/AKT pathway and thus may contribute to the invasive phenotype in endometrial cancer."}
{"subject": "function activity", "sub_type": "MPA", "rel": "ThemeOf", "object": "gain", "obj_type": "PosReg", "file_name": "PubMed-19917135.json", "snippet": " significantly inhibited cell migration and invasion, and resulted in attenuation of EGFR/PI3K/AKT pathway.\nCONCLUSION: These findings show for the first time that elevated expression of p53-R175H mutant may exert  [CLS] gain-of-function activity [CLS]  to activate the EGFR/PI3K/AKT pathway and thus may contribute to the invasive phenotype in endometrial cancer."}
{"subject": "EGFR/PI3K/AKT pathway", "sub_type": "Pathway", "rel": "ThemeOf", "object": "activate", "obj_type": "PosReg", "file_name": "PubMed-19917135.json", "snippet": " migration and invasion, and resulted in attenuation of EGFR/PI3K/AKT pathway.\nCONCLUSION: These findings show for the first time that elevated expression of p53-R175H mutant may exert gain-of-function activity to  [CLS] activate the EGFR/PI3K/AKT pathway [CLS]  and thus may contribute to the invasive phenotype in endometrial cancer."}
{"subject": "endometrial cancer", "sub_type": "Disease", "rel": "ThemeOf", "object": "contribute", "obj_type": "Reg", "file_name": "PubMed-19917135.json", "snippet": " of EGFR/PI3K/AKT pathway.\nCONCLUSION: These findings show for the first time that elevated expression of p53-R175H mutant may exert gain-of-function activity to activate the EGFR/PI3K/AKT pathway and thus may  [CLS] contribute to the invasive phenotype in endometrial cancer [CLS] ."}
{"subject": "p53", "sub_type": "Gene", "rel": "ThemeOf", "object": "R175H", "obj_type": "Var", "file_name": "PubMed-19917135.json", "snippet": " with short hairpin RNA significantly inhibited cell migration and invasion, and resulted in attenuation of EGFR/PI3K/AKT pathway.\nCONCLUSION: These findings show for the first time that elevated expression of  [CLS] p53-R175H [CLS]  mutant may exert gain-of-function activity to activate the EGFR/PI3K/AKT pathway and thus may contribute to the invasive phenotype in endometrial cancer."}
{"subject": "R175H", "sub_type": "Var", "rel": "CauseOf", "object": "elevated", "obj_type": "PosReg", "file_name": "PubMed-19917135.json", "snippet": " suppression of p53-R175H with short hairpin RNA significantly inhibited cell migration and invasion, and resulted in attenuation of EGFR/PI3K/AKT pathway.\nCONCLUSION: These findings show for the first time that  [CLS] elevated expression of p53-R175H [CLS]  mutant may exert gain-of-function activity to activate the EGFR/PI3K/AKT pathway and thus may contribute to the invasive phenotype in endometrial cancer."}
{"subject": "p53", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutation", "obj_type": "Var", "file_name": "PubMed-19917135.json", "snippet": " of dominant-negative effects over the remaining wild-type protein, several p53 mutants can gain novel oncogenic functions (gain-of-function, GOF) that actively regulate cancer development and progression. In human endometrial cancer,  [CLS] p53 mutation [CLS]  is more often associated with aggressive nonendometrioid cancer. However, it was unknown if p53 mutants contributed to endometrial cancer progression through the GOF properties.\nMETHODS: To clarify the relationship"}
{"subject": "mutation", "sub_type": "Var", "rel": "CauseOf", "object": "associated", "obj_type": "Reg", "file_name": "PubMed-19917135.json", "snippet": " dominant-negative effects over the remaining wild-type protein, several p53 mutants can gain novel oncogenic functions (gain-of-function, GOF) that actively regulate cancer development and progression. In human endometrial cancer, p53  [CLS] mutation is more often associated [CLS]  with aggressive nonendometrioid cancer. However, it was unknown if p53 mutants contributed to endometrial cancer progression through the GOF properties.\nMETHODS: To clarify the relationship between expression of p53"}
{"subject": "aggressive nonendometrioid cancer", "sub_type": "Disease", "rel": "ThemeOf", "object": "associated", "obj_type": "Reg", "file_name": "PubMed-19917135.json", "snippet": " remaining wild-type protein, several p53 mutants can gain novel oncogenic functions (gain-of-function, GOF) that actively regulate cancer development and progression. In human endometrial cancer, p53 mutation is more often  [CLS] associated with aggressive nonendometrioid cancer [CLS] . However, it was unknown if p53 mutants contributed to endometrial cancer progression through the GOF properties.\nMETHODS: To clarify the relationship between expression of p53 GOF mutation (p53-R175H) and"}
{"subject": "R175H", "sub_type": "Var", "rel": "CauseOf", "object": "gain", "obj_type": "PosReg", "file_name": "PubMed-19917135.json", "snippet": " with short hairpin RNA significantly inhibited cell migration and invasion, and resulted in attenuation of EGFR/PI3K/AKT pathway.\nCONCLUSION: These findings show for the first time that elevated expression of p53- [CLS] R175H mutant may exert gain [CLS] -of-function activity to activate the EGFR/PI3K/AKT pathway and thus may contribute to the invasive phenotype in endometrial cancer."}
{"subject": "gain", "sub_type": "PosReg", "rel": "CauseOf", "object": "activate", "obj_type": "PosReg", "file_name": "PubMed-19917135.json", "snippet": " significantly inhibited cell migration and invasion, and resulted in attenuation of EGFR/PI3K/AKT pathway.\nCONCLUSION: These findings show for the first time that elevated expression of p53-R175H mutant may exert  [CLS] gain-of-function activity to activate [CLS]  the EGFR/PI3K/AKT pathway and thus may contribute to the invasive phenotype in endometrial cancer."}
{"subject": "activate", "sub_type": "PosReg", "rel": "CauseOf", "object": "contribute", "obj_type": "Reg", "file_name": "PubMed-19917135.json", "snippet": " migration and invasion, and resulted in attenuation of EGFR/PI3K/AKT pathway.\nCONCLUSION: These findings show for the first time that elevated expression of p53-R175H mutant may exert gain-of-function activity to  [CLS] activate the EGFR/PI3K/AKT pathway and thus may contribute [CLS]  to the invasive phenotype in endometrial cancer."}
{"subject": "R175H", "sub_type": "Var", "rel": "CauseOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-19917135.json", "snippet": " [CLS] gain-of-function mutation R175H [CLS]  in endometrial cancer cells can increase the invasive phenotypes by activation of the EGFR/PI3K/AKT pathway.\nBACKGROUND: p53 is the most commonly mutated tumor suppressor gene in human cancers. In"}
{"subject": "p53", "sub_type": "Gene", "rel": "ThemeOf", "object": "R175H", "obj_type": "Var", "file_name": "PubMed-19917135.json", "snippet": " [CLS] p53 gain-of-function mutation R175H [CLS]  in endometrial cancer cells can increase the invasive phenotypes by activation of the EGFR/PI3K/AKT pathway.\nBACKGROUND: p53 is the most commonly mutated tumor suppressor gene in human cancers. In"}
{"subject": "EGFR/PI3K/AKT pathway", "sub_type": "Pathway", "rel": "ThemeOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-19917135.json", "snippet": " [CLS] gain-of-function mutation R175H in endometrial cancer cells can increase the invasive phenotypes by activation of the EGFR/PI3K/AKT pathway [CLS] .\nBACKGROUND: p53 is the most commonly mutated tumor suppressor gene in human cancers. In addition to the loss of tumor suppression function and exertion of dominant-negative effects over the"}
{"subject": "p53", "sub_type": "Gene", "rel": "ThemeOf", "object": "R175H", "obj_type": "Var", "file_name": "PubMed-19917135.json", "snippet": " up-regulation and down-regulation of p53-R175H in KLE cells by inducing p53-R175H expression vector or suppressing the p53 gene with short hairpin RNA.\nRESULTS: We found that forced over-expression of  [CLS] p53-R175H [CLS]  significantly promoted cell migration and invasion, and induced activation of the epidermal growth factor receptor (EGFR)/phosphatidylinositol 3-kinase (PI3K)/AKT pathway. Conversely, suppression of p53-R175H with short hairpin RNA significantly inhibited"}
{"subject": "R175H", "sub_type": "Var", "rel": "CauseOf", "object": "over-expression", "obj_type": "PosReg", "file_name": "PubMed-19917135.json", "snippet": " consequences of up-regulation and down-regulation of p53-R175H in KLE cells by inducing p53-R175H expression vector or suppressing the p53 gene with short hairpin RNA.\nRESULTS: We found that forced  [CLS] over-expression of p53-R175H [CLS]  significantly promoted cell migration and invasion, and induced activation of the epidermal growth factor receptor (EGFR)/phosphatidylinositol 3-kinase (PI3K)/AKT pathway. Conversely, suppression of p53-R175H with short hairpin RNA significantly inhibited"}
{"subject": "R175H", "sub_type": "Var", "rel": "CauseOf", "object": "promoted", "obj_type": "PosReg", "file_name": "PubMed-19917135.json", "snippet": " up-regulation and down-regulation of p53-R175H in KLE cells by inducing p53-R175H expression vector or suppressing the p53 gene with short hairpin RNA.\nRESULTS: We found that forced over-expression of p53- [CLS] R175H significantly promoted [CLS]  cell migration and invasion, and induced activation of the epidermal growth factor receptor (EGFR)/phosphatidylinositol 3-kinase (PI3K)/AKT pathway. Conversely, suppression of p53-R175H with short hairpin RNA significantly inhibited cell migration"}
{"subject": "cell migration", "sub_type": "CPA", "rel": "ThemeOf", "object": "promoted", "obj_type": "PosReg", "file_name": "PubMed-19917135.json", "snippet": " down-regulation of p53-R175H in KLE cells by inducing p53-R175H expression vector or suppressing the p53 gene with short hairpin RNA.\nRESULTS: We found that forced over-expression of p53-R175H significantly  [CLS] promoted cell migration [CLS]  and invasion, and induced activation of the epidermal growth factor receptor (EGFR)/phosphatidylinositol 3-kinase (PI3K)/AKT pathway. Conversely, suppression of p53-R175H with short hairpin RNA significantly inhibited cell migration and invasion,"}
{"subject": "invasion", "sub_type": "CPA", "rel": "ThemeOf", "object": "promoted", "obj_type": "PosReg", "file_name": "PubMed-19917135.json", "snippet": " down-regulation of p53-R175H in KLE cells by inducing p53-R175H expression vector or suppressing the p53 gene with short hairpin RNA.\nRESULTS: We found that forced over-expression of p53-R175H significantly  [CLS] promoted cell migration and invasion [CLS] , and induced activation of the epidermal growth factor receptor (EGFR)/phosphatidylinositol 3-kinase (PI3K)/AKT pathway. Conversely, suppression of p53-R175H with short hairpin RNA significantly inhibited cell migration and invasion, and resulted"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-20399956.json", "snippet": " Shp2 mutations are also associated with several types of human malignancies, such as the most common juvenile leukemia, juvenile myelomonocytic leukemia (JMML). Whereas NS and JMML are caused by  [CLS] gain-of-function (GOF) mutations [CLS]  of Shp2, loss-of-function (LOF) mutations are thought to be associated with LEOPARD syndrome. Animal models that carry conditional LOF and GOF mutations have allowed a better understanding of the"}
{"subject": "Shp2", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-20399956.json", "snippet": " are also associated with several types of human malignancies, such as the most common juvenile leukemia, juvenile myelomonocytic leukemia (JMML). Whereas NS and JMML are caused by gain-of-function (GOF)  [CLS] mutations of Shp2 [CLS] , loss-of-function (LOF) mutations are thought to be associated with LEOPARD syndrome. Animal models that carry conditional LOF and GOF mutations have allowed a better understanding of the mechanism of"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-20399956.json", "snippet": " with several types of human malignancies, such as the most common juvenile leukemia, juvenile myelomonocytic leukemia (JMML). Whereas NS and JMML are caused by gain-of-function (GOF) mutations of Shp2,  [CLS] loss-of-function (LOF) mutations [CLS]  are thought to be associated with LEOPARD syndrome. Animal models that carry conditional LOF and GOF mutations have allowed a better understanding of the mechanism of Shp2 function in"}
{"subject": "Shp2", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-20399956.json", "snippet": " gene, encoding Shp2, were linked to Noonan (NS) and LEOPARD syndromes, two multisymptomatic developmental disorders that are characterized by short stature, craniofacial defects, cardiac defects, and mental retardation. Somatic  [CLS] Shp2 mutations [CLS]  are also associated with several types of human malignancies, such as the most common juvenile leukemia, juvenile myelomonocytic leukemia (JMML). Whereas NS and JMML are caused by gain-of-function (GOF)"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "associated", "obj_type": "Reg", "file_name": "PubMed-20399956.json", "snippet": " encoding Shp2, were linked to Noonan (NS) and LEOPARD syndromes, two multisymptomatic developmental disorders that are characterized by short stature, craniofacial defects, cardiac defects, and mental retardation. Somatic Shp2  [CLS] mutations are also associated [CLS]  with several types of human malignancies, such as the most common juvenile leukemia, juvenile myelomonocytic leukemia (JMML). Whereas NS and JMML are caused by gain-of-function (GOF) mutations of Shp2,"}
{"subject": "juvenile myelomonocytic leukemia", "sub_type": "Disease", "rel": "ThemeOf", "object": "associated", "obj_type": "Reg", "file_name": "PubMed-20399956.json", "snippet": " linked to Noonan (NS) and LEOPARD syndromes, two multisymptomatic developmental disorders that are characterized by short stature, craniofacial defects, cardiac defects, and mental retardation. Somatic Shp2 mutations are also  [CLS] associated with several types of human malignancies, such as the most common juvenile leukemia, juvenile myelomonocytic leukemia [CLS]  (JMML). Whereas NS and JMML are caused by gain-of-function (GOF) mutations of Shp2, loss-of-function (LOF) mutations are thought to be associated with LEOPARD syndrome. Animal models that carry conditional"}
{"subject": "NS", "sub_type": "Disease", "rel": "ThemeOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-20399956.json", "snippet": " cardiac defects, and mental retardation. Somatic Shp2 mutations are also associated with several types of human malignancies, such as the most common juvenile leukemia, juvenile myelomonocytic leukemia (JMML). Whereas  [CLS] NS and JMML are caused by gain-of-function [CLS]  (GOF) mutations of Shp2, loss-of-function (LOF) mutations are thought to be associated with LEOPARD syndrome. Animal models that carry conditional LOF and GOF mutations have allowed a better understanding"}
{"subject": "JMML", "sub_type": "Disease", "rel": "ThemeOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-20399956.json", "snippet": " and mental retardation. Somatic Shp2 mutations are also associated with several types of human malignancies, such as the most common juvenile leukemia, juvenile myelomonocytic leukemia (JMML). Whereas NS and  [CLS] JMML are caused by gain-of-function [CLS]  (GOF) mutations of Shp2, loss-of-function (LOF) mutations are thought to be associated with LEOPARD syndrome. Animal models that carry conditional LOF and GOF mutations have allowed a better understanding"}
{"subject": "LEOPARD syndrome", "sub_type": "Disease", "rel": "ThemeOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-20399956.json", "snippet": " with several types of human malignancies, such as the most common juvenile leukemia, juvenile myelomonocytic leukemia (JMML). Whereas NS and JMML are caused by gain-of-function (GOF) mutations of Shp2,  [CLS] loss-of-function (LOF) mutations are thought to be associated with LEOPARD syndrome [CLS] . Animal models that carry conditional LOF and GOF mutations have allowed a better understanding of the mechanism of Shp2 function in disease, and shed light on the role of"}
{"subject": "Shp2", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-20399956.json", "snippet": " associated with several types of human malignancies, such as the most common juvenile leukemia, juvenile myelomonocytic leukemia (JMML). Whereas NS and JMML are caused by gain-of-function (GOF) mutations of  [CLS] Shp2, loss-of-function (LOF) mutations [CLS]  are thought to be associated with LEOPARD syndrome. Animal models that carry conditional LOF and GOF mutations have allowed a better understanding of the mechanism of Shp2 function in"}
{"subject": "p53", "sub_type": "Gene", "rel": "ThemeOf", "object": "Mutant", "obj_type": "Var", "file_name": "PubMed-20696700.json", "snippet": " [CLS] Mutant p53 [CLS]  facilitates somatic cell reprogramming and augments the malignant potential of reprogrammed cells.\np53 deficiency enhances the efficiency of somatic cell reprogramming to a pluripotent state. As p53 is usually"}
{"subject": "activities", "sub_type": "MPA", "rel": "ThemeOf", "object": "gain", "obj_type": "PosReg", "file_name": "PubMed-20696700.json", "snippet": " reprogrammed cells.\np53 deficiency enhances the efficiency of somatic cell reprogramming to a pluripotent state. As p53 is usually mutated in human tumors and many mutated forms of p53  [CLS] gain novel activities [CLS] , we studied the influence of mutant p53 (mut-p53) on somatic cell reprogramming. Our data indicate a novel gain of function (GOF) property for mut-p53, which markedly enhanced the efficiency"}
{"subject": "p53", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutated", "obj_type": "Var", "file_name": "PubMed-20696700.json", "snippet": " the malignant potential of reprogrammed cells.\np53 deficiency enhances the efficiency of somatic cell reprogramming to a pluripotent state. As p53 is usually mutated in human tumors and many  [CLS] mutated forms of p53 [CLS]  gain novel activities, we studied the influence of mutant p53 (mut-p53) on somatic cell reprogramming. Our data indicate a novel gain of function (GOF) property for mut-p53, which markedly"}
{"subject": "mut-p53", "sub_type": "Var", "rel": "CauseOf", "object": "gain", "obj_type": "PosReg", "file_name": "PubMed-20696700.json", "snippet": " in human tumors and many mutated forms of p53 gain novel activities, we studied the influence of mutant p53 (mut-p53) on somatic cell reprogramming. Our data indicate a novel  [CLS] gain of function (GOF) property for mut-p53 [CLS] , which markedly enhanced the efficiency of the reprogramming process compared with p53 deficiency. Importantly, this novel activity of mut-p53 induced alterations in the characteristics of the reprogrammed cells. Although"}
{"subject": "function", "sub_type": "MPA", "rel": "ThemeOf", "object": "gain", "obj_type": "PosReg", "file_name": "PubMed-20696700.json", "snippet": " in human tumors and many mutated forms of p53 gain novel activities, we studied the influence of mutant p53 (mut-p53) on somatic cell reprogramming. Our data indicate a novel  [CLS] gain of function [CLS]  (GOF) property for mut-p53, which markedly enhanced the efficiency of the reprogramming process compared with p53 deficiency. Importantly, this novel activity of mut-p53 induced alterations in the characteristics of"}
{"subject": "mut-p53", "sub_type": "Var", "rel": "CauseOf", "object": "enhanced", "obj_type": "PosReg", "file_name": "PubMed-20696700.json", "snippet": " forms of p53 gain novel activities, we studied the influence of mutant p53 (mut-p53) on somatic cell reprogramming. Our data indicate a novel gain of function (GOF) property for  [CLS] mut-p53, which markedly enhanced [CLS]  the efficiency of the reprogramming process compared with p53 deficiency. Importantly, this novel activity of mut-p53 induced alterations in the characteristics of the reprogrammed cells. Although p53 knockout (KO)"}
{"subject": "reprogramming process", "sub_type": "CPA", "rel": "ThemeOf", "object": "enhanced", "obj_type": "PosReg", "file_name": "PubMed-20696700.json", "snippet": " gain novel activities, we studied the influence of mutant p53 (mut-p53) on somatic cell reprogramming. Our data indicate a novel gain of function (GOF) property for mut-p53, which markedly  [CLS] enhanced the efficiency of the reprogramming process [CLS]  compared with p53 deficiency. Importantly, this novel activity of mut-p53 induced alterations in the characteristics of the reprogrammed cells. Although p53 knockout (KO) cells reprogrammed with only Oct4 and"}
{"subject": "activity", "sub_type": "MPA", "rel": "ThemeOf", "object": "mut", "obj_type": "Var", "file_name": "PubMed-20696700.json", "snippet": " reprogramming. Our data indicate a novel gain of function (GOF) property for mut-p53, which markedly enhanced the efficiency of the reprogramming process compared with p53 deficiency. Importantly, this novel  [CLS] activity of mut [CLS] -p53 induced alterations in the characteristics of the reprogrammed cells. Although p53 knockout (KO) cells reprogrammed with only Oct4 and Sox2 maintained their pluripotent capacity in vivo, reprogrammed cells expressing"}
{"subject": "mut", "sub_type": "Var", "rel": "CauseOf", "object": "alterations", "obj_type": "Reg", "file_name": "PubMed-20696700.json", "snippet": " data indicate a novel gain of function (GOF) property for mut-p53, which markedly enhanced the efficiency of the reprogramming process compared with p53 deficiency. Importantly, this novel activity of  [CLS] mut-p53 induced alterations [CLS]  in the characteristics of the reprogrammed cells. Although p53 knockout (KO) cells reprogrammed with only Oct4 and Sox2 maintained their pluripotent capacity in vivo, reprogrammed cells expressing mutant p53"}
{"subject": "characteristics of the reprogrammed cells", "sub_type": "CPA", "rel": "ThemeOf", "object": "alterations", "obj_type": "Reg", "file_name": "PubMed-20696700.json", "snippet": " a novel gain of function (GOF) property for mut-p53, which markedly enhanced the efficiency of the reprogramming process compared with p53 deficiency. Importantly, this novel activity of mut-p53 induced  [CLS] alterations in the characteristics of the reprogrammed cells [CLS] . Although p53 knockout (KO) cells reprogrammed with only Oct4 and Sox2 maintained their pluripotent capacity in vivo, reprogrammed cells expressing mutant p53 lost this capability and gave rise to"}
{"subject": "mutant", "sub_type": "Var", "rel": "CauseOf", "object": "lost", "obj_type": "NegReg", "file_name": "PubMed-20696700.json", "snippet": " induced alterations in the characteristics of the reprogrammed cells. Although p53 knockout (KO) cells reprogrammed with only Oct4 and Sox2 maintained their pluripotent capacity in vivo, reprogrammed cells expressing  [CLS] mutant p53 lost [CLS]  this capability and gave rise to malignant tumors. This novel GOF of mut-p53 is not attributed to its effect on proliferation, as both p53 KO and mut-p53 cells displayed"}
{"subject": "Mutant", "sub_type": "Var", "rel": "CauseOf", "object": "facilitates", "obj_type": "PosReg", "file_name": "PubMed-20696700.json", "snippet": " [CLS] Mutant p53 facilitates [CLS]  somatic cell reprogramming and augments the malignant potential of reprogrammed cells.\np53 deficiency enhances the efficiency of somatic cell reprogramming to a pluripotent state. As p53 is usually mutated"}
{"subject": "pluripotent capacity", "sub_type": "MPA", "rel": "ThemeOf", "object": "lost", "obj_type": "NegReg", "file_name": "PubMed-20696700.json", "snippet": " deficiency. Importantly, this novel activity of mut-p53 induced alterations in the characteristics of the reprogrammed cells. Although p53 knockout (KO) cells reprogrammed with only Oct4 and Sox2 maintained their  [CLS] pluripotent capacity in vivo, reprogrammed cells expressing mutant p53 lost [CLS]  this capability and gave rise to malignant tumors. This novel GOF of mut-p53 is not attributed to its effect on proliferation, as both p53 KO and mut-p53 cells displayed"}
{"subject": "p53", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutant", "obj_type": "Var", "file_name": "PubMed-20696700.json", "snippet": " induced alterations in the characteristics of the reprogrammed cells. Although p53 knockout (KO) cells reprogrammed with only Oct4 and Sox2 maintained their pluripotent capacity in vivo, reprogrammed cells expressing  [CLS] mutant p53 [CLS]  lost this capability and gave rise to malignant tumors. This novel GOF of mut-p53 is not attributed to its effect on proliferation, as both p53 KO and mut-p53 cells"}
{"subject": "mutant", "sub_type": "Var", "rel": "CauseOf", "object": "gave rise", "obj_type": "Reg", "file_name": "PubMed-20696700.json", "snippet": " induced alterations in the characteristics of the reprogrammed cells. Although p53 knockout (KO) cells reprogrammed with only Oct4 and Sox2 maintained their pluripotent capacity in vivo, reprogrammed cells expressing  [CLS] mutant p53 lost this capability and gave rise [CLS]  to malignant tumors. This novel GOF of mut-p53 is not attributed to its effect on proliferation, as both p53 KO and mut-p53 cells displayed similar proliferation rates. In addition,"}
{"subject": "malignant tumors", "sub_type": "CPA", "rel": "ThemeOf", "object": "gave rise", "obj_type": "Reg", "file_name": "PubMed-20696700.json", "snippet": " the reprogrammed cells. Although p53 knockout (KO) cells reprogrammed with only Oct4 and Sox2 maintained their pluripotent capacity in vivo, reprogrammed cells expressing mutant p53 lost this capability and  [CLS] gave rise to malignant tumors [CLS] . This novel GOF of mut-p53 is not attributed to its effect on proliferation, as both p53 KO and mut-p53 cells displayed similar proliferation rates. In addition, we demonstrate an"}
{"subject": "overexpression", "sub_type": "PosReg", "rel": "ThemeOf", "object": "mut", "obj_type": "Var", "file_name": "PubMed-20696700.json", "snippet": " not attributed to its effect on proliferation, as both p53 KO and mut-p53 cells displayed similar proliferation rates. In addition, we demonstrate an oncogenic activity of Klf4, as its  [CLS] overexpression in either p53 KO or mut [CLS] -p53 cells induced aggressive tumors. Overall, our data show that reprogrammed cells with the capacity to differentiate into the three germ layers in vitro can form malignant tumors, suggesting that"}
{"subject": "mut", "sub_type": "Var", "rel": "CauseOf", "object": "induced", "obj_type": "PosReg", "file_name": "PubMed-20696700.json", "snippet": " proliferation, as both p53 KO and mut-p53 cells displayed similar proliferation rates. In addition, we demonstrate an oncogenic activity of Klf4, as its overexpression in either p53 KO or  [CLS] mut-p53 cells induced [CLS]  aggressive tumors. Overall, our data show that reprogrammed cells with the capacity to differentiate into the three germ layers in vitro can form malignant tumors, suggesting that in genetically"}
{"subject": "aggressive tumors", "sub_type": "CPA", "rel": "ThemeOf", "object": "induced", "obj_type": "PosReg", "file_name": "PubMed-20696700.json", "snippet": " both p53 KO and mut-p53 cells displayed similar proliferation rates. In addition, we demonstrate an oncogenic activity of Klf4, as its overexpression in either p53 KO or mut-p53 cells  [CLS] induced aggressive tumors [CLS] . Overall, our data show that reprogrammed cells with the capacity to differentiate into the three germ layers in vitro can form malignant tumors, suggesting that in genetically unstable cells,"}
{"subject": "oncogenic activity", "sub_type": "MPA", "rel": "ThemeOf", "object": "mut", "obj_type": "Var", "file_name": "PubMed-20696700.json", "snippet": " This novel GOF of mut-p53 is not attributed to its effect on proliferation, as both p53 KO and mut-p53 cells displayed similar proliferation rates. In addition, we demonstrate an  [CLS] oncogenic activity of Klf4, as its overexpression in either p53 KO or mut [CLS] -p53 cells induced aggressive tumors. Overall, our data show that reprogrammed cells with the capacity to differentiate into the three germ layers in vitro can form malignant tumors, suggesting that"}
{"subject": "p53", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutated", "obj_type": "Var", "file_name": "PubMed-20696700.json", "snippet": " reprogrammed cells with the capacity to differentiate into the three germ layers in vitro can form malignant tumors, suggesting that in genetically unstable cells, such as those in which  [CLS] p53 is mutated [CLS] , reprogramming may result in the generation of cells with malignant tumor-forming potential."}
{"subject": "mutated", "sub_type": "Var", "rel": "CauseOf", "object": "reprogramming", "obj_type": "CPA", "file_name": "PubMed-20696700.json", "snippet": " with the capacity to differentiate into the three germ layers in vitro can form malignant tumors, suggesting that in genetically unstable cells, such as those in which p53 is  [CLS] mutated, reprogramming [CLS]  may result in the generation of cells with malignant tumor-forming potential."}
{"subject": "somatic cell reprogramming", "sub_type": "CPA", "rel": "ThemeOf", "object": "facilitates", "obj_type": "PosReg", "file_name": "PubMed-20696700.json", "snippet": " [CLS] facilitates somatic cell reprogramming [CLS]  and augments the malignant potential of reprogrammed cells.\np53 deficiency enhances the efficiency of somatic cell reprogramming to a pluripotent state. As p53 is usually mutated in human tumors"}
{"subject": "reprogramming", "sub_type": "CPA", "rel": "CauseOf", "object": "result in", "obj_type": "Reg", "file_name": "PubMed-20696700.json", "snippet": " the capacity to differentiate into the three germ layers in vitro can form malignant tumors, suggesting that in genetically unstable cells, such as those in which p53 is mutated,  [CLS] reprogramming may result in [CLS]  the generation of cells with malignant tumor-forming potential."}
{"subject": "cells with malignant tumor-forming potential", "sub_type": "CPA", "rel": "ThemeOf", "object": "result in", "obj_type": "Reg", "file_name": "PubMed-20696700.json", "snippet": " to differentiate into the three germ layers in vitro can form malignant tumors, suggesting that in genetically unstable cells, such as those in which p53 is mutated, reprogramming may  [CLS] result in the generation of cells with malignant tumor-forming potential [CLS] ."}
{"subject": "p53", "sub_type": "Gene", "rel": "ThemeOf", "object": "mut", "obj_type": "Var", "file_name": "PubMed-20696700.json", "snippet": " data indicate a novel gain of function (GOF) property for mut-p53, which markedly enhanced the efficiency of the reprogramming process compared with p53 deficiency. Importantly, this novel activity of  [CLS] mut-p53 [CLS]  induced alterations in the characteristics of the reprogrammed cells. Although p53 knockout (KO) cells reprogrammed with only Oct4 and Sox2 maintained their pluripotent capacity in vivo, reprogrammed cells expressing"}
{"subject": "p53", "sub_type": "Gene", "rel": "ThemeOf", "object": "mut", "obj_type": "Var", "file_name": "PubMed-20696700.json", "snippet": " proliferation, as both p53 KO and mut-p53 cells displayed similar proliferation rates. In addition, we demonstrate an oncogenic activity of Klf4, as its overexpression in either p53 KO or  [CLS] mut-p53 [CLS]  cells induced aggressive tumors. Overall, our data show that reprogrammed cells with the capacity to differentiate into the three germ layers in vitro can form malignant tumors, suggesting that"}
{"subject": "Mutant", "sub_type": "Var", "rel": "CauseOf", "object": "augments", "obj_type": "NegReg", "file_name": "PubMed-20696700.json", "snippet": " [CLS] Mutant p53 facilitates somatic cell reprogramming and augments [CLS]  the malignant potential of reprogrammed cells.\np53 deficiency enhances the efficiency of somatic cell reprogramming to a pluripotent state. As p53 is usually mutated in human tumors and many"}
{"subject": "malignant potential of reprogrammed cells", "sub_type": "CPA", "rel": "ThemeOf", "object": "augments", "obj_type": "NegReg", "file_name": "PubMed-20696700.json", "snippet": " [CLS] augments the malignant potential of reprogrammed cells [CLS] .\np53 deficiency enhances the efficiency of somatic cell reprogramming to a pluripotent state. As p53 is usually mutated in human tumors and many mutated forms of p53 gain novel"}
{"subject": "p53", "sub_type": "Gene", "rel": "ThemeOf", "object": "deficiency", "obj_type": "Var", "file_name": "PubMed-20696700.json", "snippet": " [CLS] p53 deficiency [CLS]  enhances the efficiency of somatic cell reprogramming to a pluripotent state. As p53 is usually mutated in human tumors and many mutated forms of p53 gain novel activities, we"}
{"subject": "deficiency", "sub_type": "Var", "rel": "CauseOf", "object": "enhances", "obj_type": "PosReg", "file_name": "PubMed-20696700.json", "snippet": " [CLS] deficiency enhances [CLS]  the efficiency of somatic cell reprogramming to a pluripotent state. As p53 is usually mutated in human tumors and many mutated forms of p53 gain novel activities, we studied"}
{"subject": "somatic cell reprogramming", "sub_type": "CPA", "rel": "ThemeOf", "object": "enhances", "obj_type": "PosReg", "file_name": "PubMed-20696700.json", "snippet": " [CLS] enhances the efficiency of somatic cell reprogramming [CLS]  to a pluripotent state. As p53 is usually mutated in human tumors and many mutated forms of p53 gain novel activities, we studied the influence of mutant p53 (mut-p53)"}
{"subject": "mutated", "sub_type": "Var", "rel": "CauseOf", "object": "gain", "obj_type": "PosReg", "file_name": "PubMed-20696700.json", "snippet": " the malignant potential of reprogrammed cells.\np53 deficiency enhances the efficiency of somatic cell reprogramming to a pluripotent state. As p53 is usually mutated in human tumors and many  [CLS] mutated forms of p53 gain [CLS]  novel activities, we studied the influence of mutant p53 (mut-p53) on somatic cell reprogramming. Our data indicate a novel gain of function (GOF) property for mut-p53, which markedly enhanced"}
{"subject": "CYP2B6", "sub_type": "Var", "rel": "CauseOf", "object": "bioactivation of cyclophosphamide", "obj_type": "MPA", "file_name": "PubMed-21175440.json", "snippet": " of lupus nephritis (n= 16)\nRESULTS: In livers of known CYP2C19 and CYP2B6 genotype and protein expression we observed that there was a combined role for both CYP2C19 and  [CLS] CYP2B6 in the bioactivation of cyclophosphamide [CLS]  in vitro. The presence of at least one loss of function (LoF) allele at either CYP2C19 or CYP2B6 resulted in a significant decrease in both V(max) (P= 0.028) and"}
{"subject": "CYP2B6", "sub_type": "Var", "rel": "CauseOf", "object": "decreased", "obj_type": "NegReg", "file_name": "PubMed-21175440.json", "snippet": " 0.0007, 0.002) compared with 0.0071 (95% CI 0.0001, 0.014) in patients with no LoF alleles at either of these genes.\nCONCLUSIONS: The presence of \u22651 LoF allele(s) at either  [CLS] CYP2B6 or CYP2C19 appeared to result in decreased [CLS]  bioactivation of cyclophosphamide both in vitro and in patients. Further clinical studies to confirm this relationship are warranted."}
{"subject": "CYP2C19", "sub_type": "Var", "rel": "CauseOf", "object": "decreased", "obj_type": "NegReg", "file_name": "PubMed-21175440.json", "snippet": " compared with 0.0071 (95% CI 0.0001, 0.014) in patients with no LoF alleles at either of these genes.\nCONCLUSIONS: The presence of \u22651 LoF allele(s) at either CYP2B6 or  [CLS] CYP2C19 appeared to result in decreased [CLS]  bioactivation of cyclophosphamide both in vitro and in patients. Further clinical studies to confirm this relationship are warranted."}
{"subject": "bioactivation of cyclophosphamide", "sub_type": "MPA", "rel": "ThemeOf", "object": "decreased", "obj_type": "NegReg", "file_name": "PubMed-21175440.json", "snippet": " 0.0001, 0.014) in patients with no LoF alleles at either of these genes.\nCONCLUSIONS: The presence of \u22651 LoF allele(s) at either CYP2B6 or CYP2C19 appeared to result in  [CLS] decreased bioactivation of cyclophosphamide [CLS]  both in vitro and in patients. Further clinical studies to confirm this relationship are warranted."}
{"subject": "CYP2C19", "sub_type": "Var", "rel": "CauseOf", "object": "bioactivation of cyclophosphamide", "obj_type": "MPA", "file_name": "PubMed-21175440.json", "snippet": " for treatment of lupus nephritis (n= 16)\nRESULTS: In livers of known CYP2C19 and CYP2B6 genotype and protein expression we observed that there was a combined role for both  [CLS] CYP2C19 and CYP2B6 in the bioactivation of cyclophosphamide [CLS]  in vitro. The presence of at least one loss of function (LoF) allele at either CYP2C19 or CYP2B6 resulted in a significant decrease in both V(max) (P= 0.028) and"}
{"subject": "combined", "sub_type": "Interaction", "rel": "ThemeOf", "object": "bioactivation of cyclophosphamide", "obj_type": "MPA", "file_name": "PubMed-21175440.json", "snippet": " patients receiving the drug for treatment of lupus nephritis (n= 16)\nRESULTS: In livers of known CYP2C19 and CYP2B6 genotype and protein expression we observed that there was a  [CLS] combined role for both CYP2C19 and CYP2B6 in the bioactivation of cyclophosphamide [CLS]  in vitro. The presence of at least one loss of function (LoF) allele at either CYP2C19 or CYP2B6 resulted in a significant decrease in both V(max) (P= 0.028) and"}
{"subject": "CYP2C19", "sub_type": "Var", "rel": "CauseOf", "object": "decrease", "obj_type": "NegReg", "file_name": "PubMed-21175440.json", "snippet": " was a combined role for both CYP2C19 and CYP2B6 in the bioactivation of cyclophosphamide in vitro. The presence of at least one loss of function (LoF) allele at either  [CLS] CYP2C19 or CYP2B6 resulted in a significant decrease [CLS]  in both V(max) (P= 0.028) and CL(int) (P= 0.0017) compared with livers with no LoF alleles. This dual genotype relationship was also observed in a preliminary clinical study, with"}
{"subject": "CYP2B6", "sub_type": "Var", "rel": "CauseOf", "object": "decrease", "obj_type": "NegReg", "file_name": "PubMed-21175440.json", "snippet": " combined role for both CYP2C19 and CYP2B6 in the bioactivation of cyclophosphamide in vitro. The presence of at least one loss of function (LoF) allele at either CYP2C19 or  [CLS] CYP2B6 resulted in a significant decrease [CLS]  in both V(max) (P= 0.028) and CL(int) (P= 0.0017) compared with livers with no LoF alleles. This dual genotype relationship was also observed in a preliminary clinical study, with"}
{"subject": "V(max) (P= 0.028) and CL(int) (P= 0.0017)", "sub_type": "MPA", "rel": "ThemeOf", "object": "decrease", "obj_type": "NegReg", "file_name": "PubMed-21175440.json", "snippet": " and CYP2B6 in the bioactivation of cyclophosphamide in vitro. The presence of at least one loss of function (LoF) allele at either CYP2C19 or CYP2B6 resulted in a significant  [CLS] decrease in both V(max) (P= 0.028) and CL(int) (P= 0.0017) [CLS]  compared with livers with no LoF alleles. This dual genotype relationship was also observed in a preliminary clinical study, with patients who had \u22651 LoF allele at either CYP2C19"}
{"subject": "CYP2C19", "sub_type": "Var", "rel": "CauseOf", "object": "lower", "obj_type": "NegReg", "file_name": "PubMed-21175440.json", "snippet": " 0.0017) compared with livers with no LoF alleles. This dual genotype relationship was also observed in a preliminary clinical study, with patients who had \u22651 LoF allele at either  [CLS] CYP2C19 or CYP2B6 also displaying significantly (P= 0.0316) lower [CLS]  bioactivation of cyclophosphamide. The mean 4-OHCP : CP bioactivation ratio was 0.0014 (95% CI 0.0007, 0.002) compared with 0.0071 (95% CI 0.0001, 0.014) in patients with no LoF alleles"}
{"subject": "CYP2B6", "sub_type": "Var", "rel": "CauseOf", "object": "lower", "obj_type": "NegReg", "file_name": "PubMed-21175440.json", "snippet": " with livers with no LoF alleles. This dual genotype relationship was also observed in a preliminary clinical study, with patients who had \u22651 LoF allele at either CYP2C19 or  [CLS] CYP2B6 also displaying significantly (P= 0.0316) lower [CLS]  bioactivation of cyclophosphamide. The mean 4-OHCP : CP bioactivation ratio was 0.0014 (95% CI 0.0007, 0.002) compared with 0.0071 (95% CI 0.0001, 0.014) in patients with no LoF alleles"}
{"subject": "bioactivation of cyclophosphamide", "sub_type": "MPA", "rel": "ThemeOf", "object": "lower", "obj_type": "NegReg", "file_name": "PubMed-21175440.json", "snippet": " This dual genotype relationship was also observed in a preliminary clinical study, with patients who had \u22651 LoF allele at either CYP2C19 or CYP2B6 also displaying significantly (P= 0.0316)  [CLS] lower bioactivation of cyclophosphamide [CLS] . The mean 4-OHCP : CP bioactivation ratio was 0.0014 (95% CI 0.0007, 0.002) compared with 0.0071 (95% CI 0.0001, 0.014) in patients with no LoF alleles at either of"}
{"subject": "TP53", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-21187651.json", "snippet": " [CLS] mutations of the TP53 [CLS]  gene. In regard to the functional interaction with the remaining wild-type (WT) p53 allele, p53 mutations are classified into two types, recessive and dominant-negative (DN) mutations. The latter mutant"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "associated", "obj_type": "Reg", "file_name": "PubMed-21187651.json", "snippet": " [CLS] associated with mutations [CLS]  of the TP53 gene. In regard to the functional interaction with the remaining wild-type (WT) p53 allele, p53 mutations are classified into two types, recessive and dominant-negative (DN) mutations."}
{"subject": "human cancers", "sub_type": "Disease", "rel": "ThemeOf", "object": "associated", "obj_type": "Reg", "file_name": "PubMed-21187651.json", "snippet": " [CLS] human cancers are associated [CLS]  with mutations of the TP53 gene. In regard to the functional interaction with the remaining wild-type (WT) p53 allele, p53 mutations are classified into two types, recessive and dominant-negative"}
{"subject": "dominant-negative (DN) mutations", "sub_type": "Var", "rel": "CauseOf", "object": "over the remaining WT allele", "obj_type": "PosReg", "file_name": "PubMed-21187651.json", "snippet": " associated with mutations of the TP53 gene. In regard to the functional interaction with the remaining wild-type (WT) p53 allele, p53 mutations are classified into two types, recessive and  [CLS] dominant-negative (DN) mutations. The latter mutant protein has a DN activity over the remaining WT allele [CLS] . We previously showed that the DN p53 mutant was useful as a predictor of poor outcome or a risk factor for metastatic recurrence in patients with some types of"}
{"subject": "DN activity", "sub_type": "MPA", "rel": "ThemeOf", "object": "over the remaining WT allele", "obj_type": "PosReg", "file_name": "PubMed-21187651.json", "snippet": " to the functional interaction with the remaining wild-type (WT) p53 allele, p53 mutations are classified into two types, recessive and dominant-negative (DN) mutations. The latter mutant protein has a  [CLS] DN activity over the remaining WT allele [CLS] . We previously showed that the DN p53 mutant was useful as a predictor of poor outcome or a risk factor for metastatic recurrence in patients with some types of"}
{"subject": "p53", "sub_type": "Gene", "rel": "ThemeOf", "object": "DN", "obj_type": "Var", "file_name": "PubMed-21187651.json", "snippet": " risk factor for metastatic recurrence in patients with some types of cancers, regardless of the presence or absence of loss of heterozygosity (LOH) of WT p53, suggesting that the  [CLS] DN p53 [CLS]  had 'gain-of-function (GOF)' activity besides the transdominance function. In this study, we investigated GOF activity of two DN p53 mutants which had a point mutation at codon 248 (R248Q"}
{"subject": "DN", "sub_type": "Var", "rel": "CauseOf", "object": "'gain-of-function (GOF)' activity", "obj_type": "PosReg", "file_name": "PubMed-21187651.json", "snippet": " risk factor for metastatic recurrence in patients with some types of cancers, regardless of the presence or absence of loss of heterozygosity (LOH) of WT p53, suggesting that the  [CLS] DN p53 had 'gain-of-function (GOF)' activity [CLS]  besides the transdominance function. In this study, we investigated GOF activity of two DN p53 mutants which had a point mutation at codon 248 (R248Q and R248W), one of"}
{"subject": "R248Q-transfectants", "sub_type": "Var", "rel": "CauseOf", "object": "higher", "obj_type": "PosReg", "file_name": "PubMed-21187651.json", "snippet": " of the transfectants with the two mutants was not different from that of parent or Mock transfectants. Meanwhile, in vitro invasions of Matrigel and type I collagen gel by  [CLS] R248Q-transfectants were significantly higher [CLS]  than those by R248W-transfectants or the control cells. However, there were no differences in cell motile activities, expressions of extracellular matrix-degradative enzymes such as matrix metalloproteinases, urokinase-type plasminogen activator"}
{"subject": "vitro invasions of Matrigel and type I collagen gel", "sub_type": "CPA", "rel": "ThemeOf", "object": "higher", "obj_type": "PosReg", "file_name": "PubMed-21187651.json", "snippet": " H1299 cells which originally expressed no p53 protein. Growth activity of the transfectants with the two mutants was not different from that of parent or Mock transfectants. Meanwhile, in  [CLS] vitro invasions of Matrigel and type I collagen gel by R248Q-transfectants were significantly higher [CLS]  than those by R248W-transfectants or the control cells. However, there were no differences in cell motile activities, expressions of extracellular matrix-degradative enzymes such as matrix metalloproteinases, urokinase-type plasminogen activator"}
{"subject": "mutant", "sub_type": "Var", "rel": "CauseOf", "object": "upregulates", "obj_type": "PosReg", "file_name": "PubMed-22114072.json", "snippet": " [CLS] mutant p53 upregulates [CLS]  CXC chemokines and enhances cell migration.\nThe role of dominant transforming p53 in carcinogenesis is poorly understood. Our previous data suggested that aberrant p53 proteins can enhance tumorigenesis and"}
{"subject": "p53 -R175H, -R273H and -D281G", "sub_type": "Var", "rel": "CauseOf", "object": "enhanced", "obj_type": "PosReg", "file_name": "PubMed-22114072.json", "snippet": " previous data suggested that aberrant p53 proteins can enhance tumorigenesis and metastasis. Here, we examined potential mechanisms through which gain-of-function (GOF) p53 proteins can induce motility. Cells expressing GOF  [CLS] p53 -R175H, -R273H and -D281G showed enhanced [CLS]  migration, which was reversed by RNA interference (RNAi) or transactivation-deficient mutants. In cells with engineered or endogenous p53 mutants, enhanced migration was reduced by downregulation of nuclear factor-kappaB2, a"}
{"subject": "migration", "sub_type": "CPA", "rel": "ThemeOf", "object": "enhanced", "obj_type": "PosReg", "file_name": "PubMed-22114072.json", "snippet": " proteins can enhance tumorigenesis and metastasis. Here, we examined potential mechanisms through which gain-of-function (GOF) p53 proteins can induce motility. Cells expressing GOF p53 -R175H, -R273H and -D281G showed  [CLS] enhanced migration [CLS] , which was reversed by RNA interference (RNAi) or transactivation-deficient mutants. In cells with engineered or endogenous p53 mutants, enhanced migration was reduced by downregulation of nuclear factor-kappaB2, a GOF"}
{"subject": "GOF p53", "sub_type": "Var", "rel": "CauseOf", "object": "upregulate", "obj_type": "PosReg", "file_name": "PubMed-22114072.json", "snippet": " interference (RNAi) or transactivation-deficient mutants. In cells with engineered or endogenous p53 mutants, enhanced migration was reduced by downregulation of nuclear factor-kappaB2, a GOF p53 target. We found that  [CLS] GOF p53 proteins upregulate [CLS]  CXC-chemokine expression, the inflammatory mediators that contribute to multiple aspects of tumorigenesis. Elevated expression of CXCL5, CXCL8 and CXCL12 was found in cells expressing oncogenic p53. Transcription was elevated"}
{"subject": "CXC-chemokine expression", "sub_type": "MPA", "rel": "ThemeOf", "object": "upregulate", "obj_type": "PosReg", "file_name": "PubMed-22114072.json", "snippet": " transactivation-deficient mutants. In cells with engineered or endogenous p53 mutants, enhanced migration was reduced by downregulation of nuclear factor-kappaB2, a GOF p53 target. We found that GOF p53 proteins  [CLS] upregulate CXC-chemokine expression [CLS] , the inflammatory mediators that contribute to multiple aspects of tumorigenesis. Elevated expression of CXCL5, CXCL8 and CXCL12 was found in cells expressing oncogenic p53. Transcription was elevated as CXCL5"}
{"subject": "oncogenic p53", "sub_type": "Var", "rel": "CauseOf", "object": "Elevated", "obj_type": "PosReg", "file_name": "PubMed-22114072.json", "snippet": " reduced by downregulation of nuclear factor-kappaB2, a GOF p53 target. We found that GOF p53 proteins upregulate CXC-chemokine expression, the inflammatory mediators that contribute to multiple aspects of tumorigenesis.  [CLS] Elevated expression of CXCL5, CXCL8 and CXCL12 was found in cells expressing oncogenic p53 [CLS] . Transcription was elevated as CXCL5 and CXCL8 promoter activity was higher in cells expressing GOF p53, whereas wild-type p53 repressed promoter activity. Chromatin immunoprecipitation assays revealed enhanced presence of"}
{"subject": "expression", "sub_type": "MPA", "rel": "ThemeOf", "object": "Elevated", "obj_type": "PosReg", "file_name": "PubMed-22114072.json", "snippet": " reduced by downregulation of nuclear factor-kappaB2, a GOF p53 target. We found that GOF p53 proteins upregulate CXC-chemokine expression, the inflammatory mediators that contribute to multiple aspects of tumorigenesis.  [CLS] Elevated expression [CLS]  of CXCL5, CXCL8 and CXCL12 was found in cells expressing oncogenic p53. Transcription was elevated as CXCL5 and CXCL8 promoter activity was higher in cells expressing GOF p53, whereas"}
{"subject": "GOF p53", "sub_type": "Var", "rel": "CauseOf", "object": "higher", "obj_type": "PosReg", "file_name": "PubMed-22114072.json", "snippet": " to multiple aspects of tumorigenesis. Elevated expression of CXCL5, CXCL8 and CXCL12 was found in cells expressing oncogenic p53. Transcription was elevated as CXCL5 and CXCL8 promoter activity was  [CLS] higher in cells expressing GOF p53 [CLS] , whereas wild-type p53 repressed promoter activity. Chromatin immunoprecipitation assays revealed enhanced presence of acetylated histone H3 on the CXCL5 promoter in H1299/R273H cells, in agreement with increased transcriptional activity"}
{"subject": "CXCL5 and CXCL8 promoter activity", "sub_type": "MPA", "rel": "ThemeOf", "object": "higher", "obj_type": "PosReg", "file_name": "PubMed-22114072.json", "snippet": " expression, the inflammatory mediators that contribute to multiple aspects of tumorigenesis. Elevated expression of CXCL5, CXCL8 and CXCL12 was found in cells expressing oncogenic p53. Transcription was elevated as  [CLS] CXCL5 and CXCL8 promoter activity was higher [CLS]  in cells expressing GOF p53, whereas wild-type p53 repressed promoter activity. Chromatin immunoprecipitation assays revealed enhanced presence of acetylated histone H3 on the CXCL5 promoter in H1299/R273H cells, in"}
{"subject": "CXCL5 and CXCL8 promoter activity", "sub_type": "MPA", "rel": "CauseOf", "object": "elevated", "obj_type": "PosReg", "file_name": "PubMed-22114072.json", "snippet": " upregulate CXC-chemokine expression, the inflammatory mediators that contribute to multiple aspects of tumorigenesis. Elevated expression of CXCL5, CXCL8 and CXCL12 was found in cells expressing oncogenic p53. Transcription was  [CLS] elevated as CXCL5 and CXCL8 promoter activity [CLS]  was higher in cells expressing GOF p53, whereas wild-type p53 repressed promoter activity. Chromatin immunoprecipitation assays revealed enhanced presence of acetylated histone H3 on the CXCL5 promoter in H1299/R273H"}
{"subject": "CXC chemokines", "sub_type": "MPA", "rel": "ThemeOf", "object": "upregulates", "obj_type": "PosReg", "file_name": "PubMed-22114072.json", "snippet": " [CLS] upregulates CXC chemokines [CLS]  and enhances cell migration.\nThe role of dominant transforming p53 in carcinogenesis is poorly understood. Our previous data suggested that aberrant p53 proteins can enhance tumorigenesis and metastasis. Here,"}
{"subject": "Transcription", "sub_type": "MPA", "rel": "ThemeOf", "object": "elevated", "obj_type": "PosReg", "file_name": "PubMed-22114072.json", "snippet": " p53 proteins upregulate CXC-chemokine expression, the inflammatory mediators that contribute to multiple aspects of tumorigenesis. Elevated expression of CXCL5, CXCL8 and CXCL12 was found in cells expressing oncogenic p53.  [CLS] Transcription was elevated [CLS]  as CXCL5 and CXCL8 promoter activity was higher in cells expressing GOF p53, whereas wild-type p53 repressed promoter activity. Chromatin immunoprecipitation assays revealed enhanced presence of acetylated histone H3"}
{"subject": "endogenous mutant", "sub_type": "Var", "rel": "CauseOf", "object": "reduced", "obj_type": "NegReg", "file_name": "PubMed-22114072.json", "snippet": " the CXCL5 promoter in H1299/R273H cells, in agreement with increased transcriptional activity of the promoter, whereas RNAi-mediated repression of CXCL5 inhibited cell migration. Consistent with this, knockdown of the  [CLS] endogenous mutant p53 in lung cancer or melanoma cells reduced [CLS]  CXCL5 expression and cell migration. Furthermore, short hairpin RNA knockdown of mutant p53 in MDA-MB-231 cells reduced expression of a number of key targets, including several chemokines and other"}
{"subject": "CXCL5 expression", "sub_type": "MPA", "rel": "ThemeOf", "object": "reduced", "obj_type": "NegReg", "file_name": "PubMed-22114072.json", "snippet": " increased transcriptional activity of the promoter, whereas RNAi-mediated repression of CXCL5 inhibited cell migration. Consistent with this, knockdown of the endogenous mutant p53 in lung cancer or melanoma cells  [CLS] reduced CXCL5 expression [CLS]  and cell migration. Furthermore, short hairpin RNA knockdown of mutant p53 in MDA-MB-231 cells reduced expression of a number of key targets, including several chemokines and other inflammatory mediators."}
{"subject": "cell migration", "sub_type": "CPA", "rel": "ThemeOf", "object": "reduced", "obj_type": "NegReg", "file_name": "PubMed-22114072.json", "snippet": " increased transcriptional activity of the promoter, whereas RNAi-mediated repression of CXCL5 inhibited cell migration. Consistent with this, knockdown of the endogenous mutant p53 in lung cancer or melanoma cells  [CLS] reduced CXCL5 expression and cell migration [CLS] . Furthermore, short hairpin RNA knockdown of mutant p53 in MDA-MB-231 cells reduced expression of a number of key targets, including several chemokines and other inflammatory mediators. Finally, CXCL5 expression"}
{"subject": "p53", "sub_type": "Gene", "rel": "ThemeOf", "object": "endogenous mutant", "obj_type": "Var", "file_name": "PubMed-22114072.json", "snippet": " the CXCL5 promoter in H1299/R273H cells, in agreement with increased transcriptional activity of the promoter, whereas RNAi-mediated repression of CXCL5 inhibited cell migration. Consistent with this, knockdown of the  [CLS] endogenous mutant p53 [CLS]  in lung cancer or melanoma cells reduced CXCL5 expression and cell migration. Furthermore, short hairpin RNA knockdown of mutant p53 in MDA-MB-231 cells reduced expression of a number of"}
{"subject": "mutant", "sub_type": "Var", "rel": "CauseOf", "object": "reduced", "obj_type": "NegReg", "file_name": "PubMed-22114072.json", "snippet": " cell migration. Consistent with this, knockdown of the endogenous mutant p53 in lung cancer or melanoma cells reduced CXCL5 expression and cell migration. Furthermore, short hairpin RNA knockdown of  [CLS] mutant p53 in MDA-MB-231 cells reduced [CLS]  expression of a number of key targets, including several chemokines and other inflammatory mediators. Finally, CXCL5 expression was also elevated in lung tumor samples containing GOF p53, indicating relevance"}
{"subject": "expression of a number of key targets", "sub_type": "MPA", "rel": "ThemeOf", "object": "reduced", "obj_type": "NegReg", "file_name": "PubMed-22114072.json", "snippet": " knockdown of the endogenous mutant p53 in lung cancer or melanoma cells reduced CXCL5 expression and cell migration. Furthermore, short hairpin RNA knockdown of mutant p53 in MDA-MB-231 cells  [CLS] reduced expression of a number of key targets [CLS] , including several chemokines and other inflammatory mediators. Finally, CXCL5 expression was also elevated in lung tumor samples containing GOF p53, indicating relevance to human cancer. The data suggest a"}
{"subject": "p53", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutant", "obj_type": "Var", "file_name": "PubMed-22114072.json", "snippet": " cell migration. Consistent with this, knockdown of the endogenous mutant p53 in lung cancer or melanoma cells reduced CXCL5 expression and cell migration. Furthermore, short hairpin RNA knockdown of  [CLS] mutant p53 [CLS]  in MDA-MB-231 cells reduced expression of a number of key targets, including several chemokines and other inflammatory mediators. Finally, CXCL5 expression was also elevated in lung tumor samples containing"}
{"subject": "p53", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutant", "obj_type": "Var", "file_name": "PubMed-22114072.json", "snippet": " [CLS] mutant p53 [CLS]  upregulates CXC chemokines and enhances cell migration.\nThe role of dominant transforming p53 in carcinogenesis is poorly understood. Our previous data suggested that aberrant p53 proteins can enhance tumorigenesis"}
{"subject": "GOF p53", "sub_type": "Var", "rel": "CauseOf", "object": "elevated", "obj_type": "PosReg", "file_name": "PubMed-22114072.json", "snippet": " hairpin RNA knockdown of mutant p53 in MDA-MB-231 cells reduced expression of a number of key targets, including several chemokines and other inflammatory mediators. Finally, CXCL5 expression was also  [CLS] elevated in lung tumor samples containing GOF p53 [CLS] , indicating relevance to human cancer. The data suggest a mechanistic link between GOF p53 proteins and chemokines in enhanced cell motility."}
{"subject": "CXCL5 expression", "sub_type": "MPA", "rel": "ThemeOf", "object": "elevated", "obj_type": "PosReg", "file_name": "PubMed-22114072.json", "snippet": " cell migration. Furthermore, short hairpin RNA knockdown of mutant p53 in MDA-MB-231 cells reduced expression of a number of key targets, including several chemokines and other inflammatory mediators. Finally,  [CLS] CXCL5 expression was also elevated [CLS]  in lung tumor samples containing GOF p53, indicating relevance to human cancer. The data suggest a mechanistic link between GOF p53 proteins and chemokines in enhanced cell motility."}
{"subject": "lung tumor", "sub_type": "Disease", "rel": "ThemeOf", "object": "elevated", "obj_type": "PosReg", "file_name": "PubMed-22114072.json", "snippet": " hairpin RNA knockdown of mutant p53 in MDA-MB-231 cells reduced expression of a number of key targets, including several chemokines and other inflammatory mediators. Finally, CXCL5 expression was also  [CLS] elevated in lung tumor [CLS]  samples containing GOF p53, indicating relevance to human cancer. The data suggest a mechanistic link between GOF p53 proteins and chemokines in enhanced cell motility."}
{"subject": "CXC chemokines", "sub_type": "MPA", "rel": "CauseOf", "object": "enhances", "obj_type": "PosReg", "file_name": "PubMed-22114072.json", "snippet": " [CLS] CXC chemokines and enhances [CLS]  cell migration.\nThe role of dominant transforming p53 in carcinogenesis is poorly understood. Our previous data suggested that aberrant p53 proteins can enhance tumorigenesis and metastasis. Here, we examined"}
{"subject": "cell migration", "sub_type": "CPA", "rel": "ThemeOf", "object": "enhances", "obj_type": "PosReg", "file_name": "PubMed-22114072.json", "snippet": " [CLS] enhances cell migration [CLS] .\nThe role of dominant transforming p53 in carcinogenesis is poorly understood. Our previous data suggested that aberrant p53 proteins can enhance tumorigenesis and metastasis. Here, we examined potential mechanisms"}
{"subject": "aberrant", "sub_type": "Var", "rel": "CauseOf", "object": "enhance", "obj_type": "PosReg", "file_name": "PubMed-22114072.json", "snippet": " [CLS] aberrant p53 proteins can enhance [CLS]  tumorigenesis and metastasis. Here, we examined potential mechanisms through which gain-of-function (GOF) p53 proteins can induce motility. Cells expressing GOF p53 -R175H, -R273H and -D281G showed enhanced migration, which"}
{"subject": "tumorigenesis and metastasis", "sub_type": "CPA", "rel": "ThemeOf", "object": "enhance", "obj_type": "PosReg", "file_name": "PubMed-22114072.json", "snippet": " mutant p53 upregulates CXC chemokines and enhances cell migration.\nThe role of dominant transforming p53 in carcinogenesis is poorly understood. Our previous data suggested that aberrant p53 proteins can  [CLS] enhance tumorigenesis and metastasis [CLS] . Here, we examined potential mechanisms through which gain-of-function (GOF) p53 proteins can induce motility. Cells expressing GOF p53 -R175H, -R273H and -D281G showed enhanced migration, which was reversed by"}
{"subject": "p53 proteins", "sub_type": "Protein", "rel": "ThemeOf", "object": "aberrant", "obj_type": "Var", "file_name": "PubMed-22114072.json", "snippet": " [CLS] aberrant p53 proteins [CLS]  can enhance tumorigenesis and metastasis. Here, we examined potential mechanisms through which gain-of-function (GOF) p53 proteins can induce motility. Cells expressing GOF p53 -R175H, -R273H and -D281G showed enhanced"}
{"subject": "p53", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutants", "obj_type": "Var", "file_name": "PubMed-22989750.json", "snippet": " [CLS] p53 mutants [CLS]  in lung cancer cells.\np53 mutations are mostly single amino acid changes resulting in expression of a stable mutant protein with \"gain of function\" (GOF) activity having a dominant"}
{"subject": "mutants", "sub_type": "Var", "rel": "CauseOf", "object": "loss", "obj_type": "NegReg", "file_name": "PubMed-22989750.json", "snippet": " activity having a dominant oncogenic role rather than simple loss of function of wild-type p53. Knock-down of mutant p53 in human lung cancer cell lines with different endogenous p53  [CLS] mutants results in loss [CLS]  of GOF activity as shown by lowering of cell growth rate. Two lung cancer cell lines, ABC1 and H1437, carrying endogenous mutants p53-P278S and -R267P, show reduction in growth"}
{"subject": "activity", "sub_type": "MPA", "rel": "ThemeOf", "object": "loss", "obj_type": "NegReg", "file_name": "PubMed-22989750.json", "snippet": " dominant oncogenic role rather than simple loss of function of wild-type p53. Knock-down of mutant p53 in human lung cancer cell lines with different endogenous p53 mutants results in  [CLS] loss of GOF activity [CLS]  as shown by lowering of cell growth rate. Two lung cancer cell lines, ABC1 and H1437, carrying endogenous mutants p53-P278S and -R267P, show reduction in growth rate on knock-down"}
{"subject": "mutants", "sub_type": "Var", "rel": "CauseOf", "object": "lowering", "obj_type": "NegReg", "file_name": "PubMed-22989750.json", "snippet": " activity having a dominant oncogenic role rather than simple loss of function of wild-type p53. Knock-down of mutant p53 in human lung cancer cell lines with different endogenous p53  [CLS] mutants results in loss of GOF activity as shown by lowering [CLS]  of cell growth rate. Two lung cancer cell lines, ABC1 and H1437, carrying endogenous mutants p53-P278S and -R267P, show reduction in growth rate on knock-down on p53 levels. However,"}
{"subject": "cell growth rate", "sub_type": "CPA", "rel": "ThemeOf", "object": "lowering", "obj_type": "NegReg", "file_name": "PubMed-22989750.json", "snippet": " of function of wild-type p53. Knock-down of mutant p53 in human lung cancer cell lines with different endogenous p53 mutants results in loss of GOF activity as shown by  [CLS] lowering of cell growth rate [CLS] . Two lung cancer cell lines, ABC1 and H1437, carrying endogenous mutants p53-P278S and -R267P, show reduction in growth rate on knock-down on p53 levels. However, whereas reduction of the"}
{"subject": "mutants p53-P278S and -R267P", "sub_type": "Var", "rel": "CauseOf", "object": "reduction", "obj_type": "NegReg", "file_name": "PubMed-22989750.json", "snippet": " with different endogenous p53 mutants results in loss of GOF activity as shown by lowering of cell growth rate. Two lung cancer cell lines, ABC1 and H1437, carrying endogenous  [CLS] mutants p53-P278S and -R267P, show reduction [CLS]  in growth rate on knock-down on p53 levels. However, whereas reduction of the p53 level induces loss of tumorigenicity in nude mice for ABC1 cells, it escalates tumorigenicity for"}
{"subject": "growth rate", "sub_type": "MPA", "rel": "ThemeOf", "object": "reduction", "obj_type": "NegReg", "file_name": "PubMed-22989750.json", "snippet": " results in loss of GOF activity as shown by lowering of cell growth rate. Two lung cancer cell lines, ABC1 and H1437, carrying endogenous mutants p53-P278S and -R267P, show  [CLS] reduction in growth rate [CLS]  on knock-down on p53 levels. However, whereas reduction of the p53 level induces loss of tumorigenicity in nude mice for ABC1 cells, it escalates tumorigenicity for H1437 cells. We"}
{"subject": "tumorigenicity", "sub_type": "MPA", "rel": "ThemeOf", "object": "loss", "obj_type": "NegReg", "file_name": "PubMed-22989750.json", "snippet": " cell lines, ABC1 and H1437, carrying endogenous mutants p53-P278S and -R267P, show reduction in growth rate on knock-down on p53 levels. However, whereas reduction of the p53 level induces  [CLS] loss of tumorigenicity [CLS]  in nude mice for ABC1 cells, it escalates tumorigenicity for H1437 cells. We have tested their transactivation potential on p53 target gene promoters by performing transient transcriptional assays in"}
{"subject": "reduction", "sub_type": "NegReg", "rel": "ThemeOf", "object": "p53", "obj_type": "Var", "file_name": "PubMed-22989750.json", "snippet": " cell growth rate. Two lung cancer cell lines, ABC1 and H1437, carrying endogenous mutants p53-P278S and -R267P, show reduction in growth rate on knock-down on p53 levels. However, whereas  [CLS] reduction of the p53 [CLS]  level induces loss of tumorigenicity in nude mice for ABC1 cells, it escalates tumorigenicity for H1437 cells. We have tested their transactivation potential on p53 target gene promoters by"}
{"subject": "mutants", "sub_type": "Var", "rel": "CauseOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-22989750.json", "snippet": " [CLS] gain-of-function activity of p53 mutants [CLS]  in lung cancer cells.\np53 mutations are mostly single amino acid changes resulting in expression of a stable mutant protein with \"gain of function\" (GOF) activity having a dominant"}
{"subject": "p53", "sub_type": "Var", "rel": "CauseOf", "object": "escalates", "obj_type": "PosReg", "file_name": "PubMed-22989750.json", "snippet": " Two lung cancer cell lines, ABC1 and H1437, carrying endogenous mutants p53-P278S and -R267P, show reduction in growth rate on knock-down on p53 levels. However, whereas reduction of the  [CLS] p53 level induces loss of tumorigenicity in nude mice for ABC1 cells, it escalates [CLS]  tumorigenicity for H1437 cells. We have tested their transactivation potential on p53 target gene promoters by performing transient transcriptional assays in the p53-null H1299 lung cancer cell line. Interestingly,"}
{"subject": "tumorigenicity", "sub_type": "MPA", "rel": "ThemeOf", "object": "escalates", "obj_type": "PosReg", "file_name": "PubMed-22989750.json", "snippet": " -R267P, show reduction in growth rate on knock-down on p53 levels. However, whereas reduction of the p53 level induces loss of tumorigenicity in nude mice for ABC1 cells, it  [CLS] escalates tumorigenicity [CLS]  for H1437 cells. We have tested their transactivation potential on p53 target gene promoters by performing transient transcriptional assays in the p53-null H1299 lung cancer cell line. Interestingly, while"}
{"subject": "p53", "sub_type": "Var", "rel": "CauseOf", "object": "loss", "obj_type": "NegReg", "file_name": "PubMed-22989750.json", "snippet": " Two lung cancer cell lines, ABC1 and H1437, carrying endogenous mutants p53-P278S and -R267P, show reduction in growth rate on knock-down on p53 levels. However, whereas reduction of the  [CLS] p53 level induces loss [CLS]  of tumorigenicity in nude mice for ABC1 cells, it escalates tumorigenicity for H1437 cells. We have tested their transactivation potential on p53 target gene promoters by performing transient transcriptional"}
{"subject": "lung cancer", "sub_type": "Disease", "rel": "ThemeOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-22989750.json", "snippet": " [CLS] gain-of-function activity of p53 mutants in lung cancer [CLS]  cells.\np53 mutations are mostly single amino acid changes resulting in expression of a stable mutant protein with \"gain of function\" (GOF) activity having a dominant oncogenic role rather"}
{"subject": "activity", "sub_type": "MPA", "rel": "ThemeOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-22989750.json", "snippet": " [CLS] gain-of-function activity [CLS]  of p53 mutants in lung cancer cells.\np53 mutations are mostly single amino acid changes resulting in expression of a stable mutant protein with \"gain of function\" (GOF) activity"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "resulting in", "obj_type": "Reg", "file_name": "PubMed-22989750.json", "snippet": " [CLS] mutations are mostly single amino acid changes resulting in [CLS]  expression of a stable mutant protein with \"gain of function\" (GOF) activity having a dominant oncogenic role rather than simple loss of function of wild-type p53. Knock-down of mutant"}
{"subject": "expression", "sub_type": "MPA", "rel": "ThemeOf", "object": "resulting in", "obj_type": "Reg", "file_name": "PubMed-22989750.json", "snippet": " [CLS] resulting in expression [CLS]  of a stable mutant protein with \"gain of function\" (GOF) activity having a dominant oncogenic role rather than simple loss of function of wild-type p53. Knock-down of mutant p53"}
{"subject": "p53", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-22989750.json", "snippet": " [CLS] p53 mutations [CLS]  are mostly single amino acid changes resulting in expression of a stable mutant protein with \"gain of function\" (GOF) activity having a dominant oncogenic role rather than simple loss"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "gain of function", "obj_type": "PosReg", "file_name": "PubMed-22989750.json", "snippet": " [CLS] mutations are mostly single amino acid changes resulting in expression of a stable mutant protein with \"gain of function [CLS] \" (GOF) activity having a dominant oncogenic role rather than simple loss of function of wild-type p53. Knock-down of mutant p53 in human lung cancer cell lines with different endogenous"}
{"subject": "activity", "sub_type": "MPA", "rel": "ThemeOf", "object": "gain of function", "obj_type": "PosReg", "file_name": "PubMed-22989750.json", "snippet": " [CLS] gain of function\" (GOF) activity [CLS]  having a dominant oncogenic role rather than simple loss of function of wild-type p53. Knock-down of mutant p53 in human lung cancer cell lines with different endogenous p53 mutants"}
{"subject": "p53", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutants", "obj_type": "Var", "file_name": "PubMed-22989750.json", "snippet": " (GOF) activity having a dominant oncogenic role rather than simple loss of function of wild-type p53. Knock-down of mutant p53 in human lung cancer cell lines with different endogenous  [CLS] p53 mutants [CLS]  results in loss of GOF activity as shown by lowering of cell growth rate. Two lung cancer cell lines, ABC1 and H1437, carrying endogenous mutants p53-P278S and -R267P, show"}
{"subject": "p53", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutant", "obj_type": "Var", "file_name": "PubMed-23264849.json", "snippet": " present in up to 70% of lung cancer. Cancer cells with p53 mutations, in general, grow more aggressively than those with wild-type p53 or no p53. Expression of tumor-derived  [CLS] mutant p53 [CLS]  in cells leads to up-regulated expression of genes that may affect cell growth and oncogenesis. In our study of this aggressive phenotype, we have investigated the receptor protein tyrosine"}
{"subject": "expression of genes", "sub_type": "MPA", "rel": "CauseOf", "object": "affect", "obj_type": "Reg", "file_name": "PubMed-23264849.json", "snippet": " cancer. Cancer cells with p53 mutations, in general, grow more aggressively than those with wild-type p53 or no p53. Expression of tumor-derived mutant p53 in cells leads to up-regulated  [CLS] expression of genes that may affect [CLS]  cell growth and oncogenesis. In our study of this aggressive phenotype, we have investigated the receptor protein tyrosine kinase Axl, which is up-regulated by p53 mutants at both RNA"}
{"subject": "cell growth", "sub_type": "CPA", "rel": "ThemeOf", "object": "affect", "obj_type": "Reg", "file_name": "PubMed-23264849.json", "snippet": " mutations, in general, grow more aggressively than those with wild-type p53 or no p53. Expression of tumor-derived mutant p53 in cells leads to up-regulated expression of genes that may  [CLS] affect cell growth [CLS]  and oncogenesis. In our study of this aggressive phenotype, we have investigated the receptor protein tyrosine kinase Axl, which is up-regulated by p53 mutants at both RNA and protein"}
{"subject": "mutants", "sub_type": "Var", "rel": "CauseOf", "object": "up-regulated", "obj_type": "PosReg", "file_name": "PubMed-23264849.json", "snippet": " up-regulated expression of genes that may affect cell growth and oncogenesis. In our study of this aggressive phenotype, we have investigated the receptor protein tyrosine kinase Axl, which is  [CLS] up-regulated by p53 mutants [CLS]  at both RNA and protein levels in H1299 lung cancer cells expressing mutants p53-R175H, -R273H, and -D281G. Knockdown of endogenous mutant p53 levels in human lung cancer cells H1048"}
{"subject": "tyrosine kinase Axl", "sub_type": "Enzyme", "rel": "ThemeOf", "object": "up-regulated", "obj_type": "PosReg", "file_name": "PubMed-23264849.json", "snippet": " p53 in cells leads to up-regulated expression of genes that may affect cell growth and oncogenesis. In our study of this aggressive phenotype, we have investigated the receptor protein  [CLS] tyrosine kinase Axl, which is up-regulated [CLS]  by p53 mutants at both RNA and protein levels in H1299 lung cancer cells expressing mutants p53-R175H, -R273H, and -D281G. Knockdown of endogenous mutant p53 levels in human lung"}
{"subject": "p53", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutants", "obj_type": "Var", "file_name": "PubMed-23264849.json", "snippet": " of genes that may affect cell growth and oncogenesis. In our study of this aggressive phenotype, we have investigated the receptor protein tyrosine kinase Axl, which is up-regulated by  [CLS] p53 mutants [CLS]  at both RNA and protein levels in H1299 lung cancer cells expressing mutants p53-R175H, -R273H, and -D281G. Knockdown of endogenous mutant p53 levels in human lung cancer cells H1048"}
{"subject": "p53", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutant", "obj_type": "Var", "file_name": "PubMed-23264849.json", "snippet": " critical role in the up-regulation of Axl gene expression. Chromatin immunoprecipitation (ChIP) assays carried out with acetylated histone antibodies demonstrated induced histone acetylation on the Axl promoter region by  [CLS] mutant p53 [CLS] . Direct mutant p53 nucleation on the Axl promoter was demonstrated by ChIP assays using antibodies against p53. The Axl promoter has a p53/p63 binding site, which however is not"}
{"subject": "mutant", "sub_type": "Var", "rel": "CauseOf", "object": "histone", "obj_type": "Reg", "file_name": "PubMed-23264849.json", "snippet": " that p53's transactivation domain may not play a critical role in the up-regulation of Axl gene expression. Chromatin immunoprecipitation (ChIP) assays carried out with acetylated histone antibodies demonstrated induced  [CLS] histone acetylation on the Axl promoter region by mutant [CLS]  p53. Direct mutant p53 nucleation on the Axl promoter was demonstrated by ChIP assays using antibodies against p53. The Axl promoter has a p53/p63 binding site, which however is"}
{"subject": "acetylation on the Axl promoter region", "sub_type": "MPA", "rel": "ThemeOf", "object": "histone", "obj_type": "Reg", "file_name": "PubMed-23264849.json", "snippet": " that p53's transactivation domain may not play a critical role in the up-regulation of Axl gene expression. Chromatin immunoprecipitation (ChIP) assays carried out with acetylated histone antibodies demonstrated induced  [CLS] histone acetylation on the Axl promoter region [CLS]  by mutant p53. Direct mutant p53 nucleation on the Axl promoter was demonstrated by ChIP assays using antibodies against p53. The Axl promoter has a p53/p63 binding site, which"}
{"subject": "p53", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutant", "obj_type": "Var", "file_name": "PubMed-23264849.json", "snippet": " reduction of gain-of-function (GOF) activities, reducing the cell growth rate and motility rate in lung cancer cells expressing mutant p53. This indicates that for lung cancer cell lines with  [CLS] mutant p53 [CLS] , GOF activities are mediated in part through Axl."}
{"subject": "mutant", "sub_type": "Var", "rel": "ThemeOf", "object": "Axl", "obj_type": "Protein", "file_name": "PubMed-23264849.json", "snippet": " reduction of gain-of-function (GOF) activities, reducing the cell growth rate and motility rate in lung cancer cells expressing mutant p53. This indicates that for lung cancer cell lines with  [CLS] mutant p53, GOF activities are mediated in part through Axl [CLS] ."}
{"subject": "Axl", "sub_type": "Protein", "rel": "CauseOf", "object": "mediated", "obj_type": "Reg", "file_name": "PubMed-23264849.json", "snippet": " reducing the cell growth rate and motility rate in lung cancer cells expressing mutant p53. This indicates that for lung cancer cell lines with mutant p53, GOF activities are  [CLS] mediated in part through Axl [CLS] ."}
{"subject": "activities", "sub_type": "MPA", "rel": "ThemeOf", "object": "mediated", "obj_type": "Reg", "file_name": "PubMed-23264849.json", "snippet": " (GOF) activities, reducing the cell growth rate and motility rate in lung cancer cells expressing mutant p53. This indicates that for lung cancer cell lines with mutant p53, GOF  [CLS] activities are mediated [CLS]  in part through Axl."}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "aggressively", "obj_type": "PosReg", "file_name": "PubMed-23264849.json", "snippet": " of Mutant p53 in Lung Cancer through Up-Regulation of Receptor Protein Tyrosine Kinase Axl.\np53 mutations are present in up to 70% of lung cancer. Cancer cells with p53  [CLS] mutations, in general, grow more aggressively [CLS]  than those with wild-type p53 or no p53. Expression of tumor-derived mutant p53 in cells leads to up-regulated expression of genes that may affect cell growth and oncogenesis. In"}
{"subject": "grow", "sub_type": "CPA", "rel": "ThemeOf", "object": "aggressively", "obj_type": "PosReg", "file_name": "PubMed-23264849.json", "snippet": " in Lung Cancer through Up-Regulation of Receptor Protein Tyrosine Kinase Axl.\np53 mutations are present in up to 70% of lung cancer. Cancer cells with p53 mutations, in general,  [CLS] grow more aggressively [CLS]  than those with wild-type p53 or no p53. Expression of tumor-derived mutant p53 in cells leads to up-regulated expression of genes that may affect cell growth and oncogenesis. In"}
{"subject": "oncogenesis", "sub_type": "CPA", "rel": "ThemeOf", "object": "affect", "obj_type": "Reg", "file_name": "PubMed-23264849.json", "snippet": " mutations, in general, grow more aggressively than those with wild-type p53 or no p53. Expression of tumor-derived mutant p53 in cells leads to up-regulated expression of genes that may  [CLS] affect cell growth and oncogenesis [CLS] . In our study of this aggressive phenotype, we have investigated the receptor protein tyrosine kinase Axl, which is up-regulated by p53 mutants at both RNA and protein levels in"}
{"subject": "p53", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-23264849.json", "snippet": " Activity of Mutant p53 in Lung Cancer through Up-Regulation of Receptor Protein Tyrosine Kinase Axl.\np53 mutations are present in up to 70% of lung cancer. Cancer cells with  [CLS] p53 mutations [CLS] , in general, grow more aggressively than those with wild-type p53 or no p53. Expression of tumor-derived mutant p53 in cells leads to up-regulated expression of genes that may affect"}
{"subject": "mutant", "sub_type": "Var", "rel": "CauseOf", "object": "up-regulated", "obj_type": "PosReg", "file_name": "PubMed-23264849.json", "snippet": " present in up to 70% of lung cancer. Cancer cells with p53 mutations, in general, grow more aggressively than those with wild-type p53 or no p53. Expression of tumor-derived  [CLS] mutant p53 in cells leads to up-regulated [CLS]  expression of genes that may affect cell growth and oncogenesis. In our study of this aggressive phenotype, we have investigated the receptor protein tyrosine kinase Axl, which is up-regulated"}
{"subject": "expression of genes", "sub_type": "MPA", "rel": "ThemeOf", "object": "up-regulated", "obj_type": "PosReg", "file_name": "PubMed-23264849.json", "snippet": " lung cancer. Cancer cells with p53 mutations, in general, grow more aggressively than those with wild-type p53 or no p53. Expression of tumor-derived mutant p53 in cells leads to  [CLS] up-regulated expression of genes [CLS]  that may affect cell growth and oncogenesis. In our study of this aggressive phenotype, we have investigated the receptor protein tyrosine kinase Axl, which is up-regulated by p53 mutants"}
{"subject": "virulence", "sub_type": "MPA", "rel": "ThemeOf", "object": "enhanced", "obj_type": "PosReg", "file_name": "PubMed-23460523.json", "snippet": " consists of CgPDR1-mediated upregulation of ATP-binding cassette transporters. A range of gain-of-function (GOF) mutations in CgPDR1 have been found to lead not only to azole resistance but also to  [CLS] enhanced virulence [CLS] . This implicates CgPDR1 in the regulation of the interaction of C. glabrata with the host. To identify specific CgPDR1-regulated steps of the host-pathogen interaction, we investigated in this work"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "decreased", "obj_type": "NegReg", "file_name": "PubMed-23460523.json", "snippet": " the interaction of selected CgPDR1 GOF mutants with murine bone marrow-derived macrophages and human acute monocytic leukemia cell line (THP-1)-derived macrophages, as well as different epithelial cell lines. GOF  [CLS] mutations in CgPDR1 did not influence survival and replication within macrophages following phagocytosis but led to decreased [CLS]  adherence to and uptake by macrophages. This may allow evasion from the host's innate cellular immune response. The interaction with epithelial cells revealed an opposite trend, suggesting that GOF"}
{"subject": "adherence to and uptake by macrophages", "sub_type": "CPA", "rel": "ThemeOf", "object": "decreased", "obj_type": "NegReg", "file_name": "PubMed-23460523.json", "snippet": " leukemia cell line (THP-1)-derived macrophages, as well as different epithelial cell lines. GOF mutations in CgPDR1 did not influence survival and replication within macrophages following phagocytosis but led to  [CLS] decreased adherence to and uptake by macrophages [CLS] . This may allow evasion from the host's innate cellular immune response. The interaction with epithelial cells revealed an opposite trend, suggesting that GOF mutations in CgPDR1 may favor epithelial"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-23460523.json", "snippet": " adherence to and uptake by macrophages. This may allow evasion from the host's innate cellular immune response. The interaction with epithelial cells revealed an opposite trend, suggesting that GOF  [CLS] mutations in CgPDR1 may favor epithelial colonization of the host by C. glabrata through increased [CLS]  adherence to epithelial cell layers. These data reveal that GOF mutations in CgPDR1 modulate the interaction with host cells in ways that may contribute to increased virulence."}
{"subject": "adherence", "sub_type": "CPA", "rel": "ThemeOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-23460523.json", "snippet": " cellular immune response. The interaction with epithelial cells revealed an opposite trend, suggesting that GOF mutations in CgPDR1 may favor epithelial colonization of the host by C. glabrata through  [CLS] increased adherence [CLS]  to epithelial cell layers. These data reveal that GOF mutations in CgPDR1 modulate the interaction with host cells in ways that may contribute to increased virulence."}
{"subject": "epithelial colonization", "sub_type": "CPA", "rel": "ThemeOf", "object": "favor", "obj_type": "PosReg", "file_name": "PubMed-23460523.json", "snippet": " by macrophages. This may allow evasion from the host's innate cellular immune response. The interaction with epithelial cells revealed an opposite trend, suggesting that GOF mutations in CgPDR1 may  [CLS] favor epithelial colonization [CLS]  of the host by C. glabrata through increased adherence to epithelial cell layers. These data reveal that GOF mutations in CgPDR1 modulate the interaction with host cells in ways"}
{"subject": "CgPDR1", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-23460523.json", "snippet": " adherence to and uptake by macrophages. This may allow evasion from the host's innate cellular immune response. The interaction with epithelial cells revealed an opposite trend, suggesting that GOF  [CLS] mutations in CgPDR1 [CLS]  may favor epithelial colonization of the host by C. glabrata through increased adherence to epithelial cell layers. These data reveal that GOF mutations in CgPDR1 modulate the interaction with"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "modulate", "obj_type": "Reg", "file_name": "PubMed-23460523.json", "snippet": " trend, suggesting that GOF mutations in CgPDR1 may favor epithelial colonization of the host by C. glabrata through increased adherence to epithelial cell layers. These data reveal that GOF  [CLS] mutations in CgPDR1 modulate [CLS]  the interaction with host cells in ways that may contribute to increased virulence."}
{"subject": "interaction", "sub_type": "Interaction", "rel": "ThemeOf", "object": "modulate", "obj_type": "Reg", "file_name": "PubMed-23460523.json", "snippet": " GOF mutations in CgPDR1 may favor epithelial colonization of the host by C. glabrata through increased adherence to epithelial cell layers. These data reveal that GOF mutations in CgPDR1  [CLS] modulate the interaction [CLS]  with host cells in ways that may contribute to increased virulence."}
{"subject": "CgPDR1", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-23460523.json", "snippet": " trend, suggesting that GOF mutations in CgPDR1 may favor epithelial colonization of the host by C. glabrata through increased adherence to epithelial cell layers. These data reveal that GOF  [CLS] mutations in CgPDR1 [CLS]  modulate the interaction with host cells in ways that may contribute to increased virulence."}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-23460523.json", "snippet": " trend, suggesting that GOF mutations in CgPDR1 may favor epithelial colonization of the host by C. glabrata through increased adherence to epithelial cell layers. These data reveal that GOF  [CLS] mutations in CgPDR1 modulate the interaction with host cells in ways that may contribute to increased [CLS]  virulence."}
{"subject": "virulence", "sub_type": "MPA", "rel": "ThemeOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-23460523.json", "snippet": " C. glabrata through increased adherence to epithelial cell layers. These data reveal that GOF mutations in CgPDR1 modulate the interaction with host cells in ways that may contribute to  [CLS] increased virulence [CLS] ."}
{"subject": "CgPDR1", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-23460523.json", "snippet": " that is known to develop resistance to azole drugs due to increased drug efflux. The mechanism consists of CgPDR1-mediated upregulation of ATP-binding cassette transporters. A range of gain-of-function (GOF)  [CLS] mutations in CgPDR1 have been found to lead not only to azole resistance but also to enhanced virulence. This implicates CgPDR1 [CLS]  in the regulation of the interaction of C. glabrata with the host. To identify specific CgPDR1-regulated steps of the host-pathogen interaction, we investigated in this work the interaction of"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "implicates", "obj_type": "Reg", "file_name": "PubMed-23460523.json", "snippet": " that is known to develop resistance to azole drugs due to increased drug efflux. The mechanism consists of CgPDR1-mediated upregulation of ATP-binding cassette transporters. A range of gain-of-function (GOF)  [CLS] mutations in CgPDR1 have been found to lead not only to azole resistance but also to enhanced virulence. This implicates [CLS]  CgPDR1 in the regulation of the interaction of C. glabrata with the host. To identify specific CgPDR1-regulated steps of the host-pathogen interaction, we investigated in this work the interaction"}
{"subject": "regulation", "sub_type": "MPA", "rel": "ThemeOf", "object": "implicates", "obj_type": "Reg", "file_name": "PubMed-23460523.json", "snippet": " upregulation of ATP-binding cassette transporters. A range of gain-of-function (GOF) mutations in CgPDR1 have been found to lead not only to azole resistance but also to enhanced virulence. This  [CLS] implicates CgPDR1 in the regulation [CLS]  of the interaction of C. glabrata with the host. To identify specific CgPDR1-regulated steps of the host-pathogen interaction, we investigated in this work the interaction of selected CgPDR1 GOF"}
{"subject": "interaction", "sub_type": "Interaction", "rel": "ThemeOf", "object": "regulation", "obj_type": "MPA", "file_name": "PubMed-23460523.json", "snippet": " transporters. A range of gain-of-function (GOF) mutations in CgPDR1 have been found to lead not only to azole resistance but also to enhanced virulence. This implicates CgPDR1 in the  [CLS] regulation of the interaction [CLS]  of C. glabrata with the host. To identify specific CgPDR1-regulated steps of the host-pathogen interaction, we investigated in this work the interaction of selected CgPDR1 GOF mutants with murine"}
{"subject": "CgPDR1", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-23460523.json", "snippet": " the interaction of selected CgPDR1 GOF mutants with murine bone marrow-derived macrophages and human acute monocytic leukemia cell line (THP-1)-derived macrophages, as well as different epithelial cell lines. GOF  [CLS] mutations in CgPDR1 [CLS]  did not influence survival and replication within macrophages following phagocytosis but led to decreased adherence to and uptake by macrophages. This may allow evasion from the host's innate cellular"}
{"subject": "increased", "sub_type": "PosReg", "rel": "CauseOf", "object": "favor", "obj_type": "PosReg", "file_name": "PubMed-23460523.json", "snippet": " by macrophages. This may allow evasion from the host's innate cellular immune response. The interaction with epithelial cells revealed an opposite trend, suggesting that GOF mutations in CgPDR1 may  [CLS] favor epithelial colonization of the host by C. glabrata through increased [CLS]  adherence to epithelial cell layers. These data reveal that GOF mutations in CgPDR1 modulate the interaction with host cells in ways that may contribute to increased virulence."}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-23460523.json", "snippet": " opportunistic pathogen that is known to develop resistance to azole drugs due to increased drug efflux. The mechanism consists of CgPDR1-mediated upregulation of ATP-binding cassette transporters. A range of  [CLS] gain-of-function (GOF) mutations [CLS]  in CgPDR1 have been found to lead not only to azole resistance but also to enhanced virulence. This implicates CgPDR1 in the regulation of the interaction of C. glabrata"}
{"subject": "CgPDR1", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-23460523.json", "snippet": " that is known to develop resistance to azole drugs due to increased drug efflux. The mechanism consists of CgPDR1-mediated upregulation of ATP-binding cassette transporters. A range of gain-of-function (GOF)  [CLS] mutations in CgPDR1 [CLS]  have been found to lead not only to azole resistance but also to enhanced virulence. This implicates CgPDR1 in the regulation of the interaction of C. glabrata with the"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "lead", "obj_type": "PosReg", "file_name": "PubMed-23460523.json", "snippet": " that is known to develop resistance to azole drugs due to increased drug efflux. The mechanism consists of CgPDR1-mediated upregulation of ATP-binding cassette transporters. A range of gain-of-function (GOF)  [CLS] mutations in CgPDR1 have been found to lead [CLS]  not only to azole resistance but also to enhanced virulence. This implicates CgPDR1 in the regulation of the interaction of C. glabrata with the host. To identify specific CgPDR1-regulated"}
{"subject": "azole resistance", "sub_type": "MPA", "rel": "ThemeOf", "object": "lead", "obj_type": "PosReg", "file_name": "PubMed-23460523.json", "snippet": " azole drugs due to increased drug efflux. The mechanism consists of CgPDR1-mediated upregulation of ATP-binding cassette transporters. A range of gain-of-function (GOF) mutations in CgPDR1 have been found to  [CLS] lead not only to azole resistance [CLS]  but also to enhanced virulence. This implicates CgPDR1 in the regulation of the interaction of C. glabrata with the host. To identify specific CgPDR1-regulated steps of the host-pathogen interaction,"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "enhanced", "obj_type": "PosReg", "file_name": "PubMed-23460523.json", "snippet": " that is known to develop resistance to azole drugs due to increased drug efflux. The mechanism consists of CgPDR1-mediated upregulation of ATP-binding cassette transporters. A range of gain-of-function (GOF)  [CLS] mutations in CgPDR1 have been found to lead not only to azole resistance but also to enhanced [CLS]  virulence. This implicates CgPDR1 in the regulation of the interaction of C. glabrata with the host. To identify specific CgPDR1-regulated steps of the host-pathogen interaction, we investigated in this"}
{"subject": "mutp53", "sub_type": "Var", "rel": "CauseOf", "object": "accumulation", "obj_type": "PosReg", "file_name": "PubMed-23680148.json", "snippet": " persistent tissue damage, and are highly prone to inflammation-associated colon cancer. This mutp53 GOF is manifested by rapid onset of flat dysplastic lesions that progress to invasive carcinoma with  [CLS] mutp53 accumulation [CLS]  and augmented NF-\u03baB activation, faithfully recapitulating features frequently observed in human colitis-associated colorectal cancer (CAC). These findings might explain the early appearance of p53 mutations in human CAC."}
{"subject": "NF-\u03baB", "sub_type": "Protein", "rel": "CauseOf", "object": "activation", "obj_type": "PosReg", "file_name": "PubMed-23680148.json", "snippet": " are highly prone to inflammation-associated colon cancer. This mutp53 GOF is manifested by rapid onset of flat dysplastic lesions that progress to invasive carcinoma with mutp53 accumulation and augmented  [CLS] NF-\u03baB activation [CLS] , faithfully recapitulating features frequently observed in human colitis-associated colorectal cancer (CAC). These findings might explain the early appearance of p53 mutations in human CAC."}
{"subject": "activation", "sub_type": "PosReg", "rel": "CauseOf", "object": "progress", "obj_type": "PosReg", "file_name": "PubMed-23680148.json", "snippet": " develop severe chronic inflammation and persistent tissue damage, and are highly prone to inflammation-associated colon cancer. This mutp53 GOF is manifested by rapid onset of flat dysplastic lesions that  [CLS] progress to invasive carcinoma with mutp53 accumulation and augmented NF-\u03baB activation [CLS] , faithfully recapitulating features frequently observed in human colitis-associated colorectal cancer (CAC). These findings might explain the early appearance of p53 mutations in human CAC."}
{"subject": "invasive carcinoma", "sub_type": "Disease", "rel": "ThemeOf", "object": "progress", "obj_type": "PosReg", "file_name": "PubMed-23680148.json", "snippet": " develop severe chronic inflammation and persistent tissue damage, and are highly prone to inflammation-associated colon cancer. This mutp53 GOF is manifested by rapid onset of flat dysplastic lesions that  [CLS] progress to invasive carcinoma [CLS]  with mutp53 accumulation and augmented NF-\u03baB activation, faithfully recapitulating features frequently observed in human colitis-associated colorectal cancer (CAC). These findings might explain the early appearance of p53 mutations in"}
{"subject": "accumulation", "sub_type": "PosReg", "rel": "CauseOf", "object": "progress", "obj_type": "PosReg", "file_name": "PubMed-23680148.json", "snippet": " develop severe chronic inflammation and persistent tissue damage, and are highly prone to inflammation-associated colon cancer. This mutp53 GOF is manifested by rapid onset of flat dysplastic lesions that  [CLS] progress to invasive carcinoma with mutp53 accumulation [CLS]  and augmented NF-\u03baB activation, faithfully recapitulating features frequently observed in human colitis-associated colorectal cancer (CAC). These findings might explain the early appearance of p53 mutations in human CAC."}
{"subject": "mutp53", "sub_type": "Var", "rel": "CauseOf", "object": "activation", "obj_type": "PosReg", "file_name": "PubMed-23680148.json", "snippet": " persistent tissue damage, and are highly prone to inflammation-associated colon cancer. This mutp53 GOF is manifested by rapid onset of flat dysplastic lesions that progress to invasive carcinoma with  [CLS] mutp53 accumulation and augmented NF-\u03baB activation [CLS] , faithfully recapitulating features frequently observed in human colitis-associated colorectal cancer (CAC). These findings might explain the early appearance of p53 mutations in human CAC."}
{"subject": "colitis-associated colorectal cancer", "sub_type": "Disease", "rel": "ThemeOf", "object": "progress", "obj_type": "PosReg", "file_name": "PubMed-23680148.json", "snippet": " develop severe chronic inflammation and persistent tissue damage, and are highly prone to inflammation-associated colon cancer. This mutp53 GOF is manifested by rapid onset of flat dysplastic lesions that  [CLS] progress to invasive carcinoma with mutp53 accumulation and augmented NF-\u03baB activation, faithfully recapitulating features frequently observed in human colitis-associated colorectal cancer [CLS]  (CAC). These findings might explain the early appearance of p53 mutations in human CAC."}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "higher", "obj_type": "PosReg", "file_name": "PubMed-23967324.json", "snippet": " (NE-GOF). GOF mutations were more likely to occur within mutational hotspots, and at CpG sites, and resulted in mutp53 with higher functional severity (FS) scores. Clinically, patients with GOF  [CLS] mutations showed a higher [CLS]  frequency of platinum resistance (22/58, 37.9%) than patients with NE-GOF mutations (12/56, 21.4%) (p=0.054). Furthermore, patients with GOF mutations were more likely to develop distant metastasis (36/55, 65.5%) than"}
{"subject": "platinum resistance", "sub_type": "CPA", "rel": "ThemeOf", "object": "higher", "obj_type": "PosReg", "file_name": "PubMed-23967324.json", "snippet": " were more likely to occur within mutational hotspots, and at CpG sites, and resulted in mutp53 with higher functional severity (FS) scores. Clinically, patients with GOF mutations showed a  [CLS] higher frequency of platinum resistance [CLS]  (22/58, 37.9%) than patients with NE-GOF mutations (12/56, 21.4%) (p=0.054). Furthermore, patients with GOF mutations were more likely to develop distant metastasis (36/55, 65.5%) than local recurrence (19/55, 34.5%),"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "develop", "obj_type": "PosReg", "file_name": "PubMed-23967324.json", "snippet": " severity (FS) scores. Clinically, patients with GOF mutations showed a higher frequency of platinum resistance (22/58, 37.9%) than patients with NE-GOF mutations (12/56, 21.4%) (p=0.054). Furthermore, patients with GOF  [CLS] mutations were more likely to develop [CLS]  distant metastasis (36/55, 65.5%) than local recurrence (19/55, 34.5%), whereas patients with NE-GOF mutations showed a higher frequency of locoregional recurrence (26/47, 55.3%) than distant metastasis (21/47, 44.7%) (p=0.035)."}
{"subject": "distant metastasis", "sub_type": "CPA", "rel": "ThemeOf", "object": "develop", "obj_type": "PosReg", "file_name": "PubMed-23967324.json", "snippet": " with GOF mutations showed a higher frequency of platinum resistance (22/58, 37.9%) than patients with NE-GOF mutations (12/56, 21.4%) (p=0.054). Furthermore, patients with GOF mutations were more likely to  [CLS] develop distant metastasis [CLS]  (36/55, 65.5%) than local recurrence (19/55, 34.5%), whereas patients with NE-GOF mutations showed a higher frequency of locoregional recurrence (26/47, 55.3%) than distant metastasis (21/47, 44.7%) (p=0.035). There were"}
{"subject": "p53", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-23967324.json", "snippet": " TP53, which occurs predominantly by missense mutations in exons 4-9, is a major genetic alteration in a subset of human cancer. In spite of growing evidence that gain-of-function (GOF)  [CLS] mutations of p53 [CLS]  also have oncogenic activity, little is known about the clinical relevance of these mutations.\nMETHODS: The clinicopathological features of high-grade serous ovarian carcinoma (HGS-OvCa) patients with GOF p53 mutations"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-23967324.json", "snippet": " Inactivation of TP53, which occurs predominantly by missense mutations in exons 4-9, is a major genetic alteration in a subset of human cancer. In spite of growing evidence that  [CLS] gain-of-function (GOF) mutations [CLS]  of p53 also have oncogenic activity, little is known about the clinical relevance of these mutations.\nMETHODS: The clinicopathological features of high-grade serous ovarian carcinoma (HGS-OvCa) patients with GOF"}
{"subject": "oncogenic activity", "sub_type": "CPA", "rel": "ThemeOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-23967324.json", "snippet": " Inactivation of TP53, which occurs predominantly by missense mutations in exons 4-9, is a major genetic alteration in a subset of human cancer. In spite of growing evidence that  [CLS] gain-of-function (GOF) mutations of p53 also have oncogenic activity [CLS] , little is known about the clinical relevance of these mutations.\nMETHODS: The clinicopathological features of high-grade serous ovarian carcinoma (HGS-OvCa) patients with GOF p53 mutations were evaluated according to"}
{"subject": "mutp53", "sub_type": "Var", "rel": "CauseOf", "object": "GOF", "obj_type": "PosReg", "file_name": "PubMed-23967324.json", "snippet": " than distant metastasis (21/47, 44.7%) (p=0.035). There were no differences in overall or progression-free survival between patients with GOF or NE-GOF mutp53.\nCONCLUSION: This study demonstrates that patient with  [CLS] GOF mutp53 [CLS]  is characterized by a greater likelihood of platinum treatment resistance and distant metastatic properties in HGS-OvCa."}
{"subject": "HGS-OvCa", "sub_type": "Disease", "rel": "ThemeOf", "object": "GOF", "obj_type": "PosReg", "file_name": "PubMed-23967324.json", "snippet": " than distant metastasis (21/47, 44.7%) (p=0.035). There were no differences in overall or progression-free survival between patients with GOF or NE-GOF mutp53.\nCONCLUSION: This study demonstrates that patient with  [CLS] GOF mutp53 is characterized by a greater likelihood of platinum treatment resistance and distant metastatic properties in HGS-OvCa [CLS] ."}
{"subject": "p53", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-23967324.json", "snippet": " [CLS] mutations of p53 [CLS]  in high-grade serous ovarian carcinoma.\nPURPOSE: Inactivation of TP53, which occurs predominantly by missense mutations in exons 4-9, is a major genetic alteration in a subset of human cancer."}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-23967324.json", "snippet": " [CLS] gain-of-function mutations [CLS]  of p53 in high-grade serous ovarian carcinoma.\nPURPOSE: Inactivation of TP53, which occurs predominantly by missense mutations in exons 4-9, is a major genetic alteration in a subset of"}
{"subject": "high-grade serous ovarian carcinoma", "sub_type": "Disease", "rel": "ThemeOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-23967324.json", "snippet": " [CLS] gain-of-function mutations of p53 in high-grade serous ovarian carcinoma [CLS] .\nPURPOSE: Inactivation of TP53, which occurs predominantly by missense mutations in exons 4-9, is a major genetic alteration in a subset of human cancer. In spite of growing evidence"}
{"subject": "mutp53", "sub_type": "Var", "rel": "CauseOf", "object": "greater", "obj_type": "PosReg", "file_name": "PubMed-23967324.json", "snippet": " distant metastasis (21/47, 44.7%) (p=0.035). There were no differences in overall or progression-free survival between patients with GOF or NE-GOF mutp53.\nCONCLUSION: This study demonstrates that patient with GOF  [CLS] mutp53 is characterized by a greater [CLS]  likelihood of platinum treatment resistance and distant metastatic properties in HGS-OvCa."}
{"subject": "platinum treatment resistance", "sub_type": "CPA", "rel": "ThemeOf", "object": "greater", "obj_type": "PosReg", "file_name": "PubMed-23967324.json", "snippet": " There were no differences in overall or progression-free survival between patients with GOF or NE-GOF mutp53.\nCONCLUSION: This study demonstrates that patient with GOF mutp53 is characterized by a  [CLS] greater likelihood of platinum treatment resistance [CLS]  and distant metastatic properties in HGS-OvCa."}
{"subject": "distant metastatic properties", "sub_type": "CPA", "rel": "ThemeOf", "object": "greater", "obj_type": "PosReg", "file_name": "PubMed-23967324.json", "snippet": " There were no differences in overall or progression-free survival between patients with GOF or NE-GOF mutp53.\nCONCLUSION: This study demonstrates that patient with GOF mutp53 is characterized by a  [CLS] greater likelihood of platinum treatment resistance and distant metastatic properties [CLS]  in HGS-OvCa."}
{"subject": "p53 protein", "sub_type": "Protein", "rel": "ThemeOf", "object": "mutation", "obj_type": "Var", "file_name": "PubMed-23967324.json", "snippet": " to a comprehensive somatic mutation profile comprised of whole exome sequencing, mRNA expression, and protein expression profiles obtained from the Cancer Genome Atlas (TCGA).\nRESULTS: Patients with a mutant  [CLS] p53 protein (mutp53) with a GOF mutation [CLS]  showed higher p53 mRNA and protein expression levels than patients with p53 mutation with no evidence of GOF (NE-GOF). GOF mutations were more likely to occur within mutational hotspots,"}
{"subject": "mutation", "sub_type": "Var", "rel": "CauseOf", "object": "higher", "obj_type": "PosReg", "file_name": "PubMed-23967324.json", "snippet": " comprised of whole exome sequencing, mRNA expression, and protein expression profiles obtained from the Cancer Genome Atlas (TCGA).\nRESULTS: Patients with a mutant p53 protein (mutp53) with a GOF  [CLS] mutation showed higher [CLS]  p53 mRNA and protein expression levels than patients with p53 mutation with no evidence of GOF (NE-GOF). GOF mutations were more likely to occur within mutational hotspots, and at"}
{"subject": "p53 mRNA and protein expression levels", "sub_type": "MPA", "rel": "ThemeOf", "object": "higher", "obj_type": "PosReg", "file_name": "PubMed-23967324.json", "snippet": " whole exome sequencing, mRNA expression, and protein expression profiles obtained from the Cancer Genome Atlas (TCGA).\nRESULTS: Patients with a mutant p53 protein (mutp53) with a GOF mutation showed  [CLS] higher p53 mRNA and protein expression levels [CLS]  than patients with p53 mutation with no evidence of GOF (NE-GOF). GOF mutations were more likely to occur within mutational hotspots, and at CpG sites, and resulted in mutp53"}
{"subject": "mutp53", "sub_type": "Var", "rel": "CauseOf", "object": "GOF", "obj_type": "PosReg", "file_name": "PubMed-24356649.json", "snippet": " similar to human MDM2-B is overexpressed in the majority of tumours, which promotes mutp53 accumulation and tumorigenesis. Thus, overexpression of MDM2 isoforms promotes mutp53 accumulation in tumours, contributing to  [CLS] mutp53 GOF [CLS]  in tumorigenesis. This may be an important mechanism by which MDM2 isoforms promote tumorigenesis."}
{"subject": "tumorigenesis", "sub_type": "CPA", "rel": "ThemeOf", "object": "GOF", "obj_type": "PosReg", "file_name": "PubMed-24356649.json", "snippet": " to human MDM2-B is overexpressed in the majority of tumours, which promotes mutp53 accumulation and tumorigenesis. Thus, overexpression of MDM2 isoforms promotes mutp53 accumulation in tumours, contributing to mutp53  [CLS] GOF in tumorigenesis [CLS] . This may be an important mechanism by which MDM2 isoforms promote tumorigenesis."}
{"subject": "mutp53", "sub_type": "Var", "rel": "CauseOf", "object": "GOF", "obj_type": "PosReg", "file_name": "PubMed-24356649.json", "snippet": " frequently mutated in tumours. Mutant p53 (Mutp53) proteins often gain new activities in promoting tumorigenesis, defined as gain-of-function (GOF). Mutp53 can accumulate to high levels in tumours, which promotes  [CLS] mutp53 GOF [CLS]  in tumorigenesis. The mechanism of mutp53 accumulation is poorly understood. Here we find that MDM2 isoforms promote mutp53 accumulation in tumours. MDM2 isoform B (MDM2-B), the MDM2 isoform most"}
{"subject": "tumorigenesis", "sub_type": "CPA", "rel": "ThemeOf", "object": "GOF", "obj_type": "PosReg", "file_name": "PubMed-24356649.json", "snippet": " mutated in tumours. Mutant p53 (Mutp53) proteins often gain new activities in promoting tumorigenesis, defined as gain-of-function (GOF). Mutp53 can accumulate to high levels in tumours, which promotes mutp53  [CLS] GOF in tumorigenesis [CLS] . The mechanism of mutp53 accumulation is poorly understood. Here we find that MDM2 isoforms promote mutp53 accumulation in tumours. MDM2 isoform B (MDM2-B), the MDM2 isoform most frequently over-expressed"}
{"subject": "promoting tumorigenesis", "sub_type": "CPA", "rel": "ThemeOf", "object": "gain new activities", "obj_type": "PosReg", "file_name": "PubMed-24356649.json", "snippet": " [CLS] gain new activities in promoting tumorigenesis [CLS] , defined as gain-of-function (GOF). Mutp53 can accumulate to high levels in tumours, which promotes mutp53 GOF in tumorigenesis. The mechanism of mutp53 accumulation is poorly understood. Here we find"}
{"subject": "p53", "sub_type": "Protein", "rel": "ThemeOf", "object": "Mutant", "obj_type": "Var", "file_name": "PubMed-24356649.json", "snippet": " [CLS] Mutant p53 [CLS]  (Mutp53) proteins often gain new activities in promoting tumorigenesis, defined as gain-of-function (GOF). Mutp53 can accumulate to high levels in tumours, which promotes mutp53 GOF in tumorigenesis. The mechanism"}
{"subject": "Mutant", "sub_type": "Var", "rel": "CauseOf", "object": "gain new activities", "obj_type": "PosReg", "file_name": "PubMed-24356649.json", "snippet": " [CLS] Mutant p53 (Mutp53) proteins often gain new activities [CLS]  in promoting tumorigenesis, defined as gain-of-function (GOF). Mutp53 can accumulate to high levels in tumours, which promotes mutp53 GOF in tumorigenesis. The mechanism of mutp53 accumulation is poorly understood."}
{"subject": "p53-R248W/P72R", "sub_type": "Var", "rel": "CauseOf", "object": "promoted", "obj_type": "PosReg", "file_name": "PubMed-24373920.json", "snippet": " sensitized 3AB-OS cells to TRAIL-induced apoptosis by DR5 up-regulation; moreover, it strongly decreased the levels of stemness and invasiveness genes. We have also found that the ectopic expression of  [CLS] p53-R248W/P72R in MG63 cells promoted [CLS]  cancer stem-like features, as high proliferation rate, sphere formation, clonogenic growth, high migration and invasive ability; furthermore, it strongly increased the levels of stemness proteins. Overall, the findings suggest"}
{"subject": "cancer stem-like features", "sub_type": "CPA", "rel": "ThemeOf", "object": "promoted", "obj_type": "PosReg", "file_name": "PubMed-24373920.json", "snippet": " TRAIL-induced apoptosis by DR5 up-regulation; moreover, it strongly decreased the levels of stemness and invasiveness genes. We have also found that the ectopic expression of p53-R248W/P72R in MG63 cells  [CLS] promoted cancer stem-like features [CLS] , as high proliferation rate, sphere formation, clonogenic growth, high migration and invasive ability; furthermore, it strongly increased the levels of stemness proteins. Overall, the findings suggest the involvement of"}
{"subject": "p53-R248W/P72R", "sub_type": "Var", "rel": "CauseOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-24373920.json", "snippet": " sensitized 3AB-OS cells to TRAIL-induced apoptosis by DR5 up-regulation; moreover, it strongly decreased the levels of stemness and invasiveness genes. We have also found that the ectopic expression of  [CLS] p53-R248W/P72R in MG63 cells promoted cancer stem-like features, as high proliferation rate, sphere formation, clonogenic growth, high migration and invasive ability; furthermore, it strongly increased [CLS]  the levels of stemness proteins. Overall, the findings suggest the involvement of p53-R248W/P72R at the origin of the aberrant characters of the 3AB-OS cells with the hypothesis that its"}
{"subject": "levels of stemness proteins", "sub_type": "MPA", "rel": "ThemeOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-24373920.json", "snippet": " that the ectopic expression of p53-R248W/P72R in MG63 cells promoted cancer stem-like features, as high proliferation rate, sphere formation, clonogenic growth, high migration and invasive ability; furthermore, it strongly  [CLS] increased the levels of stemness proteins [CLS] . Overall, the findings suggest the involvement of p53-R248W/P72R at the origin of the aberrant characters of the 3AB-OS cells with the hypothesis that its GOF can be at the"}
{"subject": "p53", "sub_type": "Gene", "rel": "ThemeOf", "object": "Mutant", "obj_type": "Var", "file_name": "PubMed-24373920.json", "snippet": " [CLS] Mutant p53 [CLS]  gain of function can be at the root of dedifferentiation of human osteosarcoma MG63 cells into 3AB-OS cancer stem cells.\nOsteosarcoma is a highly metastatic tumor affecting adolescents, for"}
{"subject": "Mutant", "sub_type": "Var", "rel": "CauseOf", "object": "gain of function", "obj_type": "PosReg", "file_name": "PubMed-24373920.json", "snippet": " [CLS] Mutant p53 gain of function [CLS]  can be at the root of dedifferentiation of human osteosarcoma MG63 cells into 3AB-OS cancer stem cells.\nOsteosarcoma is a highly metastatic tumor affecting adolescents, for which there is"}
{"subject": "human osteosarcoma", "sub_type": "Disease", "rel": "ThemeOf", "object": "gain of function", "obj_type": "PosReg", "file_name": "PubMed-24373920.json", "snippet": " [CLS] gain of function can be at the root of dedifferentiation of human osteosarcoma [CLS]  MG63 cells into 3AB-OS cancer stem cells.\nOsteosarcoma is a highly metastatic tumor affecting adolescents, for which there is no second-line chemotherapy. As suggested for most tumors, its capability"}
{"subject": "high proliferation rate", "sub_type": "CPA", "rel": "ThemeOf", "object": "cancer stem-like features", "obj_type": "CPA", "file_name": "PubMed-24373920.json", "snippet": " apoptosis by DR5 up-regulation; moreover, it strongly decreased the levels of stemness and invasiveness genes. We have also found that the ectopic expression of p53-R248W/P72R in MG63 cells promoted  [CLS] cancer stem-like features, as high proliferation rate [CLS] , sphere formation, clonogenic growth, high migration and invasive ability; furthermore, it strongly increased the levels of stemness proteins. Overall, the findings suggest the involvement of p53-R248W/P72R at the origin"}
{"subject": "sphere formation", "sub_type": "CPA", "rel": "ThemeOf", "object": "cancer stem-like features", "obj_type": "CPA", "file_name": "PubMed-24373920.json", "snippet": " apoptosis by DR5 up-regulation; moreover, it strongly decreased the levels of stemness and invasiveness genes. We have also found that the ectopic expression of p53-R248W/P72R in MG63 cells promoted  [CLS] cancer stem-like features, as high proliferation rate, sphere formation [CLS] , clonogenic growth, high migration and invasive ability; furthermore, it strongly increased the levels of stemness proteins. Overall, the findings suggest the involvement of p53-R248W/P72R at the origin of the"}
{"subject": "clonogenic growth", "sub_type": "CPA", "rel": "ThemeOf", "object": "cancer stem-like features", "obj_type": "CPA", "file_name": "PubMed-24373920.json", "snippet": " apoptosis by DR5 up-regulation; moreover, it strongly decreased the levels of stemness and invasiveness genes. We have also found that the ectopic expression of p53-R248W/P72R in MG63 cells promoted  [CLS] cancer stem-like features, as high proliferation rate, sphere formation, clonogenic growth [CLS] , high migration and invasive ability; furthermore, it strongly increased the levels of stemness proteins. Overall, the findings suggest the involvement of p53-R248W/P72R at the origin of the aberrant characters"}
{"subject": "high migration", "sub_type": "CPA", "rel": "ThemeOf", "object": "cancer stem-like features", "obj_type": "CPA", "file_name": "PubMed-24373920.json", "snippet": " apoptosis by DR5 up-regulation; moreover, it strongly decreased the levels of stemness and invasiveness genes. We have also found that the ectopic expression of p53-R248W/P72R in MG63 cells promoted  [CLS] cancer stem-like features, as high proliferation rate, sphere formation, clonogenic growth, high migration [CLS]  and invasive ability; furthermore, it strongly increased the levels of stemness proteins. Overall, the findings suggest the involvement of p53-R248W/P72R at the origin of the aberrant characters of the"}
{"subject": "invasive ability", "sub_type": "CPA", "rel": "ThemeOf", "object": "cancer stem-like features", "obj_type": "CPA", "file_name": "PubMed-24373920.json", "snippet": " apoptosis by DR5 up-regulation; moreover, it strongly decreased the levels of stemness and invasiveness genes. We have also found that the ectopic expression of p53-R248W/P72R in MG63 cells promoted  [CLS] cancer stem-like features, as high proliferation rate, sphere formation, clonogenic growth, high migration and invasive ability [CLS] ; furthermore, it strongly increased the levels of stemness proteins. Overall, the findings suggest the involvement of p53-R248W/P72R at the origin of the aberrant characters of the 3AB-OS cells with"}
{"subject": "p53-R248W/P72R", "sub_type": "Var", "rel": "CauseOf", "object": "involvement", "obj_type": "Reg", "file_name": "PubMed-24373920.json", "snippet": " stem-like features, as high proliferation rate, sphere formation, clonogenic growth, high migration and invasive ability; furthermore, it strongly increased the levels of stemness proteins. Overall, the findings suggest the  [CLS] involvement of p53-R248W/P72R [CLS]  at the origin of the aberrant characters of the 3AB-OS cells with the hypothesis that its GOF can be at the root of the dedifferentiation of MG63 cells into"}
{"subject": "origin of the aberrant characters of the 3AB-OS cells", "sub_type": "CPA", "rel": "ThemeOf", "object": "involvement", "obj_type": "Reg", "file_name": "PubMed-24373920.json", "snippet": " stem-like features, as high proliferation rate, sphere formation, clonogenic growth, high migration and invasive ability; furthermore, it strongly increased the levels of stemness proteins. Overall, the findings suggest the  [CLS] involvement of p53-R248W/P72R at the origin of the aberrant characters of the 3AB-OS cells [CLS]  with the hypothesis that its GOF can be at the root of the dedifferentiation of MG63 cells into CSCs."}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "higher", "obj_type": "PosReg", "file_name": "PubMed-24603336.json", "snippet": " the Arg248 and Arg282 positions displayed significant association with shorter patient survival, but such association was not evident for other hotspot GOF mutations. Gene set enrichment analysis on these  [CLS] mutations revealed higher [CLS]  activity of drug-metabolizing enzymes, including the CYP3A4 cytochrome P450. Ectopic expression of p53 mutant R282W in H1299 and SaOS2 cells significantly upregulated CYP3A4 mRNA and protein levels, and cancer"}
{"subject": "activity", "sub_type": "MPA", "rel": "ThemeOf", "object": "higher", "obj_type": "PosReg", "file_name": "PubMed-24603336.json", "snippet": " and Arg282 positions displayed significant association with shorter patient survival, but such association was not evident for other hotspot GOF mutations. Gene set enrichment analysis on these mutations revealed  [CLS] higher activity [CLS]  of drug-metabolizing enzymes, including the CYP3A4 cytochrome P450. Ectopic expression of p53 mutant R282W in H1299 and SaOS2 cells significantly upregulated CYP3A4 mRNA and protein levels, and cancer cell"}
{"subject": "p53", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutant R282W", "obj_type": "Var", "file_name": "PubMed-24603336.json", "snippet": " was not evident for other hotspot GOF mutations. Gene set enrichment analysis on these mutations revealed higher activity of drug-metabolizing enzymes, including the CYP3A4 cytochrome P450. Ectopic expression of  [CLS] p53 mutant R282W [CLS]  in H1299 and SaOS2 cells significantly upregulated CYP3A4 mRNA and protein levels, and cancer cell lines bearing mortality-associated p53 mutations display higher CYP3A4 expression and resistance to several CYP3A4-metabolized"}
{"subject": "mutant R282W", "sub_type": "Var", "rel": "ThemeOf", "object": "Ectopic expression", "obj_type": "MPA", "file_name": "PubMed-24603336.json", "snippet": " but such association was not evident for other hotspot GOF mutations. Gene set enrichment analysis on these mutations revealed higher activity of drug-metabolizing enzymes, including the CYP3A4 cytochrome P450.  [CLS] Ectopic expression of p53 mutant R282W [CLS]  in H1299 and SaOS2 cells significantly upregulated CYP3A4 mRNA and protein levels, and cancer cell lines bearing mortality-associated p53 mutations display higher CYP3A4 expression and resistance to several CYP3A4-metabolized"}
{"subject": "Ectopic expression", "sub_type": "MPA", "rel": "CauseOf", "object": "upregulated", "obj_type": "PosReg", "file_name": "PubMed-24603336.json", "snippet": " but such association was not evident for other hotspot GOF mutations. Gene set enrichment analysis on these mutations revealed higher activity of drug-metabolizing enzymes, including the CYP3A4 cytochrome P450.  [CLS] Ectopic expression of p53 mutant R282W in H1299 and SaOS2 cells significantly upregulated [CLS]  CYP3A4 mRNA and protein levels, and cancer cell lines bearing mortality-associated p53 mutations display higher CYP3A4 expression and resistance to several CYP3A4-metabolized chemotherapeutic drugs. Our results suggest that p53"}
{"subject": "CYP3A4 mRNA and protein levels", "sub_type": "MPA", "rel": "ThemeOf", "object": "upregulated", "obj_type": "PosReg", "file_name": "PubMed-24603336.json", "snippet": " set enrichment analysis on these mutations revealed higher activity of drug-metabolizing enzymes, including the CYP3A4 cytochrome P450. Ectopic expression of p53 mutant R282W in H1299 and SaOS2 cells significantly  [CLS] upregulated CYP3A4 mRNA and protein levels [CLS] , and cancer cell lines bearing mortality-associated p53 mutations display higher CYP3A4 expression and resistance to several CYP3A4-metabolized chemotherapeutic drugs. Our results suggest that p53 mutations have unequal GOF activities"}
{"subject": "expression", "sub_type": "MPA", "rel": "ThemeOf", "object": "higher", "obj_type": "PosReg", "file_name": "PubMed-24603336.json", "snippet": " cytochrome P450. Ectopic expression of p53 mutant R282W in H1299 and SaOS2 cells significantly upregulated CYP3A4 mRNA and protein levels, and cancer cell lines bearing mortality-associated p53 mutations display  [CLS] higher CYP3A4 expression [CLS]  and resistance to several CYP3A4-metabolized chemotherapeutic drugs. Our results suggest that p53 mutations have unequal GOF activities in human cancers, and future evaluation of p53 as a cancer biomarker"}
{"subject": "resistance", "sub_type": "CPA", "rel": "ThemeOf", "object": "higher", "obj_type": "PosReg", "file_name": "PubMed-24603336.json", "snippet": " cytochrome P450. Ectopic expression of p53 mutant R282W in H1299 and SaOS2 cells significantly upregulated CYP3A4 mRNA and protein levels, and cancer cell lines bearing mortality-associated p53 mutations display  [CLS] higher CYP3A4 expression and resistance [CLS]  to several CYP3A4-metabolized chemotherapeutic drugs. Our results suggest that p53 mutations have unequal GOF activities in human cancers, and future evaluation of p53 as a cancer biomarker should consider"}
{"subject": "p53", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-24603336.json", "snippet": " including the CYP3A4 cytochrome P450. Ectopic expression of p53 mutant R282W in H1299 and SaOS2 cells significantly upregulated CYP3A4 mRNA and protein levels, and cancer cell lines bearing mortality-associated  [CLS] p53 mutations [CLS]  display higher CYP3A4 expression and resistance to several CYP3A4-metabolized chemotherapeutic drugs. Our results suggest that p53 mutations have unequal GOF activities in human cancers, and future evaluation of p53"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "higher", "obj_type": "PosReg", "file_name": "PubMed-24603336.json", "snippet": " the CYP3A4 cytochrome P450. Ectopic expression of p53 mutant R282W in H1299 and SaOS2 cells significantly upregulated CYP3A4 mRNA and protein levels, and cancer cell lines bearing mortality-associated p53  [CLS] mutations display higher [CLS]  CYP3A4 expression and resistance to several CYP3A4-metabolized chemotherapeutic drugs. Our results suggest that p53 mutations have unequal GOF activities in human cancers, and future evaluation of p53 as a"}
{"subject": "drug-metabolizing enzymes", "sub_type": "Enzyme", "rel": "ThemeOf", "object": "activity", "obj_type": "MPA", "file_name": "PubMed-24603336.json", "snippet": " Arg282 positions displayed significant association with shorter patient survival, but such association was not evident for other hotspot GOF mutations. Gene set enrichment analysis on these mutations revealed higher  [CLS] activity of drug-metabolizing enzymes [CLS] , including the CYP3A4 cytochrome P450. Ectopic expression of p53 mutant R282W in H1299 and SaOS2 cells significantly upregulated CYP3A4 mRNA and protein levels, and cancer cell lines bearing mortality-associated"}
{"subject": "CYP3A4 cytochrome P450", "sub_type": "Enzyme", "rel": "ThemeOf", "object": "drug-metabolizing enzymes", "obj_type": "Enzyme", "file_name": "PubMed-24603336.json", "snippet": " displayed significant association with shorter patient survival, but such association was not evident for other hotspot GOF mutations. Gene set enrichment analysis on these mutations revealed higher activity of  [CLS] drug-metabolizing enzymes, including the CYP3A4 cytochrome P450 [CLS] . Ectopic expression of p53 mutant R282W in H1299 and SaOS2 cells significantly upregulated CYP3A4 mRNA and protein levels, and cancer cell lines bearing mortality-associated p53 mutations display higher CYP3A4"}
{"subject": "CYP3A4", "sub_type": "Enzyme", "rel": "ThemeOf", "object": "expression", "obj_type": "MPA", "file_name": "PubMed-24603336.json", "snippet": " P450. Ectopic expression of p53 mutant R282W in H1299 and SaOS2 cells significantly upregulated CYP3A4 mRNA and protein levels, and cancer cell lines bearing mortality-associated p53 mutations display higher  [CLS] CYP3A4 expression [CLS]  and resistance to several CYP3A4-metabolized chemotherapeutic drugs. Our results suggest that p53 mutations have unequal GOF activities in human cancers, and future evaluation of p53 as a cancer biomarker"}
{"subject": "\u03b2-catenin", "sub_type": "Protein", "rel": "ThemeOf", "object": "mutants", "obj_type": "Var", "file_name": "PubMed-24632946.json", "snippet": " The expression of \u03b2-catenin is observed in endodermal epithelia, including URS epithelia. We modulated the \u03b2-catenin gene conditionally in endodermal epithelia by utilizing tamoxifen-inducible Cre driver line (Shh(CreERT2)). Both  [CLS] \u03b2-catenin loss- and gain-of-function (LOF and GOF) mutants [CLS]  displayed abnormal clefts in the perineal region and hypoplastic elongation of the URS. The mutants also displayed reduced cell proliferation in the URS mesenchyme. In addition, the \u03b2-catenin GOF"}
{"subject": "expression levels", "sub_type": "MPA", "rel": "ThemeOf", "object": "reduced", "obj_type": "NegReg", "file_name": "PubMed-24632946.json", "snippet": " reduced cell proliferation in the URS mesenchyme. In addition, the \u03b2-catenin GOF mutants displayed reduced apoptosis and subsequently increased apoptosis in the URS epithelium. This instability possibly resulted in  [CLS] reduced expression levels [CLS]  of differentiation markers, such as keratin 1 and filaggrin, in the perineal epithelia. The expression of bone morphogenetic protein (Bmp) genes, such as Bmp4 and Bmp7, was also ectopically"}
{"subject": "expression", "sub_type": "MPA", "rel": "CauseOf", "object": "induced", "obj_type": "PosReg", "file_name": "PubMed-24632946.json", "snippet": " subsequently increased apoptosis in the URS epithelium. This instability possibly resulted in reduced expression levels of differentiation markers, such as keratin 1 and filaggrin, in the perineal epithelia. The  [CLS] expression of bone morphogenetic protein (Bmp) genes, such as Bmp4 and Bmp7, was also ectopically induced [CLS]  in the epithelia of the URS in the \u03b2-catenin GOF mutants. The expression of the Msx2 gene and phosphorylated-Smad1/5/8, possible readouts of Bmp signaling, was also increased in the"}
{"subject": "\u03b2-catenin", "sub_type": "Protein", "rel": "ThemeOf", "object": "mutants", "obj_type": "Var", "file_name": "PubMed-24632946.json", "snippet": " in the perineal epithelia. The expression of bone morphogenetic protein (Bmp) genes, such as Bmp4 and Bmp7, was also ectopically induced in the epithelia of the URS in the  [CLS] \u03b2-catenin GOF mutants [CLS] . The expression of the Msx2 gene and phosphorylated-Smad1/5/8, possible readouts of Bmp signaling, was also increased in the mutants. Moreover, we introduced an additional mutation for a Bmp receptor"}
{"subject": "mutants", "sub_type": "Var", "rel": "ThemeOf", "object": "induced", "obj_type": "PosReg", "file_name": "PubMed-24632946.json", "snippet": " of differentiation markers, such as keratin 1 and filaggrin, in the perineal epithelia. The expression of bone morphogenetic protein (Bmp) genes, such as Bmp4 and Bmp7, was also ectopically  [CLS] induced in the epithelia of the URS in the \u03b2-catenin GOF mutants [CLS] . The expression of the Msx2 gene and phosphorylated-Smad1/5/8, possible readouts of Bmp signaling, was also increased in the mutants. Moreover, we introduced an additional mutation for a Bmp receptor"}
{"subject": "Msx2 gene", "sub_type": "Gene", "rel": "ThemeOf", "object": "expression", "obj_type": "MPA", "file_name": "PubMed-24632946.json", "snippet": " The expression of bone morphogenetic protein (Bmp) genes, such as Bmp4 and Bmp7, was also ectopically induced in the epithelia of the URS in the \u03b2-catenin GOF mutants. The  [CLS] expression of the Msx2 gene [CLS]  and phosphorylated-Smad1/5/8, possible readouts of Bmp signaling, was also increased in the mutants. Moreover, we introduced an additional mutation for a Bmp receptor gene: BmprIA. The Shh(CreERT2/+); \u03b2-catenin(flox(ex3)/+); BmprIA(flox/-)"}
{"subject": "expression", "sub_type": "MPA", "rel": "ThemeOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-24632946.json", "snippet": " The expression of bone morphogenetic protein (Bmp) genes, such as Bmp4 and Bmp7, was also ectopically induced in the epithelia of the URS in the \u03b2-catenin GOF mutants. The  [CLS] expression of the Msx2 gene and phosphorylated-Smad1/5/8, possible readouts of Bmp signaling, was also increased [CLS]  in the mutants. Moreover, we introduced an additional mutation for a Bmp receptor gene: BmprIA. The Shh(CreERT2/+); \u03b2-catenin(flox(ex3)/+); BmprIA(flox/-) mutants displayed partial restoration of URS elongation compared with the"}
{"subject": "readouts of Bmp signaling", "sub_type": "MPA", "rel": "ThemeOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-24632946.json", "snippet": " such as Bmp4 and Bmp7, was also ectopically induced in the epithelia of the URS in the \u03b2-catenin GOF mutants. The expression of the Msx2 gene and phosphorylated-Smad1/5/8, possible  [CLS] readouts of Bmp signaling, was also increased [CLS]  in the mutants. Moreover, we introduced an additional mutation for a Bmp receptor gene: BmprIA. The Shh(CreERT2/+); \u03b2-catenin(flox(ex3)/+); BmprIA(flox/-) mutants displayed partial restoration of URS elongation compared with the"}
{"subject": "mutants", "sub_type": "Var", "rel": "CauseOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-24632946.json", "snippet": " also ectopically induced in the epithelia of the URS in the \u03b2-catenin GOF mutants. The expression of the Msx2 gene and phosphorylated-Smad1/5/8, possible readouts of Bmp signaling, was also  [CLS] increased in the mutants [CLS] . Moreover, we introduced an additional mutation for a Bmp receptor gene: BmprIA. The Shh(CreERT2/+); \u03b2-catenin(flox(ex3)/+); BmprIA(flox/-) mutants displayed partial restoration of URS elongation compared with the \u03b2-catenin GOF mutants."}
{"subject": "mutants", "sub_type": "Var", "rel": "CauseOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-24632946.json", "snippet": " \u03b2-catenin is observed in endodermal epithelia, including URS epithelia. We modulated the \u03b2-catenin gene conditionally in endodermal epithelia by utilizing tamoxifen-inducible Cre driver line (Shh(CreERT2)). Both \u03b2-catenin loss- and  [CLS] gain-of-function (LOF and GOF) mutants [CLS]  displayed abnormal clefts in the perineal region and hypoplastic elongation of the URS. The mutants also displayed reduced cell proliferation in the URS mesenchyme. In addition, the \u03b2-catenin GOF"}
{"subject": "mutants", "sub_type": "Var", "rel": "CauseOf", "object": "loss", "obj_type": "NegReg", "file_name": "PubMed-24632946.json", "snippet": " expression of \u03b2-catenin is observed in endodermal epithelia, including URS epithelia. We modulated the \u03b2-catenin gene conditionally in endodermal epithelia by utilizing tamoxifen-inducible Cre driver line (Shh(CreERT2)). Both \u03b2-catenin  [CLS] loss- and gain-of-function (LOF and GOF) mutants [CLS]  displayed abnormal clefts in the perineal region and hypoplastic elongation of the URS. The mutants also displayed reduced cell proliferation in the URS mesenchyme. In addition, the \u03b2-catenin GOF"}
{"subject": "clefts in the perineal region", "sub_type": "CPA", "rel": "ThemeOf", "object": "loss", "obj_type": "NegReg", "file_name": "PubMed-24632946.json", "snippet": " expression of \u03b2-catenin is observed in endodermal epithelia, including URS epithelia. We modulated the \u03b2-catenin gene conditionally in endodermal epithelia by utilizing tamoxifen-inducible Cre driver line (Shh(CreERT2)). Both \u03b2-catenin  [CLS] loss- and gain-of-function (LOF and GOF) mutants displayed abnormal clefts in the perineal region [CLS]  and hypoplastic elongation of the URS. The mutants also displayed reduced cell proliferation in the URS mesenchyme. In addition, the \u03b2-catenin GOF mutants displayed reduced apoptosis and subsequently increased"}
{"subject": "hypoplastic elongation of the URS", "sub_type": "CPA", "rel": "ThemeOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-24632946.json", "snippet": " \u03b2-catenin is observed in endodermal epithelia, including URS epithelia. We modulated the \u03b2-catenin gene conditionally in endodermal epithelia by utilizing tamoxifen-inducible Cre driver line (Shh(CreERT2)). Both \u03b2-catenin loss- and  [CLS] gain-of-function (LOF and GOF) mutants displayed abnormal clefts in the perineal region and hypoplastic elongation of the URS [CLS] . The mutants also displayed reduced cell proliferation in the URS mesenchyme. In addition, the \u03b2-catenin GOF mutants displayed reduced apoptosis and subsequently increased apoptosis in the URS epithelium. This"}
{"subject": "hypoplastic elongation of the URS", "sub_type": "CPA", "rel": "CauseOf", "object": "loss", "obj_type": "NegReg", "file_name": "PubMed-24632946.json", "snippet": " expression of \u03b2-catenin is observed in endodermal epithelia, including URS epithelia. We modulated the \u03b2-catenin gene conditionally in endodermal epithelia by utilizing tamoxifen-inducible Cre driver line (Shh(CreERT2)). Both \u03b2-catenin  [CLS] loss- and gain-of-function (LOF and GOF) mutants displayed abnormal clefts in the perineal region and hypoplastic elongation of the URS [CLS] . The mutants also displayed reduced cell proliferation in the URS mesenchyme. In addition, the \u03b2-catenin GOF mutants displayed reduced apoptosis and subsequently increased apoptosis in the URS epithelium. This"}
{"subject": "clefts in the perineal region", "sub_type": "CPA", "rel": "CauseOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-24632946.json", "snippet": " \u03b2-catenin is observed in endodermal epithelia, including URS epithelia. We modulated the \u03b2-catenin gene conditionally in endodermal epithelia by utilizing tamoxifen-inducible Cre driver line (Shh(CreERT2)). Both \u03b2-catenin loss- and  [CLS] gain-of-function (LOF and GOF) mutants displayed abnormal clefts in the perineal region [CLS]  and hypoplastic elongation of the URS. The mutants also displayed reduced cell proliferation in the URS mesenchyme. In addition, the \u03b2-catenin GOF mutants displayed reduced apoptosis and subsequently increased"}
{"subject": "keratin 1", "sub_type": "Protein", "rel": "ThemeOf", "object": "expression levels", "obj_type": "MPA", "file_name": "PubMed-24632946.json", "snippet": " cell proliferation in the URS mesenchyme. In addition, the \u03b2-catenin GOF mutants displayed reduced apoptosis and subsequently increased apoptosis in the URS epithelium. This instability possibly resulted in reduced  [CLS] expression levels of differentiation markers, such as keratin 1 [CLS]  and filaggrin, in the perineal epithelia. The expression of bone morphogenetic protein (Bmp) genes, such as Bmp4 and Bmp7, was also ectopically induced in the epithelia of the URS"}
{"subject": "filaggrin", "sub_type": "Protein", "rel": "ThemeOf", "object": "expression levels", "obj_type": "MPA", "file_name": "PubMed-24632946.json", "snippet": " cell proliferation in the URS mesenchyme. In addition, the \u03b2-catenin GOF mutants displayed reduced apoptosis and subsequently increased apoptosis in the URS epithelium. This instability possibly resulted in reduced  [CLS] expression levels of differentiation markers, such as keratin 1 and filaggrin [CLS] , in the perineal epithelia. The expression of bone morphogenetic protein (Bmp) genes, such as Bmp4 and Bmp7, was also ectopically induced in the epithelia of the URS in the"}
{"subject": "mutants", "sub_type": "Var", "rel": "CauseOf", "object": "reduced", "obj_type": "NegReg", "file_name": "PubMed-24632946.json", "snippet": " displayed abnormal clefts in the perineal region and hypoplastic elongation of the URS. The mutants also displayed reduced cell proliferation in the URS mesenchyme. In addition, the \u03b2-catenin GOF  [CLS] mutants displayed reduced apoptosis and subsequently increased apoptosis in the URS epithelium. This instability possibly resulted in reduced [CLS]  expression levels of differentiation markers, such as keratin 1 and filaggrin, in the perineal epithelia. The expression of bone morphogenetic protein (Bmp) genes, such as Bmp4 and Bmp7, was"}
{"subject": "bone morphogenetic protein (Bmp) genes", "sub_type": "Gene", "rel": "ThemeOf", "object": "expression", "obj_type": "MPA", "file_name": "PubMed-24632946.json", "snippet": " subsequently increased apoptosis in the URS epithelium. This instability possibly resulted in reduced expression levels of differentiation markers, such as keratin 1 and filaggrin, in the perineal epithelia. The  [CLS] expression of bone morphogenetic protein (Bmp) genes [CLS] , such as Bmp4 and Bmp7, was also ectopically induced in the epithelia of the URS in the \u03b2-catenin GOF mutants. The expression of the Msx2 gene and phosphorylated-Smad1/5/8, possible"}
{"subject": "Bmp4", "sub_type": "Gene", "rel": "ThemeOf", "object": "bone morphogenetic protein (Bmp) genes", "obj_type": "Gene", "file_name": "PubMed-24632946.json", "snippet": " apoptosis in the URS epithelium. This instability possibly resulted in reduced expression levels of differentiation markers, such as keratin 1 and filaggrin, in the perineal epithelia. The expression of  [CLS] bone morphogenetic protein (Bmp) genes, such as Bmp4 [CLS]  and Bmp7, was also ectopically induced in the epithelia of the URS in the \u03b2-catenin GOF mutants. The expression of the Msx2 gene and phosphorylated-Smad1/5/8, possible readouts of Bmp"}
{"subject": "Bmp7", "sub_type": "Gene", "rel": "ThemeOf", "object": "bone morphogenetic protein (Bmp) genes", "obj_type": "Gene", "file_name": "PubMed-24632946.json", "snippet": " apoptosis in the URS epithelium. This instability possibly resulted in reduced expression levels of differentiation markers, such as keratin 1 and filaggrin, in the perineal epithelia. The expression of  [CLS] bone morphogenetic protein (Bmp) genes, such as Bmp4 and Bmp7 [CLS] , was also ectopically induced in the epithelia of the URS in the \u03b2-catenin GOF mutants. The expression of the Msx2 gene and phosphorylated-Smad1/5/8, possible readouts of Bmp signaling, was"}
{"subject": "ARM", "sub_type": "Disease", "rel": "ThemeOf", "object": "GOF", "obj_type": "PosReg", "file_name": "PubMed-24632946.json", "snippet": " mutation for a Bmp receptor gene: BmprIA. The Shh(CreERT2/+); \u03b2-catenin(flox(ex3)/+); BmprIA(flox/-) mutants displayed partial restoration of URS elongation compared with the \u03b2-catenin GOF mutants. These results indicate that some  [CLS] ARM phenotypes in the \u03b2-catenin GOF [CLS]  mutants were caused by abnormal Bmp signaling. The current analysis revealed the close relation of endodermal \u03b2-catenin signaling to the ARM phenotypes. These results are considered to shed light"}
{"subject": "mutants", "sub_type": "Var", "rel": "CauseOf", "object": "caused by", "obj_type": "Reg", "file_name": "PubMed-24632946.json", "snippet": " BmprIA. The Shh(CreERT2/+); \u03b2-catenin(flox(ex3)/+); BmprIA(flox/-) mutants displayed partial restoration of URS elongation compared with the \u03b2-catenin GOF mutants. These results indicate that some ARM phenotypes in the \u03b2-catenin GOF  [CLS] mutants were caused by [CLS]  abnormal Bmp signaling. The current analysis revealed the close relation of endodermal \u03b2-catenin signaling to the ARM phenotypes. These results are considered to shed light on the pathogenic mechanisms"}
{"subject": "Bmp signaling", "sub_type": "MPA", "rel": "ThemeOf", "object": "caused by", "obj_type": "Reg", "file_name": "PubMed-24632946.json", "snippet": " Shh(CreERT2/+); \u03b2-catenin(flox(ex3)/+); BmprIA(flox/-) mutants displayed partial restoration of URS elongation compared with the \u03b2-catenin GOF mutants. These results indicate that some ARM phenotypes in the \u03b2-catenin GOF mutants were  [CLS] caused by abnormal Bmp signaling [CLS] . The current analysis revealed the close relation of endodermal \u03b2-catenin signaling to the ARM phenotypes. These results are considered to shed light on the pathogenic mechanisms of human ARMs."}
{"subject": "mutants", "sub_type": "Var", "rel": "CauseOf", "object": "reduced", "obj_type": "NegReg", "file_name": "PubMed-24632946.json", "snippet": " utilizing tamoxifen-inducible Cre driver line (Shh(CreERT2)). Both \u03b2-catenin loss- and gain-of-function (LOF and GOF) mutants displayed abnormal clefts in the perineal region and hypoplastic elongation of the URS. The  [CLS] mutants also displayed reduced [CLS]  cell proliferation in the URS mesenchyme. In addition, the \u03b2-catenin GOF mutants displayed reduced apoptosis and subsequently increased apoptosis in the URS epithelium. This instability possibly resulted in reduced"}
{"subject": "\u03b2-catenin", "sub_type": "Protein", "rel": "ThemeOf", "object": "mutants", "obj_type": "Var", "file_name": "PubMed-24632946.json", "snippet": " receptor gene: BmprIA. The Shh(CreERT2/+); \u03b2-catenin(flox(ex3)/+); BmprIA(flox/-) mutants displayed partial restoration of URS elongation compared with the \u03b2-catenin GOF mutants. These results indicate that some ARM phenotypes in the  [CLS] \u03b2-catenin GOF mutants [CLS]  were caused by abnormal Bmp signaling. The current analysis revealed the close relation of endodermal \u03b2-catenin signaling to the ARM phenotypes. These results are considered to shed light on"}
{"subject": "caused by", "sub_type": "Reg", "rel": "CauseOf", "object": "GOF", "obj_type": "PosReg", "file_name": "PubMed-24632946.json", "snippet": " gene: BmprIA. The Shh(CreERT2/+); \u03b2-catenin(flox(ex3)/+); BmprIA(flox/-) mutants displayed partial restoration of URS elongation compared with the \u03b2-catenin GOF mutants. These results indicate that some ARM phenotypes in the \u03b2-catenin  [CLS] GOF mutants were caused by [CLS]  abnormal Bmp signaling. The current analysis revealed the close relation of endodermal \u03b2-catenin signaling to the ARM phenotypes. These results are considered to shed light on the pathogenic mechanisms"}
{"subject": "cell proliferation in the URS mesenchyme", "sub_type": "CPA", "rel": "ThemeOf", "object": "reduced", "obj_type": "NegReg", "file_name": "PubMed-24632946.json", "snippet": " driver line (Shh(CreERT2)). Both \u03b2-catenin loss- and gain-of-function (LOF and GOF) mutants displayed abnormal clefts in the perineal region and hypoplastic elongation of the URS. The mutants also displayed  [CLS] reduced cell proliferation in the URS mesenchyme [CLS] . In addition, the \u03b2-catenin GOF mutants displayed reduced apoptosis and subsequently increased apoptosis in the URS epithelium. This instability possibly resulted in reduced expression levels of differentiation markers, such"}
{"subject": "\u03b2-catenin", "sub_type": "Protein", "rel": "ThemeOf", "object": "mutants", "obj_type": "Var", "file_name": "PubMed-24632946.json", "snippet": " GOF) mutants displayed abnormal clefts in the perineal region and hypoplastic elongation of the URS. The mutants also displayed reduced cell proliferation in the URS mesenchyme. In addition, the  [CLS] \u03b2-catenin GOF mutants [CLS]  displayed reduced apoptosis and subsequently increased apoptosis in the URS epithelium. This instability possibly resulted in reduced expression levels of differentiation markers, such as keratin 1 and filaggrin, in"}
{"subject": "endodermal \u03b2-catenin", "sub_type": "Protein", "rel": "ThemeOf", "object": "mutant", "obj_type": "Var", "file_name": "PubMed-24632949.json", "snippet": " and Wif1 was ectopically expressed in the urs and cm associated with excessive endodermal apoptosis and septation defects in Shh(-/-) mutants. Furthermore, apoptotic cells were markedly reduced in the  [CLS] endodermal \u03b2-catenin GOF mutant [CLS]  embryos, which counteracted the inhibitory effects of Wif1. Taken altogether, these data suggest that regulated expression of Wif1 is critical for the growth of the urs during cloaca septation."}
{"subject": "mutant", "sub_type": "Var", "rel": "CauseOf", "object": "GOF", "obj_type": "PosReg", "file_name": "PubMed-24632949.json", "snippet": " was ectopically expressed in the urs and cm associated with excessive endodermal apoptosis and septation defects in Shh(-/-) mutants. Furthermore, apoptotic cells were markedly reduced in the endodermal \u03b2-catenin  [CLS] GOF mutant [CLS]  embryos, which counteracted the inhibitory effects of Wif1. Taken altogether, these data suggest that regulated expression of Wif1 is critical for the growth of the urs during cloaca septation."}
{"subject": "GOF", "sub_type": "PosReg", "rel": "CauseOf", "object": "reduced", "obj_type": "NegReg", "file_name": "PubMed-24632949.json", "snippet": " the cloaca endoderm, and Wif1 was ectopically expressed in the urs and cm associated with excessive endodermal apoptosis and septation defects in Shh(-/-) mutants. Furthermore, apoptotic cells were markedly  [CLS] reduced in the endodermal \u03b2-catenin GOF [CLS]  mutant embryos, which counteracted the inhibitory effects of Wif1. Taken altogether, these data suggest that regulated expression of Wif1 is critical for the growth of the urs during cloaca"}
{"subject": "apoptotic cells", "sub_type": "CPA", "rel": "ThemeOf", "object": "reduced", "obj_type": "NegReg", "file_name": "PubMed-24632949.json", "snippet": " a complementary manner in the cloaca endoderm, and Wif1 was ectopically expressed in the urs and cm associated with excessive endodermal apoptosis and septation defects in Shh(-/-) mutants. Furthermore,  [CLS] apoptotic cells were markedly reduced [CLS]  in the endodermal \u03b2-catenin GOF mutant embryos, which counteracted the inhibitory effects of Wif1. Taken altogether, these data suggest that regulated expression of Wif1 is critical for the growth"}
{"subject": "MC1R", "sub_type": "Protein", "rel": "ThemeOf", "object": "LOF", "obj_type": "Var", "file_name": "PubMed-24730569.json", "snippet": " 1 (Wip1), which dephosphorylates \u03b3H2AX, correlated inversely with \u03b3H2AX. We propose that \u03b1-MSH increases UV-induced \u03b3H2AX to facilitate formation of DNA repair complexes and repair of DNA photoproducts, and  [CLS] LOF of MC1R [CLS]  compromises the DDR and genomic stability of melanocytes."}
{"subject": "LOF", "sub_type": "Var", "rel": "CauseOf", "object": "compromises", "obj_type": "NegReg", "file_name": "PubMed-24730569.json", "snippet": " 1 (Wip1), which dephosphorylates \u03b3H2AX, correlated inversely with \u03b3H2AX. We propose that \u03b1-MSH increases UV-induced \u03b3H2AX to facilitate formation of DNA repair complexes and repair of DNA photoproducts, and  [CLS] LOF of MC1R compromises [CLS]  the DDR and genomic stability of melanocytes."}
{"subject": "genomic stability of melanocytes", "sub_type": "CPA", "rel": "ThemeOf", "object": "compromises", "obj_type": "NegReg", "file_name": "PubMed-24730569.json", "snippet": " dephosphorylates \u03b3H2AX, correlated inversely with \u03b3H2AX. We propose that \u03b1-MSH increases UV-induced \u03b3H2AX to facilitate formation of DNA repair complexes and repair of DNA photoproducts, and LOF of MC1R  [CLS] compromises the DDR and genomic stability of melanocytes [CLS] ."}
{"subject": "DDR", "sub_type": "MPA", "rel": "ThemeOf", "object": "compromises", "obj_type": "NegReg", "file_name": "PubMed-24730569.json", "snippet": " dephosphorylates \u03b3H2AX, correlated inversely with \u03b3H2AX. We propose that \u03b1-MSH increases UV-induced \u03b3H2AX to facilitate formation of DNA repair complexes and repair of DNA photoproducts, and LOF of MC1R  [CLS] compromises the DDR [CLS]  and genomic stability of melanocytes."}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "LOF", "obj_type": "NegReg", "file_name": "PubMed-24808909.json", "snippet": " imputed GWAS data from large biorepositories such as the electronic medical record and genomics (eMERGE) consortium to determine the effects of rare LOFs. Here, we show that two hypocholesterolemia-associated  [CLS] LOF mutations [CLS]  in the PCSK9 gene can be accurately imputed into large-scale GWAS datasets which raises the possibility of assessing LOFs through genomics-linked medical records."}
{"subject": "hypocholesterolemia", "sub_type": "Disease", "rel": "ThemeOf", "object": "LOF", "obj_type": "NegReg", "file_name": "PubMed-24808909.json", "snippet": " using imputed GWAS data from large biorepositories such as the electronic medical record and genomics (eMERGE) consortium to determine the effects of rare LOFs. Here, we show that two  [CLS] hypocholesterolemia-associated LOF [CLS]  mutations in the PCSK9 gene can be accurately imputed into large-scale GWAS datasets which raises the possibility of assessing LOFs through genomics-linked medical records."}
{"subject": "PCSK9", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-24808909.json", "snippet": " GWAS data from large biorepositories such as the electronic medical record and genomics (eMERGE) consortium to determine the effects of rare LOFs. Here, we show that two hypocholesterolemia-associated LOF  [CLS] mutations in the PCSK9 [CLS]  gene can be accurately imputed into large-scale GWAS datasets which raises the possibility of assessing LOFs through genomics-linked medical records."}
{"subject": "PDGF", "sub_type": "Protein", "rel": "ThemeOf", "object": "activity", "obj_type": "MPA", "file_name": "PubMed-24946076.json", "snippet": " (PDGFs) are important mitogens for various types of mesenchymal cells, and as such, they exert critical functions during organogenesis in mammalian embryonic and early postnatal development. Increased or ectopic  [CLS] PDGF activity [CLS]  may also cause or contribute to diseases such as cancer and tissue fibrosis. Until recently, no loss-of-function (LOF) mutations in PDGF or PDGF receptor genes were reported as causally"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "LOF", "obj_type": "NegReg", "file_name": "PubMed-24946076.json", "snippet": " recently, no loss-of-function (LOF) mutations in PDGF or PDGF receptor genes were reported as causally linked to a human disease. This changed in 2013 when reports appeared on presumed  [CLS] LOF mutations [CLS]  in the genes encoding PDGF-B and its receptor PDGF receptor-beta (PDGF-R\u03b2) in familial idiopathic basal ganglia calcification (IBGC), a brain disease characterized by anatomically localized calcifications in or near"}
{"subject": "familial idiopathic basal ganglia calcification", "sub_type": "Disease", "rel": "ThemeOf", "object": "LOF", "obj_type": "NegReg", "file_name": "PubMed-24946076.json", "snippet": " recently, no loss-of-function (LOF) mutations in PDGF or PDGF receptor genes were reported as causally linked to a human disease. This changed in 2013 when reports appeared on presumed  [CLS] LOF mutations in the genes encoding PDGF-B and its receptor PDGF receptor-beta (PDGF-R\u03b2) in familial idiopathic basal ganglia calcification [CLS]  (IBGC), a brain disease characterized by anatomically localized calcifications in or near the blood microvessels. Here, we review PDGF-B and PDGF-R\u03b2 biology with special reference to their functions in"}
{"subject": "PDGF-R\u03b2", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-24946076.json", "snippet": " no loss-of-function (LOF) mutations in PDGF or PDGF receptor genes were reported as causally linked to a human disease. This changed in 2013 when reports appeared on presumed LOF  [CLS] mutations in the genes encoding PDGF-B and its receptor PDGF receptor-beta (PDGF-R\u03b2 [CLS] ) in familial idiopathic basal ganglia calcification (IBGC), a brain disease characterized by anatomically localized calcifications in or near the blood microvessels. Here, we review PDGF-B and PDGF-R\u03b2 biology with"}
{"subject": "activity", "sub_type": "MPA", "rel": "ThemeOf", "object": "ectopic", "obj_type": "Var", "file_name": "PubMed-24946076.json", "snippet": " factors (PDGFs) are important mitogens for various types of mesenchymal cells, and as such, they exert critical functions during organogenesis in mammalian embryonic and early postnatal development. Increased or  [CLS] ectopic PDGF activity [CLS]  may also cause or contribute to diseases such as cancer and tissue fibrosis. Until recently, no loss-of-function (LOF) mutations in PDGF or PDGF receptor genes were reported as causally"}
{"subject": "ectopic", "sub_type": "Var", "rel": "CauseOf", "object": "cause", "obj_type": "Reg", "file_name": "PubMed-24946076.json", "snippet": " factors (PDGFs) are important mitogens for various types of mesenchymal cells, and as such, they exert critical functions during organogenesis in mammalian embryonic and early postnatal development. Increased or  [CLS] ectopic PDGF activity may also cause [CLS]  or contribute to diseases such as cancer and tissue fibrosis. Until recently, no loss-of-function (LOF) mutations in PDGF or PDGF receptor genes were reported as causally linked to a"}
{"subject": "ectopic", "sub_type": "Var", "rel": "CauseOf", "object": "contribute", "obj_type": "Reg", "file_name": "PubMed-24946076.json", "snippet": " factors (PDGFs) are important mitogens for various types of mesenchymal cells, and as such, they exert critical functions during organogenesis in mammalian embryonic and early postnatal development. Increased or  [CLS] ectopic PDGF activity may also cause or contribute [CLS]  to diseases such as cancer and tissue fibrosis. Until recently, no loss-of-function (LOF) mutations in PDGF or PDGF receptor genes were reported as causally linked to a human disease."}
{"subject": "cancer", "sub_type": "Disease", "rel": "ThemeOf", "object": "contribute", "obj_type": "Reg", "file_name": "PubMed-24946076.json", "snippet": " types of mesenchymal cells, and as such, they exert critical functions during organogenesis in mammalian embryonic and early postnatal development. Increased or ectopic PDGF activity may also cause or  [CLS] contribute to diseases such as cancer [CLS]  and tissue fibrosis. Until recently, no loss-of-function (LOF) mutations in PDGF or PDGF receptor genes were reported as causally linked to a human disease. This changed in 2013 when"}
{"subject": "tissue fibrosis", "sub_type": "Disease", "rel": "ThemeOf", "object": "contribute", "obj_type": "Reg", "file_name": "PubMed-24946076.json", "snippet": " types of mesenchymal cells, and as such, they exert critical functions during organogenesis in mammalian embryonic and early postnatal development. Increased or ectopic PDGF activity may also cause or  [CLS] contribute to diseases such as cancer and tissue fibrosis [CLS] . Until recently, no loss-of-function (LOF) mutations in PDGF or PDGF receptor genes were reported as causally linked to a human disease. This changed in 2013 when reports appeared on"}
{"subject": "cancer", "sub_type": "Disease", "rel": "ThemeOf", "object": "cause", "obj_type": "Reg", "file_name": "PubMed-24946076.json", "snippet": " for various types of mesenchymal cells, and as such, they exert critical functions during organogenesis in mammalian embryonic and early postnatal development. Increased or ectopic PDGF activity may also  [CLS] cause or contribute to diseases such as cancer [CLS]  and tissue fibrosis. Until recently, no loss-of-function (LOF) mutations in PDGF or PDGF receptor genes were reported as causally linked to a human disease. This changed in 2013 when"}
{"subject": "tissue fibrosis", "sub_type": "Disease", "rel": "ThemeOf", "object": "cause", "obj_type": "Reg", "file_name": "PubMed-24946076.json", "snippet": " for various types of mesenchymal cells, and as such, they exert critical functions during organogenesis in mammalian embryonic and early postnatal development. Increased or ectopic PDGF activity may also  [CLS] cause or contribute to diseases such as cancer and tissue fibrosis [CLS] . Until recently, no loss-of-function (LOF) mutations in PDGF or PDGF receptor genes were reported as causally linked to a human disease. This changed in 2013 when reports appeared on"}
{"subject": "PDGF-B", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-24946076.json", "snippet": " no loss-of-function (LOF) mutations in PDGF or PDGF receptor genes were reported as causally linked to a human disease. This changed in 2013 when reports appeared on presumed LOF  [CLS] mutations in the genes encoding PDGF-B [CLS]  and its receptor PDGF receptor-beta (PDGF-R\u03b2) in familial idiopathic basal ganglia calcification (IBGC), a brain disease characterized by anatomically localized calcifications in or near the blood microvessels. Here, we"}
{"subject": "TP53 tumor-suppressor gene", "sub_type": "Gene", "rel": "ThemeOf", "object": "Missense mutations", "obj_type": "Var", "file_name": "PubMed-24998848.json", "snippet": " [CLS] TP53 tumor-suppressor gene is frequently mutated in human cancer. Missense mutations [CLS]  can add novel functions (gain-of-function, GOF) that promote tumor malignancy. Here we report that mutant (mut) p53 promotes tumor malignancy by suppressing the expression of a natural occurring anti-inflammatory"}
{"subject": "sIL-1Ra production", "sub_type": "MPA", "rel": "ThemeOf", "object": "suppresses", "obj_type": "NegReg", "file_name": "PubMed-24998848.json", "snippet": " promotes tumor malignancy by suppressing the expression of a natural occurring anti-inflammatory cytokine, the secreted interleukin-1 receptor antagonist (sIL-1Ra, IL1RN). We show that mutp53 but not wild-type (wt) p53  [CLS] suppresses the sIL-1Ra production [CLS]  in conditioned media of cancer cells. Moreover, mutp53, but not wtp53, binds physically the sIL-1Ra promoter and the protein-protein interaction with the transcriptional co-repressor MAFF (v-MAF musculoaponeurotic fibrosarcoma oncogene"}
{"subject": "p53", "sub_type": "Gene", "rel": "ThemeOf", "object": "Mutant", "obj_type": "Var", "file_name": "PubMed-24998848.json", "snippet": " [CLS] Mutant p53 [CLS]  gains new function in promoting inflammatory signals by repression of the secreted interleukin-1 receptor antagonist.\nThe TP53 tumor-suppressor gene is frequently mutated in human cancer. Missense mutations can add"}
{"subject": "Mutant", "sub_type": "Var", "rel": "CauseOf", "object": "promoting", "obj_type": "PosReg", "file_name": "PubMed-24998848.json", "snippet": " [CLS] Mutant p53 gains new function in promoting [CLS]  inflammatory signals by repression of the secreted interleukin-1 receptor antagonist.\nThe TP53 tumor-suppressor gene is frequently mutated in human cancer. Missense mutations can add novel functions (gain-of-function, GOF) that"}
{"subject": "inflammatory signals", "sub_type": "MPA", "rel": "ThemeOf", "object": "promoting", "obj_type": "PosReg", "file_name": "PubMed-24998848.json", "snippet": " [CLS] promoting inflammatory signals [CLS]  by repression of the secreted interleukin-1 receptor antagonist.\nThe TP53 tumor-suppressor gene is frequently mutated in human cancer. Missense mutations can add novel functions (gain-of-function, GOF) that promote tumor"}
{"subject": "Mutant", "sub_type": "Var", "rel": "CauseOf", "object": "repression", "obj_type": "NegReg", "file_name": "PubMed-24998848.json", "snippet": " [CLS] Mutant p53 gains new function in promoting inflammatory signals by repression [CLS]  of the secreted interleukin-1 receptor antagonist.\nThe TP53 tumor-suppressor gene is frequently mutated in human cancer. Missense mutations can add novel functions (gain-of-function, GOF) that promote tumor malignancy. Here"}
{"subject": "Missense mutations", "sub_type": "Var", "rel": "CauseOf", "object": "promote", "obj_type": "PosReg", "file_name": "PubMed-24998848.json", "snippet": " [CLS] Missense mutations can add novel functions (gain-of-function, GOF) that promote [CLS]  tumor malignancy. Here we report that mutant (mut) p53 promotes tumor malignancy by suppressing the expression of a natural occurring anti-inflammatory cytokine, the secreted interleukin-1 receptor antagonist (sIL-1Ra, IL1RN)."}
{"subject": "tumor malignancy", "sub_type": "CPA", "rel": "ThemeOf", "object": "promote", "obj_type": "PosReg", "file_name": "PubMed-24998848.json", "snippet": " inflammatory signals by repression of the secreted interleukin-1 receptor antagonist.\nThe TP53 tumor-suppressor gene is frequently mutated in human cancer. Missense mutations can add novel functions (gain-of-function, GOF) that  [CLS] promote tumor malignancy [CLS] . Here we report that mutant (mut) p53 promotes tumor malignancy by suppressing the expression of a natural occurring anti-inflammatory cytokine, the secreted interleukin-1 receptor antagonist (sIL-1Ra, IL1RN). We show"}
{"subject": "p53", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutant", "obj_type": "Var", "file_name": "PubMed-24998848.json", "snippet": " interleukin-1 receptor antagonist.\nThe TP53 tumor-suppressor gene is frequently mutated in human cancer. Missense mutations can add novel functions (gain-of-function, GOF) that promote tumor malignancy. Here we report that  [CLS] mutant (mut) p53 [CLS]  promotes tumor malignancy by suppressing the expression of a natural occurring anti-inflammatory cytokine, the secreted interleukin-1 receptor antagonist (sIL-1Ra, IL1RN). We show that mutp53 but not wild-type (wt) p53"}
{"subject": "mutant", "sub_type": "Var", "rel": "CauseOf", "object": "suppressing", "obj_type": "NegReg", "file_name": "PubMed-24998848.json", "snippet": " interleukin-1 receptor antagonist.\nThe TP53 tumor-suppressor gene is frequently mutated in human cancer. Missense mutations can add novel functions (gain-of-function, GOF) that promote tumor malignancy. Here we report that  [CLS] mutant (mut) p53 promotes tumor malignancy by suppressing [CLS]  the expression of a natural occurring anti-inflammatory cytokine, the secreted interleukin-1 receptor antagonist (sIL-1Ra, IL1RN). We show that mutp53 but not wild-type (wt) p53 suppresses the sIL-1Ra production in"}
{"subject": "expression", "sub_type": "MPA", "rel": "ThemeOf", "object": "suppressing", "obj_type": "NegReg", "file_name": "PubMed-24998848.json", "snippet": " is frequently mutated in human cancer. Missense mutations can add novel functions (gain-of-function, GOF) that promote tumor malignancy. Here we report that mutant (mut) p53 promotes tumor malignancy by  [CLS] suppressing the expression [CLS]  of a natural occurring anti-inflammatory cytokine, the secreted interleukin-1 receptor antagonist (sIL-1Ra, IL1RN). We show that mutp53 but not wild-type (wt) p53 suppresses the sIL-1Ra production in conditioned media"}
{"subject": "suppressing", "sub_type": "NegReg", "rel": "CauseOf", "object": "promotes", "obj_type": "PosReg", "file_name": "PubMed-24998848.json", "snippet": "\nThe TP53 tumor-suppressor gene is frequently mutated in human cancer. Missense mutations can add novel functions (gain-of-function, GOF) that promote tumor malignancy. Here we report that mutant (mut) p53  [CLS] promotes tumor malignancy by suppressing [CLS]  the expression of a natural occurring anti-inflammatory cytokine, the secreted interleukin-1 receptor antagonist (sIL-1Ra, IL1RN). We show that mutp53 but not wild-type (wt) p53 suppresses the sIL-1Ra production in"}
{"subject": "tumor malignancy", "sub_type": "CPA", "rel": "ThemeOf", "object": "promotes", "obj_type": "PosReg", "file_name": "PubMed-24998848.json", "snippet": "\nThe TP53 tumor-suppressor gene is frequently mutated in human cancer. Missense mutations can add novel functions (gain-of-function, GOF) that promote tumor malignancy. Here we report that mutant (mut) p53  [CLS] promotes tumor malignancy [CLS]  by suppressing the expression of a natural occurring anti-inflammatory cytokine, the secreted interleukin-1 receptor antagonist (sIL-1Ra, IL1RN). We show that mutp53 but not wild-type (wt) p53 suppresses the sIL-1Ra"}
{"subject": "mutp53", "sub_type": "Var", "rel": "CauseOf", "object": "suppresses", "obj_type": "NegReg", "file_name": "PubMed-24998848.json", "snippet": " we report that mutant (mut) p53 promotes tumor malignancy by suppressing the expression of a natural occurring anti-inflammatory cytokine, the secreted interleukin-1 receptor antagonist (sIL-1Ra, IL1RN). We show that  [CLS] mutp53 but not wild-type (wt) p53 suppresses [CLS]  the sIL-1Ra production in conditioned media of cancer cells. Moreover, mutp53, but not wtp53, binds physically the sIL-1Ra promoter and the protein-protein interaction with the transcriptional co-repressor MAFF (v-MAF"}
{"subject": "PPARG", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-25157153.json", "snippet": " type 2 diabetes.\nPeroxisome proliferator-activated receptor gamma (PPARG) is a master transcriptional regulator of adipocyte differentiation and a canonical target of antidiabetic thiazolidinedione medications. In rare families, loss-of-function (LOF)  [CLS] mutations in PPARG [CLS]  are known to cosegregate with lipodystrophy and insulin resistance; in the general population, the common P12A variant is associated with a decreased risk of type 2 diabetes (T2D). Whether"}
{"subject": "variant", "sub_type": "Var", "rel": "CauseOf", "object": "associated", "obj_type": "Reg", "file_name": "PubMed-25157153.json", "snippet": " of T2D (OR = 7.22; P = 0.005). The combination of large-scale DNA sequencing and functional testing in the laboratory reveals that approximately 1 in 1,000 individuals carries a  [CLS] variant in PPARG that reduces function in a human adipocyte differentiation assay and is associated [CLS]  with a substantial risk of T2D."}
{"subject": "T2D", "sub_type": "Disease", "rel": "ThemeOf", "object": "associated", "obj_type": "Reg", "file_name": "PubMed-25157153.json", "snippet": " and functional testing in the laboratory reveals that approximately 1 in 1,000 individuals carries a variant in PPARG that reduces function in a human adipocyte differentiation assay and is  [CLS] associated with a substantial risk of T2D [CLS] ."}
{"subject": "PPARG", "sub_type": "Gene", "rel": "ThemeOf", "object": "P12A", "obj_type": "Var", "file_name": "PubMed-25157153.json", "snippet": " diabetes.\nPeroxisome proliferator-activated receptor gamma (PPARG) is a master transcriptional regulator of adipocyte differentiation and a canonical target of antidiabetic thiazolidinedione medications. In rare families, loss-of-function (LOF) mutations in  [CLS] PPARG are known to cosegregate with lipodystrophy and insulin resistance; in the general population, the common P12A [CLS]  variant is associated with a decreased risk of type 2 diabetes (T2D). Whether and how rare variants in PPARG and defects in adipocyte differentiation influence risk of T2D in"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-25157153.json", "snippet": " risk of type 2 diabetes.\nPeroxisome proliferator-activated receptor gamma (PPARG) is a master transcriptional regulator of adipocyte differentiation and a canonical target of antidiabetic thiazolidinedione medications. In rare families,  [CLS] loss-of-function (LOF) mutations [CLS]  in PPARG are known to cosegregate with lipodystrophy and insulin resistance; in the general population, the common P12A variant is associated with a decreased risk of type 2 diabetes"}
{"subject": "lipodystrophy", "sub_type": "Disease", "rel": "ThemeOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-25157153.json", "snippet": " risk of type 2 diabetes.\nPeroxisome proliferator-activated receptor gamma (PPARG) is a master transcriptional regulator of adipocyte differentiation and a canonical target of antidiabetic thiazolidinedione medications. In rare families,  [CLS] loss-of-function (LOF) mutations in PPARG are known to cosegregate with lipodystrophy [CLS]  and insulin resistance; in the general population, the common P12A variant is associated with a decreased risk of type 2 diabetes (T2D). Whether and how rare variants in PPARG"}
{"subject": "insulin resistance", "sub_type": "Disease", "rel": "ThemeOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-25157153.json", "snippet": " risk of type 2 diabetes.\nPeroxisome proliferator-activated receptor gamma (PPARG) is a master transcriptional regulator of adipocyte differentiation and a canonical target of antidiabetic thiazolidinedione medications. In rare families,  [CLS] loss-of-function (LOF) mutations in PPARG are known to cosegregate with lipodystrophy and insulin resistance [CLS] ; in the general population, the common P12A variant is associated with a decreased risk of type 2 diabetes (T2D). Whether and how rare variants in PPARG and defects in"}
{"subject": "P12A", "sub_type": "Var", "rel": "CauseOf", "object": "decreased", "obj_type": "NegReg", "file_name": "PubMed-25157153.json", "snippet": " canonical target of antidiabetic thiazolidinedione medications. In rare families, loss-of-function (LOF) mutations in PPARG are known to cosegregate with lipodystrophy and insulin resistance; in the general population, the common  [CLS] P12A variant is associated with a decreased [CLS]  risk of type 2 diabetes (T2D). Whether and how rare variants in PPARG and defects in adipocyte differentiation influence risk of T2D in the general population remains undetermined. By"}
{"subject": "type 2 diabetes", "sub_type": "Disease", "rel": "ThemeOf", "object": "decreased", "obj_type": "NegReg", "file_name": "PubMed-25157153.json", "snippet": " In rare families, loss-of-function (LOF) mutations in PPARG are known to cosegregate with lipodystrophy and insulin resistance; in the general population, the common P12A variant is associated with a  [CLS] decreased risk of type 2 diabetes [CLS]  (T2D). Whether and how rare variants in PPARG and defects in adipocyte differentiation influence risk of T2D in the general population remains undetermined. By sequencing PPARG in 19,752 T2D"}
{"subject": "PPARG", "sub_type": "Gene", "rel": "ThemeOf", "object": "variant", "obj_type": "Var", "file_name": "PubMed-25157153.json", "snippet": " of T2D (OR = 7.22; P = 0.005). The combination of large-scale DNA sequencing and functional testing in the laboratory reveals that approximately 1 in 1,000 individuals carries a  [CLS] variant in PPARG [CLS]  that reduces function in a human adipocyte differentiation assay and is associated with a substantial risk of T2D."}
{"subject": "variant", "sub_type": "Var", "rel": "CauseOf", "object": "reduces", "obj_type": "NegReg", "file_name": "PubMed-25157153.json", "snippet": " of T2D (OR = 7.22; P = 0.005). The combination of large-scale DNA sequencing and functional testing in the laboratory reveals that approximately 1 in 1,000 individuals carries a  [CLS] variant in PPARG that reduces [CLS]  function in a human adipocyte differentiation assay and is associated with a substantial risk of T2D."}
{"subject": "function in a human adipocyte differentiation assay", "sub_type": "CPA", "rel": "ThemeOf", "object": "reduces", "obj_type": "NegReg", "file_name": "PubMed-25157153.json", "snippet": " 7.22; P = 0.005). The combination of large-scale DNA sequencing and functional testing in the laboratory reveals that approximately 1 in 1,000 individuals carries a variant in PPARG that  [CLS] reduces function in a human adipocyte differentiation assay [CLS]  and is associated with a substantial risk of T2D."}
{"subject": "SHROOM3", "sub_type": "Gene", "rel": "ThemeOf", "object": "DNMs", "obj_type": "Var", "file_name": "PubMed-25805808.json", "snippet": " 25 cases, of which 6 were loss of function (LoF) showing a higher rate of LoF DNM in our cohort compared with control cohorts. Notably, we identified two protein-truncating  [CLS] DNMs in two independent cases in SHROOM3 [CLS] , previously associated with NTDs only in animal models. We have demonstrated a significant enrichment of LoF DNMs in this gene in NTDs compared with the gene specific DNM rate"}
{"subject": "DNMs", "sub_type": "Var", "rel": "CauseOf", "object": "truncating", "obj_type": "NegReg", "file_name": "PubMed-25805808.json", "snippet": " in 25 cases, of which 6 were loss of function (LoF) showing a higher rate of LoF DNM in our cohort compared with control cohorts. Notably, we identified two protein- [CLS] truncating DNMs [CLS]  in two independent cases in SHROOM3, previously associated with NTDs only in animal models. We have demonstrated a significant enrichment of LoF DNMs in this gene in NTDs compared"}
{"subject": "protein", "sub_type": "Protein", "rel": "ThemeOf", "object": "truncating", "obj_type": "NegReg", "file_name": "PubMed-25805808.json", "snippet": " in 25 cases, of which 6 were loss of function (LoF) showing a higher rate of LoF DNM in our cohort compared with control cohorts. Notably, we identified two  [CLS] protein-truncating [CLS]  DNMs in two independent cases in SHROOM3, previously associated with NTDs only in animal models. We have demonstrated a significant enrichment of LoF DNMs in this gene in NTDs"}
{"subject": "DNMs", "sub_type": "Var", "rel": "CauseOf", "object": "LoF", "obj_type": "NegReg", "file_name": "PubMed-25805808.json", "snippet": " from control cohorts. We also identified one nonsense DNM in PAX3 and two potentially causative missense DNMs in GRHL3 and PTPRS.\nCONCLUSIONS: Our study demonstrates an important role of  [CLS] LoF DNMs [CLS]  in the development of NTDs and strongly implicates SHROOM3 in its aetiology."}
{"subject": "NTDs", "sub_type": "Disease", "rel": "ThemeOf", "object": "LoF", "obj_type": "NegReg", "file_name": "PubMed-25805808.json", "snippet": " from control cohorts. We also identified one nonsense DNM in PAX3 and two potentially causative missense DNMs in GRHL3 and PTPRS.\nCONCLUSIONS: Our study demonstrates an important role of  [CLS] LoF DNMs in the development of NTDs [CLS]  and strongly implicates SHROOM3 in its aetiology."}
{"subject": "SHROOM3", "sub_type": "Gene", "rel": "ThemeOf", "object": "DNMs", "obj_type": "Var", "file_name": "PubMed-25805808.json", "snippet": " control cohorts. We also identified one nonsense DNM in PAX3 and two potentially causative missense DNMs in GRHL3 and PTPRS.\nCONCLUSIONS: Our study demonstrates an important role of LoF  [CLS] DNMs in the development of NTDs and strongly implicates SHROOM3 [CLS]  in its aetiology."}
{"subject": "SHROOM3", "sub_type": "Gene", "rel": "ThemeOf", "object": "DNMs", "obj_type": "Var", "file_name": "PubMed-25805808.json", "snippet": " loss of function (LoF) showing a higher rate of LoF DNM in our cohort compared with control cohorts. Notably, we identified two protein-truncating DNMs in two independent cases in  [CLS] SHROOM3, previously associated with NTDs only in animal models. We have demonstrated a significant enrichment of LoF DNMs [CLS]  in this gene in NTDs compared with the gene specific DNM rate and to the DNM rate estimated from control cohorts. We also identified one nonsense DNM in PAX3"}
{"subject": "DNMs", "sub_type": "Var", "rel": "CauseOf", "object": "LoF", "obj_type": "NegReg", "file_name": "PubMed-25805808.json", "snippet": " control cohorts. Notably, we identified two protein-truncating DNMs in two independent cases in SHROOM3, previously associated with NTDs only in animal models. We have demonstrated a significant enrichment of  [CLS] LoF DNMs [CLS]  in this gene in NTDs compared with the gene specific DNM rate and to the DNM rate estimated from control cohorts. We also identified one nonsense DNM in PAX3"}
{"subject": "NTDs", "sub_type": "Disease", "rel": "ThemeOf", "object": "LoF", "obj_type": "NegReg", "file_name": "PubMed-25805808.json", "snippet": " control cohorts. Notably, we identified two protein-truncating DNMs in two independent cases in SHROOM3, previously associated with NTDs only in animal models. We have demonstrated a significant enrichment of  [CLS] LoF DNMs in this gene in NTDs [CLS]  compared with the gene specific DNM rate and to the DNM rate estimated from control cohorts. We also identified one nonsense DNM in PAX3 and two potentially causative missense"}
{"subject": "TXNDC5", "sub_type": "Gene", "rel": "ThemeOf", "object": "variation", "obj_type": "Var", "file_name": "PubMed-25915599.json", "snippet": " of equal size verified two relationships in well-studied genes (PCSK9 and APOC3) and identified eight new loci. Previously unknown relationships included elevated fasting glucose in carriers of heterozygous LOF  [CLS] variation in TXNDC5 [CLS] , which encodes a biomarker for type 1 diabetes progression, and apparent recessive effects of C1QTNF8 on serum magnesium levels. These data demonstrate the utility of functional-variant annotation within a"}
{"subject": "variation", "sub_type": "Var", "rel": "CauseOf", "object": "LOF", "obj_type": "NegReg", "file_name": "PubMed-25915599.json", "snippet": " strata of equal size verified two relationships in well-studied genes (PCSK9 and APOC3) and identified eight new loci. Previously unknown relationships included elevated fasting glucose in carriers of heterozygous  [CLS] LOF variation [CLS]  in TXNDC5, which encodes a biomarker for type 1 diabetes progression, and apparent recessive effects of C1QTNF8 on serum magnesium levels. These data demonstrate the utility of functional-variant annotation"}
{"subject": "LOF", "sub_type": "NegReg", "rel": "CauseOf", "object": "elevated", "obj_type": "PosReg", "file_name": "PubMed-25915599.json", "snippet": " of this sample as discovery and replication strata of equal size verified two relationships in well-studied genes (PCSK9 and APOC3) and identified eight new loci. Previously unknown relationships included  [CLS] elevated fasting glucose in carriers of heterozygous LOF [CLS]  variation in TXNDC5, which encodes a biomarker for type 1 diabetes progression, and apparent recessive effects of C1QTNF8 on serum magnesium levels. These data demonstrate the utility of functional-variant"}
{"subject": "glucose", "sub_type": "MPA", "rel": "ThemeOf", "object": "elevated", "obj_type": "PosReg", "file_name": "PubMed-25915599.json", "snippet": " of this sample as discovery and replication strata of equal size verified two relationships in well-studied genes (PCSK9 and APOC3) and identified eight new loci. Previously unknown relationships included  [CLS] elevated fasting glucose [CLS]  in carriers of heterozygous LOF variation in TXNDC5, which encodes a biomarker for type 1 diabetes progression, and apparent recessive effects of C1QTNF8 on serum magnesium levels. These data"}
{"subject": "C1QTNF8", "sub_type": "Gene", "rel": "CauseOf", "object": "recessive effects", "obj_type": "NegReg", "file_name": "PubMed-25915599.json", "snippet": " eight new loci. Previously unknown relationships included elevated fasting glucose in carriers of heterozygous LOF variation in TXNDC5, which encodes a biomarker for type 1 diabetes progression, and apparent  [CLS] recessive effects of C1QTNF8 [CLS]  on serum magnesium levels. These data demonstrate the utility of functional-variant annotation within a large sample of deeply phenotyped individuals for gene discovery."}
{"subject": "serum magnesium levels", "sub_type": "MPA", "rel": "ThemeOf", "object": "recessive effects", "obj_type": "NegReg", "file_name": "PubMed-25915599.json", "snippet": " eight new loci. Previously unknown relationships included elevated fasting glucose in carriers of heterozygous LOF variation in TXNDC5, which encodes a biomarker for type 1 diabetes progression, and apparent  [CLS] recessive effects of C1QTNF8 on serum magnesium levels [CLS] . These data demonstrate the utility of functional-variant annotation within a large sample of deeply phenotyped individuals for gene discovery."}
{"subject": "p53", "sub_type": "Gene", "rel": "ThemeOf", "object": "proteins", "obj_type": "Protein", "file_name": "PubMed-25954247.json", "snippet": " transcriptional activation of apoptosis, growth arrest, or senescence in damaged cells. Not surprisingly, mutations in the p53 gene are the most frequent genetic alteration in human cancers. Importantly, mutant  [CLS] p53 (mutp53) proteins [CLS]  not only lose their wild-type tumor suppressor activity but also can actively promote tumor development. Two main mechanisms accounting for mutp53 proto-oncogenic activity are inhibition of the wild-type p53"}
{"subject": "resistant", "sub_type": "CPA", "rel": "ThemeOf", "object": "more", "obj_type": "PosReg", "file_name": "PubMed-25954247.json", "snippet": " gain-of-function (GOF). Here, we discuss a novel mechanism of mutp53 GOF, which relies on its oncogenic cooperation with the heat shock machinery. This coordinated adaptive mechanism renders cancer cells  [CLS] more resistant [CLS]  to proteotoxic stress and provides both, a strong survival advantage to cancer cells and a promising means for therapeutic intervention."}
{"subject": "survival advantage", "sub_type": "CPA", "rel": "ThemeOf", "object": "more", "obj_type": "PosReg", "file_name": "PubMed-25954247.json", "snippet": " gain-of-function (GOF). Here, we discuss a novel mechanism of mutp53 GOF, which relies on its oncogenic cooperation with the heat shock machinery. This coordinated adaptive mechanism renders cancer cells  [CLS] more resistant to proteotoxic stress and provides both, a strong survival advantage [CLS]  to cancer cells and a promising means for therapeutic intervention."}
{"subject": "proteins", "sub_type": "Protein", "rel": "ThemeOf", "object": "mutant", "obj_type": "Var", "file_name": "PubMed-25954247.json", "snippet": " by transcriptional activation of apoptosis, growth arrest, or senescence in damaged cells. Not surprisingly, mutations in the p53 gene are the most frequent genetic alteration in human cancers. Importantly,  [CLS] mutant p53 (mutp53) proteins [CLS]  not only lose their wild-type tumor suppressor activity but also can actively promote tumor development. Two main mechanisms accounting for mutp53 proto-oncogenic activity are inhibition of the wild-type p53"}
{"subject": "mutant", "sub_type": "Var", "rel": "CauseOf", "object": "lose", "obj_type": "NegReg", "file_name": "PubMed-25954247.json", "snippet": " by transcriptional activation of apoptosis, growth arrest, or senescence in damaged cells. Not surprisingly, mutations in the p53 gene are the most frequent genetic alteration in human cancers. Importantly,  [CLS] mutant p53 (mutp53) proteins not only lose [CLS]  their wild-type tumor suppressor activity but also can actively promote tumor development. Two main mechanisms accounting for mutp53 proto-oncogenic activity are inhibition of the wild-type p53 in a dominant-negative"}
{"subject": "tumor suppressor activity", "sub_type": "CPA", "rel": "ThemeOf", "object": "lose", "obj_type": "NegReg", "file_name": "PubMed-25954247.json", "snippet": " arrest, or senescence in damaged cells. Not surprisingly, mutations in the p53 gene are the most frequent genetic alteration in human cancers. Importantly, mutant p53 (mutp53) proteins not only  [CLS] lose their wild-type tumor suppressor activity [CLS]  but also can actively promote tumor development. Two main mechanisms accounting for mutp53 proto-oncogenic activity are inhibition of the wild-type p53 in a dominant-negative fashion and gain of additional"}
{"subject": "mutant", "sub_type": "Var", "rel": "CauseOf", "object": "promote", "obj_type": "PosReg", "file_name": "PubMed-25954247.json", "snippet": " by transcriptional activation of apoptosis, growth arrest, or senescence in damaged cells. Not surprisingly, mutations in the p53 gene are the most frequent genetic alteration in human cancers. Importantly,  [CLS] mutant p53 (mutp53) proteins not only lose their wild-type tumor suppressor activity but also can actively promote [CLS]  tumor development. Two main mechanisms accounting for mutp53 proto-oncogenic activity are inhibition of the wild-type p53 in a dominant-negative fashion and gain of additional oncogenic activities known as gain-of-function"}
{"subject": "tumor development", "sub_type": "CPA", "rel": "ThemeOf", "object": "promote", "obj_type": "PosReg", "file_name": "PubMed-25954247.json", "snippet": " the p53 gene are the most frequent genetic alteration in human cancers. Importantly, mutant p53 (mutp53) proteins not only lose their wild-type tumor suppressor activity but also can actively  [CLS] promote tumor development [CLS] . Two main mechanisms accounting for mutp53 proto-oncogenic activity are inhibition of the wild-type p53 in a dominant-negative fashion and gain of additional oncogenic activities known as gain-of-function (GOF). Here,"}
{"subject": "mutp53", "sub_type": "Var", "rel": "CauseOf", "object": "gain", "obj_type": "PosReg", "file_name": "PubMed-25954247.json", "snippet": " alteration in human cancers. Importantly, mutant p53 (mutp53) proteins not only lose their wild-type tumor suppressor activity but also can actively promote tumor development. Two main mechanisms accounting for  [CLS] mutp53 proto-oncogenic activity are inhibition of the wild-type p53 in a dominant-negative fashion and gain [CLS]  of additional oncogenic activities known as gain-of-function (GOF). Here, we discuss a novel mechanism of mutp53 GOF, which relies on its oncogenic cooperation with the heat shock machinery. This"}
{"subject": "oncogenic activities", "sub_type": "CPA", "rel": "ThemeOf", "object": "gain", "obj_type": "PosReg", "file_name": "PubMed-25954247.json", "snippet": " tumor suppressor activity but also can actively promote tumor development. Two main mechanisms accounting for mutp53 proto-oncogenic activity are inhibition of the wild-type p53 in a dominant-negative fashion and  [CLS] gain of additional oncogenic activities [CLS]  known as gain-of-function (GOF). Here, we discuss a novel mechanism of mutp53 GOF, which relies on its oncogenic cooperation with the heat shock machinery. This coordinated adaptive mechanism renders"}
{"subject": "mutp53", "sub_type": "Var", "rel": "CauseOf", "object": "more", "obj_type": "PosReg", "file_name": "PubMed-25954247.json", "snippet": " proto-oncogenic activity are inhibition of the wild-type p53 in a dominant-negative fashion and gain of additional oncogenic activities known as gain-of-function (GOF). Here, we discuss a novel mechanism of  [CLS] mutp53 GOF, which relies on its oncogenic cooperation with the heat shock machinery. This coordinated adaptive mechanism renders cancer cells more [CLS]  resistant to proteotoxic stress and provides both, a strong survival advantage to cancer cells and a promising means for therapeutic intervention."}
{"subject": "MC1R", "sub_type": "Gene", "rel": "ThemeOf", "object": "p.Tyr298*", "obj_type": "Var", "file_name": "PubMed-26197705.json", "snippet": " Six MC1R mutations segregated with the phenotype in seven families, including a p.Val174del in-frame deletion and a p.Tyr298* nonsense mutation, that were analyzed for function in heterologous HEK293 cells.  [CLS] p.Tyr298* MC1R [CLS]  showed no agonist-induced signaling to the cAMP or ERK pathways, nor detectable agonist binding. Conversely, signaling was comparable for p.Val174del and wild-type in HEK cells overexpressing the proteins, but"}
{"subject": "plasma membrane expression", "sub_type": "MPA", "rel": "ThemeOf", "object": "reduced", "obj_type": "NegReg", "file_name": "PubMed-26197705.json", "snippet": " Conversely, signaling was comparable for p.Val174del and wild-type in HEK cells overexpressing the proteins, but binding analysis suggested impaired cell surface expression. Flow cytometry and confocal imaging studies revealed  [CLS] reduced plasma membrane expression [CLS]  of p.Val174del and p.Tyr298*. Therefore, p.Tyr298* was a total loss-of-function (LOF) allele, while p.Val174del displayed a partial LOF attribute."}
{"subject": "p.Val174del", "sub_type": "Var", "rel": "CauseOf", "object": "reduced", "obj_type": "NegReg", "file_name": "PubMed-26197705.json", "snippet": " Conversely, signaling was comparable for p.Val174del and wild-type in HEK cells overexpressing the proteins, but binding analysis suggested impaired cell surface expression. Flow cytometry and confocal imaging studies revealed  [CLS] reduced plasma membrane expression of p.Val174del [CLS]  and p.Tyr298*. Therefore, p.Tyr298* was a total loss-of-function (LOF) allele, while p.Val174del displayed a partial LOF attribute."}
{"subject": "p.Tyr298*", "sub_type": "Var", "rel": "CauseOf", "object": "reduced", "obj_type": "NegReg", "file_name": "PubMed-26197705.json", "snippet": " Conversely, signaling was comparable for p.Val174del and wild-type in HEK cells overexpressing the proteins, but binding analysis suggested impaired cell surface expression. Flow cytometry and confocal imaging studies revealed  [CLS] reduced plasma membrane expression of p.Val174del and p.Tyr298* [CLS] . Therefore, p.Tyr298* was a total loss-of-function (LOF) allele, while p.Val174del displayed a partial LOF attribute."}
{"subject": "p.Tyr298*", "sub_type": "Var", "rel": "CauseOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-26197705.json", "snippet": " HEK cells overexpressing the proteins, but binding analysis suggested impaired cell surface expression. Flow cytometry and confocal imaging studies revealed reduced plasma membrane expression of p.Val174del and p.Tyr298*. Therefore,  [CLS] p.Tyr298* was a total loss-of-function [CLS]  (LOF) allele, while p.Val174del displayed a partial LOF attribute."}
{"subject": "p.Val174del", "sub_type": "Var", "rel": "CauseOf", "object": "partial LOF", "obj_type": "NegReg", "file_name": "PubMed-26197705.json", "snippet": " suggested impaired cell surface expression. Flow cytometry and confocal imaging studies revealed reduced plasma membrane expression of p.Val174del and p.Tyr298*. Therefore, p.Tyr298* was a total loss-of-function (LOF) allele, while  [CLS] p.Val174del displayed a partial LOF [CLS]  attribute."}
{"subject": "p.Tyr298*", "sub_type": "Var", "rel": "CauseOf", "object": "no", "obj_type": "NegReg", "file_name": "PubMed-26197705.json", "snippet": " Six MC1R mutations segregated with the phenotype in seven families, including a p.Val174del in-frame deletion and a p.Tyr298* nonsense mutation, that were analyzed for function in heterologous HEK293 cells.  [CLS] p.Tyr298* MC1R showed no [CLS]  agonist-induced signaling to the cAMP or ERK pathways, nor detectable agonist binding. Conversely, signaling was comparable for p.Val174del and wild-type in HEK cells overexpressing the proteins, but binding analysis"}
{"subject": "p.Tyr298*", "sub_type": "Var", "rel": "CauseOf", "object": "nor", "obj_type": "NegReg", "file_name": "PubMed-26197705.json", "snippet": " Six MC1R mutations segregated with the phenotype in seven families, including a p.Val174del in-frame deletion and a p.Tyr298* nonsense mutation, that were analyzed for function in heterologous HEK293 cells.  [CLS] p.Tyr298* MC1R showed no agonist-induced signaling to the cAMP or ERK pathways, nor [CLS]  detectable agonist binding. Conversely, signaling was comparable for p.Val174del and wild-type in HEK cells overexpressing the proteins, but binding analysis suggested impaired cell surface expression. Flow cytometry and confocal"}
{"subject": "agonist binding", "sub_type": "Interaction", "rel": "ThemeOf", "object": "nor", "obj_type": "NegReg", "file_name": "PubMed-26197705.json", "snippet": " p.Val174del in-frame deletion and a p.Tyr298* nonsense mutation, that were analyzed for function in heterologous HEK293 cells. p.Tyr298* MC1R showed no agonist-induced signaling to the cAMP or ERK pathways,  [CLS] nor detectable agonist binding [CLS] . Conversely, signaling was comparable for p.Val174del and wild-type in HEK cells overexpressing the proteins, but binding analysis suggested impaired cell surface expression. Flow cytometry and confocal imaging studies revealed"}
{"subject": "no", "sub_type": "NegReg", "rel": "ThemeOf", "object": "agonist-induced signaling", "obj_type": "MPA", "file_name": "PubMed-26197705.json", "snippet": " segregated with the phenotype in seven families, including a p.Val174del in-frame deletion and a p.Tyr298* nonsense mutation, that were analyzed for function in heterologous HEK293 cells. p.Tyr298* MC1R showed  [CLS] no agonist-induced signaling [CLS]  to the cAMP or ERK pathways, nor detectable agonist binding. Conversely, signaling was comparable for p.Val174del and wild-type in HEK cells overexpressing the proteins, but binding analysis suggested impaired"}
{"subject": "cAMP", "sub_type": "Pathway", "rel": "ThemeOf", "object": "agonist-induced signaling", "obj_type": "MPA", "file_name": "PubMed-26197705.json", "snippet": " with the phenotype in seven families, including a p.Val174del in-frame deletion and a p.Tyr298* nonsense mutation, that were analyzed for function in heterologous HEK293 cells. p.Tyr298* MC1R showed no  [CLS] agonist-induced signaling to the cAMP [CLS]  or ERK pathways, nor detectable agonist binding. Conversely, signaling was comparable for p.Val174del and wild-type in HEK cells overexpressing the proteins, but binding analysis suggested impaired cell surface expression."}
{"subject": "ERK pathways", "sub_type": "Pathway", "rel": "ThemeOf", "object": "agonist-induced signaling", "obj_type": "MPA", "file_name": "PubMed-26197705.json", "snippet": " with the phenotype in seven families, including a p.Val174del in-frame deletion and a p.Tyr298* nonsense mutation, that were analyzed for function in heterologous HEK293 cells. p.Tyr298* MC1R showed no  [CLS] agonist-induced signaling to the cAMP or ERK pathways [CLS] , nor detectable agonist binding. Conversely, signaling was comparable for p.Val174del and wild-type in HEK cells overexpressing the proteins, but binding analysis suggested impaired cell surface expression. Flow cytometry and"}
{"subject": "p.Val174del", "sub_type": "Var", "rel": "CauseOf", "object": "impaired", "obj_type": "NegReg", "file_name": "PubMed-26197705.json", "snippet": " were analyzed for function in heterologous HEK293 cells. p.Tyr298* MC1R showed no agonist-induced signaling to the cAMP or ERK pathways, nor detectable agonist binding. Conversely, signaling was comparable for  [CLS] p.Val174del and wild-type in HEK cells overexpressing the proteins, but binding analysis suggested impaired [CLS]  cell surface expression. Flow cytometry and confocal imaging studies revealed reduced plasma membrane expression of p.Val174del and p.Tyr298*. Therefore, p.Tyr298* was a total loss-of-function (LOF) allele, while p.Val174del displayed"}
{"subject": "cell surface expression", "sub_type": "MPA", "rel": "ThemeOf", "object": "impaired", "obj_type": "NegReg", "file_name": "PubMed-26197705.json", "snippet": " signaling to the cAMP or ERK pathways, nor detectable agonist binding. Conversely, signaling was comparable for p.Val174del and wild-type in HEK cells overexpressing the proteins, but binding analysis suggested  [CLS] impaired cell surface expression [CLS] . Flow cytometry and confocal imaging studies revealed reduced plasma membrane expression of p.Val174del and p.Tyr298*. Therefore, p.Tyr298* was a total loss-of-function (LOF) allele, while p.Val174del displayed a partial LOF"}
{"subject": "p53", "sub_type": "Gene", "rel": "ThemeOf", "object": "missense mutations", "obj_type": "Var", "file_name": "PubMed-26331536.json", "snippet": " [CLS] p53 missense mutations [CLS]  abrogate its tumour suppressive function and lead to a 'gain-of-function' (GOF) that promotes cancer. Here we show that p53 GOF mutants bind to and upregulate chromatin regulatory genes, including"}
{"subject": "MLL2", "sub_type": "Enzyme", "rel": "ThemeOf", "object": "chromatin regulatory genes", "obj_type": "Gene", "file_name": "PubMed-26331536.json", "snippet": " Prevalent p53 missense mutations abrogate its tumour suppressive function and lead to a 'gain-of-function' (GOF) that promotes cancer. Here we show that p53 GOF mutants bind to and upregulate  [CLS] chromatin regulatory genes, including the methyltransferases MLL1 (also known as KMT2A), MLL2 [CLS]  (also known as KMT2D), and acetyltransferase MOZ (also known as KAT6A or MYST3), resulting in genome-wide increases of histone methylation and acetylation. Analysis of The Cancer Genome Atlas shows"}
{"subject": "acetyltransferase MOZ", "sub_type": "Enzyme", "rel": "ThemeOf", "object": "chromatin regulatory genes", "obj_type": "Gene", "file_name": "PubMed-26331536.json", "snippet": " Prevalent p53 missense mutations abrogate its tumour suppressive function and lead to a 'gain-of-function' (GOF) that promotes cancer. Here we show that p53 GOF mutants bind to and upregulate  [CLS] chromatin regulatory genes, including the methyltransferases MLL1 (also known as KMT2A), MLL2 (also known as KMT2D), and acetyltransferase MOZ [CLS]  (also known as KAT6A or MYST3), resulting in genome-wide increases of histone methylation and acetylation. Analysis of The Cancer Genome Atlas shows specific upregulation of MLL1, MLL2, and MOZ"}
{"subject": "missense mutations", "sub_type": "Var", "rel": "CauseOf", "object": "promotes", "obj_type": "PosReg", "file_name": "PubMed-26331536.json", "snippet": " [CLS] missense mutations abrogate its tumour suppressive function and lead to a 'gain-of-function' (GOF) that promotes [CLS]  cancer. Here we show that p53 GOF mutants bind to and upregulate chromatin regulatory genes, including the methyltransferases MLL1 (also known as KMT2A), MLL2 (also known as KMT2D), and"}
{"subject": "cancer", "sub_type": "Disease", "rel": "ThemeOf", "object": "promotes", "obj_type": "PosReg", "file_name": "PubMed-26331536.json", "snippet": " encodes p53 protein) is the most frequently mutated gene among all human cancers. Prevalent p53 missense mutations abrogate its tumour suppressive function and lead to a 'gain-of-function' (GOF) that  [CLS] promotes cancer [CLS] . Here we show that p53 GOF mutants bind to and upregulate chromatin regulatory genes, including the methyltransferases MLL1 (also known as KMT2A), MLL2 (also known as KMT2D), and acetyltransferase"}
{"subject": "upregulate", "sub_type": "PosReg", "rel": "CauseOf", "object": "increases", "obj_type": "PosReg", "file_name": "PubMed-26331536.json", "snippet": " cancers. Prevalent p53 missense mutations abrogate its tumour suppressive function and lead to a 'gain-of-function' (GOF) that promotes cancer. Here we show that p53 GOF mutants bind to and  [CLS] upregulate chromatin regulatory genes, including the methyltransferases MLL1 (also known as KMT2A), MLL2 (also known as KMT2D), and acetyltransferase MOZ (also known as KAT6A or MYST3), resulting in genome-wide increases [CLS]  of histone methylation and acetylation. Analysis of The Cancer Genome Atlas shows specific upregulation of MLL1, MLL2, and MOZ in p53 GOF patient-derived tumours, but not in wild-type p53"}
{"subject": "histone methylation", "sub_type": "MPA", "rel": "ThemeOf", "object": "increases", "obj_type": "PosReg", "file_name": "PubMed-26331536.json", "snippet": " upregulate chromatin regulatory genes, including the methyltransferases MLL1 (also known as KMT2A), MLL2 (also known as KMT2D), and acetyltransferase MOZ (also known as KAT6A or MYST3), resulting in genome-wide  [CLS] increases of histone methylation [CLS]  and acetylation. Analysis of The Cancer Genome Atlas shows specific upregulation of MLL1, MLL2, and MOZ in p53 GOF patient-derived tumours, but not in wild-type p53 or p53 null"}
{"subject": "acetylation", "sub_type": "MPA", "rel": "ThemeOf", "object": "increases", "obj_type": "PosReg", "file_name": "PubMed-26331536.json", "snippet": " upregulate chromatin regulatory genes, including the methyltransferases MLL1 (also known as KMT2A), MLL2 (also known as KMT2D), and acetyltransferase MOZ (also known as KAT6A or MYST3), resulting in genome-wide  [CLS] increases of histone methylation and acetylation [CLS] . Analysis of The Cancer Genome Atlas shows specific upregulation of MLL1, MLL2, and MOZ in p53 GOF patient-derived tumours, but not in wild-type p53 or p53 null tumours. Cancer"}
{"subject": "p53", "sub_type": "Gene", "rel": "ThemeOf", "object": "GOF", "obj_type": "Var", "file_name": "PubMed-26331536.json", "snippet": " known as KAT6A or MYST3), resulting in genome-wide increases of histone methylation and acetylation. Analysis of The Cancer Genome Atlas shows specific upregulation of MLL1, MLL2, and MOZ in  [CLS] p53 GOF [CLS]  patient-derived tumours, but not in wild-type p53 or p53 null tumours. Cancer cell proliferation is markedly lowered by genetic knockdown of MLL1 or by pharmacological inhibition of the MLL1"}
{"subject": "GOF", "sub_type": "Var", "rel": "CauseOf", "object": "upregulation", "obj_type": "PosReg", "file_name": "PubMed-26331536.json", "snippet": " known as KMT2D), and acetyltransferase MOZ (also known as KAT6A or MYST3), resulting in genome-wide increases of histone methylation and acetylation. Analysis of The Cancer Genome Atlas shows specific  [CLS] upregulation of MLL1, MLL2, and MOZ in p53 GOF [CLS]  patient-derived tumours, but not in wild-type p53 or p53 null tumours. Cancer cell proliferation is markedly lowered by genetic knockdown of MLL1 or by pharmacological inhibition of the MLL1"}
{"subject": "MLL1", "sub_type": "Enzyme", "rel": "ThemeOf", "object": "upregulation", "obj_type": "PosReg", "file_name": "PubMed-26331536.json", "snippet": " known as KMT2D), and acetyltransferase MOZ (also known as KAT6A or MYST3), resulting in genome-wide increases of histone methylation and acetylation. Analysis of The Cancer Genome Atlas shows specific  [CLS] upregulation of MLL1 [CLS] , MLL2, and MOZ in p53 GOF patient-derived tumours, but not in wild-type p53 or p53 null tumours. Cancer cell proliferation is markedly lowered by genetic knockdown of MLL1 or"}
{"subject": "missense mutations", "sub_type": "Var", "rel": "CauseOf", "object": "abrogate", "obj_type": "NegReg", "file_name": "PubMed-26331536.json", "snippet": " [CLS] missense mutations abrogate [CLS]  its tumour suppressive function and lead to a 'gain-of-function' (GOF) that promotes cancer. Here we show that p53 GOF mutants bind to and upregulate chromatin regulatory genes, including the"}
{"subject": "MLL2", "sub_type": "Enzyme", "rel": "ThemeOf", "object": "upregulation", "obj_type": "PosReg", "file_name": "PubMed-26331536.json", "snippet": " known as KMT2D), and acetyltransferase MOZ (also known as KAT6A or MYST3), resulting in genome-wide increases of histone methylation and acetylation. Analysis of The Cancer Genome Atlas shows specific  [CLS] upregulation of MLL1, MLL2 [CLS] , and MOZ in p53 GOF patient-derived tumours, but not in wild-type p53 or p53 null tumours. Cancer cell proliferation is markedly lowered by genetic knockdown of MLL1 or by"}
{"subject": "MOZ", "sub_type": "Enzyme", "rel": "ThemeOf", "object": "upregulation", "obj_type": "PosReg", "file_name": "PubMed-26331536.json", "snippet": " known as KMT2D), and acetyltransferase MOZ (also known as KAT6A or MYST3), resulting in genome-wide increases of histone methylation and acetylation. Analysis of The Cancer Genome Atlas shows specific  [CLS] upregulation of MLL1, MLL2, and MOZ [CLS]  in p53 GOF patient-derived tumours, but not in wild-type p53 or p53 null tumours. Cancer cell proliferation is markedly lowered by genetic knockdown of MLL1 or by pharmacological inhibition"}
{"subject": "tumour suppressive function", "sub_type": "CPA", "rel": "ThemeOf", "object": "abrogate", "obj_type": "NegReg", "file_name": "PubMed-26331536.json", "snippet": " [CLS] abrogate its tumour suppressive function [CLS]  and lead to a 'gain-of-function' (GOF) that promotes cancer. Here we show that p53 GOF mutants bind to and upregulate chromatin regulatory genes, including the methyltransferases MLL1 (also known"}
{"subject": "missense mutations", "sub_type": "Var", "rel": "CauseOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-26331536.json", "snippet": " [CLS] missense mutations abrogate its tumour suppressive function and lead to a 'gain-of-function [CLS] ' (GOF) that promotes cancer. Here we show that p53 GOF mutants bind to and upregulate chromatin regulatory genes, including the methyltransferases MLL1 (also known as KMT2A), MLL2 (also known"}
{"subject": "p53", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutants", "obj_type": "Var", "file_name": "PubMed-26331536.json", "snippet": " frequently mutated gene among all human cancers. Prevalent p53 missense mutations abrogate its tumour suppressive function and lead to a 'gain-of-function' (GOF) that promotes cancer. Here we show that  [CLS] p53 GOF mutants [CLS]  bind to and upregulate chromatin regulatory genes, including the methyltransferases MLL1 (also known as KMT2A), MLL2 (also known as KMT2D), and acetyltransferase MOZ (also known as KAT6A or MYST3),"}
{"subject": "mutants", "sub_type": "Var", "rel": "CauseOf", "object": "GOF", "obj_type": "PosReg", "file_name": "PubMed-26331536.json", "snippet": " mutated gene among all human cancers. Prevalent p53 missense mutations abrogate its tumour suppressive function and lead to a 'gain-of-function' (GOF) that promotes cancer. Here we show that p53  [CLS] GOF mutants [CLS]  bind to and upregulate chromatin regulatory genes, including the methyltransferases MLL1 (also known as KMT2A), MLL2 (also known as KMT2D), and acetyltransferase MOZ (also known as KAT6A or MYST3),"}
{"subject": "mutants", "sub_type": "Var", "rel": "CauseOf", "object": "upregulate", "obj_type": "PosReg", "file_name": "PubMed-26331536.json", "snippet": " gene among all human cancers. Prevalent p53 missense mutations abrogate its tumour suppressive function and lead to a 'gain-of-function' (GOF) that promotes cancer. Here we show that p53 GOF  [CLS] mutants bind to and upregulate [CLS]  chromatin regulatory genes, including the methyltransferases MLL1 (also known as KMT2A), MLL2 (also known as KMT2D), and acetyltransferase MOZ (also known as KAT6A or MYST3), resulting in genome-wide increases"}
{"subject": "chromatin regulatory genes", "sub_type": "Gene", "rel": "ThemeOf", "object": "upregulate", "obj_type": "PosReg", "file_name": "PubMed-26331536.json", "snippet": " cancers. Prevalent p53 missense mutations abrogate its tumour suppressive function and lead to a 'gain-of-function' (GOF) that promotes cancer. Here we show that p53 GOF mutants bind to and  [CLS] upregulate chromatin regulatory genes [CLS] , including the methyltransferases MLL1 (also known as KMT2A), MLL2 (also known as KMT2D), and acetyltransferase MOZ (also known as KAT6A or MYST3), resulting in genome-wide increases of histone methylation"}
{"subject": "methyltransferases MLL1", "sub_type": "Enzyme", "rel": "ThemeOf", "object": "chromatin regulatory genes", "obj_type": "Gene", "file_name": "PubMed-26331536.json", "snippet": " Prevalent p53 missense mutations abrogate its tumour suppressive function and lead to a 'gain-of-function' (GOF) that promotes cancer. Here we show that p53 GOF mutants bind to and upregulate  [CLS] chromatin regulatory genes, including the methyltransferases MLL1 [CLS]  (also known as KMT2A), MLL2 (also known as KMT2D), and acetyltransferase MOZ (also known as KAT6A or MYST3), resulting in genome-wide increases of histone methylation and acetylation. Analysis of"}
{"subject": "p53", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutant", "obj_type": "Var", "file_name": "PubMed-26494468.json", "snippet": " axis. Bioinformatic analysis of the NCI-60 data set and subsequent hub prediction identified EFNB2 as a possible GOF mutant p53 target gene, responsible for chemoresistance. We show that the  [CLS] mutant p53 [CLS] -NF-Y complex transcriptionally upregulates EFNB2 expression in response to DNA damage. Moreover, the acetylated form of mutant p53 protein is recruited on the EFNB2 promoter and positively regulates its expression"}
{"subject": "expression", "sub_type": "MPA", "rel": "ThemeOf", "object": "regulates", "obj_type": "Reg", "file_name": "PubMed-26494468.json", "snippet": " the mutant p53-NF-Y complex transcriptionally upregulates EFNB2 expression in response to DNA damage. Moreover, the acetylated form of mutant p53 protein is recruited on the EFNB2 promoter and positively  [CLS] regulates its expression [CLS]  in conjunction with coactivator p300. In vitro cell line and in vivo nude mice data show that EFNB2 silencing restores chemosensitivity in mutant p53-harboring tumors. In addition, we observed"}
{"subject": "ABCG2", "sub_type": "Gene", "rel": "ThemeOf", "object": "expression", "obj_type": "MPA", "file_name": "PubMed-26494468.json", "snippet": " non-responder colorectal carcinoma compared with those having responder version of the disease. In the course of deciphering the drug resistance mechanism, we also show that ephrin-B2 reverse signaling induces  [CLS] ABCG2 expression [CLS]  after drug treatment that involves JNK-c-Jun signaling in mutant p53 cells. Moreover, 5-fluorouracil-induced ephrin-B2 reverse signaling promotes tumorigenesis through the Src-ERK pathway, and drives EMT via the Src-FAK pathway."}
{"subject": "JNK-c-Jun signaling", "sub_type": "MPA", "rel": "ThemeOf", "object": "induces", "obj_type": "PosReg", "file_name": "PubMed-26494468.json", "snippet": " neoadjuvant non-responder colorectal carcinoma compared with those having responder version of the disease. In the course of deciphering the drug resistance mechanism, we also show that ephrin-B2 reverse signaling  [CLS] induces ABCG2 expression after drug treatment that involves JNK-c-Jun signaling [CLS]  in mutant p53 cells. Moreover, 5-fluorouracil-induced ephrin-B2 reverse signaling promotes tumorigenesis through the Src-ERK pathway, and drives EMT via the Src-FAK pathway. We thus conclude that targeting ephrin-B2 might"}
{"subject": "expression", "sub_type": "MPA", "rel": "ThemeOf", "object": "induces", "obj_type": "PosReg", "file_name": "PubMed-26494468.json", "snippet": " neoadjuvant non-responder colorectal carcinoma compared with those having responder version of the disease. In the course of deciphering the drug resistance mechanism, we also show that ephrin-B2 reverse signaling  [CLS] induces ABCG2 expression [CLS]  after drug treatment that involves JNK-c-Jun signaling in mutant p53 cells. Moreover, 5-fluorouracil-induced ephrin-B2 reverse signaling promotes tumorigenesis through the Src-ERK pathway, and drives EMT via the Src-FAK pathway."}
{"subject": "p53", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutant", "obj_type": "Var", "file_name": "PubMed-26494468.json", "snippet": " the disease. In the course of deciphering the drug resistance mechanism, we also show that ephrin-B2 reverse signaling induces ABCG2 expression after drug treatment that involves JNK-c-Jun signaling in  [CLS] mutant p53 [CLS]  cells. Moreover, 5-fluorouracil-induced ephrin-B2 reverse signaling promotes tumorigenesis through the Src-ERK pathway, and drives EMT via the Src-FAK pathway. We thus conclude that targeting ephrin-B2 might enhance the therapeutic"}
{"subject": "mutant", "sub_type": "Var", "rel": "CauseOf", "object": "induces", "obj_type": "PosReg", "file_name": "PubMed-26494468.json", "snippet": " neoadjuvant non-responder colorectal carcinoma compared with those having responder version of the disease. In the course of deciphering the drug resistance mechanism, we also show that ephrin-B2 reverse signaling  [CLS] induces ABCG2 expression after drug treatment that involves JNK-c-Jun signaling in mutant [CLS]  p53 cells. Moreover, 5-fluorouracil-induced ephrin-B2 reverse signaling promotes tumorigenesis through the Src-ERK pathway, and drives EMT via the Src-FAK pathway. We thus conclude that targeting ephrin-B2 might enhance the"}
{"subject": "mutant", "sub_type": "Var", "rel": "CauseOf", "object": "upregulates", "obj_type": "PosReg", "file_name": "PubMed-26494468.json", "snippet": " axis. Bioinformatic analysis of the NCI-60 data set and subsequent hub prediction identified EFNB2 as a possible GOF mutant p53 target gene, responsible for chemoresistance. We show that the  [CLS] mutant p53-NF-Y complex transcriptionally upregulates [CLS]  EFNB2 expression in response to DNA damage. Moreover, the acetylated form of mutant p53 protein is recruited on the EFNB2 promoter and positively regulates its expression in conjunction with"}
{"subject": "EFNB2", "sub_type": "Gene", "rel": "ThemeOf", "object": "expression", "obj_type": "MPA", "file_name": "PubMed-26494468.json", "snippet": " NCI-60 data set and subsequent hub prediction identified EFNB2 as a possible GOF mutant p53 target gene, responsible for chemoresistance. We show that the mutant p53-NF-Y complex transcriptionally upregulates  [CLS] EFNB2 expression [CLS]  in response to DNA damage. Moreover, the acetylated form of mutant p53 protein is recruited on the EFNB2 promoter and positively regulates its expression in conjunction with coactivator p300."}
{"subject": "expression", "sub_type": "MPA", "rel": "ThemeOf", "object": "upregulates", "obj_type": "PosReg", "file_name": "PubMed-26494468.json", "snippet": " the NCI-60 data set and subsequent hub prediction identified EFNB2 as a possible GOF mutant p53 target gene, responsible for chemoresistance. We show that the mutant p53-NF-Y complex transcriptionally  [CLS] upregulates EFNB2 expression [CLS]  in response to DNA damage. Moreover, the acetylated form of mutant p53 protein is recruited on the EFNB2 promoter and positively regulates its expression in conjunction with coactivator p300."}
{"subject": "response to DNA damage", "sub_type": "MPA", "rel": "ThemeOf", "object": "upregulates", "obj_type": "PosReg", "file_name": "PubMed-26494468.json", "snippet": " the NCI-60 data set and subsequent hub prediction identified EFNB2 as a possible GOF mutant p53 target gene, responsible for chemoresistance. We show that the mutant p53-NF-Y complex transcriptionally  [CLS] upregulates EFNB2 expression in response to DNA damage [CLS] . Moreover, the acetylated form of mutant p53 protein is recruited on the EFNB2 promoter and positively regulates its expression in conjunction with coactivator p300. In vitro cell line and"}
{"subject": "mutant", "sub_type": "Var", "rel": "CauseOf", "object": "recruited", "obj_type": "PosReg", "file_name": "PubMed-26494468.json", "snippet": " GOF mutant p53 target gene, responsible for chemoresistance. We show that the mutant p53-NF-Y complex transcriptionally upregulates EFNB2 expression in response to DNA damage. Moreover, the acetylated form of  [CLS] mutant p53 protein is recruited [CLS]  on the EFNB2 promoter and positively regulates its expression in conjunction with coactivator p300. In vitro cell line and in vivo nude mice data show that EFNB2 silencing restores"}
{"subject": "p53", "sub_type": "Gene", "rel": "ThemeOf", "object": "protein", "obj_type": "Protein", "file_name": "PubMed-26494468.json", "snippet": " mutant p53 target gene, responsible for chemoresistance. We show that the mutant p53-NF-Y complex transcriptionally upregulates EFNB2 expression in response to DNA damage. Moreover, the acetylated form of mutant  [CLS] p53 protein [CLS]  is recruited on the EFNB2 promoter and positively regulates its expression in conjunction with coactivator p300. In vitro cell line and in vivo nude mice data show that EFNB2"}
{"subject": "protein", "sub_type": "Protein", "rel": "ThemeOf", "object": "mutant", "obj_type": "Var", "file_name": "PubMed-26494468.json", "snippet": " GOF mutant p53 target gene, responsible for chemoresistance. We show that the mutant p53-NF-Y complex transcriptionally upregulates EFNB2 expression in response to DNA damage. Moreover, the acetylated form of  [CLS] mutant p53 protein [CLS]  is recruited on the EFNB2 promoter and positively regulates its expression in conjunction with coactivator p300. In vitro cell line and in vivo nude mice data show that EFNB2"}
{"subject": "mutant", "sub_type": "Var", "rel": "CauseOf", "object": "regulates", "obj_type": "Reg", "file_name": "PubMed-26494468.json", "snippet": " GOF mutant p53 target gene, responsible for chemoresistance. We show that the mutant p53-NF-Y complex transcriptionally upregulates EFNB2 expression in response to DNA damage. Moreover, the acetylated form of  [CLS] mutant p53 protein is recruited on the EFNB2 promoter and positively regulates [CLS]  its expression in conjunction with coactivator p300. In vitro cell line and in vivo nude mice data show that EFNB2 silencing restores chemosensitivity in mutant p53-harboring tumors. In addition,"}
{"subject": "PCSK9", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-26586530.json", "snippet": " human induced pluripotent stem cells as a model to study PCSK9-mediated autosomal dominant hypercholesterolemia.\nProprotein convertase subtilisin kexin type 9 (PCSK9) is a critical modulator of cholesterol homeostasis. Whereas  [CLS] PCSK9 gain-of-function (GOF) mutations [CLS]  are associated with autosomal dominant hypercholesterolemia (ADH) and premature atherosclerosis, PCSK9 loss-of-function (LOF) mutations have a cardio-protective effect and in some cases can lead to familial hypobetalipoproteinemia (FHBL). However,"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-26586530.json", "snippet": " induced pluripotent stem cells as a model to study PCSK9-mediated autosomal dominant hypercholesterolemia.\nProprotein convertase subtilisin kexin type 9 (PCSK9) is a critical modulator of cholesterol homeostasis. Whereas PCSK9  [CLS] gain-of-function (GOF) mutations [CLS]  are associated with autosomal dominant hypercholesterolemia (ADH) and premature atherosclerosis, PCSK9 loss-of-function (LOF) mutations have a cardio-protective effect and in some cases can lead to familial hypobetalipoproteinemia (FHBL). However,"}
{"subject": "autosomal dominant hypercholesterolemia", "sub_type": "Disease", "rel": "ThemeOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-26586530.json", "snippet": " induced pluripotent stem cells as a model to study PCSK9-mediated autosomal dominant hypercholesterolemia.\nProprotein convertase subtilisin kexin type 9 (PCSK9) is a critical modulator of cholesterol homeostasis. Whereas PCSK9  [CLS] gain-of-function (GOF) mutations are associated with autosomal dominant hypercholesterolemia [CLS]  (ADH) and premature atherosclerosis, PCSK9 loss-of-function (LOF) mutations have a cardio-protective effect and in some cases can lead to familial hypobetalipoproteinemia (FHBL). However, limitations of the currently available cellular"}
{"subject": "premature atherosclerosis", "sub_type": "Disease", "rel": "ThemeOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-26586530.json", "snippet": " induced pluripotent stem cells as a model to study PCSK9-mediated autosomal dominant hypercholesterolemia.\nProprotein convertase subtilisin kexin type 9 (PCSK9) is a critical modulator of cholesterol homeostasis. Whereas PCSK9  [CLS] gain-of-function (GOF) mutations are associated with autosomal dominant hypercholesterolemia (ADH) and premature atherosclerosis [CLS] , PCSK9 loss-of-function (LOF) mutations have a cardio-protective effect and in some cases can lead to familial hypobetalipoproteinemia (FHBL). However, limitations of the currently available cellular models preclude deciphering the"}
{"subject": "PCSK9", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-26586530.json", "snippet": "\nProprotein convertase subtilisin kexin type 9 (PCSK9) is a critical modulator of cholesterol homeostasis. Whereas PCSK9 gain-of-function (GOF) mutations are associated with autosomal dominant hypercholesterolemia (ADH) and premature atherosclerosis,  [CLS] PCSK9 loss-of-function (LOF) mutations [CLS]  have a cardio-protective effect and in some cases can lead to familial hypobetalipoproteinemia (FHBL). However, limitations of the currently available cellular models preclude deciphering the consequences of PCSK9 mutation"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-26586530.json", "snippet": " convertase subtilisin kexin type 9 (PCSK9) is a critical modulator of cholesterol homeostasis. Whereas PCSK9 gain-of-function (GOF) mutations are associated with autosomal dominant hypercholesterolemia (ADH) and premature atherosclerosis, PCSK9  [CLS] loss-of-function (LOF) mutations [CLS]  have a cardio-protective effect and in some cases can lead to familial hypobetalipoproteinemia (FHBL). However, limitations of the currently available cellular models preclude deciphering the consequences of PCSK9 mutation"}
{"subject": "familial hypobetalipoproteinemia", "sub_type": "Disease", "rel": "ThemeOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-26586530.json", "snippet": " convertase subtilisin kexin type 9 (PCSK9) is a critical modulator of cholesterol homeostasis. Whereas PCSK9 gain-of-function (GOF) mutations are associated with autosomal dominant hypercholesterolemia (ADH) and premature atherosclerosis, PCSK9  [CLS] loss-of-function (LOF) mutations have a cardio-protective effect and in some cases can lead to familial hypobetalipoproteinemia [CLS]  (FHBL). However, limitations of the currently available cellular models preclude deciphering the consequences of PCSK9 mutation further. We aimed to validate urine-sample-derived human induced pluripotent stem cells (UhiPSCs) as"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "have", "obj_type": "PosReg", "file_name": "PubMed-26586530.json", "snippet": " kexin type 9 (PCSK9) is a critical modulator of cholesterol homeostasis. Whereas PCSK9 gain-of-function (GOF) mutations are associated with autosomal dominant hypercholesterolemia (ADH) and premature atherosclerosis, PCSK9 loss-of-function (LOF)  [CLS] mutations have [CLS]  a cardio-protective effect and in some cases can lead to familial hypobetalipoproteinemia (FHBL). However, limitations of the currently available cellular models preclude deciphering the consequences of PCSK9 mutation further."}
{"subject": "cardio-protective effect", "sub_type": "CPA", "rel": "ThemeOf", "object": "have", "obj_type": "PosReg", "file_name": "PubMed-26586530.json", "snippet": " type 9 (PCSK9) is a critical modulator of cholesterol homeostasis. Whereas PCSK9 gain-of-function (GOF) mutations are associated with autosomal dominant hypercholesterolemia (ADH) and premature atherosclerosis, PCSK9 loss-of-function (LOF) mutations  [CLS] have a cardio-protective effect [CLS]  and in some cases can lead to familial hypobetalipoproteinemia (FHBL). However, limitations of the currently available cellular models preclude deciphering the consequences of PCSK9 mutation further. We aimed to"}
{"subject": "MLK4", "sub_type": "Gene", "rel": "ThemeOf", "object": "Mutations", "obj_type": "Var", "file_name": "PubMed-26637668.json", "snippet": " [CLS] MLK4 Loss-of-Function Mutations [CLS]  Suppress JNK Signaling to Promote Colon Tumorigenesis.\nMLK4 is a member of the mixed-lineage family of kinases that regulate the JNK, p38, and ERK kinase signaling pathways. MLK4 mutations"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "LOF", "obj_type": "NegReg", "file_name": "PubMed-26637668.json", "snippet": " the JNK pathway and its downstream targets, cJUN, ATF3, and the cyclin-dependent kinase inhibitors CDKN1A and CDKN2B. Our work indicates that MLK4 is a novel tumor-suppressing kinase harboring frequent  [CLS] LOF mutations [CLS]  that lead to diminished signaling in the JNK pathway and enhanced proliferation in colon cancer. Cancer Res; 76(3); 1-12. \u00a92015 AACR."}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "diminished", "obj_type": "NegReg", "file_name": "PubMed-26637668.json", "snippet": " JNK pathway and its downstream targets, cJUN, ATF3, and the cyclin-dependent kinase inhibitors CDKN1A and CDKN2B. Our work indicates that MLK4 is a novel tumor-suppressing kinase harboring frequent LOF  [CLS] mutations that lead to diminished [CLS]  signaling in the JNK pathway and enhanced proliferation in colon cancer. Cancer Res; 76(3); 1-12. \u00a92015 AACR."}
{"subject": "signaling", "sub_type": "MPA", "rel": "ThemeOf", "object": "diminished", "obj_type": "NegReg", "file_name": "PubMed-26637668.json", "snippet": " downstream targets, cJUN, ATF3, and the cyclin-dependent kinase inhibitors CDKN1A and CDKN2B. Our work indicates that MLK4 is a novel tumor-suppressing kinase harboring frequent LOF mutations that lead to  [CLS] diminished signaling [CLS]  in the JNK pathway and enhanced proliferation in colon cancer. Cancer Res; 76(3); 1-12. \u00a92015 AACR."}
{"subject": "signaling", "sub_type": "MPA", "rel": "ThemeOf", "object": "JNK pathway", "obj_type": "Pathway", "file_name": "PubMed-26637668.json", "snippet": " targets, cJUN, ATF3, and the cyclin-dependent kinase inhibitors CDKN1A and CDKN2B. Our work indicates that MLK4 is a novel tumor-suppressing kinase harboring frequent LOF mutations that lead to diminished  [CLS] signaling in the JNK pathway [CLS]  and enhanced proliferation in colon cancer. Cancer Res; 76(3); 1-12. \u00a92015 AACR."}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "enhanced", "obj_type": "PosReg", "file_name": "PubMed-26637668.json", "snippet": " JNK pathway and its downstream targets, cJUN, ATF3, and the cyclin-dependent kinase inhibitors CDKN1A and CDKN2B. Our work indicates that MLK4 is a novel tumor-suppressing kinase harboring frequent LOF  [CLS] mutations that lead to diminished signaling in the JNK pathway and enhanced [CLS]  proliferation in colon cancer. Cancer Res; 76(3); 1-12. \u00a92015 AACR."}
{"subject": "proliferation", "sub_type": "CPA", "rel": "ThemeOf", "object": "enhanced", "obj_type": "PosReg", "file_name": "PubMed-26637668.json", "snippet": " kinase inhibitors CDKN1A and CDKN2B. Our work indicates that MLK4 is a novel tumor-suppressing kinase harboring frequent LOF mutations that lead to diminished signaling in the JNK pathway and  [CLS] enhanced proliferation [CLS]  in colon cancer. Cancer Res; 76(3); 1-12. \u00a92015 AACR."}
{"subject": "Mutations", "sub_type": "Var", "rel": "CauseOf", "object": "Loss-of-Function", "obj_type": "NegReg", "file_name": "PubMed-26637668.json", "snippet": " [CLS] Loss-of-Function Mutations [CLS]  Suppress JNK Signaling to Promote Colon Tumorigenesis.\nMLK4 is a member of the mixed-lineage family of kinases that regulate the JNK, p38, and ERK kinase signaling pathways. MLK4 mutations"}
{"subject": "Mutations", "sub_type": "Var", "rel": "CauseOf", "object": "Suppress", "obj_type": "NegReg", "file_name": "PubMed-26637668.json", "snippet": " [CLS] Mutations Suppress [CLS]  JNK Signaling to Promote Colon Tumorigenesis.\nMLK4 is a member of the mixed-lineage family of kinases that regulate the JNK, p38, and ERK kinase signaling pathways. MLK4 mutations have"}
{"subject": "JNK Signaling", "sub_type": "Pathway", "rel": "ThemeOf", "object": "Suppress", "obj_type": "NegReg", "file_name": "PubMed-26637668.json", "snippet": " [CLS] Suppress JNK Signaling [CLS]  to Promote Colon Tumorigenesis.\nMLK4 is a member of the mixed-lineage family of kinases that regulate the JNK, p38, and ERK kinase signaling pathways. MLK4 mutations have been identified"}
{"subject": "Mutations", "sub_type": "Var", "rel": "CauseOf", "object": "Promote", "obj_type": "PosReg", "file_name": "PubMed-26637668.json", "snippet": " [CLS] Mutations Suppress JNK Signaling to Promote [CLS]  Colon Tumorigenesis.\nMLK4 is a member of the mixed-lineage family of kinases that regulate the JNK, p38, and ERK kinase signaling pathways. MLK4 mutations have been identified in various"}
{"subject": "Colon Tumorigenesis", "sub_type": "Disease", "rel": "ThemeOf", "object": "Promote", "obj_type": "PosReg", "file_name": "PubMed-26637668.json", "snippet": " [CLS] Promote Colon Tumorigenesis [CLS] .\nMLK4 is a member of the mixed-lineage family of kinases that regulate the JNK, p38, and ERK kinase signaling pathways. MLK4 mutations have been identified in various human cancers,"}
{"subject": "MLK4", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-26637668.json", "snippet": " their function and pathobiological importance have been uncertain. In this study, we assessed the functional consequences of MLK4 mutations in colon tumorigenesis. Biochemical data indicated that a majority of  [CLS] MLK4 mutations [CLS]  are loss-of-function (LOF) mutations that can exert dominant-negative effects. In seeking to understand the abrogated activity of these mutants, we elucidated a new MLK4 catalytic domain structure. To determine"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-26637668.json", "snippet": " function and pathobiological importance have been uncertain. In this study, we assessed the functional consequences of MLK4 mutations in colon tumorigenesis. Biochemical data indicated that a majority of MLK4  [CLS] mutations are loss-of-function [CLS]  (LOF) mutations that can exert dominant-negative effects. In seeking to understand the abrogated activity of these mutants, we elucidated a new MLK4 catalytic domain structure. To determine whether MLK4"}
{"subject": "MLK4", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-26637668.json", "snippet": " that restoring the function of MLK4 selectively induced the JNK pathway and its downstream targets, cJUN, ATF3, and the cyclin-dependent kinase inhibitors CDKN1A and CDKN2B. Our work indicates that  [CLS] MLK4 is a novel tumor-suppressing kinase harboring frequent LOF mutations [CLS]  that lead to diminished signaling in the JNK pathway and enhanced proliferation in colon cancer. Cancer Res; 76(3); 1-12. \u00a92015 AACR."}
{"subject": "p53", "sub_type": "Gene", "rel": "ThemeOf", "object": "missense mutants", "obj_type": "Var", "file_name": "PubMed-27114909.json", "snippet": " genes and pathways deregulated upon floxuridine treatment in colorectal cancer cells harboring GOF mutant p53.\nMutation in TP53 is a common genetic alteration in human cancers. Certain tumor associated  [CLS] p53 missense mutants [CLS]  acquire gain-of-function (GOF) properties and confer oncogenic phenotypes including enhanced chemoresistance. The colorectal cancers (CRC) harboring mutant p53 are generally aggressive in nature and difficult to treat. To identify"}
{"subject": "missense mutants", "sub_type": "Var", "rel": "CauseOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-27114909.json", "snippet": " and pathways deregulated upon floxuridine treatment in colorectal cancer cells harboring GOF mutant p53.\nMutation in TP53 is a common genetic alteration in human cancers. Certain tumor associated p53  [CLS] missense mutants acquire gain-of-function [CLS]  (GOF) properties and confer oncogenic phenotypes including enhanced chemoresistance. The colorectal cancers (CRC) harboring mutant p53 are generally aggressive in nature and difficult to treat. To identify a potential"}
{"subject": "chemoresistance", "sub_type": "CPA", "rel": "ThemeOf", "object": "enhanced", "obj_type": "PosReg", "file_name": "PubMed-27114909.json", "snippet": " GOF mutant p53.\nMutation in TP53 is a common genetic alteration in human cancers. Certain tumor associated p53 missense mutants acquire gain-of-function (GOF) properties and confer oncogenic phenotypes including  [CLS] enhanced chemoresistance [CLS] . The colorectal cancers (CRC) harboring mutant p53 are generally aggressive in nature and difficult to treat. To identify a potential gene expression signature of GOF mutant p53-driven acquired chemoresistance"}
{"subject": "missense mutants", "sub_type": "Var", "rel": "CauseOf", "object": "enhanced", "obj_type": "PosReg", "file_name": "PubMed-27114909.json", "snippet": " and pathways deregulated upon floxuridine treatment in colorectal cancer cells harboring GOF mutant p53.\nMutation in TP53 is a common genetic alteration in human cancers. Certain tumor associated p53  [CLS] missense mutants acquire gain-of-function (GOF) properties and confer oncogenic phenotypes including enhanced [CLS]  chemoresistance. The colorectal cancers (CRC) harboring mutant p53 are generally aggressive in nature and difficult to treat. To identify a potential gene expression signature of GOF mutant p53-driven acquired"}
{"subject": "mutant", "sub_type": "Var", "rel": "CauseOf", "object": "GOF", "obj_type": "PosReg", "file_name": "PubMed-27114909.json", "snippet": " pathway analysis revealed significant enrichment of crucial biological processes and pathways upon FUdR treatment in SW480 cells. Our data suggest that in response to chemotherapeutics treatment, cancer cells with  [CLS] GOF mutant [CLS]  p53 can modulate key cellular pathways to withstand the cytotoxic effect of the drugs. The genes and pathways identified in the present study can be further validated and targeted"}
{"subject": "p53", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutant", "obj_type": "Var", "file_name": "PubMed-27114909.json", "snippet": " analysis revealed significant enrichment of crucial biological processes and pathways upon FUdR treatment in SW480 cells. Our data suggest that in response to chemotherapeutics treatment, cancer cells with GOF  [CLS] mutant p53 [CLS]  can modulate key cellular pathways to withstand the cytotoxic effect of the drugs. The genes and pathways identified in the present study can be further validated and targeted for"}
{"subject": "mutant", "sub_type": "Var", "rel": "CauseOf", "object": "modulate", "obj_type": "Reg", "file_name": "PubMed-27114909.json", "snippet": " analysis revealed significant enrichment of crucial biological processes and pathways upon FUdR treatment in SW480 cells. Our data suggest that in response to chemotherapeutics treatment, cancer cells with GOF  [CLS] mutant p53 can modulate [CLS]  key cellular pathways to withstand the cytotoxic effect of the drugs. The genes and pathways identified in the present study can be further validated and targeted for better chemotherapy"}
{"subject": "key cellular pathways", "sub_type": "Pathway", "rel": "ThemeOf", "object": "modulate", "obj_type": "Reg", "file_name": "PubMed-27114909.json", "snippet": " enrichment of crucial biological processes and pathways upon FUdR treatment in SW480 cells. Our data suggest that in response to chemotherapeutics treatment, cancer cells with GOF mutant p53 can  [CLS] modulate key cellular pathways [CLS]  to withstand the cytotoxic effect of the drugs. The genes and pathways identified in the present study can be further validated and targeted for better chemotherapy response in colorectal"}
{"subject": "withstand the cytotoxic effect of the drugs", "sub_type": "CPA", "rel": "ThemeOf", "object": "modulate", "obj_type": "Reg", "file_name": "PubMed-27114909.json", "snippet": " enrichment of crucial biological processes and pathways upon FUdR treatment in SW480 cells. Our data suggest that in response to chemotherapeutics treatment, cancer cells with GOF mutant p53 can  [CLS] modulate key cellular pathways to withstand the cytotoxic effect of the drugs [CLS] . The genes and pathways identified in the present study can be further validated and targeted for better chemotherapy response in colorectal cancer patients harboring mutant p53."}
{"subject": "TBR1", "sub_type": "Gene", "rel": "ThemeOf", "object": "variants", "obj_type": "Var", "file_name": "PubMed-27325115.json", "snippet": " [CLS] variants in individuals with autism spectrum disorders (ASD), including TBR1 [CLS] , a master regulator of cortical development. We performed ChIP-seq for TBR1 during mouse cortical neurogenesis and show that TBR1-bound regions are enriched adjacent to ASD genes. ASD genes were"}
{"subject": "variants", "sub_type": "Var", "rel": "CauseOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-27325115.json", "snippet": " [CLS] loss-of-function (LoF) variants [CLS]  in individuals with autism spectrum disorders (ASD), including TBR1, a master regulator of cortical development. We performed ChIP-seq for TBR1 during mouse cortical neurogenesis and show that TBR1-bound regions"}
{"subject": "autism spectrum disorders", "sub_type": "Disease", "rel": "ThemeOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-27325115.json", "snippet": " [CLS] loss-of-function (LoF) variants in individuals with autism spectrum disorders [CLS]  (ASD), including TBR1, a master regulator of cortical development. We performed ChIP-seq for TBR1 during mouse cortical neurogenesis and show that TBR1-bound regions are enriched adjacent to ASD genes."}
{"subject": "TNFAIP8", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutation", "obj_type": "Var", "file_name": "PubMed-27341992.json", "snippet": " [CLS] mutation in cancer confers p53 gain-of-function and tumor cell survival via TNFAIP8 [CLS]  induction.\nThe p53 tumor suppressor gene encodes a sequence-specific transcription factor. Mutations in the coding sequence of p53 occur frequently in human cancer and often result in single amino"}
{"subject": "tumor suppressive functions", "sub_type": "CPA", "rel": "ThemeOf", "object": "blocking", "obj_type": "NegReg", "file_name": "PubMed-27341992.json", "snippet": " factor. Mutations in the coding sequence of p53 occur frequently in human cancer and often result in single amino acid substitutions (missense mutations) in the DNA binding domain (DBD),  [CLS] blocking normal tumor suppressive functions [CLS] . In addition to the loss of canonical functions, some missense mutations in p53 confer gain-of-function (GOF) activities to tumor cells. While many missense mutations in p53 cluster at six"}
{"subject": "missense mutations", "sub_type": "Var", "rel": "CauseOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-27341992.json", "snippet": " often result in single amino acid substitutions (missense mutations) in the DNA binding domain (DBD), blocking normal tumor suppressive functions. In addition to the loss of canonical functions, some  [CLS] missense mutations in p53 confer gain-of-function [CLS]  (GOF) activities to tumor cells. While many missense mutations in p53 cluster at six \"hotspot\" amino acids, the majority of mutations in human cancer occur elsewhere in the DBD"}
{"subject": "activities to tumor cells", "sub_type": "CPA", "rel": "ThemeOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-27341992.json", "snippet": " acid substitutions (missense mutations) in the DNA binding domain (DBD), blocking normal tumor suppressive functions. In addition to the loss of canonical functions, some missense mutations in p53 confer  [CLS] gain-of-function (GOF) activities to tumor cells [CLS] . While many missense mutations in p53 cluster at six \"hotspot\" amino acids, the majority of mutations in human cancer occur elsewhere in the DBD and at a much lower"}
{"subject": "p53", "sub_type": "Gene", "rel": "ThemeOf", "object": "missense mutations", "obj_type": "Var", "file_name": "PubMed-27341992.json", "snippet": " often result in single amino acid substitutions (missense mutations) in the DNA binding domain (DBD), blocking normal tumor suppressive functions. In addition to the loss of canonical functions, some  [CLS] missense mutations in p53 [CLS]  confer gain-of-function (GOF) activities to tumor cells. While many missense mutations in p53 cluster at six \"hotspot\" amino acids, the majority of mutations in human cancer occur elsewhere in"}
{"subject": "mutations at K120", "sub_type": "Var", "rel": "CauseOf", "object": "confer", "obj_type": "PosReg", "file_name": "PubMed-27341992.json", "snippet": " p53 cluster at six \"hotspot\" amino acids, the majority of mutations in human cancer occur elsewhere in the DBD and at a much lower frequency. We report here that  [CLS] mutations at K120, a non-hotspot DNA contact residue, confer [CLS]  p53 with the previously unrecognized ability to bind and activate the transcription of the pro-survival TNFAIP8 gene. Mutant K120 p53 binds the TNFAIP8 locus at a cryptic p53 response"}
{"subject": "p53", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations at K120", "obj_type": "Var", "file_name": "PubMed-27341992.json", "snippet": " p53 cluster at six \"hotspot\" amino acids, the majority of mutations in human cancer occur elsewhere in the DBD and at a much lower frequency. We report here that  [CLS] mutations at K120, a non-hotspot DNA contact residue, confer p53 [CLS]  with the previously unrecognized ability to bind and activate the transcription of the pro-survival TNFAIP8 gene. Mutant K120 p53 binds the TNFAIP8 locus at a cryptic p53 response element"}
{"subject": "ability", "sub_type": "MPA", "rel": "ThemeOf", "object": "confer", "obj_type": "PosReg", "file_name": "PubMed-27341992.json", "snippet": " majority of mutations in human cancer occur elsewhere in the DBD and at a much lower frequency. We report here that mutations at K120, a non-hotspot DNA contact residue,  [CLS] confer p53 with the previously unrecognized ability [CLS]  to bind and activate the transcription of the pro-survival TNFAIP8 gene. Mutant K120 p53 binds the TNFAIP8 locus at a cryptic p53 response element that is not occupied by"}
{"subject": "bind", "sub_type": "Interaction", "rel": "ThemeOf", "object": "ability", "obj_type": "MPA", "file_name": "PubMed-27341992.json", "snippet": " occur elsewhere in the DBD and at a much lower frequency. We report here that mutations at K120, a non-hotspot DNA contact residue, confer p53 with the previously unrecognized  [CLS] ability to bind [CLS]  and activate the transcription of the pro-survival TNFAIP8 gene. Mutant K120 p53 binds the TNFAIP8 locus at a cryptic p53 response element that is not occupied by wild-type p53."}
{"subject": "mutations at K120", "sub_type": "Var", "rel": "CauseOf", "object": "activate", "obj_type": "PosReg", "file_name": "PubMed-27341992.json", "snippet": " p53 cluster at six \"hotspot\" amino acids, the majority of mutations in human cancer occur elsewhere in the DBD and at a much lower frequency. We report here that  [CLS] mutations at K120, a non-hotspot DNA contact residue, confer p53 with the previously unrecognized ability to bind and activate [CLS]  the transcription of the pro-survival TNFAIP8 gene. Mutant K120 p53 binds the TNFAIP8 locus at a cryptic p53 response element that is not occupied by wild-type p53. Furthermore, induction"}
{"subject": "transcription", "sub_type": "MPA", "rel": "ThemeOf", "object": "activate", "obj_type": "PosReg", "file_name": "PubMed-27341992.json", "snippet": " DBD and at a much lower frequency. We report here that mutations at K120, a non-hotspot DNA contact residue, confer p53 with the previously unrecognized ability to bind and  [CLS] activate the transcription [CLS]  of the pro-survival TNFAIP8 gene. Mutant K120 p53 binds the TNFAIP8 locus at a cryptic p53 response element that is not occupied by wild-type p53. Furthermore, induction of TNFAIP8"}
{"subject": "mutation", "sub_type": "Var", "rel": "CauseOf", "object": "confers", "obj_type": "PosReg", "file_name": "PubMed-27341992.json", "snippet": " [CLS] mutation in cancer confers [CLS]  p53 gain-of-function and tumor cell survival via TNFAIP8 induction.\nThe p53 tumor suppressor gene encodes a sequence-specific transcription factor. Mutations in the coding sequence of p53 occur frequently in"}
{"subject": "TNFAIP8", "sub_type": "Gene", "rel": "ThemeOf", "object": "transcription", "obj_type": "MPA", "file_name": "PubMed-27341992.json", "snippet": " at a much lower frequency. We report here that mutations at K120, a non-hotspot DNA contact residue, confer p53 with the previously unrecognized ability to bind and activate the  [CLS] transcription of the pro-survival TNFAIP8 [CLS]  gene. Mutant K120 p53 binds the TNFAIP8 locus at a cryptic p53 response element that is not occupied by wild-type p53. Furthermore, induction of TNFAIP8 is critical for the"}
{"subject": "mutant", "sub_type": "Var", "rel": "CauseOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-27341992.json", "snippet": " of TNFAIP8 is critical for the evasion of apoptosis by tumor cells expressing the K120R variant of p53. These findings identify induction of pro-survival targets as a mechanism of  [CLS] gain-of-function activity for mutant [CLS]  p53 and will likely broaden our understanding of this phenomenon beyond the limited number of GOF activities currently reported for hotspot mutants."}
{"subject": "activity", "sub_type": "MPA", "rel": "ThemeOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-27341992.json", "snippet": " of TNFAIP8 is critical for the evasion of apoptosis by tumor cells expressing the K120R variant of p53. These findings identify induction of pro-survival targets as a mechanism of  [CLS] gain-of-function activity [CLS]  for mutant p53 and will likely broaden our understanding of this phenomenon beyond the limited number of GOF activities currently reported for hotspot mutants."}
{"subject": "p53", "sub_type": "Gene", "rel": "ThemeOf", "object": "activity", "obj_type": "MPA", "file_name": "PubMed-27341992.json", "snippet": " TNFAIP8 is critical for the evasion of apoptosis by tumor cells expressing the K120R variant of p53. These findings identify induction of pro-survival targets as a mechanism of gain-of-function  [CLS] activity for mutant p53 [CLS]  and will likely broaden our understanding of this phenomenon beyond the limited number of GOF activities currently reported for hotspot mutants."}
{"subject": "binding", "sub_type": "Interaction", "rel": "ThemeOf", "object": "result in", "obj_type": "Reg", "file_name": "PubMed-27341992.json", "snippet": " cell survival via TNFAIP8 induction.\nThe p53 tumor suppressor gene encodes a sequence-specific transcription factor. Mutations in the coding sequence of p53 occur frequently in human cancer and often  [CLS] result in single amino acid substitutions (missense mutations) in the DNA binding [CLS]  domain (DBD), blocking normal tumor suppressive functions. In addition to the loss of canonical functions, some missense mutations in p53 confer gain-of-function (GOF) activities to tumor cells. While many"}
{"subject": "gain-of-function", "sub_type": "PosReg", "rel": "ThemeOf", "object": "confers", "obj_type": "PosReg", "file_name": "PubMed-27341992.json", "snippet": " [CLS] confers p53 gain-of-function [CLS]  and tumor cell survival via TNFAIP8 induction.\nThe p53 tumor suppressor gene encodes a sequence-specific transcription factor. Mutations in the coding sequence of p53 occur frequently in human cancer"}
{"subject": "p53", "sub_type": "Gene", "rel": "ThemeOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-27341992.json", "snippet": " [CLS] p53 gain-of-function [CLS]  and tumor cell survival via TNFAIP8 induction.\nThe p53 tumor suppressor gene encodes a sequence-specific transcription factor. Mutations in the coding sequence of p53 occur frequently in human cancer"}
{"subject": "tumor cell survival", "sub_type": "CPA", "rel": "ThemeOf", "object": "confers", "obj_type": "PosReg", "file_name": "PubMed-27341992.json", "snippet": " [CLS] confers p53 gain-of-function and tumor cell survival [CLS]  via TNFAIP8 induction.\nThe p53 tumor suppressor gene encodes a sequence-specific transcription factor. Mutations in the coding sequence of p53 occur frequently in human cancer and often result in"}
{"subject": "p53", "sub_type": "Gene", "rel": "ThemeOf", "object": "Mutations", "obj_type": "Var", "file_name": "PubMed-27341992.json", "snippet": " [CLS] Mutations in the coding sequence of p53 [CLS]  occur frequently in human cancer and often result in single amino acid substitutions (missense mutations) in the DNA binding domain (DBD), blocking normal tumor suppressive functions. In addition to"}
{"subject": "Mutations", "sub_type": "Var", "rel": "CauseOf", "object": "result in", "obj_type": "Reg", "file_name": "PubMed-27341992.json", "snippet": " [CLS] Mutations in the coding sequence of p53 occur frequently in human cancer and often result in [CLS]  single amino acid substitutions (missense mutations) in the DNA binding domain (DBD), blocking normal tumor suppressive functions. In addition to the loss of canonical functions, some missense mutations in"}
{"subject": "substitutions", "sub_type": "Var", "rel": "ThemeOf", "object": "result in", "obj_type": "Reg", "file_name": "PubMed-27341992.json", "snippet": " cell survival via TNFAIP8 induction.\nThe p53 tumor suppressor gene encodes a sequence-specific transcription factor. Mutations in the coding sequence of p53 occur frequently in human cancer and often  [CLS] result in single amino acid substitutions [CLS]  (missense mutations) in the DNA binding domain (DBD), blocking normal tumor suppressive functions. In addition to the loss of canonical functions, some missense mutations in p53 confer gain-of-function (GOF)"}
{"subject": "blocking", "sub_type": "NegReg", "rel": "ThemeOf", "object": "result in", "obj_type": "Reg", "file_name": "PubMed-27341992.json", "snippet": " cell survival via TNFAIP8 induction.\nThe p53 tumor suppressor gene encodes a sequence-specific transcription factor. Mutations in the coding sequence of p53 occur frequently in human cancer and often  [CLS] result in single amino acid substitutions (missense mutations) in the DNA binding domain (DBD), blocking [CLS]  normal tumor suppressive functions. In addition to the loss of canonical functions, some missense mutations in p53 confer gain-of-function (GOF) activities to tumor cells. While many missense mutations in"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-27545680.json", "snippet": " conclusively confirming these variants, as well as the underlying molecular mechanisms explaining the diseases, are often lacking. Here, we report on an ID syndrome caused by de novo heterozygous  [CLS] loss-of-function (LoF) mutations [CLS]  in SON. The syndrome is characterized by ID and/or DD, malformations of the cerebral cortex, epilepsy, vision problems, musculoskeletal abnormalities, and congenital malformations. Knockdown of son in zebrafish resulted"}
{"subject": "Intellectual-Disability Syndrome", "sub_type": "Disease", "rel": "ThemeOf", "object": "Causing", "obj_type": "Reg", "file_name": "PubMed-27545680.json", "snippet": " [CLS] Causing an Intellectual-Disability Syndrome [CLS] .\nThe overall understanding of the molecular etiologies of intellectual disability (ID) and developmental delay (DD) is increasing as next-generation sequencing technologies identify genetic variants in individuals with such disorders."}
{"subject": "SON", "sub_type": "Gene", "rel": "ThemeOf", "object": "Mutations", "obj_type": "Var", "file_name": "PubMed-27545680.json", "snippet": " [CLS] Mutations in SON [CLS]  Disrupt RNA Splicing of Genes Essential for Brain Development and Metabolism, Causing an Intellectual-Disability Syndrome.\nThe overall understanding of the molecular etiologies of intellectual disability (ID) and developmental delay"}
{"subject": "ID syndrome", "sub_type": "Disease", "rel": "ThemeOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-27545680.json", "snippet": " individuals with such disorders. However, detailed analyses conclusively confirming these variants, as well as the underlying molecular mechanisms explaining the diseases, are often lacking. Here, we report on an  [CLS] ID syndrome caused by de novo heterozygous loss-of-function [CLS]  (LoF) mutations in SON. The syndrome is characterized by ID and/or DD, malformations of the cerebral cortex, epilepsy, vision problems, musculoskeletal abnormalities, and congenital malformations. Knockdown of son in"}
{"subject": "SON", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-27545680.json", "snippet": " these variants, as well as the underlying molecular mechanisms explaining the diseases, are often lacking. Here, we report on an ID syndrome caused by de novo heterozygous loss-of-function (LoF)  [CLS] mutations in SON [CLS] . The syndrome is characterized by ID and/or DD, malformations of the cerebral cortex, epilepsy, vision problems, musculoskeletal abnormalities, and congenital malformations. Knockdown of son in zebrafish resulted in severe"}
{"subject": "erroneous SON-mediated RNA splicing", "sub_type": "Var", "rel": "CauseOf", "object": "accumulation", "obj_type": "PosReg", "file_name": "PubMed-27545680.json", "snippet": " that genes critical for neuronal migration and cortex organization (TUBG1, FLNA, PNKP, WDR62, PSMD3, and\u00a0HDAC6) and metabolism (PCK2, PFKL, IDH2, ACY1, and ADA) are significantly downregulated because of the  [CLS] accumulation of mis-spliced transcripts resulting from erroneous SON-mediated RNA splicing [CLS] . Our data highlight SON as a master regulator governing neurodevelopment and demonstrate the importance of SON-mediated RNA splicing in human development."}
{"subject": "accumulation", "sub_type": "PosReg", "rel": "CauseOf", "object": "downregulated", "obj_type": "NegReg", "file_name": "PubMed-27545680.json", "snippet": " from affected individuals revealed that genes critical for neuronal migration and cortex organization (TUBG1, FLNA, PNKP, WDR62, PSMD3, and\u00a0HDAC6) and metabolism (PCK2, PFKL, IDH2, ACY1, and ADA) are significantly  [CLS] downregulated because of the accumulation [CLS]  of mis-spliced transcripts resulting from erroneous SON-mediated RNA splicing. Our data highlight SON as a master regulator governing neurodevelopment and demonstrate the importance of SON-mediated RNA splicing in human"}
{"subject": "cortex organization", "sub_type": "CPA", "rel": "ThemeOf", "object": "downregulated", "obj_type": "NegReg", "file_name": "PubMed-27545680.json", "snippet": " of son in zebrafish resulted in severe malformation of the spine, brain, and eyes. Importantly, analyses of RNA from affected individuals revealed that genes critical for neuronal migration and  [CLS] cortex organization (TUBG1, FLNA, PNKP, WDR62, PSMD3, and\u00a0HDAC6) and metabolism (PCK2, PFKL, IDH2, ACY1, and ADA) are significantly downregulated [CLS]  because of the accumulation of mis-spliced transcripts resulting from erroneous SON-mediated RNA splicing. Our data highlight SON as a master regulator governing neurodevelopment and demonstrate the importance of SON-mediated"}
{"subject": "metabolism", "sub_type": "CPA", "rel": "ThemeOf", "object": "downregulated", "obj_type": "NegReg", "file_name": "PubMed-27545680.json", "snippet": " the spine, brain, and eyes. Importantly, analyses of RNA from affected individuals revealed that genes critical for neuronal migration and cortex organization (TUBG1, FLNA, PNKP, WDR62, PSMD3, and\u00a0HDAC6) and  [CLS] metabolism (PCK2, PFKL, IDH2, ACY1, and ADA) are significantly downregulated [CLS]  because of the accumulation of mis-spliced transcripts resulting from erroneous SON-mediated RNA splicing. Our data highlight SON as a master regulator governing neurodevelopment and demonstrate the importance of SON-mediated"}
{"subject": "neuronal migration", "sub_type": "CPA", "rel": "ThemeOf", "object": "downregulated", "obj_type": "NegReg", "file_name": "PubMed-27545680.json", "snippet": " congenital malformations. Knockdown of son in zebrafish resulted in severe malformation of the spine, brain, and eyes. Importantly, analyses of RNA from affected individuals revealed that genes critical for  [CLS] neuronal migration and cortex organization (TUBG1, FLNA, PNKP, WDR62, PSMD3, and\u00a0HDAC6) and metabolism (PCK2, PFKL, IDH2, ACY1, and ADA) are significantly downregulated [CLS]  because of the accumulation of mis-spliced transcripts resulting from erroneous SON-mediated RNA splicing. Our data highlight SON as a master regulator governing neurodevelopment and demonstrate the importance of SON-mediated"}
{"subject": "Mutations", "sub_type": "Var", "rel": "CauseOf", "object": "Causing", "obj_type": "Reg", "file_name": "PubMed-27545680.json", "snippet": " [CLS] Mutations in SON Disrupt RNA Splicing of Genes Essential for Brain Development and Metabolism, Causing [CLS]  an Intellectual-Disability Syndrome.\nThe overall understanding of the molecular etiologies of intellectual disability (ID) and developmental delay (DD) is increasing as next-generation sequencing technologies identify genetic variants in individuals"}
{"subject": "PCSK9", "sub_type": "Gene", "rel": "ThemeOf", "object": "variants", "obj_type": "Var", "file_name": "PubMed-27662822.json", "snippet": " [CLS] PCSK9 loss-of-function variants [CLS] .\nOBJECTIVE: To determine the effect of (1) an oral fat load and (2) pro-protein convertase subtilisin/kexin type (PCSK) 9 loss-of-function (LOF) variant status on the ability of peripheral blood"}
{"subject": "variant", "sub_type": "Var", "rel": "CauseOf", "object": "absence", "obj_type": "NegReg", "file_name": "PubMed-27662822.json", "snippet": " levels of interleukin-1\u03b2, tumor necrosis factor-\u03b1, sterol regulatory element binding protein-1c, CD36, and monocyte chemoattractant protein-1 (MCP-1), only MCP-1 mRNA levels increased in PBMC from non-variant controls.\nCONCLUSIONS: The  [CLS] absence of anti-adipogenic action of PBMC from PCSK9 LOF variant [CLS]  subjects points to a novel role for PCSK9 in PBMC-adipose cell interactions."}
{"subject": "variant", "sub_type": "Var", "rel": "CauseOf", "object": "novel role", "obj_type": "PosReg", "file_name": "PubMed-27662822.json", "snippet": " binding protein-1c, CD36, and monocyte chemoattractant protein-1 (MCP-1), only MCP-1 mRNA levels increased in PBMC from non-variant controls.\nCONCLUSIONS: The absence of anti-adipogenic action of PBMC from PCSK9 LOF  [CLS] variant subjects points to a novel role [CLS]  for PCSK9 in PBMC-adipose cell interactions."}
{"subject": "interactions", "sub_type": "Interaction", "rel": "ThemeOf", "object": "novel role", "obj_type": "PosReg", "file_name": "PubMed-27662822.json", "snippet": " chemoattractant protein-1 (MCP-1), only MCP-1 mRNA levels increased in PBMC from non-variant controls.\nCONCLUSIONS: The absence of anti-adipogenic action of PBMC from PCSK9 LOF variant subjects points to a  [CLS] novel role for PCSK9 in PBMC-adipose cell interactions [CLS] ."}
{"subject": "PCSK9", "sub_type": "Gene", "rel": "ThemeOf", "object": "variant", "obj_type": "Var", "file_name": "PubMed-27662822.json", "snippet": " was obtained in fasting (PBMC-CM-F) and 4-h postprandial (PBMC-CM-PP) states. PBMC-CM-PP from non-variant controls inhibited adipogenesis of human preadipocytes more than did PBMC-CM-F. In contrast, PBMC-CM-F or -PP from  [CLS] PCSK9 LOF variant [CLS]  subjects had no effect on adipogenesis. After the oral fat load, PBMC from PCSK9 LOF variant subjects showed significant increases in mRNA levels of interleukin-1\u03b2, tumor necrosis factor-\u03b1, sterol"}
{"subject": "variant", "sub_type": "Var", "rel": "CauseOf", "object": "LOF", "obj_type": "NegReg", "file_name": "PubMed-27662822.json", "snippet": " obtained in fasting (PBMC-CM-F) and 4-h postprandial (PBMC-CM-PP) states. PBMC-CM-PP from non-variant controls inhibited adipogenesis of human preadipocytes more than did PBMC-CM-F. In contrast, PBMC-CM-F or -PP from PCSK9  [CLS] LOF variant [CLS]  subjects had no effect on adipogenesis. After the oral fat load, PBMC from PCSK9 LOF variant subjects showed significant increases in mRNA levels of interleukin-1\u03b2, tumor necrosis factor-\u03b1, sterol"}
{"subject": "adipogenesis", "sub_type": "MPA", "rel": "ThemeOf", "object": "LOF", "obj_type": "NegReg", "file_name": "PubMed-27662822.json", "snippet": " obtained in fasting (PBMC-CM-F) and 4-h postprandial (PBMC-CM-PP) states. PBMC-CM-PP from non-variant controls inhibited adipogenesis of human preadipocytes more than did PBMC-CM-F. In contrast, PBMC-CM-F or -PP from PCSK9  [CLS] LOF variant subjects had no effect on adipogenesis [CLS] . After the oral fat load, PBMC from PCSK9 LOF variant subjects showed significant increases in mRNA levels of interleukin-1\u03b2, tumor necrosis factor-\u03b1, sterol regulatory element binding protein-1c, CD36, and"}
{"subject": "PCSK9", "sub_type": "Gene", "rel": "ThemeOf", "object": "variant", "obj_type": "Var", "file_name": "PubMed-27662822.json", "snippet": " of human preadipocytes more than did PBMC-CM-F. In contrast, PBMC-CM-F or -PP from PCSK9 LOF variant subjects had no effect on adipogenesis. After the oral fat load, PBMC from  [CLS] PCSK9 LOF variant [CLS]  subjects showed significant increases in mRNA levels of interleukin-1\u03b2, tumor necrosis factor-\u03b1, sterol regulatory element binding protein-1c, CD36, and monocyte chemoattractant protein-1 (MCP-1), only MCP-1 mRNA levels increased in"}
{"subject": "variant", "sub_type": "Var", "rel": "CauseOf", "object": "LOF", "obj_type": "NegReg", "file_name": "PubMed-27662822.json", "snippet": " human preadipocytes more than did PBMC-CM-F. In contrast, PBMC-CM-F or -PP from PCSK9 LOF variant subjects had no effect on adipogenesis. After the oral fat load, PBMC from PCSK9  [CLS] LOF variant [CLS]  subjects showed significant increases in mRNA levels of interleukin-1\u03b2, tumor necrosis factor-\u03b1, sterol regulatory element binding protein-1c, CD36, and monocyte chemoattractant protein-1 (MCP-1), only MCP-1 mRNA levels increased in"}
{"subject": "variant", "sub_type": "Var", "rel": "CauseOf", "object": "increases", "obj_type": "PosReg", "file_name": "PubMed-27662822.json", "snippet": " preadipocytes more than did PBMC-CM-F. In contrast, PBMC-CM-F or -PP from PCSK9 LOF variant subjects had no effect on adipogenesis. After the oral fat load, PBMC from PCSK9 LOF  [CLS] variant subjects showed significant increases [CLS]  in mRNA levels of interleukin-1\u03b2, tumor necrosis factor-\u03b1, sterol regulatory element binding protein-1c, CD36, and monocyte chemoattractant protein-1 (MCP-1), only MCP-1 mRNA levels increased in PBMC from non-variant controls."}
{"subject": "mRNA levels of interleukin-1\u03b2", "sub_type": "MPA", "rel": "ThemeOf", "object": "increases", "obj_type": "PosReg", "file_name": "PubMed-27662822.json", "snippet": " PBMC-CM-F. In contrast, PBMC-CM-F or -PP from PCSK9 LOF variant subjects had no effect on adipogenesis. After the oral fat load, PBMC from PCSK9 LOF variant subjects showed significant  [CLS] increases in mRNA levels of interleukin-1\u03b2 [CLS] , tumor necrosis factor-\u03b1, sterol regulatory element binding protein-1c, CD36, and monocyte chemoattractant protein-1 (MCP-1), only MCP-1 mRNA levels increased in PBMC from non-variant controls.\nCONCLUSIONS: The absence of anti-adipogenic"}
{"subject": "variants", "sub_type": "Var", "rel": "CauseOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-27662822.json", "snippet": " [CLS] loss-of-function variants [CLS] .\nOBJECTIVE: To determine the effect of (1) an oral fat load and (2) pro-protein convertase subtilisin/kexin type (PCSK) 9 loss-of-function (LOF) variant status on the ability of peripheral blood"}
{"subject": "tumor necrosis factor-\u03b1", "sub_type": "MPA", "rel": "ThemeOf", "object": "increases", "obj_type": "PosReg", "file_name": "PubMed-27662822.json", "snippet": " PBMC-CM-F. In contrast, PBMC-CM-F or -PP from PCSK9 LOF variant subjects had no effect on adipogenesis. After the oral fat load, PBMC from PCSK9 LOF variant subjects showed significant  [CLS] increases in mRNA levels of interleukin-1\u03b2, tumor necrosis factor-\u03b1 [CLS] , sterol regulatory element binding protein-1c, CD36, and monocyte chemoattractant protein-1 (MCP-1), only MCP-1 mRNA levels increased in PBMC from non-variant controls.\nCONCLUSIONS: The absence of anti-adipogenic action of PBMC"}
{"subject": "sterol regulatory element binding protein-1c", "sub_type": "MPA", "rel": "ThemeOf", "object": "increases", "obj_type": "PosReg", "file_name": "PubMed-27662822.json", "snippet": " PBMC-CM-F. In contrast, PBMC-CM-F or -PP from PCSK9 LOF variant subjects had no effect on adipogenesis. After the oral fat load, PBMC from PCSK9 LOF variant subjects showed significant  [CLS] increases in mRNA levels of interleukin-1\u03b2, tumor necrosis factor-\u03b1, sterol regulatory element binding protein-1c [CLS] , CD36, and monocyte chemoattractant protein-1 (MCP-1), only MCP-1 mRNA levels increased in PBMC from non-variant controls.\nCONCLUSIONS: The absence of anti-adipogenic action of PBMC from PCSK9 LOF variant subjects"}
{"subject": "CD36", "sub_type": "MPA", "rel": "ThemeOf", "object": "increases", "obj_type": "PosReg", "file_name": "PubMed-27662822.json", "snippet": " PBMC-CM-F. In contrast, PBMC-CM-F or -PP from PCSK9 LOF variant subjects had no effect on adipogenesis. After the oral fat load, PBMC from PCSK9 LOF variant subjects showed significant  [CLS] increases in mRNA levels of interleukin-1\u03b2, tumor necrosis factor-\u03b1, sterol regulatory element binding protein-1c, CD36 [CLS] , and monocyte chemoattractant protein-1 (MCP-1), only MCP-1 mRNA levels increased in PBMC from non-variant controls.\nCONCLUSIONS: The absence of anti-adipogenic action of PBMC from PCSK9 LOF variant subjects points"}
{"subject": "loss-of-function", "sub_type": "NegReg", "rel": "CauseOf", "object": "absent", "obj_type": "NegReg", "file_name": "PubMed-27662822.json", "snippet": " [CLS] absent with PCSK9 loss-of-function [CLS]  variants.\nOBJECTIVE: To determine the effect of (1) an oral fat load and (2) pro-protein convertase subtilisin/kexin type (PCSK) 9 loss-of-function (LOF) variant status on the ability of peripheral"}
{"subject": "anti-adipogenic effect", "sub_type": "MPA", "rel": "ThemeOf", "object": "absent", "obj_type": "NegReg", "file_name": "PubMed-27662822.json", "snippet": " [CLS] anti-adipogenic effect of peripheral blood mononuclear cells is absent [CLS]  with PCSK9 loss-of-function variants.\nOBJECTIVE: To determine the effect of (1) an oral fat load and (2) pro-protein convertase subtilisin/kexin type (PCSK) 9 loss-of-function (LOF) variant status on the"}
{"subject": "variant", "sub_type": "Var", "rel": "CauseOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-27662822.json", "snippet": " peripheral blood mononuclear cells is absent with PCSK9 loss-of-function variants.\nOBJECTIVE: To determine the effect of (1) an oral fat load and (2) pro-protein convertase subtilisin/kexin type (PCSK) 9  [CLS] loss-of-function (LOF) variant [CLS]  status on the ability of peripheral blood mononuclear cells (PBMC) to inhibit human adipogenesis.\nMETHODS: PBMC from subjects with one or more PCSK9 LOF variants versus non-variant controls were"}
{"subject": "loss-of-function", "sub_type": "NegReg", "rel": "CauseOf", "object": "inhibit", "obj_type": "NegReg", "file_name": "PubMed-27662822.json", "snippet": " peripheral blood mononuclear cells is absent with PCSK9 loss-of-function variants.\nOBJECTIVE: To determine the effect of (1) an oral fat load and (2) pro-protein convertase subtilisin/kexin type (PCSK) 9  [CLS] loss-of-function (LOF) variant status on the ability of peripheral blood mononuclear cells (PBMC) to inhibit [CLS]  human adipogenesis.\nMETHODS: PBMC from subjects with one or more PCSK9 LOF variants versus non-variant controls were compared in the fasting state and after an oral fat load.\nRESULTS:"}
{"subject": "human adipogenesis", "sub_type": "MPA", "rel": "ThemeOf", "object": "inhibit", "obj_type": "NegReg", "file_name": "PubMed-27662822.json", "snippet": " effect of (1) an oral fat load and (2) pro-protein convertase subtilisin/kexin type (PCSK) 9 loss-of-function (LOF) variant status on the ability of peripheral blood mononuclear cells (PBMC) to  [CLS] inhibit human adipogenesis [CLS] .\nMETHODS: PBMC from subjects with one or more PCSK9 LOF variants versus non-variant controls were compared in the fasting state and after an oral fat load.\nRESULTS: Fasting triglyceride"}
{"subject": "anti-adipogenic action", "sub_type": "MPA", "rel": "ThemeOf", "object": "absence", "obj_type": "NegReg", "file_name": "PubMed-27662822.json", "snippet": " levels of interleukin-1\u03b2, tumor necrosis factor-\u03b1, sterol regulatory element binding protein-1c, CD36, and monocyte chemoattractant protein-1 (MCP-1), only MCP-1 mRNA levels increased in PBMC from non-variant controls.\nCONCLUSIONS: The  [CLS] absence of anti-adipogenic action [CLS]  of PBMC from PCSK9 LOF variant subjects points to a novel role for PCSK9 in PBMC-adipose cell interactions."}
{"subject": "PCSK9", "sub_type": "Gene", "rel": "ThemeOf", "object": "variant", "obj_type": "Var", "file_name": "PubMed-27662822.json", "snippet": " regulatory element binding protein-1c, CD36, and monocyte chemoattractant protein-1 (MCP-1), only MCP-1 mRNA levels increased in PBMC from non-variant controls.\nCONCLUSIONS: The absence of anti-adipogenic action of PBMC from  [CLS] PCSK9 LOF variant [CLS]  subjects points to a novel role for PCSK9 in PBMC-adipose cell interactions."}
{"subject": "FLG", "sub_type": "Gene", "rel": "ThemeOf", "object": "extensive genetic variation", "obj_type": "Var", "file_name": "PubMed-27678121.json", "snippet": " [CLS] FLG) gene is widely studied for its skin-barrier function in humans. The extensive genetic variation [CLS]  in this gene, especially common loss-of-function (LoF) mutations, has been established as primary risk factors for atopic dermatitis. To investigate the evolution of this gene, we analyzed 2,504 human"}
{"subject": "extensive genetic variation", "sub_type": "Var", "rel": "CauseOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-27678121.json", "snippet": " Hitchhike Hornerin Selective Sweep.\nHuman skin has evolved rapidly, leaving evolutionary signatures in the genome. The filaggrin (FLG) gene is widely studied for its skin-barrier function in humans. The  [CLS] extensive genetic variation in this gene, especially common loss-of-function (LoF) mutations [CLS] , has been established as primary risk factors for atopic dermatitis. To investigate the evolution of this gene, we analyzed 2,504 human genomes and genotyped the copy number variation of"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-27678121.json", "snippet": " rapidly, leaving evolutionary signatures in the genome. The filaggrin (FLG) gene is widely studied for its skin-barrier function in humans. The extensive genetic variation in this gene, especially common  [CLS] loss-of-function (LoF) mutations [CLS] , has been established as primary risk factors for atopic dermatitis. To investigate the evolution of this gene, we analyzed 2,504 human genomes and genotyped the copy number variation of"}
{"subject": "loss-of-function", "sub_type": "NegReg", "rel": "ThemeOf", "object": "atopic dermatitis", "obj_type": "Disease", "file_name": "PubMed-27678121.json", "snippet": " rapidly, leaving evolutionary signatures in the genome. The filaggrin (FLG) gene is widely studied for its skin-barrier function in humans. The extensive genetic variation in this gene, especially common  [CLS] loss-of-function (LoF) mutations, has been established as primary risk factors for atopic dermatitis [CLS] . To investigate the evolution of this gene, we analyzed 2,504 human genomes and genotyped the copy number variation of filaggrin repeats within FLG in 126 individuals from diverse ancestral"}
{"subject": "variants", "sub_type": "Var", "rel": "CauseOf", "object": "dyshomeostasis", "obj_type": "Reg", "file_name": "PubMed-27975164.json", "snippet": " (20 nonsense, 16 frameshift, 14 splice sites, one stop-loss, one initiation codon) in 11.06% (50/452) AD patients, which were absent in 163 controls (P=2.5\u00d710(-5)). Transcriptome sequencing revealed that identified  [CLS] variants induced dyshomeostasis [CLS]  in expression of collagens-TIMPs/MMPs systems. The Col5a2 (-/-) rats manifested growth retardation and aortic dysplasia. Our study provides a first comprehensive map of genetic alterations in collagens-MMPs/TIMPs system in"}
{"subject": "expression of collagens-TIMPs/MMPs systems", "sub_type": "CPA", "rel": "ThemeOf", "object": "dyshomeostasis", "obj_type": "Reg", "file_name": "PubMed-27975164.json", "snippet": " 16 frameshift, 14 splice sites, one stop-loss, one initiation codon) in 11.06% (50/452) AD patients, which were absent in 163 controls (P=2.5\u00d710(-5)). Transcriptome sequencing revealed that identified variants induced  [CLS] dyshomeostasis in expression of collagens-TIMPs/MMPs systems [CLS] . The Col5a2 (-/-) rats manifested growth retardation and aortic dysplasia. Our study provides a first comprehensive map of genetic alterations in collagens-MMPs/TIMPs system in sporadic AD patients and suggests"}
{"subject": "Col5a2", "sub_type": "Gene", "rel": "ThemeOf", "object": "variants", "obj_type": "Var", "file_name": "PubMed-27975164.json", "snippet": " (20 nonsense, 16 frameshift, 14 splice sites, one stop-loss, one initiation codon) in 11.06% (50/452) AD patients, which were absent in 163 controls (P=2.5\u00d710(-5)). Transcriptome sequencing revealed that identified  [CLS] variants induced dyshomeostasis in expression of collagens-TIMPs/MMPs systems. The Col5a2 [CLS]  (-/-) rats manifested growth retardation and aortic dysplasia. Our study provides a first comprehensive map of genetic alterations in collagens-MMPs/TIMPs system in sporadic AD patients and suggests that variants"}
{"subject": "growth retardation", "sub_type": "CPA", "rel": "ThemeOf", "object": "dyshomeostasis", "obj_type": "Reg", "file_name": "PubMed-27975164.json", "snippet": " 16 frameshift, 14 splice sites, one stop-loss, one initiation codon) in 11.06% (50/452) AD patients, which were absent in 163 controls (P=2.5\u00d710(-5)). Transcriptome sequencing revealed that identified variants induced  [CLS] dyshomeostasis in expression of collagens-TIMPs/MMPs systems. The Col5a2 (-/-) rats manifested growth retardation [CLS]  and aortic dysplasia. Our study provides a first comprehensive map of genetic alterations in collagens-MMPs/TIMPs system in sporadic AD patients and suggests that variants of these genes contribute largely"}
{"subject": "aortic dysplasia", "sub_type": "CPA", "rel": "ThemeOf", "object": "dyshomeostasis", "obj_type": "Reg", "file_name": "PubMed-27975164.json", "snippet": " 16 frameshift, 14 splice sites, one stop-loss, one initiation codon) in 11.06% (50/452) AD patients, which were absent in 163 controls (P=2.5\u00d710(-5)). Transcriptome sequencing revealed that identified variants induced  [CLS] dyshomeostasis in expression of collagens-TIMPs/MMPs systems. The Col5a2 (-/-) rats manifested growth retardation and aortic dysplasia [CLS] . Our study provides a first comprehensive map of genetic alterations in collagens-MMPs/TIMPs system in sporadic AD patients and suggests that variants of these genes contribute largely to AD pathogenesis."}
{"subject": "Germline heterozygous mutations", "sub_type": "Var", "rel": "CauseOf", "object": "loss of function", "obj_type": "NegReg", "file_name": "PubMed-28011069.json", "snippet": " [CLS] Germline heterozygous mutations in human signal transducer and activator of transcription 1 (STAT1) can cause loss of function [CLS]  (LOF), as in patients with Mendelian susceptibility to mycobacterial diseases, or gain of function (GOF), as in patients with chronic mucocutaneous candidiasis. LOF and GOF mutations are equally rare"}
{"subject": "coiled-coil domain", "sub_type": "MPA", "rel": "ThemeOf", "object": "domains", "obj_type": "MPA", "file_name": "PubMed-28011069.json", "snippet": " Mendelian susceptibility to mycobacterial diseases, or gain of function (GOF), as in patients with chronic mucocutaneous candidiasis. LOF and GOF mutations are equally rare and can affect the same  [CLS] domains of STAT1, especially the coiled-coil domain [CLS]  (CCD) and DNA-binding domain (DBD). Moreover, 6% of patients with chronic mucocutaneous candidiasis with a GOF STAT1 mutation have mycobacterial disease, obscuring the functional significance of the identified STAT1"}
{"subject": "DNA-binding domain", "sub_type": "MPA", "rel": "ThemeOf", "object": "domains", "obj_type": "MPA", "file_name": "PubMed-28011069.json", "snippet": " Mendelian susceptibility to mycobacterial diseases, or gain of function (GOF), as in patients with chronic mucocutaneous candidiasis. LOF and GOF mutations are equally rare and can affect the same  [CLS] domains of STAT1, especially the coiled-coil domain (CCD) and DNA-binding domain [CLS]  (DBD). Moreover, 6% of patients with chronic mucocutaneous candidiasis with a GOF STAT1 mutation have mycobacterial disease, obscuring the functional significance of the identified STAT1 mutations. Current computational approaches,"}
{"subject": "signal transducer", "sub_type": "Gene", "rel": "ThemeOf", "object": "Germline heterozygous mutations", "obj_type": "Var", "file_name": "PubMed-28011069.json", "snippet": " [CLS] Germline heterozygous mutations in human signal transducer [CLS]  and activator of transcription 1 (STAT1) can cause loss of function (LOF), as in patients with Mendelian susceptibility to mycobacterial diseases, or gain of function (GOF), as in patients"}
{"subject": "Germline heterozygous mutations", "sub_type": "Var", "rel": "CauseOf", "object": "gain of function", "obj_type": "PosReg", "file_name": "PubMed-28011069.json", "snippet": " [CLS] Germline heterozygous mutations in human signal transducer and activator of transcription 1 (STAT1) can cause loss of function (LOF), as in patients with Mendelian susceptibility to mycobacterial diseases, or gain of function [CLS]  (GOF), as in patients with chronic mucocutaneous candidiasis. LOF and GOF mutations are equally rare and can affect the same domains of STAT1, especially the coiled-coil domain (CCD) and"}
{"subject": "chronic mucocutaneous candidiasis", "sub_type": "Disease", "rel": "ThemeOf", "object": "gain of function", "obj_type": "PosReg", "file_name": "PubMed-28011069.json", "snippet": " Germline heterozygous mutations in human signal transducer and activator of transcription 1 (STAT1) can cause loss of function (LOF), as in patients with Mendelian susceptibility to mycobacterial diseases, or  [CLS] gain of function (GOF), as in patients with chronic mucocutaneous candidiasis [CLS] . LOF and GOF mutations are equally rare and can affect the same domains of STAT1, especially the coiled-coil domain (CCD) and DNA-binding domain (DBD). Moreover, 6% of patients with"}
{"subject": "mycobacterial diseases", "sub_type": "Disease", "rel": "ThemeOf", "object": "loss of function", "obj_type": "NegReg", "file_name": "PubMed-28011069.json", "snippet": " signal transducer and activator of transcription 1 to estimate loss- or gain-of-function variants.\nBACKGROUND: Germline heterozygous mutations in human signal transducer and activator of transcription 1 (STAT1) can cause  [CLS] loss of function (LOF), as in patients with Mendelian susceptibility to mycobacterial diseases [CLS] , or gain of function (GOF), as in patients with chronic mucocutaneous candidiasis. LOF and GOF mutations are equally rare and can affect the same domains of STAT1, especially the"}
{"subject": "activator of transcription 1", "sub_type": "Gene", "rel": "ThemeOf", "object": "Germline heterozygous mutations", "obj_type": "Var", "file_name": "PubMed-28011069.json", "snippet": " [CLS] Germline heterozygous mutations in human signal transducer and activator of transcription 1 [CLS]  (STAT1) can cause loss of function (LOF), as in patients with Mendelian susceptibility to mycobacterial diseases, or gain of function (GOF), as in patients with chronic mucocutaneous candidiasis. LOF"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "affect", "obj_type": "Reg", "file_name": "PubMed-28011069.json", "snippet": " cause loss of function (LOF), as in patients with Mendelian susceptibility to mycobacterial diseases, or gain of function (GOF), as in patients with chronic mucocutaneous candidiasis. LOF and GOF  [CLS] mutations are equally rare and can affect [CLS]  the same domains of STAT1, especially the coiled-coil domain (CCD) and DNA-binding domain (DBD). Moreover, 6% of patients with chronic mucocutaneous candidiasis with a GOF STAT1 mutation have mycobacterial"}
{"subject": "domains", "sub_type": "MPA", "rel": "ThemeOf", "object": "affect", "obj_type": "Reg", "file_name": "PubMed-28011069.json", "snippet": " in patients with Mendelian susceptibility to mycobacterial diseases, or gain of function (GOF), as in patients with chronic mucocutaneous candidiasis. LOF and GOF mutations are equally rare and can  [CLS] affect the same domains [CLS]  of STAT1, especially the coiled-coil domain (CCD) and DNA-binding domain (DBD). Moreover, 6% of patients with chronic mucocutaneous candidiasis with a GOF STAT1 mutation have mycobacterial disease, obscuring the"}
{"subject": "STAT1", "sub_type": "Gene", "rel": "ThemeOf", "object": "domains", "obj_type": "MPA", "file_name": "PubMed-28011069.json", "snippet": " Mendelian susceptibility to mycobacterial diseases, or gain of function (GOF), as in patients with chronic mucocutaneous candidiasis. LOF and GOF mutations are equally rare and can affect the same  [CLS] domains of STAT1 [CLS] , especially the coiled-coil domain (CCD) and DNA-binding domain (DBD). Moreover, 6% of patients with chronic mucocutaneous candidiasis with a GOF STAT1 mutation have mycobacterial disease, obscuring the functional significance"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "impaired", "obj_type": "NegReg", "file_name": "PubMed-28139313.json", "snippet": " [CLS] mutations in the human signal transducer and activator of transcription 1 (STAT1) manifest in immunodeficiency and autoimmunity with impaired [CLS]  TH17\u00a0cell differentiation and exaggerated responsiveness to type I and II interferons. Allogeneic bone marrow transplantation has been attempted in severely affected patients, but outcomes have been poor.\nOBJECTIVE: We"}
{"subject": "TH17\u00a0cell responses", "sub_type": "CPA", "rel": "ThemeOf", "object": "suppressed", "obj_type": "NegReg", "file_name": "PubMed-28139313.json", "snippet": " the linker domain of STAT1 who had life-threatening autoimmune cytopenias and chronic mucocutaneous candidiasis. Naive lymphocytes from the affected patient displayed increased TH1 and follicular T helper cell and  [CLS] suppressed TH17\u00a0cell responses [CLS] . The mutation augmented cytokine-induced STAT1 phosphorylation without affecting dephosphorylation kinetics. Treatment with the Janus kinase 1/2 inhibitor ruxolitinib reduced hyperresponsiveness to type I and II interferons, normalized TH1 and"}
{"subject": "mutation", "sub_type": "Var", "rel": "CauseOf", "object": "augmented", "obj_type": "PosReg", "file_name": "PubMed-28139313.json", "snippet": " STAT1 who had life-threatening autoimmune cytopenias and chronic mucocutaneous candidiasis. Naive lymphocytes from the affected patient displayed increased TH1 and follicular T helper cell and suppressed TH17\u00a0cell responses. The  [CLS] mutation augmented [CLS]  cytokine-induced STAT1 phosphorylation without affecting dephosphorylation kinetics. Treatment with the Janus kinase 1/2 inhibitor ruxolitinib reduced hyperresponsiveness to type I and II interferons, normalized TH1 and follicular T helper"}
{"subject": "cytokine-induced STAT1 phosphorylation", "sub_type": "MPA", "rel": "ThemeOf", "object": "augmented", "obj_type": "PosReg", "file_name": "PubMed-28139313.json", "snippet": " who had life-threatening autoimmune cytopenias and chronic mucocutaneous candidiasis. Naive lymphocytes from the affected patient displayed increased TH1 and follicular T helper cell and suppressed TH17\u00a0cell responses. The mutation  [CLS] augmented cytokine-induced STAT1 phosphorylation [CLS]  without affecting dephosphorylation kinetics. Treatment with the Janus kinase 1/2 inhibitor ruxolitinib reduced hyperresponsiveness to type I and II interferons, normalized TH1 and follicular T helper cell responses, improved"}
{"subject": "STAT1", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutation in the linker domain", "obj_type": "Var", "file_name": "PubMed-28139313.json", "snippet": " to STAT1 GOF mutations.\nMETHODS: We used in\u00a0vitro polarization assays, as well as phenotypic and functional analysis of STAT1-mutated patient cells.\nRESULTS: We report a child with a novel  [CLS] mutation in the linker domain of STAT1 [CLS]  who had life-threatening autoimmune cytopenias and chronic mucocutaneous candidiasis. Naive lymphocytes from the affected patient displayed increased TH1 and follicular T helper cell and suppressed TH17\u00a0cell responses. The mutation"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "GOF", "obj_type": "PosReg", "file_name": "PubMed-28139313.json", "snippet": " II interferons, normalized TH1 and follicular T helper cell responses, improved TH17 differentiation, cured mucocutaneous candidiasis, and maintained remission of immune-mediated cytopenias.\nCONCLUSIONS: Autoimmunity and infection caused by STAT1  [CLS] GOF mutations [CLS]  are the result of dysregulated T helper cell responses. Janus kinase inhibitor therapy could represent an effective targeted treatment for long-term disease control in severely affected patients for whom"}
{"subject": "T helper cell responses", "sub_type": "CPA", "rel": "ThemeOf", "object": "GOF", "obj_type": "PosReg", "file_name": "PubMed-28139313.json", "snippet": " II interferons, normalized TH1 and follicular T helper cell responses, improved TH17 differentiation, cured mucocutaneous candidiasis, and maintained remission of immune-mediated cytopenias.\nCONCLUSIONS: Autoimmunity and infection caused by STAT1  [CLS] GOF mutations are the result of dysregulated T helper cell responses [CLS] . Janus kinase inhibitor therapy could represent an effective targeted treatment for long-term disease control in severely affected patients for whom hematopoietic stem cell transplantation is not available."}
{"subject": "STAT1", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-28139313.json", "snippet": " and II interferons, normalized TH1 and follicular T helper cell responses, improved TH17 differentiation, cured mucocutaneous candidiasis, and maintained remission of immune-mediated cytopenias.\nCONCLUSIONS: Autoimmunity and infection caused by  [CLS] STAT1 GOF mutations [CLS]  are the result of dysregulated T helper cell responses. Janus kinase inhibitor therapy could represent an effective targeted treatment for long-term disease control in severely affected patients for whom"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "Gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-28139313.json", "snippet": " [CLS] Gain-of-function (GOF) mutations [CLS]  in the human signal transducer and activator of transcription 1 (STAT1) manifest in immunodeficiency and autoimmunity with impaired TH17\u00a0cell differentiation and exaggerated responsiveness to type I and II interferons."}
{"subject": "human signal transducer and activator of transcription 1", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-28139313.json", "snippet": " [CLS] mutations in the human signal transducer and activator of transcription 1 [CLS]  (STAT1) manifest in immunodeficiency and autoimmunity with impaired TH17\u00a0cell differentiation and exaggerated responsiveness to type I and II interferons. Allogeneic bone marrow transplantation has been attempted in severely affected"}
{"subject": "TH17\u00a0cell differentiation", "sub_type": "CPA", "rel": "ThemeOf", "object": "impaired", "obj_type": "NegReg", "file_name": "PubMed-28139313.json", "snippet": " and activator of transcription 1 (STAT1) gain-of-function mutation.\nBACKGROUND: Gain-of-function (GOF) mutations in the human signal transducer and activator of transcription 1 (STAT1) manifest in immunodeficiency and autoimmunity with  [CLS] impaired TH17\u00a0cell differentiation [CLS]  and exaggerated responsiveness to type I and II interferons. Allogeneic bone marrow transplantation has been attempted in severely affected patients, but outcomes have been poor.\nOBJECTIVE: We sought to"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "exaggerated", "obj_type": "PosReg", "file_name": "PubMed-28139313.json", "snippet": " [CLS] mutations in the human signal transducer and activator of transcription 1 (STAT1) manifest in immunodeficiency and autoimmunity with impaired TH17\u00a0cell differentiation and exaggerated [CLS]  responsiveness to type I and II interferons. Allogeneic bone marrow transplantation has been attempted in severely affected patients, but outcomes have been poor.\nOBJECTIVE: We sought to define the"}
{"subject": "responsiveness to type I and II interferons", "sub_type": "Interaction", "rel": "ThemeOf", "object": "exaggerated", "obj_type": "PosReg", "file_name": "PubMed-28139313.json", "snippet": " 1 (STAT1) gain-of-function mutation.\nBACKGROUND: Gain-of-function (GOF) mutations in the human signal transducer and activator of transcription 1 (STAT1) manifest in immunodeficiency and autoimmunity with impaired TH17\u00a0cell differentiation and  [CLS] exaggerated responsiveness to type I and II interferons [CLS] . Allogeneic bone marrow transplantation has been attempted in severely affected patients, but outcomes have been poor.\nOBJECTIVE: We sought to define the effect of increased STAT1 activity on T"}
{"subject": "mutation in the linker domain", "sub_type": "Var", "rel": "CauseOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-28139313.json", "snippet": " to STAT1 GOF mutations.\nMETHODS: We used in\u00a0vitro polarization assays, as well as phenotypic and functional analysis of STAT1-mutated patient cells.\nRESULTS: We report a child with a novel  [CLS] mutation in the linker domain of STAT1 who had life-threatening autoimmune cytopenias and chronic mucocutaneous candidiasis. Naive lymphocytes from the affected patient displayed increased [CLS]  TH1 and follicular T helper cell and suppressed TH17\u00a0cell responses. The mutation augmented cytokine-induced STAT1 phosphorylation without affecting dephosphorylation kinetics. Treatment with the Janus kinase 1/2 inhibitor ruxolitinib reduced"}
{"subject": "TH1 and follicular T helper cell", "sub_type": "CPA", "rel": "ThemeOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-28139313.json", "snippet": " report a child with a novel mutation in the linker domain of STAT1 who had life-threatening autoimmune cytopenias and chronic mucocutaneous candidiasis. Naive lymphocytes from the affected patient displayed  [CLS] increased TH1 and follicular T helper cell [CLS]  and suppressed TH17\u00a0cell responses. The mutation augmented cytokine-induced STAT1 phosphorylation without affecting dephosphorylation kinetics. Treatment with the Janus kinase 1/2 inhibitor ruxolitinib reduced hyperresponsiveness to type I and II"}
{"subject": "mutation in the linker domain", "sub_type": "Var", "rel": "CauseOf", "object": "suppressed", "obj_type": "NegReg", "file_name": "PubMed-28139313.json", "snippet": " to STAT1 GOF mutations.\nMETHODS: We used in\u00a0vitro polarization assays, as well as phenotypic and functional analysis of STAT1-mutated patient cells.\nRESULTS: We report a child with a novel  [CLS] mutation in the linker domain of STAT1 who had life-threatening autoimmune cytopenias and chronic mucocutaneous candidiasis. Naive lymphocytes from the affected patient displayed increased TH1 and follicular T helper cell and suppressed [CLS]  TH17\u00a0cell responses. The mutation augmented cytokine-induced STAT1 phosphorylation without affecting dephosphorylation kinetics. Treatment with the Janus kinase 1/2 inhibitor ruxolitinib reduced hyperresponsiveness to type I and II interferons, normalized"}
{"subject": "variants", "sub_type": "Var", "rel": "CauseOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-28157721.json", "snippet": " [CLS] variants in proprotein convertase subtilisin-kexin type 9 (PCSK9) that are either gain-of-function [CLS]  (GOF) or loss-of-function (LOF), with downstream effects on LDL cholesterol and cardiovascular disease (CVD) risk. However, data on particular mechanisms have only been minimally curated.\nRECENT FINDINGS: GOF variants"}
{"subject": "LDL receptor", "sub_type": "Protein", "rel": "ThemeOf", "object": "expression", "obj_type": "MPA", "file_name": "PubMed-28157721.json", "snippet": " disease (CVD) risk. However, data on particular mechanisms have only been minimally curated.\nRECENT FINDINGS: GOF variants are individually ultrarare, affect all domains of the protein, act to reduce  [CLS] LDL receptor expression [CLS]  through several mechanisms, are a minor cause of familial hypercholesterolemia, have been reported mainly within families, have variable LDL cholesterol-raising effects, and are associated with increased CVD risk mainly"}
{"subject": "expression", "sub_type": "MPA", "rel": "ThemeOf", "object": "reduce", "obj_type": "NegReg", "file_name": "PubMed-28157721.json", "snippet": " cardiovascular disease (CVD) risk. However, data on particular mechanisms have only been minimally curated.\nRECENT FINDINGS: GOF variants are individually ultrarare, affect all domains of the protein, act to  [CLS] reduce LDL receptor expression [CLS]  through several mechanisms, are a minor cause of familial hypercholesterolemia, have been reported mainly within families, have variable LDL cholesterol-raising effects, and are associated with increased CVD risk mainly"}
{"subject": "variants", "sub_type": "Var", "rel": "CauseOf", "object": "cause", "obj_type": "Reg", "file_name": "PubMed-28157721.json", "snippet": " gain-of-function (GOF) or loss-of-function (LOF), with downstream effects on LDL cholesterol and cardiovascular disease (CVD) risk. However, data on particular mechanisms have only been minimally curated.\nRECENT FINDINGS: GOF  [CLS] variants are individually ultrarare, affect all domains of the protein, act to reduce LDL receptor expression through several mechanisms, are a minor cause [CLS]  of familial hypercholesterolemia, have been reported mainly within families, have variable LDL cholesterol-raising effects, and are associated with increased CVD risk mainly through observational studies in families and small"}
{"subject": "familial hypercholesterolemia", "sub_type": "Disease", "rel": "ThemeOf", "object": "cause", "obj_type": "Reg", "file_name": "PubMed-28157721.json", "snippet": " only been minimally curated.\nRECENT FINDINGS: GOF variants are individually ultrarare, affect all domains of the protein, act to reduce LDL receptor expression through several mechanisms, are a minor  [CLS] cause of familial hypercholesterolemia [CLS] , have been reported mainly within families, have variable LDL cholesterol-raising effects, and are associated with increased CVD risk mainly through observational studies in families and small cohorts. In contrast,"}
{"subject": "variants", "sub_type": "Var", "rel": "CauseOf", "object": "LOF", "obj_type": "NegReg", "file_name": "PubMed-28157721.json", "snippet": " have been reported mainly within families, have variable LDL cholesterol-raising effects, and are associated with increased CVD risk mainly through observational studies in families and small cohorts. In contrast,  [CLS] LOF variants [CLS]  can be either ultrarare mutations or relatively more common polymorphisms seen in populations, affect all domains of the protein, act to increase LDL receptor expression through several mechanisms, have"}
{"subject": "variants", "sub_type": "Var", "rel": "CauseOf", "object": "affect", "obj_type": "Reg", "file_name": "PubMed-28157721.json", "snippet": " been reported mainly within families, have variable LDL cholesterol-raising effects, and are associated with increased CVD risk mainly through observational studies in families and small cohorts. In contrast, LOF  [CLS] variants can be either ultrarare mutations or relatively more common polymorphisms seen in populations, affect [CLS]  all domains of the protein, act to increase LDL receptor expression through several mechanisms, have variable LDL cholesterol-lowering effects, and have been associated with decreased CVD risk mainly through"}
{"subject": "affect", "sub_type": "Reg", "rel": "CauseOf", "object": "increase", "obj_type": "PosReg", "file_name": "PubMed-28157721.json", "snippet": " increased CVD risk mainly through observational studies in families and small cohorts. In contrast, LOF variants can be either ultrarare mutations or relatively more common polymorphisms seen in populations,  [CLS] affect all domains of the protein, act to increase [CLS]  LDL receptor expression through several mechanisms, have variable LDL cholesterol-lowering effects, and have been associated with decreased CVD risk mainly through Mendelian randomization studies in epidemiologic populations.\nSUMMARY: There"}
{"subject": "domains of the protein", "sub_type": "Protein", "rel": "ThemeOf", "object": "affect", "obj_type": "Reg", "file_name": "PubMed-28157721.json", "snippet": " increased CVD risk mainly through observational studies in families and small cohorts. In contrast, LOF variants can be either ultrarare mutations or relatively more common polymorphisms seen in populations,  [CLS] affect all domains of the protein [CLS] , act to increase LDL receptor expression through several mechanisms, have variable LDL cholesterol-lowering effects, and have been associated with decreased CVD risk mainly through Mendelian randomization studies in epidemiologic"}
{"subject": "variants", "sub_type": "Var", "rel": "CauseOf", "object": "lowering", "obj_type": "NegReg", "file_name": "PubMed-28157721.json", "snippet": " been reported mainly within families, have variable LDL cholesterol-raising effects, and are associated with increased CVD risk mainly through observational studies in families and small cohorts. In contrast, LOF  [CLS] variants can be either ultrarare mutations or relatively more common polymorphisms seen in populations, affect all domains of the protein, act to increase LDL receptor expression through several mechanisms, have variable LDL cholesterol-lowering [CLS]  effects, and have been associated with decreased CVD risk mainly through Mendelian randomization studies in epidemiologic populations.\nSUMMARY: There is considerable complexity underlying the clinical concept of both LOF"}
{"subject": "LDL cholesterol", "sub_type": "MPA", "rel": "ThemeOf", "object": "lowering", "obj_type": "NegReg", "file_name": "PubMed-28157721.json", "snippet": " be either ultrarare mutations or relatively more common polymorphisms seen in populations, affect all domains of the protein, act to increase LDL receptor expression through several mechanisms, have variable  [CLS] LDL cholesterol-lowering [CLS]  effects, and have been associated with decreased CVD risk mainly through Mendelian randomization studies in epidemiologic populations.\nSUMMARY: There is considerable complexity underlying the clinical concept of both LOF"}
{"subject": "variants", "sub_type": "Var", "rel": "CauseOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-28157721.json", "snippet": " [CLS] variants in proprotein convertase subtilisin-kexin type 9 (PCSK9) that are either gain-of-function (GOF) or loss-of-function [CLS]  (LOF), with downstream effects on LDL cholesterol and cardiovascular disease (CVD) risk. However, data on particular mechanisms have only been minimally curated.\nRECENT FINDINGS: GOF variants are individually ultrarare,"}
{"subject": "CVD", "sub_type": "Disease", "rel": "ThemeOf", "object": "decreased", "obj_type": "NegReg", "file_name": "PubMed-28157721.json", "snippet": " polymorphisms seen in populations, affect all domains of the protein, act to increase LDL receptor expression through several mechanisms, have variable LDL cholesterol-lowering effects, and have been associated with  [CLS] decreased CVD [CLS]  risk mainly through Mendelian randomization studies in epidemiologic populations.\nSUMMARY: There is considerable complexity underlying the clinical concept of both LOF and GOF variants of PCSK9. But despite the"}
{"subject": "variants", "sub_type": "Var", "rel": "CauseOf", "object": "decreased", "obj_type": "NegReg", "file_name": "PubMed-28157721.json", "snippet": " been reported mainly within families, have variable LDL cholesterol-raising effects, and are associated with increased CVD risk mainly through observational studies in families and small cohorts. In contrast, LOF  [CLS] variants can be either ultrarare mutations or relatively more common polymorphisms seen in populations, affect all domains of the protein, act to increase LDL receptor expression through several mechanisms, have variable LDL cholesterol-lowering effects, and have been associated with decreased [CLS]  CVD risk mainly through Mendelian randomization studies in epidemiologic populations.\nSUMMARY: There is considerable complexity underlying the clinical concept of both LOF and GOF variants of PCSK9. But despite"}
{"subject": "LDL receptor", "sub_type": "Protein", "rel": "ThemeOf", "object": "expression", "obj_type": "MPA", "file_name": "PubMed-28157721.json", "snippet": " and small cohorts. In contrast, LOF variants can be either ultrarare mutations or relatively more common polymorphisms seen in populations, affect all domains of the protein, act to increase  [CLS] LDL receptor expression [CLS]  through several mechanisms, have variable LDL cholesterol-lowering effects, and have been associated with decreased CVD risk mainly through Mendelian randomization studies in epidemiologic populations.\nSUMMARY: There is considerable complexity"}
{"subject": "expression", "sub_type": "MPA", "rel": "ThemeOf", "object": "increase", "obj_type": "PosReg", "file_name": "PubMed-28157721.json", "snippet": " families and small cohorts. In contrast, LOF variants can be either ultrarare mutations or relatively more common polymorphisms seen in populations, affect all domains of the protein, act to  [CLS] increase LDL receptor expression [CLS]  through several mechanisms, have variable LDL cholesterol-lowering effects, and have been associated with decreased CVD risk mainly through Mendelian randomization studies in epidemiologic populations.\nSUMMARY: There is considerable complexity"}
{"subject": "PCSK9", "sub_type": "Gene", "rel": "ThemeOf", "object": "variants", "obj_type": "Var", "file_name": "PubMed-28157721.json", "snippet": " [CLS] variants in proprotein convertase subtilisin-kexin type 9 (PCSK9 [CLS] ) that are either gain-of-function (GOF) or loss-of-function (LOF), with downstream effects on LDL cholesterol and cardiovascular disease (CVD) risk. However, data on particular mechanisms have only been minimally curated."}
{"subject": "variants", "sub_type": "Var", "rel": "CauseOf", "object": "effects", "obj_type": "Reg", "file_name": "PubMed-28157721.json", "snippet": " [CLS] variants in proprotein convertase subtilisin-kexin type 9 (PCSK9) that are either gain-of-function (GOF) or loss-of-function (LOF), with downstream effects [CLS]  on LDL cholesterol and cardiovascular disease (CVD) risk. However, data on particular mechanisms have only been minimally curated.\nRECENT FINDINGS: GOF variants are individually ultrarare, affect all domains of"}
{"subject": "LDL cholesterol", "sub_type": "Disease", "rel": "ThemeOf", "object": "effects", "obj_type": "Reg", "file_name": "PubMed-28157721.json", "snippet": " 9 variants.\nPURPOSE OF REVIEW: There are many reports of human variants in proprotein convertase subtilisin-kexin type 9 (PCSK9) that are either gain-of-function (GOF) or loss-of-function (LOF), with downstream  [CLS] effects on LDL cholesterol [CLS]  and cardiovascular disease (CVD) risk. However, data on particular mechanisms have only been minimally curated.\nRECENT FINDINGS: GOF variants are individually ultrarare, affect all domains of the protein, act"}
{"subject": "cardiovascular disease", "sub_type": "Disease", "rel": "ThemeOf", "object": "effects", "obj_type": "Reg", "file_name": "PubMed-28157721.json", "snippet": " 9 variants.\nPURPOSE OF REVIEW: There are many reports of human variants in proprotein convertase subtilisin-kexin type 9 (PCSK9) that are either gain-of-function (GOF) or loss-of-function (LOF), with downstream  [CLS] effects on LDL cholesterol and cardiovascular disease [CLS]  (CVD) risk. However, data on particular mechanisms have only been minimally curated.\nRECENT FINDINGS: GOF variants are individually ultrarare, affect all domains of the protein, act to reduce LDL"}
{"subject": "variants", "sub_type": "Var", "rel": "CauseOf", "object": "affect", "obj_type": "Reg", "file_name": "PubMed-28157721.json", "snippet": " gain-of-function (GOF) or loss-of-function (LOF), with downstream effects on LDL cholesterol and cardiovascular disease (CVD) risk. However, data on particular mechanisms have only been minimally curated.\nRECENT FINDINGS: GOF  [CLS] variants are individually ultrarare, affect [CLS]  all domains of the protein, act to reduce LDL receptor expression through several mechanisms, are a minor cause of familial hypercholesterolemia, have been reported mainly within families, have variable"}
{"subject": "domains of the protein", "sub_type": "Protein", "rel": "ThemeOf", "object": "affect", "obj_type": "Reg", "file_name": "PubMed-28157721.json", "snippet": " (LOF), with downstream effects on LDL cholesterol and cardiovascular disease (CVD) risk. However, data on particular mechanisms have only been minimally curated.\nRECENT FINDINGS: GOF variants are individually ultrarare,  [CLS] affect all domains of the protein [CLS] , act to reduce LDL receptor expression through several mechanisms, are a minor cause of familial hypercholesterolemia, have been reported mainly within families, have variable LDL cholesterol-raising effects, and are"}
{"subject": "variants", "sub_type": "Var", "rel": "CauseOf", "object": "GOF", "obj_type": "PosReg", "file_name": "PubMed-28157721.json", "snippet": " either gain-of-function (GOF) or loss-of-function (LOF), with downstream effects on LDL cholesterol and cardiovascular disease (CVD) risk. However, data on particular mechanisms have only been minimally curated.\nRECENT FINDINGS:  [CLS] GOF variants [CLS]  are individually ultrarare, affect all domains of the protein, act to reduce LDL receptor expression through several mechanisms, are a minor cause of familial hypercholesterolemia, have been reported mainly"}
{"subject": "affect", "sub_type": "Reg", "rel": "CauseOf", "object": "reduce", "obj_type": "NegReg", "file_name": "PubMed-28157721.json", "snippet": " (LOF), with downstream effects on LDL cholesterol and cardiovascular disease (CVD) risk. However, data on particular mechanisms have only been minimally curated.\nRECENT FINDINGS: GOF variants are individually ultrarare,  [CLS] affect all domains of the protein, act to reduce [CLS]  LDL receptor expression through several mechanisms, are a minor cause of familial hypercholesterolemia, have been reported mainly within families, have variable LDL cholesterol-raising effects, and are associated with increased"}
{"subject": "DAT", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutant", "obj_type": "Var", "file_name": "PubMed-28167616.json", "snippet": " for drug development. We studied the effects of a novel pharmacological approach metabotropic glutamate receptor mGluR2/3 antagonism, in DAT mutants in a comparative way with standard medications. Loss of  [CLS] DAT functionality in mutant [CLS]  rats not only elevated subcortical extracellular dopamine concentration but also altered the balance of monoaminergic transmission. DAT mutant rats showed deficits in all five RDoC domains. Thus, mutant rats"}
{"subject": "mutant", "sub_type": "Var", "rel": "CauseOf", "object": "elevated", "obj_type": "PosReg", "file_name": "PubMed-28167616.json", "snippet": " We studied the effects of a novel pharmacological approach metabotropic glutamate receptor mGluR2/3 antagonism, in DAT mutants in a comparative way with standard medications. Loss of DAT functionality in  [CLS] mutant rats not only elevated [CLS]  subcortical extracellular dopamine concentration but also altered the balance of monoaminergic transmission. DAT mutant rats showed deficits in all five RDoC domains. Thus, mutant rats failed to show conditioned"}
{"subject": "subcortical extracellular dopamine concentration", "sub_type": "MPA", "rel": "ThemeOf", "object": "elevated", "obj_type": "PosReg", "file_name": "PubMed-28167616.json", "snippet": " of a novel pharmacological approach metabotropic glutamate receptor mGluR2/3 antagonism, in DAT mutants in a comparative way with standard medications. Loss of DAT functionality in mutant rats not only  [CLS] elevated subcortical extracellular dopamine concentration [CLS]  but also altered the balance of monoaminergic transmission. DAT mutant rats showed deficits in all five RDoC domains. Thus, mutant rats failed to show conditioned fear responses, were anhedonic,"}
{"subject": "mutant", "sub_type": "Var", "rel": "CauseOf", "object": "altered", "obj_type": "Reg", "file_name": "PubMed-28167616.json", "snippet": " We studied the effects of a novel pharmacological approach metabotropic glutamate receptor mGluR2/3 antagonism, in DAT mutants in a comparative way with standard medications. Loss of DAT functionality in  [CLS] mutant rats not only elevated subcortical extracellular dopamine concentration but also altered [CLS]  the balance of monoaminergic transmission. DAT mutant rats showed deficits in all five RDoC domains. Thus, mutant rats failed to show conditioned fear responses, were anhedonic, were unable to"}
{"subject": "balance of monoaminergic transmission", "sub_type": "MPA", "rel": "ThemeOf", "object": "altered", "obj_type": "Reg", "file_name": "PubMed-28167616.json", "snippet": " receptor mGluR2/3 antagonism, in DAT mutants in a comparative way with standard medications. Loss of DAT functionality in mutant rats not only elevated subcortical extracellular dopamine concentration but also  [CLS] altered the balance of monoaminergic transmission [CLS] . DAT mutant rats showed deficits in all five RDoC domains. Thus, mutant rats failed to show conditioned fear responses, were anhedonic, were unable to learn stimulus-reward associations, showed impaired"}
{"subject": "DAT", "sub_type": "Gene", "rel": "CauseOf", "object": "Loss", "obj_type": "NegReg", "file_name": "PubMed-28167616.json", "snippet": " particularly helpful for drug development. We studied the effects of a novel pharmacological approach metabotropic glutamate receptor mGluR2/3 antagonism, in DAT mutants in a comparative way with standard medications.  [CLS] Loss of DAT [CLS]  functionality in mutant rats not only elevated subcortical extracellular dopamine concentration but also altered the balance of monoaminergic transmission. DAT mutant rats showed deficits in all five RDoC domains."}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "caused", "obj_type": "Reg", "file_name": "PubMed-28167755.json", "snippet": " [CLS] caused by activating mutations [CLS]  in either the leukocyte-restricted p110\u03b4 catalytic (PIK3CD) subunit or the ubiquitously expressed p85\u03b1 regulatory (PIK3R1) subunit of class IA phosphoinositide 3-kinases (PI3Ks). There are two classes of APDS: APDS1"}
{"subject": "Activated PI3K Delta Syndrome", "sub_type": "Disease", "rel": "ThemeOf", "object": "caused", "obj_type": "Reg", "file_name": "PubMed-28167755.json", "snippet": " [CLS] Activated PI3K Delta Syndrome (APDS) is a primary immunodeficiency disease caused [CLS]  by activating mutations in either the leukocyte-restricted p110\u03b4 catalytic (PIK3CD) subunit or the ubiquitously expressed p85\u03b1 regulatory (PIK3R1) subunit of class IA phosphoinositide 3-kinases (PI3Ks). There are two classes"}
{"subject": "PIK3CD", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-28167755.json", "snippet": " [CLS] mutations in either the leukocyte-restricted p110\u03b4 catalytic (PIK3CD [CLS] ) subunit or the ubiquitously expressed p85\u03b1 regulatory (PIK3R1) subunit of class IA phosphoinositide 3-kinases (PI3Ks). There are two classes of APDS: APDS1 that arises from p110\u03b4 mutations that are"}
{"subject": "APDS2", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutation", "obj_type": "Var", "file_name": "PubMed-28167755.json", "snippet": " have examined the molecular mechanism of activation of both classes of APDS mutations using a combination of biochemical assays and hydrogen-deuterium exchange mass spectrometry. Intriguingly, we find that an  [CLS] APDS2 mutation [CLS]  in p85\u03b1 leads to substantial basal activation of p110\u03b4 (>300-fold) and disrupts inhibitory interactions from the nSH2, iSH2, and cSH2 domains of p85, whereas p110\u03b1 is only minimally basally"}
{"subject": "mutation", "sub_type": "Var", "rel": "CauseOf", "object": "activation", "obj_type": "PosReg", "file_name": "PubMed-28167755.json", "snippet": " examined the molecular mechanism of activation of both classes of APDS mutations using a combination of biochemical assays and hydrogen-deuterium exchange mass spectrometry. Intriguingly, we find that an APDS2  [CLS] mutation in p85\u03b1 leads to substantial basal activation [CLS]  of p110\u03b4 (>300-fold) and disrupts inhibitory interactions from the nSH2, iSH2, and cSH2 domains of p85, whereas p110\u03b1 is only minimally basally activated (\u223c2-fold) when associated with mutated p85\u03b1."}
{"subject": "p110\u03b4 (>300-fold)", "sub_type": "MPA", "rel": "ThemeOf", "object": "activation", "obj_type": "PosReg", "file_name": "PubMed-28167755.json", "snippet": " both classes of APDS mutations using a combination of biochemical assays and hydrogen-deuterium exchange mass spectrometry. Intriguingly, we find that an APDS2 mutation in p85\u03b1 leads to substantial basal  [CLS] activation of p110\u03b4 (>300-fold) [CLS]  and disrupts inhibitory interactions from the nSH2, iSH2, and cSH2 domains of p85, whereas p110\u03b1 is only minimally basally activated (\u223c2-fold) when associated with mutated p85\u03b1. APDS1 mutations in"}
{"subject": "mutation", "sub_type": "Var", "rel": "CauseOf", "object": "disrupts", "obj_type": "NegReg", "file_name": "PubMed-28167755.json", "snippet": " examined the molecular mechanism of activation of both classes of APDS mutations using a combination of biochemical assays and hydrogen-deuterium exchange mass spectrometry. Intriguingly, we find that an APDS2  [CLS] mutation in p85\u03b1 leads to substantial basal activation of p110\u03b4 (>300-fold) and disrupts [CLS]  inhibitory interactions from the nSH2, iSH2, and cSH2 domains of p85, whereas p110\u03b1 is only minimally basally activated (\u223c2-fold) when associated with mutated p85\u03b1. APDS1 mutations in p110\u03b4 (N334K,"}
{"subject": "inhibitory interactions", "sub_type": "MPA", "rel": "ThemeOf", "object": "disrupts", "obj_type": "NegReg", "file_name": "PubMed-28167755.json", "snippet": " using a combination of biochemical assays and hydrogen-deuterium exchange mass spectrometry. Intriguingly, we find that an APDS2 mutation in p85\u03b1 leads to substantial basal activation of p110\u03b4 (>300-fold) and  [CLS] disrupts inhibitory interactions [CLS]  from the nSH2, iSH2, and cSH2 domains of p85, whereas p110\u03b1 is only minimally basally activated (\u223c2-fold) when associated with mutated p85\u03b1. APDS1 mutations in p110\u03b4 (N334K, E525K, E1021K)"}
{"subject": "Cdh2", "sub_type": "Gene", "rel": "ThemeOf", "object": "deletion", "obj_type": "Var", "file_name": "PubMed-28240364.json", "snippet": " and overexpression in osteoblasts lead to low bone mass. We tested the hypothesis that N-cadherin has different effects on osteolineage cells depending upon their differentiation stage. Embryonic conditional osteolineage  [CLS] Cdh2 deletion [CLS]  in mice results in defective growth, low bone mass, and reduced osteoprogenitor number. These abnormalities are prevented by delaying Cdh2 ablation until 1 month of age, thus targeting only"}
{"subject": "deletion", "sub_type": "Var", "rel": "CauseOf", "object": "defective", "obj_type": "NegReg", "file_name": "PubMed-28240364.json", "snippet": " overexpression in osteoblasts lead to low bone mass. We tested the hypothesis that N-cadherin has different effects on osteolineage cells depending upon their differentiation stage. Embryonic conditional osteolineage Cdh2  [CLS] deletion in mice results in defective [CLS]  growth, low bone mass, and reduced osteoprogenitor number. These abnormalities are prevented by delaying Cdh2 ablation until 1 month of age, thus targeting only committed and mature osteoblasts, suggesting"}
{"subject": "growth", "sub_type": "MPA", "rel": "ThemeOf", "object": "defective", "obj_type": "NegReg", "file_name": "PubMed-28240364.json", "snippet": " low bone mass. We tested the hypothesis that N-cadherin has different effects on osteolineage cells depending upon their differentiation stage. Embryonic conditional osteolineage Cdh2 deletion in mice results in  [CLS] defective growth [CLS] , low bone mass, and reduced osteoprogenitor number. These abnormalities are prevented by delaying Cdh2 ablation until 1 month of age, thus targeting only committed and mature osteoblasts, suggesting they"}
{"subject": "deletion", "sub_type": "Var", "rel": "CauseOf", "object": "low", "obj_type": "NegReg", "file_name": "PubMed-28240364.json", "snippet": " overexpression in osteoblasts lead to low bone mass. We tested the hypothesis that N-cadherin has different effects on osteolineage cells depending upon their differentiation stage. Embryonic conditional osteolineage Cdh2  [CLS] deletion in mice results in defective growth, low [CLS]  bone mass, and reduced osteoprogenitor number. These abnormalities are prevented by delaying Cdh2 ablation until 1 month of age, thus targeting only committed and mature osteoblasts, suggesting they are"}
{"subject": "bone mass", "sub_type": "MPA", "rel": "ThemeOf", "object": "low", "obj_type": "NegReg", "file_name": "PubMed-28240364.json", "snippet": " mass. We tested the hypothesis that N-cadherin has different effects on osteolineage cells depending upon their differentiation stage. Embryonic conditional osteolineage Cdh2 deletion in mice results in defective growth,  [CLS] low bone mass [CLS] , and reduced osteoprogenitor number. These abnormalities are prevented by delaying Cdh2 ablation until 1 month of age, thus targeting only committed and mature osteoblasts, suggesting they are the consequence"}
{"subject": "deletion", "sub_type": "Var", "rel": "CauseOf", "object": "reduced", "obj_type": "NegReg", "file_name": "PubMed-28240364.json", "snippet": " overexpression in osteoblasts lead to low bone mass. We tested the hypothesis that N-cadherin has different effects on osteolineage cells depending upon their differentiation stage. Embryonic conditional osteolineage Cdh2  [CLS] deletion in mice results in defective growth, low bone mass, and reduced [CLS]  osteoprogenitor number. These abnormalities are prevented by delaying Cdh2 ablation until 1 month of age, thus targeting only committed and mature osteoblasts, suggesting they are the consequence of N-cadherin"}
{"subject": "osteoprogenitor number", "sub_type": "MPA", "rel": "ThemeOf", "object": "reduced", "obj_type": "NegReg", "file_name": "PubMed-28240364.json", "snippet": " hypothesis that N-cadherin has different effects on osteolineage cells depending upon their differentiation stage. Embryonic conditional osteolineage Cdh2 deletion in mice results in defective growth, low bone mass, and  [CLS] reduced osteoprogenitor number [CLS] . These abnormalities are prevented by delaying Cdh2 ablation until 1 month of age, thus targeting only committed and mature osteoblasts, suggesting they are the consequence of N-cadherin deficiency in"}
{"subject": "KIT", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-28270683.json", "snippet": " [CLS] KIT, PDGFRA, NF1 and SDH mutations [CLS]  are alternate initiating events, fostering hyperplasia in gastrointestinal stromal tumours (GISTs), and additional genetic alterations are required for progression to malignancy. The most frequent secondary alteration, demonstrated in \u223c70%"}
{"subject": "SDH", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-28270683.json", "snippet": " [CLS] SDH mutations [CLS]  are alternate initiating events, fostering hyperplasia in gastrointestinal stromal tumours (GISTs), and additional genetic alterations are required for progression to malignancy. The most frequent secondary alteration, demonstrated in \u223c70%"}
{"subject": "NF1", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-28270683.json", "snippet": " [CLS] NF1 and SDH mutations [CLS]  are alternate initiating events, fostering hyperplasia in gastrointestinal stromal tumours (GISTs), and additional genetic alterations are required for progression to malignancy. The most frequent secondary alteration, demonstrated in \u223c70%"}
{"subject": "PDGFRA", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-28270683.json", "snippet": " [CLS] PDGFRA, NF1 and SDH mutations [CLS]  are alternate initiating events, fostering hyperplasia in gastrointestinal stromal tumours (GISTs), and additional genetic alterations are required for progression to malignancy. The most frequent secondary alteration, demonstrated in \u223c70%"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "fostering", "obj_type": "Reg", "file_name": "PubMed-28270683.json", "snippet": " [CLS] mutations are alternate initiating events, fostering [CLS]  hyperplasia in gastrointestinal stromal tumours (GISTs), and additional genetic alterations are required for progression to malignancy. The most frequent secondary alteration, demonstrated in \u223c70% of GISTs, is chromosome 14q"}
{"subject": "gastrointestinal stromal tumours", "sub_type": "MPA", "rel": "ThemeOf", "object": "fostering", "obj_type": "Reg", "file_name": "PubMed-28270683.json", "snippet": " [CLS] fostering hyperplasia in gastrointestinal stromal tumours [CLS]  (GISTs), and additional genetic alterations are required for progression to malignancy. The most frequent secondary alteration, demonstrated in \u223c70% of GISTs, is chromosome 14q deletion. Here we report hemizygous"}
{"subject": "ATR", "sub_type": "Gene", "rel": "ThemeOf", "object": "Mutations", "obj_type": "Var", "file_name": "PubMed-28273450.json", "snippet": " [CLS] ATR Mutations [CLS]  Promote the Growth of Melanoma Tumors by Modulating the Immune Microenvironment.\nMelanomas accumulate a high burden of mutations that could potentially generate neoantigens, yet somehow suppress the immune response"}
{"subject": "mutant", "sub_type": "Var", "rel": "CauseOf", "object": "decreased", "obj_type": "NegReg", "file_name": "PubMed-28273450.json", "snippet": " we identify a subset of human melanomas that have loss-of-function mutations in ATR, a kinase that recognizes and repairs UV-induced DNA damage and is required for cellular proliferation. ATR  [CLS] mutant tumors exhibit both the accumulation of multiple mutations and the altered expression of inflammatory genes, resulting in decreased [CLS]  T\u00a0cell recruitment and increased recruitment of macrophages known to spur tumor invasion. Taken together, these studies identify a mechanism by which melanoma cells modulate the immune microenvironment to promote"}
{"subject": "T\u00a0cell recruitment", "sub_type": "MPA", "rel": "ThemeOf", "object": "decreased", "obj_type": "NegReg", "file_name": "PubMed-28273450.json", "snippet": " repairs UV-induced DNA damage and is required for cellular proliferation. ATR mutant tumors exhibit both the accumulation of multiple mutations and the altered expression of inflammatory genes, resulting in  [CLS] decreased T\u00a0cell recruitment [CLS]  and increased recruitment of macrophages known to spur tumor invasion. Taken together, these studies identify a mechanism by which melanoma cells modulate the immune microenvironment to promote continued growth."}
{"subject": "mutant", "sub_type": "Var", "rel": "CauseOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-28273450.json", "snippet": " we identify a subset of human melanomas that have loss-of-function mutations in ATR, a kinase that recognizes and repairs UV-induced DNA damage and is required for cellular proliferation. ATR  [CLS] mutant tumors exhibit both the accumulation of multiple mutations and the altered expression of inflammatory genes, resulting in decreased T\u00a0cell recruitment and increased [CLS]  recruitment of macrophages known to spur tumor invasion. Taken together, these studies identify a mechanism by which melanoma cells modulate the immune microenvironment to promote continued growth."}
{"subject": "recruitment of macrophages", "sub_type": "MPA", "rel": "ThemeOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-28273450.json", "snippet": " and is required for cellular proliferation. ATR mutant tumors exhibit both the accumulation of multiple mutations and the altered expression of inflammatory genes, resulting in decreased T\u00a0cell recruitment and  [CLS] increased recruitment of macrophages [CLS]  known to spur tumor invasion. Taken together, these studies identify a mechanism by which melanoma cells modulate the immune microenvironment to promote continued growth."}
{"subject": "Mutations", "sub_type": "Var", "rel": "CauseOf", "object": "Promote", "obj_type": "PosReg", "file_name": "PubMed-28273450.json", "snippet": " [CLS] Mutations Promote [CLS]  the Growth of Melanoma Tumors by Modulating the Immune Microenvironment.\nMelanomas accumulate a high burden of mutations that could potentially generate neoantigens, yet somehow suppress the immune response to"}
{"subject": "Growth", "sub_type": "MPA", "rel": "ThemeOf", "object": "Promote", "obj_type": "PosReg", "file_name": "PubMed-28273450.json", "snippet": " [CLS] Promote the Growth [CLS]  of Melanoma Tumors by Modulating the Immune Microenvironment.\nMelanomas accumulate a high burden of mutations that could potentially generate neoantigens, yet somehow suppress the immune response to facilitate continued"}
{"subject": "Melanoma Tumors", "sub_type": "Disease", "rel": "ThemeOf", "object": "Growth", "obj_type": "MPA", "file_name": "PubMed-28273450.json", "snippet": " [CLS] Growth of Melanoma Tumors [CLS]  by Modulating the Immune Microenvironment.\nMelanomas accumulate a high burden of mutations that could potentially generate neoantigens, yet somehow suppress the immune response to facilitate continued growth. In this"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "generate", "obj_type": "Reg", "file_name": "PubMed-28273450.json", "snippet": " [CLS] mutations that could potentially generate [CLS]  neoantigens, yet somehow suppress the immune response to facilitate continued growth. In this study, we identify a subset of human melanomas that have loss-of-function mutations in ATR, a kinase"}
{"subject": "neoantigens", "sub_type": "MPA", "rel": "ThemeOf", "object": "generate", "obj_type": "Reg", "file_name": "PubMed-28273450.json", "snippet": " [CLS] generate neoantigens [CLS] , yet somehow suppress the immune response to facilitate continued growth. In this study, we identify a subset of human melanomas that have loss-of-function mutations in ATR, a kinase that"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "suppress", "obj_type": "NegReg", "file_name": "PubMed-28273450.json", "snippet": " [CLS] mutations that could potentially generate neoantigens, yet somehow suppress [CLS]  the immune response to facilitate continued growth. In this study, we identify a subset of human melanomas that have loss-of-function mutations in ATR, a kinase that recognizes and repairs"}
{"subject": "immune response to facilitate continued growth", "sub_type": "MPA", "rel": "ThemeOf", "object": "suppress", "obj_type": "NegReg", "file_name": "PubMed-28273450.json", "snippet": " [CLS] suppress the immune response to facilitate continued growth [CLS] . In this study, we identify a subset of human melanomas that have loss-of-function mutations in ATR, a kinase that recognizes and repairs UV-induced DNA damage and is required for"}
{"subject": "ATR", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutant", "obj_type": "Var", "file_name": "PubMed-28273450.json", "snippet": " study, we identify a subset of human melanomas that have loss-of-function mutations in ATR, a kinase that recognizes and repairs UV-induced DNA damage and is required for cellular proliferation.  [CLS] ATR mutant [CLS]  tumors exhibit both the accumulation of multiple mutations and the altered expression of inflammatory genes, resulting in decreased T\u00a0cell recruitment and increased recruitment of macrophages known to spur tumor"}
{"subject": "BDNF", "sub_type": "Gene", "rel": "ThemeOf", "object": "polymorphism", "obj_type": "Var", "file_name": "PubMed-28277116.json", "snippet": " of estrogen in endometrial cells. Finally, we investigated the different role of Val66Met, a single-nucleotide polymorphism of the BDNF gene, in regulating endometrial cells proliferation. The results showed that  [CLS] BDNF(V66M) polymorphism [CLS]  is a loss-of-function polymorphism in the regulation of endometrial cells growth. Given the correlation between endometriosis and infertility, it is important to understand the role of BDNF in regulating"}
{"subject": "polymorphism", "sub_type": "Var", "rel": "CauseOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-28277116.json", "snippet": " estrogen in endometrial cells. Finally, we investigated the different role of Val66Met, a single-nucleotide polymorphism of the BDNF gene, in regulating endometrial cells proliferation. The results showed that BDNF(V66M)  [CLS] polymorphism is a loss-of-function [CLS]  polymorphism in the regulation of endometrial cells growth. Given the correlation between endometriosis and infertility, it is important to understand the role of BDNF in regulating endometrial cells proliferation"}
{"subject": "regulation of endometrial cells growth", "sub_type": "MPA", "rel": "ThemeOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-28277116.json", "snippet": " cells. Finally, we investigated the different role of Val66Met, a single-nucleotide polymorphism of the BDNF gene, in regulating endometrial cells proliferation. The results showed that BDNF(V66M) polymorphism is a  [CLS] loss-of-function polymorphism in the regulation of endometrial cells growth [CLS] . Given the correlation between endometriosis and infertility, it is important to understand the role of BDNF in regulating endometrial cells proliferation and to develop new therapeutic strategies for the"}
{"subject": "polymorphism", "sub_type": "Var", "rel": "ThemeOf", "object": "regulation of endometrial cells growth", "obj_type": "MPA", "file_name": "PubMed-28277116.json", "snippet": " Finally, we investigated the different role of Val66Met, a single-nucleotide polymorphism of the BDNF gene, in regulating endometrial cells proliferation. The results showed that BDNF(V66M) polymorphism is a loss-of-function  [CLS] polymorphism in the regulation of endometrial cells growth [CLS] . Given the correlation between endometriosis and infertility, it is important to understand the role of BDNF in regulating endometrial cells proliferation and to develop new therapeutic strategies for the"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-28283687.json", "snippet": " [CLS] gain-of-function mutations [CLS]  in the low-density lipoprotein receptor-related protein 5 (LRP5) on glucose and lipid homeostasis.\nLRP5 loss-of-function mutations have been shown to cause profound osteoporosis and have been associated with impaired"}
{"subject": "LRP5", "sub_type": "Gene", "rel": "CauseOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-28283687.json", "snippet": " and have been associated with impaired insulin sensitivity and dysregulated lipid metabolism. We hypothesized that gain-of-function mutations in LRP5 would also affect these parameters. We therefore studied individuals with  [CLS] LRP5 gain-of-function [CLS]  mutations exhibiting high bone mass (HBM) phenotypes and found that while there was no detected change in insulin sensitivity, there was a significant reduction in serum LDL.\nINTRODUCTION: Wnt"}
{"subject": "LRP5", "sub_type": "Gene", "rel": "CauseOf", "object": "reduction", "obj_type": "NegReg", "file_name": "PubMed-28283687.json", "snippet": " and have been associated with impaired insulin sensitivity and dysregulated lipid metabolism. We hypothesized that gain-of-function mutations in LRP5 would also affect these parameters. We therefore studied individuals with  [CLS] LRP5 gain-of-function mutations exhibiting high bone mass (HBM) phenotypes and found that while there was no detected change in insulin sensitivity, there was a significant reduction [CLS]  in serum LDL.\nINTRODUCTION: Wnt signaling through LRP5 represents a newly appreciated metabolic pathway, which potentially represents a target for drug discovery in type 2 diabetes and hyperlipidemia. Studies"}
{"subject": "serum LDL", "sub_type": "MPA", "rel": "ThemeOf", "object": "reduction", "obj_type": "NegReg", "file_name": "PubMed-28283687.json", "snippet": " therefore studied individuals with LRP5 gain-of-function mutations exhibiting high bone mass (HBM) phenotypes and found that while there was no detected change in insulin sensitivity, there was a significant  [CLS] reduction in serum LDL [CLS] .\nINTRODUCTION: Wnt signaling through LRP5 represents a newly appreciated metabolic pathway, which potentially represents a target for drug discovery in type 2 diabetes and hyperlipidemia. Studies in animal models"}
{"subject": "LRP5", "sub_type": "Gene", "rel": "ThemeOf", "object": "variants", "obj_type": "Var", "file_name": "PubMed-28283687.json", "snippet": " size was small, our data do not support the hypothesis that HBM-causing LRP5 mutations, associated with increased Wnt signaling, improve glucose metabolism in humans. However, it does appear that  [CLS] LRP5 variants [CLS]  may affect LDL metabolism, a major risk factor for coronary artery disease. The molecular mechanisms underpinning this effect warrant further study."}
{"subject": "variants", "sub_type": "Var", "rel": "CauseOf", "object": "affect", "obj_type": "Reg", "file_name": "PubMed-28283687.json", "snippet": " was small, our data do not support the hypothesis that HBM-causing LRP5 mutations, associated with increased Wnt signaling, improve glucose metabolism in humans. However, it does appear that LRP5  [CLS] variants may affect [CLS]  LDL metabolism, a major risk factor for coronary artery disease. The molecular mechanisms underpinning this effect warrant further study."}
{"subject": "LDL metabolism", "sub_type": "MPA", "rel": "ThemeOf", "object": "affect", "obj_type": "Reg", "file_name": "PubMed-28283687.json", "snippet": " our data do not support the hypothesis that HBM-causing LRP5 mutations, associated with increased Wnt signaling, improve glucose metabolism in humans. However, it does appear that LRP5 variants may  [CLS] affect LDL metabolism [CLS] , a major risk factor for coronary artery disease. The molecular mechanisms underpinning this effect warrant further study."}
{"subject": "LRP5", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-28283687.json", "snippet": " [CLS] mutations in the low-density lipoprotein receptor-related protein 5 (LRP5 [CLS] ) on glucose and lipid homeostasis.\nLRP5 loss-of-function mutations have been shown to cause profound osteoporosis and have been associated with impaired insulin sensitivity and dysregulated lipid metabolism. We hypothesized"}
{"subject": "glucose and lipid homeostasis", "sub_type": "MPA", "rel": "ThemeOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-28283687.json", "snippet": " [CLS] gain-of-function mutations in the low-density lipoprotein receptor-related protein 5 (LRP5) on glucose and lipid homeostasis [CLS] .\nLRP5 loss-of-function mutations have been shown to cause profound osteoporosis and have been associated with impaired insulin sensitivity and dysregulated lipid metabolism. We hypothesized that gain-of-function mutations in LRP5"}
{"subject": "LRP5", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-28283687.json", "snippet": " [CLS] LRP5 loss-of-function mutations [CLS]  have been shown to cause profound osteoporosis and have been associated with impaired insulin sensitivity and dysregulated lipid metabolism. We hypothesized that gain-of-function mutations in LRP5 would also affect"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-28283687.json", "snippet": " [CLS] loss-of-function mutations [CLS]  have been shown to cause profound osteoporosis and have been associated with impaired insulin sensitivity and dysregulated lipid metabolism. We hypothesized that gain-of-function mutations in LRP5 would also affect"}
{"subject": "profound osteoporosis", "sub_type": "MPA", "rel": "ThemeOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-28283687.json", "snippet": " [CLS] loss-of-function mutations have been shown to cause profound osteoporosis [CLS]  and have been associated with impaired insulin sensitivity and dysregulated lipid metabolism. We hypothesized that gain-of-function mutations in LRP5 would also affect these parameters. We therefore studied individuals with"}
{"subject": "impaired insulin sensitivity", "sub_type": "MPA", "rel": "ThemeOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-28283687.json", "snippet": " [CLS] loss-of-function mutations have been shown to cause profound osteoporosis and have been associated with impaired insulin sensitivity [CLS]  and dysregulated lipid metabolism. We hypothesized that gain-of-function mutations in LRP5 would also affect these parameters. We therefore studied individuals with LRP5 gain-of-function mutations exhibiting high bone mass (HBM)"}
{"subject": "dysregulated lipid metabolism", "sub_type": "MPA", "rel": "ThemeOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-28283687.json", "snippet": " [CLS] loss-of-function mutations have been shown to cause profound osteoporosis and have been associated with impaired insulin sensitivity and dysregulated lipid metabolism [CLS] . We hypothesized that gain-of-function mutations in LRP5 would also affect these parameters. We therefore studied individuals with LRP5 gain-of-function mutations exhibiting high bone mass (HBM) phenotypes and found that"}
{"subject": "LRP5", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-28283687.json", "snippet": " and have been associated with impaired insulin sensitivity and dysregulated lipid metabolism. We hypothesized that gain-of-function mutations in LRP5 would also affect these parameters. We therefore studied individuals with  [CLS] LRP5 gain-of-function mutations [CLS]  exhibiting high bone mass (HBM) phenotypes and found that while there was no detected change in insulin sensitivity, there was a significant reduction in serum LDL.\nINTRODUCTION: Wnt signaling"}
{"subject": "knockdown", "sub_type": "Var", "rel": "CauseOf", "object": "decrease", "obj_type": "NegReg", "file_name": "PubMed-28314794.json", "snippet": " elongation. Additionally, the Rop GTPase ROP2 was reported as a positive regulator of both root hair initiation and tip growth in Arabidopsis. Both loss of function of ROP2 and  [CLS] knockdown of MAP18 lead to a decrease [CLS]  in root hair length, whereas overexpression of either MAP18 or ROP2 causes multiple tips or a branching hair phenotype. However, it is unclear whether MAP18 and ROP2 coordinately regulate"}
{"subject": "root hair length", "sub_type": "MPA", "rel": "ThemeOf", "object": "decrease", "obj_type": "NegReg", "file_name": "PubMed-28314794.json", "snippet": " was reported as a positive regulator of both root hair initiation and tip growth in Arabidopsis. Both loss of function of ROP2 and knockdown of MAP18 lead to a  [CLS] decrease in root hair length [CLS] , whereas overexpression of either MAP18 or ROP2 causes multiple tips or a branching hair phenotype. However, it is unclear whether MAP18 and ROP2 coordinately regulate root hair growth. In"}
{"subject": "MAP18", "sub_type": "Gene", "rel": "ThemeOf", "object": "knockdown", "obj_type": "Var", "file_name": "PubMed-28314794.json", "snippet": " elongation. Additionally, the Rop GTPase ROP2 was reported as a positive regulator of both root hair initiation and tip growth in Arabidopsis. Both loss of function of ROP2 and  [CLS] knockdown of MAP18 [CLS]  lead to a decrease in root hair length, whereas overexpression of either MAP18 or ROP2 causes multiple tips or a branching hair phenotype. However, it is unclear whether MAP18"}
{"subject": "Deletion", "sub_type": "Var", "rel": "CauseOf", "object": "affects", "obj_type": "Reg", "file_name": "PubMed-28322269.json", "snippet": " Saccharomyces cerevisiae Ras-GAP ira1 mutant and the encoded MadC protein interacts with P. blakesleeanus Ras homologs in yeast two-hybrid assays, indicating that MadC is a regulator of Ras signaling.  [CLS] Deletion of the homolog in the filamentous ascomycete Neurospora crassa affects [CLS]  the circadian clock output, yielding a pattern of asexual conidiation similar to a ras-1 mutant that is used in circadian studies in N. crassa. Thus, MadC is unlikely to"}
{"subject": "circadian clock output", "sub_type": "MPA", "rel": "ThemeOf", "object": "affects", "obj_type": "Reg", "file_name": "PubMed-28322269.json", "snippet": " interacts with P. blakesleeanus Ras homologs in yeast two-hybrid assays, indicating that MadC is a regulator of Ras signaling. Deletion of the homolog in the filamentous ascomycete Neurospora crassa  [CLS] affects the circadian clock output [CLS] , yielding a pattern of asexual conidiation similar to a ras-1 mutant that is used in circadian studies in N. crassa. Thus, MadC is unlikely to be a photosensor, yet"}
{"subject": "Deletion", "sub_type": "Var", "rel": "CauseOf", "object": "yielding", "obj_type": "Reg", "file_name": "PubMed-28322269.json", "snippet": " Saccharomyces cerevisiae Ras-GAP ira1 mutant and the encoded MadC protein interacts with P. blakesleeanus Ras homologs in yeast two-hybrid assays, indicating that MadC is a regulator of Ras signaling.  [CLS] Deletion of the homolog in the filamentous ascomycete Neurospora crassa affects the circadian clock output, yielding [CLS]  a pattern of asexual conidiation similar to a ras-1 mutant that is used in circadian studies in N. crassa. Thus, MadC is unlikely to be a photosensor, yet is"}
{"subject": "asexual conidiation", "sub_type": "MPA", "rel": "ThemeOf", "object": "yielding", "obj_type": "Reg", "file_name": "PubMed-28322269.json", "snippet": " homologs in yeast two-hybrid assays, indicating that MadC is a regulator of Ras signaling. Deletion of the homolog in the filamentous ascomycete Neurospora crassa affects the circadian clock output,  [CLS] yielding a pattern of asexual conidiation [CLS]  similar to a ras-1 mutant that is used in circadian studies in N. crassa. Thus, MadC is unlikely to be a photosensor, yet is a fundamental link in the"}
{"subject": "mutant", "sub_type": "Var", "rel": "CauseOf", "object": "escaped", "obj_type": "NegReg", "file_name": "PubMed-28338294.json", "snippet": " proteins, such a phenomenon has not been observed in vivo. Here, we report a heterozygous frameshift mutation of PROKR2 identified in a 3.5-year-old girl with central precocious puberty. The  [CLS] mutant mRNA escaped [CLS]  nonsense-mediated decay and generated a GPCR lacking two transmembrane domains and the carboxyl-terminal tail. The mutant protein had no in vitro signal transduction activity; however, cells co-expressing the mutant"}
{"subject": "nonsense-mediated decay", "sub_type": "MPA", "rel": "ThemeOf", "object": "escaped", "obj_type": "NegReg", "file_name": "PubMed-28338294.json", "snippet": " a phenomenon has not been observed in vivo. Here, we report a heterozygous frameshift mutation of PROKR2 identified in a 3.5-year-old girl with central precocious puberty. The mutant mRNA  [CLS] escaped nonsense-mediated decay [CLS]  and generated a GPCR lacking two transmembrane domains and the carboxyl-terminal tail. The mutant protein had no in vitro signal transduction activity; however, cells co-expressing the mutant and wild-type"}
{"subject": "mutant", "sub_type": "Var", "rel": "CauseOf", "object": "lacking", "obj_type": "NegReg", "file_name": "PubMed-28338294.json", "snippet": " proteins, such a phenomenon has not been observed in vivo. Here, we report a heterozygous frameshift mutation of PROKR2 identified in a 3.5-year-old girl with central precocious puberty. The  [CLS] mutant mRNA escaped nonsense-mediated decay and generated a GPCR lacking [CLS]  two transmembrane domains and the carboxyl-terminal tail. The mutant protein had no in vitro signal transduction activity; however, cells co-expressing the mutant and wild-type PROKR2 exhibited markedly exaggerated ligand-induced"}
{"subject": "two transmembrane domains", "sub_type": "MPA", "rel": "ThemeOf", "object": "lacking", "obj_type": "NegReg", "file_name": "PubMed-28338294.json", "snippet": " vivo. Here, we report a heterozygous frameshift mutation of PROKR2 identified in a 3.5-year-old girl with central precocious puberty. The mutant mRNA escaped nonsense-mediated decay and generated a GPCR  [CLS] lacking two transmembrane domains [CLS]  and the carboxyl-terminal tail. The mutant protein had no in vitro signal transduction activity; however, cells co-expressing the mutant and wild-type PROKR2 exhibited markedly exaggerated ligand-induced Ca(2+) responses. The"}
{"subject": "PROKR2", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutants", "obj_type": "Var", "file_name": "PubMed-28338294.json", "snippet": " mutant protein had no in vitro signal transduction activity; however, cells co-expressing the mutant and wild-type PROKR2 exhibited markedly exaggerated ligand-induced Ca(2+) responses. The results indicate that certain inactive  [CLS] PROKR2 mutants [CLS]  can cause early puberty by enhancing the functional property of coexisting wild-type proteins. Considering the structural similarity among GPCRs, this paradoxical gain-of-function mechanism may underlie various human disorders."}
{"subject": "mutants", "sub_type": "Var", "rel": "CauseOf", "object": "enhancing", "obj_type": "PosReg", "file_name": "PubMed-28338294.json", "snippet": " protein had no in vitro signal transduction activity; however, cells co-expressing the mutant and wild-type PROKR2 exhibited markedly exaggerated ligand-induced Ca(2+) responses. The results indicate that certain inactive PROKR2  [CLS] mutants can cause early puberty by enhancing [CLS]  the functional property of coexisting wild-type proteins. Considering the structural similarity among GPCRs, this paradoxical gain-of-function mechanism may underlie various human disorders."}
{"subject": "functional", "sub_type": "MPA", "rel": "ThemeOf", "object": "enhancing", "obj_type": "PosReg", "file_name": "PubMed-28338294.json", "snippet": " transduction activity; however, cells co-expressing the mutant and wild-type PROKR2 exhibited markedly exaggerated ligand-induced Ca(2+) responses. The results indicate that certain inactive PROKR2 mutants can cause early puberty by  [CLS] enhancing the functional [CLS]  property of coexisting wild-type proteins. Considering the structural similarity among GPCRs, this paradoxical gain-of-function mechanism may underlie various human disorders."}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "disrupted", "obj_type": "NegReg", "file_name": "PubMed-28339550.json", "snippet": " that it can inhibit pollen germination. However, it remained unclear whether these physiological functions required ion flux through a mechanically gated channel provided by MSL8. We introduced two point  [CLS] mutations into the predicted pore-lining domain of MSL8 that disrupted [CLS]  normal channel function in different ways. The Ile711Ser mutation increased the tension threshold of the MSL8 channel while leaving conductance unchanged, and the Phe720Leu mutation severely disrupted the MSL8"}
{"subject": "MSL8", "sub_type": "Gene", "rel": "ThemeOf", "object": "Phe720Leu mutation", "obj_type": "Var", "file_name": "PubMed-28339550.json", "snippet": " pore-lining domain of MSL8 that disrupted normal channel function in different ways. The Ile711Ser mutation increased the tension threshold of the MSL8 channel while leaving conductance unchanged, and the  [CLS] Phe720Leu mutation severely disrupted the MSL8 [CLS]  channel. Both of these mutations impaired the ability of MSL8 to preserve pollen viability during hydration and to maintain the integrity of the pollen tube when expressed at endogenous"}
{"subject": "channel", "sub_type": "Pathway", "rel": "ThemeOf", "object": "disrupted", "obj_type": "NegReg", "file_name": "PubMed-28339550.json", "snippet": " MSL8 that disrupted normal channel function in different ways. The Ile711Ser mutation increased the tension threshold of the MSL8 channel while leaving conductance unchanged, and the Phe720Leu mutation severely  [CLS] disrupted the MSL8 channel [CLS] . Both of these mutations impaired the ability of MSL8 to preserve pollen viability during hydration and to maintain the integrity of the pollen tube when expressed at endogenous levels."}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "impaired", "obj_type": "NegReg", "file_name": "PubMed-28339550.json", "snippet": " different ways. The Ile711Ser mutation increased the tension threshold of the MSL8 channel while leaving conductance unchanged, and the Phe720Leu mutation severely disrupted the MSL8 channel. Both of these  [CLS] mutations impaired [CLS]  the ability of MSL8 to preserve pollen viability during hydration and to maintain the integrity of the pollen tube when expressed at endogenous levels. When overexpressed in an msl8-4"}
{"subject": "ability", "sub_type": "MPA", "rel": "ThemeOf", "object": "impaired", "obj_type": "NegReg", "file_name": "PubMed-28339550.json", "snippet": " ways. The Ile711Ser mutation increased the tension threshold of the MSL8 channel while leaving conductance unchanged, and the Phe720Leu mutation severely disrupted the MSL8 channel. Both of these mutations  [CLS] impaired the ability [CLS]  of MSL8 to preserve pollen viability during hydration and to maintain the integrity of the pollen tube when expressed at endogenous levels. When overexpressed in an msl8-4 null background,"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "maintain", "obj_type": "Reg", "file_name": "PubMed-28339550.json", "snippet": " different ways. The Ile711Ser mutation increased the tension threshold of the MSL8 channel while leaving conductance unchanged, and the Phe720Leu mutation severely disrupted the MSL8 channel. Both of these  [CLS] mutations impaired the ability of MSL8 to preserve pollen viability during hydration and to maintain [CLS]  the integrity of the pollen tube when expressed at endogenous levels. When overexpressed in an msl8-4 null background, MSL8I711S could partially rescue loss-of-function phenotypes, while MSL8F720L could not. When"}
{"subject": "integrity", "sub_type": "MPA", "rel": "ThemeOf", "object": "maintain", "obj_type": "Reg", "file_name": "PubMed-28339550.json", "snippet": " leaving conductance unchanged, and the Phe720Leu mutation severely disrupted the MSL8 channel. Both of these mutations impaired the ability of MSL8 to preserve pollen viability during hydration and to  [CLS] maintain the integrity [CLS]  of the pollen tube when expressed at endogenous levels. When overexpressed in an msl8-4 null background, MSL8I711S could partially rescue loss-of-function phenotypes, while MSL8F720L could not. When overexpressed in"}
{"subject": "normal channel function", "sub_type": "MPA", "rel": "ThemeOf", "object": "disrupted", "obj_type": "NegReg", "file_name": "PubMed-28339550.json", "snippet": " unclear whether these physiological functions required ion flux through a mechanically gated channel provided by MSL8. We introduced two point mutations into the predicted pore-lining domain of MSL8 that  [CLS] disrupted normal channel function [CLS]  in different ways. The Ile711Ser mutation increased the tension threshold of the MSL8 channel while leaving conductance unchanged, and the Phe720Leu mutation severely disrupted the MSL8 channel. Both of"}
{"subject": "MSL8", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-28339550.json", "snippet": " that it can inhibit pollen germination. However, it remained unclear whether these physiological functions required ion flux through a mechanically gated channel provided by MSL8. We introduced two point  [CLS] mutations into the predicted pore-lining domain of MSL8 [CLS]  that disrupted normal channel function in different ways. The Ile711Ser mutation increased the tension threshold of the MSL8 channel while leaving conductance unchanged, and the Phe720Leu mutation severely disrupted"}
{"subject": "Ile711Ser", "sub_type": "Var", "rel": "CauseOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-28339550.json", "snippet": " through a mechanically gated channel provided by MSL8. We introduced two point mutations into the predicted pore-lining domain of MSL8 that disrupted normal channel function in different ways. The  [CLS] Ile711Ser mutation increased [CLS]  the tension threshold of the MSL8 channel while leaving conductance unchanged, and the Phe720Leu mutation severely disrupted the MSL8 channel. Both of these mutations impaired the ability of MSL8"}
{"subject": "tension threshold", "sub_type": "MPA", "rel": "ThemeOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-28339550.json", "snippet": " mechanically gated channel provided by MSL8. We introduced two point mutations into the predicted pore-lining domain of MSL8 that disrupted normal channel function in different ways. The Ile711Ser mutation  [CLS] increased the tension threshold [CLS]  of the MSL8 channel while leaving conductance unchanged, and the Phe720Leu mutation severely disrupted the MSL8 channel. Both of these mutations impaired the ability of MSL8 to preserve pollen"}
{"subject": "MSL8", "sub_type": "Gene", "rel": "ThemeOf", "object": "Ile711Ser", "obj_type": "Var", "file_name": "PubMed-28339550.json", "snippet": " through a mechanically gated channel provided by MSL8. We introduced two point mutations into the predicted pore-lining domain of MSL8 that disrupted normal channel function in different ways. The  [CLS] Ile711Ser mutation increased the tension threshold of the MSL8 [CLS]  channel while leaving conductance unchanged, and the Phe720Leu mutation severely disrupted the MSL8 channel. Both of these mutations impaired the ability of MSL8 to preserve pollen viability during hydration"}
{"subject": "Ile711Ser", "sub_type": "Var", "rel": "CauseOf", "object": "leaving", "obj_type": "Reg", "file_name": "PubMed-28339550.json", "snippet": " through a mechanically gated channel provided by MSL8. We introduced two point mutations into the predicted pore-lining domain of MSL8 that disrupted normal channel function in different ways. The  [CLS] Ile711Ser mutation increased the tension threshold of the MSL8 channel while leaving [CLS]  conductance unchanged, and the Phe720Leu mutation severely disrupted the MSL8 channel. Both of these mutations impaired the ability of MSL8 to preserve pollen viability during hydration and to maintain"}
{"subject": "conductance unchanged", "sub_type": "MPA", "rel": "ThemeOf", "object": "leaving", "obj_type": "Reg", "file_name": "PubMed-28339550.json", "snippet": " point mutations into the predicted pore-lining domain of MSL8 that disrupted normal channel function in different ways. The Ile711Ser mutation increased the tension threshold of the MSL8 channel while  [CLS] leaving conductance unchanged [CLS] , and the Phe720Leu mutation severely disrupted the MSL8 channel. Both of these mutations impaired the ability of MSL8 to preserve pollen viability during hydration and to maintain the integrity"}
{"subject": "Phe720Leu mutation", "sub_type": "Var", "rel": "CauseOf", "object": "disrupted", "obj_type": "NegReg", "file_name": "PubMed-28339550.json", "snippet": " pore-lining domain of MSL8 that disrupted normal channel function in different ways. The Ile711Ser mutation increased the tension threshold of the MSL8 channel while leaving conductance unchanged, and the  [CLS] Phe720Leu mutation severely disrupted [CLS]  the MSL8 channel. Both of these mutations impaired the ability of MSL8 to preserve pollen viability during hydration and to maintain the integrity of the pollen tube when expressed"}
{"subject": "Rack1", "sub_type": "Gene", "rel": "ThemeOf", "object": "knock-down", "obj_type": "Var", "file_name": "PubMed-28343944.json", "snippet": " and JNK signaling pathways in melanoma cell lines had been proposed. Here, we used a genetic approach to test this hypothesis in vivo in the mouse. We show that  [CLS] Rack1 knock-down [CLS]  in the mouse melanoma cell line B16 reduces invasiveness and induces cell differentiation. We have developed the first mouse model for RACK1 gain of function, Tyr::Rack1-HA transgenic mice, targeting"}
{"subject": "knock-down", "sub_type": "Var", "rel": "CauseOf", "object": "reduces", "obj_type": "NegReg", "file_name": "PubMed-28343944.json", "snippet": " JNK signaling pathways in melanoma cell lines had been proposed. Here, we used a genetic approach to test this hypothesis in vivo in the mouse. We show that Rack1  [CLS] knock-down in the mouse melanoma cell line B16 reduces [CLS]  invasiveness and induces cell differentiation. We have developed the first mouse model for RACK1 gain of function, Tyr::Rack1-HA transgenic mice, targeting RACK1 to melanocytes in vivo. RACK1 overexpression was"}
{"subject": "invasiveness", "sub_type": "MPA", "rel": "ThemeOf", "object": "reduces", "obj_type": "NegReg", "file_name": "PubMed-28343944.json", "snippet": " been proposed. Here, we used a genetic approach to test this hypothesis in vivo in the mouse. We show that Rack1 knock-down in the mouse melanoma cell line B16  [CLS] reduces invasiveness [CLS]  and induces cell differentiation. We have developed the first mouse model for RACK1 gain of function, Tyr::Rack1-HA transgenic mice, targeting RACK1 to melanocytes in vivo. RACK1 overexpression was not"}
{"subject": "knock-down", "sub_type": "Var", "rel": "CauseOf", "object": "induces", "obj_type": "Reg", "file_name": "PubMed-28343944.json", "snippet": " JNK signaling pathways in melanoma cell lines had been proposed. Here, we used a genetic approach to test this hypothesis in vivo in the mouse. We show that Rack1  [CLS] knock-down in the mouse melanoma cell line B16 reduces invasiveness and induces [CLS]  cell differentiation. We have developed the first mouse model for RACK1 gain of function, Tyr::Rack1-HA transgenic mice, targeting RACK1 to melanocytes in vivo. RACK1 overexpression was not sufficient to"}
{"subject": "cell differentiation", "sub_type": "MPA", "rel": "ThemeOf", "object": "induces", "obj_type": "Reg", "file_name": "PubMed-28343944.json", "snippet": " we used a genetic approach to test this hypothesis in vivo in the mouse. We show that Rack1 knock-down in the mouse melanoma cell line B16 reduces invasiveness and  [CLS] induces cell differentiation [CLS] . We have developed the first mouse model for RACK1 gain of function, Tyr::Rack1-HA transgenic mice, targeting RACK1 to melanocytes in vivo. RACK1 overexpression was not sufficient to initiate melanomas"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-28373485.json", "snippet": " [CLS] loss-of-function mutations [CLS]  in human DGAT1 result in severe congenital diarrhea and protein-losing enteropathy. Additionally, pharmacologic inhibition of DGAT1 led to dose-related diarrhea in human clinical trials. Here we identify a previously"}
{"subject": "mutant", "sub_type": "Var", "rel": "CauseOf", "object": "decreased", "obj_type": "NegReg", "file_name": "PubMed-28373485.json", "snippet": " with protein-losing enteropathy and failure to thrive. Exome sequencing revealed a homozygous recessive mutation in DGAT1, c.314T>C, p.L105P. We show here that the p.L105P DGAT1 enzyme produced from the  [CLS] mutant allele is less abundant, resulting in partial loss of TG synthesis activity and decreased [CLS]  formation of lipid droplets in patient-derived primary dermal fibroblasts. Thus, in contrast with complete loss-of-function alleles of DGAT1, the p.L105P missense allele partially reduces TG synthesis activity and causes"}
{"subject": "formation of lipid droplets", "sub_type": "MPA", "rel": "ThemeOf", "object": "decreased", "obj_type": "NegReg", "file_name": "PubMed-28373485.json", "snippet": " in DGAT1, c.314T>C, p.L105P. We show here that the p.L105P DGAT1 enzyme produced from the mutant allele is less abundant, resulting in partial loss of TG synthesis activity and  [CLS] decreased formation of lipid droplets [CLS]  in patient-derived primary dermal fibroblasts. Thus, in contrast with complete loss-of-function alleles of DGAT1, the p.L105P missense allele partially reduces TG synthesis activity and causes a less severe clinical"}
{"subject": "p.L105P missense", "sub_type": "Var", "rel": "CauseOf", "object": "reduces", "obj_type": "NegReg", "file_name": "PubMed-28373485.json", "snippet": " resulting in partial loss of TG synthesis activity and decreased formation of lipid droplets in patient-derived primary dermal fibroblasts. Thus, in contrast with complete loss-of-function alleles of DGAT1, the  [CLS] p.L105P missense allele partially reduces [CLS]  TG synthesis activity and causes a less severe clinical phenotype. Our findings add to the growing recognition of DGAT1 deficiency as a cause of congenital diarrhea with protein-losing enteropathy"}
{"subject": "TG synthesis activity", "sub_type": "MPA", "rel": "ThemeOf", "object": "reduces", "obj_type": "NegReg", "file_name": "PubMed-28373485.json", "snippet": " of TG synthesis activity and decreased formation of lipid droplets in patient-derived primary dermal fibroblasts. Thus, in contrast with complete loss-of-function alleles of DGAT1, the p.L105P missense allele partially  [CLS] reduces TG synthesis activity [CLS]  and causes a less severe clinical phenotype. Our findings add to the growing recognition of DGAT1 deficiency as a cause of congenital diarrhea with protein-losing enteropathy and indicate that"}
{"subject": "p.L105P missense", "sub_type": "Var", "rel": "CauseOf", "object": "causes", "obj_type": "Reg", "file_name": "PubMed-28373485.json", "snippet": " resulting in partial loss of TG synthesis activity and decreased formation of lipid droplets in patient-derived primary dermal fibroblasts. Thus, in contrast with complete loss-of-function alleles of DGAT1, the  [CLS] p.L105P missense allele partially reduces TG synthesis activity and causes [CLS]  a less severe clinical phenotype. Our findings add to the growing recognition of DGAT1 deficiency as a cause of congenital diarrhea with protein-losing enteropathy and indicate that DGAT1 mutations"}
{"subject": "less severe clinical phenotype", "sub_type": "MPA", "rel": "ThemeOf", "object": "causes", "obj_type": "Reg", "file_name": "PubMed-28373485.json", "snippet": " decreased formation of lipid droplets in patient-derived primary dermal fibroblasts. Thus, in contrast with complete loss-of-function alleles of DGAT1, the p.L105P missense allele partially reduces TG synthesis activity and  [CLS] causes a less severe clinical phenotype [CLS] . Our findings add to the growing recognition of DGAT1 deficiency as a cause of congenital diarrhea with protein-losing enteropathy and indicate that DGAT1 mutations result in a spectrum of"}
{"subject": "DGAT1", "sub_type": "Gene", "rel": "ThemeOf", "object": "deficiency", "obj_type": "Var", "file_name": "PubMed-28373485.json", "snippet": " complete loss-of-function alleles of DGAT1, the p.L105P missense allele partially reduces TG synthesis activity and causes a less severe clinical phenotype. Our findings add to the growing recognition of  [CLS] DGAT1 deficiency [CLS]  as a cause of congenital diarrhea with protein-losing enteropathy and indicate that DGAT1 mutations result in a spectrum of diseases."}
{"subject": "deficiency", "sub_type": "Var", "rel": "CauseOf", "object": "cause", "obj_type": "Reg", "file_name": "PubMed-28373485.json", "snippet": " loss-of-function alleles of DGAT1, the p.L105P missense allele partially reduces TG synthesis activity and causes a less severe clinical phenotype. Our findings add to the growing recognition of DGAT1  [CLS] deficiency as a cause [CLS]  of congenital diarrhea with protein-losing enteropathy and indicate that DGAT1 mutations result in a spectrum of diseases."}
{"subject": "congenital diarrhea", "sub_type": "Disease", "rel": "ThemeOf", "object": "cause", "obj_type": "Reg", "file_name": "PubMed-28373485.json", "snippet": " DGAT1, the p.L105P missense allele partially reduces TG synthesis activity and causes a less severe clinical phenotype. Our findings add to the growing recognition of DGAT1 deficiency as a  [CLS] cause of congenital diarrhea [CLS]  with protein-losing enteropathy and indicate that DGAT1 mutations result in a spectrum of diseases."}
{"subject": "congenital diarrhea", "sub_type": "Disease", "rel": "ThemeOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-28373485.json", "snippet": " [CLS] loss-of-function mutations in human DGAT1 result in severe congenital diarrhea [CLS]  and protein-losing enteropathy. Additionally, pharmacologic inhibition of DGAT1 led to dose-related diarrhea in human clinical trials. Here we identify a previously unknown DGAT1 mutation in identical twins of South"}
{"subject": "protein-losing enteropathy", "sub_type": "Disease", "rel": "ThemeOf", "object": "cause", "obj_type": "Reg", "file_name": "PubMed-28373485.json", "snippet": " DGAT1, the p.L105P missense allele partially reduces TG synthesis activity and causes a less severe clinical phenotype. Our findings add to the growing recognition of DGAT1 deficiency as a  [CLS] cause of congenital diarrhea with protein-losing enteropathy [CLS]  and indicate that DGAT1 mutations result in a spectrum of diseases."}
{"subject": "DGAT1", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-28373485.json", "snippet": " and causes a less severe clinical phenotype. Our findings add to the growing recognition of DGAT1 deficiency as a cause of congenital diarrhea with protein-losing enteropathy and indicate that  [CLS] DGAT1 mutations [CLS]  result in a spectrum of diseases."}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "result in", "obj_type": "Reg", "file_name": "PubMed-28373485.json", "snippet": " causes a less severe clinical phenotype. Our findings add to the growing recognition of DGAT1 deficiency as a cause of congenital diarrhea with protein-losing enteropathy and indicate that DGAT1  [CLS] mutations result in [CLS]  a spectrum of diseases."}
{"subject": "spectrum of diseases", "sub_type": "Disease", "rel": "ThemeOf", "object": "result in", "obj_type": "Reg", "file_name": "PubMed-28373485.json", "snippet": " a less severe clinical phenotype. Our findings add to the growing recognition of DGAT1 deficiency as a cause of congenital diarrhea with protein-losing enteropathy and indicate that DGAT1 mutations  [CLS] result in a spectrum of diseases [CLS] ."}
{"subject": "DGAT1", "sub_type": "Gene", "rel": "ThemeOf", "object": "p.L105P", "obj_type": "Var", "file_name": "PubMed-28373485.json", "snippet": " developed watery diarrhea shortly after birth, with protein-losing enteropathy and failure to thrive. Exome sequencing revealed a homozygous recessive mutation in DGAT1, c.314T>C, p.L105P. We show here that the  [CLS] p.L105P DGAT1 [CLS]  enzyme produced from the mutant allele is less abundant, resulting in partial loss of TG synthesis activity and decreased formation of lipid droplets in patient-derived primary dermal fibroblasts. Thus,"}
{"subject": "protein-losing enteropathy", "sub_type": "Disease", "rel": "ThemeOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-28373485.json", "snippet": " [CLS] loss-of-function mutations in human DGAT1 result in severe congenital diarrhea and protein-losing enteropathy [CLS] . Additionally, pharmacologic inhibition of DGAT1 led to dose-related diarrhea in human clinical trials. Here we identify a previously unknown DGAT1 mutation in identical twins of South Asian descent. These"}
{"subject": "DGAT1", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-28373485.json", "snippet": " [CLS] mutations in human DGAT1 [CLS]  result in severe congenital diarrhea and protein-losing enteropathy. Additionally, pharmacologic inhibition of DGAT1 led to dose-related diarrhea in human clinical trials. Here we identify a previously unknown DGAT1 mutation"}
{"subject": "mutant", "sub_type": "Var", "rel": "CauseOf", "object": "less", "obj_type": "NegReg", "file_name": "PubMed-28373485.json", "snippet": " with protein-losing enteropathy and failure to thrive. Exome sequencing revealed a homozygous recessive mutation in DGAT1, c.314T>C, p.L105P. We show here that the p.L105P DGAT1 enzyme produced from the  [CLS] mutant allele is less [CLS]  abundant, resulting in partial loss of TG synthesis activity and decreased formation of lipid droplets in patient-derived primary dermal fibroblasts. Thus, in contrast with complete loss-of-function alleles of DGAT1,"}
{"subject": "p.L105P", "sub_type": "Var", "rel": "ThemeOf", "object": "less", "obj_type": "NegReg", "file_name": "PubMed-28373485.json", "snippet": " developed watery diarrhea shortly after birth, with protein-losing enteropathy and failure to thrive. Exome sequencing revealed a homozygous recessive mutation in DGAT1, c.314T>C, p.L105P. We show here that the  [CLS] p.L105P DGAT1 enzyme produced from the mutant allele is less [CLS]  abundant, resulting in partial loss of TG synthesis activity and decreased formation of lipid droplets in patient-derived primary dermal fibroblasts. Thus, in contrast with complete loss-of-function alleles of DGAT1,"}
{"subject": "mutant", "sub_type": "Var", "rel": "CauseOf", "object": "loss", "obj_type": "NegReg", "file_name": "PubMed-28373485.json", "snippet": " with protein-losing enteropathy and failure to thrive. Exome sequencing revealed a homozygous recessive mutation in DGAT1, c.314T>C, p.L105P. We show here that the p.L105P DGAT1 enzyme produced from the  [CLS] mutant allele is less abundant, resulting in partial loss [CLS]  of TG synthesis activity and decreased formation of lipid droplets in patient-derived primary dermal fibroblasts. Thus, in contrast with complete loss-of-function alleles of DGAT1, the p.L105P missense allele partially"}
{"subject": "TG synthesis activity", "sub_type": "MPA", "rel": "ThemeOf", "object": "loss", "obj_type": "NegReg", "file_name": "PubMed-28373485.json", "snippet": " sequencing revealed a homozygous recessive mutation in DGAT1, c.314T>C, p.L105P. We show here that the p.L105P DGAT1 enzyme produced from the mutant allele is less abundant, resulting in partial  [CLS] loss of TG synthesis activity [CLS]  and decreased formation of lipid droplets in patient-derived primary dermal fibroblasts. Thus, in contrast with complete loss-of-function alleles of DGAT1, the p.L105P missense allele partially reduces TG synthesis activity"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "caused by", "obj_type": "Reg", "file_name": "PubMed-28460636.json", "snippet": " [CLS] caused by mutations [CLS]  in the MPDZ gene.\nCongenital hydrocephalus is considered as either acquired due to haemorrhage, infection or neoplasia or as of developmental nature and is divided into two subgroups, communicating"}
{"subject": "Hydrocephalus", "sub_type": "Disease", "rel": "ThemeOf", "object": "caused by", "obj_type": "Reg", "file_name": "PubMed-28460636.json", "snippet": " [CLS] Hydrocephalus due to multiple ependymal malformations is caused by [CLS]  mutations in the MPDZ gene.\nCongenital hydrocephalus is considered as either acquired due to haemorrhage, infection or neoplasia or as of developmental nature and is divided into two subgroups,"}
{"subject": "MPDZ", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-28460636.json", "snippet": " [CLS] mutations in the MPDZ [CLS]  gene.\nCongenital hydrocephalus is considered as either acquired due to haemorrhage, infection or neoplasia or as of developmental nature and is divided into two subgroups, communicating and obstructive. Congenital"}
{"subject": "L1CAM", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-28460636.json", "snippet": " and obstructive. Congenital hydrocephalus is either syndromic or non-syndromic, and in the latter no cause is found in more than half of the patients. In patients with isolated hydrocephalus,  [CLS] L1CAM mutations [CLS]  represent the most common aetiology. More recently, a founder mutation has also been reported in the MPDZ gene in foetuses presenting massive hydrocephalus, but the neuropathology remains unknown. We"}
{"subject": "isolated hydrocephalus", "sub_type": "Disease", "rel": "ThemeOf", "object": "common", "obj_type": "Reg", "file_name": "PubMed-28460636.json", "snippet": " subgroups, communicating and obstructive. Congenital hydrocephalus is either syndromic or non-syndromic, and in the latter no cause is found in more than half of the patients. In patients with  [CLS] isolated hydrocephalus, L1CAM mutations represent the most common [CLS]  aetiology. More recently, a founder mutation has also been reported in the MPDZ gene in foetuses presenting massive hydrocephalus, but the neuropathology remains unknown. We describe here three novel"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "common", "obj_type": "Reg", "file_name": "PubMed-28460636.json", "snippet": " obstructive. Congenital hydrocephalus is either syndromic or non-syndromic, and in the latter no cause is found in more than half of the patients. In patients with isolated hydrocephalus, L1CAM  [CLS] mutations represent the most common [CLS]  aetiology. More recently, a founder mutation has also been reported in the MPDZ gene in foetuses presenting massive hydrocephalus, but the neuropathology remains unknown. We describe here three novel"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "perturb", "obj_type": "Reg", "file_name": "PubMed-28464429.json", "snippet": " factor and encodes for two proteins, PntP1 and PntP2. However, while PntP1 is constitutively active, PntP2 is only active after being phosphorylated by MAPK in the RTK pathway. As  [CLS] mutations in pnt perturb [CLS]  the development of several tissues, we wanted to examine the effect and efficacy of using RNAi to target Pnt. We have expressed pnt RNAi in the eyes, oocyte, and"}
{"subject": "development of several tissues", "sub_type": "CPA", "rel": "ThemeOf", "object": "perturb", "obj_type": "Reg", "file_name": "PubMed-28464429.json", "snippet": " for two proteins, PntP1 and PntP2. However, while PntP1 is constitutively active, PntP2 is only active after being phosphorylated by MAPK in the RTK pathway. As mutations in pnt  [CLS] perturb the development of several tissues [CLS] , we wanted to examine the effect and efficacy of using RNAi to target Pnt. We have expressed pnt RNAi in the eyes, oocyte, and heart cells using three different"}
{"subject": "pnt", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-28464429.json", "snippet": " factor and encodes for two proteins, PntP1 and PntP2. However, while PntP1 is constitutively active, PntP2 is only active after being phosphorylated by MAPK in the RTK pathway. As  [CLS] mutations in pnt [CLS]  perturb the development of several tissues, we wanted to examine the effect and efficacy of using RNAi to target Pnt. We have expressed pnt RNAi in the eyes, oocyte,"}
{"subject": "mutation", "sub_type": "Var", "rel": "CauseOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-28472301.json", "snippet": " [CLS] gain-of-function mutation [CLS]  shows CACNA1D as recurrently mutated gene in autism spectrum disorders and epilepsy.\nCACNA1D encodes the pore-forming \u03b11-subunit of Cav1.3, an L-type voltage-gated Ca2+-channel. Despite the recent discovery of two"}
{"subject": "autism spectrum disorders", "sub_type": "Disease", "rel": "ThemeOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-28472301.json", "snippet": " [CLS] gain-of-function mutation shows CACNA1D as recurrently mutated gene in autism spectrum disorders [CLS]  and epilepsy.\nCACNA1D encodes the pore-forming \u03b11-subunit of Cav1.3, an L-type voltage-gated Ca2+-channel. Despite the recent discovery of two de novo missense gain-of-function mutations in Cav1.3 in two individuals"}
{"subject": "epilepsy", "sub_type": "Disease", "rel": "ThemeOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-28472301.json", "snippet": " [CLS] gain-of-function mutation shows CACNA1D as recurrently mutated gene in autism spectrum disorders and epilepsy [CLS] .\nCACNA1D encodes the pore-forming \u03b11-subunit of Cav1.3, an L-type voltage-gated Ca2+-channel. Despite the recent discovery of two de novo missense gain-of-function mutations in Cav1.3 in two individuals with autism"}
{"subject": "CACNA1D", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutation", "obj_type": "Var", "file_name": "PubMed-28472301.json", "snippet": " [CLS] mutation shows CACNA1D [CLS]  as recurrently mutated gene in autism spectrum disorders and epilepsy.\nCACNA1D encodes the pore-forming \u03b11-subunit of Cav1.3, an L-type voltage-gated Ca2+-channel. Despite the recent discovery of two de novo"}
{"subject": "current densities", "sub_type": "MPA", "rel": "ThemeOf", "object": "enhanced", "obj_type": "PosReg", "file_name": "PubMed-28472301.json", "snippet": " C-terminal long and short Cav1.3 splice variants, expressed wild-type or mutant channel complexes in tsA-201 cells and performed whole-cell patch-clamp recordings.Mutation V401L, localized within the channel's activation gate, significantly  [CLS] enhanced current densities [CLS] , shifted voltage dependence of activation and inactivation to more negative voltages and reduced channel inactivation in both Cav1.3 splice variants. Altogether these gating changes are expected to result in"}
{"subject": "Ca2+-influx through the channel", "sub_type": "MPA", "rel": "ThemeOf", "object": "enhanced", "obj_type": "PosReg", "file_name": "PubMed-28472301.json", "snippet": " shifted voltage dependence of activation and inactivation to more negative voltages and reduced channel inactivation in both Cav1.3 splice variants. Altogether these gating changes are expected to result in  [CLS] enhanced Ca2+-influx through the channel [CLS] , thus representing a strong gain-of-function phenotype. Additionally, we also found that mutant channels retained full sensitivity towards the clinically available Ca2+ -channel blocker isradipine.Our findings strengthen the evidence for"}
{"subject": "V401L", "sub_type": "Var", "rel": "CauseOf", "object": "enhanced", "obj_type": "PosReg", "file_name": "PubMed-28472301.json", "snippet": " characterization we introduced mutation V401L into two major C-terminal long and short Cav1.3 splice variants, expressed wild-type or mutant channel complexes in tsA-201 cells and performed whole-cell patch-clamp recordings.Mutation  [CLS] V401L, localized within the channel's activation gate, significantly enhanced [CLS]  current densities, shifted voltage dependence of activation and inactivation to more negative voltages and reduced channel inactivation in both Cav1.3 splice variants. Altogether these gating changes are expected to"}
{"subject": "changes", "sub_type": "Var", "rel": "CauseOf", "object": "enhanced", "obj_type": "PosReg", "file_name": "PubMed-28472301.json", "snippet": " activation gate, significantly enhanced current densities, shifted voltage dependence of activation and inactivation to more negative voltages and reduced channel inactivation in both Cav1.3 splice variants. Altogether these gating  [CLS] changes are expected to result in enhanced [CLS]  Ca2+-influx through the channel, thus representing a strong gain-of-function phenotype. Additionally, we also found that mutant channels retained full sensitivity towards the clinically available Ca2+ -channel blocker isradipine.Our findings"}
{"subject": "Null mutations", "sub_type": "Var", "rel": "CauseOf", "object": "predispose", "obj_type": "Reg", "file_name": "PubMed-28479159.json", "snippet": " [CLS] Null mutations in filaggrin (FLG), a key epidermal barrier protein, strongly predispose [CLS]  to AE; however, the precise role of FLG deficiency in AE pathogenesis remains incompletely understood.\nOBJECTIVES: We sought to identify global proteomic changes downstream of FLG deficiency in human"}
{"subject": "AE", "sub_type": "Disease", "rel": "ThemeOf", "object": "predispose", "obj_type": "Reg", "file_name": "PubMed-28479159.json", "snippet": " molecular signatures characteristic of atopic eczema.\nBACKGROUND: Atopic eczema (AE) is characterized by skin barrier and immune dysfunction. Null mutations in filaggrin (FLG), a key epidermal barrier protein, strongly  [CLS] predispose to AE [CLS] ; however, the precise role of FLG deficiency in AE pathogenesis remains incompletely understood.\nOBJECTIVES: We sought to identify global proteomic changes downstream of FLG deficiency in human epidermal living"}
{"subject": "FLG", "sub_type": "Gene", "rel": "ThemeOf", "object": "Null mutations", "obj_type": "Var", "file_name": "PubMed-28479159.json", "snippet": " [CLS] Null mutations in filaggrin (FLG [CLS] ), a key epidermal barrier protein, strongly predispose to AE; however, the precise role of FLG deficiency in AE pathogenesis remains incompletely understood.\nOBJECTIVES: We sought to identify global proteomic"}
{"subject": "Molecular pathways", "sub_type": "Pathway", "rel": "ThemeOf", "object": "overrepresented", "obj_type": "PosReg", "file_name": "PubMed-28479159.json", "snippet": " proteins after FLG knockdown, including kallikrein-7 (KLK7; 2.2-fold), cyclophilin A\u00a0(PPIA; 0.9-fold), and cofilin-1 (CFL1, 1.3-fold). Differential protein expression was confirmed in shNT/shFLG LSEs; however, only KLK7 was transcriptionally dysregulated.  [CLS] Molecular pathways overrepresented [CLS]  after FLG knockdown included inflammation, protease activity, cell structure, and stress. Furthermore, KLK7 (1.8-fold) and PPIA (0.65-fold) proteins were differentially expressed in lesional biopsy specimens from patients with AE"}
{"subject": "FLG", "sub_type": "Gene", "rel": "ThemeOf", "object": "knockdown", "obj_type": "Var", "file_name": "PubMed-28479159.json", "snippet": " including kallikrein-7 (KLK7; 2.2-fold), cyclophilin A\u00a0(PPIA; 0.9-fold), and cofilin-1 (CFL1, 1.3-fold). Differential protein expression was confirmed in shNT/shFLG LSEs; however, only KLK7 was transcriptionally dysregulated. Molecular pathways overrepresented after  [CLS] FLG knockdown [CLS]  included inflammation, protease activity, cell structure, and stress. Furthermore, KLK7 (1.8-fold) and PPIA (0.65-fold) proteins were differentially expressed in lesional biopsy specimens from patients with AE relative to normal"}
{"subject": "knockdown", "sub_type": "Var", "rel": "CauseOf", "object": "overrepresented", "obj_type": "PosReg", "file_name": "PubMed-28479159.json", "snippet": " FLG knockdown, including kallikrein-7 (KLK7; 2.2-fold), cyclophilin A\u00a0(PPIA; 0.9-fold), and cofilin-1 (CFL1, 1.3-fold). Differential protein expression was confirmed in shNT/shFLG LSEs; however, only KLK7 was transcriptionally dysregulated. Molecular pathways  [CLS] overrepresented after FLG knockdown [CLS]  included inflammation, protease activity, cell structure, and stress. Furthermore, KLK7 (1.8-fold) and PPIA (0.65-fold) proteins were differentially expressed in lesional biopsy specimens from patients with AE relative to normal"}
{"subject": "loss", "sub_type": "Var", "rel": "CauseOf", "object": "alter", "obj_type": "Reg", "file_name": "PubMed-28479159.json", "snippet": " KLK7 (1.8-fold) and PPIA (0.65-fold) proteins were differentially expressed in lesional biopsy specimens from patients with AE relative to normal skin.\nCONCLUSIONS: For the first time, we show that  [CLS] loss of FLG in the absence of inflammation is sufficient to alter [CLS]  the expression level of proteins relevant to the pathogenesis of AE. These include proteins regulating inflammatory, proteolytic, and cytoskeletal functions. We identify PPIA as a novel protein with levels"}
{"subject": "expression level of proteins", "sub_type": "MPA", "rel": "ThemeOf", "object": "alter", "obj_type": "Reg", "file_name": "PubMed-28479159.json", "snippet": " biopsy specimens from patients with AE relative to normal skin.\nCONCLUSIONS: For the first time, we show that loss of FLG in the absence of inflammation is sufficient to  [CLS] alter the expression level of proteins [CLS]  relevant to the pathogenesis of AE. These include proteins regulating inflammatory, proteolytic, and cytoskeletal functions. We identify PPIA as a novel protein with levels that are decreased in clinically"}
{"subject": "FLG", "sub_type": "Gene", "rel": "ThemeOf", "object": "loss", "obj_type": "Var", "file_name": "PubMed-28479159.json", "snippet": " KLK7 (1.8-fold) and PPIA (0.65-fold) proteins were differentially expressed in lesional biopsy specimens from patients with AE relative to normal skin.\nCONCLUSIONS: For the first time, we show that  [CLS] loss of FLG [CLS]  in the absence of inflammation is sufficient to alter the expression level of proteins relevant to the pathogenesis of AE. These include proteins regulating inflammatory, proteolytic, and cytoskeletal functions."}
{"subject": "TREM2", "sub_type": "Gene", "rel": "ThemeOf", "object": "variations", "obj_type": "Var", "file_name": "PubMed-28483841.json", "snippet": " [CLS] variations in the triggering receptor expressed on myeloid cells 2 (TREM2 [CLS] ) have been linked to an increased risk for neurodegenerative disorders such as Alzheimer's disease and frontotemporal lobar degeneration. In the brain, TREM2 is predominantly expressed in microglia. Several disease-associated"}
{"subject": "variants", "sub_type": "Var", "rel": "CauseOf", "object": "affecting", "obj_type": "Reg", "file_name": "PubMed-28483841.json", "snippet": " been linked to an increased risk for neurodegenerative disorders such as Alzheimer's disease and frontotemporal lobar degeneration. In the brain, TREM2 is predominantly expressed in microglia. Several disease-associated TREM2  [CLS] variants result in a loss of function by reducing microglial phagocytosis, impairing lipid sensing, preventing binding of lipoproteins and affecting [CLS]  shielding of amyloid plaques. We here investigate the consequences of TREM2 loss of function on the microglia transcriptome. Among the differentially expressed messenger RNAs in wild-type and Trem2(-/-) microglia,"}
{"subject": "lipid sensing", "sub_type": "MPA", "rel": "ThemeOf", "object": "impairing", "obj_type": "NegReg", "file_name": "PubMed-28483841.json", "snippet": " Alzheimer's disease and frontotemporal lobar degeneration. In the brain, TREM2 is predominantly expressed in microglia. Several disease-associated TREM2 variants result in a loss of function by reducing microglial phagocytosis,  [CLS] impairing lipid sensing [CLS] , preventing binding of lipoproteins and affecting shielding of amyloid plaques. We here investigate the consequences of TREM2 loss of function on the microglia transcriptome. Among the differentially expressed messenger"}
{"subject": "binding", "sub_type": "Interaction", "rel": "ThemeOf", "object": "preventing", "obj_type": "NegReg", "file_name": "PubMed-28483841.json", "snippet": " frontotemporal lobar degeneration. In the brain, TREM2 is predominantly expressed in microglia. Several disease-associated TREM2 variants result in a loss of function by reducing microglial phagocytosis, impairing lipid sensing,  [CLS] preventing binding [CLS]  of lipoproteins and affecting shielding of amyloid plaques. We here investigate the consequences of TREM2 loss of function on the microglia transcriptome. Among the differentially expressed messenger RNAs in"}
{"subject": "lipoproteins", "sub_type": "Protein", "rel": "ThemeOf", "object": "binding", "obj_type": "Interaction", "file_name": "PubMed-28483841.json", "snippet": " lobar degeneration. In the brain, TREM2 is predominantly expressed in microglia. Several disease-associated TREM2 variants result in a loss of function by reducing microglial phagocytosis, impairing lipid sensing, preventing  [CLS] binding of lipoproteins [CLS]  and affecting shielding of amyloid plaques. We here investigate the consequences of TREM2 loss of function on the microglia transcriptome. Among the differentially expressed messenger RNAs in wild-type and"}
{"subject": "shielding of amyloid plaques", "sub_type": "MPA", "rel": "ThemeOf", "object": "affecting", "obj_type": "Reg", "file_name": "PubMed-28483841.json", "snippet": " brain, TREM2 is predominantly expressed in microglia. Several disease-associated TREM2 variants result in a loss of function by reducing microglial phagocytosis, impairing lipid sensing, preventing binding of lipoproteins and  [CLS] affecting shielding of amyloid plaques [CLS] . We here investigate the consequences of TREM2 loss of function on the microglia transcriptome. Among the differentially expressed messenger RNAs in wild-type and Trem2(-/-) microglia, gene clusters are identified"}
{"subject": "loss", "sub_type": "Var", "rel": "CauseOf", "object": "impairs", "obj_type": "NegReg", "file_name": "PubMed-28483841.json", "snippet": " transcriptome. Among the differentially expressed messenger RNAs in wild-type and Trem2(-/-) microglia, gene clusters are identified which represent gene functions in chemotaxis, migration and mobility. Functional analyses confirm that  [CLS] loss of TREM2 impairs [CLS]  appropriate microglial responses to injury and signals that normally evoke chemotaxis on multiple levels. In an ex vivo organotypic brain slice assay, absence of TREM2 reduces the distance migrated"}
{"subject": "TREM2", "sub_type": "Gene", "rel": "ThemeOf", "object": "loss", "obj_type": "Var", "file_name": "PubMed-28483841.json", "snippet": " transcriptome. Among the differentially expressed messenger RNAs in wild-type and Trem2(-/-) microglia, gene clusters are identified which represent gene functions in chemotaxis, migration and mobility. Functional analyses confirm that  [CLS] loss of TREM2 [CLS]  impairs appropriate microglial responses to injury and signals that normally evoke chemotaxis on multiple levels. In an ex vivo organotypic brain slice assay, absence of TREM2 reduces the distance"}
{"subject": "microglial responses to injury and signals", "sub_type": "CPA", "rel": "ThemeOf", "object": "impairs", "obj_type": "NegReg", "file_name": "PubMed-28483841.json", "snippet": " differentially expressed messenger RNAs in wild-type and Trem2(-/-) microglia, gene clusters are identified which represent gene functions in chemotaxis, migration and mobility. Functional analyses confirm that loss of TREM2  [CLS] impairs appropriate microglial responses to injury and signals [CLS]  that normally evoke chemotaxis on multiple levels. In an ex vivo organotypic brain slice assay, absence of TREM2 reduces the distance migrated by microglia. Moreover, migration towards defined chemo-attractants"}
{"subject": "variations", "sub_type": "Var", "rel": "CauseOf", "object": "linked to", "obj_type": "Reg", "file_name": "PubMed-28483841.json", "snippet": " [CLS] variations in the triggering receptor expressed on myeloid cells 2 (TREM2) have been linked to [CLS]  an increased risk for neurodegenerative disorders such as Alzheimer's disease and frontotemporal lobar degeneration. In the brain, TREM2 is predominantly expressed in microglia. Several disease-associated TREM2 variants result in"}
{"subject": "Alzheimer's disease", "sub_type": "Disease", "rel": "ThemeOf", "object": "linked to", "obj_type": "Reg", "file_name": "PubMed-28483841.json", "snippet": " [CLS] linked to an increased risk for neurodegenerative disorders such as Alzheimer's disease [CLS]  and frontotemporal lobar degeneration. In the brain, TREM2 is predominantly expressed in microglia. Several disease-associated TREM2 variants result in a loss of function by reducing microglial phagocytosis, impairing lipid"}
{"subject": "frontotemporal lobar degeneration", "sub_type": "Disease", "rel": "ThemeOf", "object": "linked to", "obj_type": "Reg", "file_name": "PubMed-28483841.json", "snippet": " [CLS] linked to an increased risk for neurodegenerative disorders such as Alzheimer's disease and frontotemporal lobar degeneration [CLS] . In the brain, TREM2 is predominantly expressed in microglia. Several disease-associated TREM2 variants result in a loss of function by reducing microglial phagocytosis, impairing lipid sensing, preventing binding of"}
{"subject": "TREM2", "sub_type": "Gene", "rel": "ThemeOf", "object": "variants", "obj_type": "Var", "file_name": "PubMed-28483841.json", "snippet": " have been linked to an increased risk for neurodegenerative disorders such as Alzheimer's disease and frontotemporal lobar degeneration. In the brain, TREM2 is predominantly expressed in microglia. Several disease-associated  [CLS] TREM2 variants [CLS]  result in a loss of function by reducing microglial phagocytosis, impairing lipid sensing, preventing binding of lipoproteins and affecting shielding of amyloid plaques. We here investigate the consequences of"}
{"subject": "variants", "sub_type": "Var", "rel": "CauseOf", "object": "reducing", "obj_type": "NegReg", "file_name": "PubMed-28483841.json", "snippet": " been linked to an increased risk for neurodegenerative disorders such as Alzheimer's disease and frontotemporal lobar degeneration. In the brain, TREM2 is predominantly expressed in microglia. Several disease-associated TREM2  [CLS] variants result in a loss of function by reducing [CLS]  microglial phagocytosis, impairing lipid sensing, preventing binding of lipoproteins and affecting shielding of amyloid plaques. We here investigate the consequences of TREM2 loss of function on the microglia transcriptome."}
{"subject": "microglial phagocytosis", "sub_type": "CPA", "rel": "ThemeOf", "object": "reducing", "obj_type": "NegReg", "file_name": "PubMed-28483841.json", "snippet": " disorders such as Alzheimer's disease and frontotemporal lobar degeneration. In the brain, TREM2 is predominantly expressed in microglia. Several disease-associated TREM2 variants result in a loss of function by  [CLS] reducing microglial phagocytosis [CLS] , impairing lipid sensing, preventing binding of lipoproteins and affecting shielding of amyloid plaques. We here investigate the consequences of TREM2 loss of function on the microglia transcriptome. Among the"}
{"subject": "variants", "sub_type": "Var", "rel": "CauseOf", "object": "impairing", "obj_type": "NegReg", "file_name": "PubMed-28483841.json", "snippet": " been linked to an increased risk for neurodegenerative disorders such as Alzheimer's disease and frontotemporal lobar degeneration. In the brain, TREM2 is predominantly expressed in microglia. Several disease-associated TREM2  [CLS] variants result in a loss of function by reducing microglial phagocytosis, impairing [CLS]  lipid sensing, preventing binding of lipoproteins and affecting shielding of amyloid plaques. We here investigate the consequences of TREM2 loss of function on the microglia transcriptome. Among the differentially"}
{"subject": "variants", "sub_type": "Var", "rel": "CauseOf", "object": "preventing", "obj_type": "NegReg", "file_name": "PubMed-28483841.json", "snippet": " been linked to an increased risk for neurodegenerative disorders such as Alzheimer's disease and frontotemporal lobar degeneration. In the brain, TREM2 is predominantly expressed in microglia. Several disease-associated TREM2  [CLS] variants result in a loss of function by reducing microglial phagocytosis, impairing lipid sensing, preventing [CLS]  binding of lipoproteins and affecting shielding of amyloid plaques. We here investigate the consequences of TREM2 loss of function on the microglia transcriptome. Among the differentially expressed messenger RNAs"}
{"subject": "mutation", "sub_type": "Var", "rel": "CauseOf", "object": "loss of function", "obj_type": "NegReg", "file_name": "PubMed-28488085.json", "snippet": " [CLS] loss of function mutation [CLS]  in KRIT1/CCM1 is associated with distinctly progressive cerebral and spinal cavernous malformations after radiochemotherapy for intracranial malignant germ cell tumor.\nPURPOSE: Cerebrospinal cavernous malformations (CCMs) are vascular lesions characterized"}
{"subject": "KRIT1 protein", "sub_type": "Protein", "rel": "ThemeOf", "object": "loss of function", "obj_type": "NegReg", "file_name": "PubMed-28488085.json", "snippet": " heterozygous KRIT1/CCM1 two base pair deletion (c.1535_1536delTG) in exon 14. This deletion leads to a frameshift with a premature stop codon at nucleotide position 1553 and a highly likely  [CLS] loss of function of the KRIT1 protein [CLS] .\nCONCLUSION: We describe a patient with a novel heterozygous germ line loss of function mutation in KRIT1, which is associated with rapid-onset and highly progressive CCMs after radiochemotherapy for"}
{"subject": "mutation", "sub_type": "Var", "rel": "CauseOf", "object": "loss of function", "obj_type": "NegReg", "file_name": "PubMed-28488085.json", "snippet": " premature stop codon at nucleotide position 1553 and a highly likely loss of function of the KRIT1 protein.\nCONCLUSION: We describe a patient with a novel heterozygous germ line  [CLS] loss of function mutation [CLS]  in KRIT1, which is associated with rapid-onset and highly progressive CCMs after radiochemotherapy for a malignant brain tumor."}
{"subject": "KRIT1", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutation", "obj_type": "Var", "file_name": "PubMed-28488085.json", "snippet": " at nucleotide position 1553 and a highly likely loss of function of the KRIT1 protein.\nCONCLUSION: We describe a patient with a novel heterozygous germ line loss of function  [CLS] mutation in KRIT1 [CLS] , which is associated with rapid-onset and highly progressive CCMs after radiochemotherapy for a malignant brain tumor."}
{"subject": "mutation", "sub_type": "Var", "rel": "CauseOf", "object": "associated with", "obj_type": "Reg", "file_name": "PubMed-28488085.json", "snippet": " at nucleotide position 1553 and a highly likely loss of function of the KRIT1 protein.\nCONCLUSION: We describe a patient with a novel heterozygous germ line loss of function  [CLS] mutation in KRIT1, which is associated with [CLS]  rapid-onset and highly progressive CCMs after radiochemotherapy for a malignant brain tumor."}
{"subject": "CCMs", "sub_type": "Disease", "rel": "ThemeOf", "object": "associated with", "obj_type": "Reg", "file_name": "PubMed-28488085.json", "snippet": " a highly likely loss of function of the KRIT1 protein.\nCONCLUSION: We describe a patient with a novel heterozygous germ line loss of function mutation in KRIT1, which is  [CLS] associated with rapid-onset and highly progressive CCMs [CLS]  after radiochemotherapy for a malignant brain tumor."}
{"subject": "KRIT1", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutation", "obj_type": "Var", "file_name": "PubMed-28488085.json", "snippet": " [CLS] mutation in KRIT1 [CLS] /CCM1 is associated with distinctly progressive cerebral and spinal cavernous malformations after radiochemotherapy for intracranial malignant germ cell tumor.\nPURPOSE: Cerebrospinal cavernous malformations (CCMs) are vascular lesions characterized by dilated"}
{"subject": "mutation", "sub_type": "Var", "rel": "CauseOf", "object": "associated with", "obj_type": "Reg", "file_name": "PubMed-28488085.json", "snippet": " [CLS] mutation in KRIT1/CCM1 is associated with [CLS]  distinctly progressive cerebral and spinal cavernous malformations after radiochemotherapy for intracranial malignant germ cell tumor.\nPURPOSE: Cerebrospinal cavernous malformations (CCMs) are vascular lesions characterized by dilated and leaky capillary"}
{"subject": "cerebral and spinal cavernous malformations", "sub_type": "Disease", "rel": "ThemeOf", "object": "associated with", "obj_type": "Reg", "file_name": "PubMed-28488085.json", "snippet": " [CLS] associated with distinctly progressive cerebral and spinal cavernous malformations [CLS]  after radiochemotherapy for intracranial malignant germ cell tumor.\nPURPOSE: Cerebrospinal cavernous malformations (CCMs) are vascular lesions characterized by dilated and leaky capillary caverns. CCMs can cause seizures, focal neurological"}
{"subject": "c.1535_1536delTG", "sub_type": "Var", "rel": "CauseOf", "object": "leads to", "obj_type": "Reg", "file_name": "PubMed-28488085.json", "snippet": "\nRESULTS: MRI revealed numerous cerebral and spinal microhemorrhages and pronounced cavernous malformations that progressed with subsequent follow-up imaging. Genetic analysis demonstrated a novel heterozygous KRIT1/CCM1 two base pair deletion ( [CLS] c.1535_1536delTG) in exon 14. This deletion leads to [CLS]  a frameshift with a premature stop codon at nucleotide position 1553 and a highly likely loss of function of the KRIT1 protein.\nCONCLUSION: We describe a patient with a"}
{"subject": "frameshift", "sub_type": "Var", "rel": "ThemeOf", "object": "leads to", "obj_type": "Reg", "file_name": "PubMed-28488085.json", "snippet": " spinal microhemorrhages and pronounced cavernous malformations that progressed with subsequent follow-up imaging. Genetic analysis demonstrated a novel heterozygous KRIT1/CCM1 two base pair deletion (c.1535_1536delTG) in exon 14. This deletion  [CLS] leads to a frameshift [CLS]  with a premature stop codon at nucleotide position 1553 and a highly likely loss of function of the KRIT1 protein.\nCONCLUSION: We describe a patient with a novel heterozygous"}
{"subject": "premature stop codon", "sub_type": "MPA", "rel": "ThemeOf", "object": "leads to", "obj_type": "Reg", "file_name": "PubMed-28488085.json", "snippet": " spinal microhemorrhages and pronounced cavernous malformations that progressed with subsequent follow-up imaging. Genetic analysis demonstrated a novel heterozygous KRIT1/CCM1 two base pair deletion (c.1535_1536delTG) in exon 14. This deletion  [CLS] leads to a frameshift with a premature stop codon [CLS]  at nucleotide position 1553 and a highly likely loss of function of the KRIT1 protein.\nCONCLUSION: We describe a patient with a novel heterozygous germ line loss of function"}
{"subject": "KRIT1", "sub_type": "Gene", "rel": "ThemeOf", "object": "c.1535_1536delTG", "obj_type": "Var", "file_name": "PubMed-28488085.json", "snippet": " reaction (PCR) and direct sequencing.\nRESULTS: MRI revealed numerous cerebral and spinal microhemorrhages and pronounced cavernous malformations that progressed with subsequent follow-up imaging. Genetic analysis demonstrated a novel heterozygous  [CLS] KRIT1/CCM1 two base pair deletion (c.1535_1536delTG [CLS] ) in exon 14. This deletion leads to a frameshift with a premature stop codon at nucleotide position 1553 and a highly likely loss of function of the KRIT1 protein."}
{"subject": "c.1535_1536delTG", "sub_type": "Var", "rel": "CauseOf", "object": "loss of function", "obj_type": "NegReg", "file_name": "PubMed-28488085.json", "snippet": "\nRESULTS: MRI revealed numerous cerebral and spinal microhemorrhages and pronounced cavernous malformations that progressed with subsequent follow-up imaging. Genetic analysis demonstrated a novel heterozygous KRIT1/CCM1 two base pair deletion ( [CLS] c.1535_1536delTG) in exon 14. This deletion leads to a frameshift with a premature stop codon at nucleotide position 1553 and a highly likely loss of function [CLS]  of the KRIT1 protein.\nCONCLUSION: We describe a patient with a novel heterozygous germ line loss of function mutation in KRIT1, which is associated with rapid-onset and highly progressive"}
{"subject": "EGFR", "sub_type": "Gene", "rel": "ThemeOf", "object": "Mutation", "obj_type": "Var", "file_name": "PubMed-28507206.json", "snippet": " [CLS] EGFR Mutation [CLS] -Positive Advanced Non-Small Cell Lung Cancer Patients Treated with First-Line Gefitinib.\nBACKGROUND: This study aimed to identify independent prognostic factors for overall survival (OS) of patients with advanced non-small cell"}
{"subject": "Mutation", "sub_type": "Var", "rel": "CauseOf", "object": "Positive", "obj_type": "Reg", "file_name": "PubMed-28507206.json", "snippet": " [CLS] Mutation-Positive [CLS]  Advanced Non-Small Cell Lung Cancer Patients Treated with First-Line Gefitinib.\nBACKGROUND: This study aimed to identify independent prognostic factors for overall survival (OS) of patients with advanced non-small cell"}
{"subject": "Non-Small Cell Lung Cancer", "sub_type": "Disease", "rel": "ThemeOf", "object": "Positive", "obj_type": "Reg", "file_name": "PubMed-28507206.json", "snippet": " [CLS] Positive Advanced Non-Small Cell Lung Cancer [CLS]  Patients Treated with First-Line Gefitinib.\nBACKGROUND: This study aimed to identify independent prognostic factors for overall survival (OS) of patients with advanced non-small cell lung cancer (NSCLC) harboring an"}
{"subject": "Loss", "sub_type": "Var", "rel": "CauseOf", "object": "leads", "obj_type": "Reg", "file_name": "PubMed-28512217.json", "snippet": " [CLS] Loss of the homologous recombination gene rad51 leads [CLS]  to Fanconi anemia-like symptoms in zebrafish.\nRAD51 is an indispensable homologous recombination protein, necessary for strand invasion and crossing over. It has recently been designated as a Fanconi anemia"}
{"subject": "Fanconi anemia-like symptoms", "sub_type": "Disease", "rel": "ThemeOf", "object": "leads", "obj_type": "Reg", "file_name": "PubMed-28512217.json", "snippet": " [CLS] leads to Fanconi anemia-like symptoms [CLS]  in zebrafish.\nRAD51 is an indispensable homologous recombination protein, necessary for strand invasion and crossing over. It has recently been designated as a Fanconi anemia (FA) gene, following the"}
{"subject": "rad51", "sub_type": "Gene", "rel": "ThemeOf", "object": "Loss", "obj_type": "Var", "file_name": "PubMed-28512217.json", "snippet": " [CLS] Loss of the homologous recombination gene rad51 [CLS]  leads to Fanconi anemia-like symptoms in zebrafish.\nRAD51 is an indispensable homologous recombination protein, necessary for strand invasion and crossing over. It has recently been designated as a Fanconi"}
{"subject": "mutants", "sub_type": "Var", "rel": "CauseOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-28512217.json", "snippet": " hereditary DNA-repair disorder characterized by various congenital abnormalities, progressive bone marrow failure, and cancer predisposition. In this report, we describe a viable vertebrate model of RAD51 loss. Zebrafish rad51  [CLS] loss-of-function mutants [CLS]  developed key features of FA, including hypocellular kidney marrow, sensitivity to cross-linking agents, and decreased size. We show that some of these symptoms stem from both decreased proliferation and"}
{"subject": "FA", "sub_type": "Disease", "rel": "ThemeOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-28512217.json", "snippet": " hereditary DNA-repair disorder characterized by various congenital abnormalities, progressive bone marrow failure, and cancer predisposition. In this report, we describe a viable vertebrate model of RAD51 loss. Zebrafish rad51  [CLS] loss-of-function mutants developed key features of FA [CLS] , including hypocellular kidney marrow, sensitivity to cross-linking agents, and decreased size. We show that some of these symptoms stem from both decreased proliferation and increased apoptosis of embryonic hematopoietic"}
{"subject": "rad51", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutants", "obj_type": "Var", "file_name": "PubMed-28512217.json", "snippet": " a hereditary DNA-repair disorder characterized by various congenital abnormalities, progressive bone marrow failure, and cancer predisposition. In this report, we describe a viable vertebrate model of RAD51 loss. Zebrafish  [CLS] rad51 loss-of-function mutants [CLS]  developed key features of FA, including hypocellular kidney marrow, sensitivity to cross-linking agents, and decreased size. We show that some of these symptoms stem from both decreased proliferation and"}
{"subject": "CAG repeat expansion", "sub_type": "Var", "rel": "CauseOf", "object": "caused by", "obj_type": "Reg", "file_name": "PubMed-28525545.json", "snippet": " [CLS] caused by CAG repeat expansion [CLS]  in the ATXN2 gene. The repeat resides in an encoded region of the gene resulting in polyglutamine (polyQ) expansion which has been assumed to result in gain of function,"}
{"subject": "ATXN2", "sub_type": "Gene", "rel": "ThemeOf", "object": "CAG repeat expansion", "obj_type": "Var", "file_name": "PubMed-28525545.json", "snippet": " [CLS] CAG repeat expansion in the ATXN2 [CLS]  gene. The repeat resides in an encoded region of the gene resulting in polyglutamine (polyQ) expansion which has been assumed to result in gain of function, predominantly, for the"}
{"subject": "Spinocerebellar ataxia type 2", "sub_type": "Disease", "rel": "ThemeOf", "object": "caused by", "obj_type": "Reg", "file_name": "PubMed-28525545.json", "snippet": " [CLS] Spinocerebellar ataxia type 2 (SCA2) is an autosomal dominant neurodegenerative disease caused by [CLS]  CAG repeat expansion in the ATXN2 gene. The repeat resides in an encoded region of the gene resulting in polyglutamine (polyQ) expansion which has been assumed to result in"}
{"subject": "FLG", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-28525834.json", "snippet": " men from the general population.\nBACKGROUND: Filaggrin is an epidermal protein that is important for normal skin barrier functions. Up to 10% of Europeans and Asians carry filaggrin gene ( [CLS] FLG) loss-of function mutations [CLS]  that appear to facilitate trans-epidermal penetration of certain chemicals. We previously showed that mutation carriers have higher internal exposure to certain phthalates, compared to controls, and hypothesized that they"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "loss-of function", "obj_type": "NegReg", "file_name": "PubMed-28525834.json", "snippet": " from the general population.\nBACKGROUND: Filaggrin is an epidermal protein that is important for normal skin barrier functions. Up to 10% of Europeans and Asians carry filaggrin gene (FLG)  [CLS] loss-of function mutations [CLS]  that appear to facilitate trans-epidermal penetration of certain chemicals. We previously showed that mutation carriers have higher internal exposure to certain phthalates, compared to controls, and hypothesized that they"}
{"subject": "trans-epidermal penetration", "sub_type": "CPA", "rel": "ThemeOf", "object": "facilitate", "obj_type": "PosReg", "file_name": "PubMed-28525834.json", "snippet": " is an epidermal protein that is important for normal skin barrier functions. Up to 10% of Europeans and Asians carry filaggrin gene (FLG) loss-of function mutations that appear to  [CLS] facilitate trans-epidermal penetration [CLS]  of certain chemicals. We previously showed that mutation carriers have higher internal exposure to certain phthalates, compared to controls, and hypothesized that they could have increased trans-epidermal penetration of"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "facilitate", "obj_type": "PosReg", "file_name": "PubMed-28525834.json", "snippet": " general population.\nBACKGROUND: Filaggrin is an epidermal protein that is important for normal skin barrier functions. Up to 10% of Europeans and Asians carry filaggrin gene (FLG) loss-of function  [CLS] mutations that appear to facilitate [CLS]  trans-epidermal penetration of certain chemicals. We previously showed that mutation carriers have higher internal exposure to certain phthalates, compared to controls, and hypothesized that they could have increased trans-epidermal"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "gain of function", "obj_type": "PosReg", "file_name": "PubMed-28533163.json", "snippet": " [CLS] gain of function mutations [CLS]  in GRIN2B encoding the GluN2B subunit of the N-methyl-d-aspartate (NMDA) receptor have been linked with epileptic encephalopathies, including infantile spasms. We investigated the effects of radiprodil, a selective GluN2B"}
{"subject": "epileptic encephalopathies", "sub_type": "Disease", "rel": "ThemeOf", "object": "gain of function", "obj_type": "PosReg", "file_name": "PubMed-28533163.json", "snippet": " [CLS] gain of function mutations in GRIN2B encoding the GluN2B subunit of the N-methyl-d-aspartate (NMDA) receptor have been linked with epileptic encephalopathies [CLS] , including infantile spasms. We investigated the effects of radiprodil, a selective GluN2B negative allosteric modulator and other non-selective NMDA receptor inhibitors on glutamate currents mediated by NMDA receptors containing"}
{"subject": "infantile spasms", "sub_type": "Disease", "rel": "ThemeOf", "object": "gain of function", "obj_type": "PosReg", "file_name": "PubMed-28533163.json", "snippet": " [CLS] gain of function mutations in GRIN2B encoding the GluN2B subunit of the N-methyl-d-aspartate (NMDA) receptor have been linked with epileptic encephalopathies, including infantile spasms [CLS] . We investigated the effects of radiprodil, a selective GluN2B negative allosteric modulator and other non-selective NMDA receptor inhibitors on glutamate currents mediated by NMDA receptors containing mutated GluN2B subunits."}
{"subject": "GRIN2B", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-28533163.json", "snippet": " [CLS] mutations in GRIN2B [CLS]  encoding the GluN2B subunit of the N-methyl-d-aspartate (NMDA) receptor have been linked with epileptic encephalopathies, including infantile spasms. We investigated the effects of radiprodil, a selective GluN2B negative allosteric"}
{"subject": "variants", "sub_type": "Var", "rel": "CauseOf", "object": "promote", "obj_type": "PosReg", "file_name": "PubMed-28543872.json", "snippet": " [CLS] variants promote [CLS]  airway fibrosis and are associated with asthma and with worse lung function in subjects with asthma.\nOBJECTIVE: We sought to determine whether the association of a gain-of-function polymorphism in"}
{"subject": "airway fibrosis", "sub_type": "CPA", "rel": "ThemeOf", "object": "promote", "obj_type": "PosReg", "file_name": "PubMed-28543872.json", "snippet": " [CLS] promote airway fibrosis [CLS]  and are associated with asthma and with worse lung function in subjects with asthma.\nOBJECTIVE: We sought to determine whether the association of a gain-of-function polymorphism in plasminogen activator"}
{"subject": "PAI-1", "sub_type": "Gene", "rel": "ThemeOf", "object": "variants", "obj_type": "Var", "file_name": "PubMed-28543872.json", "snippet": " [CLS] PAI-1 gain-of-function variants [CLS]  promote airway fibrosis and are associated with asthma and with worse lung function in subjects with asthma.\nOBJECTIVE: We sought to determine whether the association of a gain-of-function polymorphism"}
{"subject": "variants", "sub_type": "Var", "rel": "CauseOf", "object": "associated with", "obj_type": "Reg", "file_name": "PubMed-28543872.json", "snippet": " [CLS] variants promote airway fibrosis and are associated with [CLS]  asthma and with worse lung function in subjects with asthma.\nOBJECTIVE: We sought to determine whether the association of a gain-of-function polymorphism in plasminogen activator inhibitor-1 (PAI-1) with airway"}
{"subject": "asthma", "sub_type": "Disease", "rel": "ThemeOf", "object": "associated with", "obj_type": "Reg", "file_name": "PubMed-28543872.json", "snippet": " [CLS] associated with asthma [CLS]  and with worse lung function in subjects with asthma.\nOBJECTIVE: We sought to determine whether the association of a gain-of-function polymorphism in plasminogen activator inhibitor-1 (PAI-1) with airway obstruction"}
{"subject": "E396V", "sub_type": "Var", "rel": "CauseOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-28548960.json", "snippet": " [CLS] loss-of-function lipoprotein lipase gene mutations (C310R/E396V [CLS] ) in a Chinese family associated with recurrent acute pancreatitis.\nLipoprotein lipase (LPL) is widely expressed in skeletal muscles, cardiac muscles as well as adipose tissue and involved in the"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "caused", "obj_type": "Reg", "file_name": "PubMed-28548960.json", "snippet": " The specific activity of the LPL mutants remained at comparable magnitude to the wild-type. However, few LPL were detected in the culture medium for the mutants, suggesting that both  [CLS] mutations caused [CLS]  aberrant triglyceride catabolism. More specifically, E396V and double mutations dampened the transport of LPL to the cell surface, while for the C310R mutation, reducing LPL protein level might be"}
{"subject": "triglyceride catabolism", "sub_type": "MPA", "rel": "ThemeOf", "object": "caused", "obj_type": "Reg", "file_name": "PubMed-28548960.json", "snippet": " specific activity of the LPL mutants remained at comparable magnitude to the wild-type. However, few LPL were detected in the culture medium for the mutants, suggesting that both mutations  [CLS] caused aberrant triglyceride catabolism [CLS] . More specifically, E396V and double mutations dampened the transport of LPL to the cell surface, while for the C310R mutation, reducing LPL protein level might be involved. By characterizing"}
{"subject": "E396V", "sub_type": "Var", "rel": "CauseOf", "object": "dampened", "obj_type": "NegReg", "file_name": "PubMed-28548960.json", "snippet": " remained at comparable magnitude to the wild-type. However, few LPL were detected in the culture medium for the mutants, suggesting that both mutations caused aberrant triglyceride catabolism. More specifically,  [CLS] E396V and double mutations dampened [CLS]  the transport of LPL to the cell surface, while for the C310R mutation, reducing LPL protein level might be involved. By characterizing these two novel LPL mutations, this study"}
{"subject": "double mutations", "sub_type": "Var", "rel": "CauseOf", "object": "dampened", "obj_type": "NegReg", "file_name": "PubMed-28548960.json", "snippet": " comparable magnitude to the wild-type. However, few LPL were detected in the culture medium for the mutants, suggesting that both mutations caused aberrant triglyceride catabolism. More specifically, E396V and  [CLS] double mutations dampened [CLS]  the transport of LPL to the cell surface, while for the C310R mutation, reducing LPL protein level might be involved. By characterizing these two novel LPL mutations, this study"}
{"subject": "transport of LPL to the cell surface", "sub_type": "MPA", "rel": "ThemeOf", "object": "dampened", "obj_type": "NegReg", "file_name": "PubMed-28548960.json", "snippet": " to the wild-type. However, few LPL were detected in the culture medium for the mutants, suggesting that both mutations caused aberrant triglyceride catabolism. More specifically, E396V and double mutations  [CLS] dampened the transport of LPL to the cell surface [CLS] , while for the C310R mutation, reducing LPL protein level might be involved. By characterizing these two novel LPL mutations, this study has expanded our understanding on the pathogenesis of"}
{"subject": "C310R", "sub_type": "Var", "rel": "CauseOf", "object": "reducing", "obj_type": "NegReg", "file_name": "PubMed-28548960.json", "snippet": " for the mutants, suggesting that both mutations caused aberrant triglyceride catabolism. More specifically, E396V and double mutations dampened the transport of LPL to the cell surface, while for the  [CLS] C310R mutation, reducing [CLS]  LPL protein level might be involved. By characterizing these two novel LPL mutations, this study has expanded our understanding on the pathogenesis of familial hypertriglyceridemia (FHTG)."}
{"subject": "LPL protein level", "sub_type": "MPA", "rel": "ThemeOf", "object": "reducing", "obj_type": "NegReg", "file_name": "PubMed-28548960.json", "snippet": " mutants, suggesting that both mutations caused aberrant triglyceride catabolism. More specifically, E396V and double mutations dampened the transport of LPL to the cell surface, while for the C310R mutation,  [CLS] reducing LPL protein level [CLS]  might be involved. By characterizing these two novel LPL mutations, this study has expanded our understanding on the pathogenesis of familial hypertriglyceridemia (FHTG)."}
{"subject": "C310R", "sub_type": "Var", "rel": "CauseOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-28548960.json", "snippet": " [CLS] loss-of-function lipoprotein lipase gene mutations (C310R [CLS] /E396V) in a Chinese family associated with recurrent acute pancreatitis.\nLipoprotein lipase (LPL) is widely expressed in skeletal muscles, cardiac muscles as well as adipose tissue and involved in the"}
{"subject": "E396V", "sub_type": "Var", "rel": "CauseOf", "object": "associated with", "obj_type": "Reg", "file_name": "PubMed-28548960.json", "snippet": " [CLS] E396V) in a Chinese family associated with [CLS]  recurrent acute pancreatitis.\nLipoprotein lipase (LPL) is widely expressed in skeletal muscles, cardiac muscles as well as adipose tissue and involved in the catabolism of triglyceride. Herein we have"}
{"subject": "C310R", "sub_type": "Var", "rel": "CauseOf", "object": "associated with", "obj_type": "Reg", "file_name": "PubMed-28548960.json", "snippet": " [CLS] C310R/E396V) in a Chinese family associated with [CLS]  recurrent acute pancreatitis.\nLipoprotein lipase (LPL) is widely expressed in skeletal muscles, cardiac muscles as well as adipose tissue and involved in the catabolism of triglyceride. Herein we have"}
{"subject": "lipoprotein lipase", "sub_type": "Enzyme", "rel": "ThemeOf", "object": "C310R", "obj_type": "Var", "file_name": "PubMed-28548960.json", "snippet": " [CLS] lipoprotein lipase gene mutations (C310R [CLS] /E396V) in a Chinese family associated with recurrent acute pancreatitis.\nLipoprotein lipase (LPL) is widely expressed in skeletal muscles, cardiac muscles as well as adipose tissue and involved in the"}
{"subject": "recurrent acute pancreatitis", "sub_type": "Disease", "rel": "ThemeOf", "object": "associated with", "obj_type": "Reg", "file_name": "PubMed-28548960.json", "snippet": " [CLS] associated with recurrent acute pancreatitis [CLS] .\nLipoprotein lipase (LPL) is widely expressed in skeletal muscles, cardiac muscles as well as adipose tissue and involved in the catabolism of triglyceride. Herein we have systematically characterized two"}
{"subject": "hypertriglyceridemia", "sub_type": "Disease", "rel": "ThemeOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-28548960.json", "snippet": " [CLS] hypertriglyceridemia due to two novel loss-of-function [CLS]  lipoprotein lipase gene mutations (C310R/E396V) in a Chinese family associated with recurrent acute pancreatitis.\nLipoprotein lipase (LPL) is widely expressed in skeletal muscles, cardiac muscles as well as adipose"}
{"subject": "C310R", "sub_type": "Var", "rel": "CauseOf", "object": "reduced", "obj_type": "NegReg", "file_name": "PubMed-28548960.json", "snippet": " mutation also carried a novel missense mutation c.A1187T (p.E396V) in exon 8 of the LPL gene. Furthermore, COS-1 cells were transfected with lentiviruses containing the mutant LPL genes. While  [CLS] C310R markedly reduced [CLS]  the overall LPL protein level, COS-1 cells carrying E396V or double mutations contained similar overall LPL protein levels to the wild-type. The specific activity of the LPL mutants remained"}
{"subject": "LPL protein level", "sub_type": "MPA", "rel": "ThemeOf", "object": "reduced", "obj_type": "NegReg", "file_name": "PubMed-28548960.json", "snippet": " carried a novel missense mutation c.A1187T (p.E396V) in exon 8 of the LPL gene. Furthermore, COS-1 cells were transfected with lentiviruses containing the mutant LPL genes. While C310R markedly  [CLS] reduced the overall LPL protein level [CLS] , COS-1 cells carrying E396V or double mutations contained similar overall LPL protein levels to the wild-type. The specific activity of the LPL mutants remained at comparable magnitude to the"}
{"subject": "WNT10A", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutation", "obj_type": "Var", "file_name": "PubMed-28589954.json", "snippet": " [CLS] WNT10A mutation [CLS]  causes ectodermal dysplasia by impairing progenitor cell proliferation and KLF4-mediated differentiation.\nHuman WNT10A mutations are associated with developmental tooth abnormalities and adolescent onset of a broad range of ectodermal"}
{"subject": "mutation", "sub_type": "Var", "rel": "CauseOf", "object": "impairing", "obj_type": "NegReg", "file_name": "PubMed-28589954.json", "snippet": " [CLS] mutation causes ectodermal dysplasia by impairing [CLS]  progenitor cell proliferation and KLF4-mediated differentiation.\nHuman WNT10A mutations are associated with developmental tooth abnormalities and adolescent onset of a broad range of ectodermal defects. Here we show that"}
{"subject": "progenitor cell proliferation", "sub_type": "CPA", "rel": "ThemeOf", "object": "impairing", "obj_type": "NegReg", "file_name": "PubMed-28589954.json", "snippet": " [CLS] impairing progenitor cell proliferation [CLS]  and KLF4-mediated differentiation.\nHuman WNT10A mutations are associated with developmental tooth abnormalities and adolescent onset of a broad range of ectodermal defects. Here we show that \u03b2-catenin pathway activity"}
{"subject": "KLF4-mediated differentiation", "sub_type": "CPA", "rel": "ThemeOf", "object": "impairing", "obj_type": "NegReg", "file_name": "PubMed-28589954.json", "snippet": " [CLS] impairing progenitor cell proliferation and KLF4-mediated differentiation [CLS] .\nHuman WNT10A mutations are associated with developmental tooth abnormalities and adolescent onset of a broad range of ectodermal defects. Here we show that \u03b2-catenin pathway activity and adult epithelial"}
{"subject": "impairing", "sub_type": "NegReg", "rel": "CauseOf", "object": "causes", "obj_type": "Reg", "file_name": "PubMed-28589954.json", "snippet": " [CLS] causes ectodermal dysplasia by impairing [CLS]  progenitor cell proliferation and KLF4-mediated differentiation.\nHuman WNT10A mutations are associated with developmental tooth abnormalities and adolescent onset of a broad range of ectodermal defects. Here we show that"}
{"subject": "ectodermal dysplasia", "sub_type": "Disease", "rel": "ThemeOf", "object": "causes", "obj_type": "Reg", "file_name": "PubMed-28589954.json", "snippet": " [CLS] causes ectodermal dysplasia [CLS]  by impairing progenitor cell proliferation and KLF4-mediated differentiation.\nHuman WNT10A mutations are associated with developmental tooth abnormalities and adolescent onset of a broad range of ectodermal defects. Here we"}
{"subject": "ROBO1", "sub_type": "Gene", "rel": "ThemeOf", "object": "Loss of function", "obj_type": "Var", "file_name": "PubMed-28592524.json", "snippet": " [CLS] Loss of function in ROBO1 [CLS]  is associated with tetralogy of Fallot and septal defects.\nBACKGROUND: Congenital heart disease (CHD) is a common birth defect affecting approximately 1% of newborns. Great progress has been made"}
{"subject": "Loss of function", "sub_type": "Var", "rel": "CauseOf", "object": "associated", "obj_type": "Reg", "file_name": "PubMed-28592524.json", "snippet": " [CLS] Loss of function in ROBO1 is associated [CLS]  with tetralogy of Fallot and septal defects.\nBACKGROUND: Congenital heart disease (CHD) is a common birth defect affecting approximately 1% of newborns. Great progress has been made in elucidating"}
{"subject": "tetralogy of Fallot", "sub_type": "Disease", "rel": "ThemeOf", "object": "associated", "obj_type": "Reg", "file_name": "PubMed-28592524.json", "snippet": " [CLS] associated with tetralogy of Fallot [CLS]  and septal defects.\nBACKGROUND: Congenital heart disease (CHD) is a common birth defect affecting approximately 1% of newborns. Great progress has been made in elucidating the genetic aetiology of"}
{"subject": "septal defects", "sub_type": "Disease", "rel": "ThemeOf", "object": "associated", "obj_type": "Reg", "file_name": "PubMed-28592524.json", "snippet": " [CLS] associated with tetralogy of Fallot and septal defects [CLS] .\nBACKGROUND: Congenital heart disease (CHD) is a common birth defect affecting approximately 1% of newborns. Great progress has been made in elucidating the genetic aetiology of CHD with advances"}
{"subject": "NFKBIA", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-28597146.json", "snippet": " [CLS] mutations of NFKBIA [CLS] , encoding I\u03baB\u03b1, cause an autosomal dominant (AD) form of anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID). Fourteen unrelated patients have been reported since the identification of the first case in"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-28597146.json", "snippet": " [CLS] gain-of-function (GOF) mutations [CLS]  of NFKBIA, encoding I\u03baB\u03b1, cause an autosomal dominant (AD) form of anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID). Fourteen unrelated patients have been reported since the identification of the first"}
{"subject": "anhidrotic ectodermal dysplasia with immunodeficiency", "sub_type": "Disease", "rel": "ThemeOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-28597146.json", "snippet": " [CLS] gain-of-function (GOF) mutations of NFKBIA, encoding I\u03baB\u03b1, cause an autosomal dominant (AD) form of anhidrotic ectodermal dysplasia with immunodeficiency [CLS]  (EDA-ID). Fourteen unrelated patients have been reported since the identification of the first case in 2003. All mutations enhanced the inhibitory activity of I\u03baB\u03b1, by preventing its phosphorylation on"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "preventing", "obj_type": "NegReg", "file_name": "PubMed-28597146.json", "snippet": " cause an autosomal dominant (AD) form of anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID). Fourteen unrelated patients have been reported since the identification of the first case in 2003. All  [CLS] mutations enhanced the inhibitory activity of I\u03baB\u03b1, by preventing [CLS]  its phosphorylation on serine 32 or 36 and its subsequent degradation. The mutation certainly or probably occurred de novo in 13 patients, whereas it was inherited from a parent"}
{"subject": "preventing", "sub_type": "NegReg", "rel": "CauseOf", "object": "enhanced", "obj_type": "PosReg", "file_name": "PubMed-28597146.json", "snippet": " an autosomal dominant (AD) form of anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID). Fourteen unrelated patients have been reported since the identification of the first case in 2003. All mutations  [CLS] enhanced the inhibitory activity of I\u03baB\u03b1, by preventing [CLS]  its phosphorylation on serine 32 or 36 and its subsequent degradation. The mutation certainly or probably occurred de novo in 13 patients, whereas it was inherited from a parent"}
{"subject": "I\u03baB\u03b1", "sub_type": "Protein", "rel": "ThemeOf", "object": "inhibitory activity", "obj_type": "MPA", "file_name": "PubMed-28597146.json", "snippet": " dominant (AD) form of anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID). Fourteen unrelated patients have been reported since the identification of the first case in 2003. All mutations enhanced the  [CLS] inhibitory activity of I\u03baB\u03b1 [CLS] , by preventing its phosphorylation on serine 32 or 36 and its subsequent degradation. The mutation certainly or probably occurred de novo in 13 patients, whereas it was inherited from"}
{"subject": "inhibitory activity", "sub_type": "MPA", "rel": "ThemeOf", "object": "enhanced", "obj_type": "PosReg", "file_name": "PubMed-28597146.json", "snippet": " an autosomal dominant (AD) form of anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID). Fourteen unrelated patients have been reported since the identification of the first case in 2003. All mutations  [CLS] enhanced the inhibitory activity [CLS]  of I\u03baB\u03b1, by preventing its phosphorylation on serine 32 or 36 and its subsequent degradation. The mutation certainly or probably occurred de novo in 13 patients, whereas it was"}
{"subject": "degradation", "sub_type": "MPA", "rel": "ThemeOf", "object": "preventing", "obj_type": "NegReg", "file_name": "PubMed-28597146.json", "snippet": " ectodermal dysplasia with immunodeficiency (EDA-ID). Fourteen unrelated patients have been reported since the identification of the first case in 2003. All mutations enhanced the inhibitory activity of I\u03baB\u03b1, by  [CLS] preventing its phosphorylation on serine 32 or 36 and its subsequent degradation [CLS] . The mutation certainly or probably occurred de novo in 13 patients, whereas it was inherited from a parent with somatic mosaicism in one patient. Eleven mutations, belonging to two"}
{"subject": "phosphorylation on serine 32 or 36", "sub_type": "MPA", "rel": "ThemeOf", "object": "preventing", "obj_type": "NegReg", "file_name": "PubMed-28597146.json", "snippet": " ectodermal dysplasia with immunodeficiency (EDA-ID). Fourteen unrelated patients have been reported since the identification of the first case in 2003. All mutations enhanced the inhibitory activity of I\u03baB\u03b1, by  [CLS] preventing its phosphorylation on serine 32 or 36 [CLS]  and its subsequent degradation. The mutation certainly or probably occurred de novo in 13 patients, whereas it was inherited from a parent with somatic mosaicism in one patient. Eleven"}
{"subject": "ARX", "sub_type": "Gene", "rel": "ThemeOf", "object": "polyalanine expansion mutations", "obj_type": "Var", "file_name": "PubMed-28627419.json", "snippet": " including Arx protein reduction and overlapping transcriptome profiles within the developing mouse brains. Data from our study demonstrated that cortical calbindin interneuron development and migration is negatively affected by  [CLS] ARX polyalanine expansion mutations [CLS] . Understanding the cellular pathogenesis contributing to disease manifestation is necessary to screen efficacy of potential therapeutic interventions."}
{"subject": "developmental deficit of calbindin-positive cortical GABAergic interneurons", "sub_type": "CPA", "rel": "ThemeOf", "object": "lead to", "obj_type": "Reg", "file_name": "PubMed-28627419.json", "snippet": " [CLS] lead to migration impediment in the rostral cortex coupled with a developmental deficit of calbindin-positive cortical GABAergic interneurons [CLS] .\nThe Aristaless-related homeobox gene (ARX) is indispensable for interneuron development. Patients with ARX polyalanine expansion mutations of the first two tracts (namely PA1 and PA2) suffer from intellectual disability"}
{"subject": "polyalanine expansion mutations", "sub_type": "Var", "rel": "CauseOf", "object": "negatively", "obj_type": "NegReg", "file_name": "PubMed-28627419.json", "snippet": " as previously reported including Arx protein reduction and overlapping transcriptome profiles within the developing mouse brains. Data from our study demonstrated that cortical calbindin interneuron development and migration is  [CLS] negatively affected by ARX polyalanine expansion mutations [CLS] . Understanding the cellular pathogenesis contributing to disease manifestation is necessary to screen efficacy of potential therapeutic interventions."}
{"subject": "cortical calbindin interneuron", "sub_type": "CPA", "rel": "ThemeOf", "object": "development", "obj_type": "CPA", "file_name": "PubMed-28627419.json", "snippet": " robustly shared between PA1 and PA2 mutations, as previously reported including Arx protein reduction and overlapping transcriptome profiles within the developing mouse brains. Data from our study demonstrated that  [CLS] cortical calbindin interneuron development [CLS]  and migration is negatively affected by ARX polyalanine expansion mutations. Understanding the cellular pathogenesis contributing to disease manifestation is necessary to screen efficacy of potential therapeutic interventions."}
{"subject": "cortical calbindin interneuron", "sub_type": "CPA", "rel": "ThemeOf", "object": "migration", "obj_type": "CPA", "file_name": "PubMed-28627419.json", "snippet": " robustly shared between PA1 and PA2 mutations, as previously reported including Arx protein reduction and overlapping transcriptome profiles within the developing mouse brains. Data from our study demonstrated that  [CLS] cortical calbindin interneuron development and migration [CLS]  is negatively affected by ARX polyalanine expansion mutations. Understanding the cellular pathogenesis contributing to disease manifestation is necessary to screen efficacy of potential therapeutic interventions."}
{"subject": "migration", "sub_type": "CPA", "rel": "ThemeOf", "object": "negatively", "obj_type": "NegReg", "file_name": "PubMed-28627419.json", "snippet": " PA2 mutations, as previously reported including Arx protein reduction and overlapping transcriptome profiles within the developing mouse brains. Data from our study demonstrated that cortical calbindin interneuron development and  [CLS] migration is negatively [CLS]  affected by ARX polyalanine expansion mutations. Understanding the cellular pathogenesis contributing to disease manifestation is necessary to screen efficacy of potential therapeutic interventions."}
{"subject": "development", "sub_type": "CPA", "rel": "ThemeOf", "object": "negatively", "obj_type": "NegReg", "file_name": "PubMed-28627419.json", "snippet": " PA1 and PA2 mutations, as previously reported including Arx protein reduction and overlapping transcriptome profiles within the developing mouse brains. Data from our study demonstrated that cortical calbindin interneuron  [CLS] development and migration is negatively [CLS]  affected by ARX polyalanine expansion mutations. Understanding the cellular pathogenesis contributing to disease manifestation is necessary to screen efficacy of potential therapeutic interventions."}
{"subject": "ARX", "sub_type": "Gene", "rel": "ThemeOf", "object": "polyalanine expansion mutations", "obj_type": "Var", "file_name": "PubMed-28627419.json", "snippet": " [CLS] ARX polyalanine expansion mutations [CLS]  lead to migration impediment in the rostral cortex coupled with a developmental deficit of calbindin-positive cortical GABAergic interneurons.\nThe Aristaless-related homeobox gene (ARX) is indispensable for interneuron development. Patients"}
{"subject": "polyalanine expansion mutations", "sub_type": "Var", "rel": "CauseOf", "object": "lead to", "obj_type": "Reg", "file_name": "PubMed-28627419.json", "snippet": " [CLS] polyalanine expansion mutations lead to [CLS]  migration impediment in the rostral cortex coupled with a developmental deficit of calbindin-positive cortical GABAergic interneurons.\nThe Aristaless-related homeobox gene (ARX) is indispensable for interneuron development. Patients with ARX"}
{"subject": "migration impediment in the rostral cortex coupled", "sub_type": "CPA", "rel": "ThemeOf", "object": "lead to", "obj_type": "Reg", "file_name": "PubMed-28627419.json", "snippet": " [CLS] lead to migration impediment in the rostral cortex coupled [CLS]  with a developmental deficit of calbindin-positive cortical GABAergic interneurons.\nThe Aristaless-related homeobox gene (ARX) is indispensable for interneuron development. Patients with ARX polyalanine expansion mutations of the first two"}
{"subject": "FGFR2", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-28650109.json", "snippet": " [CLS] mutations in fibroblast growth factor receptor 2 (FGFR2 [CLS] ). Previous studies have shown that gain-of-function mutations of FGFR2 (S252W or P253R) cause skull malformation of human Apert syndrome by affecting both chondrogenesis and osteogenesis, underscoring the key role"}
{"subject": "bone marrow stromal cell", "sub_type": "CPA", "rel": "ThemeOf", "object": "proliferation", "obj_type": "CPA", "file_name": "PubMed-28650109.json", "snippet": " assessed by micro-computed tomography and bone histomorphometry. We found that MT mice exhibited increased trabecular bone formation and decreased bone resorption after BMX accompanied with a remarkable increase in  [CLS] bone marrow stromal cell recruitment and proliferation [CLS] , osteoblast proliferation and differentiation, and enhanced Wnt/?-catenin activity. Furthermore, pharmacologically inhibiting Wnt/\u03b2-catenin signaling can partially reverse the increased trabecular bone formation and decreased bone resorption in MT mice after"}
{"subject": "osteoblast", "sub_type": "CPA", "rel": "ThemeOf", "object": "proliferation", "obj_type": "CPA", "file_name": "PubMed-28650109.json", "snippet": " We found that MT mice exhibited increased trabecular bone formation and decreased bone resorption after BMX accompanied with a remarkable increase in bone marrow stromal cell recruitment and proliferation,  [CLS] osteoblast proliferation [CLS]  and differentiation, and enhanced Wnt/?-catenin activity. Furthermore, pharmacologically inhibiting Wnt/\u03b2-catenin signaling can partially reverse the increased trabecular bone formation and decreased bone resorption in MT mice after BMX. Our"}
{"subject": "osteoblast", "sub_type": "CPA", "rel": "ThemeOf", "object": "differentiation", "obj_type": "CPA", "file_name": "PubMed-28650109.json", "snippet": " We found that MT mice exhibited increased trabecular bone formation and decreased bone resorption after BMX accompanied with a remarkable increase in bone marrow stromal cell recruitment and proliferation,  [CLS] osteoblast proliferation and differentiation [CLS] , and enhanced Wnt/?-catenin activity. Furthermore, pharmacologically inhibiting Wnt/\u03b2-catenin signaling can partially reverse the increased trabecular bone formation and decreased bone resorption in MT mice after BMX. Our data demonstrate"}
{"subject": "mutant", "sub_type": "Var", "rel": "CauseOf", "object": "increase", "obj_type": "PosReg", "file_name": "PubMed-28650109.json", "snippet": " in bone formation, we generated mice with tamoxifen-inducible expression of mutant FGFR2 (P253R) at the adult stage. Mechanical bone marrow ablation (BMX) was performed in both wild-type and Fgfr2  [CLS] mutant (MT) mice. Changes in newly formed trabecular bone were assessed by micro-computed tomography and bone histomorphometry. We found that MT mice exhibited increased trabecular bone formation and decreased bone resorption after BMX accompanied with a remarkable increase [CLS]  in bone marrow stromal cell recruitment and proliferation, osteoblast proliferation and differentiation, and enhanced Wnt/?-catenin activity. Furthermore, pharmacologically inhibiting Wnt/\u03b2-catenin signaling can partially reverse the increased trabecular bone formation"}
{"subject": "mutant", "sub_type": "Var", "rel": "CauseOf", "object": "enhanced", "obj_type": "PosReg", "file_name": "PubMed-28650109.json", "snippet": " in bone formation, we generated mice with tamoxifen-inducible expression of mutant FGFR2 (P253R) at the adult stage. Mechanical bone marrow ablation (BMX) was performed in both wild-type and Fgfr2  [CLS] mutant (MT) mice. Changes in newly formed trabecular bone were assessed by micro-computed tomography and bone histomorphometry. We found that MT mice exhibited increased trabecular bone formation and decreased bone resorption after BMX accompanied with a remarkable increase in bone marrow stromal cell recruitment and proliferation, osteoblast proliferation and differentiation, and enhanced [CLS]  Wnt/?-catenin activity. Furthermore, pharmacologically inhibiting Wnt/\u03b2-catenin signaling can partially reverse the increased trabecular bone formation and decreased bone resorption in MT mice after BMX. Our data demonstrate that gain-of-function"}
{"subject": "Wnt/?-catenin activity", "sub_type": "CPA", "rel": "ThemeOf", "object": "enhanced", "obj_type": "PosReg", "file_name": "PubMed-28650109.json", "snippet": " exhibited increased trabecular bone formation and decreased bone resorption after BMX accompanied with a remarkable increase in bone marrow stromal cell recruitment and proliferation, osteoblast proliferation and differentiation, and  [CLS] enhanced Wnt/?-catenin activity [CLS] . Furthermore, pharmacologically inhibiting Wnt/\u03b2-catenin signaling can partially reverse the increased trabecular bone formation and decreased bone resorption in MT mice after BMX. Our data demonstrate that gain-of-function mutation in"}
{"subject": "recruitment", "sub_type": "CPA", "rel": "ThemeOf", "object": "increase", "obj_type": "PosReg", "file_name": "PubMed-28650109.json", "snippet": " bone were assessed by micro-computed tomography and bone histomorphometry. We found that MT mice exhibited increased trabecular bone formation and decreased bone resorption after BMX accompanied with a remarkable  [CLS] increase in bone marrow stromal cell recruitment [CLS]  and proliferation, osteoblast proliferation and differentiation, and enhanced Wnt/?-catenin activity. Furthermore, pharmacologically inhibiting Wnt/\u03b2-catenin signaling can partially reverse the increased trabecular bone formation and decreased bone resorption in MT"}
{"subject": "proliferation", "sub_type": "CPA", "rel": "ThemeOf", "object": "increase", "obj_type": "PosReg", "file_name": "PubMed-28650109.json", "snippet": " bone were assessed by micro-computed tomography and bone histomorphometry. We found that MT mice exhibited increased trabecular bone formation and decreased bone resorption after BMX accompanied with a remarkable  [CLS] increase in bone marrow stromal cell recruitment and proliferation [CLS] , osteoblast proliferation and differentiation, and enhanced Wnt/?-catenin activity. Furthermore, pharmacologically inhibiting Wnt/\u03b2-catenin signaling can partially reverse the increased trabecular bone formation and decreased bone resorption in MT mice after"}
{"subject": "proliferation", "sub_type": "CPA", "rel": "ThemeOf", "object": "increase", "obj_type": "PosReg", "file_name": "PubMed-28650109.json", "snippet": " bone were assessed by micro-computed tomography and bone histomorphometry. We found that MT mice exhibited increased trabecular bone formation and decreased bone resorption after BMX accompanied with a remarkable  [CLS] increase in bone marrow stromal cell recruitment and proliferation, osteoblast proliferation [CLS]  and differentiation, and enhanced Wnt/?-catenin activity. Furthermore, pharmacologically inhibiting Wnt/\u03b2-catenin signaling can partially reverse the increased trabecular bone formation and decreased bone resorption in MT mice after BMX. Our"}
{"subject": "differentiation", "sub_type": "CPA", "rel": "ThemeOf", "object": "increase", "obj_type": "PosReg", "file_name": "PubMed-28650109.json", "snippet": " bone were assessed by micro-computed tomography and bone histomorphometry. We found that MT mice exhibited increased trabecular bone formation and decreased bone resorption after BMX accompanied with a remarkable  [CLS] increase in bone marrow stromal cell recruitment and proliferation, osteoblast proliferation and differentiation [CLS] , and enhanced Wnt/?-catenin activity. Furthermore, pharmacologically inhibiting Wnt/\u03b2-catenin signaling can partially reverse the increased trabecular bone formation and decreased bone resorption in MT mice after BMX. Our data demonstrate"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-28650109.json", "snippet": " [CLS] gain-of-function mutations [CLS]  in fibroblast growth factor receptor 2 (FGFR2). Previous studies have shown that gain-of-function mutations of FGFR2 (S252W or P253R) cause skull malformation of human Apert syndrome by affecting both"}
{"subject": "FGFR2", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutation", "obj_type": "Var", "file_name": "PubMed-28650109.json", "snippet": " Wnt/?-catenin activity. Furthermore, pharmacologically inhibiting Wnt/\u03b2-catenin signaling can partially reverse the increased trabecular bone formation and decreased bone resorption in MT mice after BMX. Our data demonstrate that gain-of-function  [CLS] mutation in FGFR2 [CLS]  exerts a Wnt/\u03b2-catenin-dependent anabolic effect on trabecular bone by promoting bone formation and inhibiting bone resorption at the adult stage. This article is protected by copyright. All rights reserved."}
{"subject": "mutation", "sub_type": "Var", "rel": "CauseOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-28650109.json", "snippet": " enhanced Wnt/?-catenin activity. Furthermore, pharmacologically inhibiting Wnt/\u03b2-catenin signaling can partially reverse the increased trabecular bone formation and decreased bone resorption in MT mice after BMX. Our data demonstrate that  [CLS] gain-of-function mutation [CLS]  in FGFR2 exerts a Wnt/\u03b2-catenin-dependent anabolic effect on trabecular bone by promoting bone formation and inhibiting bone resorption at the adult stage. This article is protected by copyright. All"}
{"subject": "gain-of-function", "sub_type": "PosReg", "rel": "CauseOf", "object": "promoting", "obj_type": "PosReg", "file_name": "PubMed-28650109.json", "snippet": " enhanced Wnt/?-catenin activity. Furthermore, pharmacologically inhibiting Wnt/\u03b2-catenin signaling can partially reverse the increased trabecular bone formation and decreased bone resorption in MT mice after BMX. Our data demonstrate that  [CLS] gain-of-function mutation in FGFR2 exerts a Wnt/\u03b2-catenin-dependent anabolic effect on trabecular bone by promoting [CLS]  bone formation and inhibiting bone resorption at the adult stage. This article is protected by copyright. All rights reserved."}
{"subject": "bone formation", "sub_type": "CPA", "rel": "ThemeOf", "object": "promoting", "obj_type": "PosReg", "file_name": "PubMed-28650109.json", "snippet": " trabecular bone formation and decreased bone resorption in MT mice after BMX. Our data demonstrate that gain-of-function mutation in FGFR2 exerts a Wnt/\u03b2-catenin-dependent anabolic effect on trabecular bone by  [CLS] promoting bone formation [CLS]  and inhibiting bone resorption at the adult stage. This article is protected by copyright. All rights reserved."}
{"subject": "gain-of-function", "sub_type": "PosReg", "rel": "CauseOf", "object": "inhibiting", "obj_type": "NegReg", "file_name": "PubMed-28650109.json", "snippet": " enhanced Wnt/?-catenin activity. Furthermore, pharmacologically inhibiting Wnt/\u03b2-catenin signaling can partially reverse the increased trabecular bone formation and decreased bone resorption in MT mice after BMX. Our data demonstrate that  [CLS] gain-of-function mutation in FGFR2 exerts a Wnt/\u03b2-catenin-dependent anabolic effect on trabecular bone by promoting bone formation and inhibiting [CLS]  bone resorption at the adult stage. This article is protected by copyright. All rights reserved."}
{"subject": "bone resorption at the adult stage", "sub_type": "CPA", "rel": "ThemeOf", "object": "inhibiting", "obj_type": "NegReg", "file_name": "PubMed-28650109.json", "snippet": " decreased bone resorption in MT mice after BMX. Our data demonstrate that gain-of-function mutation in FGFR2 exerts a Wnt/\u03b2-catenin-dependent anabolic effect on trabecular bone by promoting bone formation and  [CLS] inhibiting bone resorption at the adult stage [CLS] . This article is protected by copyright. All rights reserved."}
{"subject": "exerts a Wnt/\u03b2-catenin-dependent anabolic effect", "sub_type": "MPA", "rel": "ThemeOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-28650109.json", "snippet": " enhanced Wnt/?-catenin activity. Furthermore, pharmacologically inhibiting Wnt/\u03b2-catenin signaling can partially reverse the increased trabecular bone formation and decreased bone resorption in MT mice after BMX. Our data demonstrate that  [CLS] gain-of-function mutation in FGFR2 exerts a Wnt/\u03b2-catenin-dependent anabolic effect [CLS]  on trabecular bone by promoting bone formation and inhibiting bone resorption at the adult stage. This article is protected by copyright. All rights reserved."}
{"subject": "Apert syndrome", "sub_type": "Disease", "rel": "ThemeOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-28650109.json", "snippet": " [CLS] Apert syndrome is one of the most severe craniosynostoses, resulting from gain-of-function [CLS]  mutations in fibroblast growth factor receptor 2 (FGFR2). Previous studies have shown that gain-of-function mutations of FGFR2 (S252W or P253R) cause skull malformation of human Apert syndrome by affecting"}
{"subject": "Fgfr2", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutant", "obj_type": "Var", "file_name": "PubMed-28650109.json", "snippet": " FGFR2 in bone formation, we generated mice with tamoxifen-inducible expression of mutant FGFR2 (P253R) at the adult stage. Mechanical bone marrow ablation (BMX) was performed in both wild-type and  [CLS] Fgfr2 mutant [CLS]  (MT) mice. Changes in newly formed trabecular bone were assessed by micro-computed tomography and bone histomorphometry. We found that MT mice exhibited increased trabecular bone formation and decreased bone"}
{"subject": "mutant", "sub_type": "Var", "rel": "CauseOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-28650109.json", "snippet": " in bone formation, we generated mice with tamoxifen-inducible expression of mutant FGFR2 (P253R) at the adult stage. Mechanical bone marrow ablation (BMX) was performed in both wild-type and Fgfr2  [CLS] mutant (MT) mice. Changes in newly formed trabecular bone were assessed by micro-computed tomography and bone histomorphometry. We found that MT mice exhibited increased [CLS]  trabecular bone formation and decreased bone resorption after BMX accompanied with a remarkable increase in bone marrow stromal cell recruitment and proliferation, osteoblast proliferation and differentiation, and enhanced Wnt/?-catenin"}
{"subject": "mutant", "sub_type": "Var", "rel": "CauseOf", "object": "decreased", "obj_type": "NegReg", "file_name": "PubMed-28650109.json", "snippet": " in bone formation, we generated mice with tamoxifen-inducible expression of mutant FGFR2 (P253R) at the adult stage. Mechanical bone marrow ablation (BMX) was performed in both wild-type and Fgfr2  [CLS] mutant (MT) mice. Changes in newly formed trabecular bone were assessed by micro-computed tomography and bone histomorphometry. We found that MT mice exhibited increased trabecular bone formation and decreased [CLS]  bone resorption after BMX accompanied with a remarkable increase in bone marrow stromal cell recruitment and proliferation, osteoblast proliferation and differentiation, and enhanced Wnt/?-catenin activity. Furthermore, pharmacologically inhibiting Wnt/\u03b2-catenin"}
{"subject": "trabecular bone formation", "sub_type": "CPA", "rel": "ThemeOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-28650109.json", "snippet": " performed in both wild-type and Fgfr2 mutant (MT) mice. Changes in newly formed trabecular bone were assessed by micro-computed tomography and bone histomorphometry. We found that MT mice exhibited  [CLS] increased trabecular bone formation [CLS]  and decreased bone resorption after BMX accompanied with a remarkable increase in bone marrow stromal cell recruitment and proliferation, osteoblast proliferation and differentiation, and enhanced Wnt/?-catenin activity. Furthermore, pharmacologically"}
{"subject": "bone resorption", "sub_type": "CPA", "rel": "ThemeOf", "object": "decreased", "obj_type": "NegReg", "file_name": "PubMed-28650109.json", "snippet": " Fgfr2 mutant (MT) mice. Changes in newly formed trabecular bone were assessed by micro-computed tomography and bone histomorphometry. We found that MT mice exhibited increased trabecular bone formation and  [CLS] decreased bone resorption [CLS]  after BMX accompanied with a remarkable increase in bone marrow stromal cell recruitment and proliferation, osteoblast proliferation and differentiation, and enhanced Wnt/?-catenin activity. Furthermore, pharmacologically inhibiting Wnt/\u03b2-catenin signaling can"}
{"subject": "bone marrow stromal cell", "sub_type": "CPA", "rel": "ThemeOf", "object": "recruitment", "obj_type": "CPA", "file_name": "PubMed-28650109.json", "snippet": " assessed by micro-computed tomography and bone histomorphometry. We found that MT mice exhibited increased trabecular bone formation and decreased bone resorption after BMX accompanied with a remarkable increase in  [CLS] bone marrow stromal cell recruitment [CLS]  and proliferation, osteoblast proliferation and differentiation, and enhanced Wnt/?-catenin activity. Furthermore, pharmacologically inhibiting Wnt/\u03b2-catenin signaling can partially reverse the increased trabecular bone formation and decreased bone resorption in MT"}
{"subject": "TNFAIP3", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutation", "obj_type": "Var", "file_name": "PubMed-28659290.json", "snippet": " [CLS] mutation in TNFAIP3 [CLS]  (A20).\n"}
{"subject": "mutation", "sub_type": "Var", "rel": "CauseOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-28659290.json", "snippet": " [CLS] loss-of-function mutation [CLS]  in TNFAIP3 (A20).\n"}
{"subject": "Early-onset autoimmune disease", "sub_type": "Disease", "rel": "CauseOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-28659290.json", "snippet": " [CLS] Early-onset autoimmune disease due to a heterozygous loss-of-function [CLS]  mutation in TNFAIP3 (A20).\n"}
{"subject": "TgRON4", "sub_type": "Gene", "rel": "ThemeOf", "object": "null mutation", "obj_type": "Var", "file_name": "PubMed-28662729.json", "snippet": " important MJ complex, but its mechanism of assembly remains unclear. In this study, we used the CRISPR-Cas9 system to generate a derivative of T. gondii strain RH with a  [CLS] null mutation in TgRON4 [CLS] , thought to be an essential MJ component. Deficiency of TgRON4 moderately decreased invasion ability relative to that of the wild-type parasite. In addition, expression of the endogenous N-terminal fragment"}
{"subject": "null mutation", "sub_type": "Var", "rel": "CauseOf", "object": "Deficiency", "obj_type": "NegReg", "file_name": "PubMed-28662729.json", "snippet": " important MJ complex, but its mechanism of assembly remains unclear. In this study, we used the CRISPR-Cas9 system to generate a derivative of T. gondii strain RH with a  [CLS] null mutation in TgRON4, thought to be an essential MJ component. Deficiency [CLS]  of TgRON4 moderately decreased invasion ability relative to that of the wild-type parasite. In addition, expression of the endogenous N-terminal fragment of RON5 decreased in the mutant. Together, the"}
{"subject": "TgRON4", "sub_type": "Protein", "rel": "ThemeOf", "object": "Deficiency", "obj_type": "NegReg", "file_name": "PubMed-28662729.json", "snippet": " this study, we used the CRISPR-Cas9 system to generate a derivative of T. gondii strain RH with a null mutation in TgRON4, thought to be an essential MJ component.  [CLS] Deficiency of TgRON4 [CLS]  moderately decreased invasion ability relative to that of the wild-type parasite. In addition, expression of the endogenous N-terminal fragment of RON5 decreased in the mutant. Together, the results improve"}
{"subject": "Deficiency", "sub_type": "NegReg", "rel": "CauseOf", "object": "decreased", "obj_type": "NegReg", "file_name": "PubMed-28662729.json", "snippet": " this study, we used the CRISPR-Cas9 system to generate a derivative of T. gondii strain RH with a null mutation in TgRON4, thought to be an essential MJ component.  [CLS] Deficiency of TgRON4 moderately decreased [CLS]  invasion ability relative to that of the wild-type parasite. In addition, expression of the endogenous N-terminal fragment of RON5 decreased in the mutant. Together, the results improve our understanding"}
{"subject": "invasion ability", "sub_type": "CPA", "rel": "ThemeOf", "object": "decreased", "obj_type": "NegReg", "file_name": "PubMed-28662729.json", "snippet": " the CRISPR-Cas9 system to generate a derivative of T. gondii strain RH with a null mutation in TgRON4, thought to be an essential MJ component. Deficiency of TgRON4 moderately  [CLS] decreased invasion ability [CLS]  relative to that of the wild-type parasite. In addition, expression of the endogenous N-terminal fragment of RON5 decreased in the mutant. Together, the results improve our understanding of the"}
{"subject": "mutant", "sub_type": "Var", "rel": "CauseOf", "object": "decreased", "obj_type": "NegReg", "file_name": "PubMed-28662729.json", "snippet": " be an essential MJ component. Deficiency of TgRON4 moderately decreased invasion ability relative to that of the wild-type parasite. In addition, expression of the endogenous N-terminal fragment of RON5  [CLS] decreased in the mutant [CLS] . Together, the results improve our understanding of the assembly mechanism of the MJ complex of T. gondii and raise the possibility of developing new therapeutic drugs that target this"}
{"subject": "expression of the endogenous N-terminal fragment", "sub_type": "MPA", "rel": "ThemeOf", "object": "decreased", "obj_type": "NegReg", "file_name": "PubMed-28662729.json", "snippet": " with a null mutation in TgRON4, thought to be an essential MJ component. Deficiency of TgRON4 moderately decreased invasion ability relative to that of the wild-type parasite. In addition,  [CLS] expression of the endogenous N-terminal fragment of RON5 decreased [CLS]  in the mutant. Together, the results improve our understanding of the assembly mechanism of the MJ complex of T. gondii and raise the possibility of developing new therapeutic drugs"}
{"subject": "RON5", "sub_type": "Protein", "rel": "ThemeOf", "object": "expression of the endogenous N-terminal fragment", "obj_type": "MPA", "file_name": "PubMed-28662729.json", "snippet": " with a null mutation in TgRON4, thought to be an essential MJ component. Deficiency of TgRON4 moderately decreased invasion ability relative to that of the wild-type parasite. In addition,  [CLS] expression of the endogenous N-terminal fragment of RON5 [CLS]  decreased in the mutant. Together, the results improve our understanding of the assembly mechanism of the MJ complex of T. gondii and raise the possibility of developing new therapeutic"}
{"subject": "SlMBP21", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-28667273.json", "snippet": " [CLS] mutations in SlMBP21 [CLS]  MADS-box gene led to jointless-2 phenotype in tomato.\nAbscission is the mechanism by which plants disconnect unfertilized flowers, ripe fruits, senescent or diseased organs from the plant. In tomato,"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "loss of function", "obj_type": "NegReg", "file_name": "PubMed-28667273.json", "snippet": " [CLS] loss of function mutations [CLS]  in SlMBP21 MADS-box gene led to jointless-2 phenotype in tomato.\nAbscission is the mechanism by which plants disconnect unfertilized flowers, ripe fruits, senescent or diseased organs from the plant."}
{"subject": "jointless-2 phenotype", "sub_type": "CPA", "rel": "ThemeOf", "object": "loss of function", "obj_type": "NegReg", "file_name": "PubMed-28667273.json", "snippet": " [CLS] loss of function mutations in SlMBP21 MADS-box gene led to jointless-2 phenotype [CLS]  in tomato.\nAbscission is the mechanism by which plants disconnect unfertilized flowers, ripe fruits, senescent or diseased organs from the plant. In tomato, pedicel abscission is an important agronomic"}
{"subject": "LAMB2", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-28683731.json", "snippet": " [CLS] LAMB2 mutations [CLS] .\nBACKGROUND: Congenital nephrotic syndrome (CNS) is a rare disorder caused by various structural and developmental defects of glomeruli. It occurs typically as an isolated kidney disorder but associates sometimes"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "caused by", "obj_type": "Reg", "file_name": "PubMed-28683731.json", "snippet": " [CLS] caused by null LAMB2 mutations [CLS] .\nBACKGROUND: Congenital nephrotic syndrome (CNS) is a rare disorder caused by various structural and developmental defects of glomeruli. It occurs typically as an isolated kidney disorder but associates sometimes"}
{"subject": "extrarenal features", "sub_type": "CPA", "rel": "ThemeOf", "object": "caused by", "obj_type": "Reg", "file_name": "PubMed-28683731.json", "snippet": " [CLS] extrarenal features in a child with congenital nephrotic syndrome caused by [CLS]  null LAMB2 mutations.\nBACKGROUND: Congenital nephrotic syndrome (CNS) is a rare disorder caused by various structural and developmental defects of glomeruli. It occurs typically as an isolated kidney disorder"}
{"subject": "Nephron development", "sub_type": "CPA", "rel": "ThemeOf", "object": "caused by", "obj_type": "Reg", "file_name": "PubMed-28683731.json", "snippet": " [CLS] Nephron development and extrarenal features in a child with congenital nephrotic syndrome caused by [CLS]  null LAMB2 mutations.\nBACKGROUND: Congenital nephrotic syndrome (CNS) is a rare disorder caused by various structural and developmental defects of glomeruli. It occurs typically as an isolated kidney disorder"}
{"subject": "SGCD", "sub_type": "Gene", "rel": "ThemeOf", "object": "deletions", "obj_type": "Var", "file_name": "PubMed-28697784.json", "snippet": " [CLS] SGCD deletions [CLS]  causing limb girdle muscular dystrophy in Boston terriers.\nBACKGROUND: Limb-girdle muscular dystrophies (LGMDs) are a heterogeneous group of inherited autosomal myopathies that preferentially affect voluntary muscles of the shoulders"}
{"subject": "limb girdle muscular dystrophy", "sub_type": "Disease", "rel": "ThemeOf", "object": "causing", "obj_type": "Reg", "file_name": "PubMed-28697784.json", "snippet": " [CLS] causing limb girdle muscular dystrophy [CLS]  in Boston terriers.\nBACKGROUND: Limb-girdle muscular dystrophies (LGMDs) are a heterogeneous group of inherited autosomal myopathies that preferentially affect voluntary muscles of the shoulders and hips. LGMD has been"}
{"subject": "deletions", "sub_type": "Var", "rel": "CauseOf", "object": "causing", "obj_type": "Reg", "file_name": "PubMed-28697784.json", "snippet": " [CLS] deletions causing [CLS]  limb girdle muscular dystrophy in Boston terriers.\nBACKGROUND: Limb-girdle muscular dystrophies (LGMDs) are a heterogeneous group of inherited autosomal myopathies that preferentially affect voluntary muscles of the shoulders and"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "absence", "obj_type": "NegReg", "file_name": "PubMed-28697784.json", "snippet": " (SGCD), a two base pair deletion segregating with LGMD in the family was discovered, and a deletion encompassing exons 7 and 8 was found in the unrelated dog. Both  [CLS] mutations are predicted to cause an absence [CLS]  of SGCD protein, confirmed by immunohistochemistry. The mutations are private to each family.\nCONCLUSIONS: Here, we describe the first cases of canine LGMD characterized at the molecular level with"}
{"subject": "protein", "sub_type": "Protein", "rel": "ThemeOf", "object": "absence", "obj_type": "NegReg", "file_name": "PubMed-28697784.json", "snippet": " segregating with LGMD in the family was discovered, and a deletion encompassing exons 7 and 8 was found in the unrelated dog. Both mutations are predicted to cause an  [CLS] absence of SGCD protein [CLS] , confirmed by immunohistochemistry. The mutations are private to each family.\nCONCLUSIONS: Here, we describe the first cases of canine LGMD characterized at the molecular level with the classification of"}
{"subject": "SGCD", "sub_type": "Gene", "rel": "ThemeOf", "object": "protein", "obj_type": "Protein", "file_name": "PubMed-28697784.json", "snippet": " LGMD in the family was discovered, and a deletion encompassing exons 7 and 8 was found in the unrelated dog. Both mutations are predicted to cause an absence of  [CLS] SGCD protein [CLS] , confirmed by immunohistochemistry. The mutations are private to each family.\nCONCLUSIONS: Here, we describe the first cases of canine LGMD characterized at the molecular level with the classification of"}
{"subject": "SGCD", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-28697784.json", "snippet": " sarcoglycan-sarcospan complex by immunostaining, whole exome sequencing was performed on five Boston terriers: one affected dog and its three family members and one unrelated affected dog.\nRESULTS: Within sarcoglycan-\u03b4 ( [CLS] SGCD), a two base pair deletion segregating with LGMD in the family was discovered, and a deletion encompassing exons 7 and 8 was found in the unrelated dog. Both mutations [CLS]  are predicted to cause an absence of SGCD protein, confirmed by immunohistochemistry. The mutations are private to each family.\nCONCLUSIONS: Here, we describe the first cases of canine LGMD"}
{"subject": "aca10", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutants", "obj_type": "Var", "file_name": "PubMed-28701352.json", "snippet": " that negatively regulates the expression of immune receptor genes and positively regulates stomatal closure. We found that BON1 interacts with the autoinhibitory domains of ACA10 and ACA8, and the  [CLS] aca10 loss of function (LOF) mutants [CLS]  have an autoimmune phenotype similar to that of the bon1 LOF mutants. Genetic evidences indicate that BON1 positively regulates the activities of ACA10 and ACA8. Consistent with this idea,"}
{"subject": "bon1", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutants", "obj_type": "Var", "file_name": "PubMed-28701352.json", "snippet": " by external calcium treatment was altered in aca10, aca8, and bon1 mutants in guard cells. In addition, calcium and pathogen induced stomatal closure was compromised in the aca10 and  [CLS] bon1 mutants [CLS] . Taken together, this study indicates that ACA10/8 and BON1 physically interact on plasma membrane and function in the generation of cytosol calcium signatures that are critical for stomatal movement"}
{"subject": "mutants", "sub_type": "Var", "rel": "CauseOf", "object": "compromised", "obj_type": "NegReg", "file_name": "PubMed-28701352.json", "snippet": " strikingly, cytosolic calcium oscillation imposed by external calcium treatment was altered in aca10, aca8, and bon1 mutants in guard cells. In addition, calcium and pathogen induced stomatal closure was  [CLS] compromised in the aca10 and bon1 mutants [CLS] . Taken together, this study indicates that ACA10/8 and BON1 physically interact on plasma membrane and function in the generation of cytosol calcium signatures that are critical for stomatal movement"}
{"subject": "calcium and pathogen induced stomatal closure", "sub_type": "CPA", "rel": "ThemeOf", "object": "compromised", "obj_type": "NegReg", "file_name": "PubMed-28701352.json", "snippet": " in both aca10 and bon1 mutants. Most strikingly, cytosolic calcium oscillation imposed by external calcium treatment was altered in aca10, aca8, and bon1 mutants in guard cells. In addition,  [CLS] calcium and pathogen induced stomatal closure was compromised [CLS]  in the aca10 and bon1 mutants. Taken together, this study indicates that ACA10/8 and BON1 physically interact on plasma membrane and function in the generation of cytosol calcium signatures"}
{"subject": "mutants", "sub_type": "Var", "rel": "CauseOf", "object": "loss of function", "obj_type": "NegReg", "file_name": "PubMed-28701352.json", "snippet": " negatively regulates the expression of immune receptor genes and positively regulates stomatal closure. We found that BON1 interacts with the autoinhibitory domains of ACA10 and ACA8, and the aca10  [CLS] loss of function (LOF) mutants [CLS]  have an autoimmune phenotype similar to that of the bon1 LOF mutants. Genetic evidences indicate that BON1 positively regulates the activities of ACA10 and ACA8. Consistent with this idea,"}
{"subject": "bon1", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutants", "obj_type": "Var", "file_name": "PubMed-28701352.json", "snippet": " found that BON1 interacts with the autoinhibitory domains of ACA10 and ACA8, and the aca10 loss of function (LOF) mutants have an autoimmune phenotype similar to that of the  [CLS] bon1 LOF mutants [CLS] . Genetic evidences indicate that BON1 positively regulates the activities of ACA10 and ACA8. Consistent with this idea, the steady level of calcium concentration is increased in both aca10 and"}
{"subject": "mutants", "sub_type": "Var", "rel": "CauseOf", "object": "LOF", "obj_type": "NegReg", "file_name": "PubMed-28701352.json", "snippet": " that BON1 interacts with the autoinhibitory domains of ACA10 and ACA8, and the aca10 loss of function (LOF) mutants have an autoimmune phenotype similar to that of the bon1  [CLS] LOF mutants [CLS] . Genetic evidences indicate that BON1 positively regulates the activities of ACA10 and ACA8. Consistent with this idea, the steady level of calcium concentration is increased in both aca10 and"}
{"subject": "bon1", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutants", "obj_type": "Var", "file_name": "PubMed-28701352.json", "snippet": " Genetic evidences indicate that BON1 positively regulates the activities of ACA10 and ACA8. Consistent with this idea, the steady level of calcium concentration is increased in both aca10 and  [CLS] bon1 mutants [CLS] . Most strikingly, cytosolic calcium oscillation imposed by external calcium treatment was altered in aca10, aca8, and bon1 mutants in guard cells. In addition, calcium and pathogen induced stomatal closure"}
{"subject": "aca10", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutants", "obj_type": "Var", "file_name": "PubMed-28701352.json", "snippet": " LOF mutants. Genetic evidences indicate that BON1 positively regulates the activities of ACA10 and ACA8. Consistent with this idea, the steady level of calcium concentration is increased in both  [CLS] aca10 and bon1 mutants [CLS] . Most strikingly, cytosolic calcium oscillation imposed by external calcium treatment was altered in aca10, aca8, and bon1 mutants in guard cells. In addition, calcium and pathogen induced stomatal closure"}
{"subject": "mutants", "sub_type": "Var", "rel": "CauseOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-28701352.json", "snippet": " of the bon1 LOF mutants. Genetic evidences indicate that BON1 positively regulates the activities of ACA10 and ACA8. Consistent with this idea, the steady level of calcium concentration is  [CLS] increased in both aca10 and bon1 mutants [CLS] . Most strikingly, cytosolic calcium oscillation imposed by external calcium treatment was altered in aca10, aca8, and bon1 mutants in guard cells. In addition, calcium and pathogen induced stomatal closure"}
{"subject": "steady level of calcium concentration", "sub_type": "MPA", "rel": "ThemeOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-28701352.json", "snippet": " an autoimmune phenotype similar to that of the bon1 LOF mutants. Genetic evidences indicate that BON1 positively regulates the activities of ACA10 and ACA8. Consistent with this idea, the  [CLS] steady level of calcium concentration is increased [CLS]  in both aca10 and bon1 mutants. Most strikingly, cytosolic calcium oscillation imposed by external calcium treatment was altered in aca10, aca8, and bon1 mutants in guard cells. In addition,"}
{"subject": "aca10", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutants", "obj_type": "Var", "file_name": "PubMed-28701352.json", "snippet": " oscillation imposed by external calcium treatment was altered in aca10, aca8, and bon1 mutants in guard cells. In addition, calcium and pathogen induced stomatal closure was compromised in the  [CLS] aca10 and bon1 mutants [CLS] . Taken together, this study indicates that ACA10/8 and BON1 physically interact on plasma membrane and function in the generation of cytosol calcium signatures that are critical for stomatal movement"}
{"subject": "mutation", "sub_type": "Var", "rel": "CauseOf", "object": "LoF", "obj_type": "NegReg", "file_name": "PubMed-28708837.json", "snippet": " investigational efforts, no method to overcome the pathogenesis caused by loss of function (LoF) mutations in tumor suppressor genes has been successfully translated to the clinic. The most frequent  [CLS] LoF mutation [CLS]  in human cancers is Adenomatous polyposis coli (APC), causing aberrant activation of the Wnt pathway. In nearly all colon cancer tumors, the APC protein is truncated, but still retains"}
{"subject": "mutation", "sub_type": "Var", "rel": "CauseOf", "object": "activation", "obj_type": "PosReg", "file_name": "PubMed-28708837.json", "snippet": " efforts, no method to overcome the pathogenesis caused by loss of function (LoF) mutations in tumor suppressor genes has been successfully translated to the clinic. The most frequent LoF  [CLS] mutation in human cancers is Adenomatous polyposis coli (APC), causing aberrant activation [CLS]  of the Wnt pathway. In nearly all colon cancer tumors, the APC protein is truncated, but still retains partial binding abilities.\nOBJECTIVE & METHODS: Here, we tested the hypothesis"}
{"subject": "mutation", "sub_type": "Var", "rel": "CauseOf", "object": "retains partial", "obj_type": "NegReg", "file_name": "PubMed-28708837.json", "snippet": " efforts, no method to overcome the pathogenesis caused by loss of function (LoF) mutations in tumor suppressor genes has been successfully translated to the clinic. The most frequent LoF  [CLS] mutation in human cancers is Adenomatous polyposis coli (APC), causing aberrant activation of the Wnt pathway. In nearly all colon cancer tumors, the APC protein is truncated, but still retains partial [CLS]  binding abilities.\nOBJECTIVE & METHODS: Here, we tested the hypothesis that extracellular inhibitors of the Wnt pathway, although acting upstream of the APC mutation, can restore normal levels of"}
{"subject": "Wnt pathway", "sub_type": "Pathway", "rel": "ThemeOf", "object": "activation", "obj_type": "PosReg", "file_name": "PubMed-28708837.json", "snippet": " function (LoF) mutations in tumor suppressor genes has been successfully translated to the clinic. The most frequent LoF mutation in human cancers is Adenomatous polyposis coli (APC), causing aberrant  [CLS] activation of the Wnt pathway [CLS] . In nearly all colon cancer tumors, the APC protein is truncated, but still retains partial binding abilities.\nOBJECTIVE & METHODS: Here, we tested the hypothesis that extracellular inhibitors of"}
{"subject": "APC protein", "sub_type": "Protein", "rel": "ThemeOf", "object": "abilities", "obj_type": "MPA", "file_name": "PubMed-28708837.json", "snippet": " the clinic. The most frequent LoF mutation in human cancers is Adenomatous polyposis coli (APC), causing aberrant activation of the Wnt pathway. In nearly all colon cancer tumors, the  [CLS] APC protein is truncated, but still retains partial binding abilities [CLS] .\nOBJECTIVE & METHODS: Here, we tested the hypothesis that extracellular inhibitors of the Wnt pathway, although acting upstream of the APC mutation, can restore normal levels of pathway activity"}
{"subject": "binding", "sub_type": "Interaction", "rel": "ThemeOf", "object": "abilities", "obj_type": "MPA", "file_name": "PubMed-28708837.json", "snippet": " human cancers is Adenomatous polyposis coli (APC), causing aberrant activation of the Wnt pathway. In nearly all colon cancer tumors, the APC protein is truncated, but still retains partial  [CLS] binding abilities [CLS] .\nOBJECTIVE & METHODS: Here, we tested the hypothesis that extracellular inhibitors of the Wnt pathway, although acting upstream of the APC mutation, can restore normal levels of pathway activity"}
{"subject": "abilities", "sub_type": "MPA", "rel": "ThemeOf", "object": "retains partial", "obj_type": "NegReg", "file_name": "PubMed-28708837.json", "snippet": " mutation in human cancers is Adenomatous polyposis coli (APC), causing aberrant activation of the Wnt pathway. In nearly all colon cancer tumors, the APC protein is truncated, but still  [CLS] retains partial binding abilities [CLS] .\nOBJECTIVE & METHODS: Here, we tested the hypothesis that extracellular inhibitors of the Wnt pathway, although acting upstream of the APC mutation, can restore normal levels of pathway activity"}
{"subject": "Adenomatous polyposis coli", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutation", "obj_type": "Var", "file_name": "PubMed-28708837.json", "snippet": " efforts, no method to overcome the pathogenesis caused by loss of function (LoF) mutations in tumor suppressor genes has been successfully translated to the clinic. The most frequent LoF  [CLS] mutation in human cancers is Adenomatous polyposis coli [CLS]  (APC), causing aberrant activation of the Wnt pathway. In nearly all colon cancer tumors, the APC protein is truncated, but still retains partial binding abilities.\nOBJECTIVE & METHODS: Here,"}
{"subject": "colon cancer tumors", "sub_type": "Disease", "rel": "ThemeOf", "object": "LoF", "obj_type": "NegReg", "file_name": "PubMed-28708837.json", "snippet": " investigational efforts, no method to overcome the pathogenesis caused by loss of function (LoF) mutations in tumor suppressor genes has been successfully translated to the clinic. The most frequent  [CLS] LoF mutation in human cancers is Adenomatous polyposis coli (APC), causing aberrant activation of the Wnt pathway. In nearly all colon cancer tumors [CLS] , the APC protein is truncated, but still retains partial binding abilities.\nOBJECTIVE & METHODS: Here, we tested the hypothesis that extracellular inhibitors of the Wnt pathway, although acting upstream"}
{"subject": "PCSK9", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutation", "obj_type": "Var", "file_name": "PubMed-28711549.json", "snippet": " [CLS] PCSK9 loss-of-function mutation [CLS]  and polymorphisms predisposing to nonalcoholic fatty liver disease.\nWe report a new case of hypobetalipoproteinemia in a 44-year-old man of Peruvian origin exhibiting a heterozygous PCSK9 missense mutation (c.946\u00a0G>T,"}
{"subject": "mutation", "sub_type": "Var", "rel": "CauseOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-28711549.json", "snippet": " [CLS] loss-of-function mutation [CLS]  and polymorphisms predisposing to nonalcoholic fatty liver disease.\nWe report a new case of hypobetalipoproteinemia in a 44-year-old man of Peruvian origin exhibiting a heterozygous PCSK9 missense mutation (c.946\u00a0G>T,"}
{"subject": "hypocholesterolemia", "sub_type": "Disease", "rel": "ThemeOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-28711549.json", "snippet": " [CLS] hypocholesterolemia and steatosis in a carrier of a PCSK9 loss-of-function [CLS]  mutation and polymorphisms predisposing to nonalcoholic fatty liver disease.\nWe report a new case of hypobetalipoproteinemia in a 44-year-old man of Peruvian origin exhibiting a heterozygous PCSK9 missense mutation"}
{"subject": "steatosis", "sub_type": "Disease", "rel": "ThemeOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-28711549.json", "snippet": " [CLS] steatosis in a carrier of a PCSK9 loss-of-function [CLS]  mutation and polymorphisms predisposing to nonalcoholic fatty liver disease.\nWe report a new case of hypobetalipoproteinemia in a 44-year-old man of Peruvian origin exhibiting a heterozygous PCSK9 missense mutation"}
{"subject": "PCSK9", "sub_type": "Gene", "rel": "ThemeOf", "object": "c.946\u00a0G>T", "obj_type": "Var", "file_name": "PubMed-28711549.json", "snippet": " mutation and polymorphisms predisposing to nonalcoholic fatty liver disease.\nWe report a new case of hypobetalipoproteinemia in a 44-year-old man of Peruvian origin exhibiting a heterozygous PCSK9 missense mutation ( [CLS] c.946\u00a0G>T, p. Gly316Cys). In\u00a0vitro functional studies demonstrated that this mutation leads to a loss of function of PCSK9 [CLS]  on low-density lipoprotein receptor degradation. This patient exhibited liver steatosis; he was neither diabetic, nor obese or alcoholic, but is a carrier of 2 polymorphisms, p.Ile148Met (rs738409) and p.Glu167Lys"}
{"subject": "c.946\u00a0G>T", "sub_type": "Var", "rel": "CauseOf", "object": "loss of function", "obj_type": "NegReg", "file_name": "PubMed-28711549.json", "snippet": " mutation and polymorphisms predisposing to nonalcoholic fatty liver disease.\nWe report a new case of hypobetalipoproteinemia in a 44-year-old man of Peruvian origin exhibiting a heterozygous PCSK9 missense mutation ( [CLS] c.946\u00a0G>T, p. Gly316Cys). In\u00a0vitro functional studies demonstrated that this mutation leads to a loss of function [CLS]  of PCSK9 on low-density lipoprotein receptor degradation. This patient exhibited liver steatosis; he was neither diabetic, nor obese or alcoholic, but is a carrier of 2 polymorphisms, p.Ile148Met (rs738409)"}
{"subject": "low-density lipoprotein receptor degradation", "sub_type": "MPA", "rel": "ThemeOf", "object": "loss of function", "obj_type": "NegReg", "file_name": "PubMed-28711549.json", "snippet": " case of hypobetalipoproteinemia in a 44-year-old man of Peruvian origin exhibiting a heterozygous PCSK9 missense mutation (c.946\u00a0G>T, p. Gly316Cys). In\u00a0vitro functional studies demonstrated that this mutation leads to a  [CLS] loss of function of PCSK9 on low-density lipoprotein receptor degradation [CLS] . This patient exhibited liver steatosis; he was neither diabetic, nor obese or alcoholic, but is a carrier of 2 polymorphisms, p.Ile148Met (rs738409) and p.Glu167Lys (rs58542926) on PNPLA3 and TM6SF2"}
{"subject": "Ovarian aromatase", "sub_type": "Protein", "rel": "ThemeOf", "object": "mutant", "obj_type": "Var", "file_name": "PubMed-28711606.json", "snippet": " [CLS] Ovarian aromatase loss-of-function mutant [CLS]  medaka undergo ovary degeneration and partial female-to-male sex reversal after puberty.\nAlthough estrogens have been generally considered to play a critical role in ovarian differentiation in non-mammalian vertebrates, the"}
{"subject": "mutant", "sub_type": "Var", "rel": "CauseOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-28711606.json", "snippet": " [CLS] loss-of-function mutant [CLS]  medaka undergo ovary degeneration and partial female-to-male sex reversal after puberty.\nAlthough estrogens have been generally considered to play a critical role in ovarian differentiation in non-mammalian vertebrates, the"}
{"subject": "loss-of-function", "sub_type": "NegReg", "rel": "CauseOf", "object": "undergo", "obj_type": "Reg", "file_name": "PubMed-28711606.json", "snippet": " [CLS] loss-of-function mutant medaka undergo [CLS]  ovary degeneration and partial female-to-male sex reversal after puberty.\nAlthough estrogens have been generally considered to play a critical role in ovarian differentiation in non-mammalian vertebrates, the specific functions"}
{"subject": "ovary degeneration", "sub_type": "CPA", "rel": "ThemeOf", "object": "undergo", "obj_type": "Reg", "file_name": "PubMed-28711606.json", "snippet": " [CLS] undergo ovary degeneration [CLS]  and partial female-to-male sex reversal after puberty.\nAlthough estrogens have been generally considered to play a critical role in ovarian differentiation in non-mammalian vertebrates, the specific functions of estrogens"}
{"subject": "partial female-to-male sex reversal", "sub_type": "CPA", "rel": "ThemeOf", "object": "undergo", "obj_type": "Reg", "file_name": "PubMed-28711606.json", "snippet": " [CLS] undergo ovary degeneration and partial female-to-male sex reversal [CLS]  after puberty.\nAlthough estrogens have been generally considered to play a critical role in ovarian differentiation in non-mammalian vertebrates, the specific functions of estrogens during ovarian differentiation remain unclear."}
{"subject": "ALMS1", "sub_type": "Gene", "rel": "ThemeOf", "object": "protein", "obj_type": "Protein", "file_name": "PubMed-28717663.json", "snippet": " Hedgehog-induced GLI1 expression and PDGFA signaling was assessed using quantitative real-time PCR, immunoblotting, or immunostaining of fixed cells after stimulation.\nRESULTS: In 16 of the patient cell lines examined,  [CLS] ALMS1 protein [CLS]  was undetectable (14 with biallelic loss-of-function (LoF) mutations), and in two, ALMS1 staining was equivocal (one with biallelic LoF mutations). In five lines, ALMS1 expression was normal using at"}
{"subject": "protein", "sub_type": "Protein", "rel": "ThemeOf", "object": "undetectable", "obj_type": "NegReg", "file_name": "PubMed-28717663.json", "snippet": " GLI1 expression and PDGFA signaling was assessed using quantitative real-time PCR, immunoblotting, or immunostaining of fixed cells after stimulation.\nRESULTS: In 16 of the patient cell lines examined, ALMS1  [CLS] protein was undetectable [CLS]  (14 with biallelic loss-of-function (LoF) mutations), and in two, ALMS1 staining was equivocal (one with biallelic LoF mutations). In five lines, ALMS1 expression was normal using at least one"}
{"subject": "loss-of-function", "sub_type": "NegReg", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-28717663.json", "snippet": " assessed using quantitative real-time PCR, immunoblotting, or immunostaining of fixed cells after stimulation.\nRESULTS: In 16 of the patient cell lines examined, ALMS1 protein was undetectable (14 with biallelic  [CLS] loss-of-function (LoF) mutations [CLS] ), and in two, ALMS1 staining was equivocal (one with biallelic LoF mutations). In five lines, ALMS1 expression was normal using at least one fixation method (one with biallelic LoF"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "undetectable", "obj_type": "NegReg", "file_name": "PubMed-28717663.json", "snippet": " and PDGFA signaling was assessed using quantitative real-time PCR, immunoblotting, or immunostaining of fixed cells after stimulation.\nRESULTS: In 16 of the patient cell lines examined, ALMS1 protein was  [CLS] undetectable (14 with biallelic loss-of-function (LoF) mutations [CLS] ), and in two, ALMS1 staining was equivocal (one with biallelic LoF mutations). In five lines, ALMS1 expression was normal using at least one fixation method (one with biallelic LoF"}
{"subject": "loss-of-function", "sub_type": "Var", "rel": "CauseOf", "object": "activated", "obj_type": "PosReg", "file_name": "PubMed-28720827.json", "snippet": " of a constitutively opened cation channel mutant. Here, we performed further genetic screens and identified a suppressor of neuronal necrosis, CG17259, which encodes a seryl-tRNA synthetase. We found that  [CLS] loss-of-function (LOF) CG17259 activated [CLS]  eIF2\u03b1 phosphorylation and subsequent up-regulation of chaperons (Hsp26 and Hsp27) and autophagy. Genetically, down-regulation of eIF2\u03b1 phosphorylation, Hsp26/Hsp27 or autophagy reduced the protective effect of LOF CG17259, indicating they"}
{"subject": "phosphorylation", "sub_type": "CPA", "rel": "ThemeOf", "object": "down-regulation", "obj_type": "NegReg", "file_name": "PubMed-28720827.json", "snippet": " of neuronal necrosis, CG17259, which encodes a seryl-tRNA synthetase. We found that loss-of-function (LOF) CG17259 activated eIF2\u03b1 phosphorylation and subsequent up-regulation of chaperons (Hsp26 and Hsp27) and autophagy. Genetically,  [CLS] down-regulation of eIF2\u03b1 phosphorylation [CLS] , Hsp26/Hsp27 or autophagy reduced the protective effect of LOF CG17259, indicating they function downstream of CG17259. The protective effect of these protein degradation pathways indicated activation of a toxic"}
{"subject": "Hsp26", "sub_type": "Protein", "rel": "ThemeOf", "object": "down-regulation", "obj_type": "NegReg", "file_name": "PubMed-28720827.json", "snippet": " of neuronal necrosis, CG17259, which encodes a seryl-tRNA synthetase. We found that loss-of-function (LOF) CG17259 activated eIF2\u03b1 phosphorylation and subsequent up-regulation of chaperons (Hsp26 and Hsp27) and autophagy. Genetically,  [CLS] down-regulation of eIF2\u03b1 phosphorylation, Hsp26 [CLS] /Hsp27 or autophagy reduced the protective effect of LOF CG17259, indicating they function downstream of CG17259. The protective effect of these protein degradation pathways indicated activation of a toxic protein"}
{"subject": "autophagy", "sub_type": "CPA", "rel": "ThemeOf", "object": "down-regulation", "obj_type": "NegReg", "file_name": "PubMed-28720827.json", "snippet": " of neuronal necrosis, CG17259, which encodes a seryl-tRNA synthetase. We found that loss-of-function (LOF) CG17259 activated eIF2\u03b1 phosphorylation and subsequent up-regulation of chaperons (Hsp26 and Hsp27) and autophagy. Genetically,  [CLS] down-regulation of eIF2\u03b1 phosphorylation, Hsp26/Hsp27 or autophagy [CLS]  reduced the protective effect of LOF CG17259, indicating they function downstream of CG17259. The protective effect of these protein degradation pathways indicated activation of a toxic protein during neuronal"}
{"subject": "down-regulation", "sub_type": "NegReg", "rel": "CauseOf", "object": "reduced", "obj_type": "NegReg", "file_name": "PubMed-28720827.json", "snippet": " of neuronal necrosis, CG17259, which encodes a seryl-tRNA synthetase. We found that loss-of-function (LOF) CG17259 activated eIF2\u03b1 phosphorylation and subsequent up-regulation of chaperons (Hsp26 and Hsp27) and autophagy. Genetically,  [CLS] down-regulation of eIF2\u03b1 phosphorylation, Hsp26/Hsp27 or autophagy reduced [CLS]  the protective effect of LOF CG17259, indicating they function downstream of CG17259. The protective effect of these protein degradation pathways indicated activation of a toxic protein during neuronal necrosis."}
{"subject": "CG17259", "sub_type": "Gene", "rel": "ThemeOf", "object": "loss-of-function", "obj_type": "Var", "file_name": "PubMed-28720827.json", "snippet": " of a constitutively opened cation channel mutant. Here, we performed further genetic screens and identified a suppressor of neuronal necrosis, CG17259, which encodes a seryl-tRNA synthetase. We found that  [CLS] loss-of-function (LOF) CG17259 [CLS]  activated eIF2\u03b1 phosphorylation and subsequent up-regulation of chaperons (Hsp26 and Hsp27) and autophagy. Genetically, down-regulation of eIF2\u03b1 phosphorylation, Hsp26/Hsp27 or autophagy reduced the protective effect of LOF CG17259, indicating"}
{"subject": "protective effect", "sub_type": "CPA", "rel": "ThemeOf", "object": "reduced", "obj_type": "NegReg", "file_name": "PubMed-28720827.json", "snippet": " seryl-tRNA synthetase. We found that loss-of-function (LOF) CG17259 activated eIF2\u03b1 phosphorylation and subsequent up-regulation of chaperons (Hsp26 and Hsp27) and autophagy. Genetically, down-regulation of eIF2\u03b1 phosphorylation, Hsp26/Hsp27 or autophagy  [CLS] reduced the protective effect [CLS]  of LOF CG17259, indicating they function downstream of CG17259. The protective effect of these protein degradation pathways indicated activation of a toxic protein during neuronal necrosis. Our data indicated"}
{"subject": "CG17259", "sub_type": "Gene", "rel": "ThemeOf", "object": "LOF", "obj_type": "Var", "file_name": "PubMed-28720827.json", "snippet": " loss-of-function (LOF) CG17259 activated eIF2\u03b1 phosphorylation and subsequent up-regulation of chaperons (Hsp26 and Hsp27) and autophagy. Genetically, down-regulation of eIF2\u03b1 phosphorylation, Hsp26/Hsp27 or autophagy reduced the protective effect of  [CLS] LOF CG17259 [CLS] , indicating they function downstream of CG17259. The protective effect of these protein degradation pathways indicated activation of a toxic protein during neuronal necrosis. Our data indicated that p53 was"}
{"subject": "LOF", "sub_type": "Var", "rel": "ThemeOf", "object": "protective effect", "obj_type": "CPA", "file_name": "PubMed-28720827.json", "snippet": " We found that loss-of-function (LOF) CG17259 activated eIF2\u03b1 phosphorylation and subsequent up-regulation of chaperons (Hsp26 and Hsp27) and autophagy. Genetically, down-regulation of eIF2\u03b1 phosphorylation, Hsp26/Hsp27 or autophagy reduced the  [CLS] protective effect of LOF [CLS]  CG17259, indicating they function downstream of CG17259. The protective effect of these protein degradation pathways indicated activation of a toxic protein during neuronal necrosis. Our data indicated that p53"}
{"subject": "Hsp27", "sub_type": "Protein", "rel": "ThemeOf", "object": "down-regulation", "obj_type": "NegReg", "file_name": "PubMed-28720827.json", "snippet": " of neuronal necrosis, CG17259, which encodes a seryl-tRNA synthetase. We found that loss-of-function (LOF) CG17259 activated eIF2\u03b1 phosphorylation and subsequent up-regulation of chaperons (Hsp26 and Hsp27) and autophagy. Genetically,  [CLS] down-regulation of eIF2\u03b1 phosphorylation, Hsp26/Hsp27 [CLS]  or autophagy reduced the protective effect of LOF CG17259, indicating they function downstream of CG17259. The protective effect of these protein degradation pathways indicated activation of a toxic protein"}
{"subject": "loss-of-function", "sub_type": "Var", "rel": "CauseOf", "object": "up-regulation", "obj_type": "PosReg", "file_name": "PubMed-28720827.json", "snippet": " of a constitutively opened cation channel mutant. Here, we performed further genetic screens and identified a suppressor of neuronal necrosis, CG17259, which encodes a seryl-tRNA synthetase. We found that  [CLS] loss-of-function (LOF) CG17259 activated eIF2\u03b1 phosphorylation and subsequent up-regulation [CLS]  of chaperons (Hsp26 and Hsp27) and autophagy. Genetically, down-regulation of eIF2\u03b1 phosphorylation, Hsp26/Hsp27 or autophagy reduced the protective effect of LOF CG17259, indicating they function downstream of CG17259. The"}
{"subject": "phosphorylation", "sub_type": "CPA", "rel": "ThemeOf", "object": "activated", "obj_type": "PosReg", "file_name": "PubMed-28720827.json", "snippet": " opened cation channel mutant. Here, we performed further genetic screens and identified a suppressor of neuronal necrosis, CG17259, which encodes a seryl-tRNA synthetase. We found that loss-of-function (LOF) CG17259  [CLS] activated eIF2\u03b1 phosphorylation [CLS]  and subsequent up-regulation of chaperons (Hsp26 and Hsp27) and autophagy. Genetically, down-regulation of eIF2\u03b1 phosphorylation, Hsp26/Hsp27 or autophagy reduced the protective effect of LOF CG17259, indicating they function downstream"}
{"subject": "eIF2\u03b1", "sub_type": "Protein", "rel": "ThemeOf", "object": "phosphorylation", "obj_type": "CPA", "file_name": "PubMed-28720827.json", "snippet": " cation channel mutant. Here, we performed further genetic screens and identified a suppressor of neuronal necrosis, CG17259, which encodes a seryl-tRNA synthetase. We found that loss-of-function (LOF) CG17259 activated  [CLS] eIF2\u03b1 phosphorylation [CLS]  and subsequent up-regulation of chaperons (Hsp26 and Hsp27) and autophagy. Genetically, down-regulation of eIF2\u03b1 phosphorylation, Hsp26/Hsp27 or autophagy reduced the protective effect of LOF CG17259, indicating they function downstream"}
{"subject": "Hsp26", "sub_type": "Protein", "rel": "ThemeOf", "object": "chaperons", "obj_type": "CPA", "file_name": "PubMed-28720827.json", "snippet": " further genetic screens and identified a suppressor of neuronal necrosis, CG17259, which encodes a seryl-tRNA synthetase. We found that loss-of-function (LOF) CG17259 activated eIF2\u03b1 phosphorylation and subsequent up-regulation of  [CLS] chaperons (Hsp26 [CLS]  and Hsp27) and autophagy. Genetically, down-regulation of eIF2\u03b1 phosphorylation, Hsp26/Hsp27 or autophagy reduced the protective effect of LOF CG17259, indicating they function downstream of CG17259. The protective effect of"}
{"subject": "Hsp27", "sub_type": "Protein", "rel": "ThemeOf", "object": "chaperons", "obj_type": "CPA", "file_name": "PubMed-28720827.json", "snippet": " further genetic screens and identified a suppressor of neuronal necrosis, CG17259, which encodes a seryl-tRNA synthetase. We found that loss-of-function (LOF) CG17259 activated eIF2\u03b1 phosphorylation and subsequent up-regulation of  [CLS] chaperons (Hsp26 and Hsp27 [CLS] ) and autophagy. Genetically, down-regulation of eIF2\u03b1 phosphorylation, Hsp26/Hsp27 or autophagy reduced the protective effect of LOF CG17259, indicating they function downstream of CG17259. The protective effect of these protein"}
{"subject": "chaperons", "sub_type": "CPA", "rel": "ThemeOf", "object": "up-regulation", "obj_type": "PosReg", "file_name": "PubMed-28720827.json", "snippet": " we performed further genetic screens and identified a suppressor of neuronal necrosis, CG17259, which encodes a seryl-tRNA synthetase. We found that loss-of-function (LOF) CG17259 activated eIF2\u03b1 phosphorylation and subsequent  [CLS] up-regulation of chaperons [CLS]  (Hsp26 and Hsp27) and autophagy. Genetically, down-regulation of eIF2\u03b1 phosphorylation, Hsp26/Hsp27 or autophagy reduced the protective effect of LOF CG17259, indicating they function downstream of CG17259. The protective effect"}
{"subject": "autophagy", "sub_type": "CPA", "rel": "ThemeOf", "object": "up-regulation", "obj_type": "PosReg", "file_name": "PubMed-28720827.json", "snippet": " we performed further genetic screens and identified a suppressor of neuronal necrosis, CG17259, which encodes a seryl-tRNA synthetase. We found that loss-of-function (LOF) CG17259 activated eIF2\u03b1 phosphorylation and subsequent  [CLS] up-regulation of chaperons (Hsp26 and Hsp27) and autophagy [CLS] . Genetically, down-regulation of eIF2\u03b1 phosphorylation, Hsp26/Hsp27 or autophagy reduced the protective effect of LOF CG17259, indicating they function downstream of CG17259. The protective effect of these protein degradation pathways"}
{"subject": "eIF2\u03b1", "sub_type": "Protein", "rel": "ThemeOf", "object": "phosphorylation", "obj_type": "CPA", "file_name": "PubMed-28720827.json", "snippet": " necrosis, CG17259, which encodes a seryl-tRNA synthetase. We found that loss-of-function (LOF) CG17259 activated eIF2\u03b1 phosphorylation and subsequent up-regulation of chaperons (Hsp26 and Hsp27) and autophagy. Genetically, down-regulation of  [CLS] eIF2\u03b1 phosphorylation [CLS] , Hsp26/Hsp27 or autophagy reduced the protective effect of LOF CG17259, indicating they function downstream of CG17259. The protective effect of these protein degradation pathways indicated activation of a toxic"}
{"subject": "PTPN2", "sub_type": "Gene", "rel": "ThemeOf", "object": "deletion", "obj_type": "Var", "file_name": "PubMed-28723893.json", "snippet": " resistance to immunotherapy. Tumours were sensitized to immunotherapy by deletion of genes involved in several diverse pathways, including NF-\u03baB signalling, antigen presentation and the unfolded protein response. In addition,  [CLS] deletion of the protein tyrosine phosphatase PTPN2 [CLS]  in tumour cells increased the efficacy of immunotherapy by enhancing interferon-\u03b3-mediated effects on antigen presentation and growth suppression. In vivo genetic screens in tumour models can identify new immunotherapy"}
{"subject": "deletion", "sub_type": "Var", "rel": "CauseOf", "object": "enhancing", "obj_type": "PosReg", "file_name": "PubMed-28723893.json", "snippet": " resistance to immunotherapy. Tumours were sensitized to immunotherapy by deletion of genes involved in several diverse pathways, including NF-\u03baB signalling, antigen presentation and the unfolded protein response. In addition,  [CLS] deletion of the protein tyrosine phosphatase PTPN2 in tumour cells increased the efficacy of immunotherapy by enhancing [CLS]  interferon-\u03b3-mediated effects on antigen presentation and growth suppression. In vivo genetic screens in tumour models can identify new immunotherapy targets in unanticipated pathways."}
{"subject": "interferon-\u03b3-mediated effects on antigen presentation", "sub_type": "MPA", "rel": "ThemeOf", "object": "enhancing", "obj_type": "PosReg", "file_name": "PubMed-28723893.json", "snippet": " pathways, including NF-\u03baB signalling, antigen presentation and the unfolded protein response. In addition, deletion of the protein tyrosine phosphatase PTPN2 in tumour cells increased the efficacy of immunotherapy by  [CLS] enhancing interferon-\u03b3-mediated effects on antigen presentation [CLS]  and growth suppression. In vivo genetic screens in tumour models can identify new immunotherapy targets in unanticipated pathways."}
{"subject": "growth suppression", "sub_type": "CPA", "rel": "ThemeOf", "object": "enhancing", "obj_type": "PosReg", "file_name": "PubMed-28723893.json", "snippet": " pathways, including NF-\u03baB signalling, antigen presentation and the unfolded protein response. In addition, deletion of the protein tyrosine phosphatase PTPN2 in tumour cells increased the efficacy of immunotherapy by  [CLS] enhancing interferon-\u03b3-mediated effects on antigen presentation and growth suppression [CLS] . In vivo genetic screens in tumour models can identify new immunotherapy targets in unanticipated pathways."}
{"subject": "enhancing", "sub_type": "PosReg", "rel": "CauseOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-28723893.json", "snippet": " of genes involved in several diverse pathways, including NF-\u03baB signalling, antigen presentation and the unfolded protein response. In addition, deletion of the protein tyrosine phosphatase PTPN2 in tumour cells  [CLS] increased the efficacy of immunotherapy by enhancing [CLS]  interferon-\u03b3-mediated effects on antigen presentation and growth suppression. In vivo genetic screens in tumour models can identify new immunotherapy targets in unanticipated pathways."}
{"subject": "efficacy of immunotherapy", "sub_type": "CPA", "rel": "ThemeOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-28723893.json", "snippet": " of genes involved in several diverse pathways, including NF-\u03baB signalling, antigen presentation and the unfolded protein response. In addition, deletion of the protein tyrosine phosphatase PTPN2 in tumour cells  [CLS] increased the efficacy of immunotherapy [CLS]  by enhancing interferon-\u03b3-mediated effects on antigen presentation and growth suppression. In vivo genetic screens in tumour models can identify new immunotherapy targets in unanticipated pathways."}
{"subject": "PDGFRB", "sub_type": "Gene", "rel": "ThemeOf", "object": "p.N666H", "obj_type": "Var", "file_name": "PubMed-28726812.json", "snippet": " p.N666H mutation and marked clinical response to imatinib.\nPurposeHeterozygous germ-line activating mutations in PDGFRB cause Kosaki and Penttinen syndromes and myofibromatosis. We describe a 10-year-old child with a germ-line  [CLS] PDGFRB p.N666H [CLS]  mutation who responded to the tyrosine kinase inhibitor imatinib by inhibition of PDGFRB.MethodsThe impact of p.N666H on PDGFRB function and sensitivity to imatinib was studied in cell culture.ResultsCells expressing"}
{"subject": "p.N666H", "sub_type": "Var", "rel": "CauseOf", "object": "inhibition", "obj_type": "NegReg", "file_name": "PubMed-28726812.json", "snippet": " mutation and marked clinical response to imatinib.\nPurposeHeterozygous germ-line activating mutations in PDGFRB cause Kosaki and Penttinen syndromes and myofibromatosis. We describe a 10-year-old child with a germ-line PDGFRB  [CLS] p.N666H mutation who responded to the tyrosine kinase inhibitor imatinib by inhibition [CLS]  of PDGFRB.MethodsThe impact of p.N666H on PDGFRB function and sensitivity to imatinib was studied in cell culture.ResultsCells expressing the p.N666H mutation showed constitutive PDGFRB tyrosine phosphorylation. PDGF-independent proliferation was"}
{"subject": "PDGFRB", "sub_type": "Gene", "rel": "ThemeOf", "object": "inhibition", "obj_type": "NegReg", "file_name": "PubMed-28726812.json", "snippet": " in PDGFRB cause Kosaki and Penttinen syndromes and myofibromatosis. We describe a 10-year-old child with a germ-line PDGFRB p.N666H mutation who responded to the tyrosine kinase inhibitor imatinib by  [CLS] inhibition of PDGFRB [CLS] .MethodsThe impact of p.N666H on PDGFRB function and sensitivity to imatinib was studied in cell culture.ResultsCells expressing the p.N666H mutation showed constitutive PDGFRB tyrosine phosphorylation. PDGF-independent proliferation was abolished by"}
{"subject": "inhibition", "sub_type": "NegReg", "rel": "CauseOf", "object": "responded to the tyrosine kinase inhibitor imatinib", "obj_type": "MPA", "file_name": "PubMed-28726812.json", "snippet": " clinical response to imatinib.\nPurposeHeterozygous germ-line activating mutations in PDGFRB cause Kosaki and Penttinen syndromes and myofibromatosis. We describe a 10-year-old child with a germ-line PDGFRB p.N666H mutation who  [CLS] responded to the tyrosine kinase inhibitor imatinib by inhibition [CLS]  of PDGFRB.MethodsThe impact of p.N666H on PDGFRB function and sensitivity to imatinib was studied in cell culture.ResultsCells expressing the p.N666H mutation showed constitutive PDGFRB tyrosine phosphorylation. PDGF-independent proliferation was"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "cause", "obj_type": "Reg", "file_name": "PubMed-28726812.json", "snippet": " [CLS] mutations in PDGFRB cause [CLS]  Kosaki and Penttinen syndromes and myofibromatosis. We describe a 10-year-old child with a germ-line PDGFRB p.N666H mutation who responded to the tyrosine kinase inhibitor imatinib by inhibition of PDGFRB.MethodsThe"}
{"subject": "PDGFRB", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-28726812.json", "snippet": " [CLS] mutations in PDGFRB [CLS]  cause Kosaki and Penttinen syndromes and myofibromatosis. We describe a 10-year-old child with a germ-line PDGFRB p.N666H mutation who responded to the tyrosine kinase inhibitor imatinib by inhibition of"}
{"subject": "Kosaki and Penttinen syndromes", "sub_type": "Disease", "rel": "ThemeOf", "object": "cause", "obj_type": "Reg", "file_name": "PubMed-28726812.json", "snippet": " [CLS] cause Kosaki and Penttinen syndromes [CLS]  and myofibromatosis. We describe a 10-year-old child with a germ-line PDGFRB p.N666H mutation who responded to the tyrosine kinase inhibitor imatinib by inhibition of PDGFRB.MethodsThe impact of p.N666H on"}
{"subject": "myofibromatosis", "sub_type": "Disease", "rel": "ThemeOf", "object": "cause", "obj_type": "Reg", "file_name": "PubMed-28726812.json", "snippet": " [CLS] cause Kosaki and Penttinen syndromes and myofibromatosis [CLS] . We describe a 10-year-old child with a germ-line PDGFRB p.N666H mutation who responded to the tyrosine kinase inhibitor imatinib by inhibition of PDGFRB.MethodsThe impact of p.N666H on PDGFRB function"}
{"subject": "PIEZO1", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-28728825.json", "snippet": " [CLS] mutations in the human PIEZO1 [CLS]  gene cause autosomal recessive congenital lymphatic dysplasia. Gain-of-function mutations in the human PIEZO1 gene cause the autosomal dominant hemolytic anemia, hereditary xerocytosis (also known as dehydrated stomatocytosis). Loss-of-function mutations"}
{"subject": "hereditary xerocytosis", "sub_type": "Disease", "rel": "ThemeOf", "object": "Gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-28728825.json", "snippet": " the genes encoding the mechanosensitive cation channels PIEZO1 and\u00a0PIEZO2 are responsible for multiple hereditary human diseases. Loss-of-function mutations in the human PIEZO1 gene cause autosomal recessive congenital lymphatic dysplasia.  [CLS] Gain-of-function mutations in the human PIEZO1 gene cause the autosomal dominant hemolytic anemia, hereditary xerocytosis [CLS]  (also known as dehydrated stomatocytosis). Loss-of-function mutations in the human PIEZO2 gene cause an autosomal recessive syndrome of muscular atrophy with perinatal respiratory distress, arthrogryposis, and scoliosis. Gain-of-function mutations"}
{"subject": "dehydrated stomatocytosis", "sub_type": "Disease", "rel": "ThemeOf", "object": "Gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-28728825.json", "snippet": " the genes encoding the mechanosensitive cation channels PIEZO1 and\u00a0PIEZO2 are responsible for multiple hereditary human diseases. Loss-of-function mutations in the human PIEZO1 gene cause autosomal recessive congenital lymphatic dysplasia.  [CLS] Gain-of-function mutations in the human PIEZO1 gene cause the autosomal dominant hemolytic anemia, hereditary xerocytosis (also known as dehydrated stomatocytosis [CLS] ). Loss-of-function mutations in the human PIEZO2 gene cause an autosomal recessive syndrome of muscular atrophy with perinatal respiratory distress, arthrogryposis, and scoliosis. Gain-of-function mutations in the human PIEZO2 gene"}
{"subject": "autosomal recessive syndrome of muscular atrophy", "sub_type": "Disease", "rel": "ThemeOf", "object": "Loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-28728825.json", "snippet": " human PIEZO1 gene cause autosomal recessive congenital lymphatic dysplasia. Gain-of-function mutations in the human PIEZO1 gene cause the autosomal dominant hemolytic anemia, hereditary xerocytosis (also known as dehydrated stomatocytosis).  [CLS] Loss-of-function mutations in the human PIEZO2 gene cause an autosomal recessive syndrome of muscular atrophy [CLS]  with perinatal respiratory distress, arthrogryposis, and scoliosis. Gain-of-function mutations in the human PIEZO2 gene cause three clinical types of autosomal dominant distal arthrogryposis. This chapter will review the hereditary"}
{"subject": "arthrogryposis", "sub_type": "Disease", "rel": "ThemeOf", "object": "Loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-28728825.json", "snippet": " human PIEZO1 gene cause autosomal recessive congenital lymphatic dysplasia. Gain-of-function mutations in the human PIEZO1 gene cause the autosomal dominant hemolytic anemia, hereditary xerocytosis (also known as dehydrated stomatocytosis).  [CLS] Loss-of-function mutations in the human PIEZO2 gene cause an autosomal recessive syndrome of muscular atrophy with perinatal respiratory distress, arthrogryposis [CLS] , and scoliosis. Gain-of-function mutations in the human PIEZO2 gene cause three clinical types of autosomal dominant distal arthrogryposis. This chapter will review the hereditary diseases caused by mutations in"}
{"subject": "scoliosis", "sub_type": "Disease", "rel": "ThemeOf", "object": "Loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-28728825.json", "snippet": " human PIEZO1 gene cause autosomal recessive congenital lymphatic dysplasia. Gain-of-function mutations in the human PIEZO1 gene cause the autosomal dominant hemolytic anemia, hereditary xerocytosis (also known as dehydrated stomatocytosis).  [CLS] Loss-of-function mutations in the human PIEZO2 gene cause an autosomal recessive syndrome of muscular atrophy with perinatal respiratory distress, arthrogryposis, and scoliosis [CLS] . Gain-of-function mutations in the human PIEZO2 gene cause three clinical types of autosomal dominant distal arthrogryposis. This chapter will review the hereditary diseases caused by mutations in the PIEZO"}
{"subject": "autosomal dominant distal arthrogryposis", "sub_type": "Disease", "rel": "ThemeOf", "object": "Gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-28728825.json", "snippet": " hereditary xerocytosis (also known as dehydrated stomatocytosis). Loss-of-function mutations in the human PIEZO2 gene cause an autosomal recessive syndrome of muscular atrophy with perinatal respiratory distress, arthrogryposis, and scoliosis.  [CLS] Gain-of-function mutations in the human PIEZO2 gene cause three clinical types of autosomal dominant distal arthrogryposis [CLS] . This chapter will review the hereditary diseases caused by mutations in the PIEZO genes\u00a0and will discuss additional physiological systems in which PIEZO channel dysfunction may contribute to human disease"}
{"subject": "autosomal recessive congenital lymphatic dysplasia", "sub_type": "Disease", "rel": "ThemeOf", "object": "Loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-28728825.json", "snippet": " [CLS] Loss-of-function mutations in the human PIEZO1 gene cause autosomal recessive congenital lymphatic dysplasia [CLS] . Gain-of-function mutations in the human PIEZO1 gene cause the autosomal dominant hemolytic anemia, hereditary xerocytosis (also known as dehydrated stomatocytosis). Loss-of-function mutations in the human PIEZO2 gene cause an"}
{"subject": "autosomal dominant hemolytic anemia", "sub_type": "Disease", "rel": "ThemeOf", "object": "Gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-28728825.json", "snippet": " the genes encoding the mechanosensitive cation channels PIEZO1 and\u00a0PIEZO2 are responsible for multiple hereditary human diseases. Loss-of-function mutations in the human PIEZO1 gene cause autosomal recessive congenital lymphatic dysplasia.  [CLS] Gain-of-function mutations in the human PIEZO1 gene cause the autosomal dominant hemolytic anemia [CLS] , hereditary xerocytosis (also known as dehydrated stomatocytosis). Loss-of-function mutations in the human PIEZO2 gene cause an autosomal recessive syndrome of muscular atrophy with perinatal respiratory distress, arthrogryposis, and scoliosis."}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "Loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-28728825.json", "snippet": " [CLS] Loss-of-function mutations [CLS]  in the human PIEZO1 gene cause autosomal recessive congenital lymphatic dysplasia. Gain-of-function mutations in the human PIEZO1 gene cause the autosomal dominant hemolytic anemia, hereditary xerocytosis (also known as"}
{"subject": "PIEZO1", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-28728825.json", "snippet": " genes encoding the mechanosensitive cation channels PIEZO1 and\u00a0PIEZO2 are responsible for multiple hereditary human diseases. Loss-of-function mutations in the human PIEZO1 gene cause autosomal recessive congenital lymphatic dysplasia. Gain-of-function  [CLS] mutations in the human PIEZO1 [CLS]  gene cause the autosomal dominant hemolytic anemia, hereditary xerocytosis (also known as dehydrated stomatocytosis). Loss-of-function mutations in the human PIEZO2 gene cause an autosomal recessive syndrome of muscular atrophy"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "Gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-28728825.json", "snippet": " the genes encoding the mechanosensitive cation channels PIEZO1 and\u00a0PIEZO2 are responsible for multiple hereditary human diseases. Loss-of-function mutations in the human PIEZO1 gene cause autosomal recessive congenital lymphatic dysplasia.  [CLS] Gain-of-function mutations [CLS]  in the human PIEZO1 gene cause the autosomal dominant hemolytic anemia, hereditary xerocytosis (also known as dehydrated stomatocytosis). Loss-of-function mutations in the human PIEZO2 gene cause an autosomal recessive"}
{"subject": "PIEZO2", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-28728825.json", "snippet": " PIEZO1 gene cause autosomal recessive congenital lymphatic dysplasia. Gain-of-function mutations in the human PIEZO1 gene cause the autosomal dominant hemolytic anemia, hereditary xerocytosis (also known as dehydrated stomatocytosis). Loss-of-function  [CLS] mutations in the human PIEZO2 [CLS]  gene cause an autosomal recessive syndrome of muscular atrophy with perinatal respiratory distress, arthrogryposis, and scoliosis. Gain-of-function mutations in the human PIEZO2 gene cause three clinical types of autosomal"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "Loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-28728825.json", "snippet": " human PIEZO1 gene cause autosomal recessive congenital lymphatic dysplasia. Gain-of-function mutations in the human PIEZO1 gene cause the autosomal dominant hemolytic anemia, hereditary xerocytosis (also known as dehydrated stomatocytosis).  [CLS] Loss-of-function mutations [CLS]  in the human PIEZO2 gene cause an autosomal recessive syndrome of muscular atrophy with perinatal respiratory distress, arthrogryposis, and scoliosis. Gain-of-function mutations in the human PIEZO2 gene cause three"}
{"subject": "PIEZO2", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-28728825.json", "snippet": " xerocytosis (also known as dehydrated stomatocytosis). Loss-of-function mutations in the human PIEZO2 gene cause an autosomal recessive syndrome of muscular atrophy with perinatal respiratory distress, arthrogryposis, and scoliosis. Gain-of-function  [CLS] mutations in the human PIEZO2 [CLS]  gene cause three clinical types of autosomal dominant distal arthrogryposis. This chapter will review the hereditary diseases caused by mutations in the PIEZO genes\u00a0and will discuss additional physiological systems"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "Gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-28728825.json", "snippet": " hereditary xerocytosis (also known as dehydrated stomatocytosis). Loss-of-function mutations in the human PIEZO2 gene cause an autosomal recessive syndrome of muscular atrophy with perinatal respiratory distress, arthrogryposis, and scoliosis.  [CLS] Gain-of-function mutations [CLS]  in the human PIEZO2 gene cause three clinical types of autosomal dominant distal arthrogryposis. This chapter will review the hereditary diseases caused by mutations in the PIEZO genes\u00a0and will"}
{"subject": "SCN5a", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-28734073.json", "snippet": " [CLS] SCN5a mutations [CLS]  may express gain-of-function (Long QT Syndrome-3), loss-of-function (Brugada Syndrome 1) or both (mixed syndromes), depending on the mutation and environmental triggers. One such trigger may be an increase in"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-28734073.json", "snippet": " [CLS] mutations may express gain-of-function [CLS]  (Long QT Syndrome-3), loss-of-function (Brugada Syndrome 1) or both (mixed syndromes), depending on the mutation and environmental triggers. One such trigger may be an increase in cytosolic calcium, accompanying"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-28734073.json", "snippet": " [CLS] mutations may express gain-of-function (Long QT Syndrome-3), loss-of-function [CLS]  (Brugada Syndrome 1) or both (mixed syndromes), depending on the mutation and environmental triggers. One such trigger may be an increase in cytosolic calcium, accompanying exercise. Many mixed syndromes"}
{"subject": "Long QT Syndrome-3", "sub_type": "Disease", "rel": "ThemeOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-28734073.json", "snippet": " [CLS] gain-of-function (Long QT Syndrome-3 [CLS] ), loss-of-function (Brugada Syndrome 1) or both (mixed syndromes), depending on the mutation and environmental triggers. One such trigger may be an increase in cytosolic calcium, accompanying exercise. Many mixed"}
{"subject": "Brugada Syndrome 1", "sub_type": "Disease", "rel": "ThemeOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-28734073.json", "snippet": " [CLS] loss-of-function (Brugada Syndrome 1 [CLS] ) or both (mixed syndromes), depending on the mutation and environmental triggers. One such trigger may be an increase in cytosolic calcium, accompanying exercise. Many mixed syndromes mutants, including \u2206KPQ,"}
{"subject": "activation kinetics", "sub_type": "MPA", "rel": "ThemeOf", "object": "D242N KV7.1 channels", "obj_type": "MPA", "file_name": "PubMed-28739325.json", "snippet": " the conserved charge balance of this region. Perforated patch-clamp experiments show that, unexpectedly, the mutation did not disrupt the voltage-dependent activation but it removed the inactivation and slowed the  [CLS] activation kinetics of D242N KV7.1 channels [CLS] . Biotinylation of cell-surface protein and co-immunoprecipitation experiments revealed that neither plasma membrane targeting nor co-assembly between KV7.1 and KCNE1 was altered by the mutation. However, the association of D242N"}
{"subject": "conserved charge balance of this region", "sub_type": "MPA", "rel": "ThemeOf", "object": "disrupting", "obj_type": "NegReg", "file_name": "PubMed-28739325.json", "snippet": " and cellular consequences of the D242N KV7.1 mutation associated with the LQTS. The mutation is located in the S4 transmembrane segment, within the voltage sensor of the KV7.1 channel,  [CLS] disrupting the conserved charge balance of this region [CLS] . Perforated patch-clamp experiments show that, unexpectedly, the mutation did not disrupt the voltage-dependent activation but it removed the inactivation and slowed the activation kinetics of D242N KV7.1 channels. Biotinylation"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "cause", "obj_type": "Reg", "file_name": "PubMed-28739325.json", "snippet": " co-assemble to give rise to the IKs current, one of the most important repolarizing currents of the cardiac action potential. Its relevance is underscored by the identification of >500  [CLS] mutations in KV7.1 and, at least, 36 in KCNE1, that cause [CLS]  Long QT Syndrome (LQTS). The aim of this study was to characterize the biophysical and cellular consequences of the D242N KV7.1 mutation associated with the LQTS. The mutation is"}
{"subject": "Long QT Syndrome", "sub_type": "Disease", "rel": "ThemeOf", "object": "cause", "obj_type": "Reg", "file_name": "PubMed-28739325.json", "snippet": " the most important repolarizing currents of the cardiac action potential. Its relevance is underscored by the identification of >500 mutations in KV7.1 and, at least, 36 in KCNE1, that  [CLS] cause Long QT Syndrome [CLS]  (LQTS). The aim of this study was to characterize the biophysical and cellular consequences of the D242N KV7.1 mutation associated with the LQTS. The mutation is located in the"}
{"subject": "mutations", "sub_type": "Var", "rel": "ThemeOf", "object": "KCNE1", "obj_type": "Gene", "file_name": "PubMed-28739325.json", "snippet": " co-assemble to give rise to the IKs current, one of the most important repolarizing currents of the cardiac action potential. Its relevance is underscored by the identification of >500  [CLS] mutations in KV7.1 and, at least, 36 in KCNE1 [CLS] , that cause Long QT Syndrome (LQTS). The aim of this study was to characterize the biophysical and cellular consequences of the D242N KV7.1 mutation associated with the LQTS. The"}
{"subject": "D242N", "sub_type": "Var", "rel": "CauseOf", "object": "impaired", "obj_type": "NegReg", "file_name": "PubMed-28739325.json", "snippet": " to more depolarized potentials (+50mV), hindering IKs current at physiologically relevant membrane potentials. Both functional and computational analysis suggest that the clinical phenotype of the LQTS patients carrying the  [CLS] D242N mutation is due to impaired [CLS]  action potential adaptation to exercise and, in particular, to increase in heart rate. Moreover, our data identify D242 aminoacidic position as a potential residue involved in the KCNE1-mediated regulation"}
{"subject": "action potential adaptation to exercise", "sub_type": "MPA", "rel": "ThemeOf", "object": "impaired", "obj_type": "NegReg", "file_name": "PubMed-28739325.json", "snippet": " hindering IKs current at physiologically relevant membrane potentials. Both functional and computational analysis suggest that the clinical phenotype of the LQTS patients carrying the D242N mutation is due to  [CLS] impaired action potential adaptation to exercise [CLS]  and, in particular, to increase in heart rate. Moreover, our data identify D242 aminoacidic position as a potential residue involved in the KCNE1-mediated regulation of the voltage dependence of"}
{"subject": "D242N", "sub_type": "Var", "rel": "CauseOf", "object": "increase", "obj_type": "PosReg", "file_name": "PubMed-28739325.json", "snippet": " to more depolarized potentials (+50mV), hindering IKs current at physiologically relevant membrane potentials. Both functional and computational analysis suggest that the clinical phenotype of the LQTS patients carrying the  [CLS] D242N mutation is due to impaired action potential adaptation to exercise and, in particular, to increase [CLS]  in heart rate. Moreover, our data identify D242 aminoacidic position as a potential residue involved in the KCNE1-mediated regulation of the voltage dependence of activation of the KV7.1 channel."}
{"subject": "heart rate", "sub_type": "MPA", "rel": "ThemeOf", "object": "increase", "obj_type": "PosReg", "file_name": "PubMed-28739325.json", "snippet": " and computational analysis suggest that the clinical phenotype of the LQTS patients carrying the D242N mutation is due to impaired action potential adaptation to exercise and, in particular, to  [CLS] increase in heart rate [CLS] . Moreover, our data identify D242 aminoacidic position as a potential residue involved in the KCNE1-mediated regulation of the voltage dependence of activation of the KV7.1 channel."}
{"subject": "mutation", "sub_type": "Var", "rel": "CauseOf", "object": "removed", "obj_type": "NegReg", "file_name": "PubMed-28739325.json", "snippet": " located in the S4 transmembrane segment, within the voltage sensor of the KV7.1 channel, disrupting the conserved charge balance of this region. Perforated patch-clamp experiments show that, unexpectedly, the  [CLS] mutation did not disrupt the voltage-dependent activation but it removed [CLS]  the inactivation and slowed the activation kinetics of D242N KV7.1 channels. Biotinylation of cell-surface protein and co-immunoprecipitation experiments revealed that neither plasma membrane targeting nor co-assembly between KV7.1 and"}
{"subject": "KV7.1", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-28739325.json", "snippet": " co-assemble to give rise to the IKs current, one of the most important repolarizing currents of the cardiac action potential. Its relevance is underscored by the identification of >500  [CLS] mutations in KV7.1 [CLS]  and, at least, 36 in KCNE1, that cause Long QT Syndrome (LQTS). The aim of this study was to characterize the biophysical and cellular consequences of the D242N KV7.1"}
{"subject": "KCNE1", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-28739325.json", "snippet": " co-assemble to give rise to the IKs current, one of the most important repolarizing currents of the cardiac action potential. Its relevance is underscored by the identification of >500  [CLS] mutations in KV7.1 and, at least, 36 in KCNE1 [CLS] , that cause Long QT Syndrome (LQTS). The aim of this study was to characterize the biophysical and cellular consequences of the D242N KV7.1 mutation associated with the LQTS. The"}
{"subject": "KV7.1", "sub_type": "Gene", "rel": "ThemeOf", "object": "D242N", "obj_type": "Var", "file_name": "PubMed-28739325.json", "snippet": " in KV7.1 and, at least, 36 in KCNE1, that cause Long QT Syndrome (LQTS). The aim of this study was to characterize the biophysical and cellular consequences of the  [CLS] D242N KV7.1 [CLS]  mutation associated with the LQTS. The mutation is located in the S4 transmembrane segment, within the voltage sensor of the KV7.1 channel, disrupting the conserved charge balance of this"}
{"subject": "D242N", "sub_type": "Var", "rel": "CauseOf", "object": "associated", "obj_type": "Reg", "file_name": "PubMed-28739325.json", "snippet": " in KV7.1 and, at least, 36 in KCNE1, that cause Long QT Syndrome (LQTS). The aim of this study was to characterize the biophysical and cellular consequences of the  [CLS] D242N KV7.1 mutation associated [CLS]  with the LQTS. The mutation is located in the S4 transmembrane segment, within the voltage sensor of the KV7.1 channel, disrupting the conserved charge balance of this region. Perforated"}
{"subject": "inactivation", "sub_type": "MPA", "rel": "ThemeOf", "object": "removed", "obj_type": "NegReg", "file_name": "PubMed-28739325.json", "snippet": " sensor of the KV7.1 channel, disrupting the conserved charge balance of this region. Perforated patch-clamp experiments show that, unexpectedly, the mutation did not disrupt the voltage-dependent activation but it  [CLS] removed the inactivation [CLS]  and slowed the activation kinetics of D242N KV7.1 channels. Biotinylation of cell-surface protein and co-immunoprecipitation experiments revealed that neither plasma membrane targeting nor co-assembly between KV7.1 and KCNE1 was"}
{"subject": "mutation", "sub_type": "Var", "rel": "CauseOf", "object": "slowed", "obj_type": "NegReg", "file_name": "PubMed-28739325.json", "snippet": " located in the S4 transmembrane segment, within the voltage sensor of the KV7.1 channel, disrupting the conserved charge balance of this region. Perforated patch-clamp experiments show that, unexpectedly, the  [CLS] mutation did not disrupt the voltage-dependent activation but it removed the inactivation and slowed [CLS]  the activation kinetics of D242N KV7.1 channels. Biotinylation of cell-surface protein and co-immunoprecipitation experiments revealed that neither plasma membrane targeting nor co-assembly between KV7.1 and KCNE1 was altered by"}
{"subject": "activation kinetics", "sub_type": "MPA", "rel": "ThemeOf", "object": "slowed", "obj_type": "NegReg", "file_name": "PubMed-28739325.json", "snippet": " channel, disrupting the conserved charge balance of this region. Perforated patch-clamp experiments show that, unexpectedly, the mutation did not disrupt the voltage-dependent activation but it removed the inactivation and  [CLS] slowed the activation kinetics [CLS]  of D242N KV7.1 channels. Biotinylation of cell-surface protein and co-immunoprecipitation experiments revealed that neither plasma membrane targeting nor co-assembly between KV7.1 and KCNE1 was altered by the mutation. However,"}
{"subject": "LQTS", "sub_type": "Disease", "rel": "ThemeOf", "object": "associated", "obj_type": "Reg", "file_name": "PubMed-28739325.json", "snippet": " at least, 36 in KCNE1, that cause Long QT Syndrome (LQTS). The aim of this study was to characterize the biophysical and cellular consequences of the D242N KV7.1 mutation  [CLS] associated with the LQTS [CLS] . The mutation is located in the S4 transmembrane segment, within the voltage sensor of the KV7.1 channel, disrupting the conserved charge balance of this region. Perforated patch-clamp experiments show"}
{"subject": "mutation", "sub_type": "Var", "rel": "CauseOf", "object": "disrupting", "obj_type": "NegReg", "file_name": "PubMed-28739325.json", "snippet": " that cause Long QT Syndrome (LQTS). The aim of this study was to characterize the biophysical and cellular consequences of the D242N KV7.1 mutation associated with the LQTS. The  [CLS] mutation is located in the S4 transmembrane segment, within the voltage sensor of the KV7.1 channel, disrupting [CLS]  the conserved charge balance of this region. Perforated patch-clamp experiments show that, unexpectedly, the mutation did not disrupt the voltage-dependent activation but it removed the inactivation and slowed the"}
{"subject": "variants", "sub_type": "Var", "rel": "CauseOf", "object": "cause", "obj_type": "Reg", "file_name": "PubMed-28739660.json", "snippet": " renal agenesis is almost invariably fatal at birth, and unilateral renal agenesis can lead to future health issues including end stage renal disease. Genetic investigations have identified several gene  [CLS] variants which cause [CLS]  RA, including EYA1, LHX1, and WT1 However, whereas compound null mutations of genes encoding \u03b1 and \u03b3 retinoic acid receptors (RARs) cause RA in mice, to date there have"}
{"subject": "kidney agenesis phenotypes", "sub_type": "MPA", "rel": "ThemeOf", "object": "revealed", "obj_type": "Reg", "file_name": "PubMed-28739660.json", "snippet": " candidate gene, GREB1L Analysis of a zebrafish greb1l loss-of-function mutant revealed defects in the pronephric kidney just prior to death, and F0 CRISPR/Cas9 mutagenesis of Greb1l in the mouse  [CLS] revealed kidney agenesis phenotypes [CLS] , implicating Greb1l in this disorder. GREB1L resides in a chromatin complex with RAR members, and our data implicate GREB1L as a coactivator for RARs. This study is the first"}
{"subject": "RA", "sub_type": "Disease", "rel": "ThemeOf", "object": "cause", "obj_type": "Reg", "file_name": "PubMed-28739660.json", "snippet": " is almost invariably fatal at birth, and unilateral renal agenesis can lead to future health issues including end stage renal disease. Genetic investigations have identified several gene variants which  [CLS] cause RA [CLS] , including EYA1, LHX1, and WT1 However, whereas compound null mutations of genes encoding \u03b1 and \u03b3 retinoic acid receptors (RARs) cause RA in mice, to date there have been"}
{"subject": "mutant", "sub_type": "Var", "rel": "CauseOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-28739660.json", "snippet": " carried out whole exome sequence analysis of two families showing inheritance of an RA phenotype, and in both identified a single candidate gene, GREB1L Analysis of a zebrafish greb1l  [CLS] loss-of-function mutant [CLS]  revealed defects in the pronephric kidney just prior to death, and F0 CRISPR/Cas9 mutagenesis of Greb1l in the mouse revealed kidney agenesis phenotypes, implicating Greb1l in this disorder. GREB1L"}
{"subject": "pronephric kidney just prior to death", "sub_type": "MPA", "rel": "ThemeOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-28739660.json", "snippet": " carried out whole exome sequence analysis of two families showing inheritance of an RA phenotype, and in both identified a single candidate gene, GREB1L Analysis of a zebrafish greb1l  [CLS] loss-of-function mutant revealed defects in the pronephric kidney just prior to death [CLS] , and F0 CRISPR/Cas9 mutagenesis of Greb1l in the mouse revealed kidney agenesis phenotypes, implicating Greb1l in this disorder. GREB1L resides in a chromatin complex with RAR members, and our"}
{"subject": "mutagenesis", "sub_type": "Var", "rel": "CauseOf", "object": "revealed", "obj_type": "Reg", "file_name": "PubMed-28739660.json", "snippet": " and in both identified a single candidate gene, GREB1L Analysis of a zebrafish greb1l loss-of-function mutant revealed defects in the pronephric kidney just prior to death, and F0 CRISPR/Cas9  [CLS] mutagenesis of Greb1l in the mouse revealed [CLS]  kidney agenesis phenotypes, implicating Greb1l in this disorder. GREB1L resides in a chromatin complex with RAR members, and our data implicate GREB1L as a coactivator for RARs. This study"}
{"subject": "missense variant", "sub_type": "Var", "rel": "CauseOf", "object": "causes", "obj_type": "Reg", "file_name": "PubMed-28741757.json", "snippet": " [CLS] missense variant in the FOXP2 and FOXP1 transcription factors causes [CLS]  distinct neurodevelopmental disorders.\nThe closely related paralogues FOXP2 and FOXP1 encode transcription factors with shared functions in the development of many tissues, including the brain. However, while mutations in"}
{"subject": "global developmental delay", "sub_type": "Disease", "rel": "ThemeOf", "object": "includes", "obj_type": "Reg", "file_name": "PubMed-28741757.json", "snippet": " of many tissues, including the brain. However, while mutations in FOXP2 lead to a speech/language disorder characterized by childhood apraxia of speech (CAS), the clinical profile of FOXP1 variants  [CLS] includes a broader neurodevelopmental phenotype with global developmental delay [CLS] , intellectual disability, and speech/language impairment. Using clinical whole-exome sequencing, we report an identical de novo missense FOXP1 variant identified in three unrelated patients. The variant, p.R514H, is located in"}
{"subject": "intellectual disability", "sub_type": "Disease", "rel": "ThemeOf", "object": "includes", "obj_type": "Reg", "file_name": "PubMed-28741757.json", "snippet": " of many tissues, including the brain. However, while mutations in FOXP2 lead to a speech/language disorder characterized by childhood apraxia of speech (CAS), the clinical profile of FOXP1 variants  [CLS] includes a broader neurodevelopmental phenotype with global developmental delay, intellectual disability [CLS] , and speech/language impairment. Using clinical whole-exome sequencing, we report an identical de novo missense FOXP1 variant identified in three unrelated patients. The variant, p.R514H, is located in the forkhead-box"}
{"subject": "speech/language impairment", "sub_type": "Disease", "rel": "ThemeOf", "object": "includes", "obj_type": "Reg", "file_name": "PubMed-28741757.json", "snippet": " of many tissues, including the brain. However, while mutations in FOXP2 lead to a speech/language disorder characterized by childhood apraxia of speech (CAS), the clinical profile of FOXP1 variants  [CLS] includes a broader neurodevelopmental phenotype with global developmental delay, intellectual disability, and speech/language impairment [CLS] . Using clinical whole-exome sequencing, we report an identical de novo missense FOXP1 variant identified in three unrelated patients. The variant, p.R514H, is located in the forkhead-box DNA-binding domain and"}
{"subject": "neurodevelopmental disorders", "sub_type": "Disease", "rel": "ThemeOf", "object": "causes", "obj_type": "Reg", "file_name": "PubMed-28741757.json", "snippet": " [CLS] causes distinct neurodevelopmental disorders [CLS] .\nThe closely related paralogues FOXP2 and FOXP1 encode transcription factors with shared functions in the development of many tissues, including the brain. However, while mutations in FOXP2 lead to"}
{"subject": "FOXP2", "sub_type": "Gene", "rel": "ThemeOf", "object": "missense variant", "obj_type": "Var", "file_name": "PubMed-28741757.json", "snippet": " [CLS] missense variant in the FOXP2 [CLS]  and FOXP1 transcription factors causes distinct neurodevelopmental disorders.\nThe closely related paralogues FOXP2 and FOXP1 encode transcription factors with shared functions in the development of many tissues, including the"}
{"subject": "FOXP1", "sub_type": "Gene", "rel": "ThemeOf", "object": "missense variant", "obj_type": "Var", "file_name": "PubMed-28741757.json", "snippet": " [CLS] missense variant in the FOXP2 and FOXP1 [CLS]  transcription factors causes distinct neurodevelopmental disorders.\nThe closely related paralogues FOXP2 and FOXP1 encode transcription factors with shared functions in the development of many tissues, including the brain. However,"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "lead to", "obj_type": "Reg", "file_name": "PubMed-28741757.json", "snippet": " factors causes distinct neurodevelopmental disorders.\nThe closely related paralogues FOXP2 and FOXP1 encode transcription factors with shared functions in the development of many tissues, including the brain. However, while  [CLS] mutations in FOXP2 lead to [CLS]  a speech/language disorder characterized by childhood apraxia of speech (CAS), the clinical profile of FOXP1 variants includes a broader neurodevelopmental phenotype with global developmental delay, intellectual disability, and speech/language"}
{"subject": "FOXP2", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-28741757.json", "snippet": " factors causes distinct neurodevelopmental disorders.\nThe closely related paralogues FOXP2 and FOXP1 encode transcription factors with shared functions in the development of many tissues, including the brain. However, while  [CLS] mutations in FOXP2 [CLS]  lead to a speech/language disorder characterized by childhood apraxia of speech (CAS), the clinical profile of FOXP1 variants includes a broader neurodevelopmental phenotype with global developmental delay, intellectual disability,"}
{"subject": "childhood apraxia of speech", "sub_type": "Disease", "rel": "ThemeOf", "object": "lead to", "obj_type": "Reg", "file_name": "PubMed-28741757.json", "snippet": " neurodevelopmental disorders.\nThe closely related paralogues FOXP2 and FOXP1 encode transcription factors with shared functions in the development of many tissues, including the brain. However, while mutations in FOXP2  [CLS] lead to a speech/language disorder characterized by childhood apraxia of speech [CLS]  (CAS), the clinical profile of FOXP1 variants includes a broader neurodevelopmental phenotype with global developmental delay, intellectual disability, and speech/language impairment. Using clinical whole-exome sequencing, we report an identical"}
{"subject": "FOXP1", "sub_type": "Gene", "rel": "ThemeOf", "object": "variants", "obj_type": "Var", "file_name": "PubMed-28741757.json", "snippet": " the development of many tissues, including the brain. However, while mutations in FOXP2 lead to a speech/language disorder characterized by childhood apraxia of speech (CAS), the clinical profile of  [CLS] FOXP1 variants [CLS]  includes a broader neurodevelopmental phenotype with global developmental delay, intellectual disability, and speech/language impairment. Using clinical whole-exome sequencing, we report an identical de novo missense FOXP1 variant identified in"}
{"subject": "variants", "sub_type": "Var", "rel": "CauseOf", "object": "includes", "obj_type": "Reg", "file_name": "PubMed-28741757.json", "snippet": " development of many tissues, including the brain. However, while mutations in FOXP2 lead to a speech/language disorder characterized by childhood apraxia of speech (CAS), the clinical profile of FOXP1  [CLS] variants includes [CLS]  a broader neurodevelopmental phenotype with global developmental delay, intellectual disability, and speech/language impairment. Using clinical whole-exome sequencing, we report an identical de novo missense FOXP1 variant identified in three"}
{"subject": "Leu191Phe", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutation", "obj_type": "Var", "file_name": "PubMed-28742244.json", "snippet": " (c.573G>C, p.[Leu191Phe]) was detected in the proband and his mother. Enzyme activity analysis confirmed superactivity of PRPP synthetase. Analysis of the crystal structure of human PRPPS suggests that the  [CLS] Leu191Phe mutation [CLS]  affects the architecture of both allosteric sites, thereby preventing the allosteric inhibition of the enzyme. The family reported here broadens the clinical spectrum of PRPPS superactivity and indicates that"}
{"subject": "mutation", "sub_type": "Var", "rel": "CauseOf", "object": "affects", "obj_type": "Reg", "file_name": "PubMed-28742244.json", "snippet": " p.[Leu191Phe]) was detected in the proband and his mother. Enzyme activity analysis confirmed superactivity of PRPP synthetase. Analysis of the crystal structure of human PRPPS suggests that the Leu191Phe  [CLS] mutation affects [CLS]  the architecture of both allosteric sites, thereby preventing the allosteric inhibition of the enzyme. The family reported here broadens the clinical spectrum of PRPPS superactivity and indicates that this"}
{"subject": "architecture", "sub_type": "MPA", "rel": "ThemeOf", "object": "affects", "obj_type": "Reg", "file_name": "PubMed-28742244.json", "snippet": " was detected in the proband and his mother. Enzyme activity analysis confirmed superactivity of PRPP synthetase. Analysis of the crystal structure of human PRPPS suggests that the Leu191Phe mutation  [CLS] affects the architecture [CLS]  of both allosteric sites, thereby preventing the allosteric inhibition of the enzyme. The family reported here broadens the clinical spectrum of PRPPS superactivity and indicates that this rare metabolic"}
{"subject": "architecture", "sub_type": "MPA", "rel": "CauseOf", "object": "preventing", "obj_type": "NegReg", "file_name": "PubMed-28742244.json", "snippet": " in the proband and his mother. Enzyme activity analysis confirmed superactivity of PRPP synthetase. Analysis of the crystal structure of human PRPPS suggests that the Leu191Phe mutation affects the  [CLS] architecture of both allosteric sites, thereby preventing [CLS]  the allosteric inhibition of the enzyme. The family reported here broadens the clinical spectrum of PRPPS superactivity and indicates that this rare metabolic disorder might be associated with a"}
{"subject": "allosteric inhibition", "sub_type": "MPA", "rel": "ThemeOf", "object": "preventing", "obj_type": "NegReg", "file_name": "PubMed-28742244.json", "snippet": " Enzyme activity analysis confirmed superactivity of PRPP synthetase. Analysis of the crystal structure of human PRPPS suggests that the Leu191Phe mutation affects the architecture of both allosteric sites, thereby  [CLS] preventing the allosteric inhibition [CLS]  of the enzyme. The family reported here broadens the clinical spectrum of PRPPS superactivity and indicates that this rare metabolic disorder might be associated with a recognizable facial gestalt."}
{"subject": "enzyme", "sub_type": "Enzyme", "rel": "ThemeOf", "object": "allosteric inhibition", "obj_type": "MPA", "file_name": "PubMed-28742244.json", "snippet": " analysis confirmed superactivity of PRPP synthetase. Analysis of the crystal structure of human PRPPS suggests that the Leu191Phe mutation affects the architecture of both allosteric sites, thereby preventing the  [CLS] allosteric inhibition of the enzyme [CLS] . The family reported here broadens the clinical spectrum of PRPPS superactivity and indicates that this rare metabolic disorder might be associated with a recognizable facial gestalt."}
{"subject": "Variation", "sub_type": "Var", "rel": "CauseOf", "object": "Contributes", "obj_type": "Reg", "file_name": "PubMed-28743761.json", "snippet": " [CLS] Variation at Ugt86Dd Contributes [CLS]  to Nicotine Resistance in Drosophila melanogaster.\nIdentifying the sequence polymorphisms underlying complex trait variation is a key goal of genetics research, since knowing the precise causative molecular events allows"}
{"subject": "Ugt86Dd", "sub_type": "Gene", "rel": "ThemeOf", "object": "lesions", "obj_type": "Var", "file_name": "PubMed-28743761.json", "snippet": " the InDel during mapping largely eliminates the QTL, implying the event explains the bulk of the effect of the mapped locus. CRISPR/Cas9 editing a relatively resistant genotype to generate  [CLS] lesions in Ugt86Dd [CLS]  that recapitulate the naturally-occurring putative loss-of-function allele leads to a large reduction in resistance. Despite this major effect of the deletion, the allele appears to be very rare in"}
{"subject": "Ugt86Dd", "sub_type": "Gene", "rel": "ThemeOf", "object": "Variation", "obj_type": "Var", "file_name": "PubMed-28743761.json", "snippet": " [CLS] Variation at Ugt86Dd [CLS]  Contributes to Nicotine Resistance in Drosophila melanogaster.\nIdentifying the sequence polymorphisms underlying complex trait variation is a key goal of genetics research, since knowing the precise causative molecular events"}
{"subject": "Nicotine Resistance in Drosophila melanogaster", "sub_type": "MPA", "rel": "ThemeOf", "object": "Contributes", "obj_type": "Reg", "file_name": "PubMed-28743761.json", "snippet": " [CLS] Contributes to Nicotine Resistance in Drosophila melanogaster [CLS] .\nIdentifying the sequence polymorphisms underlying complex trait variation is a key goal of genetics research, since knowing the precise causative molecular events allows insight into the pathways governing trait"}
{"subject": "frameshift deletion", "sub_type": "Var", "rel": "CauseOf", "object": "eliminates", "obj_type": "NegReg", "file_name": "PubMed-28743761.json", "snippet": " showed that Ugt86Dd had significantly higher expression in genotypes that are more resistant to nicotine, and anterior midgut-specific RNAi of this gene reduced resistance. We discovered a segregating 22-bp  [CLS] frameshift deletion in Ugt86Dd, and accounting for the InDel during mapping largely eliminates [CLS]  the QTL, implying the event explains the bulk of the effect of the mapped locus. CRISPR/Cas9 editing a relatively resistant genotype to generate lesions in Ugt86Dd that recapitulate the"}
{"subject": "QTL", "sub_type": "MPA", "rel": "ThemeOf", "object": "eliminates", "obj_type": "NegReg", "file_name": "PubMed-28743761.json", "snippet": " resistant to nicotine, and anterior midgut-specific RNAi of this gene reduced resistance. We discovered a segregating 22-bp frameshift deletion in Ugt86Dd, and accounting for the InDel during mapping largely  [CLS] eliminates the QTL [CLS] , implying the event explains the bulk of the effect of the mapped locus. CRISPR/Cas9 editing a relatively resistant genotype to generate lesions in Ugt86Dd that recapitulate the naturally-occurring putative"}
{"subject": "Ugt86Dd", "sub_type": "Gene", "rel": "ThemeOf", "object": "frameshift deletion", "obj_type": "Var", "file_name": "PubMed-28743761.json", "snippet": " showed that Ugt86Dd had significantly higher expression in genotypes that are more resistant to nicotine, and anterior midgut-specific RNAi of this gene reduced resistance. We discovered a segregating 22-bp  [CLS] frameshift deletion in Ugt86Dd [CLS] , and accounting for the InDel during mapping largely eliminates the QTL, implying the event explains the bulk of the effect of the mapped locus. CRISPR/Cas9 editing a relatively resistant"}
{"subject": "lesions", "sub_type": "Var", "rel": "CauseOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-28743761.json", "snippet": " the InDel during mapping largely eliminates the QTL, implying the event explains the bulk of the effect of the mapped locus. CRISPR/Cas9 editing a relatively resistant genotype to generate  [CLS] lesions in Ugt86Dd that recapitulate the naturally-occurring putative loss-of-function [CLS]  allele leads to a large reduction in resistance. Despite this major effect of the deletion, the allele appears to be very rare in wild-caught populations, and likely explains only"}
{"subject": "lesions", "sub_type": "Var", "rel": "CauseOf", "object": "reduction", "obj_type": "NegReg", "file_name": "PubMed-28743761.json", "snippet": " the InDel during mapping largely eliminates the QTL, implying the event explains the bulk of the effect of the mapped locus. CRISPR/Cas9 editing a relatively resistant genotype to generate  [CLS] lesions in Ugt86Dd that recapitulate the naturally-occurring putative loss-of-function allele leads to a large reduction [CLS]  in resistance. Despite this major effect of the deletion, the allele appears to be very rare in wild-caught populations, and likely explains only a small fraction of the natural"}
{"subject": "resistance", "sub_type": "MPA", "rel": "ThemeOf", "object": "reduction", "obj_type": "NegReg", "file_name": "PubMed-28743761.json", "snippet": " of the effect of the mapped locus. CRISPR/Cas9 editing a relatively resistant genotype to generate lesions in Ugt86Dd that recapitulate the naturally-occurring putative loss-of-function allele leads to a large  [CLS] reduction in resistance [CLS] . Despite this major effect of the deletion, the allele appears to be very rare in wild-caught populations, and likely explains only a small fraction of the natural variation for"}
{"subject": "Sequence exchange", "sub_type": "Var", "rel": "CauseOf", "object": "converts", "obj_type": "Reg", "file_name": "PubMed-28747428.json", "snippet": " [CLS] Sequence exchange between R genes converts [CLS]  virus resistance into nematode resistance, and vice versa.\nPlants have evolved a limited repertoire of NB-LRR disease resistance (R) genes to protect themselves against a myriad of pathogens. This"}
{"subject": "mild nematode resistance in the roots", "sub_type": "MPA", "rel": "ThemeOf", "object": "convert", "obj_type": "Reg", "file_name": "PubMed-28747428.json", "snippet": " was sufficient to regain a wild type resistance response to G. pallida in the roots. These data demonstrate that exchanging the recognition moiety in the LRR is sufficient to  [CLS] convert extreme virus resistance in the leaves into mild nematode resistance in the roots [CLS] , and vice versa. In addition, we show that the CC-NB-ARC can operate independently of the recognition specificities defined by the LRR domain, either above or belowground. These data show"}
{"subject": "nematode resistance", "sub_type": "MPA", "rel": "ThemeOf", "object": "converts", "obj_type": "Reg", "file_name": "PubMed-28747428.json", "snippet": " [CLS] converts virus resistance into nematode resistance [CLS] , and vice versa.\nPlants have evolved a limited repertoire of NB-LRR disease resistance (R) genes to protect themselves against a myriad of pathogens. This limitation is thought to be"}
{"subject": "R", "sub_type": "Gene", "rel": "ThemeOf", "object": "Sequence exchange", "obj_type": "Var", "file_name": "PubMed-28747428.json", "snippet": " [CLS] Sequence exchange between R [CLS]  genes converts virus resistance into nematode resistance, and vice versa.\nPlants have evolved a limited repertoire of NB-LRR disease resistance (R) genes to protect themselves against a myriad of"}
{"subject": "changes", "sub_type": "Var", "rel": "CauseOf", "object": "alter", "obj_type": "Reg", "file_name": "PubMed-28747428.json", "snippet": " resistance (R) genes to protect themselves against a myriad of pathogens. This limitation is thought to be counterbalanced by the rapid evolution of NB-LRR proteins, as only few sequence  [CLS] changes have been shown to be sufficient to alter [CLS]  resistance specificities towards novel strains of a pathogen. However, little is known about the flexibility of NB-LRR genes to switch resistance specificities between phylogenetically unrelated pathogens. To investigate this,"}
{"subject": "resistance specificities towards novel strains of a pathogen", "sub_type": "MPA", "rel": "ThemeOf", "object": "alter", "obj_type": "Reg", "file_name": "PubMed-28747428.json", "snippet": " myriad of pathogens. This limitation is thought to be counterbalanced by the rapid evolution of NB-LRR proteins, as only few sequence changes have been shown to be sufficient to  [CLS] alter resistance specificities towards novel strains of a pathogen [CLS] . However, little is known about the flexibility of NB-LRR genes to switch resistance specificities between phylogenetically unrelated pathogens. To investigate this, we created domain swaps between the close homologs"}
{"subject": "exchange", "sub_type": "Var", "rel": "CauseOf", "object": "regain", "obj_type": "PosReg", "file_name": "PubMed-28747428.json", "snippet": " in autoactivity, but lowering the protein levels restored its specific activation response including extreme resistance to PVX in potato shoots. The reciprocal construct (Rx1CN/Gpa2L) showed a loss-of-function phenotype, but  [CLS] exchange of the first 3 LRR repeats of Rx1 was sufficient to regain [CLS]  a wild type resistance response to G. pallida in the roots. These data demonstrate that exchanging the recognition moiety in the LRR is sufficient to convert extreme virus resistance"}
{"subject": "wild type resistance response to G. pallida in the roots", "sub_type": "MPA", "rel": "ThemeOf", "object": "regain", "obj_type": "PosReg", "file_name": "PubMed-28747428.json", "snippet": " including extreme resistance to PVX in potato shoots. The reciprocal construct (Rx1CN/Gpa2L) showed a loss-of-function phenotype, but exchange of the first 3 LRR repeats of Rx1 was sufficient to  [CLS] regain a wild type resistance response to G. pallida in the roots [CLS] . These data demonstrate that exchanging the recognition moiety in the LRR is sufficient to convert extreme virus resistance in the leaves into mild nematode resistance in the roots, and"}
{"subject": "Rx1", "sub_type": "Gene", "rel": "ThemeOf", "object": "exchange", "obj_type": "Var", "file_name": "PubMed-28747428.json", "snippet": " in autoactivity, but lowering the protein levels restored its specific activation response including extreme resistance to PVX in potato shoots. The reciprocal construct (Rx1CN/Gpa2L) showed a loss-of-function phenotype, but  [CLS] exchange of the first 3 LRR repeats of Rx1 [CLS]  was sufficient to regain a wild type resistance response to G. pallida in the roots. These data demonstrate that exchanging the recognition moiety in the LRR is sufficient to"}
{"subject": "exchanging", "sub_type": "Var", "rel": "CauseOf", "object": "convert", "obj_type": "Reg", "file_name": "PubMed-28747428.json", "snippet": " but exchange of the first 3 LRR repeats of Rx1 was sufficient to regain a wild type resistance response to G. pallida in the roots. These data demonstrate that  [CLS] exchanging the recognition moiety in the LRR is sufficient to convert [CLS]  extreme virus resistance in the leaves into mild nematode resistance in the roots, and vice versa. In addition, we show that the CC-NB-ARC can operate independently of the recognition"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "associated", "obj_type": "Reg", "file_name": "PubMed-28747464.json", "snippet": " [CLS] mutations in the K(+) channels Kir4.1 (KCNJ10) and SLACK (KCNT1) associated [CLS]  with severe-disabling seizures and neurodevelopmental delay.\nA 2-year-old boy presented profound developmental delay, failure to thrive, ataxia, hypotonia and tonic-clonic seizures that caused the death of the patient. Targeted"}
{"subject": "protein expression", "sub_type": "MPA", "rel": "ThemeOf", "object": "reduced", "obj_type": "NegReg", "file_name": "PubMed-28747464.json", "snippet": " a p.L218F substitution at a highly conserved residue site. Wild-type KCNJ10 expression yielded robust Kir currents, while currents from oocytes expressing the mutation were reduced. Western Blot analysis revealed  [CLS] reduced protein expression [CLS]  by the mutation. Kir5.1 subunits display selective heteromultimerization with Kir4.1 constituting channels with unique kinetics. The effect of the mutation on Kir4.1/5.1 channel activity was twofold: a reduction in"}
{"subject": "mutation", "sub_type": "Var", "rel": "CauseOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-28747464.json", "snippet": " kinetics. The effect of the mutation on Kir4.1/5.1 channel activity was twofold: a reduction in current amplitudes and an increase in the pH-dependent inhibition. We thus report a novel  [CLS] loss-of-function mutation [CLS]  in Kir4.1 found in a patient with a co-exiting mutation in SLACK channels that results in a fatal disease."}
{"subject": "mutation", "sub_type": "Var", "rel": "ThemeOf", "object": "mutation", "obj_type": "Var", "file_name": "PubMed-28747464.json", "snippet": " The effect of the mutation on Kir4.1/5.1 channel activity was twofold: a reduction in current amplitudes and an increase in the pH-dependent inhibition. We thus report a novel loss-of-function  [CLS] mutation in Kir4.1 found in a patient with a co-exiting mutation [CLS]  in SLACK channels that results in a fatal disease."}
{"subject": "mutation", "sub_type": "Var", "rel": "CauseOf", "object": "results in", "obj_type": "Reg", "file_name": "PubMed-28747464.json", "snippet": " The effect of the mutation on Kir4.1/5.1 channel activity was twofold: a reduction in current amplitudes and an increase in the pH-dependent inhibition. We thus report a novel loss-of-function  [CLS] mutation in Kir4.1 found in a patient with a co-exiting mutation in SLACK channels that results in [CLS]  a fatal disease."}
{"subject": "fatal disease", "sub_type": "Disease", "rel": "ThemeOf", "object": "results in", "obj_type": "Reg", "file_name": "PubMed-28747464.json", "snippet": " amplitudes and an increase in the pH-dependent inhibition. We thus report a novel loss-of-function mutation in Kir4.1 found in a patient with a co-exiting mutation in SLACK channels that  [CLS] results in a fatal disease [CLS] ."}
{"subject": "seizures", "sub_type": "Disease", "rel": "ThemeOf", "object": "associated", "obj_type": "Reg", "file_name": "PubMed-28747464.json", "snippet": " [CLS] associated with severe-disabling seizures [CLS]  and neurodevelopmental delay.\nA 2-year-old boy presented profound developmental delay, failure to thrive, ataxia, hypotonia and tonic-clonic seizures that caused the death of the patient. Targeted and whole-exome sequencing"}
{"subject": "KCNJ10", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-28747464.json", "snippet": " [CLS] mutations in the K(+) channels Kir4.1 (KCNJ10 [CLS] ) and SLACK (KCNT1) associated with severe-disabling seizures and neurodevelopmental delay.\nA 2-year-old boy presented profound developmental delay, failure to thrive, ataxia, hypotonia and tonic-clonic seizures that caused the death"}
{"subject": "KCNT1", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-28747464.json", "snippet": " [CLS] mutations in the K(+) channels Kir4.1 (KCNJ10) and SLACK (KCNT1 [CLS] ) associated with severe-disabling seizures and neurodevelopmental delay.\nA 2-year-old boy presented profound developmental delay, failure to thrive, ataxia, hypotonia and tonic-clonic seizures that caused the death of the patient."}
{"subject": "neurodevelopmental delay", "sub_type": "Disease", "rel": "ThemeOf", "object": "associated", "obj_type": "Reg", "file_name": "PubMed-28747464.json", "snippet": " [CLS] associated with severe-disabling seizures and neurodevelopmental delay [CLS] .\nA 2-year-old boy presented profound developmental delay, failure to thrive, ataxia, hypotonia and tonic-clonic seizures that caused the death of the patient. Targeted and whole-exome sequencing revealed two heterozygous"}
{"subject": "KCNJ10", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutation", "obj_type": "Var", "file_name": "PubMed-28747464.json", "snippet": " Kir4.1 mutation. The mutant and wild-type KCNJ10 constructs were generated and heterologously expressed in Xenopus laevis oocytes, and whole-cell K(+) currents were measured using the two-electrode voltage-clamp technique. The  [CLS] KCNJ10 mutation [CLS]  c.652C>T resulted in a p.L218F substitution at a highly conserved residue site. Wild-type KCNJ10 expression yielded robust Kir currents, while currents from oocytes expressing the mutation were reduced. Western"}
{"subject": "mutation", "sub_type": "Var", "rel": "CauseOf", "object": "resulted in", "obj_type": "Reg", "file_name": "PubMed-28747464.json", "snippet": " mutation. The mutant and wild-type KCNJ10 constructs were generated and heterologously expressed in Xenopus laevis oocytes, and whole-cell K(+) currents were measured using the two-electrode voltage-clamp technique. The KCNJ10  [CLS] mutation c.652C>T resulted in [CLS]  a p.L218F substitution at a highly conserved residue site. Wild-type KCNJ10 expression yielded robust Kir currents, while currents from oocytes expressing the mutation were reduced. Western Blot analysis revealed"}
{"subject": "substitution", "sub_type": "Var", "rel": "ThemeOf", "object": "resulted in", "obj_type": "Reg", "file_name": "PubMed-28747464.json", "snippet": " mutant and wild-type KCNJ10 constructs were generated and heterologously expressed in Xenopus laevis oocytes, and whole-cell K(+) currents were measured using the two-electrode voltage-clamp technique. The KCNJ10 mutation c.652C>T  [CLS] resulted in a p.L218F substitution [CLS]  at a highly conserved residue site. Wild-type KCNJ10 expression yielded robust Kir currents, while currents from oocytes expressing the mutation were reduced. Western Blot analysis revealed reduced protein expression"}
{"subject": "mutation", "sub_type": "Var", "rel": "CauseOf", "object": "reduced", "obj_type": "NegReg", "file_name": "PubMed-28747464.json", "snippet": " a p.L218F substitution at a highly conserved residue site. Wild-type KCNJ10 expression yielded robust Kir currents, while currents from oocytes expressing the mutation were reduced. Western Blot analysis revealed  [CLS] reduced protein expression by the mutation [CLS] . Kir5.1 subunits display selective heteromultimerization with Kir4.1 constituting channels with unique kinetics. The effect of the mutation on Kir4.1/5.1 channel activity was twofold: a reduction in current amplitudes and"}
{"subject": "LQTS", "sub_type": "Disease", "rel": "ThemeOf", "object": "pathogenic", "obj_type": "Reg", "file_name": "PubMed-28749435.json", "snippet": " common variants KCNH2-p.K897T and KCNE1-p.G38S were previously reported to produce more severe phenotypes when combined with disease-causing alleles. Our results indicate that the novel KCNH2-C108Y variant can be a  [CLS] pathogenic LQTS [CLS]  mutation, whereas KCNQ1-p.R583H, KCNH2-p.K897T, and KCNE1-p.G38S could be LQTS modifiers."}
{"subject": "KCNH2", "sub_type": "Gene", "rel": "ThemeOf", "object": "p.C108Y", "obj_type": "Var", "file_name": "PubMed-28749435.json", "snippet": " previous studies, we analyzed two mutated channels, KCNQ1-p.R583H and KCNH2-p.C108Y, using the whole-cell patch clamp technique. We found that KCNQ1-p.R583H was not associated with a severe functional impairment, whereas  [CLS] KCNH2-p.C108Y [CLS] , a novel variant, encoded a non-functional channel that exerts dominant-negative effects on the wild-type. Notably, the common variants KCNH2-p.K897T and KCNE1-p.G38S were previously reported to produce more severe phenotypes"}
{"subject": "p.C108Y", "sub_type": "Var", "rel": "CauseOf", "object": "encoded", "obj_type": "Reg", "file_name": "PubMed-28749435.json", "snippet": " previous studies, we analyzed two mutated channels, KCNQ1-p.R583H and KCNH2-p.C108Y, using the whole-cell patch clamp technique. We found that KCNQ1-p.R583H was not associated with a severe functional impairment, whereas KCNH2- [CLS] p.C108Y, a novel variant, encoded [CLS]  a non-functional channel that exerts dominant-negative effects on the wild-type. Notably, the common variants KCNH2-p.K897T and KCNE1-p.G38S were previously reported to produce more severe phenotypes when combined with disease-causing"}
{"subject": "non-functional channel", "sub_type": "Pathway", "rel": "ThemeOf", "object": "encoded", "obj_type": "Reg", "file_name": "PubMed-28749435.json", "snippet": " two mutated channels, KCNQ1-p.R583H and KCNH2-p.C108Y, using the whole-cell patch clamp technique. We found that KCNQ1-p.R583H was not associated with a severe functional impairment, whereas KCNH2-p.C108Y, a novel variant,  [CLS] encoded a non-functional channel [CLS]  that exerts dominant-negative effects on the wild-type. Notably, the common variants KCNH2-p.K897T and KCNE1-p.G38S were previously reported to produce more severe phenotypes when combined with disease-causing alleles. Our results"}
{"subject": "non-functional channel", "sub_type": "Pathway", "rel": "CauseOf", "object": "dominant-negative", "obj_type": "NegReg", "file_name": "PubMed-28749435.json", "snippet": " channels, KCNQ1-p.R583H and KCNH2-p.C108Y, using the whole-cell patch clamp technique. We found that KCNQ1-p.R583H was not associated with a severe functional impairment, whereas KCNH2-p.C108Y, a novel variant, encoded a  [CLS] non-functional channel that exerts dominant-negative [CLS]  effects on the wild-type. Notably, the common variants KCNH2-p.K897T and KCNE1-p.G38S were previously reported to produce more severe phenotypes when combined with disease-causing alleles. Our results indicate that the"}
{"subject": "effects", "sub_type": "MPA", "rel": "ThemeOf", "object": "dominant-negative", "obj_type": "NegReg", "file_name": "PubMed-28749435.json", "snippet": " using the whole-cell patch clamp technique. We found that KCNQ1-p.R583H was not associated with a severe functional impairment, whereas KCNH2-p.C108Y, a novel variant, encoded a non-functional channel that exerts  [CLS] dominant-negative effects [CLS]  on the wild-type. Notably, the common variants KCNH2-p.K897T and KCNE1-p.G38S were previously reported to produce more severe phenotypes when combined with disease-causing alleles. Our results indicate that the novel"}
{"subject": "KCNH2", "sub_type": "Gene", "rel": "ThemeOf", "object": "C108Y", "obj_type": "Var", "file_name": "PubMed-28749435.json", "snippet": " on the wild-type. Notably, the common variants KCNH2-p.K897T and KCNE1-p.G38S were previously reported to produce more severe phenotypes when combined with disease-causing alleles. Our results indicate that the novel  [CLS] KCNH2-C108Y [CLS]  variant can be a pathogenic LQTS mutation, whereas KCNQ1-p.R583H, KCNH2-p.K897T, and KCNE1-p.G38S could be LQTS modifiers."}
{"subject": "C108Y", "sub_type": "Var", "rel": "CauseOf", "object": "pathogenic", "obj_type": "Reg", "file_name": "PubMed-28749435.json", "snippet": " on the wild-type. Notably, the common variants KCNH2-p.K897T and KCNE1-p.G38S were previously reported to produce more severe phenotypes when combined with disease-causing alleles. Our results indicate that the novel KCNH2- [CLS] C108Y variant can be a pathogenic [CLS]  LQTS mutation, whereas KCNQ1-p.R583H, KCNH2-p.K897T, and KCNE1-p.G38S could be LQTS modifiers."}
{"subject": "mutation", "sub_type": "Var", "rel": "CauseOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-28751317.json", "snippet": " iron homeostasis in rice.\nOsHRZ1 is a potential iron-binding sensor. However, it is unclear how OsHRZ1 transmits signals. In this study, we reveal that OsPRI1 interacts with OsHRZ1. A  [CLS] loss-of-function mutation [CLS]  to OsPRI1 increased the sensitivity of plants to Fe-deficient conditions and downregulated the expression of Fe-deficiency-responsive genes. Yeast one-hybrid and electrophoretic mobility shift assay results suggested that OsPRI1 binds"}
{"subject": "pri1-1", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutation", "obj_type": "Var", "file_name": "PubMed-28751317.json", "snippet": " in wild type roots, but increased in the hrz1-2 mutant, suggesting OsHRZ1 is responsible for the instability of OsPRI1. The hrz1-2 seedlings were insensitive to Fe-deficient conditions. When the  [CLS] pri1-1 mutation [CLS]  was introduced into hrz1-2 mutants, the pri1hrz1 double mutant was more sensitive to Fe deficiency than the hrz1-2 mutant. Additionally, the expression levels of Fe-deficiency-responsive genes were lower in"}
{"subject": "mutation", "sub_type": "Var", "rel": "ThemeOf", "object": "introduced", "obj_type": "Interaction", "file_name": "PubMed-28751317.json", "snippet": " wild type roots, but increased in the hrz1-2 mutant, suggesting OsHRZ1 is responsible for the instability of OsPRI1. The hrz1-2 seedlings were insensitive to Fe-deficient conditions. When the pri1-1  [CLS] mutation was introduced [CLS]  into hrz1-2 mutants, the pri1hrz1 double mutant was more sensitive to Fe deficiency than the hrz1-2 mutant. Additionally, the expression levels of Fe-deficiency-responsive genes were lower in the hrz1pri1"}
{"subject": "mutants", "sub_type": "Var", "rel": "ThemeOf", "object": "introduced", "obj_type": "Interaction", "file_name": "PubMed-28751317.json", "snippet": " roots, but increased in the hrz1-2 mutant, suggesting OsHRZ1 is responsible for the instability of OsPRI1. The hrz1-2 seedlings were insensitive to Fe-deficient conditions. When the pri1-1 mutation was  [CLS] introduced into hrz1-2 mutants [CLS] , the pri1hrz1 double mutant was more sensitive to Fe deficiency than the hrz1-2 mutant. Additionally, the expression levels of Fe-deficiency-responsive genes were lower in the hrz1pri1 double mutant than"}
{"subject": "hrz1-2", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutants", "obj_type": "Var", "file_name": "PubMed-28751317.json", "snippet": " increased in the hrz1-2 mutant, suggesting OsHRZ1 is responsible for the instability of OsPRI1. The hrz1-2 seedlings were insensitive to Fe-deficient conditions. When the pri1-1 mutation was introduced into  [CLS] hrz1-2 mutants [CLS] , the pri1hrz1 double mutant was more sensitive to Fe deficiency than the hrz1-2 mutant. Additionally, the expression levels of Fe-deficiency-responsive genes were lower in the hrz1pri1 double mutant than"}
{"subject": "hrz1-2", "sub_type": "Gene", "rel": "CauseOf", "object": "introduced", "obj_type": "Interaction", "file_name": "PubMed-28751317.json", "snippet": " roots, but increased in the hrz1-2 mutant, suggesting OsHRZ1 is responsible for the instability of OsPRI1. The hrz1-2 seedlings were insensitive to Fe-deficient conditions. When the pri1-1 mutation was  [CLS] introduced into hrz1-2 [CLS]  mutants, the pri1hrz1 double mutant was more sensitive to Fe deficiency than the hrz1-2 mutant. Additionally, the expression levels of Fe-deficiency-responsive genes were lower in the hrz1pri1 double mutant"}
{"subject": "mutants", "sub_type": "Var", "rel": "CauseOf", "object": "more", "obj_type": "PosReg", "file_name": "PubMed-28751317.json", "snippet": " in the hrz1-2 mutant, suggesting OsHRZ1 is responsible for the instability of OsPRI1. The hrz1-2 seedlings were insensitive to Fe-deficient conditions. When the pri1-1 mutation was introduced into hrz1-2  [CLS] mutants, the pri1hrz1 double mutant was more [CLS]  sensitive to Fe deficiency than the hrz1-2 mutant. Additionally, the expression levels of Fe-deficiency-responsive genes were lower in the hrz1pri1 double mutant than in the hrz1-2 mutant. Collectively, these"}
{"subject": "sensitive to Fe deficiency", "sub_type": "MPA", "rel": "ThemeOf", "object": "more", "obj_type": "PosReg", "file_name": "PubMed-28751317.json", "snippet": " is responsible for the instability of OsPRI1. The hrz1-2 seedlings were insensitive to Fe-deficient conditions. When the pri1-1 mutation was introduced into hrz1-2 mutants, the pri1hrz1 double mutant was  [CLS] more sensitive to Fe deficiency [CLS]  than the hrz1-2 mutant. Additionally, the expression levels of Fe-deficiency-responsive genes were lower in the hrz1pri1 double mutant than in the hrz1-2 mutant. Collectively, these results imply that OsPRI1,"}
{"subject": "OsPRI1", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutation", "obj_type": "Var", "file_name": "PubMed-28751317.json", "snippet": " homeostasis in rice.\nOsHRZ1 is a potential iron-binding sensor. However, it is unclear how OsHRZ1 transmits signals. In this study, we reveal that OsPRI1 interacts with OsHRZ1. A loss-of-function  [CLS] mutation to OsPRI1 [CLS]  increased the sensitivity of plants to Fe-deficient conditions and downregulated the expression of Fe-deficiency-responsive genes. Yeast one-hybrid and electrophoretic mobility shift assay results suggested that OsPRI1 binds to the"}
{"subject": "mutation", "sub_type": "Var", "rel": "CauseOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-28751317.json", "snippet": " homeostasis in rice.\nOsHRZ1 is a potential iron-binding sensor. However, it is unclear how OsHRZ1 transmits signals. In this study, we reveal that OsPRI1 interacts with OsHRZ1. A loss-of-function  [CLS] mutation to OsPRI1 increased [CLS]  the sensitivity of plants to Fe-deficient conditions and downregulated the expression of Fe-deficiency-responsive genes. Yeast one-hybrid and electrophoretic mobility shift assay results suggested that OsPRI1 binds to the OsIRO2"}
{"subject": "sensitivity", "sub_type": "MPA", "rel": "ThemeOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-28751317.json", "snippet": "\nOsHRZ1 is a potential iron-binding sensor. However, it is unclear how OsHRZ1 transmits signals. In this study, we reveal that OsPRI1 interacts with OsHRZ1. A loss-of-function mutation to OsPRI1  [CLS] increased the sensitivity [CLS]  of plants to Fe-deficient conditions and downregulated the expression of Fe-deficiency-responsive genes. Yeast one-hybrid and electrophoretic mobility shift assay results suggested that OsPRI1 binds to the OsIRO2 and OsIRO3"}
{"subject": "mutation", "sub_type": "Var", "rel": "CauseOf", "object": "downregulated", "obj_type": "NegReg", "file_name": "PubMed-28751317.json", "snippet": " homeostasis in rice.\nOsHRZ1 is a potential iron-binding sensor. However, it is unclear how OsHRZ1 transmits signals. In this study, we reveal that OsPRI1 interacts with OsHRZ1. A loss-of-function  [CLS] mutation to OsPRI1 increased the sensitivity of plants to Fe-deficient conditions and downregulated [CLS]  the expression of Fe-deficiency-responsive genes. Yeast one-hybrid and electrophoretic mobility shift assay results suggested that OsPRI1 binds to the OsIRO2 and OsIRO3 promoters. In vitro ubiquitination experiments indicated that"}
{"subject": "expression", "sub_type": "MPA", "rel": "ThemeOf", "object": "downregulated", "obj_type": "NegReg", "file_name": "PubMed-28751317.json", "snippet": " unclear how OsHRZ1 transmits signals. In this study, we reveal that OsPRI1 interacts with OsHRZ1. A loss-of-function mutation to OsPRI1 increased the sensitivity of plants to Fe-deficient conditions and  [CLS] downregulated the expression [CLS]  of Fe-deficiency-responsive genes. Yeast one-hybrid and electrophoretic mobility shift assay results suggested that OsPRI1 binds to the OsIRO2 and OsIRO3 promoters. In vitro ubiquitination experiments indicated that OsPRI1 is"}
{"subject": "hrz1-2", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutant", "obj_type": "Var", "file_name": "PubMed-28751317.json", "snippet": " In vitro ubiquitination experiments indicated that OsPRI1 is ubiquitinated by OsHRZ1. Cell-free degradation assays revealed that the stability of OsPRI1 decreased in wild type roots, but increased in the  [CLS] hrz1-2 mutant [CLS] , suggesting OsHRZ1 is responsible for the instability of OsPRI1. The hrz1-2 seedlings were insensitive to Fe-deficient conditions. When the pri1-1 mutation was introduced into hrz1-2 mutants, the pri1hrz1 double"}
{"subject": "mutant", "sub_type": "Var", "rel": "CauseOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-28751317.json", "snippet": " and OsIRO3 promoters. In vitro ubiquitination experiments indicated that OsPRI1 is ubiquitinated by OsHRZ1. Cell-free degradation assays revealed that the stability of OsPRI1 decreased in wild type roots, but  [CLS] increased in the hrz1-2 mutant [CLS] , suggesting OsHRZ1 is responsible for the instability of OsPRI1. The hrz1-2 seedlings were insensitive to Fe-deficient conditions. When the pri1-1 mutation was introduced into hrz1-2 mutants, the pri1hrz1 double"}
{"subject": "stability", "sub_type": "MPA", "rel": "ThemeOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-28751317.json", "snippet": " assay results suggested that OsPRI1 binds to the OsIRO2 and OsIRO3 promoters. In vitro ubiquitination experiments indicated that OsPRI1 is ubiquitinated by OsHRZ1. Cell-free degradation assays revealed that the  [CLS] stability of OsPRI1 decreased in wild type roots, but increased [CLS]  in the hrz1-2 mutant, suggesting OsHRZ1 is responsible for the instability of OsPRI1. The hrz1-2 seedlings were insensitive to Fe-deficient conditions. When the pri1-1 mutation was introduced into hrz1-2"}
{"subject": "IKZF1", "sub_type": "Gene", "rel": "ThemeOf", "object": "deletions", "obj_type": "Var", "file_name": "PubMed-28751559.json", "snippet": " [CLS] IKZF1 deletions [CLS]  are associated with an adverse prognosis in adult BCR-ABL-negative acute lymphoblastic leukemia.\nGenetic alterations of the transcription factor IKZF1 (\"IKAROS\") are detected in around 15-30% of cases of BCR-ABL-negative"}
{"subject": "deletions", "sub_type": "Var", "rel": "CauseOf", "object": "Loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-28751559.json", "snippet": " [CLS] Loss-of-function but not dominant-negative intragenic IKZF1 deletions [CLS]  are associated with an adverse prognosis in adult BCR-ABL-negative acute lymphoblastic leukemia.\nGenetic alterations of the transcription factor IKZF1 (\"IKAROS\") are detected in around 15-30% of cases of BCR-ABL-negative"}
{"subject": "acute lymphoblastic leukemia", "sub_type": "Disease", "rel": "ThemeOf", "object": "Loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-28751559.json", "snippet": " [CLS] Loss-of-function but not dominant-negative intragenic IKZF1 deletions are associated with an adverse prognosis in adult BCR-ABL-negative acute lymphoblastic leukemia [CLS] .\nGenetic alterations of the transcription factor IKZF1 (\"IKAROS\") are detected in around 15-30% of cases of BCR-ABL-negative B-cell precursor acute lymphoblastic leukemia (ALL). Different types of intragenic deletions have"}
{"subject": "deletions", "sub_type": "Var", "rel": "CauseOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-28751559.json", "snippet": " lymphoblastic leukemia.\nGenetic alterations of the transcription factor IKZF1 (\"IKAROS\") are detected in around 15-30% of cases of BCR-ABL-negative B-cell precursor acute lymphoblastic leukemia (ALL). Different types of intragenic  [CLS] deletions have been observed, resulting in a functionally inactivated allele (\"loss-of-function [CLS] \") or in \"dominant-negative\" isoforms. The prognostic impact of these alterations especially in adult acute lymphoblastic leukemia is not well defined. We analyzed 482 well-characterized cases of adult BCR-ABL-negative B-precursor"}
{"subject": "functionally inactivated allele", "sub_type": "MPA", "rel": "ThemeOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-28751559.json", "snippet": " factor IKZF1 (\"IKAROS\") are detected in around 15-30% of cases of BCR-ABL-negative B-cell precursor acute lymphoblastic leukemia (ALL). Different types of intragenic deletions have been observed, resulting in a  [CLS] functionally inactivated allele (\"loss-of-function [CLS] \") or in \"dominant-negative\" isoforms. The prognostic impact of these alterations especially in adult acute lymphoblastic leukemia is not well defined. We analyzed 482 well-characterized cases of adult BCR-ABL-negative B-precursor"}
{"subject": "deletions", "sub_type": "Var", "rel": "CauseOf", "object": "dominant-negative", "obj_type": "NegReg", "file_name": "PubMed-28751559.json", "snippet": " lymphoblastic leukemia.\nGenetic alterations of the transcription factor IKZF1 (\"IKAROS\") are detected in around 15-30% of cases of BCR-ABL-negative B-cell precursor acute lymphoblastic leukemia (ALL). Different types of intragenic  [CLS] deletions have been observed, resulting in a functionally inactivated allele (\"loss-of-function\") or in \"dominant-negative [CLS] \" isoforms. The prognostic impact of these alterations especially in adult acute lymphoblastic leukemia is not well defined. We analyzed 482 well-characterized cases of adult BCR-ABL-negative B-precursor acute lymphoblastic leukemia"}
{"subject": "isoforms", "sub_type": "MPA", "rel": "ThemeOf", "object": "dominant-negative", "obj_type": "NegReg", "file_name": "PubMed-28751559.json", "snippet": " around 15-30% of cases of BCR-ABL-negative B-cell precursor acute lymphoblastic leukemia (ALL). Different types of intragenic deletions have been observed, resulting in a functionally inactivated allele (\"loss-of-function\") or in \" [CLS] dominant-negative\" isoforms [CLS] . The prognostic impact of these alterations especially in adult acute lymphoblastic leukemia is not well defined. We analyzed 482 well-characterized cases of adult BCR-ABL-negative B-precursor acute lymphoblastic leukemia uniformly"}
{"subject": "high deletion load", "sub_type": "Var", "rel": "CauseOf", "object": "shorter", "obj_type": "NegReg", "file_name": "PubMed-28751559.json", "snippet": " load\") while in 7% it was detected only in small subclones (\"low deletion load\"). Some patients showed more than one IKZF1 alteration (8%). Patients exhibiting a loss-of-function isoform with  [CLS] high deletion load had a shorter [CLS]  overall survival (OS at 5 years 28% vs. 59%, p<0.0001), also significant in a subgroup analysis of standard risk patients according to GMALL classification (OS at 5 years 37%"}
{"subject": "overall survival", "sub_type": "MPA", "rel": "ThemeOf", "object": "shorter", "obj_type": "NegReg", "file_name": "PubMed-28751559.json", "snippet": " was detected only in small subclones (\"low deletion load\"). Some patients showed more than one IKZF1 alteration (8%). Patients exhibiting a loss-of-function isoform with high deletion load had a  [CLS] shorter overall survival [CLS]  (OS at 5 years 28% vs. 59%, p<0.0001), also significant in a subgroup analysis of standard risk patients according to GMALL classification (OS at 5 years 37% vs. 68%,"}
{"subject": "mutant", "sub_type": "Var", "rel": "CauseOf", "object": "loss of function", "obj_type": "NegReg", "file_name": "PubMed-28754659.json", "snippet": " genes-atl-1 and cep-1-which encode proteins that act in the DNA damage response pathway. Loss of function mutants of atl-1 had no defect in UVC induced SIS but a partial  [CLS] loss of function mutant [CLS]  of cep-1, gk138, had decreased movement quiescence following UVC irradiation. Germline ablation experiments and tissue-specific RNA interference experiments showed that cep-1 is required somatically in neurons for its effect"}
{"subject": "cep-1", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutant", "obj_type": "Var", "file_name": "PubMed-28754659.json", "snippet": " encode proteins that act in the DNA damage response pathway. Loss of function mutants of atl-1 had no defect in UVC induced SIS but a partial loss of function  [CLS] mutant of cep-1 [CLS] , gk138, had decreased movement quiescence following UVC irradiation. Germline ablation experiments and tissue-specific RNA interference experiments showed that cep-1 is required somatically in neurons for its effect on SIS."}
{"subject": "mutant", "sub_type": "Var", "rel": "CauseOf", "object": "decreased", "obj_type": "NegReg", "file_name": "PubMed-28754659.json", "snippet": " encode proteins that act in the DNA damage response pathway. Loss of function mutants of atl-1 had no defect in UVC induced SIS but a partial loss of function  [CLS] mutant of cep-1, gk138, had decreased [CLS]  movement quiescence following UVC irradiation. Germline ablation experiments and tissue-specific RNA interference experiments showed that cep-1 is required somatically in neurons for its effect on SIS. The cep-1(gk138) mutant"}
{"subject": "movement quiescence", "sub_type": "MPA", "rel": "ThemeOf", "object": "decreased", "obj_type": "NegReg", "file_name": "PubMed-28754659.json", "snippet": " the DNA damage response pathway. Loss of function mutants of atl-1 had no defect in UVC induced SIS but a partial loss of function mutant of cep-1, gk138, had  [CLS] decreased movement quiescence [CLS]  following UVC irradiation. Germline ablation experiments and tissue-specific RNA interference experiments showed that cep-1 is required somatically in neurons for its effect on SIS. The cep-1(gk138) mutant suppressed body"}
{"subject": "cep-1", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutant", "obj_type": "Var", "file_name": "PubMed-28754659.json", "snippet": " had decreased movement quiescence following UVC irradiation. Germline ablation experiments and tissue-specific RNA interference experiments showed that cep-1 is required somatically in neurons for its effect on SIS. The  [CLS] cep-1(gk138) mutant [CLS]  suppressed body movement quiescence controlled by EGF, indicating that CEP-1 acts downstream or in parallel to ALA activation to promote quiescence in response to ultraviolet light."}
{"subject": "mutant", "sub_type": "Var", "rel": "CauseOf", "object": "suppressed", "obj_type": "NegReg", "file_name": "PubMed-28754659.json", "snippet": " decreased movement quiescence following UVC irradiation. Germline ablation experiments and tissue-specific RNA interference experiments showed that cep-1 is required somatically in neurons for its effect on SIS. The cep-1(gk138)  [CLS] mutant suppressed [CLS]  body movement quiescence controlled by EGF, indicating that CEP-1 acts downstream or in parallel to ALA activation to promote quiescence in response to ultraviolet light."}
{"subject": "body movement quiescence controlled by EGF", "sub_type": "MPA", "rel": "ThemeOf", "object": "suppressed", "obj_type": "NegReg", "file_name": "PubMed-28754659.json", "snippet": " movement quiescence following UVC irradiation. Germline ablation experiments and tissue-specific RNA interference experiments showed that cep-1 is required somatically in neurons for its effect on SIS. The cep-1(gk138) mutant  [CLS] suppressed body movement quiescence controlled by EGF [CLS] , indicating that CEP-1 acts downstream or in parallel to ALA activation to promote quiescence in response to ultraviolet light."}
{"subject": "PCSK9", "sub_type": "Gene", "rel": "ThemeOf", "object": "deficiency", "obj_type": "Var", "file_name": "PubMed-28758421.json", "snippet": " [CLS] PCSK9 deficiency [CLS]  results in increased ectopic fat accumulation in experimental models and in humans.\nBackground Proprotein convertase subtilisin kexin type 9 (PCSK9) regulates low-density lipoprotein and very low-density lipoprotein receptor expression"}
{"subject": "deficiency", "sub_type": "Var", "rel": "CauseOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-28758421.json", "snippet": " [CLS] deficiency results in increased [CLS]  ectopic fat accumulation in experimental models and in humans.\nBackground Proprotein convertase subtilisin kexin type 9 (PCSK9) regulates low-density lipoprotein and very low-density lipoprotein receptor expression in several tissues."}
{"subject": "ectopic fat accumulation", "sub_type": "MPA", "rel": "ThemeOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-28758421.json", "snippet": " [CLS] increased ectopic fat accumulation [CLS]  in experimental models and in humans.\nBackground Proprotein convertase subtilisin kexin type 9 (PCSK9) regulates low-density lipoprotein and very low-density lipoprotein receptor expression in several tissues. Here we evaluated"}
{"subject": "R46L", "sub_type": "Gene", "rel": "ThemeOf", "object": "variant", "obj_type": "Var", "file_name": "PubMed-28758421.json", "snippet": " the R46L variant ( n\u2009=\u200913) had lower low-density lipoprotein cholesterol levels, higher body mass index and increased percentage of total and android fat masses compared with non-carriers ( n\u2009=\u2009521).  [CLS] R46L variant [CLS]  associated with a two-fold increase prevalence of hepatic steatosis and higher epicardial fat thickness. These observations were replicated in PCSK9 KO mice, which showed increased visceral adipose tissue (but"}
{"subject": "variant", "sub_type": "Var", "rel": "CauseOf", "object": "increase", "obj_type": "PosReg", "file_name": "PubMed-28758421.json", "snippet": " R46L variant ( n\u2009=\u200913) had lower low-density lipoprotein cholesterol levels, higher body mass index and increased percentage of total and android fat masses compared with non-carriers ( n\u2009=\u2009521). R46L  [CLS] variant associated with a two-fold increase [CLS]  prevalence of hepatic steatosis and higher epicardial fat thickness. These observations were replicated in PCSK9 KO mice, which showed increased visceral adipose tissue (but not subcutaneous adipose tissue) when"}
{"subject": "hepatic steatosis and higher epicardial fat thickness", "sub_type": "MPA", "rel": "ThemeOf", "object": "increase", "obj_type": "PosReg", "file_name": "PubMed-28758421.json", "snippet": " lower low-density lipoprotein cholesterol levels, higher body mass index and increased percentage of total and android fat masses compared with non-carriers ( n\u2009=\u2009521). R46L variant associated with a two-fold  [CLS] increase prevalence of hepatic steatosis and higher epicardial fat thickness [CLS] . These observations were replicated in PCSK9 KO mice, which showed increased visceral adipose tissue (but not subcutaneous adipose tissue) when fed chow or high-fat diet for 20 weeks, compared"}
{"subject": "PCSK9", "sub_type": "Gene", "rel": "ThemeOf", "object": "deficiency", "obj_type": "Var", "file_name": "PubMed-28758421.json", "snippet": " visceral adipose tissue (but not subcutaneous adipose tissue) when fed chow or high-fat diet for 20 weeks, compared with wild type mice. Conclusions These data suggest that genetically determined  [CLS] PCSK9 deficiency [CLS]  might be associated with ectopic fat accumulation."}
{"subject": "deficiency", "sub_type": "Var", "rel": "CauseOf", "object": "associated", "obj_type": "Reg", "file_name": "PubMed-28758421.json", "snippet": " adipose tissue (but not subcutaneous adipose tissue) when fed chow or high-fat diet for 20 weeks, compared with wild type mice. Conclusions These data suggest that genetically determined PCSK9  [CLS] deficiency might be associated [CLS]  with ectopic fat accumulation."}
{"subject": "ectopic fat accumulation", "sub_type": "MPA", "rel": "ThemeOf", "object": "associated", "obj_type": "Reg", "file_name": "PubMed-28758421.json", "snippet": " not subcutaneous adipose tissue) when fed chow or high-fat diet for 20 weeks, compared with wild type mice. Conclusions These data suggest that genetically determined PCSK9 deficiency might be  [CLS] associated with ectopic fat accumulation [CLS] ."}
{"subject": "Braf", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutant", "obj_type": "Var", "file_name": "PubMed-28783725.json", "snippet": " [CLS] Braf kinase-inactive mutant [CLS]  induces lung adenocarcinoma.\nThe initiating oncogenic event in almost half of human lung adenocarcinomas is still unknown, a fact that complicates the development of selective targeted therapies. Yet these"}
{"subject": "Kras", "sub_type": "Gene", "rel": "ThemeOf", "object": "G12V", "obj_type": "Var", "file_name": "PubMed-28783725.json", "snippet": " vivo, indicating that BRAF-inactivating mutations are initiating events in lung oncogenesis. Moreover, inactivating BRAF mutations have also been identified in a subset of KRAS-driven human lung tumours. Co-expression of  [CLS] Kras(G12V [CLS] ) and Braf(D631A) in mouse lung cells markedly enhances tumour initiation, a phenomenon mediated by Craf kinase activity, and effectively accelerates tumour progression when activated in advanced lung adenocarcinomas. We"}
{"subject": "Braf", "sub_type": "Gene", "rel": "ThemeOf", "object": "D631A", "obj_type": "Var", "file_name": "PubMed-28783725.json", "snippet": " that BRAF-inactivating mutations are initiating events in lung oncogenesis. Moreover, inactivating BRAF mutations have also been identified in a subset of KRAS-driven human lung tumours. Co-expression of Kras(G12V) and  [CLS] Braf(D631A [CLS] ) in mouse lung cells markedly enhances tumour initiation, a phenomenon mediated by Craf kinase activity, and effectively accelerates tumour progression when activated in advanced lung adenocarcinomas. We also report"}
{"subject": "tumour initiation", "sub_type": "MPA", "rel": "ThemeOf", "object": "enhances", "obj_type": "PosReg", "file_name": "PubMed-28783725.json", "snippet": " in lung oncogenesis. Moreover, inactivating BRAF mutations have also been identified in a subset of KRAS-driven human lung tumours. Co-expression of Kras(G12V) and Braf(D631A) in mouse lung cells markedly  [CLS] enhances tumour initiation [CLS] , a phenomenon mediated by Craf kinase activity, and effectively accelerates tumour progression when activated in advanced lung adenocarcinomas. We also report a key role for the wild-type Braf kinase"}
{"subject": "G12V", "sub_type": "Var", "rel": "CauseOf", "object": "enhances", "obj_type": "PosReg", "file_name": "PubMed-28783725.json", "snippet": " vivo, indicating that BRAF-inactivating mutations are initiating events in lung oncogenesis. Moreover, inactivating BRAF mutations have also been identified in a subset of KRAS-driven human lung tumours. Co-expression of Kras( [CLS] G12V) and Braf(D631A) in mouse lung cells markedly enhances [CLS]  tumour initiation, a phenomenon mediated by Craf kinase activity, and effectively accelerates tumour progression when activated in advanced lung adenocarcinomas. We also report a key role for the wild-type"}
{"subject": "D631A", "sub_type": "Var", "rel": "CauseOf", "object": "enhances", "obj_type": "PosReg", "file_name": "PubMed-28783725.json", "snippet": " that BRAF-inactivating mutations are initiating events in lung oncogenesis. Moreover, inactivating BRAF mutations have also been identified in a subset of KRAS-driven human lung tumours. Co-expression of Kras(G12V) and Braf( [CLS] D631A) in mouse lung cells markedly enhances [CLS]  tumour initiation, a phenomenon mediated by Craf kinase activity, and effectively accelerates tumour progression when activated in advanced lung adenocarcinomas. We also report a key role for the wild-type"}
{"subject": "mutant", "sub_type": "Var", "rel": "CauseOf", "object": "induces", "obj_type": "Reg", "file_name": "PubMed-28783725.json", "snippet": " [CLS] mutant induces [CLS]  lung adenocarcinoma.\nThe initiating oncogenic event in almost half of human lung adenocarcinomas is still unknown, a fact that complicates the development of selective targeted therapies. Yet these tumours"}
{"subject": "lung adenocarcinoma", "sub_type": "Disease", "rel": "ThemeOf", "object": "induces", "obj_type": "Reg", "file_name": "PubMed-28783725.json", "snippet": " [CLS] induces lung adenocarcinoma [CLS] .\nThe initiating oncogenic event in almost half of human lung adenocarcinomas is still unknown, a fact that complicates the development of selective targeted therapies. Yet these tumours harbour a"}
{"subject": "Braf", "sub_type": "Gene", "rel": "ThemeOf", "object": "loss", "obj_type": "Var", "file_name": "PubMed-28783725.json", "snippet": " by inducing a further increase in MAPK signalling that results in oncogenic toxicity; this effect can be abolished by pharmacological inhibition of Mek to restore tumour growth. However, the  [CLS] loss of wild-type Braf [CLS]  also induces transdifferentiation of club cells, which leads to the rapid development of lethal intrabronchiolar lesions. These observations indicate that the signal intensity of the MAPK pathway is a"}
{"subject": "loss", "sub_type": "Var", "rel": "CauseOf", "object": "induces", "obj_type": "Reg", "file_name": "PubMed-28783725.json", "snippet": " by inducing a further increase in MAPK signalling that results in oncogenic toxicity; this effect can be abolished by pharmacological inhibition of Mek to restore tumour growth. However, the  [CLS] loss of wild-type Braf also induces [CLS]  transdifferentiation of club cells, which leads to the rapid development of lethal intrabronchiolar lesions. These observations indicate that the signal intensity of the MAPK pathway is a critical determinant"}
{"subject": "transdifferentiation", "sub_type": "CPA", "rel": "ThemeOf", "object": "induces", "obj_type": "Reg", "file_name": "PubMed-28783725.json", "snippet": " in MAPK signalling that results in oncogenic toxicity; this effect can be abolished by pharmacological inhibition of Mek to restore tumour growth. However, the loss of wild-type Braf also  [CLS] induces transdifferentiation [CLS]  of club cells, which leads to the rapid development of lethal intrabronchiolar lesions. These observations indicate that the signal intensity of the MAPK pathway is a critical determinant not"}
{"subject": "transdifferentiation", "sub_type": "CPA", "rel": "CauseOf", "object": "leads to", "obj_type": "Reg", "file_name": "PubMed-28783725.json", "snippet": " MAPK signalling that results in oncogenic toxicity; this effect can be abolished by pharmacological inhibition of Mek to restore tumour growth. However, the loss of wild-type Braf also induces  [CLS] transdifferentiation of club cells, which leads to [CLS]  the rapid development of lethal intrabronchiolar lesions. These observations indicate that the signal intensity of the MAPK pathway is a critical determinant not only in tumour development, but also"}
{"subject": "rapid development of lethal intrabronchiolar lesions", "sub_type": "MPA", "rel": "ThemeOf", "object": "leads to", "obj_type": "Reg", "file_name": "PubMed-28783725.json", "snippet": " oncogenic toxicity; this effect can be abolished by pharmacological inhibition of Mek to restore tumour growth. However, the loss of wild-type Braf also induces transdifferentiation of club cells, which  [CLS] leads to the rapid development of lethal intrabronchiolar lesions [CLS] . These observations indicate that the signal intensity of the MAPK pathway is a critical determinant not only in tumour development, but also in dictating the nature of the cancer-initiating"}
{"subject": "Loss-of-function", "sub_type": "Var", "rel": "CauseOf", "object": "exhibited", "obj_type": "Reg", "file_name": "PubMed-28798354.json", "snippet": " metabolism: mice mutant or deficient in Klotho exhibit phenotypes resembling human aging. Here we show that ectonucleotide pyrophosphatase/phosphodiesterase 1 (Enpp1) is required for Klotho expression under phosphate overload conditions.  [CLS] Loss-of-function Enpp1 (ttw/ttw) mice under phosphate overload conditions exhibited [CLS]  phenotypes resembling human aging and Klotho mutants, such as short life span, arteriosclerosis and osteoporosis, with elevated serum 1,25(OH)2D3 levels. Enpp1 (ttw/ttw) mice also exhibited significantly reduced renal Klotho"}
{"subject": "arteriosclerosis", "sub_type": "Disease", "rel": "ThemeOf", "object": "exhibited", "obj_type": "Reg", "file_name": "PubMed-28798354.json", "snippet": " phenotypes resembling human aging. Here we show that ectonucleotide pyrophosphatase/phosphodiesterase 1 (Enpp1) is required for Klotho expression under phosphate overload conditions. Loss-of-function Enpp1 (ttw/ttw) mice under phosphate overload conditions  [CLS] exhibited phenotypes resembling human aging and Klotho mutants, such as short life span, arteriosclerosis [CLS]  and osteoporosis, with elevated serum 1,25(OH)2D3 levels. Enpp1 (ttw/ttw) mice also exhibited significantly reduced renal Klotho expression under phosphate overload conditions, and aging phenotypes in these mice were rescued"}
{"subject": "osteoporosis", "sub_type": "Disease", "rel": "ThemeOf", "object": "exhibited", "obj_type": "Reg", "file_name": "PubMed-28798354.json", "snippet": " phenotypes resembling human aging. Here we show that ectonucleotide pyrophosphatase/phosphodiesterase 1 (Enpp1) is required for Klotho expression under phosphate overload conditions. Loss-of-function Enpp1 (ttw/ttw) mice under phosphate overload conditions  [CLS] exhibited phenotypes resembling human aging and Klotho mutants, such as short life span, arteriosclerosis and osteoporosis [CLS] , with elevated serum 1,25(OH)2D3 levels. Enpp1 (ttw/ttw) mice also exhibited significantly reduced renal Klotho expression under phosphate overload conditions, and aging phenotypes in these mice were rescued by Klotho"}
{"subject": "Enpp1", "sub_type": "Gene", "rel": "ThemeOf", "object": "Loss-of-function", "obj_type": "Var", "file_name": "PubMed-28798354.json", "snippet": " metabolism: mice mutant or deficient in Klotho exhibit phenotypes resembling human aging. Here we show that ectonucleotide pyrophosphatase/phosphodiesterase 1 (Enpp1) is required for Klotho expression under phosphate overload conditions.  [CLS] Loss-of-function Enpp1 [CLS]  (ttw/ttw) mice under phosphate overload conditions exhibited phenotypes resembling human aging and Klotho mutants, such as short life span, arteriosclerosis and osteoporosis, with elevated serum 1,25(OH)2D3 levels. Enpp1 (ttw/ttw)"}
{"subject": "serum 1,25(OH)2D3 levels", "sub_type": "MPA", "rel": "ThemeOf", "object": "elevated", "obj_type": "PosReg", "file_name": "PubMed-28798354.json", "snippet": " under phosphate overload conditions. Loss-of-function Enpp1 (ttw/ttw) mice under phosphate overload conditions exhibited phenotypes resembling human aging and Klotho mutants, such as short life span, arteriosclerosis and osteoporosis, with  [CLS] elevated serum 1,25(OH)2D3 levels [CLS] . Enpp1 (ttw/ttw) mice also exhibited significantly reduced renal Klotho expression under phosphate overload conditions, and aging phenotypes in these mice were rescued by Klotho overexpression, a low vitamin D"}
{"subject": "Loss-of-function", "sub_type": "Var", "rel": "CauseOf", "object": "elevated", "obj_type": "PosReg", "file_name": "PubMed-28798354.json", "snippet": " metabolism: mice mutant or deficient in Klotho exhibit phenotypes resembling human aging. Here we show that ectonucleotide pyrophosphatase/phosphodiesterase 1 (Enpp1) is required for Klotho expression under phosphate overload conditions.  [CLS] Loss-of-function Enpp1 (ttw/ttw) mice under phosphate overload conditions exhibited phenotypes resembling human aging and Klotho mutants, such as short life span, arteriosclerosis and osteoporosis, with elevated [CLS]  serum 1,25(OH)2D3 levels. Enpp1 (ttw/ttw) mice also exhibited significantly reduced renal Klotho expression under phosphate overload conditions, and aging phenotypes in these mice were rescued by Klotho overexpression, a"}
{"subject": "BmATG8", "sub_type": "Gene", "rel": "ThemeOf", "object": "Deletion", "obj_type": "Var", "file_name": "PubMed-28800850.json", "snippet": " autophagy in various stages of the life cycle of B. maydis, we constructed null mutants of BmATG8, an orthologue of the Saccharomyces cerevisiae autophagy gene ATG8 in B. maydis.  [CLS] Deletion of BmATG8 [CLS]  impaired localization of cytosolic components to the vacuole under nitrogen starvation, suggesting that autophagy was deficient in the null mutants. Additionally, fluorescent microscopic observations on a eGFP-fused BmATG8 expressing"}
{"subject": "Deletion", "sub_type": "Var", "rel": "CauseOf", "object": "impaired", "obj_type": "NegReg", "file_name": "PubMed-28800850.json", "snippet": " autophagy in various stages of the life cycle of B. maydis, we constructed null mutants of BmATG8, an orthologue of the Saccharomyces cerevisiae autophagy gene ATG8 in B. maydis.  [CLS] Deletion of BmATG8 impaired [CLS]  localization of cytosolic components to the vacuole under nitrogen starvation, suggesting that autophagy was deficient in the null mutants. Additionally, fluorescent microscopic observations on a eGFP-fused BmATG8 expressing strain"}
{"subject": "localization", "sub_type": "MPA", "rel": "ThemeOf", "object": "impaired", "obj_type": "NegReg", "file_name": "PubMed-28800850.json", "snippet": " stages of the life cycle of B. maydis, we constructed null mutants of BmATG8, an orthologue of the Saccharomyces cerevisiae autophagy gene ATG8 in B. maydis. Deletion of BmATG8  [CLS] impaired localization [CLS]  of cytosolic components to the vacuole under nitrogen starvation, suggesting that autophagy was deficient in the null mutants. Additionally, fluorescent microscopic observations on a eGFP-fused BmATG8 expressing strain showed"}
{"subject": "Deletion", "sub_type": "Var", "rel": "CauseOf", "object": "deficient", "obj_type": "NegReg", "file_name": "PubMed-28800850.json", "snippet": " autophagy in various stages of the life cycle of B. maydis, we constructed null mutants of BmATG8, an orthologue of the Saccharomyces cerevisiae autophagy gene ATG8 in B. maydis.  [CLS] Deletion of BmATG8 impaired localization of cytosolic components to the vacuole under nitrogen starvation, suggesting that autophagy was deficient [CLS]  in the null mutants. Additionally, fluorescent microscopic observations on a eGFP-fused BmATG8 expressing strain showed that BmATG8 is associated with autophagy-related structures. In vegetative growth, \u0394BmATG8 strains showed a"}
{"subject": "autophagy", "sub_type": "CPA", "rel": "ThemeOf", "object": "deficient", "obj_type": "NegReg", "file_name": "PubMed-28800850.json", "snippet": " BmATG8, an orthologue of the Saccharomyces cerevisiae autophagy gene ATG8 in B. maydis. Deletion of BmATG8 impaired localization of cytosolic components to the vacuole under nitrogen starvation, suggesting that  [CLS] autophagy was deficient [CLS]  in the null mutants. Additionally, fluorescent microscopic observations on a eGFP-fused BmATG8 expressing strain showed that BmATG8 is associated with autophagy-related structures. In vegetative growth, \u0394BmATG8 strains showed a"}
{"subject": "\u0394", "sub_type": "Var", "rel": "CauseOf", "object": "reduction", "obj_type": "NegReg", "file_name": "PubMed-28800850.json", "snippet": " that autophagy was deficient in the null mutants. Additionally, fluorescent microscopic observations on a eGFP-fused BmATG8 expressing strain showed that BmATG8 is associated with autophagy-related structures. In vegetative growth,  [CLS] \u0394BmATG8 strains showed a reduction [CLS]  in conidiation and aerial mycelial growth. Interestingly, the mutant conidia indicated loss of the germination rate under starvation conditions and affected longevity. However, germinated mutant conidia were still capable"}
{"subject": "BmATG8", "sub_type": "Gene", "rel": "ThemeOf", "object": "\u0394", "obj_type": "Var", "file_name": "PubMed-28800850.json", "snippet": " that autophagy was deficient in the null mutants. Additionally, fluorescent microscopic observations on a eGFP-fused BmATG8 expressing strain showed that BmATG8 is associated with autophagy-related structures. In vegetative growth,  [CLS] \u0394BmATG8 [CLS]  strains showed a reduction in conidiation and aerial mycelial growth. Interestingly, the mutant conidia indicated loss of the germination rate under starvation conditions and affected longevity. However, germinated mutant"}
{"subject": "conidiation and aerial mycelial growth", "sub_type": "CPA", "rel": "ThemeOf", "object": "reduction", "obj_type": "NegReg", "file_name": "PubMed-28800850.json", "snippet": " in the null mutants. Additionally, fluorescent microscopic observations on a eGFP-fused BmATG8 expressing strain showed that BmATG8 is associated with autophagy-related structures. In vegetative growth, \u0394BmATG8 strains showed a  [CLS] reduction in conidiation and aerial mycelial growth [CLS] . Interestingly, the mutant conidia indicated loss of the germination rate under starvation conditions and affected longevity. However, germinated mutant conidia were still capable of infecting the host plant via"}
{"subject": "haploinsufficiency", "sub_type": "Var", "rel": "CauseOf", "object": "caused by", "obj_type": "Reg", "file_name": "PubMed-28807867.json", "snippet": " presentation within Pitt-Hopkins syndrome and suggests intragenic molecular syndromology of TCF4.\nPitt-Hopkins syndrome is a neurodevelopmental disorder characterized by severe intellectual disability and a distinctive facial gestalt. It is  [CLS] caused by haploinsufficiency [CLS]  of the TCF4 gene. The TCF4 protein has different functional domains, with the NLS (nuclear localization signal) domain coded by exons 7-8 and the bHLH (basic Helix-Loop-Helix) domain coded"}
{"subject": "partial gene deletion", "sub_type": "Var", "rel": "CauseOf", "object": "with", "obj_type": "Reg", "file_name": "PubMed-28807867.json", "snippet": " final phenotype is not clear. There is recent evidence that certain loss-of-function variants disrupting TCF4 are associated with mild ID, but not with typical PTHS. We describe a frameshift-causing  [CLS] partial gene deletion encompassing exons 4-6 of TCF4 in an adult patient with [CLS]  mild ID and nonspecific facial dysmorphisms but without the typical features of PTHS, and a c.520C\u00a0>\u00a0T nonsense variant within exon 8 in a child presenting with a severe phenotype"}
{"subject": "mild ID", "sub_type": "Disease", "rel": "ThemeOf", "object": "with", "obj_type": "Reg", "file_name": "PubMed-28807867.json", "snippet": " variants disrupting TCF4 are associated with mild ID, but not with typical PTHS. We describe a frameshift-causing partial gene deletion encompassing exons 4-6 of TCF4 in an adult patient  [CLS] with mild ID [CLS]  and nonspecific facial dysmorphisms but without the typical features of PTHS, and a c.520C\u00a0>\u00a0T nonsense variant within exon 8 in a child presenting with a severe phenotype largely mimicking"}
{"subject": "c.520C\u00a0>\u00a0T", "sub_type": "Var", "rel": "CauseOf", "object": "with", "obj_type": "Reg", "file_name": "PubMed-28807867.json", "snippet": " frameshift-causing partial gene deletion encompassing exons 4-6 of TCF4 in an adult patient with mild ID and nonspecific facial dysmorphisms but without the typical features of PTHS, and a  [CLS] c.520C\u00a0>\u00a0T nonsense variant within exon 8 in a child presenting with [CLS]  a severe phenotype largely mimicking PTHS, but lacking the typical facial dysmorphism. Investigation on mRNA, along with literature review, led us to suggest a preliminary phenotypic map of loss-of-function"}
{"subject": "PTHS", "sub_type": "Disease", "rel": "ThemeOf", "object": "with", "obj_type": "Reg", "file_name": "PubMed-28807867.json", "snippet": " an adult patient with mild ID and nonspecific facial dysmorphisms but without the typical features of PTHS, and a c.520C\u00a0>\u00a0T nonsense variant within exon 8 in a child presenting  [CLS] with a severe phenotype largely mimicking PTHS [CLS] , but lacking the typical facial dysmorphism. Investigation on mRNA, along with literature review, led us to suggest a preliminary phenotypic map of loss-of-function variants affecting TCF4. An intragenic phenotypic"}
{"subject": "Pitt-Hopkins syndrome", "sub_type": "Disease", "rel": "ThemeOf", "object": "caused by", "obj_type": "Reg", "file_name": "PubMed-28807867.json", "snippet": " [CLS] Pitt-Hopkins syndrome is a neurodevelopmental disorder characterized by severe intellectual disability and a distinctive facial gestalt. It is caused by [CLS]  haploinsufficiency of the TCF4 gene. The TCF4 protein has different functional domains, with the NLS (nuclear localization signal) domain coded by exons 7-8 and the bHLH (basic Helix-Loop-Helix) domain"}
{"subject": "TCF4", "sub_type": "Gene", "rel": "ThemeOf", "object": "haploinsufficiency", "obj_type": "Var", "file_name": "PubMed-28807867.json", "snippet": " Pitt-Hopkins syndrome and suggests intragenic molecular syndromology of TCF4.\nPitt-Hopkins syndrome is a neurodevelopmental disorder characterized by severe intellectual disability and a distinctive facial gestalt. It is caused by  [CLS] haploinsufficiency of the TCF4 [CLS]  gene. The TCF4 protein has different functional domains, with the NLS (nuclear localization signal) domain coded by exons 7-8 and the bHLH (basic Helix-Loop-Helix) domain coded by exon 18."}
{"subject": "variants", "sub_type": "Var", "rel": "CauseOf", "object": "disrupting", "obj_type": "NegReg", "file_name": "PubMed-28807867.json", "snippet": " of at least the bHLH domain. To which extent impairment of the remaining domains contributes to the final phenotype is not clear. There is recent evidence that certain loss-of-function  [CLS] variants disrupting [CLS]  TCF4 are associated with mild ID, but not with typical PTHS. We describe a frameshift-causing partial gene deletion encompassing exons 4-6 of TCF4 in an adult patient with mild"}
{"subject": "TCF4", "sub_type": "Gene", "rel": "ThemeOf", "object": "variants", "obj_type": "Var", "file_name": "PubMed-28807867.json", "snippet": " of at least the bHLH domain. To which extent impairment of the remaining domains contributes to the final phenotype is not clear. There is recent evidence that certain loss-of-function  [CLS] variants disrupting TCF4 [CLS]  are associated with mild ID, but not with typical PTHS. We describe a frameshift-causing partial gene deletion encompassing exons 4-6 of TCF4 in an adult patient with mild ID"}
{"subject": "mild ID", "sub_type": "Disease", "rel": "ThemeOf", "object": "disrupting", "obj_type": "NegReg", "file_name": "PubMed-28807867.json", "snippet": " at least the bHLH domain. To which extent impairment of the remaining domains contributes to the final phenotype is not clear. There is recent evidence that certain loss-of-function variants  [CLS] disrupting TCF4 are associated with mild ID [CLS] , but not with typical PTHS. We describe a frameshift-causing partial gene deletion encompassing exons 4-6 of TCF4 in an adult patient with mild ID and nonspecific facial dysmorphisms but"}
{"subject": "frameshift", "sub_type": "Var", "rel": "CauseOf", "object": "causing", "obj_type": "Reg", "file_name": "PubMed-28807867.json", "snippet": " the final phenotype is not clear. There is recent evidence that certain loss-of-function variants disrupting TCF4 are associated with mild ID, but not with typical PTHS. We describe a  [CLS] frameshift-causing [CLS]  partial gene deletion encompassing exons 4-6 of TCF4 in an adult patient with mild ID and nonspecific facial dysmorphisms but without the typical features of PTHS, and a c.520C\u00a0>\u00a0T"}
{"subject": "partial gene deletion", "sub_type": "Var", "rel": "ThemeOf", "object": "causing", "obj_type": "Reg", "file_name": "PubMed-28807867.json", "snippet": " the final phenotype is not clear. There is recent evidence that certain loss-of-function variants disrupting TCF4 are associated with mild ID, but not with typical PTHS. We describe a frameshift- [CLS] causing partial gene deletion [CLS]  encompassing exons 4-6 of TCF4 in an adult patient with mild ID and nonspecific facial dysmorphisms but without the typical features of PTHS, and a c.520C\u00a0>\u00a0T nonsense variant within"}
{"subject": "TCF4", "sub_type": "Gene", "rel": "ThemeOf", "object": "partial gene deletion", "obj_type": "Var", "file_name": "PubMed-28807867.json", "snippet": " final phenotype is not clear. There is recent evidence that certain loss-of-function variants disrupting TCF4 are associated with mild ID, but not with typical PTHS. We describe a frameshift-causing  [CLS] partial gene deletion encompassing exons 4-6 of TCF4 [CLS]  in an adult patient with mild ID and nonspecific facial dysmorphisms but without the typical features of PTHS, and a c.520C\u00a0>\u00a0T nonsense variant within exon 8 in a child"}
{"subject": "variants", "sub_type": "Var", "rel": "CauseOf", "object": "LoF", "obj_type": "NegReg", "file_name": "PubMed-28817352.json", "snippet": " ( n = 16), and no mice were found with a cleft at birth. Collectively, our data demonstrate that ARHGAP29 is required for embryonic survival and that heterozygosity for  [CLS] LoF variants [CLS]  of Arhgap29 increases the incidence and length of oral adhesions at a critical time point during orofacial development. In conclusion, we validate the LoF nature of the human K326X"}
{"subject": "Arhgap29", "sub_type": "Gene", "rel": "ThemeOf", "object": "variants", "obj_type": "Var", "file_name": "PubMed-28817352.json", "snippet": " n = 16), and no mice were found with a cleft at birth. Collectively, our data demonstrate that ARHGAP29 is required for embryonic survival and that heterozygosity for LoF  [CLS] variants of Arhgap29 [CLS]  increases the incidence and length of oral adhesions at a critical time point during orofacial development. In conclusion, we validate the LoF nature of the human K326X mutation in"}
{"subject": "variants", "sub_type": "Var", "rel": "CauseOf", "object": "increases", "obj_type": "PosReg", "file_name": "PubMed-28817352.json", "snippet": " n = 16), and no mice were found with a cleft at birth. Collectively, our data demonstrate that ARHGAP29 is required for embryonic survival and that heterozygosity for LoF  [CLS] variants of Arhgap29 increases [CLS]  the incidence and length of oral adhesions at a critical time point during orofacial development. In conclusion, we validate the LoF nature of the human K326X mutation in vivo"}
{"subject": "incidence and length of oral adhesions at a critical time point during orofacial development", "sub_type": "CPA", "rel": "ThemeOf", "object": "increases", "obj_type": "PosReg", "file_name": "PubMed-28817352.json", "snippet": " and no mice were found with a cleft at birth. Collectively, our data demonstrate that ARHGAP29 is required for embryonic survival and that heterozygosity for LoF variants of Arhgap29  [CLS] increases the incidence and length of oral adhesions at a critical time point during orofacial development [CLS] . In conclusion, we validate the LoF nature of the human K326X mutation in vivo and reveal a previously unknown effect of Arhgap29 in murine craniofacial development."}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "associated", "obj_type": "Reg", "file_name": "PubMed-28817352.json", "snippet": " [CLS] mutations in ARHGAP29 associated [CLS]  with an increased risk for NSCL/P. To investigate the effects of ARHGAP29 in vivo, we generated a novel murine allele by inserting a point mutation identified in a patient"}
{"subject": "NSCL/P", "sub_type": "Disease", "rel": "ThemeOf", "object": "associated", "obj_type": "Reg", "file_name": "PubMed-28817352.json", "snippet": " [CLS] associated with an increased risk for NSCL/P [CLS] . To investigate the effects of ARHGAP29 in vivo, we generated a novel murine allele by inserting a point mutation identified in a patient with NSCL/P. This single-nucleotide variation of"}
{"subject": "ARHGAP29", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-28817352.json", "snippet": " [CLS] mutations in ARHGAP29 [CLS]  associated with an increased risk for NSCL/P. To investigate the effects of ARHGAP29 in vivo, we generated a novel murine allele by inserting a point mutation identified in a"}
{"subject": "single-nucleotide variation", "sub_type": "Var", "rel": "CauseOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-28817352.json", "snippet": " risk for NSCL/P. To investigate the effects of ARHGAP29 in vivo, we generated a novel murine allele by inserting a point mutation identified in a patient with NSCL/P. This  [CLS] single-nucleotide variation of ARHGAP29 translates to an early nonsense mutation (K326X), presumably resulting in loss-of-function [CLS]  (LoF). Embryos from Arhgap29(K326X/+) intercrosses were harvested at various time points. No homozygous Arhgap29(K326X) animals were found in the 45 analyzed litters, assessed as early as embryonic day 8.5"}
{"subject": "K326X", "sub_type": "Var", "rel": "ThemeOf", "object": "single-nucleotide variation", "obj_type": "Var", "file_name": "PubMed-28817352.json", "snippet": " risk for NSCL/P. To investigate the effects of ARHGAP29 in vivo, we generated a novel murine allele by inserting a point mutation identified in a patient with NSCL/P. This  [CLS] single-nucleotide variation of ARHGAP29 translates to an early nonsense mutation (K326X [CLS] ), presumably resulting in loss-of-function (LoF). Embryos from Arhgap29(K326X/+) intercrosses were harvested at various time points. No homozygous Arhgap29(K326X) animals were found in the 45 analyzed litters, assessed as early"}
{"subject": "ARHGAP29", "sub_type": "Gene", "rel": "ThemeOf", "object": "single-nucleotide variation", "obj_type": "Var", "file_name": "PubMed-28817352.json", "snippet": " risk for NSCL/P. To investigate the effects of ARHGAP29 in vivo, we generated a novel murine allele by inserting a point mutation identified in a patient with NSCL/P. This  [CLS] single-nucleotide variation of ARHGAP29 [CLS]  translates to an early nonsense mutation (K326X), presumably resulting in loss-of-function (LoF). Embryos from Arhgap29(K326X/+) intercrosses were harvested at various time points. No homozygous Arhgap29(K326X) animals were found in"}
{"subject": "K326X mutation", "sub_type": "Var", "rel": "CauseOf", "object": "LoF", "obj_type": "NegReg", "file_name": "PubMed-28817352.json", "snippet": " and that heterozygosity for LoF variants of Arhgap29 increases the incidence and length of oral adhesions at a critical time point during orofacial development. In conclusion, we validate the  [CLS] LoF nature of the human K326X mutation [CLS]  in vivo and reveal a previously unknown effect of Arhgap29 in murine craniofacial development."}
{"subject": "craniofacial development", "sub_type": "CPA", "rel": "ThemeOf", "object": "LoF", "obj_type": "NegReg", "file_name": "PubMed-28817352.json", "snippet": " and that heterozygosity for LoF variants of Arhgap29 increases the incidence and length of oral adhesions at a critical time point during orofacial development. In conclusion, we validate the  [CLS] LoF nature of the human K326X mutation in vivo and reveal a previously unknown effect of Arhgap29 in murine craniofacial development [CLS] ."}
{"subject": "Arhgap29", "sub_type": "Gene", "rel": "ThemeOf", "object": "K326X mutation", "obj_type": "Var", "file_name": "PubMed-28817352.json", "snippet": " variants of Arhgap29 increases the incidence and length of oral adhesions at a critical time point during orofacial development. In conclusion, we validate the LoF nature of the human  [CLS] K326X mutation in vivo and reveal a previously unknown effect of Arhgap29 [CLS]  in murine craniofacial development."}
{"subject": "SLC40A1", "sub_type": "Gene", "rel": "ThemeOf", "object": "missense mutations", "obj_type": "Var", "file_name": "PubMed-28826751.json", "snippet": " [CLS] SLC40A1 missense mutations [CLS]  found in suspected hemochromatosis type 4 patients.\nGenetic medicine applied to the study of hemochromatosis has identified the systemic loop controlling iron homeostasis, centered on hepcidin-ferroportin interaction. Current challenges"}
{"subject": "missense mutations", "sub_type": "Var", "rel": "CauseOf", "object": "found", "obj_type": "Reg", "file_name": "PubMed-28826751.json", "snippet": " [CLS] missense mutations found [CLS]  in suspected hemochromatosis type 4 patients.\nGenetic medicine applied to the study of hemochromatosis has identified the systemic loop controlling iron homeostasis, centered on hepcidin-ferroportin interaction. Current challenges are"}
{"subject": "hemochromatosis type 4", "sub_type": "Disease", "rel": "ThemeOf", "object": "found", "obj_type": "Reg", "file_name": "PubMed-28826751.json", "snippet": " [CLS] found in suspected hemochromatosis type 4 [CLS]  patients.\nGenetic medicine applied to the study of hemochromatosis has identified the systemic loop controlling iron homeostasis, centered on hepcidin-ferroportin interaction. Current challenges are to dissect the molecular pathways"}
{"subject": "FLG", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-28833578.json", "snippet": " [CLS] mutations in filaggrin gene (FLG [CLS] ) have been suggested to increase the susceptibility of skin malignancies due to reduced levels of epidermal filaggrin and its degradation products, urocanic acid, which may be protective against ultraviolet"}
{"subject": "skin malignancies", "sub_type": "Disease", "rel": "ThemeOf", "object": "Loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-28833578.json", "snippet": " [CLS] Loss-of-function mutations in filaggrin gene (FLG) have been suggested to increase the susceptibility of skin malignancies [CLS]  due to reduced levels of epidermal filaggrin and its degradation products, urocanic acid, which may be protective against ultraviolet irradiation.\nOBJECTIVE: We aimed to investigate the association between FLG"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "Loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-28833578.json", "snippet": " [CLS] Loss-of-function mutations [CLS]  in filaggrin gene (FLG) have been suggested to increase the susceptibility of skin malignancies due to reduced levels of epidermal filaggrin and its degradation products, urocanic acid, which may"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "reduced", "obj_type": "NegReg", "file_name": "PubMed-28833578.json", "snippet": " [CLS] mutations in filaggrin gene (FLG) have been suggested to increase the susceptibility of skin malignancies due to reduced [CLS]  levels of epidermal filaggrin and its degradation products, urocanic acid, which may be protective against ultraviolet irradiation.\nOBJECTIVE: We aimed to investigate the association between FLG mutation status and"}
{"subject": "levels of epidermal filaggrin", "sub_type": "MPA", "rel": "ThemeOf", "object": "reduced", "obj_type": "NegReg", "file_name": "PubMed-28833578.json", "snippet": " in filaggrin gene and malignant melanoma: a case control study.\nBACKGROUND: Loss-of-function mutations in filaggrin gene (FLG) have been suggested to increase the susceptibility of skin malignancies due to  [CLS] reduced levels of epidermal filaggrin [CLS]  and its degradation products, urocanic acid, which may be protective against ultraviolet irradiation.\nOBJECTIVE: We aimed to investigate the association between FLG mutation status and the occurrence of malignant"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "degradation products", "obj_type": "MPA", "file_name": "PubMed-28833578.json", "snippet": " [CLS] mutations in filaggrin gene (FLG) have been suggested to increase the susceptibility of skin malignancies due to reduced levels of epidermal filaggrin and its degradation products [CLS] , urocanic acid, which may be protective against ultraviolet irradiation.\nOBJECTIVE: We aimed to investigate the association between FLG mutation status and the occurrence of malignant melanoma (MM) in Danish"}
{"subject": "urocanic acid", "sub_type": "MPA", "rel": "ThemeOf", "object": "degradation products", "obj_type": "MPA", "file_name": "PubMed-28833578.json", "snippet": " case control study.\nBACKGROUND: Loss-of-function mutations in filaggrin gene (FLG) have been suggested to increase the susceptibility of skin malignancies due to reduced levels of epidermal filaggrin and its  [CLS] degradation products, urocanic acid [CLS] , which may be protective against ultraviolet irradiation.\nOBJECTIVE: We aimed to investigate the association between FLG mutation status and the occurrence of malignant melanoma (MM) in Danish adults.\nMETHODS:"}
{"subject": "mutation", "sub_type": "Var", "rel": "CauseOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-28834165.json", "snippet": " [CLS] gain-of-function mutation [CLS]  in TNFRSF13B is a candidate for predisposition to familial or sporadic immune thrombocytopenia.\nBACKGROUND: Most immune thrombocytopenia (ITP) is sporadic but a positive family history of ITP in some"}
{"subject": "\"cytokine-cytokine receptor interaction\" signal", "sub_type": "MPA", "rel": "ThemeOf", "object": "upregulated", "obj_type": "PosReg", "file_name": "PubMed-28834165.json", "snippet": " immune function and megakaryocyte apoptosis.\nRESULTS: Whole-exome sequencing identified a potential pathologic p.G76S heterozygous mutation on the TNFRSF13B gene in familial ITP patients. ITP patients harboring G76S mutation displayed  [CLS] upregulated \"cytokine-cytokine receptor interaction\" signal [CLS] , increased serum TNF\u03b1, IL-17\u03b1, IFN\u03b3 and BAFF levels, and enhanced binding capacity of APRIL ligand to B cells. Additionally, EBV-transformed B cells with the G76S mutation could induce human"}
{"subject": "serum TNF\u03b1, IL-17\u03b1, IFN\u03b3 and BAFF levels", "sub_type": "MPA", "rel": "ThemeOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-28834165.json", "snippet": "\nRESULTS: Whole-exome sequencing identified a potential pathologic p.G76S heterozygous mutation on the TNFRSF13B gene in familial ITP patients. ITP patients harboring G76S mutation displayed upregulated \"cytokine-cytokine receptor interaction\" signal,  [CLS] increased serum TNF\u03b1, IL-17\u03b1, IFN\u03b3 and BAFF levels [CLS] , and enhanced binding capacity of APRIL ligand to B cells. Additionally, EBV-transformed B cells with the G76S mutation could induce human megakaryocyte line (Meg-01) apoptosis significantly.\nCONCLUSION: p.G76S mutation"}
{"subject": "binding capacity of APRIL ligand to B cells", "sub_type": "Interaction", "rel": "ThemeOf", "object": "enhanced", "obj_type": "PosReg", "file_name": "PubMed-28834165.json", "snippet": " mutation on the TNFRSF13B gene in familial ITP patients. ITP patients harboring G76S mutation displayed upregulated \"cytokine-cytokine receptor interaction\" signal, increased serum TNF\u03b1, IL-17\u03b1, IFN\u03b3 and BAFF levels, and  [CLS] enhanced binding capacity of APRIL ligand to B cells [CLS] . Additionally, EBV-transformed B cells with the G76S mutation could induce human megakaryocyte line (Meg-01) apoptosis significantly.\nCONCLUSION: p.G76S mutation on TNFRSF13B gene is responsible for ITP, and is a"}
{"subject": "human megakaryocyte line (Meg-01) apoptosis", "sub_type": "CPA", "rel": "ThemeOf", "object": "induce", "obj_type": "PosReg", "file_name": "PubMed-28834165.json", "snippet": " interaction\" signal, increased serum TNF\u03b1, IL-17\u03b1, IFN\u03b3 and BAFF levels, and enhanced binding capacity of APRIL ligand to B cells. Additionally, EBV-transformed B cells with the G76S mutation could  [CLS] induce human megakaryocyte line (Meg-01) apoptosis [CLS]  significantly.\nCONCLUSION: p.G76S mutation on TNFRSF13B gene is responsible for ITP, and is a genetic predisposing factor for familial or sporadic ITP. This article is protected by copyright. All"}
{"subject": "G76S", "sub_type": "Var", "rel": "CauseOf", "object": "induce", "obj_type": "PosReg", "file_name": "PubMed-28834165.json", "snippet": " upregulated \"cytokine-cytokine receptor interaction\" signal, increased serum TNF\u03b1, IL-17\u03b1, IFN\u03b3 and BAFF levels, and enhanced binding capacity of APRIL ligand to B cells. Additionally, EBV-transformed B cells with the  [CLS] G76S mutation could induce [CLS]  human megakaryocyte line (Meg-01) apoptosis significantly.\nCONCLUSION: p.G76S mutation on TNFRSF13B gene is responsible for ITP, and is a genetic predisposing factor for familial or sporadic ITP. This article"}
{"subject": "p.G76S", "sub_type": "Var", "rel": "CauseOf", "object": "responsible", "obj_type": "Reg", "file_name": "PubMed-28834165.json", "snippet": " BAFF levels, and enhanced binding capacity of APRIL ligand to B cells. Additionally, EBV-transformed B cells with the G76S mutation could induce human megakaryocyte line (Meg-01) apoptosis significantly.\nCONCLUSION:  [CLS] p.G76S mutation on TNFRSF13B gene is responsible [CLS]  for ITP, and is a genetic predisposing factor for familial or sporadic ITP. This article is protected by copyright. All rights reserved."}
{"subject": "ITP", "sub_type": "Disease", "rel": "ThemeOf", "object": "responsible", "obj_type": "Reg", "file_name": "PubMed-28834165.json", "snippet": " of APRIL ligand to B cells. Additionally, EBV-transformed B cells with the G76S mutation could induce human megakaryocyte line (Meg-01) apoptosis significantly.\nCONCLUSION: p.G76S mutation on TNFRSF13B gene is  [CLS] responsible for ITP [CLS] , and is a genetic predisposing factor for familial or sporadic ITP. This article is protected by copyright. All rights reserved."}
{"subject": "TNFRSF13B", "sub_type": "Gene", "rel": "ThemeOf", "object": "p.G76S", "obj_type": "Var", "file_name": "PubMed-28834165.json", "snippet": " BAFF levels, and enhanced binding capacity of APRIL ligand to B cells. Additionally, EBV-transformed B cells with the G76S mutation could induce human megakaryocyte line (Meg-01) apoptosis significantly.\nCONCLUSION:  [CLS] p.G76S mutation on TNFRSF13B [CLS]  gene is responsible for ITP, and is a genetic predisposing factor for familial or sporadic ITP. This article is protected by copyright. All rights reserved."}
{"subject": "TNFRSF13B", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutation", "obj_type": "Var", "file_name": "PubMed-28834165.json", "snippet": " [CLS] mutation in TNFRSF13B [CLS]  is a candidate for predisposition to familial or sporadic immune thrombocytopenia.\nBACKGROUND: Most immune thrombocytopenia (ITP) is sporadic but a positive family history of ITP in some patients suggests"}
{"subject": "familial or sporadic immune thrombocytopenia", "sub_type": "Disease", "rel": "ThemeOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-28834165.json", "snippet": " [CLS] gain-of-function mutation in TNFRSF13B is a candidate for predisposition to familial or sporadic immune thrombocytopenia [CLS] .\nBACKGROUND: Most immune thrombocytopenia (ITP) is sporadic but a positive family history of ITP in some patients suggests that hereditary forms exist. Due to the rarity of familial ITP"}
{"subject": "TNFRSF13B", "sub_type": "Gene", "rel": "ThemeOf", "object": "p.G76S", "obj_type": "Var", "file_name": "PubMed-28834165.json", "snippet": " members, sporadic ITP cases and healthy individuals. We also evaluated the influence of potential pathogenic mutation on immune function and megakaryocyte apoptosis.\nRESULTS: Whole-exome sequencing identified a potential pathologic  [CLS] p.G76S heterozygous mutation on the TNFRSF13B [CLS]  gene in familial ITP patients. ITP patients harboring G76S mutation displayed upregulated \"cytokine-cytokine receptor interaction\" signal, increased serum TNF\u03b1, IL-17\u03b1, IFN\u03b3 and BAFF levels, and enhanced binding capacity of"}
{"subject": "familial ITP", "sub_type": "Disease", "rel": "ThemeOf", "object": "pathologic", "obj_type": "Reg", "file_name": "PubMed-28834165.json", "snippet": " ITP members, sporadic ITP cases and healthy individuals. We also evaluated the influence of potential pathogenic mutation on immune function and megakaryocyte apoptosis.\nRESULTS: Whole-exome sequencing identified a potential  [CLS] pathologic p.G76S heterozygous mutation on the TNFRSF13B gene in familial ITP [CLS]  patients. ITP patients harboring G76S mutation displayed upregulated \"cytokine-cytokine receptor interaction\" signal, increased serum TNF\u03b1, IL-17\u03b1, IFN\u03b3 and BAFF levels, and enhanced binding capacity of APRIL ligand to B"}
{"subject": "p.G76S", "sub_type": "Var", "rel": "CauseOf", "object": "pathologic", "obj_type": "Reg", "file_name": "PubMed-28834165.json", "snippet": " ITP members, sporadic ITP cases and healthy individuals. We also evaluated the influence of potential pathogenic mutation on immune function and megakaryocyte apoptosis.\nRESULTS: Whole-exome sequencing identified a potential  [CLS] pathologic p.G76S [CLS]  heterozygous mutation on the TNFRSF13B gene in familial ITP patients. ITP patients harboring G76S mutation displayed upregulated \"cytokine-cytokine receptor interaction\" signal, increased serum TNF\u03b1, IL-17\u03b1, IFN\u03b3 and BAFF levels,"}
{"subject": "G76S", "sub_type": "Var", "rel": "CauseOf", "object": "upregulated", "obj_type": "PosReg", "file_name": "PubMed-28834165.json", "snippet": " pathogenic mutation on immune function and megakaryocyte apoptosis.\nRESULTS: Whole-exome sequencing identified a potential pathologic p.G76S heterozygous mutation on the TNFRSF13B gene in familial ITP patients. ITP patients harboring  [CLS] G76S mutation displayed upregulated [CLS]  \"cytokine-cytokine receptor interaction\" signal, increased serum TNF\u03b1, IL-17\u03b1, IFN\u03b3 and BAFF levels, and enhanced binding capacity of APRIL ligand to B cells. Additionally, EBV-transformed B cells with the G76S"}
{"subject": "G76S", "sub_type": "Var", "rel": "CauseOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-28834165.json", "snippet": " pathogenic mutation on immune function and megakaryocyte apoptosis.\nRESULTS: Whole-exome sequencing identified a potential pathologic p.G76S heterozygous mutation on the TNFRSF13B gene in familial ITP patients. ITP patients harboring  [CLS] G76S mutation displayed upregulated \"cytokine-cytokine receptor interaction\" signal, increased [CLS]  serum TNF\u03b1, IL-17\u03b1, IFN\u03b3 and BAFF levels, and enhanced binding capacity of APRIL ligand to B cells. Additionally, EBV-transformed B cells with the G76S mutation could induce human megakaryocyte"}
{"subject": "G76S", "sub_type": "Var", "rel": "CauseOf", "object": "enhanced", "obj_type": "PosReg", "file_name": "PubMed-28834165.json", "snippet": " pathogenic mutation on immune function and megakaryocyte apoptosis.\nRESULTS: Whole-exome sequencing identified a potential pathologic p.G76S heterozygous mutation on the TNFRSF13B gene in familial ITP patients. ITP patients harboring  [CLS] G76S mutation displayed upregulated \"cytokine-cytokine receptor interaction\" signal, increased serum TNF\u03b1, IL-17\u03b1, IFN\u03b3 and BAFF levels, and enhanced [CLS]  binding capacity of APRIL ligand to B cells. Additionally, EBV-transformed B cells with the G76S mutation could induce human megakaryocyte line (Meg-01) apoptosis significantly.\nCONCLUSION: p.G76S mutation on TNFRSF13B"}
{"subject": "S148C", "sub_type": "Var", "rel": "CauseOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-28836768.json", "snippet": " a change in mechanism from a stepwise addition-elimination (TEWT) to a lower energy concerted acyl substitution (TES148C), accounting for the gain-of-function and improved reaction kinetics. Finally, we introduced the  [CLS] S148C mutation into a polyketide synthase module (PikAIII-TE) to impart increased [CLS]  substrate flexibility, enabling the production of diastereomeric macrolactones."}
{"subject": "substrate flexibility", "sub_type": "MPA", "rel": "ThemeOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-28836768.json", "snippet": " a lower energy concerted acyl substitution (TES148C), accounting for the gain-of-function and improved reaction kinetics. Finally, we introduced the S148C mutation into a polyketide synthase module (PikAIII-TE) to impart  [CLS] increased substrate flexibility [CLS] , enabling the production of diastereomeric macrolactones."}
{"subject": "production of diastereomeric macrolactones", "sub_type": "MPA", "rel": "ThemeOf", "object": "enabling", "obj_type": "PosReg", "file_name": "PubMed-28836768.json", "snippet": " concerted acyl substitution (TES148C), accounting for the gain-of-function and improved reaction kinetics. Finally, we introduced the S148C mutation into a polyketide synthase module (PikAIII-TE) to impart increased substrate flexibility,  [CLS] enabling the production of diastereomeric macrolactones [CLS] ."}
{"subject": "S148C", "sub_type": "Var", "rel": "CauseOf", "object": "enabling", "obj_type": "PosReg", "file_name": "PubMed-28836768.json", "snippet": " a change in mechanism from a stepwise addition-elimination (TEWT) to a lower energy concerted acyl substitution (TES148C), accounting for the gain-of-function and improved reaction kinetics. Finally, we introduced the  [CLS] S148C mutation into a polyketide synthase module (PikAIII-TE) to impart increased substrate flexibility, enabling [CLS]  the production of diastereomeric macrolactones."}
{"subject": "rs151291296", "sub_type": "Var", "rel": "CauseOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-28838926.json", "snippet": " include CES1 nsSNPs with a minor allele frequency (MAF) > 0.5% in a given population or located in close proximity to the CES1 active site. Five nsSNPs including L40Ter ( [CLS] rs151291296), G142E (rs121912777), G147C (rs146456965), Y170D (rs148947808), and R171C (rs201065375) were found to be loss-of-function [CLS]  variants for metabolizing the CES1 substrates clopidogrel, enalapril, and sacubitril. Additionally, the A158V (rs202121317), R199H (rs2307243), E220G (rs200707504), and T290M (rs202001817) decreased CES1 activity to a lesser extent in"}
{"subject": "rs151291296", "sub_type": "Var", "rel": "CauseOf", "object": "reduced", "obj_type": "NegReg", "file_name": "PubMed-28838926.json", "snippet": " and sacubitril. Additionally, the A158V (rs202121317), R199H (rs2307243), E220G (rs200707504), and T290M (rs202001817) decreased CES1 activity to a lesser extent in a substrate-dependent manner. Several nsSNPs including the L40Ter ( [CLS] rs151291296), G147C (rs146456965), Y170D (rs148947808), and R171C (rs201065375) significantly reduced [CLS]  CES1 protein and/or mRNA expressions in the transfected cells. Functions of the common nonsynonymous haplotypes D203E-A269S and S75N-D203E-A269S were evaluated using cells stably expressing the haplotypes and a large"}
{"subject": "rs146456965", "sub_type": "Var", "rel": "CauseOf", "object": "reduced", "obj_type": "NegReg", "file_name": "PubMed-28838926.json", "snippet": " Additionally, the A158V (rs202121317), R199H (rs2307243), E220G (rs200707504), and T290M (rs202001817) decreased CES1 activity to a lesser extent in a substrate-dependent manner. Several nsSNPs including the L40Ter (rs151291296), G147C ( [CLS] rs146456965), Y170D (rs148947808), and R171C (rs201065375) significantly reduced [CLS]  CES1 protein and/or mRNA expressions in the transfected cells. Functions of the common nonsynonymous haplotypes D203E-A269S and S75N-D203E-A269S were evaluated using cells stably expressing the haplotypes and a large"}
{"subject": "rs148947808", "sub_type": "Var", "rel": "CauseOf", "object": "reduced", "obj_type": "NegReg", "file_name": "PubMed-28838926.json", "snippet": " A158V (rs202121317), R199H (rs2307243), E220G (rs200707504), and T290M (rs202001817) decreased CES1 activity to a lesser extent in a substrate-dependent manner. Several nsSNPs including the L40Ter (rs151291296), G147C (rs146456965), Y170D ( [CLS] rs148947808), and R171C (rs201065375) significantly reduced [CLS]  CES1 protein and/or mRNA expressions in the transfected cells. Functions of the common nonsynonymous haplotypes D203E-A269S and S75N-D203E-A269S were evaluated using cells stably expressing the haplotypes and a large"}
{"subject": "rs201065375", "sub_type": "Var", "rel": "CauseOf", "object": "reduced", "obj_type": "NegReg", "file_name": "PubMed-28838926.json", "snippet": " (rs2307243), E220G (rs200707504), and T290M (rs202001817) decreased CES1 activity to a lesser extent in a substrate-dependent manner. Several nsSNPs including the L40Ter (rs151291296), G147C (rs146456965), Y170D (rs148947808), and R171C ( [CLS] rs201065375) significantly reduced [CLS]  CES1 protein and/or mRNA expressions in the transfected cells. Functions of the common nonsynonymous haplotypes D203E-A269S and S75N-D203E-A269S were evaluated using cells stably expressing the haplotypes and a large"}
{"subject": "metabolizing", "sub_type": "MPA", "rel": "ThemeOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-28838926.json", "snippet": " population or located in close proximity to the CES1 active site. Five nsSNPs including L40Ter (rs151291296), G142E (rs121912777), G147C (rs146456965), Y170D (rs148947808), and R171C (rs201065375) were found to be  [CLS] loss-of-function variants for metabolizing [CLS]  the CES1 substrates clopidogrel, enalapril, and sacubitril. Additionally, the A158V (rs202121317), R199H (rs2307243), E220G (rs200707504), and T290M (rs202001817) decreased CES1 activity to a lesser extent in a substrate-dependent manner."}
{"subject": "CES1", "sub_type": "Enzyme", "rel": "ThemeOf", "object": "metabolizing", "obj_type": "MPA", "file_name": "PubMed-28838926.json", "snippet": " in close proximity to the CES1 active site. Five nsSNPs including L40Ter (rs151291296), G142E (rs121912777), G147C (rs146456965), Y170D (rs148947808), and R171C (rs201065375) were found to be loss-of-function variants for  [CLS] metabolizing the CES1 [CLS]  substrates clopidogrel, enalapril, and sacubitril. Additionally, the A158V (rs202121317), R199H (rs2307243), E220G (rs200707504), and T290M (rs202001817) decreased CES1 activity to a lesser extent in a substrate-dependent manner. Several nsSNPs"}
{"subject": "CES1", "sub_type": "Enzyme", "rel": "ThemeOf", "object": "activity", "obj_type": "MPA", "file_name": "PubMed-28838926.json", "snippet": " R171C (rs201065375) were found to be loss-of-function variants for metabolizing the CES1 substrates clopidogrel, enalapril, and sacubitril. Additionally, the A158V (rs202121317), R199H (rs2307243), E220G (rs200707504), and T290M (rs202001817) decreased  [CLS] CES1 activity [CLS]  to a lesser extent in a substrate-dependent manner. Several nsSNPs including the L40Ter (rs151291296), G147C (rs146456965), Y170D (rs148947808), and R171C (rs201065375) significantly reduced CES1 protein and/or mRNA expressions in"}
{"subject": "activity", "sub_type": "MPA", "rel": "ThemeOf", "object": "decreased", "obj_type": "NegReg", "file_name": "PubMed-28838926.json", "snippet": " and R171C (rs201065375) were found to be loss-of-function variants for metabolizing the CES1 substrates clopidogrel, enalapril, and sacubitril. Additionally, the A158V (rs202121317), R199H (rs2307243), E220G (rs200707504), and T290M (rs202001817)  [CLS] decreased CES1 activity [CLS]  to a lesser extent in a substrate-dependent manner. Several nsSNPs including the L40Ter (rs151291296), G147C (rs146456965), Y170D (rs148947808), and R171C (rs201065375) significantly reduced CES1 protein and/or mRNA expressions in"}
{"subject": "CES1 protein", "sub_type": "Protein", "rel": "ThemeOf", "object": "reduced", "obj_type": "NegReg", "file_name": "PubMed-28838926.json", "snippet": " (rs200707504), and T290M (rs202001817) decreased CES1 activity to a lesser extent in a substrate-dependent manner. Several nsSNPs including the L40Ter (rs151291296), G147C (rs146456965), Y170D (rs148947808), and R171C (rs201065375) significantly  [CLS] reduced CES1 protein [CLS]  and/or mRNA expressions in the transfected cells. Functions of the common nonsynonymous haplotypes D203E-A269S and S75N-D203E-A269S were evaluated using cells stably expressing the haplotypes and a large set of"}
{"subject": "mRNA expressions", "sub_type": "MPA", "rel": "ThemeOf", "object": "reduced", "obj_type": "NegReg", "file_name": "PubMed-28838926.json", "snippet": " (rs200707504), and T290M (rs202001817) decreased CES1 activity to a lesser extent in a substrate-dependent manner. Several nsSNPs including the L40Ter (rs151291296), G147C (rs146456965), Y170D (rs148947808), and R171C (rs201065375) significantly  [CLS] reduced CES1 protein and/or mRNA expressions [CLS]  in the transfected cells. Functions of the common nonsynonymous haplotypes D203E-A269S and S75N-D203E-A269S were evaluated using cells stably expressing the haplotypes and a large set of human livers. Neither"}
{"subject": "rs121912777", "sub_type": "Var", "rel": "CauseOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-28838926.json", "snippet": " nsSNPs with a minor allele frequency (MAF) > 0.5% in a given population or located in close proximity to the CES1 active site. Five nsSNPs including L40Ter (rs151291296), G142E ( [CLS] rs121912777), G147C (rs146456965), Y170D (rs148947808), and R171C (rs201065375) were found to be loss-of-function [CLS]  variants for metabolizing the CES1 substrates clopidogrel, enalapril, and sacubitril. Additionally, the A158V (rs202121317), R199H (rs2307243), E220G (rs200707504), and T290M (rs202001817) decreased CES1 activity to a lesser extent in"}
{"subject": "rs146456965", "sub_type": "Var", "rel": "CauseOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-28838926.json", "snippet": " a minor allele frequency (MAF) > 0.5% in a given population or located in close proximity to the CES1 active site. Five nsSNPs including L40Ter (rs151291296), G142E (rs121912777), G147C ( [CLS] rs146456965), Y170D (rs148947808), and R171C (rs201065375) were found to be loss-of-function [CLS]  variants for metabolizing the CES1 substrates clopidogrel, enalapril, and sacubitril. Additionally, the A158V (rs202121317), R199H (rs2307243), E220G (rs200707504), and T290M (rs202001817) decreased CES1 activity to a lesser extent in"}
{"subject": "rs148947808", "sub_type": "Var", "rel": "CauseOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-28838926.json", "snippet": " allele frequency (MAF) > 0.5% in a given population or located in close proximity to the CES1 active site. Five nsSNPs including L40Ter (rs151291296), G142E (rs121912777), G147C (rs146456965), Y170D ( [CLS] rs148947808), and R171C (rs201065375) were found to be loss-of-function [CLS]  variants for metabolizing the CES1 substrates clopidogrel, enalapril, and sacubitril. Additionally, the A158V (rs202121317), R199H (rs2307243), E220G (rs200707504), and T290M (rs202001817) decreased CES1 activity to a lesser extent in"}
{"subject": "rs201065375", "sub_type": "Var", "rel": "CauseOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-28838926.json", "snippet": " > 0.5% in a given population or located in close proximity to the CES1 active site. Five nsSNPs including L40Ter (rs151291296), G142E (rs121912777), G147C (rs146456965), Y170D (rs148947808), and R171C ( [CLS] rs201065375) were found to be loss-of-function [CLS]  variants for metabolizing the CES1 substrates clopidogrel, enalapril, and sacubitril. Additionally, the A158V (rs202121317), R199H (rs2307243), E220G (rs200707504), and T290M (rs202001817) decreased CES1 activity to a lesser extent in"}
{"subject": "rs202121317", "sub_type": "Var", "rel": "CauseOf", "object": "decreased", "obj_type": "NegReg", "file_name": "PubMed-28838926.json", "snippet": " L40Ter (rs151291296), G142E (rs121912777), G147C (rs146456965), Y170D (rs148947808), and R171C (rs201065375) were found to be loss-of-function variants for metabolizing the CES1 substrates clopidogrel, enalapril, and sacubitril. Additionally, the A158V ( [CLS] rs202121317), R199H (rs2307243), E220G (rs200707504), and T290M (rs202001817) decreased [CLS]  CES1 activity to a lesser extent in a substrate-dependent manner. Several nsSNPs including the L40Ter (rs151291296), G147C (rs146456965), Y170D (rs148947808), and R171C (rs201065375) significantly reduced CES1 protein and/or mRNA"}
{"subject": "rs2307243", "sub_type": "Var", "rel": "CauseOf", "object": "decreased", "obj_type": "NegReg", "file_name": "PubMed-28838926.json", "snippet": " G142E (rs121912777), G147C (rs146456965), Y170D (rs148947808), and R171C (rs201065375) were found to be loss-of-function variants for metabolizing the CES1 substrates clopidogrel, enalapril, and sacubitril. Additionally, the A158V (rs202121317), R199H ( [CLS] rs2307243), E220G (rs200707504), and T290M (rs202001817) decreased [CLS]  CES1 activity to a lesser extent in a substrate-dependent manner. Several nsSNPs including the L40Ter (rs151291296), G147C (rs146456965), Y170D (rs148947808), and R171C (rs201065375) significantly reduced CES1 protein and/or mRNA"}
{"subject": "rs200707504", "sub_type": "Var", "rel": "CauseOf", "object": "decreased", "obj_type": "NegReg", "file_name": "PubMed-28838926.json", "snippet": " G147C (rs146456965), Y170D (rs148947808), and R171C (rs201065375) were found to be loss-of-function variants for metabolizing the CES1 substrates clopidogrel, enalapril, and sacubitril. Additionally, the A158V (rs202121317), R199H (rs2307243), E220G ( [CLS] rs200707504), and T290M (rs202001817) decreased [CLS]  CES1 activity to a lesser extent in a substrate-dependent manner. Several nsSNPs including the L40Ter (rs151291296), G147C (rs146456965), Y170D (rs148947808), and R171C (rs201065375) significantly reduced CES1 protein and/or mRNA"}
{"subject": "rs202001817", "sub_type": "Var", "rel": "CauseOf", "object": "decreased", "obj_type": "NegReg", "file_name": "PubMed-28838926.json", "snippet": " (rs148947808), and R171C (rs201065375) were found to be loss-of-function variants for metabolizing the CES1 substrates clopidogrel, enalapril, and sacubitril. Additionally, the A158V (rs202121317), R199H (rs2307243), E220G (rs200707504), and T290M ( [CLS] rs202001817) decreased [CLS]  CES1 activity to a lesser extent in a substrate-dependent manner. Several nsSNPs including the L40Ter (rs151291296), G147C (rs146456965), Y170D (rs148947808), and R171C (rs201065375) significantly reduced CES1 protein and/or mRNA"}
{"subject": "Progranulin", "sub_type": "Protein", "rel": "ThemeOf", "object": "haploinsufficiency", "obj_type": "Var", "file_name": "PubMed-28845019.json", "snippet": " [CLS] Progranulin haploinsufficiency [CLS]  reduces amyloid beta deposition in Alzheimer's disease model mice.\nGranulin (Grn) mutations were identified in familial frontotemporal lobar degeneration (FTLD) patients with TAR DNA-binding protein of 43 kd (TDP-43)"}
{"subject": "Grn", "sub_type": "Protein", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-28845019.json", "snippet": " proposed as a disease mechanism that leads to the loss of functional progranulin (PGRN) protein. Thus, these mutations are strongly involved in FTLD pathogenesis. Moreover, recent findings indicate that  [CLS] Grn mutations [CLS]  are associated with other neurodegenerative disorders with tau pathology, including Alzheimer's disease. To investigate the influence of PGRN on amyloid beta (A\u03b2) accumulation, amyloid precursor protein (APP) transgenic mice"}
{"subject": "Alzheimer's disease", "sub_type": "Disease", "rel": "ThemeOf", "object": "associated", "obj_type": "Reg", "file_name": "PubMed-28845019.json", "snippet": " disease mechanism that leads to the loss of functional progranulin (PGRN) protein. Thus, these mutations are strongly involved in FTLD pathogenesis. Moreover, recent findings indicate that Grn mutations are  [CLS] associated with other neurodegenerative disorders with tau pathology, including Alzheimer's disease [CLS] . To investigate the influence of PGRN on amyloid beta (A\u03b2) accumulation, amyloid precursor protein (APP) transgenic mice were interbred with Grn-deficient mice, producing APP transgenic mice harboring the Grn"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "associated", "obj_type": "Reg", "file_name": "PubMed-28845019.json", "snippet": " as a disease mechanism that leads to the loss of functional progranulin (PGRN) protein. Thus, these mutations are strongly involved in FTLD pathogenesis. Moreover, recent findings indicate that Grn  [CLS] mutations are associated [CLS]  with other neurodegenerative disorders with tau pathology, including Alzheimer's disease. To investigate the influence of PGRN on amyloid beta (A\u03b2) accumulation, amyloid precursor protein (APP) transgenic mice were interbred"}
{"subject": "PGRN", "sub_type": "Protein", "rel": "ThemeOf", "object": "haploinsufficiency", "obj_type": "Var", "file_name": "PubMed-28845019.json", "snippet": " APP mice. Immunoblotting analysis revealed that A\u03b2 was reduced in the sarkosyl-insoluble fraction of 16-18-month-old APP/Grn+/- mice as compared with that of APP transgenic mice. Our data suggest that  [CLS] PGRN haploinsufficiency [CLS]  may decrease accumulation of A\u03b2."}
{"subject": "accumulation of A\u03b2", "sub_type": "MPA", "rel": "ThemeOf", "object": "decrease", "obj_type": "NegReg", "file_name": "PubMed-28845019.json", "snippet": " analysis revealed that A\u03b2 was reduced in the sarkosyl-insoluble fraction of 16-18-month-old APP/Grn+/- mice as compared with that of APP transgenic mice. Our data suggest that PGRN haploinsufficiency may  [CLS] decrease accumulation of A\u03b2 [CLS] ."}
{"subject": "haploinsufficiency", "sub_type": "Var", "rel": "CauseOf", "object": "decrease", "obj_type": "NegReg", "file_name": "PubMed-28845019.json", "snippet": " mice. Immunoblotting analysis revealed that A\u03b2 was reduced in the sarkosyl-insoluble fraction of 16-18-month-old APP/Grn+/- mice as compared with that of APP transgenic mice. Our data suggest that PGRN  [CLS] haploinsufficiency may decrease [CLS]  accumulation of A\u03b2."}
{"subject": "amyloid beta deposition", "sub_type": "MPA", "rel": "ThemeOf", "object": "reduces", "obj_type": "NegReg", "file_name": "PubMed-28845019.json", "snippet": " [CLS] reduces amyloid beta deposition [CLS]  in Alzheimer's disease model mice.\nGranulin (Grn) mutations were identified in familial frontotemporal lobar degeneration (FTLD) patients with TAR DNA-binding protein of 43 kd (TDP-43) pathology. Grn transcript haploinsufficiency"}
{"subject": "Alzheimer's disease", "sub_type": "Disease", "rel": "ThemeOf", "object": "reduces", "obj_type": "NegReg", "file_name": "PubMed-28845019.json", "snippet": " [CLS] reduces amyloid beta deposition in Alzheimer's disease [CLS]  model mice.\nGranulin (Grn) mutations were identified in familial frontotemporal lobar degeneration (FTLD) patients with TAR DNA-binding protein of 43 kd (TDP-43) pathology. Grn transcript haploinsufficiency is proposed as"}
{"subject": "haploinsufficiency", "sub_type": "Var", "rel": "CauseOf", "object": "reduces", "obj_type": "NegReg", "file_name": "PubMed-28845019.json", "snippet": " [CLS] haploinsufficiency reduces [CLS]  amyloid beta deposition in Alzheimer's disease model mice.\nGranulin (Grn) mutations were identified in familial frontotemporal lobar degeneration (FTLD) patients with TAR DNA-binding protein of 43 kd (TDP-43) pathology."}
{"subject": "Grn", "sub_type": "Protein", "rel": "ThemeOf", "object": "haploinsufficiency", "obj_type": "Var", "file_name": "PubMed-28845019.json", "snippet": " amyloid beta deposition in Alzheimer's disease model mice.\nGranulin (Grn) mutations were identified in familial frontotemporal lobar degeneration (FTLD) patients with TAR DNA-binding protein of 43 kd (TDP-43) pathology.  [CLS] Grn transcript haploinsufficiency [CLS]  is proposed as a disease mechanism that leads to the loss of functional progranulin (PGRN) protein. Thus, these mutations are strongly involved in FTLD pathogenesis. Moreover, recent findings indicate"}
{"subject": "PGRN", "sub_type": "Protein", "rel": "ThemeOf", "object": "loss of functional", "obj_type": "NegReg", "file_name": "PubMed-28845019.json", "snippet": " in familial frontotemporal lobar degeneration (FTLD) patients with TAR DNA-binding protein of 43 kd (TDP-43) pathology. Grn transcript haploinsufficiency is proposed as a disease mechanism that leads to the  [CLS] loss of functional progranulin (PGRN [CLS] ) protein. Thus, these mutations are strongly involved in FTLD pathogenesis. Moreover, recent findings indicate that Grn mutations are associated with other neurodegenerative disorders with tau pathology, including Alzheimer's disease."}
{"subject": "FTLD", "sub_type": "Disease", "rel": "ThemeOf", "object": "involved", "obj_type": "Reg", "file_name": "PubMed-28845019.json", "snippet": " of 43 kd (TDP-43) pathology. Grn transcript haploinsufficiency is proposed as a disease mechanism that leads to the loss of functional progranulin (PGRN) protein. Thus, these mutations are strongly  [CLS] involved in FTLD [CLS]  pathogenesis. Moreover, recent findings indicate that Grn mutations are associated with other neurodegenerative disorders with tau pathology, including Alzheimer's disease. To investigate the influence of PGRN on amyloid beta"}
{"subject": "haploinsufficiency", "sub_type": "Var", "rel": "CauseOf", "object": "loss of functional", "obj_type": "NegReg", "file_name": "PubMed-28845019.json", "snippet": " deposition in Alzheimer's disease model mice.\nGranulin (Grn) mutations were identified in familial frontotemporal lobar degeneration (FTLD) patients with TAR DNA-binding protein of 43 kd (TDP-43) pathology. Grn transcript  [CLS] haploinsufficiency is proposed as a disease mechanism that leads to the loss of functional [CLS]  progranulin (PGRN) protein. Thus, these mutations are strongly involved in FTLD pathogenesis. Moreover, recent findings indicate that Grn mutations are associated with other neurodegenerative disorders with tau pathology, including"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "involved", "obj_type": "Reg", "file_name": "PubMed-28845019.json", "snippet": " TAR DNA-binding protein of 43 kd (TDP-43) pathology. Grn transcript haploinsufficiency is proposed as a disease mechanism that leads to the loss of functional progranulin (PGRN) protein. Thus, these  [CLS] mutations are strongly involved [CLS]  in FTLD pathogenesis. Moreover, recent findings indicate that Grn mutations are associated with other neurodegenerative disorders with tau pathology, including Alzheimer's disease. To investigate the influence of PGRN on"}
{"subject": "CUL3", "sub_type": "Gene", "rel": "ThemeOf", "object": "deleted", "obj_type": "Var", "file_name": "PubMed-28860350.json", "snippet": " has prognostic value in OSCC. Two newly discovered SMGs, CUL3 and ZFP36L2, were validated as important tumour-suppressors specific to the OSCC subtype. We further identified their additional loss-of-function mechanisms.  [CLS] CUL3 was homozygously deleted [CLS]  specifically in OSCC and other squamous cell cancers (SCCs). Notably, ZFP36L2 is associated with super-enhancer in healthy oesophageal mucosa; DNA hypermethylation in its super-enhancer reduced active histone markers in"}
{"subject": "deleted", "sub_type": "Var", "rel": "CauseOf", "object": "in", "obj_type": "Reg", "file_name": "PubMed-28860350.json", "snippet": " in OSCC. Two newly discovered SMGs, CUL3 and ZFP36L2, were validated as important tumour-suppressors specific to the OSCC subtype. We further identified their additional loss-of-function mechanisms. CUL3 was homozygously  [CLS] deleted specifically in [CLS]  OSCC and other squamous cell cancers (SCCs). Notably, ZFP36L2 is associated with super-enhancer in healthy oesophageal mucosa; DNA hypermethylation in its super-enhancer reduced active histone markers in squamous cancer"}
{"subject": "OSCC", "sub_type": "Disease", "rel": "ThemeOf", "object": "in", "obj_type": "Reg", "file_name": "PubMed-28860350.json", "snippet": " Two newly discovered SMGs, CUL3 and ZFP36L2, were validated as important tumour-suppressors specific to the OSCC subtype. We further identified their additional loss-of-function mechanisms. CUL3 was homozygously deleted specifically  [CLS] in OSCC [CLS]  and other squamous cell cancers (SCCs). Notably, ZFP36L2 is associated with super-enhancer in healthy oesophageal mucosa; DNA hypermethylation in its super-enhancer reduced active histone markers in squamous cancer cells,"}
{"subject": "squamous cell cancers", "sub_type": "Disease", "rel": "ThemeOf", "object": "in", "obj_type": "Reg", "file_name": "PubMed-28860350.json", "snippet": " Two newly discovered SMGs, CUL3 and ZFP36L2, were validated as important tumour-suppressors specific to the OSCC subtype. We further identified their additional loss-of-function mechanisms. CUL3 was homozygously deleted specifically  [CLS] in OSCC and other squamous cell cancers [CLS]  (SCCs). Notably, ZFP36L2 is associated with super-enhancer in healthy oesophageal mucosa; DNA hypermethylation in its super-enhancer reduced active histone markers in squamous cancer cells, suggesting an epigenetic inactivation of"}
{"subject": "PIK3CA", "sub_type": "Gene", "rel": "ThemeOf", "object": "c.3140 A\u00a0>\u00a0G", "obj_type": "Var", "file_name": "PubMed-28867506.json", "snippet": " macrodactyly of the foot, and mild intellectual disability. Imaging of the lower limb showed a lipoblastoma of the right thigh. A mosaic gain-of-function mutation in the catalytic domain of  [CLS] PIK3CA (c.3140 A\u00a0>\u00a0G [CLS] ; p.His1047Arg) was detected in the adipose tissue and in skin cultured fibroblasts from the macrodactyly but not in blood. The leg pain and the severe walking disturbance improved slightly"}
{"subject": "PIK3CA", "sub_type": "Gene", "rel": "ThemeOf", "object": "p.His1047Arg", "obj_type": "Var", "file_name": "PubMed-28867506.json", "snippet": " macrodactyly of the foot, and mild intellectual disability. Imaging of the lower limb showed a lipoblastoma of the right thigh. A mosaic gain-of-function mutation in the catalytic domain of  [CLS] PIK3CA (c.3140 A\u00a0>\u00a0G; p.His1047Arg [CLS] ) was detected in the adipose tissue and in skin cultured fibroblasts from the macrodactyly but not in blood. The leg pain and the severe walking disturbance improved slightly over"}
{"subject": "c.3140 A\u00a0>\u00a0G", "sub_type": "Var", "rel": "CauseOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-28867506.json", "snippet": " patient with gait disturbance, leg pain, isolated macrodactyly of the foot, and mild intellectual disability. Imaging of the lower limb showed a lipoblastoma of the right thigh. A mosaic  [CLS] gain-of-function mutation in the catalytic domain of PIK3CA (c.3140 A\u00a0>\u00a0G [CLS] ; p.His1047Arg) was detected in the adipose tissue and in skin cultured fibroblasts from the macrodactyly but not in blood. The leg pain and the severe walking disturbance improved slightly"}
{"subject": "p.His1047Arg", "sub_type": "Var", "rel": "CauseOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-28867506.json", "snippet": " patient with gait disturbance, leg pain, isolated macrodactyly of the foot, and mild intellectual disability. Imaging of the lower limb showed a lipoblastoma of the right thigh. A mosaic  [CLS] gain-of-function mutation in the catalytic domain of PIK3CA (c.3140 A\u00a0>\u00a0G; p.His1047Arg [CLS] ) was detected in the adipose tissue and in skin cultured fibroblasts from the macrodactyly but not in blood. The leg pain and the severe walking disturbance improved slightly over"}
{"subject": "mutation", "sub_type": "Var", "rel": "CauseOf", "object": "damaged", "obj_type": "NegReg", "file_name": "PubMed-28886269.json", "snippet": " including the 1000 Genomes database (which includes data from Africa). However, 4 of the 5 mutations were present in unaffected mothers, indicating that their penetrance is incomplete. Interestingly, 1  [CLS] mutation damaged [CLS]  a predicted sumoylation site, and another disrupted a predicted CK1 phosphorylation site. Overexpression assays in zebrafish and reporter assays in vitro indicated that 4 variants were functionally null or"}
{"subject": "sumoylation site", "sub_type": "MPA", "rel": "ThemeOf", "object": "damaged", "obj_type": "NegReg", "file_name": "PubMed-28886269.json", "snippet": " the 1000 Genomes database (which includes data from Africa). However, 4 of the 5 mutations were present in unaffected mothers, indicating that their penetrance is incomplete. Interestingly, 1 mutation  [CLS] damaged a predicted sumoylation site [CLS] , and another disrupted a predicted CK1 phosphorylation site. Overexpression assays in zebrafish and reporter assays in vitro indicated that 4 variants were functionally null or hypomorphic, while 1 was"}
{"subject": "mutation", "sub_type": "Var", "rel": "CauseOf", "object": "disrupted", "obj_type": "NegReg", "file_name": "PubMed-28886269.json", "snippet": " including the 1000 Genomes database (which includes data from Africa). However, 4 of the 5 mutations were present in unaffected mothers, indicating that their penetrance is incomplete. Interestingly, 1  [CLS] mutation damaged a predicted sumoylation site, and another disrupted [CLS]  a predicted CK1 phosphorylation site. Overexpression assays in zebrafish and reporter assays in vitro indicated that 4 variants were functionally null or hypomorphic, while 1 was dominant negative. This"}
{"subject": "CK1 phosphorylation", "sub_type": "MPA", "rel": "ThemeOf", "object": "disrupted", "obj_type": "NegReg", "file_name": "PubMed-28886269.json", "snippet": " from Africa). However, 4 of the 5 mutations were present in unaffected mothers, indicating that their penetrance is incomplete. Interestingly, 1 mutation damaged a predicted sumoylation site, and another  [CLS] disrupted a predicted CK1 phosphorylation [CLS]  site. Overexpression assays in zebrafish and reporter assays in vitro indicated that 4 variants were functionally null or hypomorphic, while 1 was dominant negative. This study provides evidence that,"}
{"subject": "GRHL3", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-28886269.json", "snippet": " zebrafish and reporter assays in vitro indicated that 4 variants were functionally null or hypomorphic, while 1 was dominant negative. This study provides evidence that, as in Caucasian populations,  [CLS] mutations in GRHL3 [CLS]  contribute to the risk of nonsyndromic CPO in the African population."}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "risk", "obj_type": "Reg", "file_name": "PubMed-28886269.json", "snippet": " zebrafish and reporter assays in vitro indicated that 4 variants were functionally null or hypomorphic, while 1 was dominant negative. This study provides evidence that, as in Caucasian populations,  [CLS] mutations in GRHL3 contribute to the risk [CLS]  of nonsyndromic CPO in the African population."}
{"subject": "CPO", "sub_type": "Disease", "rel": "ThemeOf", "object": "risk", "obj_type": "Reg", "file_name": "PubMed-28886269.json", "snippet": " indicated that 4 variants were functionally null or hypomorphic, while 1 was dominant negative. This study provides evidence that, as in Caucasian populations, mutations in GRHL3 contribute to the  [CLS] risk of nonsyndromic CPO [CLS]  in the African population."}
{"subject": "apolipoprotein C-III", "sub_type": "Protein", "rel": "ThemeOf", "object": "Gln38Lys", "obj_type": "Var", "file_name": "PubMed-28887372.json", "snippet": " [CLS] apolipoprotein C-III (Gln38Lys [CLS] ) variant associated with human hypertriglyceridemia is a gain-of-function mutation.\nRecent cell culture and animal studies have suggested that expression of human apo C-III in the liver has a profound"}
{"subject": "C3QK", "sub_type": "Var", "rel": "ThemeOf", "object": "enhanced", "obj_type": "PosReg", "file_name": "PubMed-28887372.json", "snippet": " with C3WT mice. Liver of C3QK mice also displayed an increase in DNL and expression of lipogenic genes as compared with that in C3WT mice. These results suggest that  [CLS] C3QK variant is a gain-of-function mutation that can stimulate VLDL1 production, through enhanced [CLS]  DNL."}
{"subject": "Gln38Lys", "sub_type": "Var", "rel": "ThemeOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-28887372.json", "snippet": " [CLS] Gln38Lys) variant associated with human hypertriglyceridemia is a gain-of-function [CLS]  mutation.\nRecent cell culture and animal studies have suggested that expression of human apo C-III in the liver has a profound impact on the triacylglycerol (TAG)-rich VLDL1 production under"}
{"subject": "human hypertriglyceridemia", "sub_type": "Disease", "rel": "ThemeOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-28887372.json", "snippet": " [CLS] human hypertriglyceridemia is a gain-of-function [CLS]  mutation.\nRecent cell culture and animal studies have suggested that expression of human apo C-III in the liver has a profound impact on the triacylglycerol (TAG)-rich VLDL1 production under"}
{"subject": "DNL", "sub_type": "MPA", "rel": "ThemeOf", "object": "increase", "obj_type": "PosReg", "file_name": "PubMed-28887372.json", "snippet": " lipogenesis (DNL). Fasting plasma concentration of TAG, cholesterol, cholesteryl ester, and FA were increased in C3QK mice as compared with C3WT mice. Liver of C3QK mice also displayed an  [CLS] increase in DNL [CLS]  and expression of lipogenic genes as compared with that in C3WT mice. These results suggest that C3QK variant is a gain-of-function mutation that can stimulate VLDL1 production, through enhanced"}
{"subject": "lipogenic genes", "sub_type": "Gene", "rel": "ThemeOf", "object": "expression", "obj_type": "MPA", "file_name": "PubMed-28887372.json", "snippet": " concentration of TAG, cholesterol, cholesteryl ester, and FA were increased in C3QK mice as compared with C3WT mice. Liver of C3QK mice also displayed an increase in DNL and  [CLS] expression of lipogenic genes [CLS]  as compared with that in C3WT mice. These results suggest that C3QK variant is a gain-of-function mutation that can stimulate VLDL1 production, through enhanced DNL."}
{"subject": "expression", "sub_type": "MPA", "rel": "ThemeOf", "object": "increase", "obj_type": "PosReg", "file_name": "PubMed-28887372.json", "snippet": " lipogenesis (DNL). Fasting plasma concentration of TAG, cholesterol, cholesteryl ester, and FA were increased in C3QK mice as compared with C3WT mice. Liver of C3QK mice also displayed an  [CLS] increase in DNL and expression [CLS]  of lipogenic genes as compared with that in C3WT mice. These results suggest that C3QK variant is a gain-of-function mutation that can stimulate VLDL1 production, through enhanced DNL."}
{"subject": "VLDL1 production", "sub_type": "MPA", "rel": "ThemeOf", "object": "stimulate", "obj_type": "PosReg", "file_name": "PubMed-28887372.json", "snippet": " displayed an increase in DNL and expression of lipogenic genes as compared with that in C3WT mice. These results suggest that C3QK variant is a gain-of-function mutation that can  [CLS] stimulate VLDL1 production [CLS] , through enhanced DNL."}
{"subject": "DNL", "sub_type": "MPA", "rel": "ThemeOf", "object": "enhanced", "obj_type": "PosReg", "file_name": "PubMed-28887372.json", "snippet": " DNL and expression of lipogenic genes as compared with that in C3WT mice. These results suggest that C3QK variant is a gain-of-function mutation that can stimulate VLDL1 production, through  [CLS] enhanced DNL [CLS] ."}
{"subject": "C3QK", "sub_type": "Var", "rel": "CauseOf", "object": "increase", "obj_type": "PosReg", "file_name": "PubMed-28887372.json", "snippet": " an increase in de novo lipogenesis (DNL). Fasting plasma concentration of TAG, cholesterol, cholesteryl ester, and FA were increased in C3QK mice as compared with C3WT mice. Liver of  [CLS] C3QK mice also displayed an increase [CLS]  in DNL and expression of lipogenic genes as compared with that in C3WT mice. These results suggest that C3QK variant is a gain-of-function mutation that can stimulate VLDL1 production,"}
{"subject": "C3QK", "sub_type": "Var", "rel": "ThemeOf", "object": "stimulate", "obj_type": "PosReg", "file_name": "PubMed-28887372.json", "snippet": " with C3WT mice. Liver of C3QK mice also displayed an increase in DNL and expression of lipogenic genes as compared with that in C3WT mice. These results suggest that  [CLS] C3QK variant is a gain-of-function mutation that can stimulate [CLS]  VLDL1 production, through enhanced DNL."}
{"subject": "KCNK3", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-28889099.json", "snippet": " [CLS] mutations in the KCNK3 [CLS]  gene cause hereditary pulmonary arterial hypertension (PAH). KCNK3 encodes an acid-sensitive potassium channel, which contributes to the resting potential of human pulmonary artery smooth muscle cells. KCNK3 is widely"}
{"subject": "pulmonary arterial hypertension", "sub_type": "Disease", "rel": "ThemeOf", "object": "cause", "obj_type": "Reg", "file_name": "PubMed-28889099.json", "snippet": " [CLS] cause hereditary pulmonary arterial hypertension [CLS]  (PAH). KCNK3 encodes an acid-sensitive potassium channel, which contributes to the resting potential of human pulmonary artery smooth muscle cells. KCNK3 is widely expressed in the body, and dimerizes"}
{"subject": "channel function", "sub_type": "MPA", "rel": "ThemeOf", "object": "loss", "obj_type": "NegReg", "file_name": "PubMed-28889099.json", "snippet": " and demonstrated in functional studies that KCNK9 minimizes the impact of select KCNK3 mutations when the 2 channel subunits co-assemble.\nCONCLUSIONS: Heterozygous KCNK3 mutations in PAH lead to variable  [CLS] loss of channel function [CLS]  via distinct mechanisms. Homomeric and heterodimeric mutant KCNK3 channels represent novel therapeutic substrates in PAH. Pharmacological and pH-dependent activation of wildtype and mutant KCNK3 channels in pulmonary artery smooth"}
{"subject": "KCNK3", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-28889099.json", "snippet": " lungs, but no quantifiable expression of KCNK9, and demonstrated in functional studies that KCNK9 minimizes the impact of select KCNK3 mutations when the 2 channel subunits co-assemble.\nCONCLUSIONS: Heterozygous  [CLS] KCNK3 mutations [CLS]  in PAH lead to variable loss of channel function via distinct mechanisms. Homomeric and heterodimeric mutant KCNK3 channels represent novel therapeutic substrates in PAH. Pharmacological and pH-dependent activation of"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "cause", "obj_type": "Reg", "file_name": "PubMed-28889099.json", "snippet": " [CLS] mutations in the KCNK3 gene cause [CLS]  hereditary pulmonary arterial hypertension (PAH). KCNK3 encodes an acid-sensitive potassium channel, which contributes to the resting potential of human pulmonary artery smooth muscle cells. KCNK3 is widely expressed in"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "loss", "obj_type": "NegReg", "file_name": "PubMed-28889099.json", "snippet": " but no quantifiable expression of KCNK9, and demonstrated in functional studies that KCNK9 minimizes the impact of select KCNK3 mutations when the 2 channel subunits co-assemble.\nCONCLUSIONS: Heterozygous KCNK3  [CLS] mutations in PAH lead to variable loss [CLS]  of channel function via distinct mechanisms. Homomeric and heterodimeric mutant KCNK3 channels represent novel therapeutic substrates in PAH. Pharmacological and pH-dependent activation of wildtype and mutant KCNK3 channels in"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-28890134.json", "snippet": " [CLS] loss-of-function (LOF) mutations [CLS]  in the human progranulin gene (GRN) cause frontotemporal lobar degeneration (FTLD) by a mechanism of haploinsufficiency. Patients present most frequently with frontotemporal dementia, which is the second most common"}
{"subject": "GRN", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-28890134.json", "snippet": " [CLS] mutations in the human progranulin gene (GRN [CLS] ) cause frontotemporal lobar degeneration (FTLD) by a mechanism of haploinsufficiency. Patients present most frequently with frontotemporal dementia, which is the second most common neurodegenerative dementia at young age. Currently,"}
{"subject": "frontotemporal lobar degeneration", "sub_type": "Disease", "rel": "ThemeOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-28890134.json", "snippet": " [CLS] loss-of-function (LOF) mutations in the human progranulin gene (GRN) cause frontotemporal lobar degeneration [CLS]  (FTLD) by a mechanism of haploinsufficiency. Patients present most frequently with frontotemporal dementia, which is the second most common neurodegenerative dementia at young age. Currently, no disease-modifying therapies are"}
{"subject": "SETD5", "sub_type": "Gene", "rel": "ThemeOf", "object": "variant", "obj_type": "Var", "file_name": "PubMed-28905509.json", "snippet": " [CLS] SETD5 loss-of-function variant [CLS]  as a cause for intellectual disability in a 10-year old boy with an aberrant blind ending bronchus.\nAlthough rare, 3p microdeletion cases have been well described in the clinical"}
{"subject": "intellectual disability", "sub_type": "Disease", "rel": "ThemeOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-28905509.json", "snippet": " [CLS] loss-of-function variant as a cause for intellectual disability [CLS]  in a 10-year old boy with an aberrant blind ending bronchus.\nAlthough rare, 3p microdeletion cases have been well described in the clinical literature. The clinical phenotype includes; intellectual"}
{"subject": "ID", "sub_type": "Disease", "rel": "ThemeOf", "object": "Loss-of-Function", "obj_type": "NegReg", "file_name": "PubMed-28905509.json", "snippet": " testing narrowed the 3p25 critical region to a 124\u2009kb region, and recent Whole Exome Sequencing (WES) studies have suggested that the SETD5 gene contributes significantly to the 3p25 phenotype.  [CLS] Loss-of-Function (LoF) variants in SETD5 are now considered a likely cause of ID [CLS] . We report here a patient with a frameshift LoF variant in exon 12 of SETD5. This patient has features overlapping with other patients described with LoF SETD5 variants to"}
{"subject": "SETD5", "sub_type": "Gene", "rel": "ThemeOf", "object": "variants", "obj_type": "Var", "file_name": "PubMed-28905509.json", "snippet": " the 3p25 critical region to a 124\u2009kb region, and recent Whole Exome Sequencing (WES) studies have suggested that the SETD5 gene contributes significantly to the 3p25 phenotype. Loss-of-Function (LoF)  [CLS] variants in SETD5 [CLS]  are now considered a likely cause of ID. We report here a patient with a frameshift LoF variant in exon 12 of SETD5. This patient has features overlapping with"}
{"subject": "variant", "sub_type": "Var", "rel": "CauseOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-28905509.json", "snippet": " [CLS] loss-of-function variant [CLS]  as a cause for intellectual disability in a 10-year old boy with an aberrant blind ending bronchus.\nAlthough rare, 3p microdeletion cases have been well described in the clinical"}
{"subject": "variants", "sub_type": "Var", "rel": "CauseOf", "object": "Loss-of-Function", "obj_type": "NegReg", "file_name": "PubMed-28905509.json", "snippet": " testing narrowed the 3p25 critical region to a 124\u2009kb region, and recent Whole Exome Sequencing (WES) studies have suggested that the SETD5 gene contributes significantly to the 3p25 phenotype.  [CLS] Loss-of-Function (LoF) variants [CLS]  in SETD5 are now considered a likely cause of ID. We report here a patient with a frameshift LoF variant in exon 12 of SETD5. This patient has features"}
{"subject": "STAT", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-28914637.json", "snippet": " [CLS] mutations of signal transducer and activator of transcription (STAT [CLS] ) genes, a group of genetically determined disorders characterized by susceptibility to infections and, in many cases, autoimmune manifestations.\nRECENT FINDINGS: GOF mutations affecting STAT1 result in increased STAT tyrosine"}
{"subject": "primary immunodeficiencies", "sub_type": "Disease", "rel": "ThemeOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-28914637.json", "snippet": " [CLS] primary immunodeficiencies caused by gain-of-function [CLS]  (GOF) mutations of signal transducer and activator of transcription (STAT) genes, a group of genetically determined disorders characterized by susceptibility to infections and, in many cases, autoimmune manifestations.\nRECENT"}
{"subject": "STAT1", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-28914637.json", "snippet": " of signal transducer and activator of transcription (STAT) genes, a group of genetically determined disorders characterized by susceptibility to infections and, in many cases, autoimmune manifestations.\nRECENT FINDINGS: GOF  [CLS] mutations affecting STAT1 [CLS]  result in increased STAT tyrosine phosphorylation and secondarily increased response to STAT1-signaling cytokines, such as interferons. In contrast, STAT3 hyperactivity is not usually related to hyperphosphorylation but rather to"}
{"subject": "STAT tyrosine phosphorylation", "sub_type": "MPA", "rel": "ThemeOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-28914637.json", "snippet": " of transcription (STAT) genes, a group of genetically determined disorders characterized by susceptibility to infections and, in many cases, autoimmune manifestations.\nRECENT FINDINGS: GOF mutations affecting STAT1 result in  [CLS] increased STAT tyrosine phosphorylation [CLS]  and secondarily increased response to STAT1-signaling cytokines, such as interferons. In contrast, STAT3 hyperactivity is not usually related to hyperphosphorylation but rather to increased STAT3-mediated transcriptional activity. In both"}
{"subject": "response to STAT1-signaling cytokines", "sub_type": "MPA", "rel": "ThemeOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-28914637.json", "snippet": " of genetically determined disorders characterized by susceptibility to infections and, in many cases, autoimmune manifestations.\nRECENT FINDINGS: GOF mutations affecting STAT1 result in increased STAT tyrosine phosphorylation and secondarily  [CLS] increased response to STAT1-signaling cytokines [CLS] , such as interferons. In contrast, STAT3 hyperactivity is not usually related to hyperphosphorylation but rather to increased STAT3-mediated transcriptional activity. In both cases, heterozygous STAT1 and STAT3 GOF mutations"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-28914637.json", "snippet": " [CLS] gain-of-function (GOF) mutations [CLS]  of signal transducer and activator of transcription (STAT) genes, a group of genetically determined disorders characterized by susceptibility to infections and, in many cases, autoimmune manifestations.\nRECENT FINDINGS: GOF"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-28914637.json", "snippet": " of signal transducer and activator of transcription (STAT) genes, a group of genetically determined disorders characterized by susceptibility to infections and, in many cases, autoimmune manifestations.\nRECENT FINDINGS: GOF  [CLS] mutations affecting STAT1 result in increased [CLS]  STAT tyrosine phosphorylation and secondarily increased response to STAT1-signaling cytokines, such as interferons. In contrast, STAT3 hyperactivity is not usually related to hyperphosphorylation but rather to increased STAT3-mediated transcriptional"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-28914637.json", "snippet": " of signal transducer and activator of transcription (STAT) genes, a group of genetically determined disorders characterized by susceptibility to infections and, in many cases, autoimmune manifestations.\nRECENT FINDINGS: GOF  [CLS] mutations affecting STAT1 result in increased STAT tyrosine phosphorylation and secondarily increased [CLS]  response to STAT1-signaling cytokines, such as interferons. In contrast, STAT3 hyperactivity is not usually related to hyperphosphorylation but rather to increased STAT3-mediated transcriptional activity. In both cases, heterozygous STAT1"}
{"subject": "GNPTAB", "sub_type": "Gene", "rel": "ThemeOf", "object": "p.D76G", "obj_type": "Var", "file_name": "PubMed-28918368.json", "snippet": " GlcNAc-1-phosphotransferase. To determine genotype-phenotype correlation and functional analysis of mutant GlcNAc-1-phosphotransferase, 13 Brazilian patients clinically and biochemical diagnosed for MLII or III alpha/beta were studied. By sequencing of genomic  [CLS] GNPTAB of the MLII and MLIII alpha/beta patients we identified six novel mutations: p.D76G [CLS] , p.S385L, p.Q278Kfs*3, p.H588Qfs*27, p.N642Lfs*10 and p.Y1111*. Expression analysis by western blotting and immunofluorescence microscopy revealed that the mutant \u03b1\u2044\u03b2-subunit precursor p.D76G is retained in the endoplasmic reticulum whereas the"}
{"subject": "activity", "sub_type": "MPA", "rel": "ThemeOf", "object": "loss", "obj_type": "NegReg", "file_name": "PubMed-28918368.json", "snippet": " mutant \u03b1\u2044\u03b2-subunit precursor p.D76G is retained in the endoplasmic reticulum whereas the mutant p.S385L is correctly transported to the cis-Golgi apparatus and proteolytically processed. Both mutations lead to complete  [CLS] loss of GlcNAc-1-phosphotransferase activity [CLS] , consistent with the severe clinical MLII phenotype of the patients. Our study expands the genotypic spectrum of MLII and provides novel insights into structural requirements to ensure GlcNAc-1-phosphotransferase activity."}
{"subject": "GNPTAB", "sub_type": "Gene", "rel": "ThemeOf", "object": "p.S385L", "obj_type": "Var", "file_name": "PubMed-28918368.json", "snippet": " GlcNAc-1-phosphotransferase. To determine genotype-phenotype correlation and functional analysis of mutant GlcNAc-1-phosphotransferase, 13 Brazilian patients clinically and biochemical diagnosed for MLII or III alpha/beta were studied. By sequencing of genomic  [CLS] GNPTAB of the MLII and MLIII alpha/beta patients we identified six novel mutations: p.D76G, p.S385L [CLS] , p.Q278Kfs*3, p.H588Qfs*27, p.N642Lfs*10 and p.Y1111*. Expression analysis by western blotting and immunofluorescence microscopy revealed that the mutant \u03b1\u2044\u03b2-subunit precursor p.D76G is retained in the endoplasmic reticulum whereas the mutant"}
{"subject": "GNPTAB", "sub_type": "Gene", "rel": "ThemeOf", "object": "p.Q278Kfs*3", "obj_type": "Var", "file_name": "PubMed-28918368.json", "snippet": " GlcNAc-1-phosphotransferase. To determine genotype-phenotype correlation and functional analysis of mutant GlcNAc-1-phosphotransferase, 13 Brazilian patients clinically and biochemical diagnosed for MLII or III alpha/beta were studied. By sequencing of genomic  [CLS] GNPTAB of the MLII and MLIII alpha/beta patients we identified six novel mutations: p.D76G, p.S385L, p.Q278Kfs*3 [CLS] , p.H588Qfs*27, p.N642Lfs*10 and p.Y1111*. Expression analysis by western blotting and immunofluorescence microscopy revealed that the mutant \u03b1\u2044\u03b2-subunit precursor p.D76G is retained in the endoplasmic reticulum whereas the mutant p.S385L"}
{"subject": "GNPTAB", "sub_type": "Gene", "rel": "ThemeOf", "object": "p.H588Qfs*27", "obj_type": "Var", "file_name": "PubMed-28918368.json", "snippet": " GlcNAc-1-phosphotransferase. To determine genotype-phenotype correlation and functional analysis of mutant GlcNAc-1-phosphotransferase, 13 Brazilian patients clinically and biochemical diagnosed for MLII or III alpha/beta were studied. By sequencing of genomic  [CLS] GNPTAB of the MLII and MLIII alpha/beta patients we identified six novel mutations: p.D76G, p.S385L, p.Q278Kfs*3, p.H588Qfs*27 [CLS] , p.N642Lfs*10 and p.Y1111*. Expression analysis by western blotting and immunofluorescence microscopy revealed that the mutant \u03b1\u2044\u03b2-subunit precursor p.D76G is retained in the endoplasmic reticulum whereas the mutant p.S385L is"}
{"subject": "GNPTAB", "sub_type": "Gene", "rel": "ThemeOf", "object": "p.N642Lfs*10", "obj_type": "Var", "file_name": "PubMed-28918368.json", "snippet": " GlcNAc-1-phosphotransferase. To determine genotype-phenotype correlation and functional analysis of mutant GlcNAc-1-phosphotransferase, 13 Brazilian patients clinically and biochemical diagnosed for MLII or III alpha/beta were studied. By sequencing of genomic  [CLS] GNPTAB of the MLII and MLIII alpha/beta patients we identified six novel mutations: p.D76G, p.S385L, p.Q278Kfs*3, p.H588Qfs*27, p.N642Lfs*10 [CLS]  and p.Y1111*. Expression analysis by western blotting and immunofluorescence microscopy revealed that the mutant \u03b1\u2044\u03b2-subunit precursor p.D76G is retained in the endoplasmic reticulum whereas the mutant p.S385L is correctly"}
{"subject": "GNPTAB", "sub_type": "Gene", "rel": "ThemeOf", "object": "p.Y1111*", "obj_type": "Var", "file_name": "PubMed-28918368.json", "snippet": " GlcNAc-1-phosphotransferase. To determine genotype-phenotype correlation and functional analysis of mutant GlcNAc-1-phosphotransferase, 13 Brazilian patients clinically and biochemical diagnosed for MLII or III alpha/beta were studied. By sequencing of genomic  [CLS] GNPTAB of the MLII and MLIII alpha/beta patients we identified six novel mutations: p.D76G, p.S385L, p.Q278Kfs*3, p.H588Qfs*27, p.N642Lfs*10 and p.Y1111* [CLS] . Expression analysis by western blotting and immunofluorescence microscopy revealed that the mutant \u03b1\u2044\u03b2-subunit precursor p.D76G is retained in the endoplasmic reticulum whereas the mutant p.S385L is correctly transported to"}
{"subject": "p.D76G", "sub_type": "Var", "rel": "CauseOf", "object": "loss", "obj_type": "NegReg", "file_name": "PubMed-28918368.json", "snippet": " MLIII alpha/beta patients we identified six novel mutations: p.D76G, p.S385L, p.Q278Kfs*3, p.H588Qfs*27, p.N642Lfs*10 and p.Y1111*. Expression analysis by western blotting and immunofluorescence microscopy revealed that the mutant \u03b1\u2044\u03b2-subunit precursor  [CLS] p.D76G is retained in the endoplasmic reticulum whereas the mutant p.S385L is correctly transported to the cis-Golgi apparatus and proteolytically processed. Both mutations lead to complete loss [CLS]  of GlcNAc-1-phosphotransferase activity, consistent with the severe clinical MLII phenotype of the patients. Our study expands the genotypic spectrum of MLII and provides novel insights into structural requirements to"}
{"subject": "p.S385L", "sub_type": "Var", "rel": "CauseOf", "object": "loss", "obj_type": "NegReg", "file_name": "PubMed-28918368.json", "snippet": " p.Q278Kfs*3, p.H588Qfs*27, p.N642Lfs*10 and p.Y1111*. Expression analysis by western blotting and immunofluorescence microscopy revealed that the mutant \u03b1\u2044\u03b2-subunit precursor p.D76G is retained in the endoplasmic reticulum whereas the mutant  [CLS] p.S385L is correctly transported to the cis-Golgi apparatus and proteolytically processed. Both mutations lead to complete loss [CLS]  of GlcNAc-1-phosphotransferase activity, consistent with the severe clinical MLII phenotype of the patients. Our study expands the genotypic spectrum of MLII and provides novel insights into structural requirements to"}
{"subject": "GlcNAc-1-phosphotransferase", "sub_type": "Enzyme", "rel": "ThemeOf", "object": "activity", "obj_type": "MPA", "file_name": "PubMed-28918368.json", "snippet": " precursor p.D76G is retained in the endoplasmic reticulum whereas the mutant p.S385L is correctly transported to the cis-Golgi apparatus and proteolytically processed. Both mutations lead to complete loss of  [CLS] GlcNAc-1-phosphotransferase activity [CLS] , consistent with the severe clinical MLII phenotype of the patients. Our study expands the genotypic spectrum of MLII and provides novel insights into structural requirements to ensure GlcNAc-1-phosphotransferase activity."}
{"subject": "CACNA1C", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutation", "obj_type": "Var", "file_name": "PubMed-28921675.json", "snippet": " L-type calcium channels, has one of the strongest genetic linkages to schizophrenia, bipolar disorder and major depressive disorder: psychopathologies in which serotonin signaling has been implicated. Additionally, a gain-of-function  [CLS] mutation in CACNA1C [CLS]  is responsible for the neurodevelopmental disorder Timothy syndrome that presents with prominent behavioral features on the autism spectrum. Given an emerging role for serotonin in the etiology of autism"}
{"subject": "mutation", "sub_type": "Var", "rel": "CauseOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-28921675.json", "snippet": " Cav1.2 L-type calcium channels, has one of the strongest genetic linkages to schizophrenia, bipolar disorder and major depressive disorder: psychopathologies in which serotonin signaling has been implicated. Additionally, a  [CLS] gain-of-function mutation [CLS]  in CACNA1C is responsible for the neurodevelopmental disorder Timothy syndrome that presents with prominent behavioral features on the autism spectrum. Given an emerging role for serotonin in the etiology"}
{"subject": "Timothy syndrome", "sub_type": "Disease", "rel": "ThemeOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-28921675.json", "snippet": " Cav1.2 L-type calcium channels, has one of the strongest genetic linkages to schizophrenia, bipolar disorder and major depressive disorder: psychopathologies in which serotonin signaling has been implicated. Additionally, a  [CLS] gain-of-function mutation in CACNA1C is responsible for the neurodevelopmental disorder Timothy syndrome [CLS]  that presents with prominent behavioral features on the autism spectrum. Given an emerging role for serotonin in the etiology of autism spectrum disorders (ASD), we investigate the relationship between"}
{"subject": "Cdc7", "sub_type": "Gene", "rel": "ThemeOf", "object": "point mutation", "obj_type": "Var", "file_name": "PubMed-28924058.json", "snippet": " origins of replication. We also discovered Cdc7 binding throughout the genome, which may be necessary to initiate other cellular processes, including meiotic recombination and translesion synthesis. A kinase dead  [CLS] Cdc7 point mutation [CLS]  increases the Ty5 retrotransposon integration efficiency and a 55-amino acid C-terminal truncation of Cdc7, unable to bind Dbf4, reduces Cdc7 binding suggesting a requirement for Dbf4 to stabilize Cdc7"}
{"subject": "55-amino acid C-terminal truncation", "sub_type": "MPA", "rel": "ThemeOf", "object": "Cdc7", "obj_type": "Gene", "file_name": "PubMed-28924058.json", "snippet": " which may be necessary to initiate other cellular processes, including meiotic recombination and translesion synthesis. A kinase dead Cdc7 point mutation increases the Ty5 retrotransposon integration efficiency and a  [CLS] 55-amino acid C-terminal truncation of Cdc7 [CLS] , unable to bind Dbf4, reduces Cdc7 binding suggesting a requirement for Dbf4 to stabilize Cdc7 on chromatin during S phase. Chromatin immunoprecipitation demonstrates that Cdc7 binding near specific origins"}
{"subject": "Cdc7", "sub_type": "Gene", "rel": "ThemeOf", "object": "bind", "obj_type": "Interaction", "file_name": "PubMed-28924058.json", "snippet": " initiate other cellular processes, including meiotic recombination and translesion synthesis. A kinase dead Cdc7 point mutation increases the Ty5 retrotransposon integration efficiency and a 55-amino acid C-terminal truncation of  [CLS] Cdc7, unable to bind [CLS]  Dbf4, reduces Cdc7 binding suggesting a requirement for Dbf4 to stabilize Cdc7 on chromatin during S phase. Chromatin immunoprecipitation demonstrates that Cdc7 binding near specific origins changes during S"}
{"subject": "point mutation", "sub_type": "Var", "rel": "CauseOf", "object": "increases", "obj_type": "PosReg", "file_name": "PubMed-28924058.json", "snippet": " of replication. We also discovered Cdc7 binding throughout the genome, which may be necessary to initiate other cellular processes, including meiotic recombination and translesion synthesis. A kinase dead Cdc7  [CLS] point mutation increases [CLS]  the Ty5 retrotransposon integration efficiency and a 55-amino acid C-terminal truncation of Cdc7, unable to bind Dbf4, reduces Cdc7 binding suggesting a requirement for Dbf4 to stabilize Cdc7 on"}
{"subject": "point mutation", "sub_type": "Var", "rel": "CauseOf", "object": "unable", "obj_type": "NegReg", "file_name": "PubMed-28924058.json", "snippet": " of replication. We also discovered Cdc7 binding throughout the genome, which may be necessary to initiate other cellular processes, including meiotic recombination and translesion synthesis. A kinase dead Cdc7  [CLS] point mutation increases the Ty5 retrotransposon integration efficiency and a 55-amino acid C-terminal truncation of Cdc7, unable [CLS]  to bind Dbf4, reduces Cdc7 binding suggesting a requirement for Dbf4 to stabilize Cdc7 on chromatin during S phase. Chromatin immunoprecipitation demonstrates that Cdc7 binding near specific origins changes"}
{"subject": "bind", "sub_type": "Interaction", "rel": "ThemeOf", "object": "unable", "obj_type": "NegReg", "file_name": "PubMed-28924058.json", "snippet": " other cellular processes, including meiotic recombination and translesion synthesis. A kinase dead Cdc7 point mutation increases the Ty5 retrotransposon integration efficiency and a 55-amino acid C-terminal truncation of Cdc7,  [CLS] unable to bind [CLS]  Dbf4, reduces Cdc7 binding suggesting a requirement for Dbf4 to stabilize Cdc7 on chromatin during S phase. Chromatin immunoprecipitation demonstrates that Cdc7 binding near specific origins changes during S"}
{"subject": "Dbf4", "sub_type": "Gene", "rel": "ThemeOf", "object": "bind", "obj_type": "Interaction", "file_name": "PubMed-28924058.json", "snippet": " processes, including meiotic recombination and translesion synthesis. A kinase dead Cdc7 point mutation increases the Ty5 retrotransposon integration efficiency and a 55-amino acid C-terminal truncation of Cdc7, unable to  [CLS] bind Dbf4 [CLS] , reduces Cdc7 binding suggesting a requirement for Dbf4 to stabilize Cdc7 on chromatin during S phase. Chromatin immunoprecipitation demonstrates that Cdc7 binding near specific origins changes during S phase."}
{"subject": "unable", "sub_type": "NegReg", "rel": "ThemeOf", "object": "reduces", "obj_type": "NegReg", "file_name": "PubMed-28924058.json", "snippet": " other cellular processes, including meiotic recombination and translesion synthesis. A kinase dead Cdc7 point mutation increases the Ty5 retrotransposon integration efficiency and a 55-amino acid C-terminal truncation of Cdc7,  [CLS] unable to bind Dbf4, reduces [CLS]  Cdc7 binding suggesting a requirement for Dbf4 to stabilize Cdc7 on chromatin during S phase. Chromatin immunoprecipitation demonstrates that Cdc7 binding near specific origins changes during S phase. Our"}
{"subject": "Cdc7", "sub_type": "Gene", "rel": "ThemeOf", "object": "binding", "obj_type": "Interaction", "file_name": "PubMed-28924058.json", "snippet": " recombination and translesion synthesis. A kinase dead Cdc7 point mutation increases the Ty5 retrotransposon integration efficiency and a 55-amino acid C-terminal truncation of Cdc7, unable to bind Dbf4, reduces  [CLS] Cdc7 binding [CLS]  suggesting a requirement for Dbf4 to stabilize Cdc7 on chromatin during S phase. Chromatin immunoprecipitation demonstrates that Cdc7 binding near specific origins changes during S phase. Our results suggest"}
{"subject": "binding", "sub_type": "Interaction", "rel": "ThemeOf", "object": "reduces", "obj_type": "NegReg", "file_name": "PubMed-28924058.json", "snippet": " meiotic recombination and translesion synthesis. A kinase dead Cdc7 point mutation increases the Ty5 retrotransposon integration efficiency and a 55-amino acid C-terminal truncation of Cdc7, unable to bind Dbf4,  [CLS] reduces Cdc7 binding [CLS]  suggesting a requirement for Dbf4 to stabilize Cdc7 on chromatin during S phase. Chromatin immunoprecipitation demonstrates that Cdc7 binding near specific origins changes during S phase. Our results suggest"}
{"subject": "Ty5 retrotransposon integration efficiency", "sub_type": "MPA", "rel": "ThemeOf", "object": "increases", "obj_type": "PosReg", "file_name": "PubMed-28924058.json", "snippet": " We also discovered Cdc7 binding throughout the genome, which may be necessary to initiate other cellular processes, including meiotic recombination and translesion synthesis. A kinase dead Cdc7 point mutation  [CLS] increases the Ty5 retrotransposon integration efficiency [CLS]  and a 55-amino acid C-terminal truncation of Cdc7, unable to bind Dbf4, reduces Cdc7 binding suggesting a requirement for Dbf4 to stabilize Cdc7 on chromatin during S phase. Chromatin"}
{"subject": "PTPN11", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutation", "obj_type": "Var", "file_name": "PubMed-28929581.json", "snippet": " [CLS] mutation in PTPN11 [CLS]  in histiocytic sarcomas of Bernese Mountain Dogs.\nHistiocytic sarcoma (HS) is an aggressive malignant neoplasm of dendritic cell origin that is common in certain breeds of dogs. High prevalence"}
{"subject": "mutation", "sub_type": "Var", "rel": "CauseOf", "object": "Gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-28929581.json", "snippet": " [CLS] Gain-of-function mutation [CLS]  in PTPN11 in histiocytic sarcomas of Bernese Mountain Dogs.\nHistiocytic sarcoma (HS) is an aggressive malignant neoplasm of dendritic cell origin that is common in certain breeds of dogs."}
{"subject": "histiocytic sarcomas", "sub_type": "Disease", "rel": "ThemeOf", "object": "Gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-28929581.json", "snippet": " [CLS] Gain-of-function mutation in PTPN11 in histiocytic sarcomas [CLS]  of Bernese Mountain Dogs.\nHistiocytic sarcoma (HS) is an aggressive malignant neoplasm of dendritic cell origin that is common in certain breeds of dogs. High prevalence of fatal, disseminated"}
{"subject": "PTPN11", "sub_type": "Gene", "rel": "ThemeOf", "object": "E76K", "obj_type": "Var", "file_name": "PubMed-28929581.json", "snippet": " develop HS has been presented in several studies, but to date, causative genetic events have not been reported. In addition, no driver mutations have been identified in tumours. Recently,  [CLS] E76K gain-of-function mutation in SHP2 encoded by the PTPN11 [CLS]  gene has been described in human histiocytic malignancies. In our study, we identified the PTPN11E76K in HS of BMDs. Amplification of exon 3 of the PTPN11 gene followed by"}
{"subject": "E76K", "sub_type": "Var", "rel": "CauseOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-28929581.json", "snippet": " develop HS has been presented in several studies, but to date, causative genetic events have not been reported. In addition, no driver mutations have been identified in tumours. Recently,  [CLS] E76K gain-of-function [CLS]  mutation in SHP2 encoded by the PTPN11 gene has been described in human histiocytic malignancies. In our study, we identified the PTPN11E76K in HS of BMDs. Amplification of exon"}
{"subject": "histiocytic malignancies", "sub_type": "Disease", "rel": "ThemeOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-28929581.json", "snippet": " HS has been presented in several studies, but to date, causative genetic events have not been reported. In addition, no driver mutations have been identified in tumours. Recently, E76K  [CLS] gain-of-function mutation in SHP2 encoded by the PTPN11 gene has been described in human histiocytic malignancies [CLS] . In our study, we identified the PTPN11E76K in HS of BMDs. Amplification of exon 3 of the PTPN11 gene followed by Sanger sequencing was used to detect the mutation"}
{"subject": "KIDINS220", "sub_type": "Gene", "rel": "ThemeOf", "object": "variants", "obj_type": "Var", "file_name": "PubMed-28934391.json", "snippet": " [CLS] KIDINS220 loss-of-function variants [CLS]  in fetuses with cerebral ventriculomegaly and limb contractures.\nHeterozygous mutations in KIDINS220 were recently suggested a cause of spastic paraplegia, intellectual disability, nystagmus and obesity. All patients carried terminal"}
{"subject": "obesity", "sub_type": "Disease", "rel": "ThemeOf", "object": "cause", "obj_type": "Reg", "file_name": "PubMed-28934391.json", "snippet": " [CLS] cause of spastic paraplegia, intellectual disability, nystagmus and obesity [CLS] . All patients carried terminal nonsense de novo mutations that seemed to escape nonsense-mediated mRNA decay. The mechanism for pathogenicity is yet unexplained, as it seems that heterozygous loss-of-function variants"}
{"subject": "variants", "sub_type": "Var", "rel": "CauseOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-28934391.json", "snippet": " [CLS] loss-of-function variants [CLS]  in fetuses with cerebral ventriculomegaly and limb contractures.\nHeterozygous mutations in KIDINS220 were recently suggested a cause of spastic paraplegia, intellectual disability, nystagmus and obesity. All patients carried terminal"}
{"subject": "loss-of-function", "sub_type": "NegReg", "rel": "CauseOf", "object": "cerebral ventriculomegaly", "obj_type": "CPA", "file_name": "PubMed-28934391.json", "snippet": " [CLS] loss-of-function variants in fetuses with cerebral ventriculomegaly [CLS]  and limb contractures.\nHeterozygous mutations in KIDINS220 were recently suggested a cause of spastic paraplegia, intellectual disability, nystagmus and obesity. All patients carried terminal nonsense de novo mutations that"}
{"subject": "loss-of-function", "sub_type": "NegReg", "rel": "CauseOf", "object": "limb contractures", "obj_type": "CPA", "file_name": "PubMed-28934391.json", "snippet": " [CLS] loss-of-function variants in fetuses with cerebral ventriculomegaly and limb contractures [CLS] .\nHeterozygous mutations in KIDINS220 were recently suggested a cause of spastic paraplegia, intellectual disability, nystagmus and obesity. All patients carried terminal nonsense de novo mutations that seemed to escape"}
{"subject": "KIDINS220", "sub_type": "Gene", "rel": "ThemeOf", "object": "Heterozygous mutations", "obj_type": "Var", "file_name": "PubMed-28934391.json", "snippet": " [CLS] Heterozygous mutations in KIDINS220 [CLS]  were recently suggested a cause of spastic paraplegia, intellectual disability, nystagmus and obesity. All patients carried terminal nonsense de novo mutations that seemed to escape nonsense-mediated mRNA decay. The"}
{"subject": "Heterozygous mutations", "sub_type": "Var", "rel": "CauseOf", "object": "cause", "obj_type": "Reg", "file_name": "PubMed-28934391.json", "snippet": " [CLS] Heterozygous mutations in KIDINS220 were recently suggested a cause [CLS]  of spastic paraplegia, intellectual disability, nystagmus and obesity. All patients carried terminal nonsense de novo mutations that seemed to escape nonsense-mediated mRNA decay. The mechanism for pathogenicity is yet"}
{"subject": "spastic paraplegia", "sub_type": "Disease", "rel": "ThemeOf", "object": "cause", "obj_type": "Reg", "file_name": "PubMed-28934391.json", "snippet": " [CLS] cause of spastic paraplegia [CLS] , intellectual disability, nystagmus and obesity. All patients carried terminal nonsense de novo mutations that seemed to escape nonsense-mediated mRNA decay. The mechanism for pathogenicity is yet unexplained, as it"}
{"subject": "intellectual disability", "sub_type": "Disease", "rel": "ThemeOf", "object": "cause", "obj_type": "Reg", "file_name": "PubMed-28934391.json", "snippet": " [CLS] cause of spastic paraplegia, intellectual disability [CLS] , nystagmus and obesity. All patients carried terminal nonsense de novo mutations that seemed to escape nonsense-mediated mRNA decay. The mechanism for pathogenicity is yet unexplained, as it seems that"}
{"subject": "nystagmus", "sub_type": "Disease", "rel": "ThemeOf", "object": "cause", "obj_type": "Reg", "file_name": "PubMed-28934391.json", "snippet": " [CLS] cause of spastic paraplegia, intellectual disability, nystagmus [CLS]  and obesity. All patients carried terminal nonsense de novo mutations that seemed to escape nonsense-mediated mRNA decay. The mechanism for pathogenicity is yet unexplained, as it seems that heterozygous"}
{"subject": "GNAS", "sub_type": "Gene", "rel": "ThemeOf", "object": "missense mutation", "obj_type": "Var", "file_name": "PubMed-28939416.json", "snippet": " for transformation. To achieve this, the biological impact of CHIP variants on HSC function must be validated. One variant that has been identified recurrently in CHIP is a gain-of-function  [CLS] missense mutation in the imprinted gene GNAS [CLS]  (Guanine Nucleotide Binding Protein, Alpha Stimulating). In this study, we examined the effect of the GNASR201C variant on HSC function. Ectopic expression of GNASR201C supported transplantable HSC activity and"}
{"subject": "missense mutation", "sub_type": "Var", "rel": "CauseOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-28939416.json", "snippet": " risk for transformation. To achieve this, the biological impact of CHIP variants on HSC function must be validated. One variant that has been identified recurrently in CHIP is a  [CLS] gain-of-function missense mutation [CLS]  in the imprinted gene GNAS (Guanine Nucleotide Binding Protein, Alpha Stimulating). In this study, we examined the effect of the GNASR201C variant on HSC function. Ectopic expression of GNASR201C"}
{"subject": "GNAS", "sub_type": "Gene", "rel": "ThemeOf", "object": "R201C", "obj_type": "Var", "file_name": "PubMed-28939416.json", "snippet": " mutation in the imprinted gene GNAS (Guanine Nucleotide Binding Protein, Alpha Stimulating). In this study, we examined the effect of the GNASR201C variant on HSC function. Ectopic expression of  [CLS] GNASR201C [CLS]  supported transplantable HSC activity and improved lymphoid output in secondary recipients. Because declining lymphoid output is a hallmark of aging, GNASR201C mutations may sustain lymphoid-biased HSCs over time and"}
{"subject": "CHIP", "sub_type": "CPA", "rel": "ThemeOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-28939416.json", "snippet": " individuals at greater risk for transformation. To achieve this, the biological impact of CHIP variants on HSC function must be validated. One variant that has been identified recurrently in  [CLS] CHIP is a gain-of-function [CLS]  missense mutation in the imprinted gene GNAS (Guanine Nucleotide Binding Protein, Alpha Stimulating). In this study, we examined the effect of the GNASR201C variant on HSC function. Ectopic expression"}
{"subject": "R201C", "sub_type": "Var", "rel": "CauseOf", "object": "supported", "obj_type": "PosReg", "file_name": "PubMed-28939416.json", "snippet": " mutation in the imprinted gene GNAS (Guanine Nucleotide Binding Protein, Alpha Stimulating). In this study, we examined the effect of the GNASR201C variant on HSC function. Ectopic expression of GNAS [CLS] R201C supported [CLS]  transplantable HSC activity and improved lymphoid output in secondary recipients. Because declining lymphoid output is a hallmark of aging, GNASR201C mutations may sustain lymphoid-biased HSCs over time and maintain"}
{"subject": "transplantable HSC activity", "sub_type": "CPA", "rel": "ThemeOf", "object": "supported", "obj_type": "PosReg", "file_name": "PubMed-28939416.json", "snippet": " in the imprinted gene GNAS (Guanine Nucleotide Binding Protein, Alpha Stimulating). In this study, we examined the effect of the GNASR201C variant on HSC function. Ectopic expression of GNASR201C  [CLS] supported transplantable HSC activity [CLS]  and improved lymphoid output in secondary recipients. Because declining lymphoid output is a hallmark of aging, GNASR201C mutations may sustain lymphoid-biased HSCs over time and maintain them in a"}
{"subject": "lymphoid output", "sub_type": "CPA", "rel": "ThemeOf", "object": "improved", "obj_type": "PosReg", "file_name": "PubMed-28939416.json", "snippet": " (Guanine Nucleotide Binding Protein, Alpha Stimulating). In this study, we examined the effect of the GNASR201C variant on HSC function. Ectopic expression of GNASR201C supported transplantable HSC activity and  [CLS] improved lymphoid output [CLS]  in secondary recipients. Because declining lymphoid output is a hallmark of aging, GNASR201C mutations may sustain lymphoid-biased HSCs over time and maintain them in a developmental state favorable for"}
{"subject": "R201C", "sub_type": "Var", "rel": "CauseOf", "object": "improved", "obj_type": "PosReg", "file_name": "PubMed-28939416.json", "snippet": " mutation in the imprinted gene GNAS (Guanine Nucleotide Binding Protein, Alpha Stimulating). In this study, we examined the effect of the GNASR201C variant on HSC function. Ectopic expression of GNAS [CLS] R201C supported transplantable HSC activity and improved [CLS]  lymphoid output in secondary recipients. Because declining lymphoid output is a hallmark of aging, GNASR201C mutations may sustain lymphoid-biased HSCs over time and maintain them in a developmental state"}
{"subject": "SCN4A", "sub_type": "Gene", "rel": "ThemeOf", "object": "missense mutations", "obj_type": "Var", "file_name": "PubMed-28940424.json", "snippet": " [CLS] missense mutations in the SCN4A [CLS]  gene, which encodes the \u03b1 subunit of the human skeletal muscle voltage-gated sodium channel NaV1.4. Affected individuals suffered from myotonia and paralysis of muscles, which were aggravated by exposure"}
{"subject": "N1366S", "sub_type": "Var", "rel": "CauseOf", "object": "accelerated", "obj_type": "PosReg", "file_name": "PubMed-28940424.json", "snippet": " channel protein expressed in HEK293 cells by whole-cell patch clamp recording revealed that the N1366S mutation led to significant alterations in the gating process of the NaV1.4 channel. The  [CLS] N1366S mutant displayed a cold-induced hyperpolarizing shift in the voltage dependence of activation and a depolarizing shift in fast inactivation, as well as a reduced rate of fast inactivation and accelerated [CLS]  recovery from fast inactivation. In addition, homology modelling and molecular dynamic simulation of N1366S and wild-type NaV1.4 channels indicated that the arginine-to-serine substitution disrupted the hydrogen bond formed between"}
{"subject": "fast inactivation", "sub_type": "MPA", "rel": "ThemeOf", "object": "rate", "obj_type": "MPA", "file_name": "PubMed-28940424.json", "snippet": " the NaV1.4 channel. The N1366S mutant displayed a cold-induced hyperpolarizing shift in the voltage dependence of activation and a depolarizing shift in fast inactivation, as well as a reduced  [CLS] rate of fast inactivation [CLS]  and accelerated recovery from fast inactivation. In addition, homology modelling and molecular dynamic simulation of N1366S and wild-type NaV1.4 channels indicated that the arginine-to-serine substitution disrupted the hydrogen bond"}
{"subject": "rate", "sub_type": "MPA", "rel": "ThemeOf", "object": "reduced", "obj_type": "NegReg", "file_name": "PubMed-28940424.json", "snippet": " of the NaV1.4 channel. The N1366S mutant displayed a cold-induced hyperpolarizing shift in the voltage dependence of activation and a depolarizing shift in fast inactivation, as well as a  [CLS] reduced rate [CLS]  of fast inactivation and accelerated recovery from fast inactivation. In addition, homology modelling and molecular dynamic simulation of N1366S and wild-type NaV1.4 channels indicated that the arginine-to-serine substitution disrupted"}
{"subject": "fast inactivation", "sub_type": "MPA", "rel": "ThemeOf", "object": "recovery", "obj_type": "MPA", "file_name": "PubMed-28940424.json", "snippet": " displayed a cold-induced hyperpolarizing shift in the voltage dependence of activation and a depolarizing shift in fast inactivation, as well as a reduced rate of fast inactivation and accelerated  [CLS] recovery from fast inactivation [CLS] . In addition, homology modelling and molecular dynamic simulation of N1366S and wild-type NaV1.4 channels indicated that the arginine-to-serine substitution disrupted the hydrogen bond formed between N1366 and R1454. Together,"}
{"subject": "recovery", "sub_type": "MPA", "rel": "ThemeOf", "object": "accelerated", "obj_type": "PosReg", "file_name": "PubMed-28940424.json", "snippet": " mutant displayed a cold-induced hyperpolarizing shift in the voltage dependence of activation and a depolarizing shift in fast inactivation, as well as a reduced rate of fast inactivation and  [CLS] accelerated recovery [CLS]  from fast inactivation. In addition, homology modelling and molecular dynamic simulation of N1366S and wild-type NaV1.4 channels indicated that the arginine-to-serine substitution disrupted the hydrogen bond formed between N1366"}
{"subject": "missense mutations", "sub_type": "Var", "rel": "CauseOf", "object": "caused", "obj_type": "Reg", "file_name": "PubMed-28940424.json", "snippet": " [CLS] caused by missense mutations [CLS]  in the SCN4A gene, which encodes the \u03b1 subunit of the human skeletal muscle voltage-gated sodium channel NaV1.4. Affected individuals suffered from myotonia and paralysis of muscles, which were"}
{"subject": "Paramyotonia congenita", "sub_type": "Disease", "rel": "ThemeOf", "object": "caused", "obj_type": "Reg", "file_name": "PubMed-28940424.json", "snippet": " [CLS] Paramyotonia congenita is a hereditary channelopathy caused [CLS]  by missense mutations in the SCN4A gene, which encodes the \u03b1 subunit of the human skeletal muscle voltage-gated sodium channel NaV1.4. Affected individuals suffered from myotonia and paralysis of"}
{"subject": "SCN4A", "sub_type": "Gene", "rel": "ThemeOf", "object": "missense mutations", "obj_type": "Var", "file_name": "PubMed-28940424.json", "snippet": " alteration of N1366S channel activity may be responsible for the pronounced paramyotonia congenita symptoms of these patients.\nABSTRACT: Paramyotonia congenita is an autosomal dominant skeletal muscle channelopathy caused by  [CLS] missense mutations in SCN4A [CLS] , the gene encoding the \u03b1 subunit of the human skeletal muscle voltage-gated sodium channel NaV1.4. We report a three-generation family in which six members present clinical symptoms of paramyotonia"}
{"subject": "missense mutations", "sub_type": "Var", "rel": "CauseOf", "object": "caused", "obj_type": "Reg", "file_name": "PubMed-28940424.json", "snippet": " the temperature-sensitive alteration of N1366S channel activity may be responsible for the pronounced paramyotonia congenita symptoms of these patients.\nABSTRACT: Paramyotonia congenita is an autosomal dominant skeletal muscle channelopathy  [CLS] caused by missense mutations [CLS]  in SCN4A, the gene encoding the \u03b1 subunit of the human skeletal muscle voltage-gated sodium channel NaV1.4. We report a three-generation family in which six members present clinical symptoms"}
{"subject": "Paramyotonia congenita", "sub_type": "Disease", "rel": "ThemeOf", "object": "caused", "obj_type": "Reg", "file_name": "PubMed-28940424.json", "snippet": " demonstrate that N1366S is a disease-causing mutation and that the temperature-sensitive alteration of N1366S channel activity may be responsible for the pronounced paramyotonia congenita symptoms of these patients.\nABSTRACT:  [CLS] Paramyotonia congenita is an autosomal dominant skeletal muscle channelopathy caused [CLS]  by missense mutations in SCN4A, the gene encoding the \u03b1 subunit of the human skeletal muscle voltage-gated sodium channel NaV1.4. We report a three-generation family in which six members"}
{"subject": "N1366S", "sub_type": "Var", "rel": "CauseOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-28940424.json", "snippet": " and molecular dynamic simulation of N1366S and wild-type NaV1.4 channels indicated that the arginine-to-serine substitution disrupted the hydrogen bond formed between N1366 and R1454. Together, our results suggest that  [CLS] N1366S is a gain-of-function [CLS]  mutation of NaV1.4 at low temperature and the mutation may be responsible for the clinical symptoms of paramyotonia congenita in the affected family and constitute a basis for studies"}
{"subject": "paramyotonia congenita", "sub_type": "Disease", "rel": "ThemeOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-28940424.json", "snippet": " simulation of N1366S and wild-type NaV1.4 channels indicated that the arginine-to-serine substitution disrupted the hydrogen bond formed between N1366 and R1454. Together, our results suggest that N1366S is a  [CLS] gain-of-function mutation of NaV1.4 at low temperature and the mutation may be responsible for the clinical symptoms of paramyotonia congenita [CLS]  in the affected family and constitute a basis for studies into its pathogenesis."}
{"subject": "N1366S", "sub_type": "Var", "rel": "CauseOf", "object": "reduced", "obj_type": "NegReg", "file_name": "PubMed-28940424.json", "snippet": " channel protein expressed in HEK293 cells by whole-cell patch clamp recording revealed that the N1366S mutation led to significant alterations in the gating process of the NaV1.4 channel. The  [CLS] N1366S mutant displayed a cold-induced hyperpolarizing shift in the voltage dependence of activation and a depolarizing shift in fast inactivation, as well as a reduced [CLS]  rate of fast inactivation and accelerated recovery from fast inactivation. In addition, homology modelling and molecular dynamic simulation of N1366S and wild-type NaV1.4 channels indicated that the arginine-to-serine substitution"}
{"subject": "NFIA", "sub_type": "Gene", "rel": "ThemeOf", "object": "variants", "obj_type": "Var", "file_name": "PubMed-28941020.json", "snippet": " [CLS] variants in NFIA [CLS]  provide further support that NFIA is a critical gene in 1p32-p31 deletion syndrome: A four patient series.\nThe association between 1p32-p31 contiguous gene deletions and a distinct phenotype that"}
{"subject": "1p32-p31 deletion syndrome", "sub_type": "Disease", "rel": "ThemeOf", "object": "Loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-28941020.json", "snippet": " [CLS] Loss-of-function variants in NFIA provide further support that NFIA is a critical gene in 1p32-p31 deletion syndrome [CLS] : A four patient series.\nThe association between 1p32-p31 contiguous gene deletions and a distinct phenotype that includes anomalies of the corpus callosum, ventriculomegaly, developmental delay, seizures, and dysmorphic features"}
{"subject": "variants", "sub_type": "Var", "rel": "CauseOf", "object": "Loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-28941020.json", "snippet": " [CLS] Loss-of-function variants [CLS]  in NFIA provide further support that NFIA is a critical gene in 1p32-p31 deletion syndrome: A four patient series.\nThe association between 1p32-p31 contiguous gene deletions and a distinct"}
{"subject": "CLCN7", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-28942122.json", "snippet": " [CLS] mutations in CLCN7 [CLS] , which encodes a homodimeric chloride channel needed for matrix acidification by osteoclasts, cause Albers-Sch\u00f6nberg disease (also known as autosomal dominant osteopetrosis type 2). More than 25 different CLCN7 mutations"}
{"subject": "p.F318L", "sub_type": "Var", "rel": "CauseOf", "object": "non", "obj_type": "NegReg", "file_name": "PubMed-28942122.json", "snippet": " trabecular bone volume, consistent with Clcn7F318L acting as a dominant negative mutation. Clcn7F318L/F318L and Clcn7F318L/G213R mice die by 1month of age and resemble Clcn7 knockout mice, which indicate that  [CLS] p.F318L mutant protein is non [CLS] -functional and p.F318L and p.G213R mutant proteins do not complement one another. Since it has been reported that treatment with interferon gamma (IFN-G) improves bone properties in Clcn7G213R/+ mice, we"}
{"subject": "functional", "sub_type": "MPA", "rel": "ThemeOf", "object": "non", "obj_type": "NegReg", "file_name": "PubMed-28942122.json", "snippet": " with Clcn7F318L acting as a dominant negative mutation. Clcn7F318L/F318L and Clcn7F318L/G213R mice die by 1month of age and resemble Clcn7 knockout mice, which indicate that p.F318L mutant protein is  [CLS] non-functional [CLS]  and p.F318L and p.G213R mutant proteins do not complement one another. Since it has been reported that treatment with interferon gamma (IFN-G) improves bone properties in Clcn7G213R/+ mice, we"}
{"subject": "protein", "sub_type": "Protein", "rel": "ThemeOf", "object": "p.F318L", "obj_type": "Var", "file_name": "PubMed-28942122.json", "snippet": " trabecular bone volume, consistent with Clcn7F318L acting as a dominant negative mutation. Clcn7F318L/F318L and Clcn7F318L/G213R mice die by 1month of age and resemble Clcn7 knockout mice, which indicate that  [CLS] p.F318L mutant protein [CLS]  is non-functional and p.F318L and p.G213R mutant proteins do not complement one another. Since it has been reported that treatment with interferon gamma (IFN-G) improves bone properties in Clcn7G213R/+"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "negative", "obj_type": "NegReg", "file_name": "PubMed-28942122.json", "snippet": " [CLS] negative mutations [CLS]  in CLCN7, which encodes a homodimeric chloride channel needed for matrix acidification by osteoclasts, cause Albers-Sch\u00f6nberg disease (also known as autosomal dominant osteopetrosis type 2). More than 25 different"}
{"subject": "Albers-Sch\u00f6nberg disease", "sub_type": "Disease", "rel": "ThemeOf", "object": "negative", "obj_type": "NegReg", "file_name": "PubMed-28942122.json", "snippet": " [CLS] negative mutations in CLCN7, which encodes a homodimeric chloride channel needed for matrix acidification by osteoclasts, cause Albers-Sch\u00f6nberg disease [CLS]  (also known as autosomal dominant osteopetrosis type 2). More than 25 different CLCN7 mutations have been identified in patients affected with Albers-Sch\u00f6nberg disease, but only one mutation (Clcn7G213R) has"}
{"subject": "Clcn7", "sub_type": "Gene", "rel": "ThemeOf", "object": "F318L", "obj_type": "Var", "file_name": "PubMed-28942122.json", "snippet": " of this disease. Here we describe a mouse with a different osteopetrosis-causing mutation (Clcn7F318L). Compared to Clcn7+/+ mice, 12-week-old Clcn7F318L/+ mice have significantly increased trabecular bone volume, consistent with  [CLS] Clcn7F318L [CLS]  acting as a dominant negative mutation. Clcn7F318L/F318L and Clcn7F318L/G213R mice die by 1month of age and resemble Clcn7 knockout mice, which indicate that p.F318L mutant protein is non-functional and"}
{"subject": "F318L", "sub_type": "Var", "rel": "CauseOf", "object": "negative", "obj_type": "NegReg", "file_name": "PubMed-28942122.json", "snippet": " of this disease. Here we describe a mouse with a different osteopetrosis-causing mutation (Clcn7F318L). Compared to Clcn7+/+ mice, 12-week-old Clcn7F318L/+ mice have significantly increased trabecular bone volume, consistent with Clcn7 [CLS] F318L acting as a dominant negative [CLS]  mutation. Clcn7F318L/F318L and Clcn7F318L/G213R mice die by 1month of age and resemble Clcn7 knockout mice, which indicate that p.F318L mutant protein is non-functional and p.F318L and p.G213R mutant proteins"}
{"subject": "negative", "sub_type": "NegReg", "rel": "CauseOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-28942122.json", "snippet": " mice to create an animal model of this disease. Here we describe a mouse with a different osteopetrosis-causing mutation (Clcn7F318L). Compared to Clcn7+/+ mice, 12-week-old Clcn7F318L/+ mice have significantly  [CLS] increased trabecular bone volume, consistent with Clcn7F318L acting as a dominant negative [CLS]  mutation. Clcn7F318L/F318L and Clcn7F318L/G213R mice die by 1month of age and resemble Clcn7 knockout mice, which indicate that p.F318L mutant protein is non-functional and p.F318L and p.G213R mutant proteins"}
{"subject": "trabecular bone volume", "sub_type": "CPA", "rel": "ThemeOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-28942122.json", "snippet": " mice to create an animal model of this disease. Here we describe a mouse with a different osteopetrosis-causing mutation (Clcn7F318L). Compared to Clcn7+/+ mice, 12-week-old Clcn7F318L/+ mice have significantly  [CLS] increased trabecular bone volume [CLS] , consistent with Clcn7F318L acting as a dominant negative mutation. Clcn7F318L/F318L and Clcn7F318L/G213R mice die by 1month of age and resemble Clcn7 knockout mice, which indicate that p.F318L mutant protein"}
{"subject": "IL-36Ra", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutation", "obj_type": "Var", "file_name": "PubMed-28967976.json", "snippet": " functional activation of the IL-36 receptor (IL-36R) was discovered to be another driving force in the pathogenesis of psoriasis. This was first highlighted by the discovery that a loss-of-function  [CLS] mutation of the IL-36R antagonist (IL-36Ra [CLS] ) causes pustular psoriasis. Although the TNF-?/IL-23/IL-17/IL-22 axis and the functional activation of IL-36R are fundamentally involved in plaque psoriasis and pustular psoriasis, respectively, the 2 pathways are closely related"}
{"subject": "pustular psoriasis", "sub_type": "Disease", "rel": "ThemeOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-28967976.json", "snippet": " Recently, functional activation of the IL-36 receptor (IL-36R) was discovered to be another driving force in the pathogenesis of psoriasis. This was first highlighted by the discovery that a  [CLS] loss-of-function mutation of the IL-36R antagonist (IL-36Ra) causes pustular psoriasis [CLS] . Although the TNF-?/IL-23/IL-17/IL-22 axis and the functional activation of IL-36R are fundamentally involved in plaque psoriasis and pustular psoriasis, respectively, the 2 pathways are closely related and mutually reinforced,"}
{"subject": "mutation", "sub_type": "Var", "rel": "CauseOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-28967976.json", "snippet": " Recently, functional activation of the IL-36 receptor (IL-36R) was discovered to be another driving force in the pathogenesis of psoriasis. This was first highlighted by the discovery that a  [CLS] loss-of-function mutation [CLS]  of the IL-36R antagonist (IL-36Ra) causes pustular psoriasis. Although the TNF-?/IL-23/IL-17/IL-22 axis and the functional activation of IL-36R are fundamentally involved in plaque psoriasis and pustular psoriasis, respectively, the"}
{"subject": "TNF\u03b1", "sub_type": "Protein", "rel": "ThemeOf", "object": "expression", "obj_type": "MPA", "file_name": "PubMed-28969941.json", "snippet": " allele-carriers proved significantly protected against chronic (OR 0.49; 95% CI 0.29-0.83; p-value 0.01) and aggressive (OR 0.46; 95% CI 0.22-0.94; p-value 0.03) periodontitis. Further, heterozygous subjects exhibited significantly decreased  [CLS] expression of TNF\u03b1 [CLS]  in periodontal tissues, pointing to a functional effect of the mutation in periodontal tissues during the progression of the disease. Conversely, no significant changes were observed in the presence"}
{"subject": "expression", "sub_type": "MPA", "rel": "ThemeOf", "object": "decreased", "obj_type": "NegReg", "file_name": "PubMed-28969941.json", "snippet": " mutant allele-carriers proved significantly protected against chronic (OR 0.49; 95% CI 0.29-0.83; p-value 0.01) and aggressive (OR 0.46; 95% CI 0.22-0.94; p-value 0.03) periodontitis. Further, heterozygous subjects exhibited significantly  [CLS] decreased expression [CLS]  of TNF\u03b1 in periodontal tissues, pointing to a functional effect of the mutation in periodontal tissues during the progression of the disease. Conversely, no significant changes were observed in"}
{"subject": "host response", "sub_type": "CPA", "rel": "ThemeOf", "object": "modulate", "obj_type": "Reg", "file_name": "PubMed-28969941.json", "snippet": " chemokine receptor CCR5 play an important role in disease pathogenesis, contributing to pro-inflammatory response and osteoclastogenesis. CCR5\u039432 (rs333) is a loss-of-function mutation in the CCR5 gene, which can potentially  [CLS] modulate the host response [CLS]  and, consequently periodontitis outcome. Thus, we investigated the effect of the CCR5\u039432 mutation over the risk to suffer periodontitis in a cohort of Brazilian patients (total N=699), representative of"}
{"subject": "loss-of-function", "sub_type": "NegReg", "rel": "CauseOf", "object": "modulate", "obj_type": "Reg", "file_name": "PubMed-28969941.json", "snippet": " host inflammatory immune response triggered by periodontal infection. The chemokine receptor CCR5 play an important role in disease pathogenesis, contributing to pro-inflammatory response and osteoclastogenesis. CCR5\u039432 (rs333) is a  [CLS] loss-of-function mutation in the CCR5 gene, which can potentially modulate [CLS]  the host response and, consequently periodontitis outcome. Thus, we investigated the effect of the CCR5\u039432 mutation over the risk to suffer periodontitis in a cohort of Brazilian patients (total"}
{"subject": "CCR5", "sub_type": "Gene", "rel": "ThemeOf", "object": "rs333", "obj_type": "Var", "file_name": "PubMed-28969941.json", "snippet": " mediated by the host inflammatory immune response triggered by periodontal infection. The chemokine receptor CCR5 play an important role in disease pathogenesis, contributing to pro-inflammatory response and osteoclastogenesis. CCR5\u039432 ( [CLS] rs333) is a loss-of-function mutation in the CCR5 [CLS]  gene, which can potentially modulate the host response and, consequently periodontitis outcome. Thus, we investigated the effect of the CCR5\u039432 mutation over the risk to suffer periodontitis in a"}
{"subject": "rs333", "sub_type": "Var", "rel": "CauseOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-28969941.json", "snippet": " mediated by the host inflammatory immune response triggered by periodontal infection. The chemokine receptor CCR5 play an important role in disease pathogenesis, contributing to pro-inflammatory response and osteoclastogenesis. CCR5\u039432 ( [CLS] rs333) is a loss-of-function [CLS]  mutation in the CCR5 gene, which can potentially modulate the host response and, consequently periodontitis outcome. Thus, we investigated the effect of the CCR5\u039432 mutation over the risk to"}
{"subject": "mutation", "sub_type": "Var", "rel": "CauseOf", "object": "decreased", "obj_type": "NegReg", "file_name": "PubMed-28969941.json", "snippet": " mutant allele-carriers proved significantly protected against chronic (OR 0.49; 95% CI 0.29-0.83; p-value 0.01) and aggressive (OR 0.46; 95% CI 0.22-0.94; p-value 0.03) periodontitis. Further, heterozygous subjects exhibited significantly  [CLS] decreased expression of TNF\u03b1 in periodontal tissues, pointing to a functional effect of the mutation [CLS]  in periodontal tissues during the progression of the disease. Conversely, no significant changes were observed in the presence or quantity of the periodontal pathogens P. gingivalis, T. forsythia, and"}
{"subject": "(BMP9)-ALK1-Smad1/5/8 signaling", "sub_type": "MPA", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-28973643.json", "snippet": " (HHT) is a highly debilitating and life-threatening genetic vascular disorder arising from endothelial cell (EC) proliferation and hypervascularization, for which no cure exists. Because HHT is caused by loss-of-function  [CLS] mutations in bone morphogenetic protein 9 (BMP9)-ALK1-Smad1/5/8 signaling [CLS] , interventions aimed at activating this pathway are of therapeutic value. We interrogated the whole-transcriptome in human umbilical vein ECs (HUVECs) and found that ALK1 signaling inhibition was associated with"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-28973643.json", "snippet": " telangiectasia (HHT) is a highly debilitating and life-threatening genetic vascular disorder arising from endothelial cell (EC) proliferation and hypervascularization, for which no cure exists. Because HHT is caused by  [CLS] loss-of-function mutations [CLS]  in bone morphogenetic protein 9 (BMP9)-ALK1-Smad1/5/8 signaling, interventions aimed at activating this pathway are of therapeutic value. We interrogated the whole-transcriptome in human umbilical vein ECs (HUVECs) and found"}
{"subject": "HHT", "sub_type": "Disease", "rel": "ThemeOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-28973643.json", "snippet": " vascular pathology.\nHereditary hemorrhagic telangiectasia (HHT) is a highly debilitating and life-threatening genetic vascular disorder arising from endothelial cell (EC) proliferation and hypervascularization, for which no cure exists. Because  [CLS] HHT is caused by loss-of-function [CLS]  mutations in bone morphogenetic protein 9 (BMP9)-ALK1-Smad1/5/8 signaling, interventions aimed at activating this pathway are of therapeutic value. We interrogated the whole-transcriptome in human umbilical vein ECs (HUVECs) and"}
{"subject": "ORC1", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-28985365.json", "snippet": " [CLS] mutations in ORC1 [CLS] , ORC4, ORC6, CDT1 or CDC6 of the preRC in human cause Meier-Gorlin syndrome (MGS) that is characterized by impaired post-natal growth, short stature and microcephaly. However, vertebrate models of"}
{"subject": "cell cycle arrest at the S phase", "sub_type": "CPA", "rel": "ThemeOf", "object": "Loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-28985365.json", "snippet": " post-natal growth, short stature and microcephaly. However, vertebrate models of MGS have not been reported. Through N-ethyl-N-nitrosourea mutagenesis and Cas9 knockout, we generate several cdc6 mutant lines in zebrafish.  [CLS] Loss-of-function mutations of cdc6, as manifested by cdc6tsu4305 and cdc6tsu7cd mutants, lead to embryonic lethality due to cell cycle arrest at the S phase [CLS]  and extensive apoptosis. Embryos homozygous for a cdc6 hypomorphic mutation, cdc6tsu21cd, develop normally during embryogenesis. Later on, compared with their wild-type (WT) siblings, cdc6tsu21cd mutant fish show growth retardation,"}
{"subject": "apoptosis", "sub_type": "CPA", "rel": "ThemeOf", "object": "Loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-28985365.json", "snippet": " post-natal growth, short stature and microcephaly. However, vertebrate models of MGS have not been reported. Through N-ethyl-N-nitrosourea mutagenesis and Cas9 knockout, we generate several cdc6 mutant lines in zebrafish.  [CLS] Loss-of-function mutations of cdc6, as manifested by cdc6tsu4305 and cdc6tsu7cd mutants, lead to embryonic lethality due to cell cycle arrest at the S phase and extensive apoptosis [CLS] . Embryos homozygous for a cdc6 hypomorphic mutation, cdc6tsu21cd, develop normally during embryogenesis. Later on, compared with their wild-type (WT) siblings, cdc6tsu21cd mutant fish show growth retardation, and their body"}
{"subject": "Loss-of-function", "sub_type": "NegReg", "rel": "CauseOf", "object": "embryonic lethality", "obj_type": "CPA", "file_name": "PubMed-28985365.json", "snippet": " post-natal growth, short stature and microcephaly. However, vertebrate models of MGS have not been reported. Through N-ethyl-N-nitrosourea mutagenesis and Cas9 knockout, we generate several cdc6 mutant lines in zebrafish.  [CLS] Loss-of-function mutations of cdc6, as manifested by cdc6tsu4305 and cdc6tsu7cd mutants, lead to embryonic lethality [CLS]  due to cell cycle arrest at the S phase and extensive apoptosis. Embryos homozygous for a cdc6 hypomorphic mutation, cdc6tsu21cd, develop normally during embryogenesis. Later on, compared with their"}
{"subject": "body weight and length", "sub_type": "CPA", "rel": "ThemeOf", "object": "reduced", "obj_type": "NegReg", "file_name": "PubMed-28985365.json", "snippet": " apoptosis. Embryos homozygous for a cdc6 hypomorphic mutation, cdc6tsu21cd, develop normally during embryogenesis. Later on, compared with their wild-type (WT) siblings, cdc6tsu21cd mutant fish show growth retardation, and their  [CLS] body weight and length in adulthood are greatly reduced [CLS] , which resemble human MGS. Surprisingly, cdc6tsu21cd mutant fish become males with a short life and fail to mate with WT females, suggesting defective reproduction. Overexpression of Cdc6 mutant forms,"}
{"subject": "cdc6tsu21cd mutant", "sub_type": "Var", "rel": "CauseOf", "object": "reduced", "obj_type": "NegReg", "file_name": "PubMed-28985365.json", "snippet": " cycle arrest at the S phase and extensive apoptosis. Embryos homozygous for a cdc6 hypomorphic mutation, cdc6tsu21cd, develop normally during embryogenesis. Later on, compared with their wild-type (WT) siblings,  [CLS] cdc6tsu21cd mutant fish show growth retardation, and their body weight and length in adulthood are greatly reduced [CLS] , which resemble human MGS. Surprisingly, cdc6tsu21cd mutant fish become males with a short life and fail to mate with WT females, suggesting defective reproduction. Overexpression of Cdc6 mutant forms,"}
{"subject": "cdc6tsu21cd mutant", "sub_type": "Var", "rel": "CauseOf", "object": "defective", "obj_type": "NegReg", "file_name": "PubMed-28985365.json", "snippet": " on, compared with their wild-type (WT) siblings, cdc6tsu21cd mutant fish show growth retardation, and their body weight and length in adulthood are greatly reduced, which resemble human MGS. Surprisingly,  [CLS] cdc6tsu21cd mutant fish become males with a short life and fail to mate with WT females, suggesting defective [CLS]  reproduction. Overexpression of Cdc6 mutant forms, which mimic human CDC6(T323R) mutation found in a MGS patient, in zebrafish cdc6tsu4305 mutant embryos partially represses cell death phenotype, suggesting that the"}
{"subject": "reproduction", "sub_type": "CPA", "rel": "ThemeOf", "object": "defective", "obj_type": "NegReg", "file_name": "PubMed-28985365.json", "snippet": " and length in adulthood are greatly reduced, which resemble human MGS. Surprisingly, cdc6tsu21cd mutant fish become males with a short life and fail to mate with WT females, suggesting  [CLS] defective reproduction [CLS] . Overexpression of Cdc6 mutant forms, which mimic human CDC6(T323R) mutation found in a MGS patient, in zebrafish cdc6tsu4305 mutant embryos partially represses cell death phenotype, suggesting that the human"}
{"subject": "CDC6", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutation", "obj_type": "Var", "file_name": "PubMed-28985365.json", "snippet": " MGS. Surprisingly, cdc6tsu21cd mutant fish become males with a short life and fail to mate with WT females, suggesting defective reproduction. Overexpression of Cdc6 mutant forms, which mimic human  [CLS] CDC6(T323R) mutation [CLS]  found in a MGS patient, in zebrafish cdc6tsu4305 mutant embryos partially represses cell death phenotype, suggesting that the human CDC6(T323R) mutation is a hypomorph. cdc6tsu21cd mutant fish will be"}
{"subject": "mutation", "sub_type": "Var", "rel": "CauseOf", "object": "represses", "obj_type": "NegReg", "file_name": "PubMed-28985365.json", "snippet": " Surprisingly, cdc6tsu21cd mutant fish become males with a short life and fail to mate with WT females, suggesting defective reproduction. Overexpression of Cdc6 mutant forms, which mimic human CDC6(T323R)  [CLS] mutation found in a MGS patient, in zebrafish cdc6tsu4305 mutant embryos partially represses [CLS]  cell death phenotype, suggesting that the human CDC6(T323R) mutation is a hypomorph. cdc6tsu21cd mutant fish will be useful to detect more tissue defects and develop medical treatment strategies for"}
{"subject": "cell death phenotype", "sub_type": "CPA", "rel": "ThemeOf", "object": "represses", "obj_type": "NegReg", "file_name": "PubMed-28985365.json", "snippet": " to mate with WT females, suggesting defective reproduction. Overexpression of Cdc6 mutant forms, which mimic human CDC6(T323R) mutation found in a MGS patient, in zebrafish cdc6tsu4305 mutant embryos partially  [CLS] represses cell death phenotype [CLS] , suggesting that the human CDC6(T323R) mutation is a hypomorph. cdc6tsu21cd mutant fish will be useful to detect more tissue defects and develop medical treatment strategies for MGS patients."}
{"subject": "ORC4", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-28985365.json", "snippet": " [CLS] mutations in ORC1, ORC4 [CLS] , ORC6, CDT1 or CDC6 of the preRC in human cause Meier-Gorlin syndrome (MGS) that is characterized by impaired post-natal growth, short stature and microcephaly. However, vertebrate models of MGS"}
{"subject": "ORC6", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-28985365.json", "snippet": " [CLS] mutations in ORC1, ORC4, ORC6 [CLS] , CDT1 or CDC6 of the preRC in human cause Meier-Gorlin syndrome (MGS) that is characterized by impaired post-natal growth, short stature and microcephaly. However, vertebrate models of MGS have"}
{"subject": "CDT1", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-28985365.json", "snippet": " [CLS] mutations in ORC1, ORC4, ORC6, CDT1 [CLS]  or CDC6 of the preRC in human cause Meier-Gorlin syndrome (MGS) that is characterized by impaired post-natal growth, short stature and microcephaly. However, vertebrate models of MGS have not"}
{"subject": "CDC6", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-28985365.json", "snippet": " [CLS] mutations in ORC1, ORC4, ORC6, CDT1 or CDC6 [CLS]  of the preRC in human cause Meier-Gorlin syndrome (MGS) that is characterized by impaired post-natal growth, short stature and microcephaly. However, vertebrate models of MGS have not been reported."}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "cause", "obj_type": "Reg", "file_name": "PubMed-28985365.json", "snippet": " [CLS] mutations in ORC1, ORC4, ORC6, CDT1 or CDC6 of the preRC in human cause [CLS]  Meier-Gorlin syndrome (MGS) that is characterized by impaired post-natal growth, short stature and microcephaly. However, vertebrate models of MGS have not been reported. Through N-ethyl-N-nitrosourea mutagenesis and Cas9 knockout,"}
{"subject": "Meier-Gorlin syndrome", "sub_type": "Disease", "rel": "ThemeOf", "object": "cause", "obj_type": "Reg", "file_name": "PubMed-28985365.json", "snippet": " (Cdc6) is a component of pre-replicative complex (preRC) forming on DNA replication origins in eukaryotes. Recessive mutations in ORC1, ORC4, ORC6, CDT1 or CDC6 of the preRC in human  [CLS] cause Meier-Gorlin syndrome [CLS]  (MGS) that is characterized by impaired post-natal growth, short stature and microcephaly. However, vertebrate models of MGS have not been reported. Through N-ethyl-N-nitrosourea mutagenesis and Cas9 knockout, we generate"}
{"subject": "cdc6", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-28985365.json", "snippet": " growth, short stature and microcephaly. However, vertebrate models of MGS have not been reported. Through N-ethyl-N-nitrosourea mutagenesis and Cas9 knockout, we generate several cdc6 mutant lines in zebrafish. Loss-of-function  [CLS] mutations of cdc6 [CLS] , as manifested by cdc6tsu4305 and cdc6tsu7cd mutants, lead to embryonic lethality due to cell cycle arrest at the S phase and extensive apoptosis. Embryos homozygous for a cdc6 hypomorphic"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "Loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-28985365.json", "snippet": " post-natal growth, short stature and microcephaly. However, vertebrate models of MGS have not been reported. Through N-ethyl-N-nitrosourea mutagenesis and Cas9 knockout, we generate several cdc6 mutant lines in zebrafish.  [CLS] Loss-of-function mutations [CLS]  of cdc6, as manifested by cdc6tsu4305 and cdc6tsu7cd mutants, lead to embryonic lethality due to cell cycle arrest at the S phase and extensive apoptosis. Embryos homozygous for a"}
{"subject": "KCNT1", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-28987752.json", "snippet": " [CLS] KCNT1 mutations [CLS]  are gain-of-function mutations in potassium channels resulting in severe infantile epilepsy. Herein we describe 3 infants with malignant migrating partial seizures with KCNT1 mutations accompanied by massive systemic to"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-28987752.json", "snippet": " [CLS] mutations are gain-of-function [CLS]  mutations in potassium channels resulting in severe infantile epilepsy. Herein we describe 3 infants with malignant migrating partial seizures with KCNT1 mutations accompanied by massive systemic to pulmonary collateral"}
{"subject": "infantile epilepsy", "sub_type": "Disease", "rel": "ThemeOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-28987752.json", "snippet": " [CLS] gain-of-function mutations in potassium channels resulting in severe infantile epilepsy [CLS] . Herein we describe 3 infants with malignant migrating partial seizures with KCNT1 mutations accompanied by massive systemic to pulmonary collateral arteries with life-threatening hemoptysis and heart failure."}
{"subject": "CDH11", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-28988429.json", "snippet": " showed absence of the protein expression in patient fibroblasts. In addition, cell proliferation rate was slow and osteogenic differentiation potential was delayed. We consider that this study reveals loss-of-function  [CLS] mutations in CDH11 [CLS]  as a probable cause of this phenotype. Next generation sequencing in further patients would both prove this gene as causative, and finely delineate this clinical spectrum further contributing in"}
{"subject": "Elsahy-Waters syndrome", "sub_type": "Disease", "rel": "ThemeOf", "object": "cause", "obj_type": "Reg", "file_name": "PubMed-28988429.json", "snippet": " [CLS] cause of Elsahy-Waters syndrome [CLS] .\nTwo sisters from a consanguineous couple were seen in genetics department for facial dysmorphic features and glaucoma. They both had broad foreheads, hypertelorism, megalocorneas, thick eyebrows with synophrys, flat"}
{"subject": "cell proliferation rate", "sub_type": "CPA", "rel": "ThemeOf", "object": "slow", "obj_type": "NegReg", "file_name": "PubMed-28988429.json", "snippet": " CDH11 expression was decreased in patient-derived fibroblasts as compared to the heterozygous parent and another healthy donor. Immunostaining showed absence of the protein expression in patient fibroblasts. In addition,  [CLS] cell proliferation rate was slow [CLS]  and osteogenic differentiation potential was delayed. We consider that this study reveals loss-of-function mutations in CDH11 as a probable cause of this phenotype. Next generation sequencing in further patients"}
{"subject": "osteogenic differentiation potential", "sub_type": "CPA", "rel": "ThemeOf", "object": "delayed", "obj_type": "NegReg", "file_name": "PubMed-28988429.json", "snippet": " fibroblasts as compared to the heterozygous parent and another healthy donor. Immunostaining showed absence of the protein expression in patient fibroblasts. In addition, cell proliferation rate was slow and  [CLS] osteogenic differentiation potential was delayed [CLS] . We consider that this study reveals loss-of-function mutations in CDH11 as a probable cause of this phenotype. Next generation sequencing in further patients would both prove this gene as"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "slow", "obj_type": "NegReg", "file_name": "PubMed-28988429.json", "snippet": " in patient-derived fibroblasts as compared to the heterozygous parent and another healthy donor. Immunostaining showed absence of the protein expression in patient fibroblasts. In addition, cell proliferation rate was  [CLS] slow and osteogenic differentiation potential was delayed. We consider that this study reveals loss-of-function mutations [CLS]  in CDH11 as a probable cause of this phenotype. Next generation sequencing in further patients would both prove this gene as causative, and finely delineate this clinical spectrum further"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "delayed", "obj_type": "NegReg", "file_name": "PubMed-28988429.json", "snippet": " the heterozygous parent and another healthy donor. Immunostaining showed absence of the protein expression in patient fibroblasts. In addition, cell proliferation rate was slow and osteogenic differentiation potential was  [CLS] delayed. We consider that this study reveals loss-of-function mutations [CLS]  in CDH11 as a probable cause of this phenotype. Next generation sequencing in further patients would both prove this gene as causative, and finely delineate this clinical spectrum further"}
{"subject": "CDH11", "sub_type": "Gene", "rel": "ThemeOf", "object": "Homozygous indel mutation", "obj_type": "Var", "file_name": "PubMed-28988429.json", "snippet": " [CLS] Homozygous indel mutation in CDH11 [CLS]  as the probable cause of Elsahy-Waters syndrome.\nTwo sisters from a consanguineous couple were seen in genetics department for facial dysmorphic features and glaucoma. They both had broad foreheads,"}
{"subject": "Homozygous indel mutation", "sub_type": "Var", "rel": "CauseOf", "object": "cause", "obj_type": "Reg", "file_name": "PubMed-28988429.json", "snippet": " [CLS] Homozygous indel mutation in CDH11 as the probable cause [CLS]  of Elsahy-Waters syndrome.\nTwo sisters from a consanguineous couple were seen in genetics department for facial dysmorphic features and glaucoma. They both had broad foreheads, hypertelorism, megalocorneas, thick eyebrows"}
{"subject": "Mutant", "sub_type": "Var", "rel": "CauseOf", "object": "Effect", "obj_type": "Reg", "file_name": "PubMed-28993478.json", "snippet": " [CLS] Effect of Mutant [CLS]  p53 Proteins on Glycolysis and Mitochondrial Metabolism.\nTP53 is one of the most commonly mutated genes in human cancers. Unlike other tumor suppressors that are frequently deleted or acquire"}
{"subject": "proteins", "sub_type": "Protein", "rel": "ThemeOf", "object": "mutant", "obj_type": "Var", "file_name": "PubMed-28993478.json", "snippet": " Unlike other tumor suppressors that are frequently deleted or acquire loss-of-function mutations, the majority of TP53 mutations in tumors are missense substitutions, which lead to the expression of full-length  [CLS] mutant proteins [CLS]  that accumulate in cancer cells and may confer unique gain-of-function (GOF) activities to promote tumorigenic events. Recently, mutant p53 proteins have been shown to mediate metabolic changes as a"}
{"subject": "activities", "sub_type": "MPA", "rel": "ThemeOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-28993478.json", "snippet": " mutations, the majority of TP53 mutations in tumors are missense substitutions, which lead to the expression of full-length mutant proteins that accumulate in cancer cells and may confer unique  [CLS] gain-of-function (GOF) activities [CLS]  to promote tumorigenic events. Recently, mutant p53 proteins have been shown to mediate metabolic changes as a novel GOF to promote tumor development. There is a strong rationale that"}
{"subject": "accumulate", "sub_type": "PosReg", "rel": "CauseOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-28993478.json", "snippet": " suppressors that are frequently deleted or acquire loss-of-function mutations, the majority of TP53 mutations in tumors are missense substitutions, which lead to the expression of full-length mutant proteins that  [CLS] accumulate in cancer cells and may confer unique gain-of-function [CLS]  (GOF) activities to promote tumorigenic events. Recently, mutant p53 proteins have been shown to mediate metabolic changes as a novel GOF to promote tumor development. There is a strong"}
{"subject": "gain-of-function", "sub_type": "PosReg", "rel": "CauseOf", "object": "promote", "obj_type": "PosReg", "file_name": "PubMed-28993478.json", "snippet": " mutations, the majority of TP53 mutations in tumors are missense substitutions, which lead to the expression of full-length mutant proteins that accumulate in cancer cells and may confer unique  [CLS] gain-of-function (GOF) activities to promote [CLS]  tumorigenic events. Recently, mutant p53 proteins have been shown to mediate metabolic changes as a novel GOF to promote tumor development. There is a strong rationale that the GOF"}
{"subject": "tumorigenic events", "sub_type": "CPA", "rel": "ThemeOf", "object": "promote", "obj_type": "PosReg", "file_name": "PubMed-28993478.json", "snippet": " TP53 mutations in tumors are missense substitutions, which lead to the expression of full-length mutant proteins that accumulate in cancer cells and may confer unique gain-of-function (GOF) activities to  [CLS] promote tumorigenic events [CLS] . Recently, mutant p53 proteins have been shown to mediate metabolic changes as a novel GOF to promote tumor development. There is a strong rationale that the GOF activities, including"}
{"subject": "tumor development", "sub_type": "CPA", "rel": "ThemeOf", "object": "promote", "obj_type": "PosReg", "file_name": "PubMed-28993478.json", "snippet": " cancer cells and may confer unique gain-of-function (GOF) activities to promote tumorigenic events. Recently, mutant p53 proteins have been shown to mediate metabolic changes as a novel GOF to  [CLS] promote tumor development [CLS] . There is a strong rationale that the GOF activities, including alterations in cellular metabolism, might vary between the different p53 mutants. Accordingly, the effect of different mutant p53 proteins"}
{"subject": "GOF", "sub_type": "PosReg", "rel": "CauseOf", "object": "promote", "obj_type": "PosReg", "file_name": "PubMed-28993478.json", "snippet": " accumulate in cancer cells and may confer unique gain-of-function (GOF) activities to promote tumorigenic events. Recently, mutant p53 proteins have been shown to mediate metabolic changes as a novel  [CLS] GOF to promote [CLS]  tumor development. There is a strong rationale that the GOF activities, including alterations in cellular metabolism, might vary between the different p53 mutants. Accordingly, the effect of different mutant"}
{"subject": "mutant", "sub_type": "Var", "rel": "CauseOf", "object": "GOF", "obj_type": "PosReg", "file_name": "PubMed-28993478.json", "snippet": " are missense substitutions, which lead to the expression of full-length mutant proteins that accumulate in cancer cells and may confer unique gain-of-function (GOF) activities to promote tumorigenic events. Recently,  [CLS] mutant p53 proteins have been shown to mediate metabolic changes as a novel GOF [CLS]  to promote tumor development. There is a strong rationale that the GOF activities, including alterations in cellular metabolism, might vary between the different p53 mutants. Accordingly, the effect of"}
{"subject": "metabolic changes", "sub_type": "CPA", "rel": "ThemeOf", "object": "GOF", "obj_type": "PosReg", "file_name": "PubMed-28993478.json", "snippet": " of full-length mutant proteins that accumulate in cancer cells and may confer unique gain-of-function (GOF) activities to promote tumorigenic events. Recently, mutant p53 proteins have been shown to mediate  [CLS] metabolic changes as a novel GOF [CLS]  to promote tumor development. There is a strong rationale that the GOF activities, including alterations in cellular metabolism, might vary between the different p53 mutants. Accordingly, the effect of"}
{"subject": "proteins", "sub_type": "Protein", "rel": "ThemeOf", "object": "mutant", "obj_type": "Var", "file_name": "PubMed-28993478.json", "snippet": " are missense substitutions, which lead to the expression of full-length mutant proteins that accumulate in cancer cells and may confer unique gain-of-function (GOF) activities to promote tumorigenic events. Recently,  [CLS] mutant p53 proteins [CLS]  have been shown to mediate metabolic changes as a novel GOF to promote tumor development. There is a strong rationale that the GOF activities, including alterations in cellular metabolism,"}
{"subject": "Glycolysis", "sub_type": "MPA", "rel": "ThemeOf", "object": "Effect", "obj_type": "Reg", "file_name": "PubMed-28993478.json", "snippet": " [CLS] Effect of Mutant p53 Proteins on Glycolysis [CLS]  and Mitochondrial Metabolism.\nTP53 is one of the most commonly mutated genes in human cancers. Unlike other tumor suppressors that are frequently deleted or acquire loss-of-function mutations, the majority"}
{"subject": "p53", "sub_type": "Gene", "rel": "ThemeOf", "object": "proteins", "obj_type": "Protein", "file_name": "PubMed-28993478.json", "snippet": " missense substitutions, which lead to the expression of full-length mutant proteins that accumulate in cancer cells and may confer unique gain-of-function (GOF) activities to promote tumorigenic events. Recently, mutant  [CLS] p53 proteins [CLS]  have been shown to mediate metabolic changes as a novel GOF to promote tumor development. There is a strong rationale that the GOF activities, including alterations in cellular metabolism,"}
{"subject": "p53", "sub_type": "Gene", "rel": "ThemeOf", "object": "Proteins", "obj_type": "Protein", "file_name": "PubMed-28993478.json", "snippet": " [CLS] p53 Proteins [CLS]  on Glycolysis and Mitochondrial Metabolism.\nTP53 is one of the most commonly mutated genes in human cancers. Unlike other tumor suppressors that are frequently deleted or acquire loss-of-function mutations,"}
{"subject": "Mitochondrial Metabolism", "sub_type": "MPA", "rel": "ThemeOf", "object": "Effect", "obj_type": "Reg", "file_name": "PubMed-28993478.json", "snippet": " [CLS] Effect of Mutant p53 Proteins on Glycolysis and Mitochondrial Metabolism [CLS] .\nTP53 is one of the most commonly mutated genes in human cancers. Unlike other tumor suppressors that are frequently deleted or acquire loss-of-function mutations, the majority of TP53 mutations"}
{"subject": "Proteins", "sub_type": "Protein", "rel": "ThemeOf", "object": "Mutant", "obj_type": "Var", "file_name": "PubMed-28993478.json", "snippet": " [CLS] Mutant p53 Proteins [CLS]  on Glycolysis and Mitochondrial Metabolism.\nTP53 is one of the most commonly mutated genes in human cancers. Unlike other tumor suppressors that are frequently deleted or acquire loss-of-function mutations,"}
{"subject": "TP53", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-28993478.json", "snippet": " Mitochondrial Metabolism.\nTP53 is one of the most commonly mutated genes in human cancers. Unlike other tumor suppressors that are frequently deleted or acquire loss-of-function mutations, the majority of  [CLS] TP53 mutations [CLS]  in tumors are missense substitutions, which lead to the expression of full-length mutant proteins that accumulate in cancer cells and may confer unique gain-of-function (GOF) activities to promote tumorigenic"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "accumulate", "obj_type": "PosReg", "file_name": "PubMed-28993478.json", "snippet": " Metabolism.\nTP53 is one of the most commonly mutated genes in human cancers. Unlike other tumor suppressors that are frequently deleted or acquire loss-of-function mutations, the majority of TP53  [CLS] mutations in tumors are missense substitutions, which lead to the expression of full-length mutant proteins that accumulate [CLS]  in cancer cells and may confer unique gain-of-function (GOF) activities to promote tumorigenic events. Recently, mutant p53 proteins have been shown to mediate metabolic changes as a novel GOF"}
{"subject": "missense substitutions", "sub_type": "Var", "rel": "CauseOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-28993478.json", "snippet": " Metabolism.\nTP53 is one of the most commonly mutated genes in human cancers. Unlike other tumor suppressors that are frequently deleted or acquire loss-of-function mutations, the majority of TP53  [CLS] mutations in tumors are missense substitutions [CLS] , which lead to the expression of full-length mutant proteins that accumulate in cancer cells and may confer unique gain-of-function (GOF) activities to promote tumorigenic events. Recently, mutant p53 proteins"}
{"subject": "proteins", "sub_type": "Protein", "rel": "ThemeOf", "object": "expression", "obj_type": "MPA", "file_name": "PubMed-28993478.json", "snippet": " in human cancers. Unlike other tumor suppressors that are frequently deleted or acquire loss-of-function mutations, the majority of TP53 mutations in tumors are missense substitutions, which lead to the  [CLS] expression of full-length mutant proteins [CLS]  that accumulate in cancer cells and may confer unique gain-of-function (GOF) activities to promote tumorigenic events. Recently, mutant p53 proteins have been shown to mediate metabolic changes as a"}
{"subject": "expression", "sub_type": "MPA", "rel": "ThemeOf", "object": "accumulate", "obj_type": "PosReg", "file_name": "PubMed-28993478.json", "snippet": " in human cancers. Unlike other tumor suppressors that are frequently deleted or acquire loss-of-function mutations, the majority of TP53 mutations in tumors are missense substitutions, which lead to the  [CLS] expression of full-length mutant proteins that accumulate [CLS]  in cancer cells and may confer unique gain-of-function (GOF) activities to promote tumorigenic events. Recently, mutant p53 proteins have been shown to mediate metabolic changes as a novel GOF"}
{"subject": "Mparf1", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutants", "obj_type": "Var", "file_name": "PubMed-29016901.json", "snippet": " phylogenetically distinct ARFs: MpARF1, the sole 'activator' ARF; and MpARF2 and MpARF3, two 'repressor' ARFs. Genetic screens for auxin-resistant mutants revealed that loss of MpARF1 function conferred auxin insensitivity.  [CLS] Mparf1 mutants [CLS]  showed reduced auxin-inducible gene expression and various developmental defects, including thallus twisting and gemma malformation. We further investigated the role of MpARF1 in gemma development, which is traceable at"}
{"subject": "mutants", "sub_type": "Var", "rel": "CauseOf", "object": "reduced", "obj_type": "NegReg", "file_name": "PubMed-29016901.json", "snippet": " distinct ARFs: MpARF1, the sole 'activator' ARF; and MpARF2 and MpARF3, two 'repressor' ARFs. Genetic screens for auxin-resistant mutants revealed that loss of MpARF1 function conferred auxin insensitivity. Mparf1  [CLS] mutants showed reduced [CLS]  auxin-inducible gene expression and various developmental defects, including thallus twisting and gemma malformation. We further investigated the role of MpARF1 in gemma development, which is traceable at the cellular"}
{"subject": "auxin-inducible gene", "sub_type": "Gene", "rel": "ThemeOf", "object": "expression", "obj_type": "MPA", "file_name": "PubMed-29016901.json", "snippet": " the sole 'activator' ARF; and MpARF2 and MpARF3, two 'repressor' ARFs. Genetic screens for auxin-resistant mutants revealed that loss of MpARF1 function conferred auxin insensitivity. Mparf1 mutants showed reduced  [CLS] auxin-inducible gene expression [CLS]  and various developmental defects, including thallus twisting and gemma malformation. We further investigated the role of MpARF1 in gemma development, which is traceable at the cellular level. In wild-type"}
{"subject": "expression", "sub_type": "MPA", "rel": "ThemeOf", "object": "reduced", "obj_type": "NegReg", "file_name": "PubMed-29016901.json", "snippet": " MpARF1, the sole 'activator' ARF; and MpARF2 and MpARF3, two 'repressor' ARFs. Genetic screens for auxin-resistant mutants revealed that loss of MpARF1 function conferred auxin insensitivity. Mparf1 mutants showed  [CLS] reduced auxin-inducible gene expression [CLS]  and various developmental defects, including thallus twisting and gemma malformation. We further investigated the role of MpARF1 in gemma development, which is traceable at the cellular level. In wild-type"}
{"subject": "developmental defects", "sub_type": "CPA", "rel": "ThemeOf", "object": "reduced", "obj_type": "NegReg", "file_name": "PubMed-29016901.json", "snippet": " MpARF1, the sole 'activator' ARF; and MpARF2 and MpARF3, two 'repressor' ARFs. Genetic screens for auxin-resistant mutants revealed that loss of MpARF1 function conferred auxin insensitivity. Mparf1 mutants showed  [CLS] reduced auxin-inducible gene expression and various developmental defects [CLS] , including thallus twisting and gemma malformation. We further investigated the role of MpARF1 in gemma development, which is traceable at the cellular level. In wild-type plants, a gemma initial"}
{"subject": "Tas1R3", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutant", "obj_type": "Var", "file_name": "PubMed-29019082.json", "snippet": " cortical bone mass but the underlying cellular mechanism leading to this phenotype remains unclear. Here, we independently corroborate the increased thickness of cortical bone in femurs of 20-week-old male  [CLS] Tas1R3 mutant [CLS]  mice and confirm that Tas1R3 is expressed in the bone environment. Tas1R3 is expressed in undifferentiated bone marrow stromal cells (BMSCs) in vitro and its expression is maintained during"}
{"subject": "cortical bone mass", "sub_type": "CPA", "rel": "ThemeOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-29019082.json", "snippet": " fructose when dimerized with TAS1R member 1 (TAS1R1) or TAS1R member 2 (TAS1R2), respectively. It was recently reported that deletion of TAS1R3 expression in Tas1R3 mutant mice leads to  [CLS] increased cortical bone mass [CLS]  but the underlying cellular mechanism leading to this phenotype remains unclear. Here, we independently corroborate the increased thickness of cortical bone in femurs of 20-week-old male Tas1R3 mutant mice"}
{"subject": "mutant", "sub_type": "Var", "rel": "CauseOf", "object": "reduced", "obj_type": "NegReg", "file_name": "PubMed-29019082.json", "snippet": " its putative signaling partner Tas1R2 are expressed in primary osteoclasts and their expression levels positively correlate with differentiation status. Collectively, these findings suggest that high bone mass in Tas1R3  [CLS] mutant mice is due to uncoupled bone remodeling with reduced [CLS]  osteoclast function and provide rationale for future experiments examining the cell-type-dependent role for TAS1R family members in nutrient sensing in postnatal bone remodeling."}
{"subject": "osteoclast function", "sub_type": "CPA", "rel": "ThemeOf", "object": "reduced", "obj_type": "NegReg", "file_name": "PubMed-29019082.json", "snippet": " osteoclasts and their expression levels positively correlate with differentiation status. Collectively, these findings suggest that high bone mass in Tas1R3 mutant mice is due to uncoupled bone remodeling with  [CLS] reduced osteoclast function [CLS]  and provide rationale for future experiments examining the cell-type-dependent role for TAS1R family members in nutrient sensing in postnatal bone remodeling."}
{"subject": "reduced", "sub_type": "NegReg", "rel": "CauseOf", "object": "high", "obj_type": "PosReg", "file_name": "PubMed-29019082.json", "snippet": " Consistent with this, Tas1R3 and its putative signaling partner Tas1R2 are expressed in primary osteoclasts and their expression levels positively correlate with differentiation status. Collectively, these findings suggest that  [CLS] high bone mass in Tas1R3 mutant mice is due to uncoupled bone remodeling with reduced [CLS]  osteoclast function and provide rationale for future experiments examining the cell-type-dependent role for TAS1R family members in nutrient sensing in postnatal bone remodeling."}
{"subject": "bone mass", "sub_type": "CPA", "rel": "ThemeOf", "object": "high", "obj_type": "PosReg", "file_name": "PubMed-29019082.json", "snippet": " Consistent with this, Tas1R3 and its putative signaling partner Tas1R2 are expressed in primary osteoclasts and their expression levels positively correlate with differentiation status. Collectively, these findings suggest that  [CLS] high bone mass [CLS]  in Tas1R3 mutant mice is due to uncoupled bone remodeling with reduced osteoclast function and provide rationale for future experiments examining the cell-type-dependent role for TAS1R family members in"}
{"subject": "mutant", "sub_type": "Var", "rel": "CauseOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-29019082.json", "snippet": " of TAS1R3 expression in Tas1R3 mutant mice leads to increased cortical bone mass but the underlying cellular mechanism leading to this phenotype remains unclear. Here, we independently corroborate the  [CLS] increased thickness of cortical bone in femurs of 20-week-old male Tas1R3 mutant [CLS]  mice and confirm that Tas1R3 is expressed in the bone environment. Tas1R3 is expressed in undifferentiated bone marrow stromal cells (BMSCs) in vitro and its expression is maintained during"}
{"subject": "thickness of cortical bone", "sub_type": "CPA", "rel": "ThemeOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-29019082.json", "snippet": " of TAS1R3 expression in Tas1R3 mutant mice leads to increased cortical bone mass but the underlying cellular mechanism leading to this phenotype remains unclear. Here, we independently corroborate the  [CLS] increased thickness of cortical bone [CLS]  in femurs of 20-week-old male Tas1R3 mutant mice and confirm that Tas1R3 is expressed in the bone environment. Tas1R3 is expressed in undifferentiated bone marrow stromal cells (BMSCs) in"}
{"subject": "Tas1R3", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutant", "obj_type": "Var", "file_name": "PubMed-29019082.json", "snippet": " the serum of 20-week-old Tas1R3 mutant mice as compared to controls. In contrast, levels of the bone resorption marker collagen type I C-telopeptide are reduced greater than 60% in  [CLS] Tas1R3 mutant [CLS]  mice. Consistent with this, Tas1R3 and its putative signaling partner Tas1R2 are expressed in primary osteoclasts and their expression levels positively correlate with differentiation status. Collectively, these findings suggest"}
{"subject": "mutant", "sub_type": "Var", "rel": "CauseOf", "object": "reduced", "obj_type": "NegReg", "file_name": "PubMed-29019082.json", "snippet": " propeptide (PINP) are unchanged in the serum of 20-week-old Tas1R3 mutant mice as compared to controls. In contrast, levels of the bone resorption marker collagen type I C-telopeptide are  [CLS] reduced greater than 60% in Tas1R3 mutant [CLS]  mice. Consistent with this, Tas1R3 and its putative signaling partner Tas1R2 are expressed in primary osteoclasts and their expression levels positively correlate with differentiation status. Collectively, these findings suggest"}
{"subject": "levels of the bone resorption marker collagen type I C-telopeptide", "sub_type": "MPA", "rel": "ThemeOf", "object": "reduced", "obj_type": "NegReg", "file_name": "PubMed-29019082.json", "snippet": " However, levels of the bone formation marker procollagen type I N-terminal propeptide (PINP) are unchanged in the serum of 20-week-old Tas1R3 mutant mice as compared to controls. In contrast,  [CLS] levels of the bone resorption marker collagen type I C-telopeptide are reduced [CLS]  greater than 60% in Tas1R3 mutant mice. Consistent with this, Tas1R3 and its putative signaling partner Tas1R2 are expressed in primary osteoclasts and their expression levels positively correlate with"}
{"subject": "Tas1R3", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutant", "obj_type": "Var", "file_name": "PubMed-29019082.json", "snippet": " and its putative signaling partner Tas1R2 are expressed in primary osteoclasts and their expression levels positively correlate with differentiation status. Collectively, these findings suggest that high bone mass in  [CLS] Tas1R3 mutant [CLS]  mice is due to uncoupled bone remodeling with reduced osteoclast function and provide rationale for future experiments examining the cell-type-dependent role for TAS1R family members in nutrient sensing in"}
{"subject": "TAS1R3", "sub_type": "Gene", "rel": "ThemeOf", "object": "deletion", "obj_type": "Var", "file_name": "PubMed-29019082.json", "snippet": " L-glycine and L-glutamate or sweet molecules such as sucrose and fructose when dimerized with TAS1R member 1 (TAS1R1) or TAS1R member 2 (TAS1R2), respectively. It was recently reported that  [CLS] deletion of TAS1R3 [CLS]  expression in Tas1R3 mutant mice leads to increased cortical bone mass but the underlying cellular mechanism leading to this phenotype remains unclear. Here, we independently corroborate the increased thickness"}
{"subject": "deletion", "sub_type": "Var", "rel": "CauseOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-29019082.json", "snippet": " L-glycine and L-glutamate or sweet molecules such as sucrose and fructose when dimerized with TAS1R member 1 (TAS1R1) or TAS1R member 2 (TAS1R2), respectively. It was recently reported that  [CLS] deletion of TAS1R3 expression in Tas1R3 mutant mice leads to increased [CLS]  cortical bone mass but the underlying cellular mechanism leading to this phenotype remains unclear. Here, we independently corroborate the increased thickness of cortical bone in femurs of 20-week-old male"}
{"subject": "FGF5", "sub_type": "Gene", "rel": "ThemeOf", "object": "c.499C>T", "obj_type": "Var", "file_name": "PubMed-29024003.json", "snippet": " (c.351_352insCATATAACATAG) and a non-sense mutation (c.499C>T). The deletion was always found together with the insertion forming a haplotype and producing a putative truncated protein of 123 amino acids. The  [CLS] c.499C>T mutation also leads to a premature stop codon at position 168. In both cases, critical functional domains of FGF5 [CLS] , including one heparin binding site, are lost. All animals analyzed were homozygous for one of the deleterious mutations or compound heterozygous for both (i.e. c.348delA, c.351_352insCATATAACATAG/c.499T). Sequencing of guanaco"}
{"subject": "FGF5", "sub_type": "Gene", "rel": "ThemeOf", "object": "c.348delA", "obj_type": "Var", "file_name": "PubMed-29024003.json", "snippet": " alternative spliced transcripts, in one of which exon 2 is absent. DNA variation analysis showed four polymorphisms in the coding region: a synonymous SNP (c.210A>G), a single base deletion ( [CLS] c.348delA), a 12-bp insertion (c.351_352insCATATAACATAG) and a non-sense mutation (c.499C>T). The deletion was always found together with the insertion forming a haplotype and producing a putative truncated protein of 123 amino acids. The c.499C>T mutation also leads to a premature stop codon at position 168. In both cases, critical functional domains of FGF5 [CLS] , including one heparin binding site, are lost. All animals analyzed were homozygous for one of the deleterious mutations or compound heterozygous for both (i.e. c.348delA, c.351_352insCATATAACATAG/c.499T). Sequencing of guanaco"}
{"subject": "c.348delA", "sub_type": "Var", "rel": "CauseOf", "object": "lost", "obj_type": "NegReg", "file_name": "PubMed-29024003.json", "snippet": " alternative spliced transcripts, in one of which exon 2 is absent. DNA variation analysis showed four polymorphisms in the coding region: a synonymous SNP (c.210A>G), a single base deletion ( [CLS] c.348delA), a 12-bp insertion (c.351_352insCATATAACATAG) and a non-sense mutation (c.499C>T). The deletion was always found together with the insertion forming a haplotype and producing a putative truncated protein of 123 amino acids. The c.499C>T mutation also leads to a premature stop codon at position 168. In both cases, critical functional domains of FGF5, including one heparin binding site, are lost [CLS] . All animals analyzed were homozygous for one of the deleterious mutations or compound heterozygous for both (i.e. c.348delA, c.351_352insCATATAACATAG/c.499T). Sequencing of guanaco samples showed that the FGF5 gene encodes"}
{"subject": "c.499C>T", "sub_type": "Var", "rel": "CauseOf", "object": "lost", "obj_type": "NegReg", "file_name": "PubMed-29024003.json", "snippet": " (c.351_352insCATATAACATAG) and a non-sense mutation (c.499C>T). The deletion was always found together with the insertion forming a haplotype and producing a putative truncated protein of 123 amino acids. The  [CLS] c.499C>T mutation also leads to a premature stop codon at position 168. In both cases, critical functional domains of FGF5, including one heparin binding site, are lost [CLS] . All animals analyzed were homozygous for one of the deleterious mutations or compound heterozygous for both (i.e. c.348delA, c.351_352insCATATAACATAG/c.499T). Sequencing of guanaco samples showed that the FGF5 gene encodes"}
{"subject": "heparin binding site", "sub_type": "MPA", "rel": "ThemeOf", "object": "lost", "obj_type": "NegReg", "file_name": "PubMed-29024003.json", "snippet": " truncated protein of 123 amino acids. The c.499C>T mutation also leads to a premature stop codon at position 168. In both cases, critical functional domains of FGF5, including one  [CLS] heparin binding site, are lost [CLS] . All animals analyzed were homozygous for one of the deleterious mutations or compound heterozygous for both (i.e. c.348delA, c.351_352insCATATAACATAG/c.499T). Sequencing of guanaco samples showed that the FGF5 gene encodes"}
{"subject": "critical functional domains", "sub_type": "MPA", "rel": "ThemeOf", "object": "lost", "obj_type": "NegReg", "file_name": "PubMed-29024003.json", "snippet": " forming a haplotype and producing a putative truncated protein of 123 amino acids. The c.499C>T mutation also leads to a premature stop codon at position 168. In both cases,  [CLS] critical functional domains of FGF5, including one heparin binding site, are lost [CLS] . All animals analyzed were homozygous for one of the deleterious mutations or compound heterozygous for both (i.e. c.348delA, c.351_352insCATATAACATAG/c.499T). Sequencing of guanaco samples showed that the FGF5 gene encodes"}
{"subject": "FLNA", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-29024177.json", "snippet": " [CLS] mutations in the X-linked gene FLNA [CLS]  can lead to abnormal neuronal migration, vascular and cardiac defects, and congenital intestinal pseudo-obstruction (CIPO), the latter characterized by anomalous intestinal smooth muscle layering. Survival in male hemizygotes for"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "Loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-29024177.json", "snippet": " [CLS] Loss-of-function mutations [CLS]  in the X-linked gene FLNA can lead to abnormal neuronal migration, vascular and cardiac defects, and congenital intestinal pseudo-obstruction (CIPO), the latter characterized by anomalous intestinal smooth muscle layering."}
{"subject": "abnormal neuronal migration", "sub_type": "CPA", "rel": "ThemeOf", "object": "Loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-29024177.json", "snippet": " [CLS] Loss-of-function mutations in the X-linked gene FLNA can lead to abnormal neuronal migration [CLS] , vascular and cardiac defects, and congenital intestinal pseudo-obstruction (CIPO), the latter characterized by anomalous intestinal smooth muscle layering. Survival in male hemizygotes for such mutations is dependent on retention"}
{"subject": "vascular and cardiac defects", "sub_type": "CPA", "rel": "ThemeOf", "object": "Loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-29024177.json", "snippet": " [CLS] Loss-of-function mutations in the X-linked gene FLNA can lead to abnormal neuronal migration, vascular and cardiac defects [CLS] , and congenital intestinal pseudo-obstruction (CIPO), the latter characterized by anomalous intestinal smooth muscle layering. Survival in male hemizygotes for such mutations is dependent on retention of residual FLNA function"}
{"subject": "congenital intestinal pseudo-obstruction", "sub_type": "Disease", "rel": "ThemeOf", "object": "Loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-29024177.json", "snippet": " [CLS] Loss-of-function mutations in the X-linked gene FLNA can lead to abnormal neuronal migration, vascular and cardiac defects, and congenital intestinal pseudo-obstruction [CLS]  (CIPO), the latter characterized by anomalous intestinal smooth muscle layering. Survival in male hemizygotes for such mutations is dependent on retention of residual FLNA function but it is unclear"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "confer", "obj_type": "Reg", "file_name": "PubMed-29036710.json", "snippet": " controlled by the pistil-specific S-RNases and the pollen S-locus F-box proteins but non-S-specific factors, namely modifiers, are also required. In apricot, Prunus armeniaca (Rosaceae), we previously mapped two pollen-part  [CLS] mutations that confer [CLS]  self-compatibility in cultivars Canino and Katy at the distal end of chromosome 3 (M-locus) unlinked to the S-locus. Here, we used high-resolution mapping to identify the M-locus with an"}
{"subject": "self-compatibility", "sub_type": "MPA", "rel": "ThemeOf", "object": "confer", "obj_type": "Reg", "file_name": "PubMed-29036710.json", "snippet": " the pistil-specific S-RNases and the pollen S-locus F-box proteins but non-S-specific factors, namely modifiers, are also required. In apricot, Prunus armeniaca (Rosaceae), we previously mapped two pollen-part mutations that  [CLS] confer self-compatibility [CLS]  in cultivars Canino and Katy at the distal end of chromosome 3 (M-locus) unlinked to the S-locus. Here, we used high-resolution mapping to identify the M-locus with an ~134"}
{"subject": "MITE", "sub_type": "Gene", "rel": "ThemeOf", "object": "insertion", "obj_type": "Var", "file_name": "PubMed-29036710.json", "snippet": " in ParM-7 shared only by self-compatible apricots, supporting ParM-7 as strong candidate gene required for SI. ParM-7 encodes a disulfide bond A-like oxidoreductase protein, which we named ParMDO. The  [CLS] MITE insertion [CLS]  truncates the ParMDO ORF and produces a loss of SI function, suggesting that pollen rejection in Prunus is dependent on redox regulation. Based on phylogentic analyses we also suggest"}
{"subject": "insertion", "sub_type": "Var", "rel": "CauseOf", "object": "truncates", "obj_type": "NegReg", "file_name": "PubMed-29036710.json", "snippet": " ParM-7 shared only by self-compatible apricots, supporting ParM-7 as strong candidate gene required for SI. ParM-7 encodes a disulfide bond A-like oxidoreductase protein, which we named ParMDO. The MITE  [CLS] insertion truncates [CLS]  the ParMDO ORF and produces a loss of SI function, suggesting that pollen rejection in Prunus is dependent on redox regulation. Based on phylogentic analyses we also suggest that"}
{"subject": "ParMDO ORF", "sub_type": "MPA", "rel": "ThemeOf", "object": "truncates", "obj_type": "NegReg", "file_name": "PubMed-29036710.json", "snippet": " shared only by self-compatible apricots, supporting ParM-7 as strong candidate gene required for SI. ParM-7 encodes a disulfide bond A-like oxidoreductase protein, which we named ParMDO. The MITE insertion  [CLS] truncates the ParMDO ORF [CLS]  and produces a loss of SI function, suggesting that pollen rejection in Prunus is dependent on redox regulation. Based on phylogentic analyses we also suggest that ParMDO may have"}
{"subject": "insertion", "sub_type": "Var", "rel": "CauseOf", "object": "loss", "obj_type": "NegReg", "file_name": "PubMed-29036710.json", "snippet": " ParM-7 shared only by self-compatible apricots, supporting ParM-7 as strong candidate gene required for SI. ParM-7 encodes a disulfide bond A-like oxidoreductase protein, which we named ParMDO. The MITE  [CLS] insertion truncates the ParMDO ORF and produces a loss [CLS]  of SI function, suggesting that pollen rejection in Prunus is dependent on redox regulation. Based on phylogentic analyses we also suggest that ParMDO may have originated from a tandem"}
{"subject": "SI function", "sub_type": "MPA", "rel": "ThemeOf", "object": "loss", "obj_type": "NegReg", "file_name": "PubMed-29036710.json", "snippet": " as strong candidate gene required for SI. ParM-7 encodes a disulfide bond A-like oxidoreductase protein, which we named ParMDO. The MITE insertion truncates the ParMDO ORF and produces a  [CLS] loss of SI function [CLS] , suggesting that pollen rejection in Prunus is dependent on redox regulation. Based on phylogentic analyses we also suggest that ParMDO may have originated from a tandem duplication followed by"}
{"subject": "Variant", "sub_type": "Var", "rel": "CauseOf", "object": "Gain-of-Function", "obj_type": "PosReg", "file_name": "PubMed-29038237.json", "snippet": " [CLS] Gain-of-Function Integrin \u03b23 Pro33 Variant [CLS]  Alters the Serotonin System in the Mouse Brain.\nEngagement of integrins by the extracellular matrix initiates signaling cascades that drive a variety of cellular functions, including neuronal migration and"}
{"subject": "Itgb3", "sub_type": "Gene", "rel": "ThemeOf", "object": "variant", "obj_type": "Var", "file_name": "PubMed-29038237.json", "snippet": " a phenome-wide scan of psychiatric diagnoses, we found significant, male-specific associations between the Pro33 allele and attention-deficit hyperactivity disorder and ASDs. Here, we used knock-in (KI) mice expressing an  [CLS] Itgb3 variant [CLS]  that phenocopies the human Pro33 variant to elucidate the consequences of constitutively enhanced \u03b1v\u03b23 signaling to the 5-HT system in the brain. KI mice displayed deficits in multiple behaviors,"}
{"subject": "variant", "sub_type": "Var", "rel": "CauseOf", "object": "enhanced", "obj_type": "PosReg", "file_name": "PubMed-29038237.json", "snippet": " phenome-wide scan of psychiatric diagnoses, we found significant, male-specific associations between the Pro33 allele and attention-deficit hyperactivity disorder and ASDs. Here, we used knock-in (KI) mice expressing an Itgb3  [CLS] variant that phenocopies the human Pro33 variant to elucidate the consequences of constitutively enhanced [CLS]  \u03b1v\u03b23 signaling to the 5-HT system in the brain. KI mice displayed deficits in multiple behaviors, including anxiety, repetitive, and social behaviors. Anatomical studies revealed a significant decrease in"}
{"subject": "\u03b1v\u03b23 signaling to the 5-HT system", "sub_type": "MPA", "rel": "ThemeOf", "object": "enhanced", "obj_type": "PosReg", "file_name": "PubMed-29038237.json", "snippet": " allele and attention-deficit hyperactivity disorder and ASDs. Here, we used knock-in (KI) mice expressing an Itgb3 variant that phenocopies the human Pro33 variant to elucidate the consequences of constitutively  [CLS] enhanced \u03b1v\u03b23 signaling to the 5-HT system [CLS]  in the brain. KI mice displayed deficits in multiple behaviors, including anxiety, repetitive, and social behaviors. Anatomical studies revealed a significant decrease in 5-HT synapses in the midbrain, accompanied"}
{"subject": "Serotonin System", "sub_type": "MPA", "rel": "ThemeOf", "object": "Gain-of-Function", "obj_type": "PosReg", "file_name": "PubMed-29038237.json", "snippet": " [CLS] Gain-of-Function Integrin \u03b23 Pro33 Variant Alters the Serotonin System [CLS]  in the Mouse Brain.\nEngagement of integrins by the extracellular matrix initiates signaling cascades that drive a variety of cellular functions, including neuronal migration and axonal pathfinding in the"}
{"subject": "ITGB3", "sub_type": "Gene", "rel": "ThemeOf", "object": "Leu33Pro", "obj_type": "Var", "file_name": "PubMed-29038237.json", "snippet": " brain. Multiple lines of evidence link the ITGB3 gene encoding the integrin \u03b23 subunit with the serotonin (5-HT) system, likely via its modulation of the 5-HT transporter (SERT). The  [CLS] ITGB3 coding polymorphism Leu33Pro [CLS]  (rs5918, PlA2) produces hyperactive \u03b1v\u03b23 receptors that influence whole-blood 5-HT levels and may influence the risk for autism spectrum disorder (ASD). Using a phenome-wide scan of psychiatric diagnoses, we"}
{"subject": "Leu33Pro", "sub_type": "Var", "rel": "CauseOf", "object": "hyperactive", "obj_type": "PosReg", "file_name": "PubMed-29038237.json", "snippet": " of evidence link the ITGB3 gene encoding the integrin \u03b23 subunit with the serotonin (5-HT) system, likely via its modulation of the 5-HT transporter (SERT). The ITGB3 coding polymorphism  [CLS] Leu33Pro (rs5918, PlA2) produces hyperactive [CLS]  \u03b1v\u03b23 receptors that influence whole-blood 5-HT levels and may influence the risk for autism spectrum disorder (ASD). Using a phenome-wide scan of psychiatric diagnoses, we found significant, male-specific associations"}
{"subject": "\u03b1v\u03b23 receptors", "sub_type": "Protein", "rel": "ThemeOf", "object": "hyperactive", "obj_type": "PosReg", "file_name": "PubMed-29038237.json", "snippet": " ITGB3 gene encoding the integrin \u03b23 subunit with the serotonin (5-HT) system, likely via its modulation of the 5-HT transporter (SERT). The ITGB3 coding polymorphism Leu33Pro (rs5918, PlA2) produces  [CLS] hyperactive \u03b1v\u03b23 receptors [CLS]  that influence whole-blood 5-HT levels and may influence the risk for autism spectrum disorder (ASD). Using a phenome-wide scan of psychiatric diagnoses, we found significant, male-specific associations between the"}
{"subject": "\u03b1v\u03b23 receptors", "sub_type": "Protein", "rel": "CauseOf", "object": "influence", "obj_type": "Reg", "file_name": "PubMed-29038237.json", "snippet": " gene encoding the integrin \u03b23 subunit with the serotonin (5-HT) system, likely via its modulation of the 5-HT transporter (SERT). The ITGB3 coding polymorphism Leu33Pro (rs5918, PlA2) produces hyperactive  [CLS] \u03b1v\u03b23 receptors that influence [CLS]  whole-blood 5-HT levels and may influence the risk for autism spectrum disorder (ASD). Using a phenome-wide scan of psychiatric diagnoses, we found significant, male-specific associations between the Pro33 allele"}
{"subject": "whole-blood 5-HT levels", "sub_type": "MPA", "rel": "ThemeOf", "object": "influence", "obj_type": "Reg", "file_name": "PubMed-29038237.json", "snippet": " integrin \u03b23 subunit with the serotonin (5-HT) system, likely via its modulation of the 5-HT transporter (SERT). The ITGB3 coding polymorphism Leu33Pro (rs5918, PlA2) produces hyperactive \u03b1v\u03b23 receptors that  [CLS] influence whole-blood 5-HT levels [CLS]  and may influence the risk for autism spectrum disorder (ASD). Using a phenome-wide scan of psychiatric diagnoses, we found significant, male-specific associations between the Pro33 allele and attention-deficit hyperactivity"}
{"subject": "Leu33Pro", "sub_type": "Var", "rel": "CauseOf", "object": "influence", "obj_type": "Reg", "file_name": "PubMed-29038237.json", "snippet": " of evidence link the ITGB3 gene encoding the integrin \u03b23 subunit with the serotonin (5-HT) system, likely via its modulation of the 5-HT transporter (SERT). The ITGB3 coding polymorphism  [CLS] Leu33Pro (rs5918, PlA2) produces hyperactive \u03b1v\u03b23 receptors that influence whole-blood 5-HT levels and may influence [CLS]  the risk for autism spectrum disorder (ASD). Using a phenome-wide scan of psychiatric diagnoses, we found significant, male-specific associations between the Pro33 allele and attention-deficit hyperactivity disorder and ASDs."}
{"subject": "autism spectrum disorder", "sub_type": "Disease", "rel": "ThemeOf", "object": "influence", "obj_type": "Reg", "file_name": "PubMed-29038237.json", "snippet": " (5-HT) system, likely via its modulation of the 5-HT transporter (SERT). The ITGB3 coding polymorphism Leu33Pro (rs5918, PlA2) produces hyperactive \u03b1v\u03b23 receptors that influence whole-blood 5-HT levels and may  [CLS] influence the risk for autism spectrum disorder [CLS]  (ASD). Using a phenome-wide scan of psychiatric diagnoses, we found significant, male-specific associations between the Pro33 allele and attention-deficit hyperactivity disorder and ASDs. Here, we used knock-in (KI) mice"}
{"subject": "Parkin", "sub_type": "Gene", "rel": "ThemeOf", "object": "absence", "obj_type": "Var", "file_name": "PubMed-29040870.json", "snippet": " [CLS] Parkin absence [CLS]  accelerates microtubule aging in dopaminergic neurons.\nLoss-of-function caused by mutations in the parkin gene (PARK2) lead to early-onset familial Parkinson's disease. Recently, mechanistic studies proved the ability of parkin"}
{"subject": "loss", "sub_type": "Var", "rel": "CauseOf", "object": "affects", "obj_type": "Reg", "file_name": "PubMed-29040870.json", "snippet": " localized in the substantia nigra and corpus striatum, respectively. Interestingly, in PARK2 knockout mice, changes of MT stability preceded the alteration of mitochondria transport. Moreover, in-cell experiments confirmed that  [CLS] loss of parkin affects [CLS]  mitochondria mobility and showed that this defect depends on MT system as it is rescued by paclitaxel, a well-known MT-targeted agent. Furthermore, both in PC12 neuronal cells and in"}
{"subject": "mitochondria mobility", "sub_type": "MPA", "rel": "ThemeOf", "object": "affects", "obj_type": "Reg", "file_name": "PubMed-29040870.json", "snippet": " substantia nigra and corpus striatum, respectively. Interestingly, in PARK2 knockout mice, changes of MT stability preceded the alteration of mitochondria transport. Moreover, in-cell experiments confirmed that loss of parkin  [CLS] affects mitochondria mobility [CLS]  and showed that this defect depends on MT system as it is rescued by paclitaxel, a well-known MT-targeted agent. Furthermore, both in PC12 neuronal cells and in patients' induced"}
{"subject": "parkin", "sub_type": "Gene", "rel": "ThemeOf", "object": "loss", "obj_type": "Var", "file_name": "PubMed-29040870.json", "snippet": " localized in the substantia nigra and corpus striatum, respectively. Interestingly, in PARK2 knockout mice, changes of MT stability preceded the alteration of mitochondria transport. Moreover, in-cell experiments confirmed that  [CLS] loss of parkin [CLS]  affects mitochondria mobility and showed that this defect depends on MT system as it is rescued by paclitaxel, a well-known MT-targeted agent. Furthermore, both in PC12 neuronal cells and"}
{"subject": "absence", "sub_type": "Var", "rel": "CauseOf", "object": "accelerates", "obj_type": "PosReg", "file_name": "PubMed-29040870.json", "snippet": " [CLS] absence accelerates [CLS]  microtubule aging in dopaminergic neurons.\nLoss-of-function caused by mutations in the parkin gene (PARK2) lead to early-onset familial Parkinson's disease. Recently, mechanistic studies proved the ability of parkin in"}
{"subject": "microtubule aging in dopaminergic neurons", "sub_type": "MPA", "rel": "ThemeOf", "object": "accelerates", "obj_type": "PosReg", "file_name": "PubMed-29040870.json", "snippet": " [CLS] accelerates microtubule aging in dopaminergic neurons [CLS] .\nLoss-of-function caused by mutations in the parkin gene (PARK2) lead to early-onset familial Parkinson's disease. Recently, mechanistic studies proved the ability of parkin in regulating mitochondria homeostasis and microtubule"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "Loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-29040870.json", "snippet": " [CLS] Loss-of-function caused by mutations [CLS]  in the parkin gene (PARK2) lead to early-onset familial Parkinson's disease. Recently, mechanistic studies proved the ability of parkin in regulating mitochondria homeostasis and microtubule (MT) stability. Looking at"}
{"subject": "early-onset familial Parkinson's disease", "sub_type": "Disease", "rel": "ThemeOf", "object": "Loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-29040870.json", "snippet": " [CLS] Loss-of-function caused by mutations in the parkin gene (PARK2) lead to early-onset familial Parkinson's disease [CLS] . Recently, mechanistic studies proved the ability of parkin in regulating mitochondria homeostasis and microtubule (MT) stability. Looking at these systems during aging of PARK2 knockout mice, we found that"}
{"subject": "PARK2", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-29040870.json", "snippet": " [CLS] mutations in the parkin gene (PARK2 [CLS] ) lead to early-onset familial Parkinson's disease. Recently, mechanistic studies proved the ability of parkin in regulating mitochondria homeostasis and microtubule (MT) stability. Looking at these systems during aging of"}
{"subject": "loss", "sub_type": "Var", "rel": "CauseOf", "object": "accelerated", "obj_type": "PosReg", "file_name": "PubMed-29040870.json", "snippet": " Recently, mechanistic studies proved the ability of parkin in regulating mitochondria homeostasis and microtubule (MT) stability. Looking at these systems during aging of PARK2 knockout mice, we found that  [CLS] loss of parkin induced an accelerated [CLS]  (over)acetylation of MT system both in dopaminergic neuron cell bodies and fibers, localized in the substantia nigra and corpus striatum, respectively. Interestingly, in PARK2 knockout mice, changes of MT"}
{"subject": "acetylation", "sub_type": "MPA", "rel": "ThemeOf", "object": "accelerated", "obj_type": "PosReg", "file_name": "PubMed-29040870.json", "snippet": " ability of parkin in regulating mitochondria homeostasis and microtubule (MT) stability. Looking at these systems during aging of PARK2 knockout mice, we found that loss of parkin induced an  [CLS] accelerated (over)acetylation [CLS]  of MT system both in dopaminergic neuron cell bodies and fibers, localized in the substantia nigra and corpus striatum, respectively. Interestingly, in PARK2 knockout mice, changes of MT stability"}
{"subject": "parkin", "sub_type": "Gene", "rel": "ThemeOf", "object": "loss", "obj_type": "Var", "file_name": "PubMed-29040870.json", "snippet": " Recently, mechanistic studies proved the ability of parkin in regulating mitochondria homeostasis and microtubule (MT) stability. Looking at these systems during aging of PARK2 knockout mice, we found that  [CLS] loss of parkin [CLS]  induced an accelerated (over)acetylation of MT system both in dopaminergic neuron cell bodies and fibers, localized in the substantia nigra and corpus striatum, respectively. Interestingly, in PARK2 knockout mice,"}
{"subject": "LRRK2", "sub_type": "Gene", "rel": "ThemeOf", "object": "Mutant", "obj_type": "Var", "file_name": "PubMed-29054882.json", "snippet": " [CLS] LRRK2 Hyperactive Kinase Mutant [CLS]  Disrupts Synaptic Vesicle Trafficking in Ventral Midbrain Neurons.\nParkinson's disease (PD) is characterized pathologically by the selective loss of substantia nigra (SN) dopaminergic (DAergic) neurons. Recent evidence has suggested"}
{"subject": "SV endocytosis in ventral midbrain (MB) neurons, including DA neurons", "sub_type": "MPA", "rel": "ThemeOf", "object": "impairs", "obj_type": "NegReg", "file_name": "PubMed-29054882.json", "snippet": " in regulating synaptic vesicle (SV) trafficking. However, the mechanism whereby LRRK2 mutants contribute to nigral vulnerability remains unclear. Here we show that the most common PD mutation LRRK2 G2019S  [CLS] impairs SV endocytosis in ventral midbrain (MB) neurons, including DA neurons [CLS] , and the slowed endocytosis can be rescued by inhibition of LRRK2 kinase activity. A similar endocytic defect, however, was not observed in LRRK2 mutant neurons from the neocortex (hereafter,"}
{"subject": "SYNJ1", "sub_type": "Gene", "rel": "ThemeOf", "object": "deletion", "obj_type": "Var", "file_name": "PubMed-29054882.json", "snippet": " the neocortex (hereafter, cortical neurons) or the hippocampus, suggesting a brain region-specific vulnerability to the G2019S mutation. Additionally, we found MB-specific impairment of SV endocytosis in neurons carrying heterozygous  [CLS] deletion of SYNJ1 [CLS]  (PARK20), a gene that is associated with recessive Parkinsonism. Combining SYNJ1+/- and LRRK2 G2019S does not exacerbate SV endocytosis but impairs sustained exocytosis in MB neurons and alters specific"}
{"subject": "deletion", "sub_type": "Var", "rel": "CauseOf", "object": "impairment", "obj_type": "NegReg", "file_name": "PubMed-29054882.json", "snippet": " was not observed in LRRK2 mutant neurons from the neocortex (hereafter, cortical neurons) or the hippocampus, suggesting a brain region-specific vulnerability to the G2019S mutation. Additionally, we found MB-specific  [CLS] impairment of SV endocytosis in neurons carrying heterozygous deletion [CLS]  of SYNJ1 (PARK20), a gene that is associated with recessive Parkinsonism. Combining SYNJ1+/- and LRRK2 G2019S does not exacerbate SV endocytosis but impairs sustained exocytosis in MB neurons and"}
{"subject": "SV endocytosis in neurons", "sub_type": "MPA", "rel": "ThemeOf", "object": "impairment", "obj_type": "NegReg", "file_name": "PubMed-29054882.json", "snippet": " was not observed in LRRK2 mutant neurons from the neocortex (hereafter, cortical neurons) or the hippocampus, suggesting a brain region-specific vulnerability to the G2019S mutation. Additionally, we found MB-specific  [CLS] impairment of SV endocytosis in neurons [CLS]  carrying heterozygous deletion of SYNJ1 (PARK20), a gene that is associated with recessive Parkinsonism. Combining SYNJ1+/- and LRRK2 G2019S does not exacerbate SV endocytosis but impairs sustained exocytosis in"}
{"subject": "SYNJ1+/-", "sub_type": "Var", "rel": "CauseOf", "object": "impairs", "obj_type": "NegReg", "file_name": "PubMed-29054882.json", "snippet": " to the G2019S mutation. Additionally, we found MB-specific impairment of SV endocytosis in neurons carrying heterozygous deletion of SYNJ1 (PARK20), a gene that is associated with recessive Parkinsonism. Combining  [CLS] SYNJ1+/- and LRRK2 G2019S does not exacerbate SV endocytosis but impairs [CLS]  sustained exocytosis in MB neurons and alters specific motor functions of 1-year-old male mice. Interestingly, we show that LRRK2 directly phosphorylates synaptojanin1 in vitro, resulting in the disruption of"}
{"subject": "sustained exocytosis in MB neurons", "sub_type": "MPA", "rel": "ThemeOf", "object": "impairs", "obj_type": "NegReg", "file_name": "PubMed-29054882.json", "snippet": " SV endocytosis in neurons carrying heterozygous deletion of SYNJ1 (PARK20), a gene that is associated with recessive Parkinsonism. Combining SYNJ1+/- and LRRK2 G2019S does not exacerbate SV endocytosis but  [CLS] impairs sustained exocytosis in MB neurons [CLS]  and alters specific motor functions of 1-year-old male mice. Interestingly, we show that LRRK2 directly phosphorylates synaptojanin1 in vitro, resulting in the disruption of endophilin-synaptojanin1 interaction required for SV"}
{"subject": "LRRK2 G2019S", "sub_type": "Var", "rel": "CauseOf", "object": "impairs", "obj_type": "NegReg", "file_name": "PubMed-29054882.json", "snippet": " G2019S mutation. Additionally, we found MB-specific impairment of SV endocytosis in neurons carrying heterozygous deletion of SYNJ1 (PARK20), a gene that is associated with recessive Parkinsonism. Combining SYNJ1+/- and  [CLS] LRRK2 G2019S does not exacerbate SV endocytosis but impairs [CLS]  sustained exocytosis in MB neurons and alters specific motor functions of 1-year-old male mice. Interestingly, we show that LRRK2 directly phosphorylates synaptojanin1 in vitro, resulting in the disruption of"}
{"subject": "SYNJ1+/-", "sub_type": "Var", "rel": "CauseOf", "object": "alters", "obj_type": "Reg", "file_name": "PubMed-29054882.json", "snippet": " to the G2019S mutation. Additionally, we found MB-specific impairment of SV endocytosis in neurons carrying heterozygous deletion of SYNJ1 (PARK20), a gene that is associated with recessive Parkinsonism. Combining  [CLS] SYNJ1+/- and LRRK2 G2019S does not exacerbate SV endocytosis but impairs sustained exocytosis in MB neurons and alters [CLS]  specific motor functions of 1-year-old male mice. Interestingly, we show that LRRK2 directly phosphorylates synaptojanin1 in vitro, resulting in the disruption of endophilin-synaptojanin1 interaction required for SV endocytosis. Our"}
{"subject": "LRRK2 G2019S", "sub_type": "Var", "rel": "CauseOf", "object": "alters", "obj_type": "Reg", "file_name": "PubMed-29054882.json", "snippet": " G2019S mutation. Additionally, we found MB-specific impairment of SV endocytosis in neurons carrying heterozygous deletion of SYNJ1 (PARK20), a gene that is associated with recessive Parkinsonism. Combining SYNJ1+/- and  [CLS] LRRK2 G2019S does not exacerbate SV endocytosis but impairs sustained exocytosis in MB neurons and alters [CLS]  specific motor functions of 1-year-old male mice. Interestingly, we show that LRRK2 directly phosphorylates synaptojanin1 in vitro, resulting in the disruption of endophilin-synaptojanin1 interaction required for SV endocytosis. Our"}
{"subject": "specific motor functions", "sub_type": "MPA", "rel": "ThemeOf", "object": "alters", "obj_type": "Reg", "file_name": "PubMed-29054882.json", "snippet": " of SYNJ1 (PARK20), a gene that is associated with recessive Parkinsonism. Combining SYNJ1+/- and LRRK2 G2019S does not exacerbate SV endocytosis but impairs sustained exocytosis in MB neurons and  [CLS] alters specific motor functions [CLS]  of 1-year-old male mice. Interestingly, we show that LRRK2 directly phosphorylates synaptojanin1 in vitro, resulting in the disruption of endophilin-synaptojanin1 interaction required for SV endocytosis. Our work suggests a"}
{"subject": "Mutant", "sub_type": "Var", "rel": "CauseOf", "object": "Disrupts", "obj_type": "NegReg", "file_name": "PubMed-29054882.json", "snippet": " [CLS] Mutant Disrupts [CLS]  Synaptic Vesicle Trafficking in Ventral Midbrain Neurons.\nParkinson's disease (PD) is characterized pathologically by the selective loss of substantia nigra (SN) dopaminergic (DAergic) neurons. Recent evidence has suggested a"}
{"subject": "G2019S", "sub_type": "Var", "rel": "CauseOf", "object": "enhanced", "obj_type": "PosReg", "file_name": "PubMed-29054882.json", "snippet": " a nerve terminal impairment in SV trafficking selectively in MB neurons but not cortical neurons caused by two PARK genes: LRRK2 (PARK8) and SYNJ1 (PARK20). We demonstrate that the  [CLS] enhanced kinase activity resulting from the most frequent G2019S [CLS]  mutation in LRRK2 is the key to this impairment. We provide evidence suggesting that LRRK2 G2019S and SYNJ1 loss of function share a similar pathogenic pathway in deregulating DAergic"}
{"subject": "kinase activity", "sub_type": "MPA", "rel": "ThemeOf", "object": "enhanced", "obj_type": "PosReg", "file_name": "PubMed-29054882.json", "snippet": " a nerve terminal impairment in SV trafficking selectively in MB neurons but not cortical neurons caused by two PARK genes: LRRK2 (PARK8) and SYNJ1 (PARK20). We demonstrate that the  [CLS] enhanced kinase activity [CLS]  resulting from the most frequent G2019S mutation in LRRK2 is the key to this impairment. We provide evidence suggesting that LRRK2 G2019S and SYNJ1 loss of function share a"}
{"subject": "LRRK2", "sub_type": "Gene", "rel": "ThemeOf", "object": "G2019S", "obj_type": "Var", "file_name": "PubMed-29054882.json", "snippet": " in MB neurons but not cortical neurons caused by two PARK genes: LRRK2 (PARK8) and SYNJ1 (PARK20). We demonstrate that the enhanced kinase activity resulting from the most frequent  [CLS] G2019S mutation in LRRK2 [CLS]  is the key to this impairment. We provide evidence suggesting that LRRK2 G2019S and SYNJ1 loss of function share a similar pathogenic pathway in deregulating DAergic neuron SV endocytosis"}
{"subject": "G2019S", "sub_type": "Var", "rel": "CauseOf", "object": "loss of function", "obj_type": "NegReg", "file_name": "PubMed-29054882.json", "snippet": " (PARK20). We demonstrate that the enhanced kinase activity resulting from the most frequent G2019S mutation in LRRK2 is the key to this impairment. We provide evidence suggesting that LRRK2  [CLS] G2019S and SYNJ1 loss of function [CLS]  share a similar pathogenic pathway in deregulating DAergic neuron SV endocytosis and that they play additive roles in facilitating each other's pathogenic functions in PD."}
{"subject": "SYNJ1", "sub_type": "Gene", "rel": "CauseOf", "object": "loss of function", "obj_type": "NegReg", "file_name": "PubMed-29054882.json", "snippet": " demonstrate that the enhanced kinase activity resulting from the most frequent G2019S mutation in LRRK2 is the key to this impairment. We provide evidence suggesting that LRRK2 G2019S and  [CLS] SYNJ1 loss of function [CLS]  share a similar pathogenic pathway in deregulating DAergic neuron SV endocytosis and that they play additive roles in facilitating each other's pathogenic functions in PD."}
{"subject": "deregulating DAergic neuron SV endocytosis", "sub_type": "MPA", "rel": "ThemeOf", "object": "loss of function", "obj_type": "NegReg", "file_name": "PubMed-29054882.json", "snippet": " that the enhanced kinase activity resulting from the most frequent G2019S mutation in LRRK2 is the key to this impairment. We provide evidence suggesting that LRRK2 G2019S and SYNJ1  [CLS] loss of function share a similar pathogenic pathway in deregulating DAergic neuron SV endocytosis [CLS]  and that they play additive roles in facilitating each other's pathogenic functions in PD."}
{"subject": "SYNJ1", "sub_type": "Gene", "rel": "CauseOf", "object": "play additive roles", "obj_type": "Reg", "file_name": "PubMed-29054882.json", "snippet": " demonstrate that the enhanced kinase activity resulting from the most frequent G2019S mutation in LRRK2 is the key to this impairment. We provide evidence suggesting that LRRK2 G2019S and  [CLS] SYNJ1 loss of function share a similar pathogenic pathway in deregulating DAergic neuron SV endocytosis and that they play additive roles [CLS]  in facilitating each other's pathogenic functions in PD."}
{"subject": "G2019S", "sub_type": "Var", "rel": "CauseOf", "object": "play additive roles", "obj_type": "Reg", "file_name": "PubMed-29054882.json", "snippet": " (PARK20). We demonstrate that the enhanced kinase activity resulting from the most frequent G2019S mutation in LRRK2 is the key to this impairment. We provide evidence suggesting that LRRK2  [CLS] G2019S and SYNJ1 loss of function share a similar pathogenic pathway in deregulating DAergic neuron SV endocytosis and that they play additive roles [CLS]  in facilitating each other's pathogenic functions in PD."}
{"subject": "PD", "sub_type": "Disease", "rel": "ThemeOf", "object": "play additive roles", "obj_type": "Reg", "file_name": "PubMed-29054882.json", "snippet": " to this impairment. We provide evidence suggesting that LRRK2 G2019S and SYNJ1 loss of function share a similar pathogenic pathway in deregulating DAergic neuron SV endocytosis and that they  [CLS] play additive roles in facilitating each other's pathogenic functions in PD [CLS] ."}
{"subject": "LRRK2", "sub_type": "Var", "rel": "CauseOf", "object": "resulting in", "obj_type": "Reg", "file_name": "PubMed-29054882.json", "snippet": " SYNJ1+/- and LRRK2 G2019S does not exacerbate SV endocytosis but impairs sustained exocytosis in MB neurons and alters specific motor functions of 1-year-old male mice. Interestingly, we show that  [CLS] LRRK2 directly phosphorylates synaptojanin1 in vitro, resulting in [CLS]  the disruption of endophilin-synaptojanin1 interaction required for SV endocytosis. Our work suggests a merge of LRRK2 and SYNJ1 pathogenic pathways in deregulating SV trafficking in MB neurons as an"}
{"subject": "Synaptic Vesicle Trafficking in Ventral Midbrain Neurons", "sub_type": "MPA", "rel": "ThemeOf", "object": "Disrupts", "obj_type": "NegReg", "file_name": "PubMed-29054882.json", "snippet": " [CLS] Disrupts Synaptic Vesicle Trafficking in Ventral Midbrain Neurons [CLS] .\nParkinson's disease (PD) is characterized pathologically by the selective loss of substantia nigra (SN) dopaminergic (DAergic) neurons. Recent evidence has suggested a role of LRRK2, linked to the most"}
{"subject": "disruption of endophilin-synaptojanin1 interaction required for SV endocytosis", "sub_type": "MPA", "rel": "ThemeOf", "object": "resulting in", "obj_type": "Reg", "file_name": "PubMed-29054882.json", "snippet": " exacerbate SV endocytosis but impairs sustained exocytosis in MB neurons and alters specific motor functions of 1-year-old male mice. Interestingly, we show that LRRK2 directly phosphorylates synaptojanin1 in vitro,  [CLS] resulting in the disruption of endophilin-synaptojanin1 interaction required for SV endocytosis [CLS] . Our work suggests a merge of LRRK2 and SYNJ1 pathogenic pathways in deregulating SV trafficking in MB neurons as an underlying molecular mechanism of early PD pathogenesis.SIGNIFICANCE STATEMENT Understanding"}
{"subject": "LRRK2", "sub_type": "Gene", "rel": "ThemeOf", "object": "G2019S", "obj_type": "Var", "file_name": "PubMed-29054882.json", "snippet": " SYNJ1 (PARK20). We demonstrate that the enhanced kinase activity resulting from the most frequent G2019S mutation in LRRK2 is the key to this impairment. We provide evidence suggesting that  [CLS] LRRK2 G2019S [CLS]  and SYNJ1 loss of function share a similar pathogenic pathway in deregulating DAergic neuron SV endocytosis and that they play additive roles in facilitating each other's pathogenic functions in"}
{"subject": "Mutant", "sub_type": "Var", "rel": "CauseOf", "object": "Parkinson's Disease", "obj_type": "Disease", "file_name": "PubMed-29054882.json", "snippet": " [CLS] Parkinson's Disease-Associated LRRK2 Hyperactive Kinase Mutant [CLS]  Disrupts Synaptic Vesicle Trafficking in Ventral Midbrain Neurons.\nParkinson's disease (PD) is characterized pathologically by the selective loss of substantia nigra (SN) dopaminergic (DAergic) neurons. Recent evidence has suggested"}
{"subject": "LRRK2", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutants", "obj_type": "Var", "file_name": "PubMed-29054882.json", "snippet": " (SN) dopaminergic (DAergic) neurons. Recent evidence has suggested a role of LRRK2, linked to the most frequent familial PD, in regulating synaptic vesicle (SV) trafficking. However, the mechanism whereby  [CLS] LRRK2 mutants [CLS]  contribute to nigral vulnerability remains unclear. Here we show that the most common PD mutation LRRK2 G2019S impairs SV endocytosis in ventral midbrain (MB) neurons, including DA neurons, and"}
{"subject": "mutants", "sub_type": "Var", "rel": "CauseOf", "object": "contribute", "obj_type": "Reg", "file_name": "PubMed-29054882.json", "snippet": " dopaminergic (DAergic) neurons. Recent evidence has suggested a role of LRRK2, linked to the most frequent familial PD, in regulating synaptic vesicle (SV) trafficking. However, the mechanism whereby LRRK2  [CLS] mutants contribute [CLS]  to nigral vulnerability remains unclear. Here we show that the most common PD mutation LRRK2 G2019S impairs SV endocytosis in ventral midbrain (MB) neurons, including DA neurons, and the"}
{"subject": "nigral vulnerability", "sub_type": "MPA", "rel": "ThemeOf", "object": "contribute", "obj_type": "Reg", "file_name": "PubMed-29054882.json", "snippet": " (DAergic) neurons. Recent evidence has suggested a role of LRRK2, linked to the most frequent familial PD, in regulating synaptic vesicle (SV) trafficking. However, the mechanism whereby LRRK2 mutants  [CLS] contribute to nigral vulnerability [CLS]  remains unclear. Here we show that the most common PD mutation LRRK2 G2019S impairs SV endocytosis in ventral midbrain (MB) neurons, including DA neurons, and the slowed endocytosis can"}
{"subject": "LRRK2", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutation", "obj_type": "Var", "file_name": "PubMed-29054882.json", "snippet": " frequent familial PD, in regulating synaptic vesicle (SV) trafficking. However, the mechanism whereby LRRK2 mutants contribute to nigral vulnerability remains unclear. Here we show that the most common PD  [CLS] mutation LRRK2 [CLS]  G2019S impairs SV endocytosis in ventral midbrain (MB) neurons, including DA neurons, and the slowed endocytosis can be rescued by inhibition of LRRK2 kinase activity. A similar endocytic defect,"}
{"subject": "mutation", "sub_type": "Var", "rel": "CauseOf", "object": "impairs", "obj_type": "NegReg", "file_name": "PubMed-29054882.json", "snippet": " frequent familial PD, in regulating synaptic vesicle (SV) trafficking. However, the mechanism whereby LRRK2 mutants contribute to nigral vulnerability remains unclear. Here we show that the most common PD  [CLS] mutation LRRK2 G2019S impairs [CLS]  SV endocytosis in ventral midbrain (MB) neurons, including DA neurons, and the slowed endocytosis can be rescued by inhibition of LRRK2 kinase activity. A similar endocytic defect, however, was"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "inactivation", "obj_type": "NegReg", "file_name": "PubMed-29058783.json", "snippet": " [CLS] mutations in p53 exert activities that go beyond simply inactivation [CLS]  of wildtype functions but rather elicits downstream interactions that promote malignancy described as mutant p53 gain-of-function (GOF). Here we report the first account of the dynamics of mutation-induced structural"}
{"subject": "p53", "sub_type": "Gene", "rel": "ThemeOf", "object": "R273C", "obj_type": "Var", "file_name": "PubMed-29058783.json", "snippet": " Here we report the first account of the dynamics of mutation-induced structural transition of native p53 to an aberrant gain-of-function state, studying the wildtype (WT) and high incidence contact ( [CLS] R273C) and structural (R175H) mutant p53 [CLS]  (mutp53) through molecular dynamics simulation. Result analysis revealed that both mutants exhibited structural distortion and reduced flexibility, indicative of rigidity and kinetic stability. In addition, surface analysis revealed an"}
{"subject": "p53", "sub_type": "Gene", "rel": "ThemeOf", "object": "R175H", "obj_type": "Var", "file_name": "PubMed-29058783.json", "snippet": " the first account of the dynamics of mutation-induced structural transition of native p53 to an aberrant gain-of-function state, studying the wildtype (WT) and high incidence contact (R273C) and structural ( [CLS] R175H) mutant p53 [CLS]  (mutp53) through molecular dynamics simulation. Result analysis revealed that both mutants exhibited structural distortion and reduced flexibility, indicative of rigidity and kinetic stability. In addition, surface analysis revealed an"}
{"subject": "R273C", "sub_type": "Var", "rel": "CauseOf", "object": "exhibited", "obj_type": "Reg", "file_name": "PubMed-29058783.json", "snippet": " Here we report the first account of the dynamics of mutation-induced structural transition of native p53 to an aberrant gain-of-function state, studying the wildtype (WT) and high incidence contact ( [CLS] R273C) and structural (R175H) mutant p53 (mutp53) through molecular dynamics simulation. Result analysis revealed that both mutants exhibited [CLS]  structural distortion and reduced flexibility, indicative of rigidity and kinetic stability. In addition, surface analysis revealed an increase in the accessible surface area in the p53 mutants. This suggests"}
{"subject": "structural distortion", "sub_type": "Var", "rel": "ThemeOf", "object": "exhibited", "obj_type": "Reg", "file_name": "PubMed-29058783.json", "snippet": " an aberrant gain-of-function state, studying the wildtype (WT) and high incidence contact (R273C) and structural (R175H) mutant p53 (mutp53) through molecular dynamics simulation. Result analysis revealed that both mutants  [CLS] exhibited structural distortion [CLS]  and reduced flexibility, indicative of rigidity and kinetic stability. In addition, surface analysis revealed an increase in the accessible surface area in the p53 mutants. This suggests that the"}
{"subject": "R273C", "sub_type": "Var", "rel": "CauseOf", "object": "reduced", "obj_type": "NegReg", "file_name": "PubMed-29058783.json", "snippet": " Here we report the first account of the dynamics of mutation-induced structural transition of native p53 to an aberrant gain-of-function state, studying the wildtype (WT) and high incidence contact ( [CLS] R273C) and structural (R175H) mutant p53 (mutp53) through molecular dynamics simulation. Result analysis revealed that both mutants exhibited structural distortion and reduced [CLS]  flexibility, indicative of rigidity and kinetic stability. In addition, surface analysis revealed an increase in the accessible surface area in the p53 mutants. This suggests that the GOF transition"}
{"subject": "flexibility", "sub_type": "MPA", "rel": "ThemeOf", "object": "reduced", "obj_type": "NegReg", "file_name": "PubMed-29058783.json", "snippet": " studying the wildtype (WT) and high incidence contact (R273C) and structural (R175H) mutant p53 (mutp53) through molecular dynamics simulation. Result analysis revealed that both mutants exhibited structural distortion and  [CLS] reduced flexibility [CLS] , indicative of rigidity and kinetic stability. In addition, surface analysis revealed an increase in the accessible surface area in the p53 mutants. This suggests that the GOF transition involves"}
{"subject": "mutation", "sub_type": "Var", "rel": "CauseOf", "object": "induced", "obj_type": "Reg", "file_name": "PubMed-29058783.json", "snippet": " and p73 homologs. Further validation revealed binding cavities, similar in the mutants but dissimilar to the WT. Taken together, this study complements experimental findings and reveals the interplay between  [CLS] mutation-induced [CLS]  structural distortion, loss of flexibility, rigidity, enhanced stability, protein unfolding and ultimately, exposure of binding surfaces as conformational attributes that characterize mutP53 structure-GOF activities. This insight is, therefore, of"}
{"subject": "structural distortion", "sub_type": "Var", "rel": "ThemeOf", "object": "induced", "obj_type": "Reg", "file_name": "PubMed-29058783.json", "snippet": " and p73 homologs. Further validation revealed binding cavities, similar in the mutants but dissimilar to the WT. Taken together, this study complements experimental findings and reveals the interplay between mutation- [CLS] induced structural distortion [CLS] , loss of flexibility, rigidity, enhanced stability, protein unfolding and ultimately, exposure of binding surfaces as conformational attributes that characterize mutP53 structure-GOF activities. This insight is, therefore, of great importance"}
{"subject": "flexibility", "sub_type": "MPA", "rel": "ThemeOf", "object": "loss", "obj_type": "NegReg", "file_name": "PubMed-29058783.json", "snippet": " Further validation revealed binding cavities, similar in the mutants but dissimilar to the WT. Taken together, this study complements experimental findings and reveals the interplay between mutation-induced structural distortion,  [CLS] loss of flexibility [CLS] , rigidity, enhanced stability, protein unfolding and ultimately, exposure of binding surfaces as conformational attributes that characterize mutP53 structure-GOF activities. This insight is, therefore, of great importance as it opens"}
{"subject": "rigidity", "sub_type": "MPA", "rel": "ThemeOf", "object": "loss", "obj_type": "NegReg", "file_name": "PubMed-29058783.json", "snippet": " Further validation revealed binding cavities, similar in the mutants but dissimilar to the WT. Taken together, this study complements experimental findings and reveals the interplay between mutation-induced structural distortion,  [CLS] loss of flexibility, rigidity [CLS] , enhanced stability, protein unfolding and ultimately, exposure of binding surfaces as conformational attributes that characterize mutP53 structure-GOF activities. This insight is, therefore, of great importance as it opens up"}
{"subject": "p53", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-29058783.json", "snippet": " [CLS] mutations in p53 [CLS]  exert activities that go beyond simply inactivation of wildtype functions but rather elicits downstream interactions that promote malignancy described as mutant p53 gain-of-function (GOF). Here we report the first"}
{"subject": "stability", "sub_type": "MPA", "rel": "ThemeOf", "object": "enhanced", "obj_type": "PosReg", "file_name": "PubMed-29058783.json", "snippet": " cavities, similar in the mutants but dissimilar to the WT. Taken together, this study complements experimental findings and reveals the interplay between mutation-induced structural distortion, loss of flexibility, rigidity,  [CLS] enhanced stability [CLS] , protein unfolding and ultimately, exposure of binding surfaces as conformational attributes that characterize mutP53 structure-GOF activities. This insight is, therefore, of great importance as it opens up a novel"}
{"subject": "mutation", "sub_type": "Var", "rel": "CauseOf", "object": "enhanced", "obj_type": "PosReg", "file_name": "PubMed-29058783.json", "snippet": " and p73 homologs. Further validation revealed binding cavities, similar in the mutants but dissimilar to the WT. Taken together, this study complements experimental findings and reveals the interplay between  [CLS] mutation-induced structural distortion, loss of flexibility, rigidity, enhanced [CLS]  stability, protein unfolding and ultimately, exposure of binding surfaces as conformational attributes that characterize mutP53 structure-GOF activities. This insight is, therefore, of great importance as it opens up a"}
{"subject": "mutation", "sub_type": "Var", "rel": "CauseOf", "object": "loss", "obj_type": "NegReg", "file_name": "PubMed-29058783.json", "snippet": " and p73 homologs. Further validation revealed binding cavities, similar in the mutants but dissimilar to the WT. Taken together, this study complements experimental findings and reveals the interplay between  [CLS] mutation-induced structural distortion, loss [CLS]  of flexibility, rigidity, enhanced stability, protein unfolding and ultimately, exposure of binding surfaces as conformational attributes that characterize mutP53 structure-GOF activities. This insight is, therefore, of great importance as"}
{"subject": "wildtype functions", "sub_type": "MPA", "rel": "ThemeOf", "object": "inactivation", "obj_type": "NegReg", "file_name": "PubMed-29058783.json", "snippet": " [CLS] inactivation of wildtype functions [CLS]  but rather elicits downstream interactions that promote malignancy described as mutant p53 gain-of-function (GOF). Here we report the first account of the dynamics of mutation-induced structural transition of native"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "elicits", "obj_type": "Reg", "file_name": "PubMed-29058783.json", "snippet": " [CLS] mutations in p53 exert activities that go beyond simply inactivation of wildtype functions but rather elicits [CLS]  downstream interactions that promote malignancy described as mutant p53 gain-of-function (GOF). Here we report the first account of the dynamics of mutation-induced structural transition of native p53 to an"}
{"subject": "interactions", "sub_type": "Interaction", "rel": "ThemeOf", "object": "elicits", "obj_type": "Reg", "file_name": "PubMed-29058783.json", "snippet": " Unraveling the structural basis of mutant p53 oncogenic transition.\nVarious evidence has revealed that mutations in p53 exert activities that go beyond simply inactivation of wildtype functions but rather  [CLS] elicits downstream interactions [CLS]  that promote malignancy described as mutant p53 gain-of-function (GOF). Here we report the first account of the dynamics of mutation-induced structural transition of native p53 to an aberrant gain-of-function"}
{"subject": "mutant", "sub_type": "Var", "rel": "CauseOf", "object": "promote", "obj_type": "PosReg", "file_name": "PubMed-29058783.json", "snippet": " of mutant p53 oncogenic transition.\nVarious evidence has revealed that mutations in p53 exert activities that go beyond simply inactivation of wildtype functions but rather elicits downstream interactions that  [CLS] promote malignancy described as mutant [CLS]  p53 gain-of-function (GOF). Here we report the first account of the dynamics of mutation-induced structural transition of native p53 to an aberrant gain-of-function state, studying the wildtype (WT) and"}
{"subject": "malignancy", "sub_type": "Disease", "rel": "ThemeOf", "object": "promote", "obj_type": "PosReg", "file_name": "PubMed-29058783.json", "snippet": " of mutant p53 oncogenic transition.\nVarious evidence has revealed that mutations in p53 exert activities that go beyond simply inactivation of wildtype functions but rather elicits downstream interactions that  [CLS] promote malignancy [CLS]  described as mutant p53 gain-of-function (GOF). Here we report the first account of the dynamics of mutation-induced structural transition of native p53 to an aberrant gain-of-function state, studying the"}
{"subject": "p53", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutant", "obj_type": "Var", "file_name": "PubMed-29058783.json", "snippet": " transition.\nVarious evidence has revealed that mutations in p53 exert activities that go beyond simply inactivation of wildtype functions but rather elicits downstream interactions that promote malignancy described as  [CLS] mutant p53 [CLS]  gain-of-function (GOF). Here we report the first account of the dynamics of mutation-induced structural transition of native p53 to an aberrant gain-of-function state, studying the wildtype (WT) and high"}
{"subject": "mutant", "sub_type": "Var", "rel": "CauseOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-29058783.json", "snippet": " transition.\nVarious evidence has revealed that mutations in p53 exert activities that go beyond simply inactivation of wildtype functions but rather elicits downstream interactions that promote malignancy described as  [CLS] mutant p53 gain-of-function [CLS]  (GOF). Here we report the first account of the dynamics of mutation-induced structural transition of native p53 to an aberrant gain-of-function state, studying the wildtype (WT) and high incidence"}
{"subject": "p.S632W", "sub_type": "Var", "rel": "CauseOf", "object": "activation", "obj_type": "PosReg", "file_name": "PubMed-29064616.json", "snippet": " of 238 familial GGE cases. The p.V246M variant was identified in a patient with photo-sensitive GGE and his father diagnosed with juvenile myoclonic epilepsy. Functional studies revealed that both  [CLS] p.S632W and p.V246M had an identical functional impact including a depolarizing shift in the voltage dependence of activation [CLS]  that is consistent with a gain-of-function. In contrast, no biophysical changes resulted from the introduction of common population variants, p.E280K and p.A705T, and the p.R756C variant from EPGP that"}
{"subject": "p.V246M", "sub_type": "Var", "rel": "CauseOf", "object": "activation", "obj_type": "PosReg", "file_name": "PubMed-29064616.json", "snippet": " familial GGE cases. The p.V246M variant was identified in a patient with photo-sensitive GGE and his father diagnosed with juvenile myoclonic epilepsy. Functional studies revealed that both p.S632W and  [CLS] p.V246M had an identical functional impact including a depolarizing shift in the voltage dependence of activation [CLS]  that is consistent with a gain-of-function. In contrast, no biophysical changes resulted from the introduction of common population variants, p.E280K and p.A705T, and the p.R756C variant from EPGP that"}
{"subject": "depolarizing shift in the voltage dependence", "sub_type": "MPA", "rel": "ThemeOf", "object": "activation", "obj_type": "PosReg", "file_name": "PubMed-29064616.json", "snippet": " in a patient with photo-sensitive GGE and his father diagnosed with juvenile myoclonic epilepsy. Functional studies revealed that both p.S632W and p.V246M had an identical functional impact including a  [CLS] depolarizing shift in the voltage dependence of activation [CLS]  that is consistent with a gain-of-function. In contrast, no biophysical changes resulted from the introduction of common population variants, p.E280K and p.A705T, and the p.R756C variant from EPGP that"}
{"subject": "HCN2", "sub_type": "Gene", "rel": "ThemeOf", "object": "variants", "obj_type": "Var", "file_name": "PubMed-29064616.json", "snippet": " biophysical changes resulted from the introduction of common population variants, p.E280K and p.A705T, and the p.R756C variant from EPGP that did not segregate with disease. Our data suggest that  [CLS] HCN2 variants [CLS]  can confer susceptibility to GGE via a gain-of-function mechanism."}
{"subject": "variants", "sub_type": "Var", "rel": "CauseOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-29064616.json", "snippet": " changes resulted from the introduction of common population variants, p.E280K and p.A705T, and the p.R756C variant from EPGP that did not segregate with disease. Our data suggest that HCN2  [CLS] variants can confer susceptibility to GGE via a gain-of-function [CLS]  mechanism."}
{"subject": "susceptibility", "sub_type": "MPA", "rel": "ThemeOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-29064616.json", "snippet": " the introduction of common population variants, p.E280K and p.A705T, and the p.R756C variant from EPGP that did not segregate with disease. Our data suggest that HCN2 variants can confer  [CLS] susceptibility to GGE via a gain-of-function [CLS]  mechanism."}
{"subject": "HCN2", "sub_type": "Gene", "rel": "ThemeOf", "object": "variants", "obj_type": "Var", "file_name": "PubMed-29064616.json", "snippet": " [CLS] HCN2 variants [CLS]  in genetic epilepsy.\nGenetic generalized epilepsy (GGE) is a common epilepsy syndrome that encompasses seizure disorders characterized by spike-and-wave discharges (SWDs). Pacemaker hyperpolarization-activated cyclic nucleotide-gated channels (HCN) are considered"}
{"subject": "variants", "sub_type": "Var", "rel": "CauseOf", "object": "Gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-29064616.json", "snippet": " [CLS] Gain-of-function HCN2 variants [CLS]  in genetic epilepsy.\nGenetic generalized epilepsy (GGE) is a common epilepsy syndrome that encompasses seizure disorders characterized by spike-and-wave discharges (SWDs). Pacemaker hyperpolarization-activated cyclic nucleotide-gated channels (HCN) are considered"}
{"subject": "epilepsy", "sub_type": "Disease", "rel": "ThemeOf", "object": "Gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-29064616.json", "snippet": " [CLS] Gain-of-function HCN2 variants in genetic epilepsy [CLS] .\nGenetic generalized epilepsy (GGE) is a common epilepsy syndrome that encompasses seizure disorders characterized by spike-and-wave discharges (SWDs). Pacemaker hyperpolarization-activated cyclic nucleotide-gated channels (HCN) are considered integral to SWD"}
{"subject": "Polymorphisms", "sub_type": "Var", "rel": "CauseOf", "object": "lead to", "obj_type": "Reg", "file_name": "PubMed-29067933.json", "snippet": " oxidative stress and resulting inflammation has been emphasized as a factor in the pathogenesis of many diseases including psoriasis. Glutathione S-transferases (GSTs) protect against oxidative stress, inflammation, and genotoxicity.  [CLS] Polymorphisms in the GST genes may lead to [CLS]  an imbalance in pro- and antioxidant systems resulting in the increased production of reactive oxygen species that could influence the pathogenesis of psoriasis.\nAIM: The aim of this study"}
{"subject": "GSTT1", "sub_type": "Gene", "rel": "ThemeOf", "object": "presence", "obj_type": "Var", "file_name": "PubMed-29067933.json", "snippet": " between the null alleles of the GSTT1 (OR = 2.74) and GSTM1 (OR = 1.58) alone or in combination with tobacco use (P < 0.001) and psoriasis risk. The  [CLS] presence of both null genotypes of GSTM1 and GSTT1 [CLS]  further increased the risk of psoriasis (OR = 3.52) when compared with the positive genotypes of GSTM1 and GSTT1.\nLIMITATIONS: A major limitation of this study was the small"}
{"subject": "GSTM1", "sub_type": "Gene", "rel": "ThemeOf", "object": "presence", "obj_type": "Var", "file_name": "PubMed-29067933.json", "snippet": " between the null alleles of the GSTT1 (OR = 2.74) and GSTM1 (OR = 1.58) alone or in combination with tobacco use (P < 0.001) and psoriasis risk. The  [CLS] presence of both null genotypes of GSTM1 [CLS]  and GSTT1 further increased the risk of psoriasis (OR = 3.52) when compared with the positive genotypes of GSTM1 and GSTT1.\nLIMITATIONS: A major limitation of this study was"}
{"subject": "imbalance in pro- and antioxidant systems", "sub_type": "MPA", "rel": "ThemeOf", "object": "lead to", "obj_type": "Reg", "file_name": "PubMed-29067933.json", "snippet": " been emphasized as a factor in the pathogenesis of many diseases including psoriasis. Glutathione S-transferases (GSTs) protect against oxidative stress, inflammation, and genotoxicity. Polymorphisms in the GST genes may  [CLS] lead to an imbalance in pro- and antioxidant systems [CLS]  resulting in the increased production of reactive oxygen species that could influence the pathogenesis of psoriasis.\nAIM: The aim of this study was to investigate the association between GSTs"}
{"subject": "GST", "sub_type": "Gene", "rel": "ThemeOf", "object": "Polymorphisms", "obj_type": "Var", "file_name": "PubMed-29067933.json", "snippet": " oxidative stress and resulting inflammation has been emphasized as a factor in the pathogenesis of many diseases including psoriasis. Glutathione S-transferases (GSTs) protect against oxidative stress, inflammation, and genotoxicity.  [CLS] Polymorphisms in the GST [CLS]  genes may lead to an imbalance in pro- and antioxidant systems resulting in the increased production of reactive oxygen species that could influence the pathogenesis of psoriasis.\nAIM: The"}
{"subject": "imbalance in pro- and antioxidant systems", "sub_type": "MPA", "rel": "CauseOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-29067933.json", "snippet": " a factor in the pathogenesis of many diseases including psoriasis. Glutathione S-transferases (GSTs) protect against oxidative stress, inflammation, and genotoxicity. Polymorphisms in the GST genes may lead to an  [CLS] imbalance in pro- and antioxidant systems resulting in the increased [CLS]  production of reactive oxygen species that could influence the pathogenesis of psoriasis.\nAIM: The aim of this study was to investigate the association between GSTs (GSTM1 and GSTT1) gene"}
{"subject": "production of reactive oxygen species", "sub_type": "MPA", "rel": "ThemeOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-29067933.json", "snippet": " psoriasis. Glutathione S-transferases (GSTs) protect against oxidative stress, inflammation, and genotoxicity. Polymorphisms in the GST genes may lead to an imbalance in pro- and antioxidant systems resulting in the  [CLS] increased production of reactive oxygen species [CLS]  that could influence the pathogenesis of psoriasis.\nAIM: The aim of this study was to investigate the association between GSTs (GSTM1 and GSTT1) gene polymorphism in patients with chronic"}
{"subject": "production of reactive oxygen species", "sub_type": "MPA", "rel": "CauseOf", "object": "influence", "obj_type": "Reg", "file_name": "PubMed-29067933.json", "snippet": " Glutathione S-transferases (GSTs) protect against oxidative stress, inflammation, and genotoxicity. Polymorphisms in the GST genes may lead to an imbalance in pro- and antioxidant systems resulting in the increased  [CLS] production of reactive oxygen species that could influence [CLS]  the pathogenesis of psoriasis.\nAIM: The aim of this study was to investigate the association between GSTs (GSTM1 and GSTT1) gene polymorphism in patients with chronic plaque psoriasis as"}
{"subject": "psoriasis", "sub_type": "Disease", "rel": "ThemeOf", "object": "influence", "obj_type": "Reg", "file_name": "PubMed-29067933.json", "snippet": " inflammation, and genotoxicity. Polymorphisms in the GST genes may lead to an imbalance in pro- and antioxidant systems resulting in the increased production of reactive oxygen species that could  [CLS] influence the pathogenesis of psoriasis [CLS] .\nAIM: The aim of this study was to investigate the association between GSTs (GSTM1 and GSTT1) gene polymorphism in patients with chronic plaque psoriasis as a factor in the"}
{"subject": "presence", "sub_type": "Var", "rel": "CauseOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-29067933.json", "snippet": " between the null alleles of the GSTT1 (OR = 2.74) and GSTM1 (OR = 1.58) alone or in combination with tobacco use (P < 0.001) and psoriasis risk. The  [CLS] presence of both null genotypes of GSTM1 and GSTT1 further increased [CLS]  the risk of psoriasis (OR = 3.52) when compared with the positive genotypes of GSTM1 and GSTT1.\nLIMITATIONS: A major limitation of this study was the small sample size."}
{"subject": "psoriasis", "sub_type": "Disease", "rel": "ThemeOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-29067933.json", "snippet": " and GSTM1 (OR = 1.58) alone or in combination with tobacco use (P < 0.001) and psoriasis risk. The presence of both null genotypes of GSTM1 and GSTT1 further  [CLS] increased the risk of psoriasis [CLS]  (OR = 3.52) when compared with the positive genotypes of GSTM1 and GSTT1.\nLIMITATIONS: A major limitation of this study was the small sample size. A large epidemiological study"}
{"subject": "Fix- mutants", "sub_type": "Var", "rel": "CauseOf", "object": "indicating", "obj_type": "Reg", "file_name": "PubMed-29086445.json", "snippet": " which showed a very specific symbiotic phenotype. It formed ineffective nodules when inoculated with the Mesorhizobium loti strain TONO. In these nodules, infected cells disintegrated and successively became necrotic,  [CLS] indicating premature senescence typical of Fix- mutants [CLS] . However, it formed effective nodules when inoculated with the M. loti strain MAFF303099. Among nine different M. loti strains tested, four formed ineffective nodules and five formed effective nodules"}
{"subject": "premature senescence", "sub_type": "MPA", "rel": "ThemeOf", "object": "indicating", "obj_type": "Reg", "file_name": "PubMed-29086445.json", "snippet": " which showed a very specific symbiotic phenotype. It formed ineffective nodules when inoculated with the Mesorhizobium loti strain TONO. In these nodules, infected cells disintegrated and successively became necrotic,  [CLS] indicating premature senescence [CLS]  typical of Fix- mutants. However, it formed effective nodules when inoculated with the M. loti strain MAFF303099. Among nine different M. loti strains tested, four formed ineffective nodules and"}
{"subject": "Null-mutations", "sub_type": "Var", "rel": "CauseOf", "object": "loss of function", "obj_type": "NegReg", "file_name": "PubMed-29087092.json", "snippet": " [CLS] Null-mutations which cause loss of function [CLS]  of the gene encoding filaggrin (FLG) have been strongly linked to the\ndevelopment of atopic disorders, predominantly atopic eczema/dermatitis syndrome (AEDS). Filaggrin plays a key role in\nepidermal barrier"}
{"subject": "Null-mutations", "sub_type": "Var", "rel": "CauseOf", "object": "linked", "obj_type": "Reg", "file_name": "PubMed-29087092.json", "snippet": " [CLS] Null-mutations which cause loss of function of the gene encoding filaggrin (FLG) have been strongly linked [CLS]  to the\ndevelopment of atopic disorders, predominantly atopic eczema/dermatitis syndrome (AEDS). Filaggrin plays a key role in\nepidermal barrier function by upholding epidermal structure and moisturization. Up to now,"}
{"subject": "atopic eczema/dermatitis syndrome", "sub_type": "Disease", "rel": "ThemeOf", "object": "linked", "obj_type": "Reg", "file_name": "PubMed-29087092.json", "snippet": " [CLS] linked to the\ndevelopment of atopic disorders, predominantly atopic eczema/dermatitis syndrome [CLS]  (AEDS). Filaggrin plays a key role in\nepidermal barrier function by upholding epidermal structure and moisturization. Up to now, around 40 variants of FLG null-mutations\nhave been genotyped among"}
{"subject": "FLG", "sub_type": "Gene", "rel": "ThemeOf", "object": "null-mutations", "obj_type": "Var", "file_name": "PubMed-29087092.json", "snippet": " related to atopic and non-atopic skin disorders due to their defect of epidermal\nbarrier function, which allows greater skin penetration of various hazards. Epidemiological studies indicate an association\nof  [CLS] FLG null-mutations [CLS]  with AEDS, whereas results regarding an association of FLG null-mutations with sensitization to\ncommon inhalant allergens and development of rhinitis and asthma are incoherent. A study conducted in Croatia"}
{"subject": "null-mutations", "sub_type": "Var", "rel": "CauseOf", "object": "association", "obj_type": "Interaction", "file_name": "PubMed-29087092.json", "snippet": " skin symptoms related to atopic and non-atopic skin disorders due to their defect of epidermal\nbarrier function, which allows greater skin penetration of various hazards. Epidemiological studies indicate an  [CLS] association\nof FLG null-mutations [CLS]  with AEDS, whereas results regarding an association of FLG null-mutations with sensitization to\ncommon inhalant allergens and development of rhinitis and asthma are incoherent. A study conducted in Croatia"}
{"subject": "AEDS", "sub_type": "Disease", "rel": "ThemeOf", "object": "association", "obj_type": "Interaction", "file_name": "PubMed-29087092.json", "snippet": " skin symptoms related to atopic and non-atopic skin disorders due to their defect of epidermal\nbarrier function, which allows greater skin penetration of various hazards. Epidemiological studies indicate an  [CLS] association\nof FLG null-mutations with AEDS [CLS] , whereas results regarding an association of FLG null-mutations with sensitization to\ncommon inhalant allergens and development of rhinitis and asthma are incoherent. A study conducted in Croatia found a"}
{"subject": "FLG", "sub_type": "Gene", "rel": "ThemeOf", "object": "null-mutation", "obj_type": "Var", "file_name": "PubMed-29087092.json", "snippet": " the most common null-mutations.\nEpidemiological studies conducted in Europe indicate a latitude dependent distribution of common FLG null-mutations\nwith a decreasing north-south gradient of R501X and 2282del4 mutation frequencies.  [CLS] FLG null-mutation [CLS]  carriers are prone\nto develop unspecific skin symptoms related to atopic and non-atopic skin disorders due to their defect of epidermal\nbarrier function, which allows greater skin penetration of"}
{"subject": "null-mutation", "sub_type": "Var", "rel": "CauseOf", "object": "develop", "obj_type": "PosReg", "file_name": "PubMed-29087092.json", "snippet": " most common null-mutations.\nEpidemiological studies conducted in Europe indicate a latitude dependent distribution of common FLG null-mutations\nwith a decreasing north-south gradient of R501X and 2282del4 mutation frequencies. FLG  [CLS] null-mutation carriers are prone\nto develop [CLS]  unspecific skin symptoms related to atopic and non-atopic skin disorders due to their defect of epidermal\nbarrier function, which allows greater skin penetration of various hazards. Epidemiological studies indicate"}
{"subject": "unspecific skin symptoms", "sub_type": "Disease", "rel": "ThemeOf", "object": "develop", "obj_type": "PosReg", "file_name": "PubMed-29087092.json", "snippet": " conducted in Europe indicate a latitude dependent distribution of common FLG null-mutations\nwith a decreasing north-south gradient of R501X and 2282del4 mutation frequencies. FLG null-mutation carriers are prone\nto  [CLS] develop unspecific skin symptoms [CLS]  related to atopic and non-atopic skin disorders due to their defect of epidermal\nbarrier function, which allows greater skin penetration of various hazards. Epidemiological studies indicate an association\nof"}
{"subject": "FLG", "sub_type": "Gene", "rel": "ThemeOf", "object": "Null-mutations", "obj_type": "Var", "file_name": "PubMed-29087092.json", "snippet": " [CLS] Null-mutations which cause loss of function of the gene encoding filaggrin (FLG [CLS] ) have been strongly linked to the\ndevelopment of atopic disorders, predominantly atopic eczema/dermatitis syndrome (AEDS). Filaggrin plays a key role in\nepidermal barrier function by upholding epidermal structure and"}
{"subject": "Deleting", "sub_type": "Var", "rel": "CauseOf", "object": "impaired", "obj_type": "NegReg", "file_name": "PubMed-29097598.json", "snippet": " has been proposed as a core factor in the etiology of many neurological diseases. We found that excessive glutamate transmission upregulated mRNA expression of Fgfrs and their ligands Fgfs  [CLS] Deleting Fgfr1/2/3 not only impaired [CLS]  bSC dendritogenesis but also abolished glutamate transmission-induced dendritic overgrowth. Overexpressing FGF9 or FGF10 in cortical glutamatergic neurons results in excessive dendritic outgrowth within 24 h, resembling the changes induced"}
{"subject": "bSC dendritogenesis", "sub_type": "MPA", "rel": "ThemeOf", "object": "impaired", "obj_type": "NegReg", "file_name": "PubMed-29097598.json", "snippet": " a core factor in the etiology of many neurological diseases. We found that excessive glutamate transmission upregulated mRNA expression of Fgfrs and their ligands Fgfs Deleting Fgfr1/2/3 not only  [CLS] impaired bSC dendritogenesis [CLS]  but also abolished glutamate transmission-induced dendritic overgrowth. Overexpressing FGF9 or FGF10 in cortical glutamatergic neurons results in excessive dendritic outgrowth within 24 h, resembling the changes induced by excessive"}
{"subject": "Deleting", "sub_type": "Var", "rel": "CauseOf", "object": "abolished", "obj_type": "NegReg", "file_name": "PubMed-29097598.json", "snippet": " has been proposed as a core factor in the etiology of many neurological diseases. We found that excessive glutamate transmission upregulated mRNA expression of Fgfrs and their ligands Fgfs  [CLS] Deleting Fgfr1/2/3 not only impaired bSC dendritogenesis but also abolished [CLS]  glutamate transmission-induced dendritic overgrowth. Overexpressing FGF9 or FGF10 in cortical glutamatergic neurons results in excessive dendritic outgrowth within 24 h, resembling the changes induced by excessive glutamate transmission. Our"}
{"subject": "glutamate transmission-induced dendritic overgrowth", "sub_type": "MPA", "rel": "ThemeOf", "object": "abolished", "obj_type": "NegReg", "file_name": "PubMed-29097598.json", "snippet": " etiology of many neurological diseases. We found that excessive glutamate transmission upregulated mRNA expression of Fgfrs and their ligands Fgfs Deleting Fgfr1/2/3 not only impaired bSC dendritogenesis but also  [CLS] abolished glutamate transmission-induced dendritic overgrowth [CLS] . Overexpressing FGF9 or FGF10 in cortical glutamatergic neurons results in excessive dendritic outgrowth within 24 h, resembling the changes induced by excessive glutamate transmission. Our findings provide strong evidence"}
{"subject": "Fgfr1/2/3", "sub_type": "Gene", "rel": "ThemeOf", "object": "Deleting", "obj_type": "Var", "file_name": "PubMed-29097598.json", "snippet": " has been proposed as a core factor in the etiology of many neurological diseases. We found that excessive glutamate transmission upregulated mRNA expression of Fgfrs and their ligands Fgfs  [CLS] Deleting Fgfr1/2/3 [CLS]  not only impaired bSC dendritogenesis but also abolished glutamate transmission-induced dendritic overgrowth. Overexpressing FGF9 or FGF10 in cortical glutamatergic neurons results in excessive dendritic outgrowth within 24 h, resembling"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "regulates", "obj_type": "Reg", "file_name": "PubMed-29099487.json", "snippet": " ~50-60% of human cancers. About 90% of these mutations encode missense mutant proteins that span ~190 different codons localized in the DNA-binding domain of the gene and protein. These  [CLS] mutations produce a protein with a reduced capacity to bind to a specific DNA sequence that regulates [CLS]  the p53 transcriptional pathway. Eight of these mutations are localized in codons that account for ~28% of the total p53 mutations and these alleles appear to be selected for"}
{"subject": "p53 transcriptional pathway", "sub_type": "Pathway", "rel": "ThemeOf", "object": "regulates", "obj_type": "Reg", "file_name": "PubMed-29099487.json", "snippet": " different codons localized in the DNA-binding domain of the gene and protein. These mutations produce a protein with a reduced capacity to bind to a specific DNA sequence that  [CLS] regulates the p53 transcriptional pathway [CLS] . Eight of these mutations are localized in codons that account for ~28% of the total p53 mutations and these alleles appear to be selected for preferentially in human cancers"}
{"subject": "mutant", "sub_type": "Var", "rel": "CauseOf", "object": "altered", "obj_type": "Reg", "file_name": "PubMed-29099487.json", "snippet": " tissue types. This article explores the question 'Why are there hotspot mutations in the p53 gene in human cancers?' Four possible reasons for this are considered; (1) the hotspot  [CLS] mutant alleles produce a protein that has a highly altered [CLS]  structure, (2) environmental mutagens produce allele-specific changes in the p53 gene, (3) these mutations arise at selected sites in the gene due to a specific DNA sequence, such as"}
{"subject": "structure", "sub_type": "MPA", "rel": "ThemeOf", "object": "altered", "obj_type": "Reg", "file_name": "PubMed-29099487.json", "snippet": " there hotspot mutations in the p53 gene in human cancers?' Four possible reasons for this are considered; (1) the hotspot mutant alleles produce a protein that has a highly  [CLS] altered structure [CLS] , (2) environmental mutagens produce allele-specific changes in the p53 gene, (3) these mutations arise at selected sites in the gene due to a specific DNA sequence, such as a"}
{"subject": "mutant", "sub_type": "Var", "rel": "CauseOf", "object": "gain of function", "obj_type": "PosReg", "file_name": "PubMed-29099487.json", "snippet": " higher mutation rate changing C to T nucleotides, (4) along with the observed change in mutant p53 proteins, which produce a loss of function (DNA binding and transcription), some  [CLS] mutant proteins have an allele-specific gain of function [CLS]  that promotes cancer. Evidence is presented that demonstrates the first three possibilities all contribute some property to this list of hotspot mutations. The fourth possibility remains to be tested."}
{"subject": "cancer", "sub_type": "Disease", "rel": "ThemeOf", "object": "gain of function", "obj_type": "PosReg", "file_name": "PubMed-29099487.json", "snippet": " to T nucleotides, (4) along with the observed change in mutant p53 proteins, which produce a loss of function (DNA binding and transcription), some mutant proteins have an allele-specific  [CLS] gain of function that promotes cancer [CLS] . Evidence is presented that demonstrates the first three possibilities all contribute some property to this list of hotspot mutations. The fourth possibility remains to be tested."}
{"subject": "proteins", "sub_type": "Protein", "rel": "ThemeOf", "object": "mutant", "obj_type": "Var", "file_name": "PubMed-29099487.json", "snippet": " higher mutation rate changing C to T nucleotides, (4) along with the observed change in mutant p53 proteins, which produce a loss of function (DNA binding and transcription), some  [CLS] mutant proteins [CLS]  have an allele-specific gain of function that promotes cancer. Evidence is presented that demonstrates the first three possibilities all contribute some property to this list of hotspot mutations. The"}
{"subject": "Mutant", "sub_type": "Var", "rel": "CauseOf", "object": "changes", "obj_type": "Reg", "file_name": "PubMed-29099488.json", "snippet": " [CLS] Mutant p53 proteins impart changes [CLS]  in cellular behavior and function through interactions with proteins that alter gene expression. The milieu of intracellular proteins available to interact with mutant p53 is context specific and changes"}
{"subject": "p53", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutant", "obj_type": "Var", "file_name": "PubMed-29099488.json", "snippet": " alter gene expression. The milieu of intracellular proteins available to interact with mutant p53 is context specific and changes with disease, cell type, and environmental conditions. Varying conformations of  [CLS] mutant p53 [CLS]  largely dictate protein-protein interactions as different point mutations within protein-coding regions greatly alter the extent and array of gain-of-function (GOF) activities. Given such variables, how can knowledge regarding p53"}
{"subject": "mutant", "sub_type": "Var", "rel": "CauseOf", "object": "activation", "obj_type": "PosReg", "file_name": "PubMed-29099488.json", "snippet": " regarding mutant p53 functions within certain disease contexts be harnessed to blunt or ablate mutant p53 GOF for therapy? In this article, we review known proteins that interact with  [CLS] mutant p53 and result in the activation [CLS]  of genes that contribute to p53 GOF with particular emphasis on context dependency and an evolving appreciation of GOF mechanisms."}
{"subject": "genes", "sub_type": "Gene", "rel": "ThemeOf", "object": "activation", "obj_type": "PosReg", "file_name": "PubMed-29099488.json", "snippet": " disease contexts be harnessed to blunt or ablate mutant p53 GOF for therapy? In this article, we review known proteins that interact with mutant p53 and result in the  [CLS] activation of genes [CLS]  that contribute to p53 GOF with particular emphasis on context dependency and an evolving appreciation of GOF mechanisms."}
{"subject": "p53", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutant", "obj_type": "Var", "file_name": "PubMed-29099488.json", "snippet": " regarding mutant p53 functions within certain disease contexts be harnessed to blunt or ablate mutant p53 GOF for therapy? In this article, we review known proteins that interact with  [CLS] mutant p53 [CLS]  and result in the activation of genes that contribute to p53 GOF with particular emphasis on context dependency and an evolving appreciation of GOF mechanisms."}
{"subject": "cellular behavior", "sub_type": "MPA", "rel": "ThemeOf", "object": "changes", "obj_type": "Reg", "file_name": "PubMed-29099488.json", "snippet": " [CLS] changes in cellular behavior [CLS]  and function through interactions with proteins that alter gene expression. The milieu of intracellular proteins available to interact with mutant p53 is context specific and changes with disease, cell"}
{"subject": "function", "sub_type": "MPA", "rel": "ThemeOf", "object": "changes", "obj_type": "Reg", "file_name": "PubMed-29099488.json", "snippet": " [CLS] changes in cellular behavior and function [CLS]  through interactions with proteins that alter gene expression. The milieu of intracellular proteins available to interact with mutant p53 is context specific and changes with disease, cell type, and"}
{"subject": "Mutant", "sub_type": "Var", "rel": "CauseOf", "object": "interactions", "obj_type": "Interaction", "file_name": "PubMed-29099488.json", "snippet": " [CLS] Mutant p53 proteins impart changes in cellular behavior and function through interactions [CLS]  with proteins that alter gene expression. The milieu of intracellular proteins available to interact with mutant p53 is context specific and changes with disease, cell type, and environmental conditions."}
{"subject": "proteins", "sub_type": "Protein", "rel": "ThemeOf", "object": "interactions", "obj_type": "Interaction", "file_name": "PubMed-29099488.json", "snippet": " [CLS] interactions with proteins [CLS]  that alter gene expression. The milieu of intracellular proteins available to interact with mutant p53 is context specific and changes with disease, cell type, and environmental conditions. Varying conformations"}
{"subject": "p53", "sub_type": "Gene", "rel": "ThemeOf", "object": "Mutant", "obj_type": "Var", "file_name": "PubMed-29099488.json", "snippet": " [CLS] Mutant p53 [CLS]  proteins impart changes in cellular behavior and function through interactions with proteins that alter gene expression. The milieu of intracellular proteins available to interact with mutant p53 is context"}
{"subject": "proteins", "sub_type": "Protein", "rel": "ThemeOf", "object": "p53", "obj_type": "Gene", "file_name": "PubMed-29099488.json", "snippet": " [CLS] p53 proteins [CLS]  impart changes in cellular behavior and function through interactions with proteins that alter gene expression. The milieu of intracellular proteins available to interact with mutant p53 is context specific"}
{"subject": "mutant", "sub_type": "Var", "rel": "CauseOf", "object": "dictate", "obj_type": "Reg", "file_name": "PubMed-29099488.json", "snippet": " alter gene expression. The milieu of intracellular proteins available to interact with mutant p53 is context specific and changes with disease, cell type, and environmental conditions. Varying conformations of  [CLS] mutant p53 largely dictate [CLS]  protein-protein interactions as different point mutations within protein-coding regions greatly alter the extent and array of gain-of-function (GOF) activities. Given such variables, how can knowledge regarding p53 missense mutations"}
{"subject": "protein-protein interactions", "sub_type": "MPA", "rel": "ThemeOf", "object": "dictate", "obj_type": "Reg", "file_name": "PubMed-29099488.json", "snippet": " The milieu of intracellular proteins available to interact with mutant p53 is context specific and changes with disease, cell type, and environmental conditions. Varying conformations of mutant p53 largely  [CLS] dictate protein-protein interactions [CLS]  as different point mutations within protein-coding regions greatly alter the extent and array of gain-of-function (GOF) activities. Given such variables, how can knowledge regarding p53 missense mutations be translated"}
{"subject": "MTOR", "sub_type": "Gene", "rel": "ThemeOf", "object": "variant", "obj_type": "Var", "file_name": "PubMed-29118224.json", "snippet": " missense mutation in MTOR (p.Y1974H). The MTOR mutation was present in all tumor regions, with similar allele frequency as the VHL mutation, and in vitro functional assessment of the  [CLS] MTOR variant [CLS]  demonstrated that it increased mTORC1 activity. Consistently, immunohistochemistry in the tumor samples demonstrated increased levels of phospho-S6. In conclusion, multiregion WES identified a novel MTOR mutation acquired early during"}
{"subject": "variant", "sub_type": "Var", "rel": "CauseOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-29118224.json", "snippet": " mutation in MTOR (p.Y1974H). The MTOR mutation was present in all tumor regions, with similar allele frequency as the VHL mutation, and in vitro functional assessment of the MTOR  [CLS] variant demonstrated that it increased [CLS]  mTORC1 activity. Consistently, immunohistochemistry in the tumor samples demonstrated increased levels of phospho-S6. In conclusion, multiregion WES identified a novel MTOR mutation acquired early during tumor development as the"}
{"subject": "mTORC1 activity", "sub_type": "MPA", "rel": "ThemeOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-29118224.json", "snippet": " The MTOR mutation was present in all tumor regions, with similar allele frequency as the VHL mutation, and in vitro functional assessment of the MTOR variant demonstrated that it  [CLS] increased mTORC1 activity [CLS] . Consistently, immunohistochemistry in the tumor samples demonstrated increased levels of phospho-S6. In conclusion, multiregion WES identified a novel MTOR mutation acquired early during tumor development as the event leading"}
{"subject": "MTOR", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutation", "obj_type": "Var", "file_name": "PubMed-29118224.json", "snippet": " assessment of the MTOR variant demonstrated that it increased mTORC1 activity. Consistently, immunohistochemistry in the tumor samples demonstrated increased levels of phospho-S6. In conclusion, multiregion WES identified a novel  [CLS] MTOR mutation [CLS]  acquired early during tumor development as the event leading to a high sensitivity to temsirolimus treatment. This study supports tumor multiregion sequencing to detect truncal mutations in the mTOR"}
{"subject": "mutation", "sub_type": "Var", "rel": "CauseOf", "object": "leading to", "obj_type": "Reg", "file_name": "PubMed-29118224.json", "snippet": " of the MTOR variant demonstrated that it increased mTORC1 activity. Consistently, immunohistochemistry in the tumor samples demonstrated increased levels of phospho-S6. In conclusion, multiregion WES identified a novel MTOR  [CLS] mutation acquired early during tumor development as the event leading to [CLS]  a high sensitivity to temsirolimus treatment. This study supports tumor multiregion sequencing to detect truncal mutations in the mTOR pathway to identify patients sensitive to mTOR inhibitors."}
{"subject": "high sensitivity to temsirolimus treatment", "sub_type": "MPA", "rel": "ThemeOf", "object": "leading to", "obj_type": "Reg", "file_name": "PubMed-29118224.json", "snippet": " activity. Consistently, immunohistochemistry in the tumor samples demonstrated increased levels of phospho-S6. In conclusion, multiregion WES identified a novel MTOR mutation acquired early during tumor development as the event  [CLS] leading to a high sensitivity to temsirolimus treatment [CLS] . This study supports tumor multiregion sequencing to detect truncal mutations in the mTOR pathway to identify patients sensitive to mTOR inhibitors."}
{"subject": "frameshift mutations", "sub_type": "Var", "rel": "CauseOf", "object": "associated", "obj_type": "Reg", "file_name": "PubMed-29121062.json", "snippet": " JAK family kinases (JAK1/2/3, TYK2). We used The Cancer Genome Atlas and Cancer Cell Line Encyclopedia data to confirm and extend our findings by analyzing gene expression patterns. Recurrent  [CLS] frameshift mutations in JAK1 were associated [CLS]  with high mutation burden and microsatellite instability. These mutations occurred in multiple tumor types including endometrial, colorectal, stomach, and prostate carcinomas. Analyzing gene expression signatures in endometrial and stomach"}
{"subject": "colorectal", "sub_type": "Disease", "rel": "ThemeOf", "object": "carcinomas", "obj_type": "Disease", "file_name": "PubMed-29121062.json", "snippet": " findings by analyzing gene expression patterns. Recurrent frameshift mutations in JAK1 were associated with high mutation burden and microsatellite instability. These mutations occurred in multiple tumor types including endometrial,  [CLS] colorectal, stomach, and prostate carcinomas [CLS] . Analyzing gene expression signatures in endometrial and stomach adenocarcinomas revealed that tumors with a JAK1 frameshift exhibited reduced expression of interferon response signatures and multiple anti-tumor immune signatures. Importantly,"}
{"subject": "stomach", "sub_type": "Disease", "rel": "ThemeOf", "object": "carcinomas", "obj_type": "Disease", "file_name": "PubMed-29121062.json", "snippet": " by analyzing gene expression patterns. Recurrent frameshift mutations in JAK1 were associated with high mutation burden and microsatellite instability. These mutations occurred in multiple tumor types including endometrial, colorectal,  [CLS] stomach, and prostate carcinomas [CLS] . Analyzing gene expression signatures in endometrial and stomach adenocarcinomas revealed that tumors with a JAK1 frameshift exhibited reduced expression of interferon response signatures and multiple anti-tumor immune signatures. Importantly,"}
{"subject": "prostate", "sub_type": "Disease", "rel": "ThemeOf", "object": "carcinomas", "obj_type": "Disease", "file_name": "PubMed-29121062.json", "snippet": " gene expression patterns. Recurrent frameshift mutations in JAK1 were associated with high mutation burden and microsatellite instability. These mutations occurred in multiple tumor types including endometrial, colorectal, stomach, and  [CLS] prostate carcinomas [CLS] . Analyzing gene expression signatures in endometrial and stomach adenocarcinomas revealed that tumors with a JAK1 frameshift exhibited reduced expression of interferon response signatures and multiple anti-tumor immune signatures. Importantly,"}
{"subject": "JAK1", "sub_type": "Gene", "rel": "ThemeOf", "object": "frameshift mutations", "obj_type": "Var", "file_name": "PubMed-29121062.json", "snippet": " JAK family kinases (JAK1/2/3, TYK2). We used The Cancer Genome Atlas and Cancer Cell Line Encyclopedia data to confirm and extend our findings by analyzing gene expression patterns. Recurrent  [CLS] frameshift mutations in JAK1 [CLS]  were associated with high mutation burden and microsatellite instability. These mutations occurred in multiple tumor types including endometrial, colorectal, stomach, and prostate carcinomas. Analyzing gene expression signatures in endometrial"}
{"subject": "high mutation burden", "sub_type": "MPA", "rel": "ThemeOf", "object": "frameshift mutations", "obj_type": "Var", "file_name": "PubMed-29121062.json", "snippet": " JAK family kinases (JAK1/2/3, TYK2). We used The Cancer Genome Atlas and Cancer Cell Line Encyclopedia data to confirm and extend our findings by analyzing gene expression patterns. Recurrent  [CLS] frameshift mutations in JAK1 were associated with high mutation burden [CLS]  and microsatellite instability. These mutations occurred in multiple tumor types including endometrial, colorectal, stomach, and prostate carcinomas. Analyzing gene expression signatures in endometrial and stomach adenocarcinomas revealed that tumors"}
{"subject": "microsatellite instability", "sub_type": "MPA", "rel": "ThemeOf", "object": "frameshift mutations", "obj_type": "Var", "file_name": "PubMed-29121062.json", "snippet": " JAK family kinases (JAK1/2/3, TYK2). We used The Cancer Genome Atlas and Cancer Cell Line Encyclopedia data to confirm and extend our findings by analyzing gene expression patterns. Recurrent  [CLS] frameshift mutations in JAK1 were associated with high mutation burden and microsatellite instability [CLS] . These mutations occurred in multiple tumor types including endometrial, colorectal, stomach, and prostate carcinomas. Analyzing gene expression signatures in endometrial and stomach adenocarcinomas revealed that tumors with a JAK1"}
{"subject": "JAK1", "sub_type": "Var", "rel": "CauseOf", "object": "loss of function", "obj_type": "NegReg", "file_name": "PubMed-29121062.json", "snippet": " primary conclusions: 1) JAK1 frameshifts are loss of function alterations that represent a potential pan-cancer adaptation to immune responses against tumors with microsatellite instability; 2) The mechanism by which  [CLS] JAK1 loss of function [CLS]  contributes to tumor immune evasion is likely associated with loss of the JAK1-mediated interferon response."}
{"subject": "tumor immune evasion", "sub_type": "MPA", "rel": "ThemeOf", "object": "loss of function", "obj_type": "NegReg", "file_name": "PubMed-29121062.json", "snippet": " conclusions: 1) JAK1 frameshifts are loss of function alterations that represent a potential pan-cancer adaptation to immune responses against tumors with microsatellite instability; 2) The mechanism by which JAK1  [CLS] loss of function contributes to tumor immune evasion [CLS]  is likely associated with loss of the JAK1-mediated interferon response."}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "occurred", "obj_type": "Reg", "file_name": "PubMed-29121062.json", "snippet": " Line Encyclopedia data to confirm and extend our findings by analyzing gene expression patterns. Recurrent frameshift mutations in JAK1 were associated with high mutation burden and microsatellite instability. These  [CLS] mutations occurred [CLS]  in multiple tumor types including endometrial, colorectal, stomach, and prostate carcinomas. Analyzing gene expression signatures in endometrial and stomach adenocarcinomas revealed that tumors with a JAK1 frameshift exhibited reduced"}
{"subject": "carcinomas", "sub_type": "Disease", "rel": "ThemeOf", "object": "occurred", "obj_type": "Reg", "file_name": "PubMed-29121062.json", "snippet": " Encyclopedia data to confirm and extend our findings by analyzing gene expression patterns. Recurrent frameshift mutations in JAK1 were associated with high mutation burden and microsatellite instability. These mutations  [CLS] occurred in multiple tumor types including endometrial, colorectal, stomach, and prostate carcinomas [CLS] . Analyzing gene expression signatures in endometrial and stomach adenocarcinomas revealed that tumors with a JAK1 frameshift exhibited reduced expression of interferon response signatures and multiple anti-tumor immune signatures. Importantly,"}
{"subject": "endometrial", "sub_type": "Disease", "rel": "ThemeOf", "object": "carcinomas", "obj_type": "Disease", "file_name": "PubMed-29121062.json", "snippet": " our findings by analyzing gene expression patterns. Recurrent frameshift mutations in JAK1 were associated with high mutation burden and microsatellite instability. These mutations occurred in multiple tumor types including  [CLS] endometrial, colorectal, stomach, and prostate carcinomas [CLS] . Analyzing gene expression signatures in endometrial and stomach adenocarcinomas revealed that tumors with a JAK1 frameshift exhibited reduced expression of interferon response signatures and multiple anti-tumor immune signatures. Importantly,"}
{"subject": "mutation", "sub_type": "Var", "rel": "CauseOf", "object": "Gain of function", "obj_type": "PosReg", "file_name": "PubMed-29124309.json", "snippet": " [CLS] Gain of function of TMEM16E/ANO5 scrambling activity caused by a mutation [CLS]  associated with gnathodiaphyseal dysplasia.\nMutations in the human TMEM16E (ANO5) gene are associated both with the bone disease gnathodiaphyseal dysplasia (GDD; OMIM: 166260) and muscle dystrophies (OMIM: 611307, 613319)."}
{"subject": "gnathodiaphyseal dysplasia", "sub_type": "Disease", "rel": "ThemeOf", "object": "Gain of function", "obj_type": "PosReg", "file_name": "PubMed-29124309.json", "snippet": " [CLS] Gain of function of TMEM16E/ANO5 scrambling activity caused by a mutation associated with gnathodiaphyseal dysplasia [CLS] .\nMutations in the human TMEM16E (ANO5) gene are associated both with the bone disease gnathodiaphyseal dysplasia (GDD; OMIM: 166260) and muscle dystrophies (OMIM: 611307, 613319). However, the physiological function"}
{"subject": "TMEM16E", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutation", "obj_type": "Var", "file_name": "PubMed-29124309.json", "snippet": " [CLS] TMEM16E/ANO5 scrambling activity caused by a mutation [CLS]  associated with gnathodiaphyseal dysplasia.\nMutations in the human TMEM16E (ANO5) gene are associated both with the bone disease gnathodiaphyseal dysplasia (GDD; OMIM: 166260) and muscle dystrophies (OMIM: 611307, 613319)."}
{"subject": "scrambling activity", "sub_type": "MPA", "rel": "ThemeOf", "object": "Gain of function", "obj_type": "PosReg", "file_name": "PubMed-29124309.json", "snippet": " [CLS] Gain of function of TMEM16E/ANO5 scrambling activity [CLS]  caused by a mutation associated with gnathodiaphyseal dysplasia.\nMutations in the human TMEM16E (ANO5) gene are associated both with the bone disease gnathodiaphyseal dysplasia (GDD; OMIM: 166260) and muscle"}
{"subject": "Mutations", "sub_type": "Var", "rel": "CauseOf", "object": "associated", "obj_type": "Reg", "file_name": "PubMed-29124309.json", "snippet": " [CLS] Mutations in the human TMEM16E (ANO5) gene are associated [CLS]  both with the bone disease gnathodiaphyseal dysplasia (GDD; OMIM: 166260) and muscle dystrophies (OMIM: 611307, 613319). However, the physiological function of TMEM16E has remained unclear. We show here that"}
{"subject": "gnathodiaphyseal dysplasia", "sub_type": "Disease", "rel": "ThemeOf", "object": "associated", "obj_type": "Reg", "file_name": "PubMed-29124309.json", "snippet": " [CLS] associated both with the bone disease gnathodiaphyseal dysplasia [CLS]  (GDD; OMIM: 166260) and muscle dystrophies (OMIM: 611307, 613319). However, the physiological function of TMEM16E has remained unclear. We show here that human TMEM16E, when overexpressed in mammalian cell"}
{"subject": "muscle dystrophies", "sub_type": "Disease", "rel": "ThemeOf", "object": "associated", "obj_type": "Reg", "file_name": "PubMed-29124309.json", "snippet": " [CLS] associated both with the bone disease gnathodiaphyseal dysplasia (GDD; OMIM: 166260) and muscle dystrophies [CLS]  (OMIM: 611307, 613319). However, the physiological function of TMEM16E has remained unclear. We show here that human TMEM16E, when overexpressed in mammalian cell lines, displayed partial plasma membrane localization"}
{"subject": "TMEM16E", "sub_type": "Gene", "rel": "ThemeOf", "object": "Mutations", "obj_type": "Var", "file_name": "PubMed-29124309.json", "snippet": " [CLS] Mutations in the human TMEM16E [CLS]  (ANO5) gene are associated both with the bone disease gnathodiaphyseal dysplasia (GDD; OMIM: 166260) and muscle dystrophies (OMIM: 611307, 613319). However, the physiological function of TMEM16E has remained unclear."}
{"subject": "gnathodiaphyseal dysplasia", "sub_type": "Disease", "rel": "CauseOf", "object": "bone disease", "obj_type": "Disease", "file_name": "PubMed-29124309.json", "snippet": " [CLS] bone disease gnathodiaphyseal dysplasia [CLS]  (GDD; OMIM: 166260) and muscle dystrophies (OMIM: 611307, 613319). However, the physiological function of TMEM16E has remained unclear. We show here that human TMEM16E, when overexpressed in mammalian cell"}
{"subject": "muscle dystrophies", "sub_type": "Disease", "rel": "CauseOf", "object": "bone disease", "obj_type": "Disease", "file_name": "PubMed-29124309.json", "snippet": " [CLS] bone disease gnathodiaphyseal dysplasia (GDD; OMIM: 166260) and muscle dystrophies [CLS]  (OMIM: 611307, 613319). However, the physiological function of TMEM16E has remained unclear. We show here that human TMEM16E, when overexpressed in mammalian cell lines, displayed partial plasma membrane localization"}
{"subject": "L. pneumophila", "sub_type": "CPA", "rel": "ThemeOf", "object": "enhanced", "obj_type": "PosReg", "file_name": "PubMed-29133401.json", "snippet": " Screen results were validated for several effector mutants displaying different virulence phenotypes using genetic complementation studies and infection assays. Specifically, loss-of-function mutations in the gene encoding LegC4 resulted in  [CLS] enhanced L. pneumophila [CLS]  in the lungs of infected mice but not within cultured host cells, which indicates LegC4 augments bacterial clearance by the host immune system. The effector proteins RavY and Lpg2505"}
{"subject": "LegC4", "sub_type": "Var", "rel": "CauseOf", "object": "augments", "obj_type": "PosReg", "file_name": "PubMed-29133401.json", "snippet": " infection assays. Specifically, loss-of-function mutations in the gene encoding LegC4 resulted in enhanced L. pneumophila in the lungs of infected mice but not within cultured host cells, which indicates  [CLS] LegC4 augments [CLS]  bacterial clearance by the host immune system. The effector proteins RavY and Lpg2505 were important for efficient replication within both mammalian and protozoan hosts. Further analysis of Lpg2505 revealed"}
{"subject": "bacterial clearance", "sub_type": "CPA", "rel": "ThemeOf", "object": "augments", "obj_type": "PosReg", "file_name": "PubMed-29133401.json", "snippet": " assays. Specifically, loss-of-function mutations in the gene encoding LegC4 resulted in enhanced L. pneumophila in the lungs of infected mice but not within cultured host cells, which indicates LegC4  [CLS] augments bacterial clearance [CLS]  by the host immune system. The effector proteins RavY and Lpg2505 were important for efficient replication within both mammalian and protozoan hosts. Further analysis of Lpg2505 revealed that this"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "Loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-29133401.json", "snippet": " sequencing technology called INSeq was used to analyze replication of a pool of effector mutants in parallel both in a mouse model of infection and in cultured host cells.  [CLS] Loss-of-function mutations [CLS]  in genes encoding effector proteins resulted in host-specific or broad virulence phenotypes. Screen results were validated for several effector mutants displaying different virulence phenotypes using genetic complementation studies and"}
{"subject": "host-specific", "sub_type": "MPA", "rel": "ThemeOf", "object": "Loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-29133401.json", "snippet": " sequencing technology called INSeq was used to analyze replication of a pool of effector mutants in parallel both in a mouse model of infection and in cultured host cells.  [CLS] Loss-of-function mutations in genes encoding effector proteins resulted in host-specific [CLS]  or broad virulence phenotypes. Screen results were validated for several effector mutants displaying different virulence phenotypes using genetic complementation studies and infection assays. Specifically, loss-of-function mutations in the gene"}
{"subject": "broad virulence phenotypes", "sub_type": "MPA", "rel": "ThemeOf", "object": "Loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-29133401.json", "snippet": " sequencing technology called INSeq was used to analyze replication of a pool of effector mutants in parallel both in a mouse model of infection and in cultured host cells.  [CLS] Loss-of-function mutations in genes encoding effector proteins resulted in host-specific or broad virulence phenotypes [CLS] . Screen results were validated for several effector mutants displaying different virulence phenotypes using genetic complementation studies and infection assays. Specifically, loss-of-function mutations in the gene encoding LegC4 resulted in"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-29133401.json", "snippet": " effector proteins resulted in host-specific or broad virulence phenotypes. Screen results were validated for several effector mutants displaying different virulence phenotypes using genetic complementation studies and infection assays. Specifically,  [CLS] loss-of-function mutations [CLS]  in the gene encoding LegC4 resulted in enhanced L. pneumophila in the lungs of infected mice but not within cultured host cells, which indicates LegC4 augments bacterial clearance by"}
{"subject": "LegC4", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-29133401.json", "snippet": " proteins resulted in host-specific or broad virulence phenotypes. Screen results were validated for several effector mutants displaying different virulence phenotypes using genetic complementation studies and infection assays. Specifically, loss-of-function  [CLS] mutations in the gene encoding LegC4 [CLS]  resulted in enhanced L. pneumophila in the lungs of infected mice but not within cultured host cells, which indicates LegC4 augments bacterial clearance by the host immune system. The"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "enhanced", "obj_type": "PosReg", "file_name": "PubMed-29133401.json", "snippet": " proteins resulted in host-specific or broad virulence phenotypes. Screen results were validated for several effector mutants displaying different virulence phenotypes using genetic complementation studies and infection assays. Specifically, loss-of-function  [CLS] mutations in the gene encoding LegC4 resulted in enhanced [CLS]  L. pneumophila in the lungs of infected mice but not within cultured host cells, which indicates LegC4 augments bacterial clearance by the host immune system. The effector proteins RavY"}
{"subject": "AKT2", "sub_type": "Gene", "rel": "ThemeOf", "object": "Variant", "obj_type": "Var", "file_name": "PubMed-29141982.json", "snippet": " [CLS] Variant in AKT2 [CLS]  Is Associated With Reduced Insulin-Mediated Glucose Uptake in Multiple Insulin-Sensitive Tissues: A Genotype-Based Callback Positron Emission Tomography Study.\nRare fully penetrant mutations in AKT2 are an established cause of"}
{"subject": "Variant", "sub_type": "Var", "rel": "CauseOf", "object": "Loss-of-Function", "obj_type": "NegReg", "file_name": "PubMed-29141982.json", "snippet": " [CLS] Loss-of-Function Variant [CLS]  in AKT2 Is Associated With Reduced Insulin-Mediated Glucose Uptake in Multiple Insulin-Sensitive Tissues: A Genotype-Based Callback Positron Emission Tomography Study.\nRare fully penetrant mutations in AKT2 are an established"}
{"subject": "Insulin-Mediated Glucose Uptake", "sub_type": "CPA", "rel": "ThemeOf", "object": "Reduced", "obj_type": "NegReg", "file_name": "PubMed-29141982.json", "snippet": " [CLS] Reduced Insulin-Mediated Glucose Uptake [CLS]  in Multiple Insulin-Sensitive Tissues: A Genotype-Based Callback Positron Emission Tomography Study.\nRare fully penetrant mutations in AKT2 are an established cause of monogenic disorders of glucose metabolism. Recently, a"}
{"subject": "insulin-mediated GU", "sub_type": "MPA", "rel": "ThemeOf", "object": "influences", "obj_type": "Reg", "file_name": "PubMed-29141982.json", "snippet": " tissues-skeletal muscle (36.4%), liver (16.1%), brown adipose (29.7%), and bone marrow (32.9%)-and increases of 16.8-19.1% in seven tested brain regions. These data demonstrate that the p.P50T substitution of AKT2  [CLS] influences insulin-mediated GU [CLS]  in multiple insulin-sensitive tissues and may explain, at least in part, the increased risk of type 2 diabetes in p.P50T/AKT2 carriers."}
{"subject": "AKT2", "sub_type": "Gene", "rel": "ThemeOf", "object": "p.P50T", "obj_type": "Var", "file_name": "PubMed-29141982.json", "snippet": " in GU in multiple tissues-skeletal muscle (36.4%), liver (16.1%), brown adipose (29.7%), and bone marrow (32.9%)-and increases of 16.8-19.1% in seven tested brain regions. These data demonstrate that the  [CLS] p.P50T substitution of AKT2 [CLS]  influences insulin-mediated GU in multiple insulin-sensitive tissues and may explain, at least in part, the increased risk of type 2 diabetes in p.P50T/AKT2 carriers."}
{"subject": "Variant", "sub_type": "Var", "rel": "CauseOf", "object": "Reduced", "obj_type": "NegReg", "file_name": "PubMed-29141982.json", "snippet": " [CLS] Variant in AKT2 Is Associated With Reduced [CLS]  Insulin-Mediated Glucose Uptake in Multiple Insulin-Sensitive Tissues: A Genotype-Based Callback Positron Emission Tomography Study.\nRare fully penetrant mutations in AKT2 are an established cause of monogenic disorders of glucose"}
{"subject": "p.P50T", "sub_type": "Var", "rel": "CauseOf", "object": "influences", "obj_type": "Reg", "file_name": "PubMed-29141982.json", "snippet": " in GU in multiple tissues-skeletal muscle (36.4%), liver (16.1%), brown adipose (29.7%), and bone marrow (32.9%)-and increases of 16.8-19.1% in seven tested brain regions. These data demonstrate that the  [CLS] p.P50T substitution of AKT2 influences [CLS]  insulin-mediated GU in multiple insulin-sensitive tissues and may explain, at least in part, the increased risk of type 2 diabetes in p.P50T/AKT2 carriers."}
{"subject": "TBK1", "sub_type": "Gene", "rel": "ThemeOf", "object": "variants", "obj_type": "Var", "file_name": "PubMed-29146049.json", "snippet": " [CLS] TBK1 variants [CLS]  in early-onset Alzheimer disease in a European cohort.\nTANK-binding kinase 1 (TBK1) loss-of-function (LoF) mutations are known to cause frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS), often combined"}
{"subject": "early-onset Alzheimer disease", "sub_type": "Disease", "rel": "ThemeOf", "object": "in", "obj_type": "Reg", "file_name": "PubMed-29146049.json", "snippet": " [CLS] in early-onset Alzheimer disease [CLS]  in a European cohort.\nTANK-binding kinase 1 (TBK1) loss-of-function (LoF) mutations are known to cause frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS), often combined with memory deficits early"}
{"subject": "TBK1", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-29146049.json", "snippet": " [CLS] TBK1) loss-of-function (LoF) mutations [CLS]  are known to cause frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS), often combined with memory deficits early in the disease course. We performed targeted resequencing of TBK1 in"}
{"subject": "frontotemporal dementia", "sub_type": "Disease", "rel": "ThemeOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-29146049.json", "snippet": " [CLS] loss-of-function (LoF) mutations are known to cause frontotemporal dementia [CLS]  (FTD) and amyotrophic lateral sclerosis (ALS), often combined with memory deficits early in the disease course. We performed targeted resequencing of TBK1 in 1253 early onset Alzheimer's disease (EOAD)"}
{"subject": "amyotrophic lateral sclerosis", "sub_type": "Disease", "rel": "ThemeOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-29146049.json", "snippet": " [CLS] loss-of-function (LoF) mutations are known to cause frontotemporal dementia (FTD) and amyotrophic lateral sclerosis [CLS]  (ALS), often combined with memory deficits early in the disease course. We performed targeted resequencing of TBK1 in 1253 early onset Alzheimer's disease (EOAD) patients from 8 European countries"}
{"subject": "variants", "sub_type": "Var", "rel": "CauseOf", "object": "in", "obj_type": "Reg", "file_name": "PubMed-29146049.json", "snippet": " [CLS] variants in [CLS]  early-onset Alzheimer disease in a European cohort.\nTANK-binding kinase 1 (TBK1) loss-of-function (LoF) mutations are known to cause frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS), often combined with"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-29146049.json", "snippet": " [CLS] loss-of-function (LoF) mutations [CLS]  are known to cause frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS), often combined with memory deficits early in the disease course. We performed targeted resequencing of TBK1 in"}
{"subject": "NLRP1", "sub_type": "Gene", "rel": "ThemeOf", "object": "variants", "obj_type": "Var", "file_name": "PubMed-29154202.json", "snippet": " hypothesize that inflammasome genetics could contribute to the development of asthma. Selected functional polymorphisms in inflammasome genes are evaluated in a cohort of asthmatic children and their families. Gain-of-function  [CLS] NLRP1 variants [CLS]  rs11651270, rs12150220 and rs2670660 resulted significantly associated to asthma in trios (TDT) analysis; and rs11651270 and rs2670660 also with asthma severity and total IgE level in asthmatic children. NLRP1"}
{"subject": "rs11651270", "sub_type": "Var", "rel": "CauseOf", "object": "with", "obj_type": "Reg", "file_name": "PubMed-29154202.json", "snippet": " genes are evaluated in a cohort of asthmatic children and their families. Gain-of-function NLRP1 variants rs11651270, rs12150220 and rs2670660 resulted significantly associated to asthma in trios (TDT) analysis; and  [CLS] rs11651270 and rs2670660 also with [CLS]  asthma severity and total IgE level in asthmatic children. NLRP1 activators in humans are still unknown, however we hypothesized that individuals with gain-of-function SNPs in NLRP1 could be more"}
{"subject": "rs2670660", "sub_type": "Var", "rel": "CauseOf", "object": "with", "obj_type": "Reg", "file_name": "PubMed-29154202.json", "snippet": " evaluated in a cohort of asthmatic children and their families. Gain-of-function NLRP1 variants rs11651270, rs12150220 and rs2670660 resulted significantly associated to asthma in trios (TDT) analysis; and rs11651270 and  [CLS] rs2670660 also with [CLS]  asthma severity and total IgE level in asthmatic children. NLRP1 activators in humans are still unknown, however we hypothesized that individuals with gain-of-function SNPs in NLRP1 could be more"}
{"subject": "IgE level", "sub_type": "MPA", "rel": "ThemeOf", "object": "with", "obj_type": "Reg", "file_name": "PubMed-29154202.json", "snippet": " a cohort of asthmatic children and their families. Gain-of-function NLRP1 variants rs11651270, rs12150220 and rs2670660 resulted significantly associated to asthma in trios (TDT) analysis; and rs11651270 and rs2670660 also  [CLS] with asthma severity and total IgE level [CLS]  in asthmatic children. NLRP1 activators in humans are still unknown, however we hypothesized that individuals with gain-of-function SNPs in NLRP1 could be more prone in activating inflammasome in the"}
{"subject": "asthma", "sub_type": "Disease", "rel": "ThemeOf", "object": "with", "obj_type": "Reg", "file_name": "PubMed-29154202.json", "snippet": " a cohort of asthmatic children and their families. Gain-of-function NLRP1 variants rs11651270, rs12150220 and rs2670660 resulted significantly associated to asthma in trios (TDT) analysis; and rs11651270 and rs2670660 also  [CLS] with asthma [CLS]  severity and total IgE level in asthmatic children. NLRP1 activators in humans are still unknown, however we hypothesized that individuals with gain-of-function SNPs in NLRP1 could be more prone"}
{"subject": "SNPs", "sub_type": "Var", "rel": "CauseOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-29154202.json", "snippet": " analysis; and rs11651270 and rs2670660 also with asthma severity and total IgE level in asthmatic children. NLRP1 activators in humans are still unknown, however we hypothesized that individuals with  [CLS] gain-of-function SNPs [CLS]  in NLRP1 could be more prone in activating inflammasome in the presence of asthma-related cell stressors (i.e. ER stress or ROS), and this activation contribute to exacerbate inflammatory response"}
{"subject": "NLRP1", "sub_type": "Gene", "rel": "ThemeOf", "object": "SNPs", "obj_type": "Var", "file_name": "PubMed-29154202.json", "snippet": " and rs11651270 and rs2670660 also with asthma severity and total IgE level in asthmatic children. NLRP1 activators in humans are still unknown, however we hypothesized that individuals with gain-of-function  [CLS] SNPs in NLRP1 [CLS]  could be more prone in activating inflammasome in the presence of asthma-related cell stressors (i.e. ER stress or ROS), and this activation contribute to exacerbate inflammatory response and asthma"}
{"subject": "activating inflammasome", "sub_type": "MPA", "rel": "ThemeOf", "object": "prone", "obj_type": "PosReg", "file_name": "PubMed-29154202.json", "snippet": " asthma severity and total IgE level in asthmatic children. NLRP1 activators in humans are still unknown, however we hypothesized that individuals with gain-of-function SNPs in NLRP1 could be more  [CLS] prone in activating inflammasome [CLS]  in the presence of asthma-related cell stressors (i.e. ER stress or ROS), and this activation contribute to exacerbate inflammatory response and asthma development. Gain-of-function IL1A rs17561 resulted significantly associated"}
{"subject": "SNPs", "sub_type": "Var", "rel": "CauseOf", "object": "prone", "obj_type": "PosReg", "file_name": "PubMed-29154202.json", "snippet": " and rs11651270 and rs2670660 also with asthma severity and total IgE level in asthmatic children. NLRP1 activators in humans are still unknown, however we hypothesized that individuals with gain-of-function  [CLS] SNPs in NLRP1 could be more prone [CLS]  in activating inflammasome in the presence of asthma-related cell stressors (i.e. ER stress or ROS), and this activation contribute to exacerbate inflammatory response and asthma development. Gain-of-function IL1A rs17561"}
{"subject": "SNPs", "sub_type": "Var", "rel": "CauseOf", "object": "exacerbate", "obj_type": "PosReg", "file_name": "PubMed-29154202.json", "snippet": " and rs11651270 and rs2670660 also with asthma severity and total IgE level in asthmatic children. NLRP1 activators in humans are still unknown, however we hypothesized that individuals with gain-of-function  [CLS] SNPs in NLRP1 could be more prone in activating inflammasome in the presence of asthma-related cell stressors (i.e. ER stress or ROS), and this activation contribute to exacerbate [CLS]  inflammatory response and asthma development. Gain-of-function IL1A rs17561 resulted significantly associated with a reduced pulmonary capacity in asthmatic children. IL18 rs5744256 which lead to lower serum level of IL-18"}
{"subject": "NLRP1", "sub_type": "Gene", "rel": "ThemeOf", "object": "rs11651270", "obj_type": "Var", "file_name": "PubMed-29154202.json", "snippet": " hypothesize that inflammasome genetics could contribute to the development of asthma. Selected functional polymorphisms in inflammasome genes are evaluated in a cohort of asthmatic children and their families. Gain-of-function  [CLS] NLRP1 variants rs11651270 [CLS] , rs12150220 and rs2670660 resulted significantly associated to asthma in trios (TDT) analysis; and rs11651270 and rs2670660 also with asthma severity and total IgE level in asthmatic children. NLRP1 activators"}
{"subject": "inflammatory response", "sub_type": "CPA", "rel": "ThemeOf", "object": "exacerbate", "obj_type": "PosReg", "file_name": "PubMed-29154202.json", "snippet": " with gain-of-function SNPs in NLRP1 could be more prone in activating inflammasome in the presence of asthma-related cell stressors (i.e. ER stress or ROS), and this activation contribute to  [CLS] exacerbate inflammatory response [CLS]  and asthma development. Gain-of-function IL1A rs17561 resulted significantly associated with a reduced pulmonary capacity in asthmatic children. IL18 rs5744256 which lead to lower serum level of IL-18 appeared to"}
{"subject": "asthma development", "sub_type": "CPA", "rel": "ThemeOf", "object": "exacerbate", "obj_type": "PosReg", "file_name": "PubMed-29154202.json", "snippet": " with gain-of-function SNPs in NLRP1 could be more prone in activating inflammasome in the presence of asthma-related cell stressors (i.e. ER stress or ROS), and this activation contribute to  [CLS] exacerbate inflammatory response and asthma development [CLS] . Gain-of-function IL1A rs17561 resulted significantly associated with a reduced pulmonary capacity in asthmatic children. IL18 rs5744256 which lead to lower serum level of IL-18 appeared to be associated to"}
{"subject": "IL1A", "sub_type": "Gene", "rel": "ThemeOf", "object": "rs17561", "obj_type": "Var", "file_name": "PubMed-29154202.json", "snippet": " more prone in activating inflammasome in the presence of asthma-related cell stressors (i.e. ER stress or ROS), and this activation contribute to exacerbate inflammatory response and asthma development. Gain-of-function  [CLS] IL1A rs17561 [CLS]  resulted significantly associated with a reduced pulmonary capacity in asthmatic children. IL18 rs5744256 which lead to lower serum level of IL-18 appeared to be associated to a worse response"}
{"subject": "rs17561", "sub_type": "Var", "rel": "CauseOf", "object": "reduced", "obj_type": "NegReg", "file_name": "PubMed-29154202.json", "snippet": " prone in activating inflammasome in the presence of asthma-related cell stressors (i.e. ER stress or ROS), and this activation contribute to exacerbate inflammatory response and asthma development. Gain-of-function IL1A  [CLS] rs17561 resulted significantly associated with a reduced [CLS]  pulmonary capacity in asthmatic children. IL18 rs5744256 which lead to lower serum level of IL-18 appeared to be associated to a worse response to bronchodilators. Concluding, this work provides"}
{"subject": "pulmonary capacity", "sub_type": "CPA", "rel": "ThemeOf", "object": "reduced", "obj_type": "NegReg", "file_name": "PubMed-29154202.json", "snippet": " presence of asthma-related cell stressors (i.e. ER stress or ROS), and this activation contribute to exacerbate inflammatory response and asthma development. Gain-of-function IL1A rs17561 resulted significantly associated with a  [CLS] reduced pulmonary capacity [CLS]  in asthmatic children. IL18 rs5744256 which lead to lower serum level of IL-18 appeared to be associated to a worse response to bronchodilators. Concluding, this work provides evidences about"}
{"subject": "IL18", "sub_type": "Gene", "rel": "ThemeOf", "object": "rs5744256", "obj_type": "Var", "file_name": "PubMed-29154202.json", "snippet": " ER stress or ROS), and this activation contribute to exacerbate inflammatory response and asthma development. Gain-of-function IL1A rs17561 resulted significantly associated with a reduced pulmonary capacity in asthmatic children.  [CLS] IL18 rs5744256 [CLS]  which lead to lower serum level of IL-18 appeared to be associated to a worse response to bronchodilators. Concluding, this work provides evidences about the contribution of inflammasome genetics"}
{"subject": "serum level of IL-18", "sub_type": "MPA", "rel": "ThemeOf", "object": "lower", "obj_type": "NegReg", "file_name": "PubMed-29154202.json", "snippet": " this activation contribute to exacerbate inflammatory response and asthma development. Gain-of-function IL1A rs17561 resulted significantly associated with a reduced pulmonary capacity in asthmatic children. IL18 rs5744256 which lead to  [CLS] lower serum level of IL-18 [CLS]  appeared to be associated to a worse response to bronchodilators. Concluding, this work provides evidences about the contribution of inflammasome genetics in the development of paediatric asthma, both considering"}
{"subject": "rs5744256", "sub_type": "Var", "rel": "CauseOf", "object": "lower", "obj_type": "NegReg", "file_name": "PubMed-29154202.json", "snippet": " stress or ROS), and this activation contribute to exacerbate inflammatory response and asthma development. Gain-of-function IL1A rs17561 resulted significantly associated with a reduced pulmonary capacity in asthmatic children. IL18  [CLS] rs5744256 which lead to lower [CLS]  serum level of IL-18 appeared to be associated to a worse response to bronchodilators. Concluding, this work provides evidences about the contribution of inflammasome genetics in the development of"}
{"subject": "NLRP1", "sub_type": "Gene", "rel": "ThemeOf", "object": "rs12150220", "obj_type": "Var", "file_name": "PubMed-29154202.json", "snippet": " hypothesize that inflammasome genetics could contribute to the development of asthma. Selected functional polymorphisms in inflammasome genes are evaluated in a cohort of asthmatic children and their families. Gain-of-function  [CLS] NLRP1 variants rs11651270, rs12150220 [CLS]  and rs2670660 resulted significantly associated to asthma in trios (TDT) analysis; and rs11651270 and rs2670660 also with asthma severity and total IgE level in asthmatic children. NLRP1 activators in"}
{"subject": "variants", "sub_type": "Var", "rel": "CauseOf", "object": "Gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-29154202.json", "snippet": " we hypothesize that inflammasome genetics could contribute to the development of asthma. Selected functional polymorphisms in inflammasome genes are evaluated in a cohort of asthmatic children and their families.  [CLS] Gain-of-function NLRP1 variants [CLS]  rs11651270, rs12150220 and rs2670660 resulted significantly associated to asthma in trios (TDT) analysis; and rs11651270 and rs2670660 also with asthma severity and total IgE level in asthmatic children. NLRP1"}
{"subject": "rs11651270", "sub_type": "Var", "rel": "CauseOf", "object": "Gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-29154202.json", "snippet": " we hypothesize that inflammasome genetics could contribute to the development of asthma. Selected functional polymorphisms in inflammasome genes are evaluated in a cohort of asthmatic children and their families.  [CLS] Gain-of-function NLRP1 variants rs11651270 [CLS] , rs12150220 and rs2670660 resulted significantly associated to asthma in trios (TDT) analysis; and rs11651270 and rs2670660 also with asthma severity and total IgE level in asthmatic children. NLRP1 activators"}
{"subject": "rs12150220", "sub_type": "Var", "rel": "CauseOf", "object": "Gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-29154202.json", "snippet": " we hypothesize that inflammasome genetics could contribute to the development of asthma. Selected functional polymorphisms in inflammasome genes are evaluated in a cohort of asthmatic children and their families.  [CLS] Gain-of-function NLRP1 variants rs11651270, rs12150220 [CLS]  and rs2670660 resulted significantly associated to asthma in trios (TDT) analysis; and rs11651270 and rs2670660 also with asthma severity and total IgE level in asthmatic children. NLRP1 activators in"}
{"subject": "rs2670660", "sub_type": "Var", "rel": "CauseOf", "object": "Gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-29154202.json", "snippet": " we hypothesize that inflammasome genetics could contribute to the development of asthma. Selected functional polymorphisms in inflammasome genes are evaluated in a cohort of asthmatic children and their families.  [CLS] Gain-of-function NLRP1 variants rs11651270, rs12150220 and rs2670660 [CLS]  resulted significantly associated to asthma in trios (TDT) analysis; and rs11651270 and rs2670660 also with asthma severity and total IgE level in asthmatic children. NLRP1 activators in humans are"}
{"subject": "NLRP1", "sub_type": "Gene", "rel": "ThemeOf", "object": "rs2670660", "obj_type": "Var", "file_name": "PubMed-29154202.json", "snippet": " hypothesize that inflammasome genetics could contribute to the development of asthma. Selected functional polymorphisms in inflammasome genes are evaluated in a cohort of asthmatic children and their families. Gain-of-function  [CLS] NLRP1 variants rs11651270, rs12150220 and rs2670660 [CLS]  resulted significantly associated to asthma in trios (TDT) analysis; and rs11651270 and rs2670660 also with asthma severity and total IgE level in asthmatic children. NLRP1 activators in humans are"}
{"subject": "asthma", "sub_type": "Disease", "rel": "ThemeOf", "object": "Gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-29154202.json", "snippet": " we hypothesize that inflammasome genetics could contribute to the development of asthma. Selected functional polymorphisms in inflammasome genes are evaluated in a cohort of asthmatic children and their families.  [CLS] Gain-of-function NLRP1 variants rs11651270, rs12150220 and rs2670660 resulted significantly associated to asthma [CLS]  in trios (TDT) analysis; and rs11651270 and rs2670660 also with asthma severity and total IgE level in asthmatic children. NLRP1 activators in humans are still unknown, however we hypothesized"}
{"subject": "MED13L", "sub_type": "Gene", "rel": "ThemeOf", "object": "variants", "obj_type": "Var", "file_name": "PubMed-29159987.json", "snippet": " [CLS] MED13L loss-of-function variants [CLS]  in two patients with syndromic Pierre Robin sequence.\nWe report two unrelated patients with Pierre Robin sequence (PRS) and a strikingly similar combination of associated features. Whole exome sequencing"}
{"subject": "variants", "sub_type": "Var", "rel": "CauseOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-29159987.json", "snippet": " [CLS] loss-of-function variants [CLS]  in two patients with syndromic Pierre Robin sequence.\nWe report two unrelated patients with Pierre Robin sequence (PRS) and a strikingly similar combination of associated features. Whole exome sequencing"}
{"subject": "Pierre Robin sequence", "sub_type": "Disease", "rel": "ThemeOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-29159987.json", "snippet": " [CLS] loss-of-function variants in two patients with syndromic Pierre Robin sequence [CLS] .\nWe report two unrelated patients with Pierre Robin sequence (PRS) and a strikingly similar combination of associated features. Whole exome sequencing was performed for both patients. No single gene"}
{"subject": "MED13L", "sub_type": "Gene", "rel": "ThemeOf", "object": "Disruption", "obj_type": "Var", "file_name": "PubMed-29159987.json", "snippet": " mediator complex subunit 13 like (MED13L) in one patient prompted the investigation of copy number variants in MED13L in the other, leading to the identification of an intragenic deletion.  [CLS] Disruption of MED13L [CLS] , encoding a component of the Mediator complex, is increasingly recognized as the cause of an intellectual disability syndrome with associated facial dysmorphism. Our findings suggest that MED13L-related disorders are"}
{"subject": "Disruption", "sub_type": "Var", "rel": "CauseOf", "object": "cause", "obj_type": "Reg", "file_name": "PubMed-29159987.json", "snippet": " mediator complex subunit 13 like (MED13L) in one patient prompted the investigation of copy number variants in MED13L in the other, leading to the identification of an intragenic deletion.  [CLS] Disruption of MED13L, encoding a component of the Mediator complex, is increasingly recognized as the cause [CLS]  of an intellectual disability syndrome with associated facial dysmorphism. Our findings suggest that MED13L-related disorders are a possible differential diagnosis for syndromic PRS."}
{"subject": "intellectual disability syndrome", "sub_type": "Disease", "rel": "ThemeOf", "object": "cause", "obj_type": "Reg", "file_name": "PubMed-29159987.json", "snippet": " variants in MED13L in the other, leading to the identification of an intragenic deletion. Disruption of MED13L, encoding a component of the Mediator complex, is increasingly recognized as the  [CLS] cause of an intellectual disability syndrome [CLS]  with associated facial dysmorphism. Our findings suggest that MED13L-related disorders are a possible differential diagnosis for syndromic PRS."}
{"subject": "facial dysmorphism", "sub_type": "Disease", "rel": "ThemeOf", "object": "cause", "obj_type": "Reg", "file_name": "PubMed-29159987.json", "snippet": " variants in MED13L in the other, leading to the identification of an intragenic deletion. Disruption of MED13L, encoding a component of the Mediator complex, is increasingly recognized as the  [CLS] cause of an intellectual disability syndrome with associated facial dysmorphism [CLS] . Our findings suggest that MED13L-related disorders are a possible differential diagnosis for syndromic PRS."}
{"subject": "mutation", "sub_type": "Var", "rel": "CauseOf", "object": "Loss-of-activity", "obj_type": "NegReg", "file_name": "PubMed-29167417.json", "snippet": " [CLS] Loss-of-activity-mutation [CLS]  in the cardiac chloride-bicarbonate exchanger AE3 causes short QT syndrome.\nPatients with short QT syndrome (SQTS) may present with syncope, ventricular fibrillation or sudden cardiac death. Six SQTS susceptibility"}
{"subject": "cardiac chloride-bicarbonate exchanger AE3", "sub_type": "MPA", "rel": "ThemeOf", "object": "Loss-of-activity", "obj_type": "NegReg", "file_name": "PubMed-29167417.json", "snippet": " [CLS] Loss-of-activity-mutation in the cardiac chloride-bicarbonate exchanger AE3 [CLS]  causes short QT syndrome.\nPatients with short QT syndrome (SQTS) may present with syncope, ventricular fibrillation or sudden cardiac death. Six SQTS susceptibility genes, encoding cation channels, explain <25%"}
{"subject": "short QT syndrome", "sub_type": "Disease", "rel": "ThemeOf", "object": "Loss-of-activity", "obj_type": "NegReg", "file_name": "PubMed-29167417.json", "snippet": " [CLS] Loss-of-activity-mutation in the cardiac chloride-bicarbonate exchanger AE3 causes short QT syndrome [CLS] .\nPatients with short QT syndrome (SQTS) may present with syncope, ventricular fibrillation or sudden cardiac death. Six SQTS susceptibility genes, encoding cation channels, explain <25% of SQTS cases. Here"}
{"subject": "missense mutation", "sub_type": "Var", "rel": "CauseOf", "object": "reduced", "obj_type": "NegReg", "file_name": "PubMed-29167417.json", "snippet": " QT syndrome (SQTS) may present with syncope, ventricular fibrillation or sudden cardiac death. Six SQTS susceptibility genes, encoding cation channels, explain <25% of SQTS cases. Here we identify a  [CLS] missense mutation in the anion exchanger (AE3)-encoding SLC4A3 gene in two unrelated families with SQTS. The mutation causes reduced [CLS]  surface expression of AE3 and reduced membrane bicarbonate transport. Slc4a3 knockdown in zebrafish causes increased cardiac pHi, short QTc, and reduced systolic duration, which is rescued by wildtype but"}
{"subject": "SLC4A3", "sub_type": "Gene", "rel": "ThemeOf", "object": "missense mutation", "obj_type": "Var", "file_name": "PubMed-29167417.json", "snippet": " QT syndrome (SQTS) may present with syncope, ventricular fibrillation or sudden cardiac death. Six SQTS susceptibility genes, encoding cation channels, explain <25% of SQTS cases. Here we identify a  [CLS] missense mutation in the anion exchanger (AE3)-encoding SLC4A3 [CLS]  gene in two unrelated families with SQTS. The mutation causes reduced surface expression of AE3 and reduced membrane bicarbonate transport. Slc4a3 knockdown in zebrafish causes increased cardiac pHi, short"}
{"subject": "surface expression of AE3", "sub_type": "MPA", "rel": "ThemeOf", "object": "reduced", "obj_type": "NegReg", "file_name": "PubMed-29167417.json", "snippet": " cation channels, explain <25% of SQTS cases. Here we identify a missense mutation in the anion exchanger (AE3)-encoding SLC4A3 gene in two unrelated families with SQTS. The mutation causes  [CLS] reduced surface expression of AE3 [CLS]  and reduced membrane bicarbonate transport. Slc4a3 knockdown in zebrafish causes increased cardiac pHi, short QTc, and reduced systolic duration, which is rescued by wildtype but not mutated SLC4A3. Mechanistic"}
{"subject": "missense mutation", "sub_type": "Var", "rel": "CauseOf", "object": "reduced", "obj_type": "NegReg", "file_name": "PubMed-29167417.json", "snippet": " QT syndrome (SQTS) may present with syncope, ventricular fibrillation or sudden cardiac death. Six SQTS susceptibility genes, encoding cation channels, explain <25% of SQTS cases. Here we identify a  [CLS] missense mutation in the anion exchanger (AE3)-encoding SLC4A3 gene in two unrelated families with SQTS. The mutation causes reduced surface expression of AE3 and reduced [CLS]  membrane bicarbonate transport. Slc4a3 knockdown in zebrafish causes increased cardiac pHi, short QTc, and reduced systolic duration, which is rescued by wildtype but not mutated SLC4A3. Mechanistic analyses suggest"}
{"subject": "membrane bicarbonate transport", "sub_type": "MPA", "rel": "ThemeOf", "object": "reduced", "obj_type": "NegReg", "file_name": "PubMed-29167417.json", "snippet": " cases. Here we identify a missense mutation in the anion exchanger (AE3)-encoding SLC4A3 gene in two unrelated families with SQTS. The mutation causes reduced surface expression of AE3 and  [CLS] reduced membrane bicarbonate transport [CLS] . Slc4a3 knockdown in zebrafish causes increased cardiac pHi, short QTc, and reduced systolic duration, which is rescued by wildtype but not mutated SLC4A3. Mechanistic analyses suggest that an increase"}
{"subject": "LDLR", "sub_type": "Gene", "rel": "ThemeOf", "object": "c.1429G>A", "obj_type": "Var", "file_name": "PubMed-29172679.json", "snippet": " A total of 21 variants were detected with majority rate in LDLR (81%). Variants were classified based on the type of mutation. Missense variants resulting in amino acid changes,  [CLS] c.1429G>A (p.D477N), c.1474G>A (p.D492N), c.1731G>T (p.W577C), and c.1783C>T (p.R595W) in LDLR [CLS]  gene, in addition to c.9835A>G (p.S3279G) in APOB, were shown to be deleterious by concordant analysis. Furthermore, functional interaction deformities showed a significant loss and gain of energies in"}
{"subject": "c.9835A>G", "sub_type": "Var", "rel": "CauseOf", "object": "deformities", "obj_type": "Reg", "file_name": "PubMed-29172679.json", "snippet": " classified based on the type of mutation. Missense variants resulting in amino acid changes, c.1429G>A (p.D477N), c.1474G>A (p.D492N), c.1731G>T (p.W577C), and c.1783C>T (p.R595W) in LDLR gene, in addition to  [CLS] c.9835A>G (p.S3279G) in APOB, were shown to be deleterious by concordant analysis. Furthermore, functional interaction deformities [CLS]  showed a significant loss and gain of energies in the mutated proteins. These findings will help in distinguishing the most harmful mutations needed to be screened for clinically diagnosed"}
{"subject": "functional interaction", "sub_type": "Interaction", "rel": "ThemeOf", "object": "deformities", "obj_type": "Reg", "file_name": "PubMed-29172679.json", "snippet": " changes, c.1429G>A (p.D477N), c.1474G>A (p.D492N), c.1731G>T (p.W577C), and c.1783C>T (p.R595W) in LDLR gene, in addition to c.9835A>G (p.S3279G) in APOB, were shown to be deleterious by concordant analysis. Furthermore,  [CLS] functional interaction deformities [CLS]  showed a significant loss and gain of energies in the mutated proteins. These findings will help in distinguishing the most harmful mutations needed to be screened for clinically diagnosed"}
{"subject": "c.1731G>T", "sub_type": "Var", "rel": "CauseOf", "object": "loss", "obj_type": "NegReg", "file_name": "PubMed-29172679.json", "snippet": " variants were detected with majority rate in LDLR (81%). Variants were classified based on the type of mutation. Missense variants resulting in amino acid changes, c.1429G>A (p.D477N), c.1474G>A (p.D492N),  [CLS] c.1731G>T (p.W577C), and c.1783C>T (p.R595W) in LDLR gene, in addition to c.9835A>G (p.S3279G) in APOB, were shown to be deleterious by concordant analysis. Furthermore, functional interaction deformities showed a significant loss [CLS]  and gain of energies in the mutated proteins. These findings will help in distinguishing the most harmful mutations needed to be screened for clinically diagnosed FH patients in SA."}
{"subject": "c.1783C>T", "sub_type": "Var", "rel": "CauseOf", "object": "loss", "obj_type": "NegReg", "file_name": "PubMed-29172679.json", "snippet": " with majority rate in LDLR (81%). Variants were classified based on the type of mutation. Missense variants resulting in amino acid changes, c.1429G>A (p.D477N), c.1474G>A (p.D492N), c.1731G>T (p.W577C), and  [CLS] c.1783C>T (p.R595W) in LDLR gene, in addition to c.9835A>G (p.S3279G) in APOB, were shown to be deleterious by concordant analysis. Furthermore, functional interaction deformities showed a significant loss [CLS]  and gain of energies in the mutated proteins. These findings will help in distinguishing the most harmful mutations needed to be screened for clinically diagnosed FH patients in SA."}
{"subject": "c.1429G>A", "sub_type": "Var", "rel": "CauseOf", "object": "loss", "obj_type": "NegReg", "file_name": "PubMed-29172679.json", "snippet": " A total of 21 variants were detected with majority rate in LDLR (81%). Variants were classified based on the type of mutation. Missense variants resulting in amino acid changes,  [CLS] c.1429G>A (p.D477N), c.1474G>A (p.D492N), c.1731G>T (p.W577C), and c.1783C>T (p.R595W) in LDLR gene, in addition to c.9835A>G (p.S3279G) in APOB, were shown to be deleterious by concordant analysis. Furthermore, functional interaction deformities showed a significant loss [CLS]  and gain of energies in the mutated proteins. These findings will help in distinguishing the most harmful mutations needed to be screened for clinically diagnosed FH patients in SA."}
{"subject": "c.1474G>A", "sub_type": "Var", "rel": "CauseOf", "object": "loss", "obj_type": "NegReg", "file_name": "PubMed-29172679.json", "snippet": " of 21 variants were detected with majority rate in LDLR (81%). Variants were classified based on the type of mutation. Missense variants resulting in amino acid changes, c.1429G>A (p.D477N),  [CLS] c.1474G>A (p.D492N), c.1731G>T (p.W577C), and c.1783C>T (p.R595W) in LDLR gene, in addition to c.9835A>G (p.S3279G) in APOB, were shown to be deleterious by concordant analysis. Furthermore, functional interaction deformities showed a significant loss [CLS]  and gain of energies in the mutated proteins. These findings will help in distinguishing the most harmful mutations needed to be screened for clinically diagnosed FH patients in SA."}
{"subject": "c.9835A>G", "sub_type": "Var", "rel": "CauseOf", "object": "loss", "obj_type": "NegReg", "file_name": "PubMed-29172679.json", "snippet": " classified based on the type of mutation. Missense variants resulting in amino acid changes, c.1429G>A (p.D477N), c.1474G>A (p.D492N), c.1731G>T (p.W577C), and c.1783C>T (p.R595W) in LDLR gene, in addition to  [CLS] c.9835A>G (p.S3279G) in APOB, were shown to be deleterious by concordant analysis. Furthermore, functional interaction deformities showed a significant loss [CLS]  and gain of energies in the mutated proteins. These findings will help in distinguishing the most harmful mutations needed to be screened for clinically diagnosed FH patients in SA."}
{"subject": "energies in the mutated proteins", "sub_type": "MPA", "rel": "ThemeOf", "object": "loss", "obj_type": "NegReg", "file_name": "PubMed-29172679.json", "snippet": " (p.W577C), and c.1783C>T (p.R595W) in LDLR gene, in addition to c.9835A>G (p.S3279G) in APOB, were shown to be deleterious by concordant analysis. Furthermore, functional interaction deformities showed a significant  [CLS] loss and gain of energies in the mutated proteins [CLS] . These findings will help in distinguishing the most harmful mutations needed to be screened for clinically diagnosed FH patients in SA. Such computational research is necessary to avoid time"}
{"subject": "c.1731G>T", "sub_type": "Var", "rel": "CauseOf", "object": "gain", "obj_type": "PosReg", "file_name": "PubMed-29172679.json", "snippet": " variants were detected with majority rate in LDLR (81%). Variants were classified based on the type of mutation. Missense variants resulting in amino acid changes, c.1429G>A (p.D477N), c.1474G>A (p.D492N),  [CLS] c.1731G>T (p.W577C), and c.1783C>T (p.R595W) in LDLR gene, in addition to c.9835A>G (p.S3279G) in APOB, were shown to be deleterious by concordant analysis. Furthermore, functional interaction deformities showed a significant loss and gain [CLS]  of energies in the mutated proteins. These findings will help in distinguishing the most harmful mutations needed to be screened for clinically diagnosed FH patients in SA. Such computational"}
{"subject": "c.1783C>T", "sub_type": "Var", "rel": "CauseOf", "object": "gain", "obj_type": "PosReg", "file_name": "PubMed-29172679.json", "snippet": " with majority rate in LDLR (81%). Variants were classified based on the type of mutation. Missense variants resulting in amino acid changes, c.1429G>A (p.D477N), c.1474G>A (p.D492N), c.1731G>T (p.W577C), and  [CLS] c.1783C>T (p.R595W) in LDLR gene, in addition to c.9835A>G (p.S3279G) in APOB, were shown to be deleterious by concordant analysis. Furthermore, functional interaction deformities showed a significant loss and gain [CLS]  of energies in the mutated proteins. These findings will help in distinguishing the most harmful mutations needed to be screened for clinically diagnosed FH patients in SA. Such computational"}
{"subject": "LDLR", "sub_type": "Gene", "rel": "ThemeOf", "object": "c.1474G>A", "obj_type": "Var", "file_name": "PubMed-29172679.json", "snippet": " of 21 variants were detected with majority rate in LDLR (81%). Variants were classified based on the type of mutation. Missense variants resulting in amino acid changes, c.1429G>A (p.D477N),  [CLS] c.1474G>A (p.D492N), c.1731G>T (p.W577C), and c.1783C>T (p.R595W) in LDLR [CLS]  gene, in addition to c.9835A>G (p.S3279G) in APOB, were shown to be deleterious by concordant analysis. Furthermore, functional interaction deformities showed a significant loss and gain of energies in"}
{"subject": "c.1429G>A", "sub_type": "Var", "rel": "CauseOf", "object": "gain", "obj_type": "PosReg", "file_name": "PubMed-29172679.json", "snippet": " A total of 21 variants were detected with majority rate in LDLR (81%). Variants were classified based on the type of mutation. Missense variants resulting in amino acid changes,  [CLS] c.1429G>A (p.D477N), c.1474G>A (p.D492N), c.1731G>T (p.W577C), and c.1783C>T (p.R595W) in LDLR gene, in addition to c.9835A>G (p.S3279G) in APOB, were shown to be deleterious by concordant analysis. Furthermore, functional interaction deformities showed a significant loss and gain [CLS]  of energies in the mutated proteins. These findings will help in distinguishing the most harmful mutations needed to be screened for clinically diagnosed FH patients in SA. Such computational"}
{"subject": "c.1474G>A", "sub_type": "Var", "rel": "CauseOf", "object": "gain", "obj_type": "PosReg", "file_name": "PubMed-29172679.json", "snippet": " of 21 variants were detected with majority rate in LDLR (81%). Variants were classified based on the type of mutation. Missense variants resulting in amino acid changes, c.1429G>A (p.D477N),  [CLS] c.1474G>A (p.D492N), c.1731G>T (p.W577C), and c.1783C>T (p.R595W) in LDLR gene, in addition to c.9835A>G (p.S3279G) in APOB, were shown to be deleterious by concordant analysis. Furthermore, functional interaction deformities showed a significant loss and gain [CLS]  of energies in the mutated proteins. These findings will help in distinguishing the most harmful mutations needed to be screened for clinically diagnosed FH patients in SA. Such computational"}
{"subject": "c.9835A>G", "sub_type": "Var", "rel": "CauseOf", "object": "gain", "obj_type": "PosReg", "file_name": "PubMed-29172679.json", "snippet": " classified based on the type of mutation. Missense variants resulting in amino acid changes, c.1429G>A (p.D477N), c.1474G>A (p.D492N), c.1731G>T (p.W577C), and c.1783C>T (p.R595W) in LDLR gene, in addition to  [CLS] c.9835A>G (p.S3279G) in APOB, were shown to be deleterious by concordant analysis. Furthermore, functional interaction deformities showed a significant loss and gain [CLS]  of energies in the mutated proteins. These findings will help in distinguishing the most harmful mutations needed to be screened for clinically diagnosed FH patients in SA. Such computational"}
{"subject": "LDLR", "sub_type": "Gene", "rel": "ThemeOf", "object": "c.1731G>T", "obj_type": "Var", "file_name": "PubMed-29172679.json", "snippet": " variants were detected with majority rate in LDLR (81%). Variants were classified based on the type of mutation. Missense variants resulting in amino acid changes, c.1429G>A (p.D477N), c.1474G>A (p.D492N),  [CLS] c.1731G>T (p.W577C), and c.1783C>T (p.R595W) in LDLR [CLS]  gene, in addition to c.9835A>G (p.S3279G) in APOB, were shown to be deleterious by concordant analysis. Furthermore, functional interaction deformities showed a significant loss and gain of energies in"}
{"subject": "LDLR", "sub_type": "Gene", "rel": "ThemeOf", "object": "c.1783C>T", "obj_type": "Var", "file_name": "PubMed-29172679.json", "snippet": " with majority rate in LDLR (81%). Variants were classified based on the type of mutation. Missense variants resulting in amino acid changes, c.1429G>A (p.D477N), c.1474G>A (p.D492N), c.1731G>T (p.W577C), and  [CLS] c.1783C>T (p.R595W) in LDLR [CLS]  gene, in addition to c.9835A>G (p.S3279G) in APOB, were shown to be deleterious by concordant analysis. Furthermore, functional interaction deformities showed a significant loss and gain of energies in"}
{"subject": "APOB", "sub_type": "Gene", "rel": "ThemeOf", "object": "c.9835A>G", "obj_type": "Var", "file_name": "PubMed-29172679.json", "snippet": " classified based on the type of mutation. Missense variants resulting in amino acid changes, c.1429G>A (p.D477N), c.1474G>A (p.D492N), c.1731G>T (p.W577C), and c.1783C>T (p.R595W) in LDLR gene, in addition to  [CLS] c.9835A>G (p.S3279G) in APOB [CLS] , were shown to be deleterious by concordant analysis. Furthermore, functional interaction deformities showed a significant loss and gain of energies in the mutated proteins. These findings will help in"}
{"subject": "c.1429G>A", "sub_type": "Var", "rel": "CauseOf", "object": "deformities", "obj_type": "Reg", "file_name": "PubMed-29172679.json", "snippet": " A total of 21 variants were detected with majority rate in LDLR (81%). Variants were classified based on the type of mutation. Missense variants resulting in amino acid changes,  [CLS] c.1429G>A (p.D477N), c.1474G>A (p.D492N), c.1731G>T (p.W577C), and c.1783C>T (p.R595W) in LDLR gene, in addition to c.9835A>G (p.S3279G) in APOB, were shown to be deleterious by concordant analysis. Furthermore, functional interaction deformities [CLS]  showed a significant loss and gain of energies in the mutated proteins. These findings will help in distinguishing the most harmful mutations needed to be screened for clinically diagnosed"}
{"subject": "c.1474G>A", "sub_type": "Var", "rel": "CauseOf", "object": "deformities", "obj_type": "Reg", "file_name": "PubMed-29172679.json", "snippet": " of 21 variants were detected with majority rate in LDLR (81%). Variants were classified based on the type of mutation. Missense variants resulting in amino acid changes, c.1429G>A (p.D477N),  [CLS] c.1474G>A (p.D492N), c.1731G>T (p.W577C), and c.1783C>T (p.R595W) in LDLR gene, in addition to c.9835A>G (p.S3279G) in APOB, were shown to be deleterious by concordant analysis. Furthermore, functional interaction deformities [CLS]  showed a significant loss and gain of energies in the mutated proteins. These findings will help in distinguishing the most harmful mutations needed to be screened for clinically diagnosed"}
{"subject": "c.1731G>T", "sub_type": "Var", "rel": "CauseOf", "object": "deformities", "obj_type": "Reg", "file_name": "PubMed-29172679.json", "snippet": " variants were detected with majority rate in LDLR (81%). Variants were classified based on the type of mutation. Missense variants resulting in amino acid changes, c.1429G>A (p.D477N), c.1474G>A (p.D492N),  [CLS] c.1731G>T (p.W577C), and c.1783C>T (p.R595W) in LDLR gene, in addition to c.9835A>G (p.S3279G) in APOB, were shown to be deleterious by concordant analysis. Furthermore, functional interaction deformities [CLS]  showed a significant loss and gain of energies in the mutated proteins. These findings will help in distinguishing the most harmful mutations needed to be screened for clinically diagnosed"}
{"subject": "c.1783C>T", "sub_type": "Var", "rel": "CauseOf", "object": "deformities", "obj_type": "Reg", "file_name": "PubMed-29172679.json", "snippet": " with majority rate in LDLR (81%). Variants were classified based on the type of mutation. Missense variants resulting in amino acid changes, c.1429G>A (p.D477N), c.1474G>A (p.D492N), c.1731G>T (p.W577C), and  [CLS] c.1783C>T (p.R595W) in LDLR gene, in addition to c.9835A>G (p.S3279G) in APOB, were shown to be deleterious by concordant analysis. Furthermore, functional interaction deformities [CLS]  showed a significant loss and gain of energies in the mutated proteins. These findings will help in distinguishing the most harmful mutations needed to be screened for clinically diagnosed"}
{"subject": "htpG", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutant", "obj_type": "Var", "file_name": "PubMed-29199454.json", "snippet": " P. aeruginosa.\nMETHODOLOGY: By characterizing a htpG null mutant of P. aeruginosa, we have identified the role of HtpG in the production of selected factors.\nRESULTS: We showed that \u0394 [CLS] htpG mutant [CLS]  affects many physiological processes containing: decreased activity of the LasA protease, reduction of biofilm formation, decreased motility, and diminished amount of rhamnolipids and pyoverdine/pyocyanin. These defects were most evident"}
{"subject": "amount of rhamnolipids and pyoverdine/pyocyanin", "sub_type": "MPA", "rel": "ThemeOf", "object": "diminished", "obj_type": "NegReg", "file_name": "PubMed-29199454.json", "snippet": " the production of selected factors.\nRESULTS: We showed that \u0394htpG mutant affects many physiological processes containing: decreased activity of the LasA protease, reduction of biofilm formation, decreased motility, and  [CLS] diminished amount of rhamnolipids and pyoverdine/pyocyanin [CLS] . These defects were most evident when the \u0394htpG strain was cultured at 42\u00b0C.\nCONCLUSION: Our findings demonstrate the unexplored role of HtpG in the pathogenicity of P. aeruginosa, and"}
{"subject": "mutant", "sub_type": "Var", "rel": "CauseOf", "object": "decreased", "obj_type": "NegReg", "file_name": "PubMed-29199454.json", "snippet": " aeruginosa.\nMETHODOLOGY: By characterizing a htpG null mutant of P. aeruginosa, we have identified the role of HtpG in the production of selected factors.\nRESULTS: We showed that \u0394htpG  [CLS] mutant affects many physiological processes containing: decreased [CLS]  activity of the LasA protease, reduction of biofilm formation, decreased motility, and diminished amount of rhamnolipids and pyoverdine/pyocyanin. These defects were most evident when the \u0394htpG strain was cultured"}
{"subject": "activity", "sub_type": "MPA", "rel": "ThemeOf", "object": "decreased", "obj_type": "NegReg", "file_name": "PubMed-29199454.json", "snippet": " null mutant of P. aeruginosa, we have identified the role of HtpG in the production of selected factors.\nRESULTS: We showed that \u0394htpG mutant affects many physiological processes containing:  [CLS] decreased activity [CLS]  of the LasA protease, reduction of biofilm formation, decreased motility, and diminished amount of rhamnolipids and pyoverdine/pyocyanin. These defects were most evident when the \u0394htpG strain was cultured at"}
{"subject": "LasA protease", "sub_type": "Enzyme", "rel": "ThemeOf", "object": "activity", "obj_type": "MPA", "file_name": "PubMed-29199454.json", "snippet": " mutant of P. aeruginosa, we have identified the role of HtpG in the production of selected factors.\nRESULTS: We showed that \u0394htpG mutant affects many physiological processes containing: decreased  [CLS] activity of the LasA protease [CLS] , reduction of biofilm formation, decreased motility, and diminished amount of rhamnolipids and pyoverdine/pyocyanin. These defects were most evident when the \u0394htpG strain was cultured at 42\u00b0C.\nCONCLUSION: Our findings"}
{"subject": "mutant", "sub_type": "Var", "rel": "CauseOf", "object": "reduction", "obj_type": "NegReg", "file_name": "PubMed-29199454.json", "snippet": " aeruginosa.\nMETHODOLOGY: By characterizing a htpG null mutant of P. aeruginosa, we have identified the role of HtpG in the production of selected factors.\nRESULTS: We showed that \u0394htpG  [CLS] mutant affects many physiological processes containing: decreased activity of the LasA protease, reduction [CLS]  of biofilm formation, decreased motility, and diminished amount of rhamnolipids and pyoverdine/pyocyanin. These defects were most evident when the \u0394htpG strain was cultured at 42\u00b0C.\nCONCLUSION: Our findings demonstrate"}
{"subject": "biofilm formation", "sub_type": "MPA", "rel": "ThemeOf", "object": "reduction", "obj_type": "NegReg", "file_name": "PubMed-29199454.json", "snippet": " have identified the role of HtpG in the production of selected factors.\nRESULTS: We showed that \u0394htpG mutant affects many physiological processes containing: decreased activity of the LasA protease,  [CLS] reduction of biofilm formation [CLS] , decreased motility, and diminished amount of rhamnolipids and pyoverdine/pyocyanin. These defects were most evident when the \u0394htpG strain was cultured at 42\u00b0C.\nCONCLUSION: Our findings demonstrate the unexplored role"}
{"subject": "mutant", "sub_type": "Var", "rel": "CauseOf", "object": "decreased", "obj_type": "NegReg", "file_name": "PubMed-29199454.json", "snippet": " aeruginosa.\nMETHODOLOGY: By characterizing a htpG null mutant of P. aeruginosa, we have identified the role of HtpG in the production of selected factors.\nRESULTS: We showed that \u0394htpG  [CLS] mutant affects many physiological processes containing: decreased activity of the LasA protease, reduction of biofilm formation, decreased [CLS]  motility, and diminished amount of rhamnolipids and pyoverdine/pyocyanin. These defects were most evident when the \u0394htpG strain was cultured at 42\u00b0C.\nCONCLUSION: Our findings demonstrate the unexplored role of"}
{"subject": "motility", "sub_type": "CPA", "rel": "ThemeOf", "object": "decreased", "obj_type": "NegReg", "file_name": "PubMed-29199454.json", "snippet": " of HtpG in the production of selected factors.\nRESULTS: We showed that \u0394htpG mutant affects many physiological processes containing: decreased activity of the LasA protease, reduction of biofilm formation,  [CLS] decreased motility [CLS] , and diminished amount of rhamnolipids and pyoverdine/pyocyanin. These defects were most evident when the \u0394htpG strain was cultured at 42\u00b0C.\nCONCLUSION: Our findings demonstrate the unexplored role of HtpG"}
{"subject": "mutant", "sub_type": "Var", "rel": "CauseOf", "object": "diminished", "obj_type": "NegReg", "file_name": "PubMed-29199454.json", "snippet": " aeruginosa.\nMETHODOLOGY: By characterizing a htpG null mutant of P. aeruginosa, we have identified the role of HtpG in the production of selected factors.\nRESULTS: We showed that \u0394htpG  [CLS] mutant affects many physiological processes containing: decreased activity of the LasA protease, reduction of biofilm formation, decreased motility, and diminished [CLS]  amount of rhamnolipids and pyoverdine/pyocyanin. These defects were most evident when the \u0394htpG strain was cultured at 42\u00b0C.\nCONCLUSION: Our findings demonstrate the unexplored role of HtpG in the"}
{"subject": "KMT2A", "sub_type": "Gene", "rel": "ThemeOf", "object": "variants", "obj_type": "Var", "file_name": "PubMed-29203834.json", "snippet": " [CLS] KMT2A variants [CLS]  involved in Wiedemann-Steiner syndrome.\nVariants in KMT2A, encoding the histone methyltransferase KMT2A, are a growing cause of intellectual disability (ID). Up to now, the majority of KMT2A variants are"}
{"subject": "variants", "sub_type": "Var", "rel": "CauseOf", "object": "causing", "obj_type": "Reg", "file_name": "PubMed-29203834.json", "snippet": " KMT2A variants involved in Wiedemann-Steiner syndrome.\nVariants in KMT2A, encoding the histone methyltransferase KMT2A, are a growing cause of intellectual disability (ID). Up to now, the majority of KMT2A  [CLS] variants are non-sense and frameshift variants causing [CLS]  a typical form of Wiedemann-Steiner syndrome. We studied KMT2A gene in a cohort of 200 patients with unexplained syndromic and non-syndromic ID and identified four novel variants, one splice"}
{"subject": "Wiedemann-Steiner syndrome", "sub_type": "Disease", "rel": "ThemeOf", "object": "causing", "obj_type": "Reg", "file_name": "PubMed-29203834.json", "snippet": "\nVariants in KMT2A, encoding the histone methyltransferase KMT2A, are a growing cause of intellectual disability (ID). Up to now, the majority of KMT2A variants are non-sense and frameshift variants  [CLS] causing a typical form of Wiedemann-Steiner syndrome [CLS] . We studied KMT2A gene in a cohort of 200 patients with unexplained syndromic and non-syndromic ID and identified four novel variants, one splice and three missense variants, possibly deleterious."}
{"subject": "KMT2A", "sub_type": "Gene", "rel": "ThemeOf", "object": "variants", "obj_type": "Var", "file_name": "PubMed-29203834.json", "snippet": " identified four novel variants, one splice and three missense variants, possibly deleterious. We used primary cells from the patients and molecular approaches to determine the deleterious effects of those  [CLS] variants on KMT2A [CLS]  expression and function. For the putative splice variant c.11322-1G>A, we showed that it led to only one nucleotide deletion and loss of the C-terminal part of the protein. For"}
{"subject": "variants", "sub_type": "Var", "rel": "CauseOf", "object": "effects", "obj_type": "Reg", "file_name": "PubMed-29203834.json", "snippet": " non-syndromic ID and identified four novel variants, one splice and three missense variants, possibly deleterious. We used primary cells from the patients and molecular approaches to determine the deleterious  [CLS] effects of those variants [CLS]  on KMT2A expression and function. For the putative splice variant c.11322-1G>A, we showed that it led to only one nucleotide deletion and loss of the C-terminal part of the"}
{"subject": "expression", "sub_type": "MPA", "rel": "ThemeOf", "object": "effects", "obj_type": "Reg", "file_name": "PubMed-29203834.json", "snippet": " non-syndromic ID and identified four novel variants, one splice and three missense variants, possibly deleterious. We used primary cells from the patients and molecular approaches to determine the deleterious  [CLS] effects of those variants on KMT2A expression [CLS]  and function. For the putative splice variant c.11322-1G>A, we showed that it led to only one nucleotide deletion and loss of the C-terminal part of the protein. For two"}
{"subject": "function", "sub_type": "MPA", "rel": "ThemeOf", "object": "effects", "obj_type": "Reg", "file_name": "PubMed-29203834.json", "snippet": " non-syndromic ID and identified four novel variants, one splice and three missense variants, possibly deleterious. We used primary cells from the patients and molecular approaches to determine the deleterious  [CLS] effects of those variants on KMT2A expression and function [CLS] . For the putative splice variant c.11322-1G>A, we showed that it led to only one nucleotide deletion and loss of the C-terminal part of the protein. For two studied KMT2A"}
{"subject": "c.11322-1G>A", "sub_type": "Var", "rel": "CauseOf", "object": "loss", "obj_type": "NegReg", "file_name": "PubMed-29203834.json", "snippet": " deleterious. We used primary cells from the patients and molecular approaches to determine the deleterious effects of those variants on KMT2A expression and function. For the putative splice variant  [CLS] c.11322-1G>A, we showed that it led to only one nucleotide deletion and loss [CLS]  of the C-terminal part of the protein. For two studied KMT2A missense variants, c.3460C>T (p.(Arg1154Trp)) and c.8558T>G (p.(Met2853Arg)), located at the cysteine-rich CXXC domain and the transactivation domain of"}
{"subject": "C-terminal part of the protein", "sub_type": "MPA", "rel": "ThemeOf", "object": "loss", "obj_type": "NegReg", "file_name": "PubMed-29203834.json", "snippet": " determine the deleterious effects of those variants on KMT2A expression and function. For the putative splice variant c.11322-1G>A, we showed that it led to only one nucleotide deletion and  [CLS] loss of the C-terminal part of the protein [CLS] . For two studied KMT2A missense variants, c.3460C>T (p.(Arg1154Trp)) and c.8558T>G (p.(Met2853Arg)), located at the cysteine-rich CXXC domain and the transactivation domain of the protein, respectively, we found altered KMT2A"}
{"subject": "KMT2A", "sub_type": "Gene", "rel": "ThemeOf", "object": "c.3460C>T", "obj_type": "Var", "file_name": "PubMed-29203834.json", "snippet": " function. For the putative splice variant c.11322-1G>A, we showed that it led to only one nucleotide deletion and loss of the C-terminal part of the protein. For two studied  [CLS] KMT2A missense variants, c.3460C>T [CLS]  (p.(Arg1154Trp)) and c.8558T>G (p.(Met2853Arg)), located at the cysteine-rich CXXC domain and the transactivation domain of the protein, respectively, we found altered KMT2A target genes expression in patient's fibroblasts compared"}
{"subject": "KMT2A", "sub_type": "Gene", "rel": "ThemeOf", "object": "c.8558T>G", "obj_type": "Var", "file_name": "PubMed-29203834.json", "snippet": " function. For the putative splice variant c.11322-1G>A, we showed that it led to only one nucleotide deletion and loss of the C-terminal part of the protein. For two studied  [CLS] KMT2A missense variants, c.3460C>T (p.(Arg1154Trp)) and c.8558T>G [CLS]  (p.(Met2853Arg)), located at the cysteine-rich CXXC domain and the transactivation domain of the protein, respectively, we found altered KMT2A target genes expression in patient's fibroblasts compared to controls. Furthermore,"}
{"subject": "variants", "sub_type": "Var", "rel": "CauseOf", "object": "involved in", "obj_type": "Reg", "file_name": "PubMed-29203834.json", "snippet": " [CLS] variants involved in [CLS]  Wiedemann-Steiner syndrome.\nVariants in KMT2A, encoding the histone methyltransferase KMT2A, are a growing cause of intellectual disability (ID). Up to now, the majority of KMT2A variants are non-sense and"}
{"subject": "c.8558T>G", "sub_type": "Var", "rel": "CauseOf", "object": "altered", "obj_type": "Reg", "file_name": "PubMed-29203834.json", "snippet": " c.11322-1G>A, we showed that it led to only one nucleotide deletion and loss of the C-terminal part of the protein. For two studied KMT2A missense variants, c.3460C>T (p.(Arg1154Trp)) and  [CLS] c.8558T>G (p.(Met2853Arg)), located at the cysteine-rich CXXC domain and the transactivation domain of the protein, respectively, we found altered [CLS]  KMT2A target genes expression in patient's fibroblasts compared to controls. Furthermore, we found a disturbed subcellular distribution of KMT2A for the c.3460C>T mutant. Taken together, our results demonstrated the"}
{"subject": "c.3460C>T", "sub_type": "Var", "rel": "CauseOf", "object": "altered", "obj_type": "Reg", "file_name": "PubMed-29203834.json", "snippet": " putative splice variant c.11322-1G>A, we showed that it led to only one nucleotide deletion and loss of the C-terminal part of the protein. For two studied KMT2A missense variants,  [CLS] c.3460C>T (p.(Arg1154Trp)) and c.8558T>G (p.(Met2853Arg)), located at the cysteine-rich CXXC domain and the transactivation domain of the protein, respectively, we found altered [CLS]  KMT2A target genes expression in patient's fibroblasts compared to controls. Furthermore, we found a disturbed subcellular distribution of KMT2A for the c.3460C>T mutant. Taken together, our results demonstrated the"}
{"subject": "expression", "sub_type": "MPA", "rel": "ThemeOf", "object": "altered", "obj_type": "Reg", "file_name": "PubMed-29203834.json", "snippet": " the protein. For two studied KMT2A missense variants, c.3460C>T (p.(Arg1154Trp)) and c.8558T>G (p.(Met2853Arg)), located at the cysteine-rich CXXC domain and the transactivation domain of the protein, respectively, we found  [CLS] altered KMT2A target genes expression [CLS]  in patient's fibroblasts compared to controls. Furthermore, we found a disturbed subcellular distribution of KMT2A for the c.3460C>T mutant. Taken together, our results demonstrated the deleterious impact of the"}
{"subject": "KMT2A", "sub_type": "Gene", "rel": "ThemeOf", "object": "c.3460C>T", "obj_type": "Var", "file_name": "PubMed-29203834.json", "snippet": " and the transactivation domain of the protein, respectively, we found altered KMT2A target genes expression in patient's fibroblasts compared to controls. Furthermore, we found a disturbed subcellular distribution of  [CLS] KMT2A for the c.3460C>T [CLS]  mutant. Taken together, our results demonstrated the deleterious impact of the splice variant and of the missense variants located at two different functional domains and suggested reduction of KMT2A"}
{"subject": "c.3460C>T", "sub_type": "Var", "rel": "CauseOf", "object": "disturbed", "obj_type": "Reg", "file_name": "PubMed-29203834.json", "snippet": " the cysteine-rich CXXC domain and the transactivation domain of the protein, respectively, we found altered KMT2A target genes expression in patient's fibroblasts compared to controls. Furthermore, we found a  [CLS] disturbed subcellular distribution of KMT2A for the c.3460C>T [CLS]  mutant. Taken together, our results demonstrated the deleterious impact of the splice variant and of the missense variants located at two different functional domains and suggested reduction of KMT2A"}
{"subject": "subcellular distribution", "sub_type": "MPA", "rel": "ThemeOf", "object": "disturbed", "obj_type": "Reg", "file_name": "PubMed-29203834.json", "snippet": " the cysteine-rich CXXC domain and the transactivation domain of the protein, respectively, we found altered KMT2A target genes expression in patient's fibroblasts compared to controls. Furthermore, we found a  [CLS] disturbed subcellular distribution [CLS]  of KMT2A for the c.3460C>T mutant. Taken together, our results demonstrated the deleterious impact of the splice variant and of the missense variants located at two different functional domains"}
{"subject": "Wiedemann-Steiner syndrome", "sub_type": "Disease", "rel": "ThemeOf", "object": "involved in", "obj_type": "Reg", "file_name": "PubMed-29203834.json", "snippet": " [CLS] involved in Wiedemann-Steiner syndrome [CLS] .\nVariants in KMT2A, encoding the histone methyltransferase KMT2A, are a growing cause of intellectual disability (ID). Up to now, the majority of KMT2A variants are non-sense and frameshift variants"}
{"subject": "KMT2A", "sub_type": "Gene", "rel": "ThemeOf", "object": "Variants", "obj_type": "Var", "file_name": "PubMed-29203834.json", "snippet": " [CLS] Variants in KMT2A [CLS] , encoding the histone methyltransferase KMT2A, are a growing cause of intellectual disability (ID). Up to now, the majority of KMT2A variants are non-sense and frameshift variants causing a typical"}
{"subject": "intellectual disability", "sub_type": "Disease", "rel": "ThemeOf", "object": "cause", "obj_type": "Reg", "file_name": "PubMed-29203834.json", "snippet": " [CLS] cause of intellectual disability [CLS]  (ID). Up to now, the majority of KMT2A variants are non-sense and frameshift variants causing a typical form of Wiedemann-Steiner syndrome. We studied KMT2A gene in a cohort of"}
{"subject": "Variants", "sub_type": "Var", "rel": "CauseOf", "object": "cause", "obj_type": "Reg", "file_name": "PubMed-29203834.json", "snippet": " [CLS] Variants in KMT2A, encoding the histone methyltransferase KMT2A, are a growing cause [CLS]  of intellectual disability (ID). Up to now, the majority of KMT2A variants are non-sense and frameshift variants causing a typical form of Wiedemann-Steiner syndrome. We studied KMT2A gene in"}
{"subject": "KMT2A", "sub_type": "Gene", "rel": "ThemeOf", "object": "variants", "obj_type": "Var", "file_name": "PubMed-29203834.json", "snippet": " of KMT2A variants involved in Wiedemann-Steiner syndrome.\nVariants in KMT2A, encoding the histone methyltransferase KMT2A, are a growing cause of intellectual disability (ID). Up to now, the majority of  [CLS] KMT2A variants [CLS]  are non-sense and frameshift variants causing a typical form of Wiedemann-Steiner syndrome. We studied KMT2A gene in a cohort of 200 patients with unexplained syndromic and non-syndromic ID and"}
{"subject": "non-sense", "sub_type": "Var", "rel": "ThemeOf", "object": "variants", "obj_type": "Var", "file_name": "PubMed-29203834.json", "snippet": " KMT2A variants involved in Wiedemann-Steiner syndrome.\nVariants in KMT2A, encoding the histone methyltransferase KMT2A, are a growing cause of intellectual disability (ID). Up to now, the majority of KMT2A  [CLS] variants are non-sense [CLS]  and frameshift variants causing a typical form of Wiedemann-Steiner syndrome. We studied KMT2A gene in a cohort of 200 patients with unexplained syndromic and non-syndromic ID and identified four"}
{"subject": "frameshift", "sub_type": "Var", "rel": "ThemeOf", "object": "variants", "obj_type": "Var", "file_name": "PubMed-29203834.json", "snippet": " KMT2A variants involved in Wiedemann-Steiner syndrome.\nVariants in KMT2A, encoding the histone methyltransferase KMT2A, are a growing cause of intellectual disability (ID). Up to now, the majority of KMT2A  [CLS] variants are non-sense and frameshift [CLS]  variants causing a typical form of Wiedemann-Steiner syndrome. We studied KMT2A gene in a cohort of 200 patients with unexplained syndromic and non-syndromic ID and identified four novel variants,"}
{"subject": "Abnormalities", "sub_type": "Var", "rel": "CauseOf", "object": "associated", "obj_type": "Reg", "file_name": "PubMed-29216801.json", "snippet": " a Fetus With Homozygous Loss of the SOX10 Gene and Phenotypic Correlation by Autopsy Examination.\nThe SOX10 gene plays a vital role in neural crest cell development and migration.  [CLS] Abnormalities in SOX10 are associated [CLS]  with Waardenburg syndrome Types II and IV, and these patients have recognizable clinical features. This case report highlights the first ever reported homozygous loss of function of the SOX10"}
{"subject": "SOX10", "sub_type": "Gene", "rel": "ThemeOf", "object": "Abnormalities", "obj_type": "Var", "file_name": "PubMed-29216801.json", "snippet": " a Fetus With Homozygous Loss of the SOX10 Gene and Phenotypic Correlation by Autopsy Examination.\nThe SOX10 gene plays a vital role in neural crest cell development and migration.  [CLS] Abnormalities in SOX10 [CLS]  are associated with Waardenburg syndrome Types II and IV, and these patients have recognizable clinical features. This case report highlights the first ever reported homozygous loss of function of"}
{"subject": "Waardenburg syndrome", "sub_type": "Disease", "rel": "ThemeOf", "object": "associated", "obj_type": "Reg", "file_name": "PubMed-29216801.json", "snippet": " Loss of the SOX10 Gene and Phenotypic Correlation by Autopsy Examination.\nThe SOX10 gene plays a vital role in neural crest cell development and migration. Abnormalities in SOX10 are  [CLS] associated with Waardenburg syndrome [CLS]  Types II and IV, and these patients have recognizable clinical features. This case report highlights the first ever reported homozygous loss of function of the SOX10 gene in a"}
{"subject": "Types II", "sub_type": "Disease", "rel": "ThemeOf", "object": "Waardenburg syndrome", "obj_type": "Disease", "file_name": "PubMed-29216801.json", "snippet": " the SOX10 Gene and Phenotypic Correlation by Autopsy Examination.\nThe SOX10 gene plays a vital role in neural crest cell development and migration. Abnormalities in SOX10 are associated with  [CLS] Waardenburg syndrome Types II [CLS]  and IV, and these patients have recognizable clinical features. This case report highlights the first ever reported homozygous loss of function of the SOX10 gene in a human. This"}
{"subject": "IV", "sub_type": "Disease", "rel": "ThemeOf", "object": "Waardenburg syndrome", "obj_type": "Disease", "file_name": "PubMed-29216801.json", "snippet": " the SOX10 Gene and Phenotypic Correlation by Autopsy Examination.\nThe SOX10 gene plays a vital role in neural crest cell development and migration. Abnormalities in SOX10 are associated with  [CLS] Waardenburg syndrome Types II and IV [CLS] , and these patients have recognizable clinical features. This case report highlights the first ever reported homozygous loss of function of the SOX10 gene in a human. This deletion is"}
{"subject": "NR2F2", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutation", "obj_type": "Var", "file_name": "PubMed-29222010.json", "snippet": " [CLS] NR2F2 loss-of-function mutation [CLS]  predisposes to congenital heart defect.\nCongenital heart defect (CHD) is the most common type of birth defect in humans and a leading cause of infant morbidity and mortality. Previous"}
{"subject": "NR2F2", "sub_type": "Gene", "rel": "ThemeOf", "object": "synergistic transcriptional activation", "obj_type": "MPA", "file_name": "PubMed-29222010.json", "snippet": " deciphers by using a dual-luciferase reporter assay system revealed that the mutant NR2F2 protein had no transcriptional activity as compared with its wild-type counterpart. Furthermore, the mutation abrogated the  [CLS] synergistic transcriptional activation between NR2F2 [CLS]  and GATA4, another core cardiac transcription factor associated with CHD. This study firstly associates NR2F2 loss-of-function mutation with an increased susceptibility to double outlet right ventricle in humans, which"}
{"subject": "GATA4", "sub_type": "Gene", "rel": "ThemeOf", "object": "synergistic transcriptional activation", "obj_type": "MPA", "file_name": "PubMed-29222010.json", "snippet": " deciphers by using a dual-luciferase reporter assay system revealed that the mutant NR2F2 protein had no transcriptional activity as compared with its wild-type counterpart. Furthermore, the mutation abrogated the  [CLS] synergistic transcriptional activation between NR2F2 and GATA4 [CLS] , another core cardiac transcription factor associated with CHD. This study firstly associates NR2F2 loss-of-function mutation with an increased susceptibility to double outlet right ventricle in humans, which provides further"}
{"subject": "mutation", "sub_type": "Var", "rel": "CauseOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-29222010.json", "snippet": " [CLS] loss-of-function mutation [CLS]  predisposes to congenital heart defect.\nCongenital heart defect (CHD) is the most common type of birth defect in humans and a leading cause of infant morbidity and mortality. Previous"}
{"subject": "congenital heart defect", "sub_type": "Disease", "rel": "ThemeOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-29222010.json", "snippet": " [CLS] loss-of-function mutation predisposes to congenital heart defect [CLS] .\nCongenital heart defect (CHD) is the most common type of birth defect in humans and a leading cause of infant morbidity and mortality. Previous studies have demonstrated that genetic"}
{"subject": "NR2F2", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutant", "obj_type": "Var", "file_name": "PubMed-29222010.json", "snippet": " with complete penetrance. The nonsense mutation was absent in 230 unrelated, ethnically-matched healthy individuals used as controls. Functional deciphers by using a dual-luciferase reporter assay system revealed that the  [CLS] mutant NR2F2 [CLS]  protein had no transcriptional activity as compared with its wild-type counterpart. Furthermore, the mutation abrogated the synergistic transcriptional activation between NR2F2 and GATA4, another core cardiac transcription factor associated"}
{"subject": "mutant", "sub_type": "Var", "rel": "CauseOf", "object": "no", "obj_type": "NegReg", "file_name": "PubMed-29222010.json", "snippet": " with complete penetrance. The nonsense mutation was absent in 230 unrelated, ethnically-matched healthy individuals used as controls. Functional deciphers by using a dual-luciferase reporter assay system revealed that the  [CLS] mutant NR2F2 protein had no [CLS]  transcriptional activity as compared with its wild-type counterpart. Furthermore, the mutation abrogated the synergistic transcriptional activation between NR2F2 and GATA4, another core cardiac transcription factor associated with CHD. This"}
{"subject": "transcriptional activity", "sub_type": "MPA", "rel": "ThemeOf", "object": "no", "obj_type": "NegReg", "file_name": "PubMed-29222010.json", "snippet": " nonsense mutation was absent in 230 unrelated, ethnically-matched healthy individuals used as controls. Functional deciphers by using a dual-luciferase reporter assay system revealed that the mutant NR2F2 protein had  [CLS] no transcriptional activity [CLS]  as compared with its wild-type counterpart. Furthermore, the mutation abrogated the synergistic transcriptional activation between NR2F2 and GATA4, another core cardiac transcription factor associated with CHD. This study firstly"}
{"subject": "NR2F2", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutation", "obj_type": "Var", "file_name": "PubMed-29222010.json", "snippet": " complete penetrance. The nonsense mutation was absent in 230 unrelated, ethnically-matched healthy individuals used as controls. Functional deciphers by using a dual-luciferase reporter assay system revealed that the mutant  [CLS] NR2F2 protein had no transcriptional activity as compared with its wild-type counterpart. Furthermore, the mutation [CLS]  abrogated the synergistic transcriptional activation between NR2F2 and GATA4, another core cardiac transcription factor associated with CHD. This study firstly associates NR2F2 loss-of-function mutation with an increased susceptibility to"}
{"subject": "mutation", "sub_type": "Var", "rel": "CauseOf", "object": "abrogated", "obj_type": "NegReg", "file_name": "PubMed-29222010.json", "snippet": " as controls. Functional deciphers by using a dual-luciferase reporter assay system revealed that the mutant NR2F2 protein had no transcriptional activity as compared with its wild-type counterpart. Furthermore, the  [CLS] mutation abrogated [CLS]  the synergistic transcriptional activation between NR2F2 and GATA4, another core cardiac transcription factor associated with CHD. This study firstly associates NR2F2 loss-of-function mutation with an increased susceptibility to double"}
{"subject": "synergistic transcriptional activation", "sub_type": "MPA", "rel": "ThemeOf", "object": "abrogated", "obj_type": "NegReg", "file_name": "PubMed-29222010.json", "snippet": " controls. Functional deciphers by using a dual-luciferase reporter assay system revealed that the mutant NR2F2 protein had no transcriptional activity as compared with its wild-type counterpart. Furthermore, the mutation  [CLS] abrogated the synergistic transcriptional activation [CLS]  between NR2F2 and GATA4, another core cardiac transcription factor associated with CHD. This study firstly associates NR2F2 loss-of-function mutation with an increased susceptibility to double outlet right ventricle in"}
{"subject": "FMR1", "sub_type": "Gene", "rel": "ThemeOf", "object": "expansion of 55-200 CGG repeats", "obj_type": "Var", "file_name": "PubMed-29223504.json", "snippet": " [CLS] expansion of 55-200 CGG repeats located in the FMR1 [CLS]  gene. The main clinical and neuropathological features of FXTAS are progressive intention tremor and gait ataxia associated with brain atrophy, neuronal cell loss and presence of ubiquitin-positive intranuclear inclusions"}
{"subject": "expansion of 55-200 CGG repeats", "sub_type": "Var", "rel": "CauseOf", "object": "caused by", "obj_type": "Reg", "file_name": "PubMed-29223504.json", "snippet": " [CLS] caused by an expansion of 55-200 CGG repeats [CLS]  located in the FMR1 gene. The main clinical and neuropathological features of FXTAS are progressive intention tremor and gait ataxia associated with brain atrophy, neuronal cell loss and presence"}
{"subject": "Fragile X-associated tremor/ataxia syndrome", "sub_type": "Disease", "rel": "ThemeOf", "object": "caused by", "obj_type": "Reg", "file_name": "PubMed-29223504.json", "snippet": " [CLS] Fragile X-associated tremor/ataxia syndrome (FXTAS) is an inherited neurodegenerative disease caused by [CLS]  an expansion of 55-200 CGG repeats located in the FMR1 gene. The main clinical and neuropathological features of FXTAS are progressive intention tremor and gait ataxia associated with brain"}
{"subject": "DCHS1", "sub_type": "Gene", "rel": "ThemeOf", "object": "variants", "obj_type": "Var", "file_name": "PubMed-29224215.json", "snippet": " [CLS] variants in DCHS1 [CLS]  are prevalent in sporadic cases of mitral valve prolapse.\nBACKGROUND: A recent study identified DCHS1 as a causal gene for mitral valve prolapse. The goal of this study is"}
{"subject": "variants", "sub_type": "Var", "rel": "CauseOf", "object": "prevalent", "obj_type": "Reg", "file_name": "PubMed-29224215.json", "snippet": " [CLS] variants in DCHS1 are prevalent [CLS]  in sporadic cases of mitral valve prolapse.\nBACKGROUND: A recent study identified DCHS1 as a causal gene for mitral valve prolapse. The goal of this study is to investigate"}
{"subject": "mitral valve prolapse", "sub_type": "Disease", "rel": "ThemeOf", "object": "prevalent", "obj_type": "Reg", "file_name": "PubMed-29224215.json", "snippet": " [CLS] prevalent in sporadic cases of mitral valve prolapse [CLS] .\nBACKGROUND: A recent study identified DCHS1 as a causal gene for mitral valve prolapse. The goal of this study is to investigate the presence and frequency of known and"}
{"subject": "DCHS1", "sub_type": "Gene", "rel": "ThemeOf", "object": "p.R2330C", "obj_type": "Var", "file_name": "PubMed-29224215.json", "snippet": " variants in this gene in 100 asymptomatic patients with moderate to severe organic mitral regurgitation.\nMETHODS: DNA sequencing assays were developed for two previously identified functional missense variants, namely  [CLS] p.R2330C and p.R2513H, and all 21 exons of DCHS1 [CLS] . Pathogenicity of variants was evaluated in silico.\nRESULTS: p.R2330C and p.R2513H were not identified in this cohort. Sequencing all coding regions revealed eight missense variants including six considered deleterious."}
{"subject": "DCHS1", "sub_type": "Gene", "rel": "ThemeOf", "object": "p.R2513H", "obj_type": "Var", "file_name": "PubMed-29224215.json", "snippet": " this gene in 100 asymptomatic patients with moderate to severe organic mitral regurgitation.\nMETHODS: DNA sequencing assays were developed for two previously identified functional missense variants, namely p.R2330C and  [CLS] p.R2513H, and all 21 exons of DCHS1 [CLS] . Pathogenicity of variants was evaluated in silico.\nRESULTS: p.R2330C and p.R2513H were not identified in this cohort. Sequencing all coding regions revealed eight missense variants including six considered deleterious."}
{"subject": "PSMC3IP", "sub_type": "Gene", "rel": "ThemeOf", "object": "Mutation", "obj_type": "Var", "file_name": "PubMed-29240891.json", "snippet": " [CLS] PSMC3IP Stop Gain Mutation [CLS] .\nContext: The etiology of primary ovarian insufficiency (POI) remains unknown in most cases.\nObjective: We sought to identify the genes causing POI.\nDesign: The study was a familial genetic"}
{"subject": "Mutation", "sub_type": "Var", "rel": "CauseOf", "object": "Carriers", "obj_type": "Reg", "file_name": "PubMed-29240891.json", "snippet": " [CLS] Carriers of a Homozygous PSMC3IP Stop Gain Mutation [CLS] .\nContext: The etiology of primary ovarian insufficiency (POI) remains unknown in most cases.\nObjective: We sought to identify the genes causing POI.\nDesign: The study was a familial genetic"}
{"subject": "Azoospermia", "sub_type": "Disease", "rel": "ThemeOf", "object": "Carriers", "obj_type": "Reg", "file_name": "PubMed-29240891.json", "snippet": " [CLS] Azoospermia in Carriers [CLS]  of a Homozygous PSMC3IP Stop Gain Mutation.\nContext: The etiology of primary ovarian insufficiency (POI) remains unknown in most cases.\nObjective: We sought to identify the genes causing POI."}
{"subject": "Primary Ovarian Insufficiency", "sub_type": "Disease", "rel": "ThemeOf", "object": "Carriers", "obj_type": "Reg", "file_name": "PubMed-29240891.json", "snippet": " [CLS] Primary Ovarian Insufficiency and Azoospermia in Carriers [CLS]  of a Homozygous PSMC3IP Stop Gain Mutation.\nContext: The etiology of primary ovarian insufficiency (POI) remains unknown in most cases.\nObjective: We sought to identify the genes causing POI."}
{"subject": "c.100C>T", "sub_type": "Var", "rel": "ThemeOf", "object": "mutation", "obj_type": "Var", "file_name": "PubMed-29240891.json", "snippet": " the four sisters.\nResults: The sisters shared a homozygous stop gain mutation in exon 6 of PSMC3IP (c.489 C>G, p.Tyr163Ter) and a missense variant in exon 1 of CLPP ( [CLS] c.100C>T, p.Pro34Ser). The affected brother also carried the homozygous PSMC3IP mutation. Functional studies demonstrated mitochondrial fragmentation in cells infected with the CLPP mutation [CLS] . However, no abnormality was found in mitochondrial targeting or respiration.\nConclusions: The PSMC3IP mutation provides additional evidence that mutations in meiotic homologous recombination and DNA repair genes result in"}
{"subject": "CLPP", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutation", "obj_type": "Var", "file_name": "PubMed-29240891.json", "snippet": " a missense variant in exon 1 of CLPP (c.100C>T, p.Pro34Ser). The affected brother also carried the homozygous PSMC3IP mutation. Functional studies demonstrated mitochondrial fragmentation in cells infected with the  [CLS] CLPP mutation [CLS] . However, no abnormality was found in mitochondrial targeting or respiration.\nConclusions: The PSMC3IP mutation provides additional evidence that mutations in meiotic homologous recombination and DNA repair genes result in"}
{"subject": "mutation", "sub_type": "Var", "rel": "CauseOf", "object": "demonstrated", "obj_type": "Reg", "file_name": "PubMed-29240891.json", "snippet": " exon 6 of PSMC3IP (c.489 C>G, p.Tyr163Ter) and a missense variant in exon 1 of CLPP (c.100C>T, p.Pro34Ser). The affected brother also carried the homozygous PSMC3IP mutation. Functional studies  [CLS] demonstrated mitochondrial fragmentation in cells infected with the CLPP mutation [CLS] . However, no abnormality was found in mitochondrial targeting or respiration.\nConclusions: The PSMC3IP mutation provides additional evidence that mutations in meiotic homologous recombination and DNA repair genes result in"}
{"subject": "mitochondrial fragmentation", "sub_type": "CPA", "rel": "ThemeOf", "object": "demonstrated", "obj_type": "Reg", "file_name": "PubMed-29240891.json", "snippet": " exon 6 of PSMC3IP (c.489 C>G, p.Tyr163Ter) and a missense variant in exon 1 of CLPP (c.100C>T, p.Pro34Ser). The affected brother also carried the homozygous PSMC3IP mutation. Functional studies  [CLS] demonstrated mitochondrial fragmentation [CLS]  in cells infected with the CLPP mutation. However, no abnormality was found in mitochondrial targeting or respiration.\nConclusions: The PSMC3IP mutation provides additional evidence that mutations in meiotic homologous"}
{"subject": "hop-1", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutants", "obj_type": "Var", "file_name": "PubMed-29242286.json", "snippet": " of an adult stem cell pool relies exclusively on HOP-1-mediated Notch signaling. We also show that HOP-1 is necessary for maximum fecundity and reproductive span. The low-fecundity phenotype of  [CLS] hop-1 mutants [CLS]  can be phenocopied by switching off glp-1/Notch function during the last stage of larval development. We propose that at the end of larval development, dual presenilin usage switches exclusively"}
{"subject": "production", "sub_type": "CPA", "rel": "ThemeOf", "object": "defects", "obj_type": "NegReg", "file_name": "PubMed-29242286.json", "snippet": " development. We propose that at the end of larval development, dual presenilin usage switches exclusively to HOP-1, perhaps offering opportunities for differential regulation of the germline during adulthood. Additional  [CLS] defects in oocyte size and production [CLS]  rate in hop-1 and glp-1 mutants indicate that the process of oogenesis is compromised when germline Notch signaling is switched off. We calculate that in wild-type adults, as much"}
{"subject": "oocyte size", "sub_type": "CPA", "rel": "ThemeOf", "object": "defects", "obj_type": "NegReg", "file_name": "PubMed-29242286.json", "snippet": " development. We propose that at the end of larval development, dual presenilin usage switches exclusively to HOP-1, perhaps offering opportunities for differential regulation of the germline during adulthood. Additional  [CLS] defects in oocyte size [CLS]  and production rate in hop-1 and glp-1 mutants indicate that the process of oogenesis is compromised when germline Notch signaling is switched off. We calculate that in wild-type adults,"}
{"subject": "fecundity", "sub_type": "CPA", "rel": "ThemeOf", "object": "low", "obj_type": "NegReg", "file_name": "PubMed-29242286.json", "snippet": " germline, but maintenance of an adult stem cell pool relies exclusively on HOP-1-mediated Notch signaling. We also show that HOP-1 is necessary for maximum fecundity and reproductive span. The  [CLS] low-fecundity [CLS]  phenotype of hop-1 mutants can be phenocopied by switching off glp-1/Notch function during the last stage of larval development. We propose that at the end of larval development, dual"}
{"subject": "mutants", "sub_type": "Var", "rel": "CauseOf", "object": "switching off", "obj_type": "NegReg", "file_name": "PubMed-29242286.json", "snippet": " an adult stem cell pool relies exclusively on HOP-1-mediated Notch signaling. We also show that HOP-1 is necessary for maximum fecundity and reproductive span. The low-fecundity phenotype of hop-1  [CLS] mutants can be phenocopied by switching off [CLS]  glp-1/Notch function during the last stage of larval development. We propose that at the end of larval development, dual presenilin usage switches exclusively to HOP-1, perhaps offering opportunities for"}
{"subject": "glp-1/Notch function", "sub_type": "MPA", "rel": "ThemeOf", "object": "switching off", "obj_type": "NegReg", "file_name": "PubMed-29242286.json", "snippet": " relies exclusively on HOP-1-mediated Notch signaling. We also show that HOP-1 is necessary for maximum fecundity and reproductive span. The low-fecundity phenotype of hop-1 mutants can be phenocopied by  [CLS] switching off glp-1/Notch function [CLS]  during the last stage of larval development. We propose that at the end of larval development, dual presenilin usage switches exclusively to HOP-1, perhaps offering opportunities for differential regulation"}
{"subject": "switching off", "sub_type": "NegReg", "rel": "CauseOf", "object": "fecundity", "obj_type": "CPA", "file_name": "PubMed-29242286.json", "snippet": " germline, but maintenance of an adult stem cell pool relies exclusively on HOP-1-mediated Notch signaling. We also show that HOP-1 is necessary for maximum fecundity and reproductive span. The low- [CLS] fecundity phenotype of hop-1 mutants can be phenocopied by switching off [CLS]  glp-1/Notch function during the last stage of larval development. We propose that at the end of larval development, dual presenilin usage switches exclusively to HOP-1, perhaps offering opportunities for"}
{"subject": "glp-1", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutants", "obj_type": "Var", "file_name": "PubMed-29242286.json", "snippet": " dual presenilin usage switches exclusively to HOP-1, perhaps offering opportunities for differential regulation of the germline during adulthood. Additional defects in oocyte size and production rate in hop-1 and  [CLS] glp-1 mutants [CLS]  indicate that the process of oogenesis is compromised when germline Notch signaling is switched off. We calculate that in wild-type adults, as much as 86% of cells derived from"}
{"subject": "hop-1", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutants", "obj_type": "Var", "file_name": "PubMed-29242286.json", "snippet": " larval development, dual presenilin usage switches exclusively to HOP-1, perhaps offering opportunities for differential regulation of the germline during adulthood. Additional defects in oocyte size and production rate in  [CLS] hop-1 and glp-1 mutants [CLS]  indicate that the process of oogenesis is compromised when germline Notch signaling is switched off. We calculate that in wild-type adults, as much as 86% of cells derived from"}
{"subject": "mutants", "sub_type": "Var", "rel": "CauseOf", "object": "defects", "obj_type": "NegReg", "file_name": "PubMed-29242286.json", "snippet": " development. We propose that at the end of larval development, dual presenilin usage switches exclusively to HOP-1, perhaps offering opportunities for differential regulation of the germline during adulthood. Additional  [CLS] defects in oocyte size and production rate in hop-1 and glp-1 mutants [CLS]  indicate that the process of oogenesis is compromised when germline Notch signaling is switched off. We calculate that in wild-type adults, as much as 86% of cells derived from"}
{"subject": "lac4", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutants", "obj_type": "Var", "file_name": "PubMed-29242289.json", "snippet": " results show that a mutant of Kluyveromyces lactis with stably short telomeres produced a large increase in the frequency of mutations affecting the native subtelomeric \u03b2-galactosidase (LAC4) gene. All  [CLS] lac4 mutants [CLS]  examined from strains with severe telomere dysfunction underwent terminal deletion/duplication events consistent with being due to break-induced replication. In contrast, although cells with mild telomere dysfunction also exhibited similar"}
{"subject": "mutants", "sub_type": "Var", "rel": "CauseOf", "object": "underwent", "obj_type": "Reg", "file_name": "PubMed-29242289.json", "snippet": " show that a mutant of Kluyveromyces lactis with stably short telomeres produced a large increase in the frequency of mutations affecting the native subtelomeric \u03b2-galactosidase (LAC4) gene. All lac4  [CLS] mutants examined from strains with severe telomere dysfunction underwent [CLS]  terminal deletion/duplication events consistent with being due to break-induced replication. In contrast, although cells with mild telomere dysfunction also exhibited similar terminal deletion and duplication events, up to 50%"}
{"subject": "terminal deletion/duplication", "sub_type": "MPA", "rel": "ThemeOf", "object": "underwent", "obj_type": "Reg", "file_name": "PubMed-29242289.json", "snippet": " stably short telomeres produced a large increase in the frequency of mutations affecting the native subtelomeric \u03b2-galactosidase (LAC4) gene. All lac4 mutants examined from strains with severe telomere dysfunction  [CLS] underwent terminal deletion/duplication [CLS]  events consistent with being due to break-induced replication. In contrast, although cells with mild telomere dysfunction also exhibited similar terminal deletion and duplication events, up to 50% of lac4"}
{"subject": "lac4", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutants", "obj_type": "Var", "file_name": "PubMed-29242289.json", "snippet": " deletion/duplication events consistent with being due to break-induced replication. In contrast, although cells with mild telomere dysfunction also exhibited similar terminal deletion and duplication events, up to 50% of  [CLS] lac4 mutants [CLS]  from this background unexpectedly contained base changes within the LAC4 coding region. This mutational bias for producing base changes demonstrates that mild telomere dysfunction can be well suited as"}
{"subject": "mutants", "sub_type": "Var", "rel": "CauseOf", "object": "contained", "obj_type": "Reg", "file_name": "PubMed-29242289.json", "snippet": " events consistent with being due to break-induced replication. In contrast, although cells with mild telomere dysfunction also exhibited similar terminal deletion and duplication events, up to 50% of lac4  [CLS] mutants from this background unexpectedly contained [CLS]  base changes within the LAC4 coding region. This mutational bias for producing base changes demonstrates that mild telomere dysfunction can be well suited as a force for altering the"}
{"subject": "base changes", "sub_type": "MPA", "rel": "ThemeOf", "object": "contained", "obj_type": "Reg", "file_name": "PubMed-29242289.json", "snippet": " to break-induced replication. In contrast, although cells with mild telomere dysfunction also exhibited similar terminal deletion and duplication events, up to 50% of lac4 mutants from this background unexpectedly  [CLS] contained base changes [CLS]  within the LAC4 coding region. This mutational bias for producing base changes demonstrates that mild telomere dysfunction can be well suited as a force for altering the adaptive potential"}
{"subject": "variants", "sub_type": "Var", "rel": "CauseOf", "object": "loss of function", "obj_type": "NegReg", "file_name": "PubMed-29255178.json", "snippet": " [CLS] loss of function variants [CLS]  in either of two genes encoding histone-modifying enzymes. We performed targeted sequencing in a cohort of 27 probands with a clinical diagnosis of Kabuki syndrome. Of these, 12 had"}
{"subject": "Kabuki syndrome", "sub_type": "Disease", "rel": "ThemeOf", "object": "loss of function", "obj_type": "NegReg", "file_name": "PubMed-29255178.json", "snippet": " [CLS] Kabuki syndrome is a monogenic disorder caused by loss of function [CLS]  variants in either of two genes encoding histone-modifying enzymes. We performed targeted sequencing in a cohort of 27 probands with a clinical diagnosis of Kabuki syndrome. Of these, 12"}
{"subject": "variants", "sub_type": "Var", "rel": "CauseOf", "object": "associated", "obj_type": "Reg", "file_name": "PubMed-29255178.json", "snippet": " a clinical diagnosis of Kabuki syndrome. Of these, 12 had causative variants in the two known Kabuki syndrome genes. In 2, we identified presumptive loss of function de novo  [CLS] variants in KMT2A (missense and splice site variants), a gene that encodes another histone modifying enzyme previously exclusively associated [CLS]  with Wiedermann-Steiner syndrome. Although Kabuki syndrome is a disorder of histone modification, we also find alterations in DNA methylation among individuals with a Kabuki syndrome diagnosis relative to matched"}
{"subject": "Wiedermann-Steiner syndrome", "sub_type": "Disease", "rel": "ThemeOf", "object": "associated", "obj_type": "Reg", "file_name": "PubMed-29255178.json", "snippet": " genes. In 2, we identified presumptive loss of function de novo variants in KMT2A (missense and splice site variants), a gene that encodes another histone modifying enzyme previously exclusively  [CLS] associated with Wiedermann-Steiner syndrome [CLS] . Although Kabuki syndrome is a disorder of histone modification, we also find alterations in DNA methylation among individuals with a Kabuki syndrome diagnosis relative to matched normal controls, regardless"}
{"subject": "KMT2A", "sub_type": "Gene", "rel": "ThemeOf", "object": "variants", "obj_type": "Var", "file_name": "PubMed-29255178.json", "snippet": " a clinical diagnosis of Kabuki syndrome. Of these, 12 had causative variants in the two known Kabuki syndrome genes. In 2, we identified presumptive loss of function de novo  [CLS] variants in KMT2A [CLS]  (missense and splice site variants), a gene that encodes another histone modifying enzyme previously exclusively associated with Wiedermann-Steiner syndrome. Although Kabuki syndrome is a disorder of histone modification, we"}
{"subject": "ARL13B", "sub_type": "Gene", "rel": "ThemeOf", "object": "variant", "obj_type": "Var", "file_name": "PubMed-29255182.json", "snippet": " [CLS] ARL13B variant [CLS]  in patients with Joubert syndrome impairs its guanine nucleotide-exchange factor activity.\nARL13B encodes for the ADP-ribosylation factor-like 13B GTPase, which is required for normal cilia structure and Sonic hedgehog"}
{"subject": "variant", "sub_type": "Var", "rel": "CauseOf", "object": "impairs", "obj_type": "NegReg", "file_name": "PubMed-29255182.json", "snippet": " [CLS] variant in patients with Joubert syndrome impairs [CLS]  its guanine nucleotide-exchange factor activity.\nARL13B encodes for the ADP-ribosylation factor-like 13B GTPase, which is required for normal cilia structure and Sonic hedgehog (Shh) signaling. Disruptions in cilia structure"}
{"subject": "guanine nucleotide-exchange factor activity", "sub_type": "MPA", "rel": "ThemeOf", "object": "impairs", "obj_type": "NegReg", "file_name": "PubMed-29255182.json", "snippet": " [CLS] impairs its guanine nucleotide-exchange factor activity [CLS] .\nARL13B encodes for the ADP-ribosylation factor-like 13B GTPase, which is required for normal cilia structure and Sonic hedgehog (Shh) signaling. Disruptions in cilia structure or function lead to a"}
{"subject": "ARL13B", "sub_type": "Gene", "rel": "ThemeOf", "object": "c.[223G>A]", "obj_type": "Var", "file_name": "PubMed-29255182.json", "snippet": " and ARL13B-c.[223G>A] (p.(Gly75Arg) expression rescued the cilia length and Shh defects displayed by Arl13b hennin (null) cells, indicating that the variant did not disrupt either ARL13B function. In contrast,  [CLS] ARL13B-c.[223G>A] [CLS]  (p.(Gly75Arg) displayed a marked loss of ARL3 guanine nucleotide-exchange factor activity, with retention of its GTPase activities, highlighting the correlation between its loss of function as an ARL3 guanine"}
{"subject": "c.[223G>A]", "sub_type": "Var", "rel": "CauseOf", "object": "loss", "obj_type": "NegReg", "file_name": "PubMed-29255182.json", "snippet": " and ARL13B-c.[223G>A] (p.(Gly75Arg) expression rescued the cilia length and Shh defects displayed by Arl13b hennin (null) cells, indicating that the variant did not disrupt either ARL13B function. In contrast, ARL13B- [CLS] c.[223G>A] (p.(Gly75Arg) displayed a marked loss [CLS]  of ARL3 guanine nucleotide-exchange factor activity, with retention of its GTPase activities, highlighting the correlation between its loss of function as an ARL3 guanine nucleotide-exchange factor and Joubert syndrome."}
{"subject": "ARL3 guanine nucleotide-exchange factor activity", "sub_type": "MPA", "rel": "ThemeOf", "object": "loss", "obj_type": "NegReg", "file_name": "PubMed-29255182.json", "snippet": " the cilia length and Shh defects displayed by Arl13b hennin (null) cells, indicating that the variant did not disrupt either ARL13B function. In contrast, ARL13B-c.[223G>A] (p.(Gly75Arg) displayed a marked  [CLS] loss of ARL3 guanine nucleotide-exchange factor activity [CLS] , with retention of its GTPase activities, highlighting the correlation between its loss of function as an ARL3 guanine nucleotide-exchange factor and Joubert syndrome."}
{"subject": "Joubert syndrome", "sub_type": "Disease", "rel": "ThemeOf", "object": "loss", "obj_type": "NegReg", "file_name": "PubMed-29255182.json", "snippet": " the cilia length and Shh defects displayed by Arl13b hennin (null) cells, indicating that the variant did not disrupt either ARL13B function. In contrast, ARL13B-c.[223G>A] (p.(Gly75Arg) displayed a marked  [CLS] loss of ARL3 guanine nucleotide-exchange factor activity, with retention of its GTPase activities, highlighting the correlation between its loss of function as an ARL3 guanine nucleotide-exchange factor and Joubert syndrome [CLS] ."}
{"subject": "ABCC9", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-29275331.json", "snippet": " [CLS] ABCC9) mutations [CLS]  in distinct structural domains result in KATP channel gain-of-function by differential mechanisms.\nThe complex disorder Cantu syndrome (CS) arises from gain-of-function mutations in either KCNJ8 or ABCC9, the genes"}
{"subject": "channel activity", "sub_type": "MPA", "rel": "ThemeOf", "object": "increase", "obj_type": "PosReg", "file_name": "PubMed-29275331.json", "snippet": " from gain-of-function mutations in either KCNJ8 or ABCC9, the genes encoding the Kir6.1 and SUR2 subunits of ATP-sensitive potassium (KATP) channels, respectively. Recent reports indicate that such mutations can  [CLS] increase channel activity [CLS]  by multiple molecular mechanisms. In this study, we determined the mechanism by which KATP function is altered by several substitutions in distinct structural domains of SUR2: D207E in the"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "increase", "obj_type": "PosReg", "file_name": "PubMed-29275331.json", "snippet": " (CS) arises from gain-of-function mutations in either KCNJ8 or ABCC9, the genes encoding the Kir6.1 and SUR2 subunits of ATP-sensitive potassium (KATP) channels, respectively. Recent reports indicate that such  [CLS] mutations can increase [CLS]  channel activity by multiple molecular mechanisms. In this study, we determined the mechanism by which KATP function is altered by several substitutions in distinct structural domains of SUR2: D207E"}
{"subject": "SUR2", "sub_type": "Gene", "rel": "ThemeOf", "object": "D207E", "obj_type": "Var", "file_name": "PubMed-29275331.json", "snippet": " can increase channel activity by multiple molecular mechanisms. In this study, we determined the mechanism by which KATP function is altered by several substitutions in distinct structural domains of  [CLS] SUR2: D207E [CLS]  in the intracellular L0-linker and Y985S, G989E, M1060I, and R1154Q/R1154W in TMD2. We engineered substitutions at their equivalent positions in rat SUR2A (D207E, Y981S, G985E, M1056I, and R1150Q/R1150W) and"}
{"subject": "SUR2", "sub_type": "Gene", "rel": "ThemeOf", "object": "Y985S", "obj_type": "Var", "file_name": "PubMed-29275331.json", "snippet": " can increase channel activity by multiple molecular mechanisms. In this study, we determined the mechanism by which KATP function is altered by several substitutions in distinct structural domains of  [CLS] SUR2: D207E in the intracellular L0-linker and Y985S [CLS] , G989E, M1060I, and R1154Q/R1154W in TMD2. We engineered substitutions at their equivalent positions in rat SUR2A (D207E, Y981S, G985E, M1056I, and R1150Q/R1150W) and investigated functional consequences using macroscopic rubidium"}
{"subject": "SUR2", "sub_type": "Gene", "rel": "ThemeOf", "object": "G989E", "obj_type": "Var", "file_name": "PubMed-29275331.json", "snippet": " can increase channel activity by multiple molecular mechanisms. In this study, we determined the mechanism by which KATP function is altered by several substitutions in distinct structural domains of  [CLS] SUR2: D207E in the intracellular L0-linker and Y985S, G989E [CLS] , M1060I, and R1154Q/R1154W in TMD2. We engineered substitutions at their equivalent positions in rat SUR2A (D207E, Y981S, G985E, M1056I, and R1150Q/R1150W) and investigated functional consequences using macroscopic rubidium (86Rb+)"}
{"subject": "SUR2", "sub_type": "Gene", "rel": "ThemeOf", "object": "M1060I", "obj_type": "Var", "file_name": "PubMed-29275331.json", "snippet": " can increase channel activity by multiple molecular mechanisms. In this study, we determined the mechanism by which KATP function is altered by several substitutions in distinct structural domains of  [CLS] SUR2: D207E in the intracellular L0-linker and Y985S, G989E, M1060I [CLS] , and R1154Q/R1154W in TMD2. We engineered substitutions at their equivalent positions in rat SUR2A (D207E, Y981S, G985E, M1056I, and R1150Q/R1150W) and investigated functional consequences using macroscopic rubidium (86Rb+) efflux"}
{"subject": "SUR2", "sub_type": "Gene", "rel": "ThemeOf", "object": "R1154Q", "obj_type": "Var", "file_name": "PubMed-29275331.json", "snippet": " can increase channel activity by multiple molecular mechanisms. In this study, we determined the mechanism by which KATP function is altered by several substitutions in distinct structural domains of  [CLS] SUR2: D207E in the intracellular L0-linker and Y985S, G989E, M1060I, and R1154Q [CLS] /R1154W in TMD2. We engineered substitutions at their equivalent positions in rat SUR2A (D207E, Y981S, G985E, M1056I, and R1150Q/R1150W) and investigated functional consequences using macroscopic rubidium (86Rb+) efflux assays and"}
{"subject": "SUR2", "sub_type": "Gene", "rel": "ThemeOf", "object": "R1154W", "obj_type": "Var", "file_name": "PubMed-29275331.json", "snippet": " can increase channel activity by multiple molecular mechanisms. In this study, we determined the mechanism by which KATP function is altered by several substitutions in distinct structural domains of  [CLS] SUR2: D207E in the intracellular L0-linker and Y985S, G989E, M1060I, and R1154Q/R1154W [CLS]  in TMD2. We engineered substitutions at their equivalent positions in rat SUR2A (D207E, Y981S, G985E, M1056I, and R1150Q/R1150W) and investigated functional consequences using macroscopic rubidium (86Rb+) efflux assays and"}
{"subject": "R1154W", "sub_type": "Var", "rel": "CauseOf", "object": "altered", "obj_type": "Reg", "file_name": "PubMed-29275331.json", "snippet": " (KATP) channels, respectively. Recent reports indicate that such mutations can increase channel activity by multiple molecular mechanisms. In this study, we determined the mechanism by which KATP function is  [CLS] altered by several substitutions in distinct structural domains of SUR2: D207E in the intracellular L0-linker and Y985S, G989E, M1060I, and R1154Q/R1154W [CLS]  in TMD2. We engineered substitutions at their equivalent positions in rat SUR2A (D207E, Y981S, G985E, M1056I, and R1150Q/R1150W) and investigated functional consequences using macroscopic rubidium (86Rb+) efflux assays and"}
{"subject": "R1154Q", "sub_type": "Var", "rel": "CauseOf", "object": "altered", "obj_type": "Reg", "file_name": "PubMed-29275331.json", "snippet": " (KATP) channels, respectively. Recent reports indicate that such mutations can increase channel activity by multiple molecular mechanisms. In this study, we determined the mechanism by which KATP function is  [CLS] altered by several substitutions in distinct structural domains of SUR2: D207E in the intracellular L0-linker and Y985S, G989E, M1060I, and R1154Q [CLS] /R1154W in TMD2. We engineered substitutions at their equivalent positions in rat SUR2A (D207E, Y981S, G985E, M1056I, and R1150Q/R1150W) and investigated functional consequences using macroscopic rubidium (86Rb+) efflux assays and"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-29275331.json", "snippet": " [CLS] mutations in distinct structural domains result in KATP channel gain-of-function [CLS]  by differential mechanisms.\nThe complex disorder Cantu syndrome (CS) arises from gain-of-function mutations in either KCNJ8 or ABCC9, the genes encoding the Kir6.1 and SUR2 subunits of ATP-sensitive potassium"}
{"subject": "Y985S", "sub_type": "Var", "rel": "CauseOf", "object": "altered", "obj_type": "Reg", "file_name": "PubMed-29275331.json", "snippet": " (KATP) channels, respectively. Recent reports indicate that such mutations can increase channel activity by multiple molecular mechanisms. In this study, we determined the mechanism by which KATP function is  [CLS] altered by several substitutions in distinct structural domains of SUR2: D207E in the intracellular L0-linker and Y985S [CLS] , G989E, M1060I, and R1154Q/R1154W in TMD2. We engineered substitutions at their equivalent positions in rat SUR2A (D207E, Y981S, G985E, M1056I, and R1150Q/R1150W) and investigated functional consequences using macroscopic rubidium"}
{"subject": "G989E", "sub_type": "Var", "rel": "CauseOf", "object": "altered", "obj_type": "Reg", "file_name": "PubMed-29275331.json", "snippet": " (KATP) channels, respectively. Recent reports indicate that such mutations can increase channel activity by multiple molecular mechanisms. In this study, we determined the mechanism by which KATP function is  [CLS] altered by several substitutions in distinct structural domains of SUR2: D207E in the intracellular L0-linker and Y985S, G989E [CLS] , M1060I, and R1154Q/R1154W in TMD2. We engineered substitutions at their equivalent positions in rat SUR2A (D207E, Y981S, G985E, M1056I, and R1150Q/R1150W) and investigated functional consequences using macroscopic rubidium (86Rb+)"}
{"subject": "M1060I", "sub_type": "Var", "rel": "CauseOf", "object": "altered", "obj_type": "Reg", "file_name": "PubMed-29275331.json", "snippet": " (KATP) channels, respectively. Recent reports indicate that such mutations can increase channel activity by multiple molecular mechanisms. In this study, we determined the mechanism by which KATP function is  [CLS] altered by several substitutions in distinct structural domains of SUR2: D207E in the intracellular L0-linker and Y985S, G989E, M1060I [CLS] , and R1154Q/R1154W in TMD2. We engineered substitutions at their equivalent positions in rat SUR2A (D207E, Y981S, G985E, M1056I, and R1150Q/R1150W) and investigated functional consequences using macroscopic rubidium (86Rb+) efflux"}
{"subject": "KATP function", "sub_type": "MPA", "rel": "ThemeOf", "object": "altered", "obj_type": "Reg", "file_name": "PubMed-29275331.json", "snippet": " of ATP-sensitive potassium (KATP) channels, respectively. Recent reports indicate that such mutations can increase channel activity by multiple molecular mechanisms. In this study, we determined the mechanism by which  [CLS] KATP function is altered [CLS]  by several substitutions in distinct structural domains of SUR2: D207E in the intracellular L0-linker and Y985S, G989E, M1060I, and R1154Q/R1154W in TMD2. We engineered substitutions at their equivalent positions"}
{"subject": "D207E", "sub_type": "Var", "rel": "CauseOf", "object": "increasing", "obj_type": "PosReg", "file_name": "PubMed-29275331.json", "snippet": " their equivalent positions in rat SUR2A (D207E, Y981S, G985E, M1056I, and R1150Q/R1150W) and investigated functional consequences using macroscopic rubidium (86Rb+) efflux assays and patch-clamp electrophysiology. Our results indicate that  [CLS] D207E increases KATP channel activity by increasing [CLS]  intrinsic stability of the open state, whereas the cluster of Y981S/G985E/M1056I substitutions, as well as R1150Q/R1150W, augmented Mg-nucleotide activation. We also tested the responses of these channel variants to"}
{"subject": "intrinsic stability of the open state", "sub_type": "MPA", "rel": "ThemeOf", "object": "increasing", "obj_type": "PosReg", "file_name": "PubMed-29275331.json", "snippet": " (D207E, Y981S, G985E, M1056I, and R1150Q/R1150W) and investigated functional consequences using macroscopic rubidium (86Rb+) efflux assays and patch-clamp electrophysiology. Our results indicate that D207E increases KATP channel activity by  [CLS] increasing intrinsic stability of the open state [CLS] , whereas the cluster of Y981S/G985E/M1056I substitutions, as well as R1150Q/R1150W, augmented Mg-nucleotide activation. We also tested the responses of these channel variants to inhibition by the sulfonylurea drug glibenclamide,"}
{"subject": "increasing", "sub_type": "PosReg", "rel": "CauseOf", "object": "increases", "obj_type": "PosReg", "file_name": "PubMed-29275331.json", "snippet": " equivalent positions in rat SUR2A (D207E, Y981S, G985E, M1056I, and R1150Q/R1150W) and investigated functional consequences using macroscopic rubidium (86Rb+) efflux assays and patch-clamp electrophysiology. Our results indicate that D207E  [CLS] increases KATP channel activity by increasing [CLS]  intrinsic stability of the open state, whereas the cluster of Y981S/G985E/M1056I substitutions, as well as R1150Q/R1150W, augmented Mg-nucleotide activation. We also tested the responses of these channel variants to"}
{"subject": "KATP channel activity", "sub_type": "MPA", "rel": "ThemeOf", "object": "increases", "obj_type": "PosReg", "file_name": "PubMed-29275331.json", "snippet": " equivalent positions in rat SUR2A (D207E, Y981S, G985E, M1056I, and R1150Q/R1150W) and investigated functional consequences using macroscopic rubidium (86Rb+) efflux assays and patch-clamp electrophysiology. Our results indicate that D207E  [CLS] increases KATP channel activity [CLS]  by increasing intrinsic stability of the open state, whereas the cluster of Y981S/G985E/M1056I substitutions, as well as R1150Q/R1150W, augmented Mg-nucleotide activation. We also tested the responses of these channel"}
{"subject": "Y981S", "sub_type": "Var", "rel": "CauseOf", "object": "augmented", "obj_type": "PosReg", "file_name": "PubMed-29275331.json", "snippet": " macroscopic rubidium (86Rb+) efflux assays and patch-clamp electrophysiology. Our results indicate that D207E increases KATP channel activity by increasing intrinsic stability of the open state, whereas the cluster of  [CLS] Y981S/G985E/M1056I substitutions, as well as R1150Q/R1150W, augmented [CLS]  Mg-nucleotide activation. We also tested the responses of these channel variants to inhibition by the sulfonylurea drug glibenclamide, a potential pharmacotherapy for CS. None of the D207E, Y981S, G985E,"}
{"subject": "G985E", "sub_type": "Var", "rel": "CauseOf", "object": "augmented", "obj_type": "PosReg", "file_name": "PubMed-29275331.json", "snippet": " macroscopic rubidium (86Rb+) efflux assays and patch-clamp electrophysiology. Our results indicate that D207E increases KATP channel activity by increasing intrinsic stability of the open state, whereas the cluster of Y981S/ [CLS] G985E/M1056I substitutions, as well as R1150Q/R1150W, augmented [CLS]  Mg-nucleotide activation. We also tested the responses of these channel variants to inhibition by the sulfonylurea drug glibenclamide, a potential pharmacotherapy for CS. None of the D207E, Y981S, G985E,"}
{"subject": "KATP channel", "sub_type": "MPA", "rel": "ThemeOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-29275331.json", "snippet": " [CLS] KATP channel gain-of-function [CLS]  by differential mechanisms.\nThe complex disorder Cantu syndrome (CS) arises from gain-of-function mutations in either KCNJ8 or ABCC9, the genes encoding the Kir6.1 and SUR2 subunits of ATP-sensitive potassium"}
{"subject": "M1056I", "sub_type": "Var", "rel": "CauseOf", "object": "augmented", "obj_type": "PosReg", "file_name": "PubMed-29275331.json", "snippet": " macroscopic rubidium (86Rb+) efflux assays and patch-clamp electrophysiology. Our results indicate that D207E increases KATP channel activity by increasing intrinsic stability of the open state, whereas the cluster of Y981S/G985E/ [CLS] M1056I substitutions, as well as R1150Q/R1150W, augmented [CLS]  Mg-nucleotide activation. We also tested the responses of these channel variants to inhibition by the sulfonylurea drug glibenclamide, a potential pharmacotherapy for CS. None of the D207E, Y981S, G985E,"}
{"subject": "R1150Q", "sub_type": "Var", "rel": "CauseOf", "object": "augmented", "obj_type": "PosReg", "file_name": "PubMed-29275331.json", "snippet": " and patch-clamp electrophysiology. Our results indicate that D207E increases KATP channel activity by increasing intrinsic stability of the open state, whereas the cluster of Y981S/G985E/M1056I substitutions, as well as  [CLS] R1150Q/R1150W, augmented [CLS]  Mg-nucleotide activation. We also tested the responses of these channel variants to inhibition by the sulfonylurea drug glibenclamide, a potential pharmacotherapy for CS. None of the D207E, Y981S, G985E,"}
{"subject": "R1150W", "sub_type": "Var", "rel": "CauseOf", "object": "augmented", "obj_type": "PosReg", "file_name": "PubMed-29275331.json", "snippet": " and patch-clamp electrophysiology. Our results indicate that D207E increases KATP channel activity by increasing intrinsic stability of the open state, whereas the cluster of Y981S/G985E/M1056I substitutions, as well as R1150Q/ [CLS] R1150W, augmented [CLS]  Mg-nucleotide activation. We also tested the responses of these channel variants to inhibition by the sulfonylurea drug glibenclamide, a potential pharmacotherapy for CS. None of the D207E, Y981S, G985E,"}
{"subject": "Mg-nucleotide activation", "sub_type": "MPA", "rel": "ThemeOf", "object": "augmented", "obj_type": "PosReg", "file_name": "PubMed-29275331.json", "snippet": " patch-clamp electrophysiology. Our results indicate that D207E increases KATP channel activity by increasing intrinsic stability of the open state, whereas the cluster of Y981S/G985E/M1056I substitutions, as well as R1150Q/R1150W,  [CLS] augmented Mg-nucleotide activation [CLS] . We also tested the responses of these channel variants to inhibition by the sulfonylurea drug glibenclamide, a potential pharmacotherapy for CS. None of the D207E, Y981S, G985E, or M1056I"}
{"subject": "KCNJ8", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-29275331.json", "snippet": " [CLS] mutations in either KCNJ8 [CLS]  or ABCC9, the genes encoding the Kir6.1 and SUR2 subunits of ATP-sensitive potassium (KATP) channels, respectively. Recent reports indicate that such mutations can increase channel activity by multiple molecular"}
{"subject": "ABCC9", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-29275331.json", "snippet": " [CLS] mutations in either KCNJ8 or ABCC9 [CLS] , the genes encoding the Kir6.1 and SUR2 subunits of ATP-sensitive potassium (KATP) channels, respectively. Recent reports indicate that such mutations can increase channel activity by multiple molecular mechanisms. In"}
{"subject": "Cantu syndrome", "sub_type": "Disease", "rel": "ThemeOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-29275331.json", "snippet": " [CLS] Cantu syndrome (CS) arises from gain-of-function [CLS]  mutations in either KCNJ8 or ABCC9, the genes encoding the Kir6.1 and SUR2 subunits of ATP-sensitive potassium (KATP) channels, respectively. Recent reports indicate that such mutations can increase channel"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-29275331.json", "snippet": " [CLS] gain-of-function mutations [CLS]  in either KCNJ8 or ABCC9, the genes encoding the Kir6.1 and SUR2 subunits of ATP-sensitive potassium (KATP) channels, respectively. Recent reports indicate that such mutations can increase channel activity"}
{"subject": "KCNJ8", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-29275331.json", "snippet": " [CLS] KCNJ8 or ABCC9, the genes encoding the Kir6.1 and SUR2 subunits of ATP-sensitive potassium (KATP) channels, respectively. Recent reports indicate that such mutations [CLS]  can increase channel activity by multiple molecular mechanisms. In this study, we determined the mechanism by which KATP function is altered by several substitutions in distinct structural domains of"}
{"subject": "ABCC9", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-29275331.json", "snippet": " SUR2 (ABCC9) mutations in distinct structural domains result in KATP channel gain-of-function by differential mechanisms.\nThe complex disorder Cantu syndrome (CS) arises from gain-of-function mutations in either KCNJ8 or  [CLS] ABCC9, the genes encoding the Kir6.1 and SUR2 subunits of ATP-sensitive potassium (KATP) channels, respectively. Recent reports indicate that such mutations [CLS]  can increase channel activity by multiple molecular mechanisms. In this study, we determined the mechanism by which KATP function is altered by several substitutions in distinct structural domains of"}
{"subject": "PLC3", "sub_type": "Gene", "rel": "ThemeOf", "object": "knock-down mutants", "obj_type": "Var", "file_name": "PubMed-29309666.json", "snippet": " and because PIP2 levels are extremely low. Nonetheless, the Arabidopsis genome encodes nine PLCs. We used a reversed-genetic approach to explore PLC's function in Arabidopsis, and report here that  [CLS] PLC3 is required for proper root development, seed germination and stomatal opening. Two independent knock-down mutants [CLS] , plc3-2 and plc3-3, were found to exhibit reduced lateral root densities by 10-20%. Mutant seeds germinated more slowly but were less sensitive to ABA to prevent germination. Guard cells"}
{"subject": "knock-down mutants", "sub_type": "Var", "rel": "CauseOf", "object": "reduced", "obj_type": "NegReg", "file_name": "PubMed-29309666.json", "snippet": " We used a reversed-genetic approach to explore PLC's function in Arabidopsis, and report here that PLC3 is required for proper root development, seed germination and stomatal opening. Two independent  [CLS] knock-down mutants, plc3-2 and plc3-3, were found to exhibit reduced [CLS]  lateral root densities by 10-20%. Mutant seeds germinated more slowly but were less sensitive to ABA to prevent germination. Guard cells of plc3 were also compromised in ABA-dependent stomatal"}
{"subject": "lateral root densities", "sub_type": "CPA", "rel": "ThemeOf", "object": "reduced", "obj_type": "NegReg", "file_name": "PubMed-29309666.json", "snippet": " in Arabidopsis, and report here that PLC3 is required for proper root development, seed germination and stomatal opening. Two independent knock-down mutants, plc3-2 and plc3-3, were found to exhibit  [CLS] reduced lateral root densities [CLS]  by 10-20%. Mutant seeds germinated more slowly but were less sensitive to ABA to prevent germination. Guard cells of plc3 were also compromised in ABA-dependent stomatal closure. Promoter-\u03b2-glucuronidase (GUS)"}
{"subject": "Mutant", "sub_type": "Var", "rel": "CauseOf", "object": "slowly", "obj_type": "NegReg", "file_name": "PubMed-29309666.json", "snippet": " PLC3 is required for proper root development, seed germination and stomatal opening. Two independent knock-down mutants, plc3-2 and plc3-3, were found to exhibit reduced lateral root densities by 10-20%.  [CLS] Mutant seeds germinated more slowly [CLS]  but were less sensitive to ABA to prevent germination. Guard cells of plc3 were also compromised in ABA-dependent stomatal closure. Promoter-\u03b2-glucuronidase (GUS) analyses confirmed PLC3 expression in guard cells"}
{"subject": "germinated", "sub_type": "CPA", "rel": "ThemeOf", "object": "slowly", "obj_type": "NegReg", "file_name": "PubMed-29309666.json", "snippet": " required for proper root development, seed germination and stomatal opening. Two independent knock-down mutants, plc3-2 and plc3-3, were found to exhibit reduced lateral root densities by 10-20%. Mutant seeds  [CLS] germinated more slowly [CLS]  but were less sensitive to ABA to prevent germination. Guard cells of plc3 were also compromised in ABA-dependent stomatal closure. Promoter-\u03b2-glucuronidase (GUS) analyses confirmed PLC3 expression in guard cells"}
{"subject": "plc3", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutants", "obj_type": "Var", "file_name": "PubMed-29309666.json", "snippet": " roots, leaves and flowers. In vivo 32Pi labeling revealed that ABA stimulated the formation of PIP2 in germinating seeds and guard cell-enriched leaf peels, which was significantly reduced in  [CLS] plc3 mutants [CLS] . Overexpression of PLC3 had no effect on root system architecture or seed germination, but increased the plant's tolerance to drought. Our results provide genetic evidence for PLC's involvement in"}
{"subject": "mutants", "sub_type": "Var", "rel": "CauseOf", "object": "reduced", "obj_type": "NegReg", "file_name": "PubMed-29309666.json", "snippet": " cells, in roots, leaves and flowers. In vivo 32Pi labeling revealed that ABA stimulated the formation of PIP2 in germinating seeds and guard cell-enriched leaf peels, which was significantly  [CLS] reduced in plc3 mutants [CLS] . Overexpression of PLC3 had no effect on root system architecture or seed germination, but increased the plant's tolerance to drought. Our results provide genetic evidence for PLC's involvement in"}
{"subject": "formation of PIP2", "sub_type": "MPA", "rel": "ThemeOf", "object": "reduced", "obj_type": "NegReg", "file_name": "PubMed-29309666.json", "snippet": " and revealed that the majority is expressed in vascular tissue, most probably phloem companion cells, in roots, leaves and flowers. In vivo 32Pi labeling revealed that ABA stimulated the  [CLS] formation of PIP2 in germinating seeds and guard cell-enriched leaf peels, which was significantly reduced [CLS]  in plc3 mutants. Overexpression of PLC3 had no effect on root system architecture or seed germination, but increased the plant's tolerance to drought. Our results provide genetic evidence for"}
{"subject": "N-methyl-D-aspartate glutamate receptors", "sub_type": "Protein", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-29317596.json", "snippet": " [CLS] mutations in N-methyl-D-aspartate glutamate receptors [CLS]  and their contributions to schizophrenia susceptibility.\nIn schizophrenia (SCZ) and autism spectrum disorder (ASD), the dysregulation of glutamate transmission through N-methyl-D-aspartate receptors (NMDARs) has been implicated as a potential"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "loss of function", "obj_type": "NegReg", "file_name": "PubMed-29317596.json", "snippet": " [CLS] loss of function mutations [CLS]  in N-methyl-D-aspartate glutamate receptors and their contributions to schizophrenia susceptibility.\nIn schizophrenia (SCZ) and autism spectrum disorder (ASD), the dysregulation of glutamate transmission through N-methyl-D-aspartate receptors (NMDARs) has been"}
{"subject": "schizophrenia", "sub_type": "Disease", "rel": "ThemeOf", "object": "loss of function", "obj_type": "NegReg", "file_name": "PubMed-29317596.json", "snippet": " [CLS] loss of function mutations in N-methyl-D-aspartate glutamate receptors and their contributions to schizophrenia [CLS]  susceptibility.\nIn schizophrenia (SCZ) and autism spectrum disorder (ASD), the dysregulation of glutamate transmission through N-methyl-D-aspartate receptors (NMDARs) has been implicated as a potential etiological mechanism. Previous studies have"}
{"subject": "NMDARs", "sub_type": "Gene", "rel": "ThemeOf", "object": "nonsense or splice site", "obj_type": "Var", "file_name": "PubMed-29317596.json", "snippet": " cases, and 2040 controls. Both of them were revealed to be singleton. Our study gives evidence in support of the view that ultra-rare variants with loss of function (frameshift,  [CLS] nonsense or splice site) in NMDARs [CLS]  genes may contribute to possible risk of SCZ."}
{"subject": "NMDARs", "sub_type": "Gene", "rel": "ThemeOf", "object": "frameshift", "obj_type": "Var", "file_name": "PubMed-29317596.json", "snippet": " ASD cases, and 2040 controls. Both of them were revealed to be singleton. Our study gives evidence in support of the view that ultra-rare variants with loss of function ( [CLS] frameshift, nonsense or splice site) in NMDARs [CLS]  genes may contribute to possible risk of SCZ."}
{"subject": "frameshift", "sub_type": "Var", "rel": "CauseOf", "object": "loss of function", "obj_type": "NegReg", "file_name": "PubMed-29317596.json", "snippet": " SCZ cases, 382 ASD cases, and 2040 controls. Both of them were revealed to be singleton. Our study gives evidence in support of the view that ultra-rare variants with  [CLS] loss of function (frameshift [CLS] , nonsense or splice site) in NMDARs genes may contribute to possible risk of SCZ."}
{"subject": "nonsense or splice site", "sub_type": "Var", "rel": "CauseOf", "object": "loss of function", "obj_type": "NegReg", "file_name": "PubMed-29317596.json", "snippet": " SCZ cases, 382 ASD cases, and 2040 controls. Both of them were revealed to be singleton. Our study gives evidence in support of the view that ultra-rare variants with  [CLS] loss of function (frameshift, nonsense or splice site [CLS] ) in NMDARs genes may contribute to possible risk of SCZ."}
{"subject": "SCZ", "sub_type": "Disease", "rel": "ThemeOf", "object": "loss of function", "obj_type": "NegReg", "file_name": "PubMed-29317596.json", "snippet": " SCZ cases, 382 ASD cases, and 2040 controls. Both of them were revealed to be singleton. Our study gives evidence in support of the view that ultra-rare variants with  [CLS] loss of function (frameshift, nonsense or splice site) in NMDARs genes may contribute to possible risk of SCZ [CLS] ."}
{"subject": "fln1", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutants", "obj_type": "Var", "file_name": "PubMed-29319227.json", "snippet": " phenotype to that of the fln1 mutants. Quantitative reverse transcription polymerase chain reaction and immunoblot analysis revealed that the transcription and translation of PEP-dependent genes were strongly inhibited in  [CLS] fln1 and trxz mutants [CLS] , indicating that loss of OsFLN1, HSA1/OsFLN2, or OsTRXz function perturbs the stability of the transcriptionally active chromosome complex and PEP activity. These results show that OsFLN1 and HSA1/OsFLN2 contribute"}
{"subject": "stability of the transcriptionally active chromosome complex", "sub_type": "CPA", "rel": "ThemeOf", "object": "perturbs", "obj_type": "NegReg", "file_name": "PubMed-29319227.json", "snippet": " and immunoblot analysis revealed that the transcription and translation of PEP-dependent genes were strongly inhibited in fln1 and trxz mutants, indicating that loss of OsFLN1, HSA1/OsFLN2, or OsTRXz function  [CLS] perturbs the stability of the transcriptionally active chromosome complex [CLS]  and PEP activity. These results show that OsFLN1 and HSA1/OsFLN2 contribute to chloroplast biogenesis and plant growth."}
{"subject": "mutants", "sub_type": "Var", "rel": "CauseOf", "object": "inhibited", "obj_type": "NegReg", "file_name": "PubMed-29319227.json", "snippet": " seedling lethality phenotype to that of the fln1 mutants. Quantitative reverse transcription polymerase chain reaction and immunoblot analysis revealed that the transcription and translation of PEP-dependent genes were strongly  [CLS] inhibited in fln1 and trxz mutants [CLS] , indicating that loss of OsFLN1, HSA1/OsFLN2, or OsTRXz function perturbs the stability of the transcriptionally active chromosome complex and PEP activity. These results show that OsFLN1 and HSA1/OsFLN2 contribute"}
{"subject": "transcription", "sub_type": "MPA", "rel": "ThemeOf", "object": "inhibited", "obj_type": "NegReg", "file_name": "PubMed-29319227.json", "snippet": " of OsTRXz resulted in a similar albino and seedling lethality phenotype to that of the fln1 mutants. Quantitative reverse transcription polymerase chain reaction and immunoblot analysis revealed that the  [CLS] transcription and translation of PEP-dependent genes were strongly inhibited [CLS]  in fln1 and trxz mutants, indicating that loss of OsFLN1, HSA1/OsFLN2, or OsTRXz function perturbs the stability of the transcriptionally active chromosome complex and PEP activity. These results show"}
{"subject": "translation", "sub_type": "MPA", "rel": "ThemeOf", "object": "inhibited", "obj_type": "NegReg", "file_name": "PubMed-29319227.json", "snippet": " resulted in a similar albino and seedling lethality phenotype to that of the fln1 mutants. Quantitative reverse transcription polymerase chain reaction and immunoblot analysis revealed that the transcription and  [CLS] translation of PEP-dependent genes were strongly inhibited [CLS]  in fln1 and trxz mutants, indicating that loss of OsFLN1, HSA1/OsFLN2, or OsTRXz function perturbs the stability of the transcriptionally active chromosome complex and PEP activity. These results show"}
{"subject": "PEP-dependent genes", "sub_type": "Gene", "rel": "ThemeOf", "object": "translation", "obj_type": "MPA", "file_name": "PubMed-29319227.json", "snippet": " resulted in a similar albino and seedling lethality phenotype to that of the fln1 mutants. Quantitative reverse transcription polymerase chain reaction and immunoblot analysis revealed that the transcription and  [CLS] translation of PEP-dependent genes [CLS]  were strongly inhibited in fln1 and trxz mutants, indicating that loss of OsFLN1, HSA1/OsFLN2, or OsTRXz function perturbs the stability of the transcriptionally active chromosome complex and PEP activity."}
{"subject": "PEP-dependent genes", "sub_type": "Gene", "rel": "ThemeOf", "object": "transcription", "obj_type": "MPA", "file_name": "PubMed-29319227.json", "snippet": " of OsTRXz resulted in a similar albino and seedling lethality phenotype to that of the fln1 mutants. Quantitative reverse transcription polymerase chain reaction and immunoblot analysis revealed that the  [CLS] transcription and translation of PEP-dependent genes [CLS]  were strongly inhibited in fln1 and trxz mutants, indicating that loss of OsFLN1, HSA1/OsFLN2, or OsTRXz function perturbs the stability of the transcriptionally active chromosome complex and PEP activity."}
{"subject": "inhibited", "sub_type": "NegReg", "rel": "CauseOf", "object": "perturbs", "obj_type": "NegReg", "file_name": "PubMed-29319227.json", "snippet": " seedling lethality phenotype to that of the fln1 mutants. Quantitative reverse transcription polymerase chain reaction and immunoblot analysis revealed that the transcription and translation of PEP-dependent genes were strongly  [CLS] inhibited in fln1 and trxz mutants, indicating that loss of OsFLN1, HSA1/OsFLN2, or OsTRXz function perturbs [CLS]  the stability of the transcriptionally active chromosome complex and PEP activity. These results show that OsFLN1 and HSA1/OsFLN2 contribute to chloroplast biogenesis and plant growth."}
{"subject": "PEP", "sub_type": "Enzyme", "rel": "ThemeOf", "object": "activity", "obj_type": "MPA", "file_name": "PubMed-29319227.json", "snippet": " PEP-dependent genes were strongly inhibited in fln1 and trxz mutants, indicating that loss of OsFLN1, HSA1/OsFLN2, or OsTRXz function perturbs the stability of the transcriptionally active chromosome complex and  [CLS] PEP activity [CLS] . These results show that OsFLN1 and HSA1/OsFLN2 contribute to chloroplast biogenesis and plant growth."}
{"subject": "activity", "sub_type": "MPA", "rel": "ThemeOf", "object": "perturbs", "obj_type": "NegReg", "file_name": "PubMed-29319227.json", "snippet": " and immunoblot analysis revealed that the transcription and translation of PEP-dependent genes were strongly inhibited in fln1 and trxz mutants, indicating that loss of OsFLN1, HSA1/OsFLN2, or OsTRXz function  [CLS] perturbs the stability of the transcriptionally active chromosome complex and PEP activity [CLS] . These results show that OsFLN1 and HSA1/OsFLN2 contribute to chloroplast biogenesis and plant growth."}
{"subject": "SHP2", "sub_type": "Gene", "rel": "ThemeOf", "object": "E76K", "obj_type": "Var", "file_name": "PubMed-29323748.json", "snippet": " [CLS] E76K in SHP2 [CLS]  promotes CAC tumorigenesis and induces EMT via the Wnt/\u03b2-catenin signaling pathway.\nSHP2 is encoded by the protein tyrosine phosphatase 11 (Ptpn11) gene. Several gain-of-function (GOF) mutations in Ptpn11 have"}
{"subject": "E76K", "sub_type": "Var", "rel": "CauseOf", "object": "aggravated", "obj_type": "PosReg", "file_name": "PubMed-29323748.json", "snippet": " knock-in mice to study this GOF mutation in colitis-associated CRC (CAC) and used the CRC cell lines HT29 and HCT116 to determine the relationship between SHP2 and Wnt/\u03b2-catenin signaling. Ptpn11 [CLS] E76K conditional knock-in mice exhibited aggravated [CLS]  inflammation and increased CAC tumorigenesis. In vitro, SHP2E76K and SHP2WT promoted malignant biological behaviors of CRC cells and induced epithelial-mesenchymal transition (EMT) via the Wnt/\u03b2-catenin signaling pathway. Together, our"}
{"subject": "inflammation", "sub_type": "CPA", "rel": "ThemeOf", "object": "aggravated", "obj_type": "PosReg", "file_name": "PubMed-29323748.json", "snippet": " GOF mutation in colitis-associated CRC (CAC) and used the CRC cell lines HT29 and HCT116 to determine the relationship between SHP2 and Wnt/\u03b2-catenin signaling. Ptpn11E76K conditional knock-in mice exhibited  [CLS] aggravated inflammation [CLS]  and increased CAC tumorigenesis. In vitro, SHP2E76K and SHP2WT promoted malignant biological behaviors of CRC cells and induced epithelial-mesenchymal transition (EMT) via the Wnt/\u03b2-catenin signaling pathway. Together, our results"}
{"subject": "E76K", "sub_type": "Var", "rel": "CauseOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-29323748.json", "snippet": " knock-in mice to study this GOF mutation in colitis-associated CRC (CAC) and used the CRC cell lines HT29 and HCT116 to determine the relationship between SHP2 and Wnt/\u03b2-catenin signaling. Ptpn11 [CLS] E76K conditional knock-in mice exhibited aggravated inflammation and increased [CLS]  CAC tumorigenesis. In vitro, SHP2E76K and SHP2WT promoted malignant biological behaviors of CRC cells and induced epithelial-mesenchymal transition (EMT) via the Wnt/\u03b2-catenin signaling pathway. Together, our results showed that"}
{"subject": "SHP2", "sub_type": "Gene", "rel": "ThemeOf", "object": "E76K", "obj_type": "Var", "file_name": "PubMed-29323748.json", "snippet": " the CRC cell lines HT29 and HCT116 to determine the relationship between SHP2 and Wnt/\u03b2-catenin signaling. Ptpn11E76K conditional knock-in mice exhibited aggravated inflammation and increased CAC tumorigenesis. In vitro,  [CLS] SHP2E76K [CLS]  and SHP2WT promoted malignant biological behaviors of CRC cells and induced epithelial-mesenchymal transition (EMT) via the Wnt/\u03b2-catenin signaling pathway. Together, our results showed that SHP2E76K acts as an oncogene"}
{"subject": "E76K", "sub_type": "Var", "rel": "CauseOf", "object": "promoted", "obj_type": "PosReg", "file_name": "PubMed-29323748.json", "snippet": " the CRC cell lines HT29 and HCT116 to determine the relationship between SHP2 and Wnt/\u03b2-catenin signaling. Ptpn11E76K conditional knock-in mice exhibited aggravated inflammation and increased CAC tumorigenesis. In vitro, SHP2 [CLS] E76K and SHP2WT promoted [CLS]  malignant biological behaviors of CRC cells and induced epithelial-mesenchymal transition (EMT) via the Wnt/\u03b2-catenin signaling pathway. Together, our results showed that SHP2E76K acts as an oncogene that promotes the"}
{"subject": "E76K", "sub_type": "Var", "rel": "CauseOf", "object": "induced", "obj_type": "PosReg", "file_name": "PubMed-29323748.json", "snippet": " the CRC cell lines HT29 and HCT116 to determine the relationship between SHP2 and Wnt/\u03b2-catenin signaling. Ptpn11E76K conditional knock-in mice exhibited aggravated inflammation and increased CAC tumorigenesis. In vitro, SHP2 [CLS] E76K and SHP2WT promoted malignant biological behaviors of CRC cells and induced [CLS]  epithelial-mesenchymal transition (EMT) via the Wnt/\u03b2-catenin signaling pathway. Together, our results showed that SHP2E76K acts as an oncogene that promotes the tumorigenesis and metastasis of CRC."}
{"subject": "malignant biological behaviors of CRC cells", "sub_type": "CPA", "rel": "ThemeOf", "object": "promoted", "obj_type": "PosReg", "file_name": "PubMed-29323748.json", "snippet": " lines HT29 and HCT116 to determine the relationship between SHP2 and Wnt/\u03b2-catenin signaling. Ptpn11E76K conditional knock-in mice exhibited aggravated inflammation and increased CAC tumorigenesis. In vitro, SHP2E76K and SHP2WT  [CLS] promoted malignant biological behaviors of CRC cells [CLS]  and induced epithelial-mesenchymal transition (EMT) via the Wnt/\u03b2-catenin signaling pathway. Together, our results showed that SHP2E76K acts as an oncogene that promotes the tumorigenesis and metastasis of CRC."}
{"subject": "epithelial-mesenchymal transition", "sub_type": "CPA", "rel": "ThemeOf", "object": "induced", "obj_type": "PosReg", "file_name": "PubMed-29323748.json", "snippet": " between SHP2 and Wnt/\u03b2-catenin signaling. Ptpn11E76K conditional knock-in mice exhibited aggravated inflammation and increased CAC tumorigenesis. In vitro, SHP2E76K and SHP2WT promoted malignant biological behaviors of CRC cells and  [CLS] induced epithelial-mesenchymal transition [CLS]  (EMT) via the Wnt/\u03b2-catenin signaling pathway. Together, our results showed that SHP2E76K acts as an oncogene that promotes the tumorigenesis and metastasis of CRC."}
{"subject": "E76K", "sub_type": "Var", "rel": "CauseOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-29323748.json", "snippet": " [CLS] gain-of-function mutation E76K [CLS]  in SHP2 promotes CAC tumorigenesis and induces EMT via the Wnt/\u03b2-catenin signaling pathway.\nSHP2 is encoded by the protein tyrosine phosphatase 11 (Ptpn11) gene. Several gain-of-function (GOF) mutations in"}
{"subject": "SHP2", "sub_type": "Gene", "rel": "ThemeOf", "object": "E76K", "obj_type": "Var", "file_name": "PubMed-29323748.json", "snippet": " CAC tumorigenesis. In vitro, SHP2E76K and SHP2WT promoted malignant biological behaviors of CRC cells and induced epithelial-mesenchymal transition (EMT) via the Wnt/\u03b2-catenin signaling pathway. Together, our results showed that  [CLS] SHP2E76K [CLS]  acts as an oncogene that promotes the tumorigenesis and metastasis of CRC."}
{"subject": "E76K", "sub_type": "Var", "rel": "CauseOf", "object": "promotes", "obj_type": "PosReg", "file_name": "PubMed-29323748.json", "snippet": " CAC tumorigenesis. In vitro, SHP2E76K and SHP2WT promoted malignant biological behaviors of CRC cells and induced epithelial-mesenchymal transition (EMT) via the Wnt/\u03b2-catenin signaling pathway. Together, our results showed that SHP2 [CLS] E76K acts as an oncogene that promotes [CLS]  the tumorigenesis and metastasis of CRC."}
{"subject": "tumorigenesis", "sub_type": "CPA", "rel": "ThemeOf", "object": "promotes", "obj_type": "PosReg", "file_name": "PubMed-29323748.json", "snippet": " SHP2WT promoted malignant biological behaviors of CRC cells and induced epithelial-mesenchymal transition (EMT) via the Wnt/\u03b2-catenin signaling pathway. Together, our results showed that SHP2E76K acts as an oncogene that  [CLS] promotes the tumorigenesis [CLS]  and metastasis of CRC."}
{"subject": "metastasis", "sub_type": "CPA", "rel": "ThemeOf", "object": "promotes", "obj_type": "PosReg", "file_name": "PubMed-29323748.json", "snippet": " SHP2WT promoted malignant biological behaviors of CRC cells and induced epithelial-mesenchymal transition (EMT) via the Wnt/\u03b2-catenin signaling pathway. Together, our results showed that SHP2E76K acts as an oncogene that  [CLS] promotes the tumorigenesis and metastasis [CLS]  of CRC."}
{"subject": "CRC", "sub_type": "Disease", "rel": "ThemeOf", "object": "metastasis", "obj_type": "CPA", "file_name": "PubMed-29323748.json", "snippet": " behaviors of CRC cells and induced epithelial-mesenchymal transition (EMT) via the Wnt/\u03b2-catenin signaling pathway. Together, our results showed that SHP2E76K acts as an oncogene that promotes the tumorigenesis and  [CLS] metastasis of CRC [CLS] ."}
{"subject": "CRC", "sub_type": "Disease", "rel": "ThemeOf", "object": "tumorigenesis", "obj_type": "CPA", "file_name": "PubMed-29323748.json", "snippet": " malignant biological behaviors of CRC cells and induced epithelial-mesenchymal transition (EMT) via the Wnt/\u03b2-catenin signaling pathway. Together, our results showed that SHP2E76K acts as an oncogene that promotes the  [CLS] tumorigenesis and metastasis of CRC [CLS] ."}
{"subject": "tumorigenesis", "sub_type": "CPA", "rel": "ThemeOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-29323748.json", "snippet": " colitis-associated CRC (CAC) and used the CRC cell lines HT29 and HCT116 to determine the relationship between SHP2 and Wnt/\u03b2-catenin signaling. Ptpn11E76K conditional knock-in mice exhibited aggravated inflammation and  [CLS] increased CAC tumorigenesis [CLS] . In vitro, SHP2E76K and SHP2WT promoted malignant biological behaviors of CRC cells and induced epithelial-mesenchymal transition (EMT) via the Wnt/\u03b2-catenin signaling pathway. Together, our results showed that SHP2E76K acts"}
{"subject": "CAC", "sub_type": "Disease", "rel": "ThemeOf", "object": "tumorigenesis", "obj_type": "CPA", "file_name": "PubMed-29323748.json", "snippet": " CRC (CAC) and used the CRC cell lines HT29 and HCT116 to determine the relationship between SHP2 and Wnt/\u03b2-catenin signaling. Ptpn11E76K conditional knock-in mice exhibited aggravated inflammation and increased  [CLS] CAC tumorigenesis [CLS] . In vitro, SHP2E76K and SHP2WT promoted malignant biological behaviors of CRC cells and induced epithelial-mesenchymal transition (EMT) via the Wnt/\u03b2-catenin signaling pathway. Together, our results showed that SHP2E76K acts"}
{"subject": "CAC", "sub_type": "Disease", "rel": "ThemeOf", "object": "tumorigenesis", "obj_type": "CPA", "file_name": "PubMed-29323748.json", "snippet": " [CLS] CAC tumorigenesis [CLS]  and induces EMT via the Wnt/\u03b2-catenin signaling pathway.\nSHP2 is encoded by the protein tyrosine phosphatase 11 (Ptpn11) gene. Several gain-of-function (GOF) mutations in Ptpn11 have been identified in"}
{"subject": "tumorigenesis", "sub_type": "CPA", "rel": "ThemeOf", "object": "promotes", "obj_type": "PosReg", "file_name": "PubMed-29323748.json", "snippet": " [CLS] promotes CAC tumorigenesis [CLS]  and induces EMT via the Wnt/\u03b2-catenin signaling pathway.\nSHP2 is encoded by the protein tyrosine phosphatase 11 (Ptpn11) gene. Several gain-of-function (GOF) mutations in Ptpn11 have been identified in"}
{"subject": "gain-of-function", "sub_type": "PosReg", "rel": "CauseOf", "object": "promotes", "obj_type": "PosReg", "file_name": "PubMed-29323748.json", "snippet": " [CLS] gain-of-function mutation E76K in SHP2 promotes [CLS]  CAC tumorigenesis and induces EMT via the Wnt/\u03b2-catenin signaling pathway.\nSHP2 is encoded by the protein tyrosine phosphatase 11 (Ptpn11) gene. Several gain-of-function (GOF) mutations in Ptpn11 have been"}
{"subject": "SHP2", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutation", "obj_type": "Var", "file_name": "PubMed-29323748.json", "snippet": " is encoded by the protein tyrosine phosphatase 11 (Ptpn11) gene. Several gain-of-function (GOF) mutations in Ptpn11 have been identified in human hematopoietic malignancies and solid tumors. In addition, the  [CLS] mutation rate for SHP2 [CLS]  is the highest for colorectal cancer (CRC) among solid tumors. The E76K GOF mutation is the most common and active SHP2 mutation; however, the pathogenic effects and function of"}
{"subject": "mutation", "sub_type": "Var", "rel": "CauseOf", "object": "highest", "obj_type": "Reg", "file_name": "PubMed-29323748.json", "snippet": " is encoded by the protein tyrosine phosphatase 11 (Ptpn11) gene. Several gain-of-function (GOF) mutations in Ptpn11 have been identified in human hematopoietic malignancies and solid tumors. In addition, the  [CLS] mutation rate for SHP2 is the highest [CLS]  for colorectal cancer (CRC) among solid tumors. The E76K GOF mutation is the most common and active SHP2 mutation; however, the pathogenic effects and function of this mutation in"}
{"subject": "colorectal cancer", "sub_type": "Disease", "rel": "ThemeOf", "object": "highest", "obj_type": "Reg", "file_name": "PubMed-29323748.json", "snippet": " phosphatase 11 (Ptpn11) gene. Several gain-of-function (GOF) mutations in Ptpn11 have been identified in human hematopoietic malignancies and solid tumors. In addition, the mutation rate for SHP2 is the  [CLS] highest for colorectal cancer [CLS]  (CRC) among solid tumors. The E76K GOF mutation is the most common and active SHP2 mutation; however, the pathogenic effects and function of this mutation in CRC tumor progression"}
{"subject": "Wnt/\u03b2-catenin signaling pathway", "sub_type": "Pathway", "rel": "ThemeOf", "object": "induces", "obj_type": "PosReg", "file_name": "PubMed-29323748.json", "snippet": " [CLS] induces EMT via the Wnt/\u03b2-catenin signaling pathway [CLS] .\nSHP2 is encoded by the protein tyrosine phosphatase 11 (Ptpn11) gene. Several gain-of-function (GOF) mutations in Ptpn11 have been identified in human hematopoietic malignancies and solid tumors. In addition,"}
{"subject": "EMT", "sub_type": "CPA", "rel": "ThemeOf", "object": "induces", "obj_type": "PosReg", "file_name": "PubMed-29323748.json", "snippet": " [CLS] induces EMT [CLS]  via the Wnt/\u03b2-catenin signaling pathway.\nSHP2 is encoded by the protein tyrosine phosphatase 11 (Ptpn11) gene. Several gain-of-function (GOF) mutations in Ptpn11 have been identified in human hematopoietic malignancies"}
{"subject": "gain-of-function", "sub_type": "PosReg", "rel": "CauseOf", "object": "induces", "obj_type": "PosReg", "file_name": "PubMed-29323748.json", "snippet": " [CLS] gain-of-function mutation E76K in SHP2 promotes CAC tumorigenesis and induces [CLS]  EMT via the Wnt/\u03b2-catenin signaling pathway.\nSHP2 is encoded by the protein tyrosine phosphatase 11 (Ptpn11) gene. Several gain-of-function (GOF) mutations in Ptpn11 have been identified in human hematopoietic"}
{"subject": "Ptpn11", "sub_type": "Gene", "rel": "ThemeOf", "object": "E76K", "obj_type": "Var", "file_name": "PubMed-29323748.json", "snippet": " knock-in mice to study this GOF mutation in colitis-associated CRC (CAC) and used the CRC cell lines HT29 and HCT116 to determine the relationship between SHP2 and Wnt/\u03b2-catenin signaling.  [CLS] Ptpn11E76K [CLS]  conditional knock-in mice exhibited aggravated inflammation and increased CAC tumorigenesis. In vitro, SHP2E76K and SHP2WT promoted malignant biological behaviors of CRC cells and induced epithelial-mesenchymal transition (EMT) via the"}
{"subject": "PIGN", "sub_type": "Gene", "rel": "ThemeOf", "object": "missense", "obj_type": "Var", "file_name": "PubMed-29330547.json", "snippet": " in PIGN, encoding a component of the glycosylphosphatidylinositol (GPI)-anchor biosynthesis pathway, have been identified in a limited number of cases with a phenotype compatible with FS. Biallelic variants in  [CLS] PIGN, typically missense [CLS]  or compound missense with truncating, also cause multiple congenital anomalies-hypotonia-seizures syndrome 1 (MCAHS1). Here we report six further patients with FS with or without congenital diaphragmatic hernia and recessive"}
{"subject": "compound missense", "sub_type": "Var", "rel": "CauseOf", "object": "truncating", "obj_type": "MPA", "file_name": "PubMed-29330547.json", "snippet": " component of the glycosylphosphatidylinositol (GPI)-anchor biosynthesis pathway, have been identified in a limited number of cases with a phenotype compatible with FS. Biallelic variants in PIGN, typically missense or  [CLS] compound missense with truncating [CLS] , also cause multiple congenital anomalies-hypotonia-seizures syndrome 1 (MCAHS1). Here we report six further patients with FS with or without congenital diaphragmatic hernia and recessive loss of function PIGN alleles,"}
{"subject": "truncating", "sub_type": "MPA", "rel": "CauseOf", "object": "cause", "obj_type": "Reg", "file_name": "PubMed-29330547.json", "snippet": " glycosylphosphatidylinositol (GPI)-anchor biosynthesis pathway, have been identified in a limited number of cases with a phenotype compatible with FS. Biallelic variants in PIGN, typically missense or compound missense with  [CLS] truncating, also cause [CLS]  multiple congenital anomalies-hypotonia-seizures syndrome 1 (MCAHS1). Here we report six further patients with FS with or without congenital diaphragmatic hernia and recessive loss of function PIGN alleles, including an"}
{"subject": "PIGN", "sub_type": "Gene", "rel": "ThemeOf", "object": "compound missense", "obj_type": "Var", "file_name": "PubMed-29330547.json", "snippet": " in PIGN, encoding a component of the glycosylphosphatidylinositol (GPI)-anchor biosynthesis pathway, have been identified in a limited number of cases with a phenotype compatible with FS. Biallelic variants in  [CLS] PIGN, typically missense or compound missense [CLS]  with truncating, also cause multiple congenital anomalies-hypotonia-seizures syndrome 1 (MCAHS1). Here we report six further patients with FS with or without congenital diaphragmatic hernia and recessive loss of function"}
{"subject": "multiple congenital anomalies-hypotonia-seizures syndrome 1", "sub_type": "Disease", "rel": "ThemeOf", "object": "cause", "obj_type": "Reg", "file_name": "PubMed-29330547.json", "snippet": " biosynthesis pathway, have been identified in a limited number of cases with a phenotype compatible with FS. Biallelic variants in PIGN, typically missense or compound missense with truncating, also  [CLS] cause multiple congenital anomalies-hypotonia-seizures syndrome 1 [CLS]  (MCAHS1). Here we report six further patients with FS with or without congenital diaphragmatic hernia and recessive loss of function PIGN alleles, including an intragenic deletion with a likely"}
{"subject": "PIGN", "sub_type": "Gene", "rel": "ThemeOf", "object": "biallelic truncating variants", "obj_type": "Var", "file_name": "PubMed-29330547.json", "snippet": " other lower frequency malformations. FS is typically lethal in the fetal or neonatal period. Inheritance is presumed autosomal recessive. Although no major genetic cause has been identified for FS,  [CLS] biallelic truncating variants in PIGN [CLS] , encoding a component of the glycosylphosphatidylinositol (GPI)-anchor biosynthesis pathway, have been identified in a limited number of cases with a phenotype compatible with FS. Biallelic variants in PIGN, typically"}
{"subject": "biallelic truncating variants", "sub_type": "Var", "rel": "CauseOf", "object": "identified", "obj_type": "Reg", "file_name": "PubMed-29330547.json", "snippet": " other lower frequency malformations. FS is typically lethal in the fetal or neonatal period. Inheritance is presumed autosomal recessive. Although no major genetic cause has been identified for FS,  [CLS] biallelic truncating variants in PIGN, encoding a component of the glycosylphosphatidylinositol (GPI)-anchor biosynthesis pathway, have been identified [CLS]  in a limited number of cases with a phenotype compatible with FS. Biallelic variants in PIGN, typically missense or compound missense with truncating, also cause multiple congenital anomalies-hypotonia-seizures syndrome"}
{"subject": "FS", "sub_type": "Disease", "rel": "ThemeOf", "object": "identified", "obj_type": "Reg", "file_name": "PubMed-29330547.json", "snippet": " presumed autosomal recessive. Although no major genetic cause has been identified for FS, biallelic truncating variants in PIGN, encoding a component of the glycosylphosphatidylinositol (GPI)-anchor biosynthesis pathway, have been  [CLS] identified in a limited number of cases with a phenotype compatible with FS [CLS] . Biallelic variants in PIGN, typically missense or compound missense with truncating, also cause multiple congenital anomalies-hypotonia-seizures syndrome 1 (MCAHS1). Here we report six further patients with FS with or"}
{"subject": "missense", "sub_type": "Var", "rel": "CauseOf", "object": "truncating", "obj_type": "MPA", "file_name": "PubMed-29330547.json", "snippet": " encoding a component of the glycosylphosphatidylinositol (GPI)-anchor biosynthesis pathway, have been identified in a limited number of cases with a phenotype compatible with FS. Biallelic variants in PIGN, typically  [CLS] missense or compound missense with truncating [CLS] , also cause multiple congenital anomalies-hypotonia-seizures syndrome 1 (MCAHS1). Here we report six further patients with FS with or without congenital diaphragmatic hernia and recessive loss of function PIGN alleles,"}
{"subject": "ANGPTL3", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-29334984.json", "snippet": " could obviously reduce the level of TG, LDL-C and the atherosclerotic lesion size, leading to a lower risk for dyslipidemia and CVD. Additionally, in humans, carriers with homozygous LOF  [CLS] mutations in ANGPTL3 [CLS]  have lower plasma LDL-C, TG levels and lower risk of atherosclerosis compared to the non-carriers. Here, we collect the latest data and results, giving a new insight into the"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "LOF", "obj_type": "NegReg", "file_name": "PubMed-29334984.json", "snippet": " mice could obviously reduce the level of TG, LDL-C and the atherosclerotic lesion size, leading to a lower risk for dyslipidemia and CVD. Additionally, in humans, carriers with homozygous  [CLS] LOF mutations [CLS]  in ANGPTL3 have lower plasma LDL-C, TG levels and lower risk of atherosclerosis compared to the non-carriers. Here, we collect the latest data and results, giving a new insight"}
{"subject": "plasma LDL-C", "sub_type": "MPA", "rel": "ThemeOf", "object": "lower", "obj_type": "NegReg", "file_name": "PubMed-29334984.json", "snippet": " level of TG, LDL-C and the atherosclerotic lesion size, leading to a lower risk for dyslipidemia and CVD. Additionally, in humans, carriers with homozygous LOF mutations in ANGPTL3 have  [CLS] lower plasma LDL-C [CLS] , TG levels and lower risk of atherosclerosis compared to the non-carriers. Here, we collect the latest data and results, giving a new insight into the important role of ANGPTL3"}
{"subject": "TG levels", "sub_type": "MPA", "rel": "ThemeOf", "object": "lower", "obj_type": "NegReg", "file_name": "PubMed-29334984.json", "snippet": " level of TG, LDL-C and the atherosclerotic lesion size, leading to a lower risk for dyslipidemia and CVD. Additionally, in humans, carriers with homozygous LOF mutations in ANGPTL3 have  [CLS] lower plasma LDL-C, TG levels [CLS]  and lower risk of atherosclerosis compared to the non-carriers. Here, we collect the latest data and results, giving a new insight into the important role of ANGPTL3 in controlling"}
{"subject": "LOF", "sub_type": "NegReg", "rel": "CauseOf", "object": "lower", "obj_type": "NegReg", "file_name": "PubMed-29334984.json", "snippet": " mice could obviously reduce the level of TG, LDL-C and the atherosclerotic lesion size, leading to a lower risk for dyslipidemia and CVD. Additionally, in humans, carriers with homozygous  [CLS] LOF mutations in ANGPTL3 have lower [CLS]  plasma LDL-C, TG levels and lower risk of atherosclerosis compared to the non-carriers. Here, we collect the latest data and results, giving a new insight into the important role"}
{"subject": "NT5C2", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-29342136.json", "snippet": " [CLS] mutations in the 5'-nucleotidase, cytosolic II (NT5C2 [CLS] ) gene induce resistance to 6-mercaptopurine and are selectively present in relapsed ALL. Yet, the mechanisms involved in NT5C2 mutation-driven clonal evolution during the initiation of leukaemia, disease progression and"}
{"subject": "depletion of the intracellular purine-nucleotide pool", "sub_type": "MPA", "rel": "ThemeOf", "object": "excess", "obj_type": "PosReg", "file_name": "PubMed-29342136.json", "snippet": " mutation, induces resistance to chemotherapy with 6-mercaptopurine at the cost of impaired leukaemia cell growth and leukaemia-initiating cell activity. The loss-of-fitness phenotype of NT5C2+/R367Q mutant cells is associated with  [CLS] excess export of purines to the extracellular space and depletion of the intracellular purine-nucleotide pool [CLS] . Consequently, blocking guanosine synthesis by inhibition of inosine-5'-monophosphate dehydrogenase (IMPDH) induced increased cytotoxicity against NT5C2-mutant leukaemia lymphoblasts. These results identify the fitness cost of NT5C2 mutation and resistance to"}
{"subject": "R367Q", "sub_type": "Var", "rel": "CauseOf", "object": "induces", "obj_type": "PosReg", "file_name": "PubMed-29342136.json", "snippet": " involved in NT5C2 mutation-driven clonal evolution during the initiation of leukaemia, disease progression and relapse remain unknown. Here we use a conditional-and-inducible leukaemia model to demonstrate that expression of NT5C2( [CLS] R367Q), a highly prevalent relapsed-ALL NT5C2 mutation, induces [CLS]  resistance to chemotherapy with 6-mercaptopurine at the cost of impaired leukaemia cell growth and leukaemia-initiating cell activity. The loss-of-fitness phenotype of NT5C2+/R367Q mutant cells is associated with excess export"}
{"subject": "R367Q", "sub_type": "Var", "rel": "CauseOf", "object": "excess", "obj_type": "PosReg", "file_name": "PubMed-29342136.json", "snippet": " NT5C2(R367Q), a highly prevalent relapsed-ALL NT5C2 mutation, induces resistance to chemotherapy with 6-mercaptopurine at the cost of impaired leukaemia cell growth and leukaemia-initiating cell activity. The loss-of-fitness phenotype of NT5C2+/ [CLS] R367Q mutant cells is associated with excess [CLS]  export of purines to the extracellular space and depletion of the intracellular purine-nucleotide pool. Consequently, blocking guanosine synthesis by inhibition of inosine-5'-monophosphate dehydrogenase (IMPDH) induced increased cytotoxicity against NT5C2-mutant"}
{"subject": "excess", "sub_type": "PosReg", "rel": "CauseOf", "object": "loss-of-fitness", "obj_type": "NegReg", "file_name": "PubMed-29342136.json", "snippet": " that expression of NT5C2(R367Q), a highly prevalent relapsed-ALL NT5C2 mutation, induces resistance to chemotherapy with 6-mercaptopurine at the cost of impaired leukaemia cell growth and leukaemia-initiating cell activity. The  [CLS] loss-of-fitness phenotype of NT5C2+/R367Q mutant cells is associated with excess [CLS]  export of purines to the extracellular space and depletion of the intracellular purine-nucleotide pool. Consequently, blocking guanosine synthesis by inhibition of inosine-5'-monophosphate dehydrogenase (IMPDH) induced increased cytotoxicity against NT5C2-mutant"}
{"subject": "induces", "sub_type": "PosReg", "rel": "CauseOf", "object": "relapsed-ALL", "obj_type": "Disease", "file_name": "PubMed-29342136.json", "snippet": " clonal evolution during the initiation of leukaemia, disease progression and relapse remain unknown. Here we use a conditional-and-inducible leukaemia model to demonstrate that expression of NT5C2(R367Q), a highly prevalent  [CLS] relapsed-ALL NT5C2 mutation, induces [CLS]  resistance to chemotherapy with 6-mercaptopurine at the cost of impaired leukaemia cell growth and leukaemia-initiating cell activity. The loss-of-fitness phenotype of NT5C2+/R367Q mutant cells is associated with excess export"}
{"subject": "NT5C2", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutant", "obj_type": "Var", "file_name": "PubMed-29342136.json", "snippet": " [CLS] NT5C2 mutant [CLS] -relapsed acute lymphoblastic leukaemia.\nRelapsed acute lymphoblastic leukaemia (ALL) is associated with resistance to chemotherapy and poor prognosis. Gain-of-function mutations in the 5'-nucleotidase, cytosolic II (NT5C2) gene induce resistance to"}
{"subject": "mutant", "sub_type": "Var", "rel": "CauseOf", "object": "mechanisms", "obj_type": "Reg", "file_name": "PubMed-29342136.json", "snippet": " [CLS] mechanisms in NT5C2 mutant [CLS] -relapsed acute lymphoblastic leukaemia.\nRelapsed acute lymphoblastic leukaemia (ALL) is associated with resistance to chemotherapy and poor prognosis. Gain-of-function mutations in the 5'-nucleotidase, cytosolic II (NT5C2) gene induce resistance to"}
{"subject": "relapsed acute lymphoblastic leukaemia", "sub_type": "Disease", "rel": "ThemeOf", "object": "mechanisms", "obj_type": "Reg", "file_name": "PubMed-29342136.json", "snippet": " [CLS] mechanisms in NT5C2 mutant-relapsed acute lymphoblastic leukaemia [CLS] .\nRelapsed acute lymphoblastic leukaemia (ALL) is associated with resistance to chemotherapy and poor prognosis. Gain-of-function mutations in the 5'-nucleotidase, cytosolic II (NT5C2) gene induce resistance to 6-mercaptopurine and are"}
{"subject": "resistance to 6-mercaptopurine", "sub_type": "MPA", "rel": "ThemeOf", "object": "induce", "obj_type": "PosReg", "file_name": "PubMed-29342136.json", "snippet": " in NT5C2 mutant-relapsed acute lymphoblastic leukaemia.\nRelapsed acute lymphoblastic leukaemia (ALL) is associated with resistance to chemotherapy and poor prognosis. Gain-of-function mutations in the 5'-nucleotidase, cytosolic II (NT5C2) gene  [CLS] induce resistance to 6-mercaptopurine [CLS]  and are selectively present in relapsed ALL. Yet, the mechanisms involved in NT5C2 mutation-driven clonal evolution during the initiation of leukaemia, disease progression and relapse remain unknown. Here we"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "Gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-29342136.json", "snippet": " [CLS] Gain-of-function mutations [CLS]  in the 5'-nucleotidase, cytosolic II (NT5C2) gene induce resistance to 6-mercaptopurine and are selectively present in relapsed ALL. Yet, the mechanisms involved in NT5C2 mutation-driven clonal evolution during the"}
{"subject": "Gain-of-function", "sub_type": "PosReg", "rel": "CauseOf", "object": "induce", "obj_type": "PosReg", "file_name": "PubMed-29342136.json", "snippet": " [CLS] Gain-of-function mutations in the 5'-nucleotidase, cytosolic II (NT5C2) gene induce [CLS]  resistance to 6-mercaptopurine and are selectively present in relapsed ALL. Yet, the mechanisms involved in NT5C2 mutation-driven clonal evolution during the initiation of leukaemia, disease progression and relapse remain"}
{"subject": "NT5C2", "sub_type": "Gene", "rel": "ThemeOf", "object": "R367Q", "obj_type": "Var", "file_name": "PubMed-29342136.json", "snippet": " involved in NT5C2 mutation-driven clonal evolution during the initiation of leukaemia, disease progression and relapse remain unknown. Here we use a conditional-and-inducible leukaemia model to demonstrate that expression of NT5C2( [CLS] R367Q), a highly prevalent relapsed-ALL NT5C2 [CLS]  mutation, induces resistance to chemotherapy with 6-mercaptopurine at the cost of impaired leukaemia cell growth and leukaemia-initiating cell activity. The loss-of-fitness phenotype of NT5C2+/R367Q mutant cells is associated with"}
{"subject": "resistance to chemotherapy with 6-mercaptopurine", "sub_type": "MPA", "rel": "ThemeOf", "object": "induces", "obj_type": "PosReg", "file_name": "PubMed-29342136.json", "snippet": " the initiation of leukaemia, disease progression and relapse remain unknown. Here we use a conditional-and-inducible leukaemia model to demonstrate that expression of NT5C2(R367Q), a highly prevalent relapsed-ALL NT5C2 mutation,  [CLS] induces resistance to chemotherapy with 6-mercaptopurine [CLS]  at the cost of impaired leukaemia cell growth and leukaemia-initiating cell activity. The loss-of-fitness phenotype of NT5C2+/R367Q mutant cells is associated with excess export of purines to the extracellular"}
{"subject": "NT5C2", "sub_type": "Gene", "rel": "ThemeOf", "object": "R367Q", "obj_type": "Var", "file_name": "PubMed-29342136.json", "snippet": " NT5C2(R367Q), a highly prevalent relapsed-ALL NT5C2 mutation, induces resistance to chemotherapy with 6-mercaptopurine at the cost of impaired leukaemia cell growth and leukaemia-initiating cell activity. The loss-of-fitness phenotype of  [CLS] NT5C2+/R367Q [CLS]  mutant cells is associated with excess export of purines to the extracellular space and depletion of the intracellular purine-nucleotide pool. Consequently, blocking guanosine synthesis by inhibition of inosine-5'-monophosphate dehydrogenase"}
{"subject": "export of purines to the extracellular space", "sub_type": "MPA", "rel": "ThemeOf", "object": "excess", "obj_type": "PosReg", "file_name": "PubMed-29342136.json", "snippet": " mutation, induces resistance to chemotherapy with 6-mercaptopurine at the cost of impaired leukaemia cell growth and leukaemia-initiating cell activity. The loss-of-fitness phenotype of NT5C2+/R367Q mutant cells is associated with  [CLS] excess export of purines to the extracellular space [CLS]  and depletion of the intracellular purine-nucleotide pool. Consequently, blocking guanosine synthesis by inhibition of inosine-5'-monophosphate dehydrogenase (IMPDH) induced increased cytotoxicity against NT5C2-mutant leukaemia lymphoblasts. These results identify the fitness"}
{"subject": "phenotype", "sub_type": "CPA", "rel": "ThemeOf", "object": "loss-of-fitness", "obj_type": "NegReg", "file_name": "PubMed-29342136.json", "snippet": " that expression of NT5C2(R367Q), a highly prevalent relapsed-ALL NT5C2 mutation, induces resistance to chemotherapy with 6-mercaptopurine at the cost of impaired leukaemia cell growth and leukaemia-initiating cell activity. The  [CLS] loss-of-fitness phenotype [CLS]  of NT5C2+/R367Q mutant cells is associated with excess export of purines to the extracellular space and depletion of the intracellular purine-nucleotide pool. Consequently, blocking guanosine synthesis by inhibition of"}
{"subject": "DOT1L", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-29343685.json", "snippet": " plays an oncogenic role in MLL-rearranged leukemogenesis. Here, we demonstrate that, in contrast to MLL-rearranged leukemia, DOT1L plays a protective role in ultraviolet radiation (UVR)-induced melanoma development. Specifically, the  [CLS] DOT1L gene is located in a frequently deleted region and undergoes somatic mutation in human melanoma. Specific mutations [CLS]  functionally compromise DOT1L methyltransferase enzyme activity leading to reduced H3K79 methylation. Importantly, in the absence of DOT1L, UVR-induced DNA damage is inefficiently repaired, so that DOT1L loss promotes melanoma"}
{"subject": "melanoma development", "sub_type": "CPA", "rel": "ThemeOf", "object": "promotes", "obj_type": "PosReg", "file_name": "PubMed-29343685.json", "snippet": " Specific mutations functionally compromise DOT1L methyltransferase enzyme activity leading to reduced H3K79 methylation. Importantly, in the absence of DOT1L, UVR-induced DNA damage is inefficiently repaired, so that DOT1L loss  [CLS] promotes melanoma development [CLS]  in mice after exposure to UVR. Mechanistically, DOT1L facilitates DNA damage repair, with DOT1L-methylated H3K79 involvement in binding and recruiting XPC to the DNA damage site for nucleotide excision"}
{"subject": "loss", "sub_type": "NegReg", "rel": "CauseOf", "object": "promotes", "obj_type": "PosReg", "file_name": "PubMed-29343685.json", "snippet": " melanoma. Specific mutations functionally compromise DOT1L methyltransferase enzyme activity leading to reduced H3K79 methylation. Importantly, in the absence of DOT1L, UVR-induced DNA damage is inefficiently repaired, so that DOT1L  [CLS] loss promotes [CLS]  melanoma development in mice after exposure to UVR. Mechanistically, DOT1L facilitates DNA damage repair, with DOT1L-methylated H3K79 involvement in binding and recruiting XPC to the DNA damage site for"}
{"subject": "DOT1L", "sub_type": "Gene", "rel": "ThemeOf", "object": "methyltransferase enzyme", "obj_type": "Enzyme", "file_name": "PubMed-29343685.json", "snippet": " role in ultraviolet radiation (UVR)-induced melanoma development. Specifically, the DOT1L gene is located in a frequently deleted region and undergoes somatic mutation in human melanoma. Specific mutations functionally compromise  [CLS] DOT1L methyltransferase enzyme [CLS]  activity leading to reduced H3K79 methylation. Importantly, in the absence of DOT1L, UVR-induced DNA damage is inefficiently repaired, so that DOT1L loss promotes melanoma development in mice after exposure"}
{"subject": "methyltransferase enzyme", "sub_type": "Enzyme", "rel": "ThemeOf", "object": "activity", "obj_type": "MPA", "file_name": "PubMed-29343685.json", "snippet": " in ultraviolet radiation (UVR)-induced melanoma development. Specifically, the DOT1L gene is located in a frequently deleted region and undergoes somatic mutation in human melanoma. Specific mutations functionally compromise DOT1L  [CLS] methyltransferase enzyme activity [CLS]  leading to reduced H3K79 methylation. Importantly, in the absence of DOT1L, UVR-induced DNA damage is inefficiently repaired, so that DOT1L loss promotes melanoma development in mice after exposure to"}
{"subject": "H3K79", "sub_type": "Protein", "rel": "ThemeOf", "object": "methylation", "obj_type": "MPA", "file_name": "PubMed-29343685.json", "snippet": " Specifically, the DOT1L gene is located in a frequently deleted region and undergoes somatic mutation in human melanoma. Specific mutations functionally compromise DOT1L methyltransferase enzyme activity leading to reduced  [CLS] H3K79 methylation [CLS] . Importantly, in the absence of DOT1L, UVR-induced DNA damage is inefficiently repaired, so that DOT1L loss promotes melanoma development in mice after exposure to UVR. Mechanistically, DOT1L facilitates DNA"}
{"subject": "methylation", "sub_type": "MPA", "rel": "ThemeOf", "object": "reduced", "obj_type": "NegReg", "file_name": "PubMed-29343685.json", "snippet": " development. Specifically, the DOT1L gene is located in a frequently deleted region and undergoes somatic mutation in human melanoma. Specific mutations functionally compromise DOT1L methyltransferase enzyme activity leading to  [CLS] reduced H3K79 methylation [CLS] . Importantly, in the absence of DOT1L, UVR-induced DNA damage is inefficiently repaired, so that DOT1L loss promotes melanoma development in mice after exposure to UVR. Mechanistically, DOT1L facilitates DNA"}
{"subject": "activity", "sub_type": "MPA", "rel": "ThemeOf", "object": "compromise", "obj_type": "NegReg", "file_name": "PubMed-29343685.json", "snippet": " protective role in ultraviolet radiation (UVR)-induced melanoma development. Specifically, the DOT1L gene is located in a frequently deleted region and undergoes somatic mutation in human melanoma. Specific mutations functionally  [CLS] compromise DOT1L methyltransferase enzyme activity [CLS]  leading to reduced H3K79 methylation. Importantly, in the absence of DOT1L, UVR-induced DNA damage is inefficiently repaired, so that DOT1L loss promotes melanoma development in mice after exposure to"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "compromise", "obj_type": "NegReg", "file_name": "PubMed-29343685.json", "snippet": " plays a protective role in ultraviolet radiation (UVR)-induced melanoma development. Specifically, the DOT1L gene is located in a frequently deleted region and undergoes somatic mutation in human melanoma. Specific  [CLS] mutations functionally compromise [CLS]  DOT1L methyltransferase enzyme activity leading to reduced H3K79 methylation. Importantly, in the absence of DOT1L, UVR-induced DNA damage is inefficiently repaired, so that DOT1L loss promotes melanoma development in"}
{"subject": "compromise", "sub_type": "NegReg", "rel": "CauseOf", "object": "reduced", "obj_type": "NegReg", "file_name": "PubMed-29343685.json", "snippet": " protective role in ultraviolet radiation (UVR)-induced melanoma development. Specifically, the DOT1L gene is located in a frequently deleted region and undergoes somatic mutation in human melanoma. Specific mutations functionally  [CLS] compromise DOT1L methyltransferase enzyme activity leading to reduced [CLS]  H3K79 methylation. Importantly, in the absence of DOT1L, UVR-induced DNA damage is inefficiently repaired, so that DOT1L loss promotes melanoma development in mice after exposure to UVR. Mechanistically, DOT1L"}
{"subject": "DOT1L", "sub_type": "Gene", "rel": "ThemeOf", "object": "loss", "obj_type": "NegReg", "file_name": "PubMed-29343685.json", "snippet": " human melanoma. Specific mutations functionally compromise DOT1L methyltransferase enzyme activity leading to reduced H3K79 methylation. Importantly, in the absence of DOT1L, UVR-induced DNA damage is inefficiently repaired, so that  [CLS] DOT1L loss [CLS]  promotes melanoma development in mice after exposure to UVR. Mechanistically, DOT1L facilitates DNA damage repair, with DOT1L-methylated H3K79 involvement in binding and recruiting XPC to the DNA damage site"}
{"subject": "KIF14", "sub_type": "Gene", "rel": "ThemeOf", "object": "Biallelic variants", "obj_type": "Var", "file_name": "PubMed-29343805.json", "snippet": " [CLS] Biallelic variants in KIF14 [CLS]  cause intellectual disability with microcephaly.\nKinesin proteins are critical for various cellular functions such as intracellular transport and cell division, and many members of the family have been linked"}
{"subject": "p.Asn83Ilefs*3", "sub_type": "Var", "rel": "CauseOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-29343805.json", "snippet": " with intellectual disability and microcephaly from four unrelated families with parental consanguinity. In the affected individuals of each family, homozygosity for likely pathogenic variants in KIF14 were detected; two  [CLS] loss-of-function (p.Asn83Ilefs*3 [CLS]  and p.Ser1478fs), and two missense substitutions (p.Ser841Phe and p.Gly459Arg). KIF14 is a mitotic motor protein that is required for spindle localization of the mitotic citron rho-interacting kinase, CIT, also"}
{"subject": "p.Ser1478fs", "sub_type": "Var", "rel": "CauseOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-29343805.json", "snippet": " with intellectual disability and microcephaly from four unrelated families with parental consanguinity. In the affected individuals of each family, homozygosity for likely pathogenic variants in KIF14 were detected; two  [CLS] loss-of-function (p.Asn83Ilefs*3 and p.Ser1478fs [CLS] ), and two missense substitutions (p.Ser841Phe and p.Gly459Arg). KIF14 is a mitotic motor protein that is required for spindle localization of the mitotic citron rho-interacting kinase, CIT, also mutated in"}
{"subject": "pathogenic", "sub_type": "CPA", "rel": "ThemeOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-29343805.json", "snippet": " disorders and cancer. We report eight individuals with intellectual disability and microcephaly from four unrelated families with parental consanguinity. In the affected individuals of each family, homozygosity for likely  [CLS] pathogenic variants in KIF14 were detected; two loss-of-function [CLS]  (p.Asn83Ilefs*3 and p.Ser1478fs), and two missense substitutions (p.Ser841Phe and p.Gly459Arg). KIF14 is a mitotic motor protein that is required for spindle localization of the mitotic citron rho-interacting kinase, CIT,"}
{"subject": "KIF14", "sub_type": "Gene", "rel": "ThemeOf", "object": "p.Ser841Phe", "obj_type": "Var", "file_name": "PubMed-29343805.json", "snippet": " We report eight individuals with intellectual disability and microcephaly from four unrelated families with parental consanguinity. In the affected individuals of each family, homozygosity for likely pathogenic variants in  [CLS] KIF14 were detected; two loss-of-function (p.Asn83Ilefs*3 and p.Ser1478fs), and two missense substitutions (p.Ser841Phe [CLS]  and p.Gly459Arg). KIF14 is a mitotic motor protein that is required for spindle localization of the mitotic citron rho-interacting kinase, CIT, also mutated in microcephaly. Our results demonstrate the"}
{"subject": "KIF14", "sub_type": "Gene", "rel": "ThemeOf", "object": "p.Gly459Arg", "obj_type": "Var", "file_name": "PubMed-29343805.json", "snippet": " We report eight individuals with intellectual disability and microcephaly from four unrelated families with parental consanguinity. In the affected individuals of each family, homozygosity for likely pathogenic variants in  [CLS] KIF14 were detected; two loss-of-function (p.Asn83Ilefs*3 and p.Ser1478fs), and two missense substitutions (p.Ser841Phe and p.Gly459Arg [CLS] ). KIF14 is a mitotic motor protein that is required for spindle localization of the mitotic citron rho-interacting kinase, CIT, also mutated in microcephaly. Our results demonstrate the involvement of"}
{"subject": "pathogenic", "sub_type": "CPA", "rel": "ThemeOf", "object": "missense substitutions", "obj_type": "Reg", "file_name": "PubMed-29343805.json", "snippet": " disorders and cancer. We report eight individuals with intellectual disability and microcephaly from four unrelated families with parental consanguinity. In the affected individuals of each family, homozygosity for likely  [CLS] pathogenic variants in KIF14 were detected; two loss-of-function (p.Asn83Ilefs*3 and p.Ser1478fs), and two missense substitutions [CLS]  (p.Ser841Phe and p.Gly459Arg). KIF14 is a mitotic motor protein that is required for spindle localization of the mitotic citron rho-interacting kinase, CIT, also mutated in microcephaly. Our results demonstrate"}
{"subject": "p.Ser841Phe", "sub_type": "Var", "rel": "CauseOf", "object": "missense substitutions", "obj_type": "Reg", "file_name": "PubMed-29343805.json", "snippet": " four unrelated families with parental consanguinity. In the affected individuals of each family, homozygosity for likely pathogenic variants in KIF14 were detected; two loss-of-function (p.Asn83Ilefs*3 and p.Ser1478fs), and two  [CLS] missense substitutions (p.Ser841Phe [CLS]  and p.Gly459Arg). KIF14 is a mitotic motor protein that is required for spindle localization of the mitotic citron rho-interacting kinase, CIT, also mutated in microcephaly. Our results demonstrate the"}
{"subject": "p.Gly459Arg", "sub_type": "Var", "rel": "CauseOf", "object": "missense substitutions", "obj_type": "Reg", "file_name": "PubMed-29343805.json", "snippet": " four unrelated families with parental consanguinity. In the affected individuals of each family, homozygosity for likely pathogenic variants in KIF14 were detected; two loss-of-function (p.Asn83Ilefs*3 and p.Ser1478fs), and two  [CLS] missense substitutions (p.Ser841Phe and p.Gly459Arg [CLS] ). KIF14 is a mitotic motor protein that is required for spindle localization of the mitotic citron rho-interacting kinase, CIT, also mutated in microcephaly. Our results demonstrate the involvement of"}
{"subject": "intellectual disability", "sub_type": "Disease", "rel": "ThemeOf", "object": "cause", "obj_type": "Reg", "file_name": "PubMed-29343805.json", "snippet": " [CLS] cause intellectual disability [CLS]  with microcephaly.\nKinesin proteins are critical for various cellular functions such as intracellular transport and cell division, and many members of the family have been linked to monogenic disorders"}
{"subject": "microcephaly", "sub_type": "Disease", "rel": "ThemeOf", "object": "cause", "obj_type": "Reg", "file_name": "PubMed-29343805.json", "snippet": " [CLS] cause intellectual disability with microcephaly [CLS] .\nKinesin proteins are critical for various cellular functions such as intracellular transport and cell division, and many members of the family have been linked to monogenic disorders and cancer."}
{"subject": "Biallelic variants", "sub_type": "Var", "rel": "CauseOf", "object": "cause", "obj_type": "Reg", "file_name": "PubMed-29343805.json", "snippet": " [CLS] Biallelic variants in KIF14 cause [CLS]  intellectual disability with microcephaly.\nKinesin proteins are critical for various cellular functions such as intracellular transport and cell division, and many members of the family have been linked to"}
{"subject": "CIT", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutated", "obj_type": "Var", "file_name": "PubMed-29343805.json", "snippet": " loss-of-function (p.Asn83Ilefs*3 and p.Ser1478fs), and two missense substitutions (p.Ser841Phe and p.Gly459Arg). KIF14 is a mitotic motor protein that is required for spindle localization of the mitotic citron rho-interacting kinase,  [CLS] CIT, also mutated [CLS]  in microcephaly. Our results demonstrate the involvement of KIF14 in development and reveal a wide phenotypic variability ranging from fetal lethality to moderate developmental delay and microcephaly."}
{"subject": "microcephaly", "sub_type": "Disease", "rel": "ThemeOf", "object": "in", "obj_type": "Reg", "file_name": "PubMed-29343805.json", "snippet": " p.Ser1478fs), and two missense substitutions (p.Ser841Phe and p.Gly459Arg). KIF14 is a mitotic motor protein that is required for spindle localization of the mitotic citron rho-interacting kinase, CIT, also mutated  [CLS] in microcephaly [CLS] . Our results demonstrate the involvement of KIF14 in development and reveal a wide phenotypic variability ranging from fetal lethality to moderate developmental delay and microcephaly."}
{"subject": "mutated", "sub_type": "Var", "rel": "CauseOf", "object": "in", "obj_type": "Reg", "file_name": "PubMed-29343805.json", "snippet": " and p.Ser1478fs), and two missense substitutions (p.Ser841Phe and p.Gly459Arg). KIF14 is a mitotic motor protein that is required for spindle localization of the mitotic citron rho-interacting kinase, CIT, also  [CLS] mutated in [CLS]  microcephaly. Our results demonstrate the involvement of KIF14 in development and reveal a wide phenotypic variability ranging from fetal lethality to moderate developmental delay and microcephaly."}
{"subject": "KIF14", "sub_type": "Gene", "rel": "ThemeOf", "object": "p.Asn83Ilefs*3", "obj_type": "Var", "file_name": "PubMed-29343805.json", "snippet": " We report eight individuals with intellectual disability and microcephaly from four unrelated families with parental consanguinity. In the affected individuals of each family, homozygosity for likely pathogenic variants in  [CLS] KIF14 were detected; two loss-of-function (p.Asn83Ilefs*3 [CLS]  and p.Ser1478fs), and two missense substitutions (p.Ser841Phe and p.Gly459Arg). KIF14 is a mitotic motor protein that is required for spindle localization of the mitotic citron rho-interacting kinase, CIT, also"}
{"subject": "KIF14", "sub_type": "Gene", "rel": "ThemeOf", "object": "p.Ser1478fs", "obj_type": "Var", "file_name": "PubMed-29343805.json", "snippet": " We report eight individuals with intellectual disability and microcephaly from four unrelated families with parental consanguinity. In the affected individuals of each family, homozygosity for likely pathogenic variants in  [CLS] KIF14 were detected; two loss-of-function (p.Asn83Ilefs*3 and p.Ser1478fs [CLS] ), and two missense substitutions (p.Ser841Phe and p.Gly459Arg). KIF14 is a mitotic motor protein that is required for spindle localization of the mitotic citron rho-interacting kinase, CIT, also mutated in"}
{"subject": "APOC3", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-29348120.json", "snippet": " [CLS] mutations in APOC3 [CLS]  associate with low remnant cholesterol levels and low risk of ischemic vascular disease (IVD). Because some studies show an additional association with low levels of low-density lipoprotein cholesterol (LDL-C),"}
{"subject": "APOC3", "sub_type": "Gene", "rel": "ThemeOf", "object": "Mutations", "obj_type": "Var", "file_name": "PubMed-29348120.json", "snippet": " [CLS] APOC3 Loss-of-Function Mutations [CLS] , Remnant Cholesterol, Low-Density Lipoprotein Cholesterol, and Cardiovascular Risk: Mediation- and Meta-Analyses of 137\u2009895 Individuals.\nOBJECTIVE: Loss-of-function mutations in APOC3 associate with low remnant cholesterol levels and low risk of"}
{"subject": "Mutations", "sub_type": "Var", "rel": "CauseOf", "object": "Loss-of-Function", "obj_type": "NegReg", "file_name": "PubMed-29348120.json", "snippet": " [CLS] Loss-of-Function Mutations [CLS] , Remnant Cholesterol, Low-Density Lipoprotein Cholesterol, and Cardiovascular Risk: Mediation- and Meta-Analyses of 137\u2009895 Individuals.\nOBJECTIVE: Loss-of-function mutations in APOC3 associate with low remnant cholesterol levels and low risk of"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "Loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-29348120.json", "snippet": " [CLS] Loss-of-function mutations [CLS]  in APOC3 associate with low remnant cholesterol levels and low risk of ischemic vascular disease (IVD). Because some studies show an additional association with low levels of low-density lipoprotein"}
{"subject": "Loss-of-function", "sub_type": "NegReg", "rel": "CauseOf", "object": "low", "obj_type": "NegReg", "file_name": "PubMed-29348120.json", "snippet": " [CLS] Loss-of-function mutations in APOC3 associate with low [CLS]  remnant cholesterol levels and low risk of ischemic vascular disease (IVD). Because some studies show an additional association with low levels of low-density lipoprotein cholesterol (LDL-C), low LDL-C may"}
{"subject": "remnant cholesterol levels", "sub_type": "MPA", "rel": "ThemeOf", "object": "low", "obj_type": "NegReg", "file_name": "PubMed-29348120.json", "snippet": " [CLS] low remnant cholesterol levels [CLS]  and low risk of ischemic vascular disease (IVD). Because some studies show an additional association with low levels of low-density lipoprotein cholesterol (LDL-C), low LDL-C may explain the low"}
{"subject": "APOC3", "sub_type": "Gene", "rel": "ThemeOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-29348120.json", "snippet": " and 54% of the observed 36% lower risk of ischemic heart disease; corresponding values mediated by LDL-C were 1% and 2%.\nCONCLUSIONS: The low risk of IVD observed in  [CLS] APOC3 loss-of-function [CLS]  heterozygotes is mainly mediated by the associated low remnant cholesterol and not by low LDL-C. Furthermore, the contribution of LDL-C to IVD risk was not masked by lipid-lowering therapy."}
{"subject": "loss-of-function", "sub_type": "NegReg", "rel": "CauseOf", "object": "low", "obj_type": "NegReg", "file_name": "PubMed-29348120.json", "snippet": " 54% of the observed 36% lower risk of ischemic heart disease; corresponding values mediated by LDL-C were 1% and 2%.\nCONCLUSIONS: The low risk of IVD observed in APOC3  [CLS] loss-of-function heterozygotes is mainly mediated by the associated low [CLS]  remnant cholesterol and not by low LDL-C. Furthermore, the contribution of LDL-C to IVD risk was not masked by lipid-lowering therapy. This suggests APOC3 and remnant cholesterol as important"}
{"subject": "remnant cholesterol", "sub_type": "MPA", "rel": "ThemeOf", "object": "low", "obj_type": "NegReg", "file_name": "PubMed-29348120.json", "snippet": " ischemic heart disease; corresponding values mediated by LDL-C were 1% and 2%.\nCONCLUSIONS: The low risk of IVD observed in APOC3 loss-of-function heterozygotes is mainly mediated by the associated  [CLS] low remnant cholesterol [CLS]  and not by low LDL-C. Furthermore, the contribution of LDL-C to IVD risk was not masked by lipid-lowering therapy. This suggests APOC3 and remnant cholesterol as important new targets"}
{"subject": "APAF1", "sub_type": "Gene", "rel": "ThemeOf", "object": "apoptotic genes", "obj_type": "Gene", "file_name": "PubMed-29358613.json", "snippet": " [CLS] apoptotic genes APAF1 [CLS]  and CASP9 implicated in recurrent folate-resistant neural tube defects.\nNeural tube defects (NTDs) remain one of the most serious birth defects, and although genes in several pathways have been"}
{"subject": "CASP9", "sub_type": "Gene", "rel": "ThemeOf", "object": "apoptotic genes", "obj_type": "Gene", "file_name": "PubMed-29358613.json", "snippet": " [CLS] apoptotic genes APAF1 and CASP9 [CLS]  implicated in recurrent folate-resistant neural tube defects.\nNeural tube defects (NTDs) remain one of the most serious birth defects, and although genes in several pathways have been implicated as"}
{"subject": "variants", "sub_type": "Var", "rel": "CauseOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-29358613.json", "snippet": " humans have been identified. Whole exome sequencing identified deleterious variants in key apoptotic genes in two families with recurrent neural tube defects. Functional studies in fibroblasts indicate that these  [CLS] variants are loss-of-function [CLS] , as apoptosis is significantly reduced. This is the first report of variants in apoptotic genes contributing to neural tube defect risk in humans."}
{"subject": "variants", "sub_type": "Var", "rel": "CauseOf", "object": "reduced", "obj_type": "NegReg", "file_name": "PubMed-29358613.json", "snippet": " humans have been identified. Whole exome sequencing identified deleterious variants in key apoptotic genes in two families with recurrent neural tube defects. Functional studies in fibroblasts indicate that these  [CLS] variants are loss-of-function, as apoptosis is significantly reduced [CLS] . This is the first report of variants in apoptotic genes contributing to neural tube defect risk in humans."}
{"subject": "apoptosis", "sub_type": "CPA", "rel": "ThemeOf", "object": "reduced", "obj_type": "NegReg", "file_name": "PubMed-29358613.json", "snippet": " Whole exome sequencing identified deleterious variants in key apoptotic genes in two families with recurrent neural tube defects. Functional studies in fibroblasts indicate that these variants are loss-of-function, as  [CLS] apoptosis is significantly reduced [CLS] . This is the first report of variants in apoptotic genes contributing to neural tube defect risk in humans."}
{"subject": "variants", "sub_type": "Var", "rel": "CauseOf", "object": "contributing", "obj_type": "Reg", "file_name": "PubMed-29358613.json", "snippet": " in two families with recurrent neural tube defects. Functional studies in fibroblasts indicate that these variants are loss-of-function, as apoptosis is significantly reduced. This is the first report of  [CLS] variants in apoptotic genes contributing [CLS]  to neural tube defect risk in humans."}
{"subject": "neural tube defect", "sub_type": "Disease", "rel": "ThemeOf", "object": "contributing", "obj_type": "Reg", "file_name": "PubMed-29358613.json", "snippet": " recurrent neural tube defects. Functional studies in fibroblasts indicate that these variants are loss-of-function, as apoptosis is significantly reduced. This is the first report of variants in apoptotic genes  [CLS] contributing to neural tube defect [CLS]  risk in humans."}
{"subject": "apoptotic genes", "sub_type": "Gene", "rel": "ThemeOf", "object": "variants", "obj_type": "Var", "file_name": "PubMed-29358613.json", "snippet": " in two families with recurrent neural tube defects. Functional studies in fibroblasts indicate that these variants are loss-of-function, as apoptosis is significantly reduced. This is the first report of  [CLS] variants in apoptotic genes [CLS]  contributing to neural tube defect risk in humans."}
{"subject": "NHS", "sub_type": "Gene", "rel": "ThemeOf", "object": "nonsense", "obj_type": "Var", "file_name": "PubMed-29358614.json", "snippet": " a rare X-linked developmental disorder characterized by bilateral congenital cataract, dental anomalies, facial dysmorphism, and intellectual disability. Here, we identify a patient with Nance-Horan syndrome caused by a new  [CLS] nonsense NHS [CLS]  variant. In addition, the patient presented congenital diaphragmatic hernia. NHS gene expression in murine fetal diaphragm was demonstrated, suggesting a possible involvement of NHS in diaphragm development. Congenital diaphragmatic"}
{"subject": "nonsense", "sub_type": "Var", "rel": "CauseOf", "object": "caused by", "obj_type": "Reg", "file_name": "PubMed-29358614.json", "snippet": " syndrome?\nNance-Horan syndrome is a rare X-linked developmental disorder characterized by bilateral congenital cataract, dental anomalies, facial dysmorphism, and intellectual disability. Here, we identify a patient with Nance-Horan syndrome  [CLS] caused by a new nonsense [CLS]  NHS variant. In addition, the patient presented congenital diaphragmatic hernia. NHS gene expression in murine fetal diaphragm was demonstrated, suggesting a possible involvement of NHS in diaphragm development. Congenital"}
{"subject": "Nance-Horan syndrome", "sub_type": "Disease", "rel": "ThemeOf", "object": "caused by", "obj_type": "Reg", "file_name": "PubMed-29358614.json", "snippet": " of Nance-Horan syndrome?\nNance-Horan syndrome is a rare X-linked developmental disorder characterized by bilateral congenital cataract, dental anomalies, facial dysmorphism, and intellectual disability. Here, we identify a patient with  [CLS] Nance-Horan syndrome caused by [CLS]  a new nonsense NHS variant. In addition, the patient presented congenital diaphragmatic hernia. NHS gene expression in murine fetal diaphragm was demonstrated, suggesting a possible involvement of NHS in"}
{"subject": "congenital diaphragmatic hernia", "sub_type": "Disease", "rel": "ThemeOf", "object": "caused by", "obj_type": "Reg", "file_name": "PubMed-29358614.json", "snippet": " syndrome?\nNance-Horan syndrome is a rare X-linked developmental disorder characterized by bilateral congenital cataract, dental anomalies, facial dysmorphism, and intellectual disability. Here, we identify a patient with Nance-Horan syndrome  [CLS] caused by a new nonsense NHS variant. In addition, the patient presented congenital diaphragmatic hernia [CLS] . NHS gene expression in murine fetal diaphragm was demonstrated, suggesting a possible involvement of NHS in diaphragm development. Congenital diaphragmatic hernia could result from NHS loss of function in"}
{"subject": "NHS", "sub_type": "Gene", "rel": "ThemeOf", "object": "loss of function", "obj_type": "NegReg", "file_name": "PubMed-29358614.json", "snippet": " patient presented congenital diaphragmatic hernia. NHS gene expression in murine fetal diaphragm was demonstrated, suggesting a possible involvement of NHS in diaphragm development. Congenital diaphragmatic hernia could result from  [CLS] NHS loss of function [CLS]  in pleuroperitoneal fold or in somites-derived muscle progenitor cells leading to an impairment of their cells migration."}
{"subject": "loss of function", "sub_type": "NegReg", "rel": "CauseOf", "object": "cells migration", "obj_type": "CPA", "file_name": "PubMed-29358614.json", "snippet": " presented congenital diaphragmatic hernia. NHS gene expression in murine fetal diaphragm was demonstrated, suggesting a possible involvement of NHS in diaphragm development. Congenital diaphragmatic hernia could result from NHS  [CLS] loss of function in pleuroperitoneal fold or in somites-derived muscle progenitor cells leading to an impairment of their cells migration [CLS] ."}
{"subject": "cells migration", "sub_type": "CPA", "rel": "CauseOf", "object": "Congenital diaphragmatic hernia", "obj_type": "Disease", "file_name": "PubMed-29358614.json", "snippet": " nonsense NHS variant. In addition, the patient presented congenital diaphragmatic hernia. NHS gene expression in murine fetal diaphragm was demonstrated, suggesting a possible involvement of NHS in diaphragm development.  [CLS] Congenital diaphragmatic hernia could result from NHS loss of function in pleuroperitoneal fold or in somites-derived muscle progenitor cells leading to an impairment of their cells migration [CLS] ."}
{"subject": "FLG", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-29367526.json", "snippet": " [CLS] mutations in filaggrin (FLG [CLS] ) gene in atopic dermatitis (AD) individuals, significant attention has been paid against the skin barrier as an initial starting point of atopic march. Although FLG is a significant cornification-associated"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-29367526.json", "snippet": " [CLS] loss-of-function mutations [CLS]  in filaggrin (FLG) gene in atopic dermatitis (AD) individuals, significant attention has been paid against the skin barrier as an initial starting point of atopic march. Although FLG is"}
{"subject": "atopic dermatitis", "sub_type": "Disease", "rel": "ThemeOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-29367526.json", "snippet": " [CLS] loss-of-function mutations in filaggrin (FLG) gene in atopic dermatitis [CLS]  (AD) individuals, significant attention has been paid against the skin barrier as an initial starting point of atopic march. Although FLG is a significant cornification-associated gene, skin barrier formation"}
{"subject": "TRH", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-29367674.json", "snippet": " [CLS] TRH) loss of function mutations [CLS]  induce growth and behavioral defects in Daphnia magna.\nTryptophan hydroxylase (TRH) is the rate limiting enzyme in the serotonin synthesis. CRISPR-Cas9 technology was used to generate seven indel TRH"}
{"subject": "lacking", "sub_type": "NegReg", "rel": "CauseOf", "object": "reproduced", "obj_type": "CPA", "file_name": "PubMed-29367674.json", "snippet": " TRH-/- clones showed no detectable levels of serotonin. Life history and behavioral responses of TRH-/- clones showed the anti-phenotype of those exposed to selective serotonin reuptake inhibitors (SSRI). Mutants  [CLS] lacking serotonin grew less and hence reproduced [CLS]  latter, produced smaller clutches of smaller offspring and responded to a greater extent to light than wild type individuals. Mono-allelic indel TRH-/+ individuals showed the intermediate phenotype. The SSRI"}
{"subject": "offspring", "sub_type": "CPA", "rel": "ThemeOf", "object": "smaller", "obj_type": "NegReg", "file_name": "PubMed-29367674.json", "snippet": " responses of TRH-/- clones showed the anti-phenotype of those exposed to selective serotonin reuptake inhibitors (SSRI). Mutants lacking serotonin grew less and hence reproduced latter, produced smaller clutches of  [CLS] smaller offspring [CLS]  and responded to a greater extent to light than wild type individuals. Mono-allelic indel TRH-/+ individuals showed the intermediate phenotype. The SSRI fluoxetine enhanced offspring production in all clones"}
{"subject": "smaller", "sub_type": "NegReg", "rel": "ThemeOf", "object": "clutches", "obj_type": "CPA", "file_name": "PubMed-29367674.json", "snippet": " and behavioral responses of TRH-/- clones showed the anti-phenotype of those exposed to selective serotonin reuptake inhibitors (SSRI). Mutants lacking serotonin grew less and hence reproduced latter, produced smaller  [CLS] clutches of smaller [CLS]  offspring and responded to a greater extent to light than wild type individuals. Mono-allelic indel TRH-/+ individuals showed the intermediate phenotype. The SSRI fluoxetine enhanced offspring production in all"}
{"subject": "clutches", "sub_type": "CPA", "rel": "ThemeOf", "object": "smaller", "obj_type": "NegReg", "file_name": "PubMed-29367674.json", "snippet": " history and behavioral responses of TRH-/- clones showed the anti-phenotype of those exposed to selective serotonin reuptake inhibitors (SSRI). Mutants lacking serotonin grew less and hence reproduced latter, produced  [CLS] smaller clutches [CLS]  of smaller offspring and responded to a greater extent to light than wild type individuals. Mono-allelic indel TRH-/+ individuals showed the intermediate phenotype. The SSRI fluoxetine enhanced offspring production"}
{"subject": "lacking", "sub_type": "NegReg", "rel": "CauseOf", "object": "smaller", "obj_type": "NegReg", "file_name": "PubMed-29367674.json", "snippet": " TRH-/- clones showed no detectable levels of serotonin. Life history and behavioral responses of TRH-/- clones showed the anti-phenotype of those exposed to selective serotonin reuptake inhibitors (SSRI). Mutants  [CLS] lacking serotonin grew less and hence reproduced latter, produced smaller [CLS]  clutches of smaller offspring and responded to a greater extent to light than wild type individuals. Mono-allelic indel TRH-/+ individuals showed the intermediate phenotype. The SSRI fluoxetine enhanced offspring"}
{"subject": "growth and behavioral defects", "sub_type": "CPA", "rel": "ThemeOf", "object": "loss of function", "obj_type": "NegReg", "file_name": "PubMed-29367674.json", "snippet": " [CLS] loss of function mutations induce growth and behavioral defects [CLS]  in Daphnia magna.\nTryptophan hydroxylase (TRH) is the rate limiting enzyme in the serotonin synthesis. CRISPR-Cas9 technology was used to generate seven indel TRH mutants in Daphnia magna. Mono-allelic"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "loss of function", "obj_type": "NegReg", "file_name": "PubMed-29367674.json", "snippet": " [CLS] loss of function mutations [CLS]  induce growth and behavioral defects in Daphnia magna.\nTryptophan hydroxylase (TRH) is the rate limiting enzyme in the serotonin synthesis. CRISPR-Cas9 technology was used to generate seven indel TRH"}
{"subject": "serotonin", "sub_type": "MPA", "rel": "ThemeOf", "object": "lacking", "obj_type": "NegReg", "file_name": "PubMed-29367674.json", "snippet": " TRH-/- clones showed no detectable levels of serotonin. Life history and behavioral responses of TRH-/- clones showed the anti-phenotype of those exposed to selective serotonin reuptake inhibitors (SSRI). Mutants  [CLS] lacking serotonin [CLS]  grew less and hence reproduced latter, produced smaller clutches of smaller offspring and responded to a greater extent to light than wild type individuals. Mono-allelic indel TRH-/+ individuals showed"}
{"subject": "Mutants", "sub_type": "Var", "rel": "CauseOf", "object": "lacking", "obj_type": "NegReg", "file_name": "PubMed-29367674.json", "snippet": " indel TRH-/- clones showed no detectable levels of serotonin. Life history and behavioral responses of TRH-/- clones showed the anti-phenotype of those exposed to selective serotonin reuptake inhibitors (SSRI).  [CLS] Mutants lacking [CLS]  serotonin grew less and hence reproduced latter, produced smaller clutches of smaller offspring and responded to a greater extent to light than wild type individuals. Mono-allelic indel TRH-/+ individuals"}
{"subject": "lacking", "sub_type": "NegReg", "rel": "CauseOf", "object": "less", "obj_type": "NegReg", "file_name": "PubMed-29367674.json", "snippet": " TRH-/- clones showed no detectable levels of serotonin. Life history and behavioral responses of TRH-/- clones showed the anti-phenotype of those exposed to selective serotonin reuptake inhibitors (SSRI). Mutants  [CLS] lacking serotonin grew less [CLS]  and hence reproduced latter, produced smaller clutches of smaller offspring and responded to a greater extent to light than wild type individuals. Mono-allelic indel TRH-/+ individuals showed the intermediate"}
{"subject": "grew", "sub_type": "CPA", "rel": "ThemeOf", "object": "less", "obj_type": "NegReg", "file_name": "PubMed-29367674.json", "snippet": " showed no detectable levels of serotonin. Life history and behavioral responses of TRH-/- clones showed the anti-phenotype of those exposed to selective serotonin reuptake inhibitors (SSRI). Mutants lacking serotonin  [CLS] grew less [CLS]  and hence reproduced latter, produced smaller clutches of smaller offspring and responded to a greater extent to light than wild type individuals. Mono-allelic indel TRH-/+ individuals showed the intermediate"}
{"subject": "FLT3", "sub_type": "Gene", "rel": "ThemeOf", "object": "Internal tandem duplication mutations", "obj_type": "Var", "file_name": "PubMed-29372308.json", "snippet": " [CLS] Internal tandem duplication mutations in the tyrosine kinase domain of FLT3 [CLS]  display a higher oncogenic potential than the activation loop D835Y mutation.\nAcute myeloid leukemia (AML) remains the most common form of acute leukemia among adults and accounts for a"}
{"subject": "STAT5", "sub_type": "Protein", "rel": "ThemeOf", "object": "phosphorylation", "obj_type": "MPA", "file_name": "PubMed-29372308.json", "snippet": " D835Y/FLT3 failed to form colonies. Cell proliferation and cell survival was also significantly higher in TKD-ITD expressing cells, compared to cells expressing D835Y/FLT3. Furthermore, TKD-ITD is capable of inducing  [CLS] phosphorylation of STAT5 [CLS] , while D835Y/FLT3 fails to induce tyrosine phosphorylation of STAT5. Other signal transduction pathways such as the RAS/ERK and the PI3K/AKT pathways were activated to the same level in TKD-ITD"}
{"subject": "phosphorylation", "sub_type": "MPA", "rel": "ThemeOf", "object": "inducing", "obj_type": "PosReg", "file_name": "PubMed-29372308.json", "snippet": " expressing D835Y/FLT3 failed to form colonies. Cell proliferation and cell survival was also significantly higher in TKD-ITD expressing cells, compared to cells expressing D835Y/FLT3. Furthermore, TKD-ITD is capable of  [CLS] inducing phosphorylation [CLS]  of STAT5, while D835Y/FLT3 fails to induce tyrosine phosphorylation of STAT5. Other signal transduction pathways such as the RAS/ERK and the PI3K/AKT pathways were activated to the same level"}
{"subject": "Mutations", "sub_type": "Var", "rel": "CauseOf", "object": "prevalent", "obj_type": "Reg", "file_name": "PubMed-29372308.json", "snippet": " than the activation loop D835Y mutation.\nAcute myeloid leukemia (AML) remains the most common form of acute leukemia among adults and accounts for a large number of leukemia-related deaths.  [CLS] Mutations in FMS-like tyrosine kinase 3 (FLT3) is one of the most prevalent [CLS]  findings in this heterogeneous disease. The major types of mutations in FLT3 can be categorized as internal tandem duplications (ITD) and point mutations. Recent studies suggest that ITDs not"}
{"subject": "Acute myeloid leukemia", "sub_type": "Disease", "rel": "ThemeOf", "object": "prevalent", "obj_type": "Reg", "file_name": "PubMed-29372308.json", "snippet": " [CLS] Acute myeloid leukemia (AML) remains the most common form of acute leukemia among adults and accounts for a large number of leukemia-related deaths. Mutations in FMS-like tyrosine kinase 3 (FLT3) is one of the most prevalent [CLS]  findings in this heterogeneous disease. The major types of mutations in FLT3 can be categorized as internal tandem duplications (ITD) and point mutations. Recent studies suggest that ITDs not"}
{"subject": "FLT3", "sub_type": "Gene", "rel": "ThemeOf", "object": "Mutations", "obj_type": "Var", "file_name": "PubMed-29372308.json", "snippet": " than the activation loop D835Y mutation.\nAcute myeloid leukemia (AML) remains the most common form of acute leukemia among adults and accounts for a large number of leukemia-related deaths.  [CLS] Mutations in FMS-like tyrosine kinase 3 (FLT3 [CLS] ) is one of the most prevalent findings in this heterogeneous disease. The major types of mutations in FLT3 can be categorized as internal tandem duplications (ITD) and point mutations."}
{"subject": "Internal tandem duplication mutations", "sub_type": "Var", "rel": "CauseOf", "object": "higher", "obj_type": "PosReg", "file_name": "PubMed-29372308.json", "snippet": " [CLS] Internal tandem duplication mutations in the tyrosine kinase domain of FLT3 display a higher [CLS]  oncogenic potential than the activation loop D835Y mutation.\nAcute myeloid leukemia (AML) remains the most common form of acute leukemia among adults and accounts for a large number of"}
{"subject": "oncogenic potential", "sub_type": "CPA", "rel": "ThemeOf", "object": "higher", "obj_type": "PosReg", "file_name": "PubMed-29372308.json", "snippet": " [CLS] higher oncogenic potential [CLS]  than the activation loop D835Y mutation.\nAcute myeloid leukemia (AML) remains the most common form of acute leukemia among adults and accounts for a large number of leukemia-related deaths."}
{"subject": "TKD-ITD", "sub_type": "Var", "rel": "CauseOf", "object": "higher", "obj_type": "PosReg", "file_name": "PubMed-29372308.json", "snippet": " of the receptor (JMD-ITD) or the tyrosine kinase domain (TKD)-ITD were indistinguishable, while Ba/F3 cells expressing D835Y/FLT3 failed to form colonies. Cell proliferation and cell survival was also significantly  [CLS] higher in TKD-ITD [CLS]  expressing cells, compared to cells expressing D835Y/FLT3. Furthermore, TKD-ITD is capable of inducing phosphorylation of STAT5, while D835Y/FLT3 fails to induce tyrosine phosphorylation of STAT5. Other signal transduction pathways"}
{"subject": "cell survival", "sub_type": "CPA", "rel": "ThemeOf", "object": "higher", "obj_type": "PosReg", "file_name": "PubMed-29372308.json", "snippet": " internal tandem duplication within juxtamembrane\u00a0domain of the receptor (JMD-ITD) or the tyrosine kinase domain (TKD)-ITD were indistinguishable, while Ba/F3 cells expressing D835Y/FLT3 failed to form colonies. Cell proliferation and  [CLS] cell survival was also significantly higher [CLS]  in TKD-ITD expressing cells, compared to cells expressing D835Y/FLT3. Furthermore, TKD-ITD is capable of inducing phosphorylation of STAT5, while D835Y/FLT3 fails to induce tyrosine phosphorylation of STAT5. Other signal"}
{"subject": "Cell proliferation", "sub_type": "CPA", "rel": "ThemeOf", "object": "higher", "obj_type": "PosReg", "file_name": "PubMed-29372308.json", "snippet": " expressing either the internal tandem duplication within juxtamembrane\u00a0domain of the receptor (JMD-ITD) or the tyrosine kinase domain (TKD)-ITD were indistinguishable, while Ba/F3 cells expressing D835Y/FLT3 failed to form colonies.  [CLS] Cell proliferation and cell survival was also significantly higher [CLS]  in TKD-ITD expressing cells, compared to cells expressing D835Y/FLT3. Furthermore, TKD-ITD is capable of inducing phosphorylation of STAT5, while D835Y/FLT3 fails to induce tyrosine phosphorylation of STAT5. Other signal"}
{"subject": "TKD-ITD", "sub_type": "Var", "rel": "CauseOf", "object": "inducing", "obj_type": "PosReg", "file_name": "PubMed-29372308.json", "snippet": " indistinguishable, while Ba/F3 cells expressing D835Y/FLT3 failed to form colonies. Cell proliferation and cell survival was also significantly higher in TKD-ITD expressing cells, compared to cells expressing D835Y/FLT3. Furthermore,  [CLS] TKD-ITD is capable of inducing [CLS]  phosphorylation of STAT5, while D835Y/FLT3 fails to induce tyrosine phosphorylation of STAT5. Other signal transduction pathways such as the RAS/ERK and the PI3K/AKT pathways were activated to the same"}
{"subject": "HJV", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutation", "obj_type": "Var", "file_name": "PubMed-29373985.json", "snippet": " of iron burden. Serial outpatient echocardiograms demonstrated myocardial recovery such that a successful biventricular assist device explant occurred 131 days after initial implant. Targeted gene sequencing revealed a loss-of-function  [CLS] mutation within the HJV [CLS]  gene, which is consistent with juvenile hemochromatosis.\nCONCLUSIONS: This rare case of a patient with juvenile hemochromatosis associated with a HJV mutation provides histologic evidence documenting the reversal of"}
{"subject": "mutation", "sub_type": "Var", "rel": "CauseOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-29373985.json", "snippet": " removal of iron burden. Serial outpatient echocardiograms demonstrated myocardial recovery such that a successful biventricular assist device explant occurred 131 days after initial implant. Targeted gene sequencing revealed a  [CLS] loss-of-function mutation [CLS]  within the HJV gene, which is consistent with juvenile hemochromatosis.\nCONCLUSIONS: This rare case of a patient with juvenile hemochromatosis associated with a HJV mutation provides histologic evidence documenting"}
{"subject": "loss-of-function", "sub_type": "NegReg", "rel": "CauseOf", "object": "juvenile hemochromatosis", "obj_type": "Disease", "file_name": "PubMed-29373985.json", "snippet": " removal of iron burden. Serial outpatient echocardiograms demonstrated myocardial recovery such that a successful biventricular assist device explant occurred 131 days after initial implant. Targeted gene sequencing revealed a  [CLS] loss-of-function mutation within the HJV gene, which is consistent with juvenile hemochromatosis [CLS] .\nCONCLUSIONS: This rare case of a patient with juvenile hemochromatosis associated with a HJV mutation provides histologic evidence documenting the reversal of associated end-stage heart failure, requiring emergent mechanical"}
{"subject": "juvenile hemochromatosis", "sub_type": "Disease", "rel": "ThemeOf", "object": "associated", "obj_type": "Reg", "file_name": "PubMed-29373985.json", "snippet": " days after initial implant. Targeted gene sequencing revealed a loss-of-function mutation within the HJV gene, which is consistent with juvenile hemochromatosis.\nCONCLUSIONS: This rare case of a patient with  [CLS] juvenile hemochromatosis associated [CLS]  with a HJV mutation provides histologic evidence documenting the reversal of associated end-stage heart failure, requiring emergent mechanical circulatory support, with iron chelation therapy."}
{"subject": "HJV", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutation", "obj_type": "Var", "file_name": "PubMed-29373985.json", "snippet": " gene sequencing revealed a loss-of-function mutation within the HJV gene, which is consistent with juvenile hemochromatosis.\nCONCLUSIONS: This rare case of a patient with juvenile hemochromatosis associated with a  [CLS] HJV mutation [CLS]  provides histologic evidence documenting the reversal of associated end-stage heart failure, requiring emergent mechanical circulatory support, with iron chelation therapy."}
{"subject": "mutation", "sub_type": "Var", "rel": "CauseOf", "object": "associated", "obj_type": "Reg", "file_name": "PubMed-29373985.json", "snippet": " initial implant. Targeted gene sequencing revealed a loss-of-function mutation within the HJV gene, which is consistent with juvenile hemochromatosis.\nCONCLUSIONS: This rare case of a patient with juvenile hemochromatosis  [CLS] associated with a HJV mutation [CLS]  provides histologic evidence documenting the reversal of associated end-stage heart failure, requiring emergent mechanical circulatory support, with iron chelation therapy."}
{"subject": "TRPV1", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutation", "obj_type": "Var", "file_name": "PubMed-29424270.json", "snippet": " [CLS] TRPV1 gain-of-function mutation [CLS]  impairs pain and itch sensations in mice.\nTransient receptor potential vanilloid 1 (TRPV1) is a non-selective cation channel, which can detect various noxious stimuli that cause pain, inflammation, hyperalgesia,"}
{"subject": "thermosensory", "sub_type": "CPA", "rel": "ThemeOf", "object": "defect", "obj_type": "NegReg", "file_name": "PubMed-29424270.json", "snippet": " that the G564S mutation in mouse TRPV1 caused increased basal current and a leftward shift of voltage dependence. Intriguingly, using behavioral analysis, we found that knock-in mice showed a  [CLS] thermosensory defect [CLS] , impaired inflammatory thermal pain, and capsaicin sensitivity. We also demonstrated an attenuated behavioral response to the pruritic agent histamine in the knock-in mice. Indeed, calcium imaging together with electrophysiology"}
{"subject": "G564S", "sub_type": "Var", "rel": "CauseOf", "object": "impaired", "obj_type": "NegReg", "file_name": "PubMed-29424270.json", "snippet": " persistent activation of TRPV1 are not completely understood. Here, we generated TRPV1 knock-in mice with a G564S mutation. In the heterologous expression system, an electrophysiological study showed that the  [CLS] G564S mutation in mouse TRPV1 caused increased basal current and a leftward shift of voltage dependence. Intriguingly, using behavioral analysis, we found that knock-in mice showed a thermosensory defect, impaired [CLS]  inflammatory thermal pain, and capsaicin sensitivity. We also demonstrated an attenuated behavioral response to the pruritic agent histamine in the knock-in mice. Indeed, calcium imaging together with electrophysiology showed"}
{"subject": "inflammatory thermal pain", "sub_type": "MPA", "rel": "ThemeOf", "object": "impaired", "obj_type": "NegReg", "file_name": "PubMed-29424270.json", "snippet": " G564S mutation in mouse TRPV1 caused increased basal current and a leftward shift of voltage dependence. Intriguingly, using behavioral analysis, we found that knock-in mice showed a thermosensory defect,  [CLS] impaired inflammatory thermal pain [CLS] , and capsaicin sensitivity. We also demonstrated an attenuated behavioral response to the pruritic agent histamine in the knock-in mice. Indeed, calcium imaging together with electrophysiology showed that the overactive"}
{"subject": "G564S", "sub_type": "Var", "rel": "CauseOf", "object": "capsaicin sensitivity", "obj_type": "CPA", "file_name": "PubMed-29424270.json", "snippet": " persistent activation of TRPV1 are not completely understood. Here, we generated TRPV1 knock-in mice with a G564S mutation. In the heterologous expression system, an electrophysiological study showed that the  [CLS] G564S mutation in mouse TRPV1 caused increased basal current and a leftward shift of voltage dependence. Intriguingly, using behavioral analysis, we found that knock-in mice showed a thermosensory defect, impaired inflammatory thermal pain, and capsaicin sensitivity [CLS] . We also demonstrated an attenuated behavioral response to the pruritic agent histamine in the knock-in mice. Indeed, calcium imaging together with electrophysiology showed that the overactive mutant had decreased"}
{"subject": "G564S", "sub_type": "Var", "rel": "CauseOf", "object": "reduced", "obj_type": "NegReg", "file_name": "PubMed-29424270.json", "snippet": " the pruritic agent histamine in the knock-in mice. Indeed, calcium imaging together with electrophysiology showed that the overactive mutant had decreased capsaicin sensitivity. Western blot analysis revealed that the  [CLS] G564S mutant reduced [CLS]  TRPV1 phosphorylation and cell membrane trafficking. Together, we have generated a mouse model with a gain-of-function mutation in Trpv1 gene and demonstrated that the pain and histamine-dependent itch sensations"}
{"subject": "TRPV1", "sub_type": "Protein", "rel": "ThemeOf", "object": "phosphorylation", "obj_type": "MPA", "file_name": "PubMed-29424270.json", "snippet": " histamine in the knock-in mice. Indeed, calcium imaging together with electrophysiology showed that the overactive mutant had decreased capsaicin sensitivity. Western blot analysis revealed that the G564S mutant reduced  [CLS] TRPV1 phosphorylation [CLS]  and cell membrane trafficking. Together, we have generated a mouse model with a gain-of-function mutation in Trpv1 gene and demonstrated that the pain and histamine-dependent itch sensations in these"}
{"subject": "phosphorylation", "sub_type": "MPA", "rel": "ThemeOf", "object": "reduced", "obj_type": "NegReg", "file_name": "PubMed-29424270.json", "snippet": " agent histamine in the knock-in mice. Indeed, calcium imaging together with electrophysiology showed that the overactive mutant had decreased capsaicin sensitivity. Western blot analysis revealed that the G564S mutant  [CLS] reduced TRPV1 phosphorylation [CLS]  and cell membrane trafficking. Together, we have generated a mouse model with a gain-of-function mutation in Trpv1 gene and demonstrated that the pain and histamine-dependent itch sensations in these"}
{"subject": "cell membrane trafficking", "sub_type": "CPA", "rel": "ThemeOf", "object": "reduced", "obj_type": "NegReg", "file_name": "PubMed-29424270.json", "snippet": " agent histamine in the knock-in mice. Indeed, calcium imaging together with electrophysiology showed that the overactive mutant had decreased capsaicin sensitivity. Western blot analysis revealed that the G564S mutant  [CLS] reduced TRPV1 phosphorylation and cell membrane trafficking [CLS] . Together, we have generated a mouse model with a gain-of-function mutation in Trpv1 gene and demonstrated that the pain and histamine-dependent itch sensations in these mice are impaired due"}
{"subject": "Trpv1", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutation", "obj_type": "Var", "file_name": "PubMed-29424270.json", "snippet": " had decreased capsaicin sensitivity. Western blot analysis revealed that the G564S mutant reduced TRPV1 phosphorylation and cell membrane trafficking. Together, we have generated a mouse model with a gain-of-function  [CLS] mutation in Trpv1 [CLS]  gene and demonstrated that the pain and histamine-dependent itch sensations in these mice are impaired due to a decreased phosphorylation level and reduced membrane localization of TRPV1."}
{"subject": "mutation", "sub_type": "Var", "rel": "CauseOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-29424270.json", "snippet": " mutant had decreased capsaicin sensitivity. Western blot analysis revealed that the G564S mutant reduced TRPV1 phosphorylation and cell membrane trafficking. Together, we have generated a mouse model with a  [CLS] gain-of-function mutation [CLS]  in Trpv1 gene and demonstrated that the pain and histamine-dependent itch sensations in these mice are impaired due to a decreased phosphorylation level and reduced membrane localization of TRPV1."}
{"subject": "mutation", "sub_type": "Var", "rel": "CauseOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-29424270.json", "snippet": " [CLS] gain-of-function mutation [CLS]  impairs pain and itch sensations in mice.\nTransient receptor potential vanilloid 1 (TRPV1) is a non-selective cation channel, which can detect various noxious stimuli that cause pain, inflammation, hyperalgesia,"}
{"subject": "gain-of-function", "sub_type": "PosReg", "rel": "CauseOf", "object": "decreased", "obj_type": "NegReg", "file_name": "PubMed-29424270.json", "snippet": " mutant had decreased capsaicin sensitivity. Western blot analysis revealed that the G564S mutant reduced TRPV1 phosphorylation and cell membrane trafficking. Together, we have generated a mouse model with a  [CLS] gain-of-function mutation in Trpv1 gene and demonstrated that the pain and histamine-dependent itch sensations in these mice are impaired due to a decreased [CLS]  phosphorylation level and reduced membrane localization of TRPV1."}
{"subject": "gain-of-function", "sub_type": "PosReg", "rel": "CauseOf", "object": "reduced", "obj_type": "NegReg", "file_name": "PubMed-29424270.json", "snippet": " mutant had decreased capsaicin sensitivity. Western blot analysis revealed that the G564S mutant reduced TRPV1 phosphorylation and cell membrane trafficking. Together, we have generated a mouse model with a  [CLS] gain-of-function mutation in Trpv1 gene and demonstrated that the pain and histamine-dependent itch sensations in these mice are impaired due to a decreased phosphorylation level and reduced [CLS]  membrane localization of TRPV1."}
{"subject": "phosphorylation level", "sub_type": "MPA", "rel": "ThemeOf", "object": "decreased", "obj_type": "NegReg", "file_name": "PubMed-29424270.json", "snippet": " have generated a mouse model with a gain-of-function mutation in Trpv1 gene and demonstrated that the pain and histamine-dependent itch sensations in these mice are impaired due to a  [CLS] decreased phosphorylation level [CLS]  and reduced membrane localization of TRPV1."}
{"subject": "TRPV1", "sub_type": "Protein", "rel": "ThemeOf", "object": "membrane localization", "obj_type": "MPA", "file_name": "PubMed-29424270.json", "snippet": " with a gain-of-function mutation in Trpv1 gene and demonstrated that the pain and histamine-dependent itch sensations in these mice are impaired due to a decreased phosphorylation level and reduced  [CLS] membrane localization of TRPV1 [CLS] ."}
{"subject": "membrane localization", "sub_type": "MPA", "rel": "ThemeOf", "object": "reduced", "obj_type": "NegReg", "file_name": "PubMed-29424270.json", "snippet": " model with a gain-of-function mutation in Trpv1 gene and demonstrated that the pain and histamine-dependent itch sensations in these mice are impaired due to a decreased phosphorylation level and  [CLS] reduced membrane localization [CLS]  of TRPV1."}
{"subject": "decreased", "sub_type": "NegReg", "rel": "CauseOf", "object": "impaired", "obj_type": "NegReg", "file_name": "PubMed-29424270.json", "snippet": " membrane trafficking. Together, we have generated a mouse model with a gain-of-function mutation in Trpv1 gene and demonstrated that the pain and histamine-dependent itch sensations in these mice are  [CLS] impaired due to a decreased [CLS]  phosphorylation level and reduced membrane localization of TRPV1."}
{"subject": "reduced", "sub_type": "NegReg", "rel": "CauseOf", "object": "impaired", "obj_type": "NegReg", "file_name": "PubMed-29424270.json", "snippet": " membrane trafficking. Together, we have generated a mouse model with a gain-of-function mutation in Trpv1 gene and demonstrated that the pain and histamine-dependent itch sensations in these mice are  [CLS] impaired due to a decreased phosphorylation level and reduced [CLS]  membrane localization of TRPV1."}
{"subject": "pain and histamine-dependent itch sensations", "sub_type": "CPA", "rel": "ThemeOf", "object": "impaired", "obj_type": "NegReg", "file_name": "PubMed-29424270.json", "snippet": " that the G564S mutant reduced TRPV1 phosphorylation and cell membrane trafficking. Together, we have generated a mouse model with a gain-of-function mutation in Trpv1 gene and demonstrated that the  [CLS] pain and histamine-dependent itch sensations in these mice are impaired [CLS]  due to a decreased phosphorylation level and reduced membrane localization of TRPV1."}
{"subject": "gain-of-function", "sub_type": "PosReg", "rel": "CauseOf", "object": "impairs", "obj_type": "NegReg", "file_name": "PubMed-29424270.json", "snippet": " [CLS] gain-of-function mutation impairs [CLS]  pain and itch sensations in mice.\nTransient receptor potential vanilloid 1 (TRPV1) is a non-selective cation channel, which can detect various noxious stimuli that cause pain, inflammation, hyperalgesia, and"}
{"subject": "pain and itch sensations", "sub_type": "CPA", "rel": "ThemeOf", "object": "impairs", "obj_type": "NegReg", "file_name": "PubMed-29424270.json", "snippet": " [CLS] impairs pain and itch sensations [CLS]  in mice.\nTransient receptor potential vanilloid 1 (TRPV1) is a non-selective cation channel, which can detect various noxious stimuli that cause pain, inflammation, hyperalgesia, and itch. TRPV1 knock-out mice"}
{"subject": "TRPV1", "sub_type": "Gene", "rel": "ThemeOf", "object": "G564S", "obj_type": "Var", "file_name": "PubMed-29424270.json", "snippet": " persistent activation of TRPV1 are not completely understood. Here, we generated TRPV1 knock-in mice with a G564S mutation. In the heterologous expression system, an electrophysiological study showed that the  [CLS] G564S mutation in mouse TRPV1 [CLS]  caused increased basal current and a leftward shift of voltage dependence. Intriguingly, using behavioral analysis, we found that knock-in mice showed a thermosensory defect, impaired inflammatory thermal pain, and"}
{"subject": "G564S", "sub_type": "Var", "rel": "CauseOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-29424270.json", "snippet": " persistent activation of TRPV1 are not completely understood. Here, we generated TRPV1 knock-in mice with a G564S mutation. In the heterologous expression system, an electrophysiological study showed that the  [CLS] G564S mutation in mouse TRPV1 caused increased [CLS]  basal current and a leftward shift of voltage dependence. Intriguingly, using behavioral analysis, we found that knock-in mice showed a thermosensory defect, impaired inflammatory thermal pain, and capsaicin sensitivity."}
{"subject": "basal current", "sub_type": "CPA", "rel": "ThemeOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-29424270.json", "snippet": " completely understood. Here, we generated TRPV1 knock-in mice with a G564S mutation. In the heterologous expression system, an electrophysiological study showed that the G564S mutation in mouse TRPV1 caused  [CLS] increased basal current [CLS]  and a leftward shift of voltage dependence. Intriguingly, using behavioral analysis, we found that knock-in mice showed a thermosensory defect, impaired inflammatory thermal pain, and capsaicin sensitivity. We also"}
{"subject": "G564S", "sub_type": "Var", "rel": "CauseOf", "object": "leftward shift of voltage dependence", "obj_type": "CPA", "file_name": "PubMed-29424270.json", "snippet": " persistent activation of TRPV1 are not completely understood. Here, we generated TRPV1 knock-in mice with a G564S mutation. In the heterologous expression system, an electrophysiological study showed that the  [CLS] G564S mutation in mouse TRPV1 caused increased basal current and a leftward shift of voltage dependence [CLS] . Intriguingly, using behavioral analysis, we found that knock-in mice showed a thermosensory defect, impaired inflammatory thermal pain, and capsaicin sensitivity. We also demonstrated an attenuated behavioral response to the"}
{"subject": "G564S", "sub_type": "Var", "rel": "CauseOf", "object": "defect", "obj_type": "NegReg", "file_name": "PubMed-29424270.json", "snippet": " persistent activation of TRPV1 are not completely understood. Here, we generated TRPV1 knock-in mice with a G564S mutation. In the heterologous expression system, an electrophysiological study showed that the  [CLS] G564S mutation in mouse TRPV1 caused increased basal current and a leftward shift of voltage dependence. Intriguingly, using behavioral analysis, we found that knock-in mice showed a thermosensory defect [CLS] , impaired inflammatory thermal pain, and capsaicin sensitivity. We also demonstrated an attenuated behavioral response to the pruritic agent histamine in the knock-in mice. Indeed, calcium imaging together with electrophysiology"}
{"subject": "UNC45A", "sub_type": "Gene", "rel": "ThemeOf", "object": "Mutations", "obj_type": "Var", "file_name": "PubMed-29429573.json", "snippet": " [CLS] Mutations in UNC45A [CLS]  Cause a Syndrome Associating Cholestasis, Diarrhea, Impaired Hearing, and Bone Fragility.\nDespite the rapid discovery of genes for rare genetic disorders, we continue to encounter individuals presenting with syndromic"}
{"subject": "biallelic mutations", "sub_type": "Var", "rel": "CauseOf", "object": "impaired hearing", "obj_type": "Disease", "file_name": "PubMed-29429573.json", "snippet": " genes for rare genetic disorders, we continue to encounter individuals presenting with syndromic manifestations. Here, we have studied four affected people in three families presenting with cholestasis, congenital diarrhea,  [CLS] impaired hearing, and bone fragility. Whole-exome sequencing of all affected individuals and their parents identified biallelic mutations [CLS]  in Unc-45 Myosin Chaperone A (UNC45A) as a likely driver for this disorder. Subsequent in\u00a0vitro and in\u00a0vivo functional studies of the candidate gene indicated a loss-of-function paradigm, wherein mutations"}
{"subject": "biallelic mutations", "sub_type": "Var", "rel": "CauseOf", "object": "congenital diarrhea", "obj_type": "Disease", "file_name": "PubMed-29429573.json", "snippet": " discovery of genes for rare genetic disorders, we continue to encounter individuals presenting with syndromic manifestations. Here, we have studied four affected people in three families presenting with cholestasis,  [CLS] congenital diarrhea, impaired hearing, and bone fragility. Whole-exome sequencing of all affected individuals and their parents identified biallelic mutations [CLS]  in Unc-45 Myosin Chaperone A (UNC45A) as a likely driver for this disorder. Subsequent in\u00a0vitro and in\u00a0vivo functional studies of the candidate gene indicated a loss-of-function paradigm, wherein mutations"}
{"subject": "biallelic mutations", "sub_type": "Var", "rel": "CauseOf", "object": "cholestasis", "obj_type": "Disease", "file_name": "PubMed-29429573.json", "snippet": " rapid discovery of genes for rare genetic disorders, we continue to encounter individuals presenting with syndromic manifestations. Here, we have studied four affected people in three families presenting with  [CLS] cholestasis, congenital diarrhea, impaired hearing, and bone fragility. Whole-exome sequencing of all affected individuals and their parents identified biallelic mutations [CLS]  in Unc-45 Myosin Chaperone A (UNC45A) as a likely driver for this disorder. Subsequent in\u00a0vitro and in\u00a0vivo functional studies of the candidate gene indicated a loss-of-function paradigm, wherein mutations"}
{"subject": "biallelic mutations", "sub_type": "Var", "rel": "CauseOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-29429573.json", "snippet": " we have studied four affected people in three families presenting with cholestasis, congenital diarrhea, impaired hearing, and bone fragility. Whole-exome sequencing of all affected individuals and their parents identified  [CLS] biallelic mutations in Unc-45 Myosin Chaperone A (UNC45A) as a likely driver for this disorder. Subsequent in\u00a0vitro and in\u00a0vivo functional studies of the candidate gene indicated a loss-of-function [CLS]  paradigm, wherein mutations attenuated or abolished protein activity with concomitant defects in gut development and function."}
{"subject": "biallelic mutations", "sub_type": "Var", "rel": "CauseOf", "object": "attenuated", "obj_type": "NegReg", "file_name": "PubMed-29429573.json", "snippet": " we have studied four affected people in three families presenting with cholestasis, congenital diarrhea, impaired hearing, and bone fragility. Whole-exome sequencing of all affected individuals and their parents identified  [CLS] biallelic mutations in Unc-45 Myosin Chaperone A (UNC45A) as a likely driver for this disorder. Subsequent in\u00a0vitro and in\u00a0vivo functional studies of the candidate gene indicated a loss-of-function paradigm, wherein mutations attenuated [CLS]  or abolished protein activity with concomitant defects in gut development and function."}
{"subject": "biallelic mutations", "sub_type": "Var", "rel": "CauseOf", "object": "abolished", "obj_type": "NegReg", "file_name": "PubMed-29429573.json", "snippet": " we have studied four affected people in three families presenting with cholestasis, congenital diarrhea, impaired hearing, and bone fragility. Whole-exome sequencing of all affected individuals and their parents identified  [CLS] biallelic mutations in Unc-45 Myosin Chaperone A (UNC45A) as a likely driver for this disorder. Subsequent in\u00a0vitro and in\u00a0vivo functional studies of the candidate gene indicated a loss-of-function paradigm, wherein mutations attenuated or abolished [CLS]  protein activity with concomitant defects in gut development and function."}
{"subject": "protein", "sub_type": "Protein", "rel": "ThemeOf", "object": "activity", "obj_type": "MPA", "file_name": "PubMed-29429573.json", "snippet": " Chaperone A (UNC45A) as a likely driver for this disorder. Subsequent in\u00a0vitro and in\u00a0vivo functional studies of the candidate gene indicated a loss-of-function paradigm, wherein mutations attenuated or abolished  [CLS] protein activity [CLS]  with concomitant defects in gut development and function."}
{"subject": "activity", "sub_type": "MPA", "rel": "ThemeOf", "object": "abolished", "obj_type": "NegReg", "file_name": "PubMed-29429573.json", "snippet": " Myosin Chaperone A (UNC45A) as a likely driver for this disorder. Subsequent in\u00a0vitro and in\u00a0vivo functional studies of the candidate gene indicated a loss-of-function paradigm, wherein mutations attenuated or  [CLS] abolished protein activity [CLS]  with concomitant defects in gut development and function."}
{"subject": "activity", "sub_type": "MPA", "rel": "ThemeOf", "object": "attenuated", "obj_type": "NegReg", "file_name": "PubMed-29429573.json", "snippet": " in Unc-45 Myosin Chaperone A (UNC45A) as a likely driver for this disorder. Subsequent in\u00a0vitro and in\u00a0vivo functional studies of the candidate gene indicated a loss-of-function paradigm, wherein mutations  [CLS] attenuated or abolished protein activity [CLS]  with concomitant defects in gut development and function."}
{"subject": "gut development", "sub_type": "CPA", "rel": "CauseOf", "object": "defects", "obj_type": "NegReg", "file_name": "PubMed-29429573.json", "snippet": " a likely driver for this disorder. Subsequent in\u00a0vitro and in\u00a0vivo functional studies of the candidate gene indicated a loss-of-function paradigm, wherein mutations attenuated or abolished protein activity with concomitant  [CLS] defects in gut development [CLS]  and function."}
{"subject": "Mutations", "sub_type": "Var", "rel": "CauseOf", "object": "Loss-of-Function", "obj_type": "NegReg", "file_name": "PubMed-29429573.json", "snippet": " [CLS] Loss-of-Function Mutations [CLS]  in UNC45A Cause a Syndrome Associating Cholestasis, Diarrhea, Impaired Hearing, and Bone Fragility.\nDespite the rapid discovery of genes for rare genetic disorders, we continue to encounter individuals presenting"}
{"subject": "biallelic mutations", "sub_type": "Var", "rel": "CauseOf", "object": "defects", "obj_type": "NegReg", "file_name": "PubMed-29429573.json", "snippet": " we have studied four affected people in three families presenting with cholestasis, congenital diarrhea, impaired hearing, and bone fragility. Whole-exome sequencing of all affected individuals and their parents identified  [CLS] biallelic mutations in Unc-45 Myosin Chaperone A (UNC45A) as a likely driver for this disorder. Subsequent in\u00a0vitro and in\u00a0vivo functional studies of the candidate gene indicated a loss-of-function paradigm, wherein mutations attenuated or abolished protein activity with concomitant defects [CLS]  in gut development and function."}
{"subject": "Loss-of-Function", "sub_type": "NegReg", "rel": "CauseOf", "object": "Syndrome", "obj_type": "Disease", "file_name": "PubMed-29429573.json", "snippet": " [CLS] Loss-of-Function Mutations in UNC45A Cause a Syndrome [CLS]  Associating Cholestasis, Diarrhea, Impaired Hearing, and Bone Fragility.\nDespite the rapid discovery of genes for rare genetic disorders, we continue to encounter individuals presenting with syndromic manifestations. Here, we"}
{"subject": "Cholestasis", "sub_type": "Disease", "rel": "ThemeOf", "object": "Syndrome", "obj_type": "Disease", "file_name": "PubMed-29429573.json", "snippet": " [CLS] Syndrome Associating Cholestasis [CLS] , Diarrhea, Impaired Hearing, and Bone Fragility.\nDespite the rapid discovery of genes for rare genetic disorders, we continue to encounter individuals presenting with syndromic manifestations. Here, we have studied"}
{"subject": "Diarrhea", "sub_type": "Disease", "rel": "ThemeOf", "object": "Syndrome", "obj_type": "Disease", "file_name": "PubMed-29429573.json", "snippet": " [CLS] Syndrome Associating Cholestasis, Diarrhea [CLS] , Impaired Hearing, and Bone Fragility.\nDespite the rapid discovery of genes for rare genetic disorders, we continue to encounter individuals presenting with syndromic manifestations. Here, we have studied four"}
{"subject": "Impaired Hearing", "sub_type": "Disease", "rel": "ThemeOf", "object": "Syndrome", "obj_type": "Disease", "file_name": "PubMed-29429573.json", "snippet": " [CLS] Syndrome Associating Cholestasis, Diarrhea, Impaired Hearing [CLS] , and Bone Fragility.\nDespite the rapid discovery of genes for rare genetic disorders, we continue to encounter individuals presenting with syndromic manifestations. Here, we have studied four affected people"}
{"subject": "Bone Fragility", "sub_type": "Disease", "rel": "ThemeOf", "object": "Syndrome", "obj_type": "Disease", "file_name": "PubMed-29429573.json", "snippet": " [CLS] Syndrome Associating Cholestasis, Diarrhea, Impaired Hearing, and Bone Fragility [CLS] .\nDespite the rapid discovery of genes for rare genetic disorders, we continue to encounter individuals presenting with syndromic manifestations. Here, we have studied four affected people in three families"}
{"subject": "UNC45A", "sub_type": "Gene", "rel": "ThemeOf", "object": "biallelic mutations", "obj_type": "Var", "file_name": "PubMed-29429573.json", "snippet": " we have studied four affected people in three families presenting with cholestasis, congenital diarrhea, impaired hearing, and bone fragility. Whole-exome sequencing of all affected individuals and their parents identified  [CLS] biallelic mutations in Unc-45 Myosin Chaperone A (UNC45A [CLS] ) as a likely driver for this disorder. Subsequent in\u00a0vitro and in\u00a0vivo functional studies of the candidate gene indicated a loss-of-function paradigm, wherein mutations attenuated or abolished protein activity with"}
{"subject": "biallelic mutations", "sub_type": "Var", "rel": "CauseOf", "object": "bone fragility", "obj_type": "Disease", "file_name": "PubMed-29429573.json", "snippet": " genetic disorders, we continue to encounter individuals presenting with syndromic manifestations. Here, we have studied four affected people in three families presenting with cholestasis, congenital diarrhea, impaired hearing, and  [CLS] bone fragility. Whole-exome sequencing of all affected individuals and their parents identified biallelic mutations [CLS]  in Unc-45 Myosin Chaperone A (UNC45A) as a likely driver for this disorder. Subsequent in\u00a0vitro and in\u00a0vivo functional studies of the candidate gene indicated a loss-of-function paradigm, wherein mutations"}
{"subject": "PPP3CA", "sub_type": "Gene", "rel": "ThemeOf", "object": "catalytic domain mutations", "obj_type": "Var", "file_name": "PubMed-29432562.json", "snippet": " in the auto-inhibitory (AI) domain. One additional frameshift insertion that caused premature termination was also identified. Detailed clinical evaluation of the six individuals revealed clinically unexpected consequences of the  [CLS] PPP3CA mutations. First, the catalytic domain mutations [CLS]  and frameshift mutation were consistently found in patients with nonsyndromic early onset epileptic encephalopathy. In contrast, the AI domain mutations were associated with multiple congenital abnormalities including craniofacial dysmorphism,"}
{"subject": "PPP3CA", "sub_type": "Gene", "rel": "ThemeOf", "object": "AI domain mutations", "obj_type": "Var", "file_name": "PubMed-29432562.json", "snippet": " individual showed severe skeletal developmental defects, namely, severe craniosynostosis and gracile bones (severe bone slenderness and perinatal fractures). Using a yeast model system, we showed that the catalytic and  [CLS] AI domain mutations visibly result in decreased and increased calcineurin signaling, respectively. These findings indicate that different functional effects of PPP3CA [CLS]  mutations are associated with two distinct disorders and suggest that functional approaches using a simple cellular system provide a tool for resolving complex genotype-phenotype correlations."}
{"subject": "AI domain mutations", "sub_type": "Var", "rel": "CauseOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-29432562.json", "snippet": " individual showed severe skeletal developmental defects, namely, severe craniosynostosis and gracile bones (severe bone slenderness and perinatal fractures). Using a yeast model system, we showed that the catalytic and  [CLS] AI domain mutations visibly result in decreased and increased [CLS]  calcineurin signaling, respectively. These findings indicate that different functional effects of PPP3CA mutations are associated with two distinct disorders and suggest that functional approaches using a simple cellular system"}
{"subject": "calcineurin signaling", "sub_type": "MPA", "rel": "ThemeOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-29432562.json", "snippet": " craniosynostosis and gracile bones (severe bone slenderness and perinatal fractures). Using a yeast model system, we showed that the catalytic and AI domain mutations visibly result in decreased and  [CLS] increased calcineurin signaling [CLS] , respectively. These findings indicate that different functional effects of PPP3CA mutations are associated with two distinct disorders and suggest that functional approaches using a simple cellular system provide a"}
{"subject": "catalytic domain mutations", "sub_type": "Var", "rel": "CauseOf", "object": "found", "obj_type": "Reg", "file_name": "PubMed-29432562.json", "snippet": " domain. One additional frameshift insertion that caused premature termination was also identified. Detailed clinical evaluation of the six individuals revealed clinically unexpected consequences of the PPP3CA mutations. First, the  [CLS] catalytic domain mutations and frameshift mutation were consistently found [CLS]  in patients with nonsyndromic early onset epileptic encephalopathy. In contrast, the AI domain mutations were associated with multiple congenital abnormalities including craniofacial dysmorphism, arthrogryposis and short stature. In addition,"}
{"subject": "frameshift mutation", "sub_type": "Var", "rel": "CauseOf", "object": "found", "obj_type": "Reg", "file_name": "PubMed-29432562.json", "snippet": " insertion that caused premature termination was also identified. Detailed clinical evaluation of the six individuals revealed clinically unexpected consequences of the PPP3CA mutations. First, the catalytic domain mutations and  [CLS] frameshift mutation were consistently found [CLS]  in patients with nonsyndromic early onset epileptic encephalopathy. In contrast, the AI domain mutations were associated with multiple congenital abnormalities including craniofacial dysmorphism, arthrogryposis and short stature. In addition,"}
{"subject": "nonsyndromic early onset epileptic encephalopathy", "sub_type": "Disease", "rel": "ThemeOf", "object": "found", "obj_type": "Reg", "file_name": "PubMed-29432562.json", "snippet": " termination was also identified. Detailed clinical evaluation of the six individuals revealed clinically unexpected consequences of the PPP3CA mutations. First, the catalytic domain mutations and frameshift mutation were consistently  [CLS] found in patients with nonsyndromic early onset epileptic encephalopathy [CLS] . In contrast, the AI domain mutations were associated with multiple congenital abnormalities including craniofacial dysmorphism, arthrogryposis and short stature. In addition, one individual showed severe skeletal developmental defects, namely,"}
{"subject": "PPP3CA", "sub_type": "Gene", "rel": "ThemeOf", "object": "frameshift mutation", "obj_type": "Var", "file_name": "PubMed-29432562.json", "snippet": " in the auto-inhibitory (AI) domain. One additional frameshift insertion that caused premature termination was also identified. Detailed clinical evaluation of the six individuals revealed clinically unexpected consequences of the  [CLS] PPP3CA mutations. First, the catalytic domain mutations and frameshift mutation [CLS]  were consistently found in patients with nonsyndromic early onset epileptic encephalopathy. In contrast, the AI domain mutations were associated with multiple congenital abnormalities including craniofacial dysmorphism, arthrogryposis and short"}
{"subject": "AI domain mutations", "sub_type": "Var", "rel": "CauseOf", "object": "associated", "obj_type": "Reg", "file_name": "PubMed-29432562.json", "snippet": " clinically unexpected consequences of the PPP3CA mutations. First, the catalytic domain mutations and frameshift mutation were consistently found in patients with nonsyndromic early onset epileptic encephalopathy. In contrast, the  [CLS] AI domain mutations were associated [CLS]  with multiple congenital abnormalities including craniofacial dysmorphism, arthrogryposis and short stature. In addition, one individual showed severe skeletal developmental defects, namely, severe craniosynostosis and gracile bones (severe bone slenderness"}
{"subject": "multiple congenital abnormalities", "sub_type": "Disease", "rel": "ThemeOf", "object": "associated", "obj_type": "Reg", "file_name": "PubMed-29432562.json", "snippet": " the PPP3CA mutations. First, the catalytic domain mutations and frameshift mutation were consistently found in patients with nonsyndromic early onset epileptic encephalopathy. In contrast, the AI domain mutations were  [CLS] associated with multiple congenital abnormalities [CLS]  including craniofacial dysmorphism, arthrogryposis and short stature. In addition, one individual showed severe skeletal developmental defects, namely, severe craniosynostosis and gracile bones (severe bone slenderness and perinatal fractures). Using"}
{"subject": "craniofacial dysmorphism", "sub_type": "Disease", "rel": "ThemeOf", "object": "multiple congenital abnormalities", "obj_type": "Disease", "file_name": "PubMed-29432562.json", "snippet": " mutations. First, the catalytic domain mutations and frameshift mutation were consistently found in patients with nonsyndromic early onset epileptic encephalopathy. In contrast, the AI domain mutations were associated with  [CLS] multiple congenital abnormalities including craniofacial dysmorphism [CLS] , arthrogryposis and short stature. In addition, one individual showed severe skeletal developmental defects, namely, severe craniosynostosis and gracile bones (severe bone slenderness and perinatal fractures). Using a yeast model"}
{"subject": "arthrogryposis", "sub_type": "Disease", "rel": "ThemeOf", "object": "multiple congenital abnormalities", "obj_type": "Disease", "file_name": "PubMed-29432562.json", "snippet": " mutations. First, the catalytic domain mutations and frameshift mutation were consistently found in patients with nonsyndromic early onset epileptic encephalopathy. In contrast, the AI domain mutations were associated with  [CLS] multiple congenital abnormalities including craniofacial dysmorphism, arthrogryposis [CLS]  and short stature. In addition, one individual showed severe skeletal developmental defects, namely, severe craniosynostosis and gracile bones (severe bone slenderness and perinatal fractures). Using a yeast model system,"}
{"subject": "short stature", "sub_type": "Disease", "rel": "ThemeOf", "object": "multiple congenital abnormalities", "obj_type": "Disease", "file_name": "PubMed-29432562.json", "snippet": " mutations. First, the catalytic domain mutations and frameshift mutation were consistently found in patients with nonsyndromic early onset epileptic encephalopathy. In contrast, the AI domain mutations were associated with  [CLS] multiple congenital abnormalities including craniofacial dysmorphism, arthrogryposis and short stature [CLS] . In addition, one individual showed severe skeletal developmental defects, namely, severe craniosynostosis and gracile bones (severe bone slenderness and perinatal fractures). Using a yeast model system, we showed that"}
{"subject": "Caenorhabditis elegans peroxidasin PXN-2", "sub_type": "Enzyme", "rel": "ThemeOf", "object": "Loss of function", "obj_type": "NegReg", "file_name": "PubMed-29440357.json", "snippet": " Attachment Genes.\nBasement membranes are extracellular matrices essential for embryonic development in animals. Peroxidasins are extracellular peroxidases implicated in the unique sulfilimine cross-links between type IV basement membrane collagens.  [CLS] Loss of function in the Caenorhabditis elegans peroxidasin PXN-2 [CLS]  results in fully penetrant embryonic or larval lethality. Using genetic suppressor screening, we find that the requirement for PXN-2 in development can be bypassed by gain of function in"}
{"subject": "Loss of function", "sub_type": "NegReg", "rel": "CauseOf", "object": "fully penetrant embryonic", "obj_type": "CPA", "file_name": "PubMed-29440357.json", "snippet": " Attachment Genes.\nBasement membranes are extracellular matrices essential for embryonic development in animals. Peroxidasins are extracellular peroxidases implicated in the unique sulfilimine cross-links between type IV basement membrane collagens.  [CLS] Loss of function in the Caenorhabditis elegans peroxidasin PXN-2 results in fully penetrant embryonic [CLS]  or larval lethality. Using genetic suppressor screening, we find that the requirement for PXN-2 in development can be bypassed by gain of function in multiple genes encoding other basement"}
{"subject": "Loss of function", "sub_type": "NegReg", "rel": "CauseOf", "object": "larval lethality", "obj_type": "CPA", "file_name": "PubMed-29440357.json", "snippet": " Attachment Genes.\nBasement membranes are extracellular matrices essential for embryonic development in animals. Peroxidasins are extracellular peroxidases implicated in the unique sulfilimine cross-links between type IV basement membrane collagens.  [CLS] Loss of function in the Caenorhabditis elegans peroxidasin PXN-2 results in fully penetrant embryonic or larval lethality [CLS] . Using genetic suppressor screening, we find that the requirement for PXN-2 in development can be bypassed by gain of function in multiple genes encoding other basement membrane components, or"}
{"subject": "let-805", "sub_type": "Gene", "rel": "ThemeOf", "object": "missense alterations", "obj_type": "Var", "file_name": "PubMed-29440357.json", "snippet": " attachment. We identify multiple alleles of let-805, encoding the transmembrane protein myotactin, which suppress phenotypes of pxn-2 null mutants and of other basement membrane mutants such as F-spondin/spon-1 These  [CLS] let-805 suppressor alleles cause missense alterations [CLS]  in two pairs of FNIII repeats in the extracellular domain; they act dominantly and have no detectable phenotypes alone, suggesting they cause gain of function. We also identify suppressor"}
{"subject": "missense alterations", "sub_type": "Var", "rel": "CauseOf", "object": "gain of function", "obj_type": "PosReg", "file_name": "PubMed-29440357.json", "snippet": " alleles of let-805, encoding the transmembrane protein myotactin, which suppress phenotypes of pxn-2 null mutants and of other basement membrane mutants such as F-spondin/spon-1 These let-805 suppressor alleles cause  [CLS] missense alterations in two pairs of FNIII repeats in the extracellular domain; they act dominantly and have no detectable phenotypes alone, suggesting they cause gain of function [CLS] . We also identify suppressor missense mutations affecting basement membrane components type IV collagen (emb-9, let-2) and perlecan (unc-52), as well as a mutation affecting spectraplakin (vab-10), a component of"}
{"subject": "GTPBP2", "sub_type": "Gene", "rel": "ThemeOf", "object": "Biallelic inactivating variants", "obj_type": "Var", "file_name": "PubMed-29449720.json", "snippet": " [CLS] Biallelic inactivating variants in the GTPBP2 [CLS]  gene cause a neurodevelopmental disorder with severe intellectual disability.\nCongenital neurological disorders are genetically highly heterogeneous. Rare forms of hereditary neurological disorders are still difficult to be adequately diagnosed."}
{"subject": "c.430[C>T];[C>T] p.(Arg144*)", "sub_type": "Var", "rel": "CauseOf", "object": "structural brain abnormalities", "obj_type": "CPA", "file_name": "PubMed-29449720.json", "snippet": " to be adequately diagnosed. Pertinent studies, especially when reporting only single families, need independent confirmation. We present three unrelated families in which whole-exome sequencing identified the homozygous non-sense variants  [CLS] c.430[C>T];[C>T] p.(Arg144*), c.1219[C>T];[C>T] p.(Gln407*) and c.1408[C>T];[C>T] p.(Arg470*) in GTPBP2. Their clinical presentations include early onset and apparently non-progressive motor and cognitive impairment, and thereby overlap with findings in a recently described family harbouring a homozygous GTPBP2 splice site variant. Notable differences include structural brain abnormalities [CLS]  (e.g., agenesis of the corpus callosum, exclusive to our patients), and evidence for brain iron accumulation (exclusive to the previously described family). This report confirms pathogenicity of biallelic GTPBP2"}
{"subject": "c.1219[C>T];[C>T] p.(Gln407*)", "sub_type": "Var", "rel": "CauseOf", "object": "structural brain abnormalities", "obj_type": "CPA", "file_name": "PubMed-29449720.json", "snippet": " adequately diagnosed. Pertinent studies, especially when reporting only single families, need independent confirmation. We present three unrelated families in which whole-exome sequencing identified the homozygous non-sense variants c.430[C>T];[C>T] p.(Arg144*),  [CLS] c.1219[C>T];[C>T] p.(Gln407*) and c.1408[C>T];[C>T] p.(Arg470*) in GTPBP2. Their clinical presentations include early onset and apparently non-progressive motor and cognitive impairment, and thereby overlap with findings in a recently described family harbouring a homozygous GTPBP2 splice site variant. Notable differences include structural brain abnormalities [CLS]  (e.g., agenesis of the corpus callosum, exclusive to our patients), and evidence for brain iron accumulation (exclusive to the previously described family). This report confirms pathogenicity of biallelic GTPBP2"}
{"subject": "c.1408[C>T];[C>T] p.(Arg470*)", "sub_type": "Var", "rel": "CauseOf", "object": "structural brain abnormalities", "obj_type": "CPA", "file_name": "PubMed-29449720.json", "snippet": " studies, especially when reporting only single families, need independent confirmation. We present three unrelated families in which whole-exome sequencing identified the homozygous non-sense variants c.430[C>T];[C>T] p.(Arg144*), c.1219[C>T];[C>T] p.(Gln407*) and  [CLS] c.1408[C>T];[C>T] p.(Arg470*) in GTPBP2. Their clinical presentations include early onset and apparently non-progressive motor and cognitive impairment, and thereby overlap with findings in a recently described family harbouring a homozygous GTPBP2 splice site variant. Notable differences include structural brain abnormalities [CLS]  (e.g., agenesis of the corpus callosum, exclusive to our patients), and evidence for brain iron accumulation (exclusive to the previously described family). This report confirms pathogenicity of biallelic GTPBP2"}
{"subject": "agenesis of the corpus callosum", "sub_type": "CPA", "rel": "ThemeOf", "object": "structural brain abnormalities", "obj_type": "CPA", "file_name": "PubMed-29449720.json", "snippet": " early onset and apparently non-progressive motor and cognitive impairment, and thereby overlap with findings in a recently described family harbouring a homozygous GTPBP2 splice site variant. Notable differences include  [CLS] structural brain abnormalities (e.g., agenesis of the corpus callosum [CLS] , exclusive to our patients), and evidence for brain iron accumulation (exclusive to the previously described family). This report confirms pathogenicity of biallelic GTPBP2 inactivation and broadens the phenotypic spectrum."}
{"subject": "brain iron accumulation", "sub_type": "CPA", "rel": "ThemeOf", "object": "structural brain abnormalities", "obj_type": "CPA", "file_name": "PubMed-29449720.json", "snippet": " early onset and apparently non-progressive motor and cognitive impairment, and thereby overlap with findings in a recently described family harbouring a homozygous GTPBP2 splice site variant. Notable differences include  [CLS] structural brain abnormalities (e.g., agenesis of the corpus callosum, exclusive to our patients), and evidence for brain iron accumulation [CLS]  (exclusive to the previously described family). This report confirms pathogenicity of biallelic GTPBP2 inactivation and broadens the phenotypic spectrum. It also underlines that a potential involvement of brain iron"}
{"subject": "neurodevelopmental disorder", "sub_type": "Disease", "rel": "ThemeOf", "object": "cause", "obj_type": "Reg", "file_name": "PubMed-29449720.json", "snippet": " [CLS] cause a neurodevelopmental disorder [CLS]  with severe intellectual disability.\nCongenital neurological disorders are genetically highly heterogeneous. Rare forms of hereditary neurological disorders are still difficult to be adequately diagnosed. Pertinent studies, especially when reporting"}
{"subject": "Biallelic inactivating variants", "sub_type": "Var", "rel": "CauseOf", "object": "cause", "obj_type": "Reg", "file_name": "PubMed-29449720.json", "snippet": " [CLS] Biallelic inactivating variants in the GTPBP2 gene cause [CLS]  a neurodevelopmental disorder with severe intellectual disability.\nCongenital neurological disorders are genetically highly heterogeneous. Rare forms of hereditary neurological disorders are still difficult to be adequately diagnosed. Pertinent studies,"}
{"subject": "GTPBP2", "sub_type": "Gene", "rel": "ThemeOf", "object": "c.1408[C>T];[C>T] p.(Arg470*)", "obj_type": "Var", "file_name": "PubMed-29449720.json", "snippet": " studies, especially when reporting only single families, need independent confirmation. We present three unrelated families in which whole-exome sequencing identified the homozygous non-sense variants c.430[C>T];[C>T] p.(Arg144*), c.1219[C>T];[C>T] p.(Gln407*) and  [CLS] c.1408[C>T];[C>T] p.(Arg470*) in GTPBP2 [CLS] . Their clinical presentations include early onset and apparently non-progressive motor and cognitive impairment, and thereby overlap with findings in a recently described family harbouring a homozygous GTPBP2 splice site"}
{"subject": "GTPBP2", "sub_type": "Gene", "rel": "ThemeOf", "object": "c.1219[C>T];[C>T] p.(Gln407*)", "obj_type": "Var", "file_name": "PubMed-29449720.json", "snippet": " adequately diagnosed. Pertinent studies, especially when reporting only single families, need independent confirmation. We present three unrelated families in which whole-exome sequencing identified the homozygous non-sense variants c.430[C>T];[C>T] p.(Arg144*),  [CLS] c.1219[C>T];[C>T] p.(Gln407*) and c.1408[C>T];[C>T] p.(Arg470*) in GTPBP2 [CLS] . Their clinical presentations include early onset and apparently non-progressive motor and cognitive impairment, and thereby overlap with findings in a recently described family harbouring a homozygous GTPBP2 splice site"}
{"subject": "GTPBP2", "sub_type": "Gene", "rel": "ThemeOf", "object": "c.430[C>T];[C>T] p.(Arg144*)", "obj_type": "Var", "file_name": "PubMed-29449720.json", "snippet": " to be adequately diagnosed. Pertinent studies, especially when reporting only single families, need independent confirmation. We present three unrelated families in which whole-exome sequencing identified the homozygous non-sense variants  [CLS] c.430[C>T];[C>T] p.(Arg144*), c.1219[C>T];[C>T] p.(Gln407*) and c.1408[C>T];[C>T] p.(Arg470*) in GTPBP2 [CLS] . Their clinical presentations include early onset and apparently non-progressive motor and cognitive impairment, and thereby overlap with findings in a recently described family harbouring a homozygous GTPBP2 splice site"}
{"subject": "c.430[C>T];[C>T] p.(Arg144*)", "sub_type": "Var", "rel": "CauseOf", "object": "non-progressive motor and cognitive impairment", "obj_type": "CPA", "file_name": "PubMed-29449720.json", "snippet": " to be adequately diagnosed. Pertinent studies, especially when reporting only single families, need independent confirmation. We present three unrelated families in which whole-exome sequencing identified the homozygous non-sense variants  [CLS] c.430[C>T];[C>T] p.(Arg144*), c.1219[C>T];[C>T] p.(Gln407*) and c.1408[C>T];[C>T] p.(Arg470*) in GTPBP2. Their clinical presentations include early onset and apparently non-progressive motor and cognitive impairment [CLS] , and thereby overlap with findings in a recently described family harbouring a homozygous GTPBP2 splice site variant. Notable differences include structural brain abnormalities (e.g., agenesis of the corpus callosum,"}
{"subject": "c.1219[C>T];[C>T] p.(Gln407*)", "sub_type": "Var", "rel": "CauseOf", "object": "non-progressive motor and cognitive impairment", "obj_type": "CPA", "file_name": "PubMed-29449720.json", "snippet": " adequately diagnosed. Pertinent studies, especially when reporting only single families, need independent confirmation. We present three unrelated families in which whole-exome sequencing identified the homozygous non-sense variants c.430[C>T];[C>T] p.(Arg144*),  [CLS] c.1219[C>T];[C>T] p.(Gln407*) and c.1408[C>T];[C>T] p.(Arg470*) in GTPBP2. Their clinical presentations include early onset and apparently non-progressive motor and cognitive impairment [CLS] , and thereby overlap with findings in a recently described family harbouring a homozygous GTPBP2 splice site variant. Notable differences include structural brain abnormalities (e.g., agenesis of the corpus callosum,"}
{"subject": "c.1408[C>T];[C>T] p.(Arg470*)", "sub_type": "Var", "rel": "CauseOf", "object": "non-progressive motor and cognitive impairment", "obj_type": "CPA", "file_name": "PubMed-29449720.json", "snippet": " studies, especially when reporting only single families, need independent confirmation. We present three unrelated families in which whole-exome sequencing identified the homozygous non-sense variants c.430[C>T];[C>T] p.(Arg144*), c.1219[C>T];[C>T] p.(Gln407*) and  [CLS] c.1408[C>T];[C>T] p.(Arg470*) in GTPBP2. Their clinical presentations include early onset and apparently non-progressive motor and cognitive impairment [CLS] , and thereby overlap with findings in a recently described family harbouring a homozygous GTPBP2 splice site variant. Notable differences include structural brain abnormalities (e.g., agenesis of the corpus callosum,"}
{"subject": "COCH", "sub_type": "Gene", "rel": "ThemeOf", "object": "Bi-allelic inactivating variants", "obj_type": "Var", "file_name": "PubMed-29449721.json", "snippet": " [CLS] Bi-allelic inactivating variants in the COCH [CLS]  gene cause autosomal recessive prelingual hearing impairment.\nPathogenic variant in COCH are a known cause of DFNA9 autosomal dominant progressive hearing loss and vestibular dysfunction with adult onset. Hitherto,"}
{"subject": "Bi-allelic inactivating variants", "sub_type": "Var", "rel": "CauseOf", "object": "cause", "obj_type": "Reg", "file_name": "PubMed-29449721.json", "snippet": " [CLS] Bi-allelic inactivating variants in the COCH gene cause [CLS]  autosomal recessive prelingual hearing impairment.\nPathogenic variant in COCH are a known cause of DFNA9 autosomal dominant progressive hearing loss and vestibular dysfunction with adult onset. Hitherto, only dominant"}
{"subject": "autosomal recessive prelingual hearing impairment", "sub_type": "Disease", "rel": "ThemeOf", "object": "cause", "obj_type": "Reg", "file_name": "PubMed-29449721.json", "snippet": " [CLS] cause autosomal recessive prelingual hearing impairment [CLS] .\nPathogenic variant in COCH are a known cause of DFNA9 autosomal dominant progressive hearing loss and vestibular dysfunction with adult onset. Hitherto, only dominant nonsynonymous variants and in-frame deletions"}
{"subject": "COCH", "sub_type": "Gene", "rel": "ThemeOf", "object": "c.292C>T(p.Arg98*)", "obj_type": "Var", "file_name": "PubMed-29449721.json", "snippet": " nonsynonymous variants and in-frame deletions with a presumed dominant negative or gain-of-function effect have been described. Here, we describe two brothers with congenital prelingual deafness and a homozygous nonsense  [CLS] c.292C>T(p.Arg98*) COCH [CLS]  variant, suggesting a loss-of-function effect. Vestibular dysfunction starting in the first decade was observed in the older patient. The heterozygous parents and sibling have normal hearing and vestibular function,"}
{"subject": "c.292C>T(p.Arg98*)", "sub_type": "Var", "rel": "CauseOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-29449721.json", "snippet": " nonsynonymous variants and in-frame deletions with a presumed dominant negative or gain-of-function effect have been described. Here, we describe two brothers with congenital prelingual deafness and a homozygous nonsense  [CLS] c.292C>T(p.Arg98*) COCH variant, suggesting a loss-of-function [CLS]  effect. Vestibular dysfunction starting in the first decade was observed in the older patient. The heterozygous parents and sibling have normal hearing and vestibular function, except for the mother,"}
{"subject": "Vestibular dysfunction", "sub_type": "Disease", "rel": "ThemeOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-29449721.json", "snippet": " with a presumed dominant negative or gain-of-function effect have been described. Here, we describe two brothers with congenital prelingual deafness and a homozygous nonsense c.292C>T(p.Arg98*) COCH variant, suggesting a  [CLS] loss-of-function effect. Vestibular dysfunction [CLS]  starting in the first decade was observed in the older patient. The heterozygous parents and sibling have normal hearing and vestibular function, except for the mother, who shows vestibular"}
{"subject": "RecQ-family DNA helicase", "sub_type": "Protein", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-29452565.json", "snippet": " C levels modulate the lifespan and endoplasmic reticulum stress response pathways in mice synthesizing a nonfunctional mutant WRN protein.\nWerner syndrome (WS) is a premature aging disorder caused by  [CLS] mutations in a RecQ-family DNA helicase [CLS]  (WRN). Mice lacking part of the helicase domain of the WRN ortholog exhibit several phenotypic features of WS. In this study, we generated a Wrn mutant line that, like"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "caused by", "obj_type": "Reg", "file_name": "PubMed-29452565.json", "snippet": " [CLS] caused by mutations [CLS]  in a RecQ-family DNA helicase (WRN). Mice lacking part of the helicase domain of the WRN ortholog exhibit several phenotypic features of WS. In this study, we generated a"}
{"subject": "Werner syndrome", "sub_type": "Disease", "rel": "ThemeOf", "object": "caused by", "obj_type": "Reg", "file_name": "PubMed-29452565.json", "snippet": " [CLS] Werner syndrome (WS) is a premature aging disorder caused by [CLS]  mutations in a RecQ-family DNA helicase (WRN). Mice lacking part of the helicase domain of the WRN ortholog exhibit several phenotypic features of WS. In this study, we generated"}
{"subject": "CgPDR1", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-29464833.json", "snippet": " [CLS] CgPDR1 gain-of-function mutations [CLS]  lead to azole-resistance and increased adhesion in clinical Candida glabrata strains.\nRecently, Candida glabrata has emerged as a health-threatening pathogen and the rising resistance to antifungal agent in C.\u00a0glabrata"}
{"subject": "drug resistance", "sub_type": "MPA", "rel": "ThemeOf", "object": "conferred", "obj_type": "Reg", "file_name": "PubMed-29464833.json", "snippet": " host cells via upregulation of EPA1 transcription. Interestingly, the drug transporter gene expression levels did not always correspond with that of the adhesin EPA1 gene. GOF mutations in CgPDR1  [CLS] conferred drug resistance [CLS]  and increased adherence in the clinical strains, possibly endowing C.\u00a0glabrata with increased viability and pathogenicity."}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-29464833.json", "snippet": " increased adherence to host cells via upregulation of EPA1 transcription. Interestingly, the drug transporter gene expression levels did not always correspond with that of the adhesin EPA1 gene. GOF  [CLS] mutations in CgPDR1 conferred drug resistance and increased [CLS]  adherence in the clinical strains, possibly endowing C.\u00a0glabrata with increased viability and pathogenicity."}
{"subject": "adherence", "sub_type": "MPA", "rel": "ThemeOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-29464833.json", "snippet": " of EPA1 transcription. Interestingly, the drug transporter gene expression levels did not always correspond with that of the adhesin EPA1 gene. GOF mutations in CgPDR1 conferred drug resistance and  [CLS] increased adherence [CLS]  in the clinical strains, possibly endowing C.\u00a0glabrata with increased viability and pathogenicity."}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "elevated", "obj_type": "PosReg", "file_name": "PubMed-29464833.json", "snippet": " were revealed by sequence analysis, namely G1099D, G346D, L344S and P927S, the last being reported for the first time. CDR1, CDR2 and SNQ2 efflux pump gene expression levels were  [CLS] elevated in strains harbouring GOF mutations [CLS]  in CgPDR1, resulting in decreased azole susceptibility. CgPDR1 alleles with distinct GOF mutations displayed different expression profiles for the drug-related genes. CgPDR1GOF mutations led to increased efflux pumps expression"}
{"subject": "CDR1, CDR2 and SNQ2 efflux pump gene expression levels", "sub_type": "MPA", "rel": "ThemeOf", "object": "elevated", "obj_type": "PosReg", "file_name": "PubMed-29464833.json", "snippet": " resistance after antifungal therapy. Four gain-of-function (GOF) mutations in CgPDR1 were revealed by sequence analysis, namely G1099D, G346D, L344S and P927S, the last being reported for the first time.  [CLS] CDR1, CDR2 and SNQ2 efflux pump gene expression levels were elevated [CLS]  in strains harbouring GOF mutations in CgPDR1, resulting in decreased azole susceptibility. CgPDR1 alleles with distinct GOF mutations displayed different expression profiles for the drug-related genes. CgPDR1GOF mutations led"}
{"subject": "CgPDR1", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-29464833.json", "snippet": " namely G1099D, G346D, L344S and P927S, the last being reported for the first time. CDR1, CDR2 and SNQ2 efflux pump gene expression levels were elevated in strains harbouring GOF  [CLS] mutations in CgPDR1 [CLS] , resulting in decreased azole susceptibility. CgPDR1 alleles with distinct GOF mutations displayed different expression profiles for the drug-related genes. CgPDR1GOF mutations led to increased efflux pumps expression levels in"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "GOF", "obj_type": "PosReg", "file_name": "PubMed-29464833.json", "snippet": " analysis, namely G1099D, G346D, L344S and P927S, the last being reported for the first time. CDR1, CDR2 and SNQ2 efflux pump gene expression levels were elevated in strains harbouring  [CLS] GOF mutations [CLS]  in CgPDR1, resulting in decreased azole susceptibility. CgPDR1 alleles with distinct GOF mutations displayed different expression profiles for the drug-related genes. CgPDR1GOF mutations led to increased efflux pumps expression"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "decreased", "obj_type": "NegReg", "file_name": "PubMed-29464833.json", "snippet": " namely G1099D, G346D, L344S and P927S, the last being reported for the first time. CDR1, CDR2 and SNQ2 efflux pump gene expression levels were elevated in strains harbouring GOF  [CLS] mutations in CgPDR1, resulting in decreased [CLS]  azole susceptibility. CgPDR1 alleles with distinct GOF mutations displayed different expression profiles for the drug-related genes. CgPDR1GOF mutations led to increased efflux pumps expression levels in a strain background"}
{"subject": "azole susceptibility", "sub_type": "MPA", "rel": "ThemeOf", "object": "decreased", "obj_type": "NegReg", "file_name": "PubMed-29464833.json", "snippet": " P927S, the last being reported for the first time. CDR1, CDR2 and SNQ2 efflux pump gene expression levels were elevated in strains harbouring GOF mutations in CgPDR1, resulting in  [CLS] decreased azole susceptibility [CLS] . CgPDR1 alleles with distinct GOF mutations displayed different expression profiles for the drug-related genes. CgPDR1GOF mutations led to increased efflux pumps expression levels in a strain background independent way."}
{"subject": "CgPDR1", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-29464833.json", "snippet": " levels were elevated in strains harbouring GOF mutations in CgPDR1, resulting in decreased azole susceptibility. CgPDR1 alleles with distinct GOF mutations displayed different expression profiles for the drug-related genes.  [CLS] CgPDR1GOF mutations [CLS]  led to increased efflux pumps expression levels in a strain background independent way. Hyperactive Pdr1G1099D and Pdr1P927S displayed strain background-dependent increased adherence to host cells via upregulation of EPA1"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-29464833.json", "snippet": " [CLS] gain-of-function mutations [CLS]  lead to azole-resistance and increased adhesion in clinical Candida glabrata strains.\nRecently, Candida glabrata has emerged as a health-threatening pathogen and the rising resistance to antifungal agent in C.\u00a0glabrata"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "GOF", "obj_type": "PosReg", "file_name": "PubMed-29464833.json", "snippet": " levels were elevated in strains harbouring GOF mutations in CgPDR1, resulting in decreased azole susceptibility. CgPDR1 alleles with distinct GOF mutations displayed different expression profiles for the drug-related genes. CgPDR1 [CLS] GOF mutations [CLS]  led to increased efflux pumps expression levels in a strain background independent way. Hyperactive Pdr1G1099D and Pdr1P927S displayed strain background-dependent increased adherence to host cells via upregulation of EPA1"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-29464833.json", "snippet": " were elevated in strains harbouring GOF mutations in CgPDR1, resulting in decreased azole susceptibility. CgPDR1 alleles with distinct GOF mutations displayed different expression profiles for the drug-related genes. CgPDR1GOF  [CLS] mutations led to increased [CLS]  efflux pumps expression levels in a strain background independent way. Hyperactive Pdr1G1099D and Pdr1P927S displayed strain background-dependent increased adherence to host cells via upregulation of EPA1 transcription. Interestingly, the"}
{"subject": "efflux pumps expression levels", "sub_type": "MPA", "rel": "ThemeOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-29464833.json", "snippet": " strains harbouring GOF mutations in CgPDR1, resulting in decreased azole susceptibility. CgPDR1 alleles with distinct GOF mutations displayed different expression profiles for the drug-related genes. CgPDR1GOF mutations led to  [CLS] increased efflux pumps expression levels [CLS]  in a strain background independent way. Hyperactive Pdr1G1099D and Pdr1P927S displayed strain background-dependent increased adherence to host cells via upregulation of EPA1 transcription. Interestingly, the drug transporter gene expression"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "lead to", "obj_type": "Reg", "file_name": "PubMed-29464833.json", "snippet": " [CLS] mutations lead to [CLS]  azole-resistance and increased adhesion in clinical Candida glabrata strains.\nRecently, Candida glabrata has emerged as a health-threatening pathogen and the rising resistance to antifungal agent in C.\u00a0glabrata often leads"}
{"subject": "azole-resistance", "sub_type": "MPA", "rel": "ThemeOf", "object": "lead to", "obj_type": "Reg", "file_name": "PubMed-29464833.json", "snippet": " [CLS] lead to azole-resistance [CLS]  and increased adhesion in clinical Candida glabrata strains.\nRecently, Candida glabrata has emerged as a health-threatening pathogen and the rising resistance to antifungal agent in C.\u00a0glabrata often leads to"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-29464833.json", "snippet": " [CLS] mutations lead to azole-resistance and increased [CLS]  adhesion in clinical Candida glabrata strains.\nRecently, Candida glabrata has emerged as a health-threatening pathogen and the rising resistance to antifungal agent in C.\u00a0glabrata often leads to clinical treatment"}
{"subject": "adhesion", "sub_type": "MPA", "rel": "ThemeOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-29464833.json", "snippet": " [CLS] increased adhesion [CLS]  in clinical Candida glabrata strains.\nRecently, Candida glabrata has emerged as a health-threatening pathogen and the rising resistance to antifungal agent in C.\u00a0glabrata often leads to clinical treatment failure."}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "GOF", "obj_type": "PosReg", "file_name": "PubMed-29464833.json", "snippet": " background-dependent increased adherence to host cells via upregulation of EPA1 transcription. Interestingly, the drug transporter gene expression levels did not always correspond with that of the adhesin EPA1 gene.  [CLS] GOF mutations [CLS]  in CgPDR1 conferred drug resistance and increased adherence in the clinical strains, possibly endowing C.\u00a0glabrata with increased viability and pathogenicity."}
{"subject": "CgPDR1", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-29464833.json", "snippet": " increased adherence to host cells via upregulation of EPA1 transcription. Interestingly, the drug transporter gene expression levels did not always correspond with that of the adhesin EPA1 gene. GOF  [CLS] mutations in CgPDR1 [CLS]  conferred drug resistance and increased adherence in the clinical strains, possibly endowing C.\u00a0glabrata with increased viability and pathogenicity."}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "conferred", "obj_type": "Reg", "file_name": "PubMed-29464833.json", "snippet": " increased adherence to host cells via upregulation of EPA1 transcription. Interestingly, the drug transporter gene expression levels did not always correspond with that of the adhesin EPA1 gene. GOF  [CLS] mutations in CgPDR1 conferred [CLS]  drug resistance and increased adherence in the clinical strains, possibly endowing C.\u00a0glabrata with increased viability and pathogenicity."}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-29478779.json", "snippet": " syndrome (BPES). The three children had androgen production, virilization of external genitalia, and biochemical or histological evidence of testicular tissue. We demonstrate a highly significant association between the NR2F2  [CLS] loss-of-function mutations [CLS]  and this syndromic form of DSD (p = 2.44\u00a0\u00d7 10-8). We show that COUP-TF2 is highly abundant in a FOXL2-negative stromal cell population of the fetal human ovary. In"}
{"subject": "syndromic form of DSD", "sub_type": "Disease", "rel": "ThemeOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-29478779.json", "snippet": " syndrome (BPES). The three children had androgen production, virilization of external genitalia, and biochemical or histological evidence of testicular tissue. We demonstrate a highly significant association between the NR2F2  [CLS] loss-of-function mutations and this syndromic form of DSD [CLS]  (p = 2.44\u00a0\u00d7 10-8). We show that COUP-TF2 is highly abundant in a FOXL2-negative stromal cell population of the fetal human ovary. In contrast to the mouse, these data"}
{"subject": "p.Gly35Argfs\u221775", "sub_type": "Var", "rel": "ThemeOf", "object": "NR2F2", "obj_type": "Gene", "file_name": "PubMed-29478779.json", "snippet": " We performed exome or Sanger sequencing on 79 46,XX SRY-negative individuals with either unexplained virilization or with testicular/ovotesticular disorders/differences of sex development (TDSD/OTDSD). We identified heterozygous frameshift mutations in  [CLS] NR2F2, encoding COUP-TF2, in three children. One carried a c.103_109delGGCGCCC (p.Gly35Argfs\u221775 [CLS] ) mutation, while two others carried a c.97_103delCCGCCCG (p.Pro33Alafs\u221777) mutation. In two of three children the mutation was de novo. All three children presented with congenital heart disease (CHD), one"}
{"subject": "p.Pro33Alafs\u221777", "sub_type": "Var", "rel": "ThemeOf", "object": "NR2F2", "obj_type": "Gene", "file_name": "PubMed-29478779.json", "snippet": " We performed exome or Sanger sequencing on 79 46,XX SRY-negative individuals with either unexplained virilization or with testicular/ovotesticular disorders/differences of sex development (TDSD/OTDSD). We identified heterozygous frameshift mutations in  [CLS] NR2F2, encoding COUP-TF2, in three children. One carried a c.103_109delGGCGCCC (p.Gly35Argfs\u221775) mutation, while two others carried a c.97_103delCCGCCCG (p.Pro33Alafs\u221777 [CLS] ) mutation. In two of three children the mutation was de novo. All three children presented with congenital heart disease (CHD), one child with congenital diaphragmatic hernia (CDH), and two"}
{"subject": "p.Pro33Alafs\u221777", "sub_type": "Var", "rel": "CauseOf", "object": "presented with", "obj_type": "Reg", "file_name": "PubMed-29478779.json", "snippet": " disorders/differences of sex development (TDSD/OTDSD). We identified heterozygous frameshift mutations in NR2F2, encoding COUP-TF2, in three children. One carried a c.103_109delGGCGCCC (p.Gly35Argfs\u221775) mutation, while two others carried a c.97_103delCCGCCCG ( [CLS] p.Pro33Alafs\u221777) mutation. In two of three children the mutation was de novo. All three children presented with [CLS]  congenital heart disease (CHD), one child with congenital diaphragmatic hernia (CDH), and two children with blepharophimosis-ptosis-epicanthus inversus syndrome (BPES). The three children had androgen production, virilization of external genitalia,"}
{"subject": "p.Gly35Argfs\u221775", "sub_type": "Var", "rel": "CauseOf", "object": "presented with", "obj_type": "Reg", "file_name": "PubMed-29478779.json", "snippet": " individuals with either unexplained virilization or with testicular/ovotesticular disorders/differences of sex development (TDSD/OTDSD). We identified heterozygous frameshift mutations in NR2F2, encoding COUP-TF2, in three children. One carried a c.103_109delGGCGCCC ( [CLS] p.Gly35Argfs\u221775) mutation, while two others carried a c.97_103delCCGCCCG (p.Pro33Alafs\u221777) mutation. In two of three children the mutation was de novo. All three children presented with [CLS]  congenital heart disease (CHD), one child with congenital diaphragmatic hernia (CDH), and two children with blepharophimosis-ptosis-epicanthus inversus syndrome (BPES). The three children had androgen production, virilization of external genitalia,"}
{"subject": "congenital heart disease", "sub_type": "Disease", "rel": "ThemeOf", "object": "presented with", "obj_type": "Reg", "file_name": "PubMed-29478779.json", "snippet": " three children. One carried a c.103_109delGGCGCCC (p.Gly35Argfs\u221775) mutation, while two others carried a c.97_103delCCGCCCG (p.Pro33Alafs\u221777) mutation. In two of three children the mutation was de novo. All three children  [CLS] presented with congenital heart disease [CLS]  (CHD), one child with congenital diaphragmatic hernia (CDH), and two children with blepharophimosis-ptosis-epicanthus inversus syndrome (BPES). The three children had androgen production, virilization of external genitalia, and biochemical or"}
{"subject": "NR2F2", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-29478779.json", "snippet": " inversus syndrome (BPES). The three children had androgen production, virilization of external genitalia, and biochemical or histological evidence of testicular tissue. We demonstrate a highly significant association between the  [CLS] NR2F2 loss-of-function mutations [CLS]  and this syndromic form of DSD (p = 2.44\u00a0\u00d7 10-8). We show that COUP-TF2 is highly abundant in a FOXL2-negative stromal cell population of the fetal human ovary. In"}
{"subject": "ATP5F1D", "sub_type": "Gene", "rel": "ThemeOf", "object": "Biallelic Mutations", "obj_type": "Var", "file_name": "PubMed-29478781.json", "snippet": " [CLS] Biallelic Mutations in ATP5F1D [CLS] , which Encodes a Subunit of ATP Synthase, Cause a Metabolic Disorder.\nATP synthase, H+ transporting, mitochondrial F1 complex, \u03b4 subunit (ATP5F1D; formerly ATP5D) is a subunit of mitochondrial ATP"}
{"subject": "Mendelian mitochondrial disease", "sub_type": "Disease", "rel": "ThemeOf", "object": "leading to", "obj_type": "Reg", "file_name": "PubMed-29478781.json", "snippet": " but recapitulated the eye and antennae defects seen in other genetic models of mitochondrial oxidative phosphorylation deficiency. Our\u00a0data establish c.245C>T (p.Pro82Leu) and c.317T>G (p.Val106Gly) in ATP5F1D as pathogenic variants  [CLS] leading to a Mendelian mitochondrial disease [CLS]  featuring episodic metabolic decompensation."}
{"subject": "missense variants", "sub_type": "Var", "rel": "CauseOf", "object": "presented", "obj_type": "Reg", "file_name": "PubMed-29478781.json", "snippet": " formerly ATP5D) is a subunit of mitochondrial ATP synthase and plays an important role in coupling proton translocation and ATP production. Here, we describe two individuals, each with homozygous  [CLS] missense variants in ATP5F1D, who presented [CLS]  with episodic lethargy, metabolic acidosis, 3-methylglutaconic aciduria, and hyperammonemia. Subject 1, homozygous for c.245C>T (p.Pro82Leu), presented with recurrent metabolic decompensation starting in the neonatal period, and subject 2, homozygous"}
{"subject": "episodic lethargy", "sub_type": "MPA", "rel": "ThemeOf", "object": "presented", "obj_type": "Reg", "file_name": "PubMed-29478781.json", "snippet": " of mitochondrial ATP synthase and plays an important role in coupling proton translocation and ATP production. Here, we describe two individuals, each with homozygous missense variants in ATP5F1D, who  [CLS] presented with episodic lethargy [CLS] , metabolic acidosis, 3-methylglutaconic aciduria, and hyperammonemia. Subject 1, homozygous for c.245C>T (p.Pro82Leu), presented with recurrent metabolic decompensation starting in the neonatal period, and subject 2, homozygous for c.317T>G (p.Val106Gly),"}
{"subject": "metabolic acidosis", "sub_type": "MPA", "rel": "ThemeOf", "object": "presented", "obj_type": "Reg", "file_name": "PubMed-29478781.json", "snippet": " of mitochondrial ATP synthase and plays an important role in coupling proton translocation and ATP production. Here, we describe two individuals, each with homozygous missense variants in ATP5F1D, who  [CLS] presented with episodic lethargy, metabolic acidosis [CLS] , 3-methylglutaconic aciduria, and hyperammonemia. Subject 1, homozygous for c.245C>T (p.Pro82Leu), presented with recurrent metabolic decompensation starting in the neonatal period, and subject 2, homozygous for c.317T>G (p.Val106Gly), presented with"}
{"subject": "3-methylglutaconic aciduria", "sub_type": "MPA", "rel": "ThemeOf", "object": "presented", "obj_type": "Reg", "file_name": "PubMed-29478781.json", "snippet": " of mitochondrial ATP synthase and plays an important role in coupling proton translocation and ATP production. Here, we describe two individuals, each with homozygous missense variants in ATP5F1D, who  [CLS] presented with episodic lethargy, metabolic acidosis, 3-methylglutaconic aciduria [CLS] , and hyperammonemia. Subject 1, homozygous for c.245C>T (p.Pro82Leu), presented with recurrent metabolic decompensation starting in the neonatal period, and subject 2, homozygous for c.317T>G (p.Val106Gly), presented with acute encephalopathy"}
{"subject": "hyperammonemia", "sub_type": "Disease", "rel": "ThemeOf", "object": "presented", "obj_type": "Reg", "file_name": "PubMed-29478781.json", "snippet": " of mitochondrial ATP synthase and plays an important role in coupling proton translocation and ATP production. Here, we describe two individuals, each with homozygous missense variants in ATP5F1D, who  [CLS] presented with episodic lethargy, metabolic acidosis, 3-methylglutaconic aciduria, and hyperammonemia [CLS] . Subject 1, homozygous for c.245C>T (p.Pro82Leu), presented with recurrent metabolic decompensation starting in the neonatal period, and subject 2, homozygous for c.317T>G (p.Val106Gly), presented with acute encephalopathy in childhood."}
{"subject": "ATP5F1D", "sub_type": "Gene", "rel": "ThemeOf", "object": "missense variants", "obj_type": "Var", "file_name": "PubMed-29478781.json", "snippet": " formerly ATP5D) is a subunit of mitochondrial ATP synthase and plays an important role in coupling proton translocation and ATP production. Here, we describe two individuals, each with homozygous  [CLS] missense variants in ATP5F1D [CLS] , who presented with episodic lethargy, metabolic acidosis, 3-methylglutaconic aciduria, and hyperammonemia. Subject 1, homozygous for c.245C>T (p.Pro82Leu), presented with recurrent metabolic decompensation starting in the neonatal period, and subject"}
{"subject": "Biallelic Mutations", "sub_type": "Var", "rel": "CauseOf", "object": "Cause", "obj_type": "Reg", "file_name": "PubMed-29478781.json", "snippet": " [CLS] Biallelic Mutations in ATP5F1D, which Encodes a Subunit of ATP Synthase, Cause [CLS]  a Metabolic Disorder.\nATP synthase, H+ transporting, mitochondrial F1 complex, \u03b4 subunit (ATP5F1D; formerly ATP5D) is a subunit of mitochondrial ATP synthase and plays an important role in coupling"}
{"subject": "Metabolic Disorder", "sub_type": "MPA", "rel": "ThemeOf", "object": "Cause", "obj_type": "Reg", "file_name": "PubMed-29478781.json", "snippet": " [CLS] Cause a Metabolic Disorder [CLS] .\nATP synthase, H+ transporting, mitochondrial F1 complex, \u03b4 subunit (ATP5F1D; formerly ATP5D) is a subunit of mitochondrial ATP synthase and plays an important role in coupling proton translocation and"}
{"subject": "variants", "sub_type": "Var", "rel": "CauseOf", "object": "rescued", "obj_type": "PosReg", "file_name": "PubMed-29478781.json", "snippet": " brains caused a near complete loss of the fly head, a phenotype that was fully rescued by wild-type human ATP5F1D. In contrast, expression of the ATP5F1D c.245C>T and c.317T>G  [CLS] variants rescued [CLS]  the head-size phenotype but recapitulated the eye and antennae defects seen in other genetic models of mitochondrial oxidative phosphorylation deficiency. Our\u00a0data establish c.245C>T (p.Pro82Leu) and c.317T>G (p.Val106Gly) in ATP5F1D"}
{"subject": "head-size phenotype", "sub_type": "MPA", "rel": "ThemeOf", "object": "rescued", "obj_type": "PosReg", "file_name": "PubMed-29478781.json", "snippet": " caused a near complete loss of the fly head, a phenotype that was fully rescued by wild-type human ATP5F1D. In contrast, expression of the ATP5F1D c.245C>T and c.317T>G variants  [CLS] rescued the head-size phenotype [CLS]  but recapitulated the eye and antennae defects seen in other genetic models of mitochondrial oxidative phosphorylation deficiency. Our\u00a0data establish c.245C>T (p.Pro82Leu) and c.317T>G (p.Val106Gly) in ATP5F1D as pathogenic variants"}
{"subject": "variants", "sub_type": "Var", "rel": "CauseOf", "object": "recapitulated", "obj_type": "NegReg", "file_name": "PubMed-29478781.json", "snippet": " brains caused a near complete loss of the fly head, a phenotype that was fully rescued by wild-type human ATP5F1D. In contrast, expression of the ATP5F1D c.245C>T and c.317T>G  [CLS] variants rescued the head-size phenotype but recapitulated [CLS]  the eye and antennae defects seen in other genetic models of mitochondrial oxidative phosphorylation deficiency. Our\u00a0data establish c.245C>T (p.Pro82Leu) and c.317T>G (p.Val106Gly) in ATP5F1D as pathogenic variants leading to"}
{"subject": "eye", "sub_type": "MPA", "rel": "ThemeOf", "object": "recapitulated", "obj_type": "NegReg", "file_name": "PubMed-29478781.json", "snippet": " of the fly head, a phenotype that was fully rescued by wild-type human ATP5F1D. In contrast, expression of the ATP5F1D c.245C>T and c.317T>G variants rescued the head-size phenotype but  [CLS] recapitulated the eye [CLS]  and antennae defects seen in other genetic models of mitochondrial oxidative phosphorylation deficiency. Our\u00a0data establish c.245C>T (p.Pro82Leu) and c.317T>G (p.Val106Gly) in ATP5F1D as pathogenic variants leading to a Mendelian"}
{"subject": "antennae defects", "sub_type": "MPA", "rel": "ThemeOf", "object": "recapitulated", "obj_type": "NegReg", "file_name": "PubMed-29478781.json", "snippet": " of the fly head, a phenotype that was fully rescued by wild-type human ATP5F1D. In contrast, expression of the ATP5F1D c.245C>T and c.317T>G variants rescued the head-size phenotype but  [CLS] recapitulated the eye and antennae defects [CLS]  seen in other genetic models of mitochondrial oxidative phosphorylation deficiency. Our\u00a0data establish c.245C>T (p.Pro82Leu) and c.317T>G (p.Val106Gly) in ATP5F1D as pathogenic variants leading to a Mendelian mitochondrial disease featuring"}
{"subject": "variants", "sub_type": "Var", "rel": "CauseOf", "object": "leading to", "obj_type": "Reg", "file_name": "PubMed-29478781.json", "snippet": " phenotype but recapitulated the eye and antennae defects seen in other genetic models of mitochondrial oxidative phosphorylation deficiency. Our\u00a0data establish c.245C>T (p.Pro82Leu) and c.317T>G (p.Val106Gly) in ATP5F1D as pathogenic  [CLS] variants leading to [CLS]  a Mendelian mitochondrial disease featuring episodic metabolic decompensation."}
{"subject": "Nav1.5", "sub_type": "Gene", "rel": "ThemeOf", "object": "G213D", "obj_type": "Var", "file_name": "PubMed-29506689.json", "snippet": " [CLS] Nav1.5 gain-of-function mutation (G213D [CLS] ).\nBACKGROUND: SCN5A mutations can lead to different cardiac diseases. Recently, SCN5A mutations have been linked to the clinical entity multifocal ectopic Purkinje-related premature contractions (MEPPC) characterized by ventricular ectopy"}
{"subject": "G213D", "sub_type": "Var", "rel": "CauseOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-29506689.json", "snippet": " [CLS] gain-of-function mutation (G213D [CLS] ).\nBACKGROUND: SCN5A mutations can lead to different cardiac diseases. Recently, SCN5A mutations have been linked to the clinical entity multifocal ectopic Purkinje-related premature contractions (MEPPC) characterized by ventricular ectopy"}
{"subject": "G213D", "sub_type": "Var", "rel": "ThemeOf", "object": "resulting in", "obj_type": "Reg", "file_name": "PubMed-29506689.json", "snippet": " ventricular ectopy was clinically assessed. Screening of the SCN5A gene revealed a missense mutation in the linker between segments 3 and 4 in domain 1 of the Nav1.5 protein,  [CLS] resulting in a glycine to aspartate substitution at position 213 (G213D [CLS] ). The phenotype co-segregated with the missense mutation. Electrophysiological studies of wild type (WT) hNav1.5 and hNav1.5_G213D expressed in CHO-K cells showed that the voltage of half-maximal activation (V\u00bd) was"}
{"subject": "Nav1.5", "sub_type": "Gene", "rel": "ThemeOf", "object": "G213D", "obj_type": "Var", "file_name": "PubMed-29506689.json", "snippet": " (V\u00bd=-86.7\u00b10.2mV for WT and -82.2\u00b10.3mV for G213D; P<0.001), also contributing to a gain-of-function phenotype. Flecainide and amiodarone markedly reduced premature atrial and ventricular contractions in four patients.\nCONCLUSION: The  [CLS] Nav1.5_G213D [CLS]  mutation is associated with a gain-of-function phenotype, multifocal atrial and ventricular ectopy and dilated cardiomyopathy. Since patients with a MEPPC-like phenotype may specifically benefit from Class-1 antiarrhythmic drugs or"}
{"subject": "G213D", "sub_type": "Var", "rel": "CauseOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-29506689.json", "snippet": " (V\u00bd=-86.7\u00b10.2mV for WT and -82.2\u00b10.3mV for G213D; P<0.001), also contributing to a gain-of-function phenotype. Flecainide and amiodarone markedly reduced premature atrial and ventricular contractions in four patients.\nCONCLUSION: The Nav1.5_ [CLS] G213D mutation is associated with a gain-of-function [CLS]  phenotype, multifocal atrial and ventricular ectopy and dilated cardiomyopathy. Since patients with a MEPPC-like phenotype may specifically benefit from Class-1 antiarrhythmic drugs or amiodarone, clinical identification of this disease"}
{"subject": "dilated cardiomyopathy", "sub_type": "Disease", "rel": "ThemeOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-29506689.json", "snippet": " G213D; P<0.001), also contributing to a gain-of-function phenotype. Flecainide and amiodarone markedly reduced premature atrial and ventricular contractions in four patients.\nCONCLUSION: The Nav1.5_G213D mutation is associated with a  [CLS] gain-of-function phenotype, multifocal atrial and ventricular ectopy and dilated cardiomyopathy [CLS] . Since patients with a MEPPC-like phenotype may specifically benefit from Class-1 antiarrhythmic drugs or amiodarone, clinical identification of this disease entity is important."}
{"subject": "dilated cardiomyopathy", "sub_type": "Disease", "rel": "ThemeOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-29506689.json", "snippet": " [CLS] dilated cardiomyopathy caused by a Nav1.5 gain-of-function [CLS]  mutation (G213D).\nBACKGROUND: SCN5A mutations can lead to different cardiac diseases. Recently, SCN5A mutations have been linked to the clinical entity multifocal ectopic Purkinje-related premature contractions (MEPPC) characterized by"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "lead to", "obj_type": "Reg", "file_name": "PubMed-29506689.json", "snippet": " [CLS] mutations can lead to [CLS]  different cardiac diseases. Recently, SCN5A mutations have been linked to the clinical entity multifocal ectopic Purkinje-related premature contractions (MEPPC) characterized by ventricular ectopy and dilated cardiomyopathy.\nMETHODS & RESULTS:"}
{"subject": "cardiac diseases", "sub_type": "Disease", "rel": "ThemeOf", "object": "lead to", "obj_type": "Reg", "file_name": "PubMed-29506689.json", "snippet": " [CLS] lead to different cardiac diseases [CLS] . Recently, SCN5A mutations have been linked to the clinical entity multifocal ectopic Purkinje-related premature contractions (MEPPC) characterized by ventricular ectopy and dilated cardiomyopathy.\nMETHODS & RESULTS: A family with"}
{"subject": "SCN5A", "sub_type": "Gene", "rel": "ThemeOf", "object": "missense mutation", "obj_type": "Var", "file_name": "PubMed-29506689.json", "snippet": " with a uniform MEPPC-like phenotype, associated with complex atrial and ventricular arrhythmias and dilated cardiomyopathy caused by a high frequency of ventricular ectopy was clinically assessed. Screening of the  [CLS] SCN5A gene revealed a missense mutation [CLS]  in the linker between segments 3 and 4 in domain 1 of the Nav1.5 protein, resulting in a glycine to aspartate substitution at position 213 (G213D). The phenotype co-segregated"}
{"subject": "missense mutation", "sub_type": "Var", "rel": "CauseOf", "object": "resulting in", "obj_type": "Reg", "file_name": "PubMed-29506689.json", "snippet": " phenotype, associated with complex atrial and ventricular arrhythmias and dilated cardiomyopathy caused by a high frequency of ventricular ectopy was clinically assessed. Screening of the SCN5A gene revealed a  [CLS] missense mutation in the linker between segments 3 and 4 in domain 1 of the Nav1.5 protein, resulting in [CLS]  a glycine to aspartate substitution at position 213 (G213D). The phenotype co-segregated with the missense mutation. Electrophysiological studies of wild type (WT) hNav1.5 and hNav1.5_G213D expressed in CHO-K cells"}
{"subject": "ego-3", "sub_type": "Gene", "rel": "ThemeOf", "object": "om40", "obj_type": "Var", "file_name": "PubMed-29507057.json", "snippet": " elegans.\nIn a genetic screen to identify genes that promote GLP-1/Notch signaling in Caenorhabditis elegans germline stem cells, we found a single mutation, om40, defining a gene called ego-3.  [CLS] ego-3(om40 [CLS] ) causes several defects in the soma and the germline, including paralysis during larval development, sterility, delayed proliferation of germline stem cells, and ectopic germline stem cell proliferation. Whole genome"}
{"subject": "om40", "sub_type": "Var", "rel": "CauseOf", "object": "causes", "obj_type": "Reg", "file_name": "PubMed-29507057.json", "snippet": " elegans.\nIn a genetic screen to identify genes that promote GLP-1/Notch signaling in Caenorhabditis elegans germline stem cells, we found a single mutation, om40, defining a gene called ego-3. ego-3( [CLS] om40) causes [CLS]  several defects in the soma and the germline, including paralysis during larval development, sterility, delayed proliferation of germline stem cells, and ectopic germline stem cell proliferation. Whole genome sequencing"}
{"subject": "defects", "sub_type": "MPA", "rel": "ThemeOf", "object": "causes", "obj_type": "Reg", "file_name": "PubMed-29507057.json", "snippet": "\nIn a genetic screen to identify genes that promote GLP-1/Notch signaling in Caenorhabditis elegans germline stem cells, we found a single mutation, om40, defining a gene called ego-3. ego-3(om40)  [CLS] causes several defects [CLS]  in the soma and the germline, including paralysis during larval development, sterility, delayed proliferation of germline stem cells, and ectopic germline stem cell proliferation. Whole genome sequencing identified om40"}
{"subject": "paralysis", "sub_type": "Disease", "rel": "ThemeOf", "object": "defects", "obj_type": "MPA", "file_name": "PubMed-29507057.json", "snippet": " genetic screen to identify genes that promote GLP-1/Notch signaling in Caenorhabditis elegans germline stem cells, we found a single mutation, om40, defining a gene called ego-3. ego-3(om40) causes several  [CLS] defects in the soma and the germline, including paralysis [CLS]  during larval development, sterility, delayed proliferation of germline stem cells, and ectopic germline stem cell proliferation. Whole genome sequencing identified om40 as an allele of hsp-90, previously known as"}
{"subject": "sterility", "sub_type": "Disease", "rel": "ThemeOf", "object": "defects", "obj_type": "MPA", "file_name": "PubMed-29507057.json", "snippet": " genetic screen to identify genes that promote GLP-1/Notch signaling in Caenorhabditis elegans germline stem cells, we found a single mutation, om40, defining a gene called ego-3. ego-3(om40) causes several  [CLS] defects in the soma and the germline, including paralysis during larval development, sterility [CLS] , delayed proliferation of germline stem cells, and ectopic germline stem cell proliferation. Whole genome sequencing identified om40 as an allele of hsp-90, previously known as daf-21, which encodes the"}
{"subject": "delayed proliferation", "sub_type": "CPA", "rel": "ThemeOf", "object": "defects", "obj_type": "MPA", "file_name": "PubMed-29507057.json", "snippet": " genetic screen to identify genes that promote GLP-1/Notch signaling in Caenorhabditis elegans germline stem cells, we found a single mutation, om40, defining a gene called ego-3. ego-3(om40) causes several  [CLS] defects in the soma and the germline, including paralysis during larval development, sterility, delayed proliferation [CLS]  of germline stem cells, and ectopic germline stem cell proliferation. Whole genome sequencing identified om40 as an allele of hsp-90, previously known as daf-21, which encodes the C. elegans"}
{"subject": "ectopic germline stem cell proliferation", "sub_type": "CPA", "rel": "ThemeOf", "object": "defects", "obj_type": "MPA", "file_name": "PubMed-29507057.json", "snippet": " genetic screen to identify genes that promote GLP-1/Notch signaling in Caenorhabditis elegans germline stem cells, we found a single mutation, om40, defining a gene called ego-3. ego-3(om40) causes several  [CLS] defects in the soma and the germline, including paralysis during larval development, sterility, delayed proliferation of germline stem cells, and ectopic germline stem cell proliferation [CLS] . Whole genome sequencing identified om40 as an allele of hsp-90, previously known as daf-21, which encodes the C. elegans ortholog of the cytosolic form of HSP90. This protein is"}
{"subject": "Platelet activity", "sub_type": "MPA", "rel": "ThemeOf", "object": "associated", "obj_type": "Interaction", "file_name": "PubMed-29509167.json", "snippet": " 1.083-7.786; P = 0.013), whereas the risk of ischemic stroke or transient ischemic attack alone was also higher (hazard ratio = 3.170; 95% confidence interval, 1.281-7.849; P = 0.034).  [CLS] Platelet activity was strongly associated [CLS]  with allele *2 status (rs = 0.21, P = 0.016) but not with other genetic polymorphisms. Carriers of allele*2 exhibited lower platelet response to adenosine diphosphate-mean LTA (30.1% vs."}
{"subject": "allele *2 status", "sub_type": "Var", "rel": "CauseOf", "object": "associated", "obj_type": "Interaction", "file_name": "PubMed-29509167.json", "snippet": " whereas the risk of ischemic stroke or transient ischemic attack alone was also higher (hazard ratio = 3.170; 95% confidence interval, 1.281-7.849; P = 0.034). Platelet activity was strongly  [CLS] associated with allele *2 status [CLS]  (rs = 0.21, P = 0.016) but not with other genetic polymorphisms. Carriers of allele*2 exhibited lower platelet response to adenosine diphosphate-mean LTA (30.1% vs. 42.0%; P = 0.017)."}
{"subject": "allele", "sub_type": "Var", "rel": "CauseOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-29509167.json", "snippet": " and myocardial infarction).\nRESULTS: Over the mean follow-up of 14.9 months, 19 patients experienced major adverse clinical events. The risk of major adverse clinical events was nearly 3-fold in  [CLS] loss-of-function allele [CLS]  carriers (hazard ratio = 2.904; 95% confidence interval, 1.083-7.786; P = 0.013), whereas the risk of ischemic stroke or transient ischemic attack alone was also higher (hazard ratio ="}
{"subject": "allele", "sub_type": "Var", "rel": "CauseOf", "object": "major adverse clinical events", "obj_type": "MPA", "file_name": "PubMed-29509167.json", "snippet": " events (composite of vascular deaths, stroke/transient ischemic attack, and myocardial infarction).\nRESULTS: Over the mean follow-up of 14.9 months, 19 patients experienced major adverse clinical events. The risk of  [CLS] major adverse clinical events was nearly 3-fold in loss-of-function allele [CLS]  carriers (hazard ratio = 2.904; 95% confidence interval, 1.083-7.786; P = 0.013), whereas the risk of ischemic stroke or transient ischemic attack alone was also higher (hazard ratio ="}
{"subject": "allele", "sub_type": "Var", "rel": "CauseOf", "object": "ischemic stroke", "obj_type": "MPA", "file_name": "PubMed-29509167.json", "snippet": " myocardial infarction).\nRESULTS: Over the mean follow-up of 14.9 months, 19 patients experienced major adverse clinical events. The risk of major adverse clinical events was nearly 3-fold in loss-of-function  [CLS] allele carriers (hazard ratio = 2.904; 95% confidence interval, 1.083-7.786; P = 0.013), whereas the risk of ischemic stroke [CLS]  or transient ischemic attack alone was also higher (hazard ratio = 3.170; 95% confidence interval, 1.281-7.849; P = 0.034). Platelet activity was strongly associated with allele *2 status (rs"}
{"subject": "allele", "sub_type": "Var", "rel": "CauseOf", "object": "transient ischemic attack alone", "obj_type": "MPA", "file_name": "PubMed-29509167.json", "snippet": " myocardial infarction).\nRESULTS: Over the mean follow-up of 14.9 months, 19 patients experienced major adverse clinical events. The risk of major adverse clinical events was nearly 3-fold in loss-of-function  [CLS] allele carriers (hazard ratio = 2.904; 95% confidence interval, 1.083-7.786; P = 0.013), whereas the risk of ischemic stroke or transient ischemic attack alone [CLS]  was also higher (hazard ratio = 3.170; 95% confidence interval, 1.281-7.849; P = 0.034). Platelet activity was strongly associated with allele *2 status (rs = 0.21, P = 0.016)"}
{"subject": "fama", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutants", "obj_type": "Var", "file_name": "PubMed-29513733.json", "snippet": " FAMA, which was previously shown to control the final proliferation/differentiation switch during stomatal development. Our research demonstrates that FAMA is also an essential component of B. cinerea resistance. The  [CLS] fama loss-of-function mutants [CLS]  (fama-1 and fama-2) increased susceptibility to B. cinerea infection and reduced defense-gene expression. On the contrary, transgenic lines constitutively overexpressing FAMA showed opposite B. cinerea responses compared with the"}
{"subject": "mutants", "sub_type": "Var", "rel": "CauseOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-29513733.json", "snippet": " which was previously shown to control the final proliferation/differentiation switch during stomatal development. Our research demonstrates that FAMA is also an essential component of B. cinerea resistance. The fama  [CLS] loss-of-function mutants [CLS]  (fama-1 and fama-2) increased susceptibility to B. cinerea infection and reduced defense-gene expression. On the contrary, transgenic lines constitutively overexpressing FAMA showed opposite B. cinerea responses compared with the"}
{"subject": "mutants", "sub_type": "Var", "rel": "CauseOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-29513733.json", "snippet": " was previously shown to control the final proliferation/differentiation switch during stomatal development. Our research demonstrates that FAMA is also an essential component of B. cinerea resistance. The fama loss-of-function  [CLS] mutants (fama-1 and fama-2) increased [CLS]  susceptibility to B. cinerea infection and reduced defense-gene expression. On the contrary, transgenic lines constitutively overexpressing FAMA showed opposite B. cinerea responses compared with the fama loss-of-function mutants. FAMA-overexpressed"}
{"subject": "susceptibility to B. cinerea infection", "sub_type": "MPA", "rel": "ThemeOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-29513733.json", "snippet": " control the final proliferation/differentiation switch during stomatal development. Our research demonstrates that FAMA is also an essential component of B. cinerea resistance. The fama loss-of-function mutants (fama-1 and fama-2)  [CLS] increased susceptibility to B. cinerea infection [CLS]  and reduced defense-gene expression. On the contrary, transgenic lines constitutively overexpressing FAMA showed opposite B. cinerea responses compared with the fama loss-of-function mutants. FAMA-overexpressed plants displayed enhanced resistance to"}
{"subject": "mutants", "sub_type": "Var", "rel": "CauseOf", "object": "reduced", "obj_type": "NegReg", "file_name": "PubMed-29513733.json", "snippet": " was previously shown to control the final proliferation/differentiation switch during stomatal development. Our research demonstrates that FAMA is also an essential component of B. cinerea resistance. The fama loss-of-function  [CLS] mutants (fama-1 and fama-2) increased susceptibility to B. cinerea infection and reduced [CLS]  defense-gene expression. On the contrary, transgenic lines constitutively overexpressing FAMA showed opposite B. cinerea responses compared with the fama loss-of-function mutants. FAMA-overexpressed plants displayed enhanced resistance to B. cinerea"}
{"subject": "defense-gene expression", "sub_type": "MPA", "rel": "ThemeOf", "object": "reduced", "obj_type": "NegReg", "file_name": "PubMed-29513733.json", "snippet": " development. Our research demonstrates that FAMA is also an essential component of B. cinerea resistance. The fama loss-of-function mutants (fama-1 and fama-2) increased susceptibility to B. cinerea infection and  [CLS] reduced defense-gene expression [CLS] . On the contrary, transgenic lines constitutively overexpressing FAMA showed opposite B. cinerea responses compared with the fama loss-of-function mutants. FAMA-overexpressed plants displayed enhanced resistance to B. cinerea infection and"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "caused", "obj_type": "Reg", "file_name": "PubMed-29514032.json", "snippet": " [CLS] caused by mutations [CLS]  in genes that regulate oxygen-dependent transcription of the gene encoding erythropoietin ( EPO). We identified a mutation in EPO that cosegregated with disease with a logarithm of the odds"}
{"subject": "Familial erythrocytosis", "sub_type": "Disease", "rel": "ThemeOf", "object": "caused", "obj_type": "Reg", "file_name": "PubMed-29514032.json", "snippet": " [CLS] Familial erythrocytosis with elevated erythropoietin levels is frequently caused [CLS]  by mutations in genes that regulate oxygen-dependent transcription of the gene encoding erythropoietin ( EPO). We identified a mutation in EPO that cosegregated with disease with a logarithm of"}
{"subject": "EPO", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-29514032.json", "snippet": " [CLS] mutations in genes that regulate oxygen-dependent transcription of the gene encoding erythropoietin ( EPO [CLS] ). We identified a mutation in EPO that cosegregated with disease with a logarithm of the odds (LOD) score of 3.3 in a family with autosomal dominant erythrocytosis. This mutation,"}
{"subject": "mutation", "sub_type": "Var", "rel": "CauseOf", "object": "interrupts", "obj_type": "NegReg", "file_name": "PubMed-29514032.json", "snippet": " EPO). We identified a mutation in EPO that cosegregated with disease with a logarithm of the odds (LOD) score of 3.3 in a family with autosomal dominant erythrocytosis. This  [CLS] mutation, a single-nucleotide deletion (c.32delG), introduces a frameshift in exon 2 that interrupts [CLS]  translation of the main EPO messenger RNA (mRNA) transcript but initiates excess production of erythropoietin from what is normally a noncoding EPO mRNA transcribed from an alternative promoter located"}
{"subject": "main EPO messenger RNA (mRNA) transcript", "sub_type": "MPA", "rel": "ThemeOf", "object": "interrupts", "obj_type": "NegReg", "file_name": "PubMed-29514032.json", "snippet": " a logarithm of the odds (LOD) score of 3.3 in a family with autosomal dominant erythrocytosis. This mutation, a single-nucleotide deletion (c.32delG), introduces a frameshift in exon 2 that  [CLS] interrupts translation of the main EPO messenger RNA (mRNA) transcript [CLS]  but initiates excess production of erythropoietin from what is normally a noncoding EPO mRNA transcribed from an alternative promoter located in intron 1. (Funded by the Gebert R\u00fcf Foundation"}
{"subject": "Fgfr2", "sub_type": "Gene", "rel": "ThemeOf", "object": "Inactivation", "obj_type": "Var", "file_name": "PubMed-29526646.json", "snippet": " [CLS] Inactivation of Fgfr2 [CLS]  gene in mouse secondary palate mesenchymal cells leads to cleft palate.\nNumerous studies have been conducted to understand the molecular mechanisms controlling mammalian secondary palate development such as growth,"}
{"subject": "Inactivation", "sub_type": "Var", "rel": "CauseOf", "object": "leads to", "obj_type": "Reg", "file_name": "PubMed-29526646.json", "snippet": " [CLS] Inactivation of Fgfr2 gene in mouse secondary palate mesenchymal cells leads to [CLS]  cleft palate.\nNumerous studies have been conducted to understand the molecular mechanisms controlling mammalian secondary palate development such as growth, reorientation and fusion. However, little is known about the"}
{"subject": "cleft palate", "sub_type": "Disease", "rel": "ThemeOf", "object": "leads to", "obj_type": "Reg", "file_name": "PubMed-29526646.json", "snippet": " [CLS] leads to cleft palate [CLS] .\nNumerous studies have been conducted to understand the molecular mechanisms controlling mammalian secondary palate development such as growth, reorientation and fusion. However, little is known about the signaling factors"}
{"subject": "inactivation", "sub_type": "Var", "rel": "CauseOf", "object": "leads to", "obj_type": "Reg", "file_name": "PubMed-29526646.json", "snippet": " a region that is responsible for palate cell specification and shelf initiation. Fgfr2 continues to express in palate on E12.5 and E13.5 in both epithelial and mesenchymal cells, and  [CLS] inactivation of Fgfr2 expression in mesenchymal cells using floxed Fgfr2 allele and Osr2-Cre leads to [CLS]  cleft palate at various stages including reorientation, horizontal growth and fusion. Notably, some mutant embryos displayed no sign of palate shelf formation suggesting that FGF receptor 2 mediated FGF"}
{"subject": "cleft palate", "sub_type": "Disease", "rel": "ThemeOf", "object": "leads to", "obj_type": "Reg", "file_name": "PubMed-29526646.json", "snippet": " continues to express in palate on E12.5 and E13.5 in both epithelial and mesenchymal cells, and inactivation of Fgfr2 expression in mesenchymal cells using floxed Fgfr2 allele and Osr2-Cre  [CLS] leads to cleft palate [CLS]  at various stages including reorientation, horizontal growth and fusion. Notably, some mutant embryos displayed no sign of palate shelf formation suggesting that FGF receptor 2 mediated FGF signaling may"}
{"subject": "Fgfr2", "sub_type": "Gene", "rel": "ThemeOf", "object": "inactivation", "obj_type": "Var", "file_name": "PubMed-29526646.json", "snippet": " a region that is responsible for palate cell specification and shelf initiation. Fgfr2 continues to express in palate on E12.5 and E13.5 in both epithelial and mesenchymal cells, and  [CLS] inactivation of Fgfr2 [CLS]  expression in mesenchymal cells using floxed Fgfr2 allele and Osr2-Cre leads to cleft palate at various stages including reorientation, horizontal growth and fusion. Notably, some mutant embryos displayed no"}
{"subject": "mib-1", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutants", "obj_type": "Var", "file_name": "PubMed-29531012.json", "snippet": " by segregation into the residual body during spermatid formation. C. elegans mib-1 expression, while upregulated during spermatogenesis, also occurs somatically, including in vulva precursor cells. Here, we show that  [CLS] mib-1 mutants [CLS]  suppress both lin-12 and glp-1 (C. elegans Notch) gain-of-function mutants, restoring anchor cell formation and a functional vulva to the former and partly restoring oocyte production to the latter."}
{"subject": "oocyte production", "sub_type": "MPA", "rel": "ThemeOf", "object": "restoring", "obj_type": "PosReg", "file_name": "PubMed-29531012.json", "snippet": " expression, while upregulated during spermatogenesis, also occurs somatically, including in vulva precursor cells. Here, we show that mib-1 mutants suppress both lin-12 and glp-1 (C. elegans Notch) gain-of-function mutants,  [CLS] restoring anchor cell formation and a functional vulva to the former and partly restoring oocyte production [CLS]  to the latter. However, suppressed hermaphrodites are only observed when grown at 25\u00b0, and they are self-sterile. This probably explains why mib-1 was not previously recovered as a Notch"}
{"subject": "mib-1", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutants", "obj_type": "Var", "file_name": "PubMed-29531012.json", "snippet": " encodes a Mind Bomb homolog (mib-1), it has never been recovered in the extensive Notch suppressor/enhancer screens that have identified numerous pathway components. Here, we show that C. elegans  [CLS] mib-1 null mutants [CLS]  have a spermatogenesis-defective phenotype that results in a heterogeneous mixture of arrested spermatocytes, defective spermatids, and motility-impaired spermatozoa. mib-1 mutants also have chromosome segregation defects during meiosis, molecular null"}
{"subject": "mutants", "sub_type": "Var", "rel": "CauseOf", "object": "results in", "obj_type": "Reg", "file_name": "PubMed-29531012.json", "snippet": " Mind Bomb homolog (mib-1), it has never been recovered in the extensive Notch suppressor/enhancer screens that have identified numerous pathway components. Here, we show that C. elegans mib-1 null  [CLS] mutants have a spermatogenesis-defective phenotype that results in [CLS]  a heterogeneous mixture of arrested spermatocytes, defective spermatids, and motility-impaired spermatozoa. mib-1 mutants also have chromosome segregation defects during meiosis, molecular null mutants are intrinsically temperature-sensitive, and many mib-1"}
{"subject": "heterogeneous mixture of arrested spermatocytes", "sub_type": "MPA", "rel": "ThemeOf", "object": "results in", "obj_type": "Reg", "file_name": "PubMed-29531012.json", "snippet": " never been recovered in the extensive Notch suppressor/enhancer screens that have identified numerous pathway components. Here, we show that C. elegans mib-1 null mutants have a spermatogenesis-defective phenotype that  [CLS] results in a heterogeneous mixture of arrested spermatocytes [CLS] , defective spermatids, and motility-impaired spermatozoa. mib-1 mutants also have chromosome segregation defects during meiosis, molecular null mutants are intrinsically temperature-sensitive, and many mib-1 spermatids contain large amounts of tubulin."}
{"subject": "heterogeneous mixture of arrested spermatocytes", "sub_type": "MPA", "rel": "CauseOf", "object": "spermatogenesis-defective phenotype", "obj_type": "Disease", "file_name": "PubMed-29531012.json", "snippet": " (mib-1), it has never been recovered in the extensive Notch suppressor/enhancer screens that have identified numerous pathway components. Here, we show that C. elegans mib-1 null mutants have a  [CLS] spermatogenesis-defective phenotype that results in a heterogeneous mixture of arrested spermatocytes [CLS] , defective spermatids, and motility-impaired spermatozoa. mib-1 mutants also have chromosome segregation defects during meiosis, molecular null mutants are intrinsically temperature-sensitive, and many mib-1 spermatids contain large amounts of tubulin."}
{"subject": "mutants", "sub_type": "Var", "rel": "CauseOf", "object": "suppress", "obj_type": "NegReg", "file_name": "PubMed-29531012.json", "snippet": " segregation into the residual body during spermatid formation. C. elegans mib-1 expression, while upregulated during spermatogenesis, also occurs somatically, including in vulva precursor cells. Here, we show that mib-1  [CLS] mutants suppress [CLS]  both lin-12 and glp-1 (C. elegans Notch) gain-of-function mutants, restoring anchor cell formation and a functional vulva to the former and partly restoring oocyte production to the latter. However,"}
{"subject": "lin-12", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutants", "obj_type": "Var", "file_name": "PubMed-29531012.json", "snippet": " residual body during spermatid formation. C. elegans mib-1 expression, while upregulated during spermatogenesis, also occurs somatically, including in vulva precursor cells. Here, we show that mib-1 mutants suppress both  [CLS] lin-12 and glp-1 (C. elegans Notch) gain-of-function mutants [CLS] , restoring anchor cell formation and a functional vulva to the former and partly restoring oocyte production to the latter. However, suppressed hermaphrodites are only observed when grown at 25\u00b0,"}
{"subject": "glp-1", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutants", "obj_type": "Var", "file_name": "PubMed-29531012.json", "snippet": " during spermatid formation. C. elegans mib-1 expression, while upregulated during spermatogenesis, also occurs somatically, including in vulva precursor cells. Here, we show that mib-1 mutants suppress both lin-12 and  [CLS] glp-1 (C. elegans Notch) gain-of-function mutants [CLS] , restoring anchor cell formation and a functional vulva to the former and partly restoring oocyte production to the latter. However, suppressed hermaphrodites are only observed when grown at 25\u00b0,"}
{"subject": "mutants", "sub_type": "Var", "rel": "CauseOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-29531012.json", "snippet": " elegans mib-1 expression, while upregulated during spermatogenesis, also occurs somatically, including in vulva precursor cells. Here, we show that mib-1 mutants suppress both lin-12 and glp-1 (C. elegans Notch)  [CLS] gain-of-function mutants [CLS] , restoring anchor cell formation and a functional vulva to the former and partly restoring oocyte production to the latter. However, suppressed hermaphrodites are only observed when grown at 25\u00b0,"}
{"subject": "mutants", "sub_type": "Var", "rel": "ThemeOf", "object": "suppress", "obj_type": "NegReg", "file_name": "PubMed-29531012.json", "snippet": " into the residual body during spermatid formation. C. elegans mib-1 expression, while upregulated during spermatogenesis, also occurs somatically, including in vulva precursor cells. Here, we show that mib-1 mutants  [CLS] suppress both lin-12 and glp-1 (C. elegans Notch) gain-of-function mutants [CLS] , restoring anchor cell formation and a functional vulva to the former and partly restoring oocyte production to the latter. However, suppressed hermaphrodites are only observed when grown at 25\u00b0,"}
{"subject": "mutants", "sub_type": "Var", "rel": "CauseOf", "object": "restoring", "obj_type": "PosReg", "file_name": "PubMed-29531012.json", "snippet": " segregation into the residual body during spermatid formation. C. elegans mib-1 expression, while upregulated during spermatogenesis, also occurs somatically, including in vulva precursor cells. Here, we show that mib-1  [CLS] mutants suppress both lin-12 and glp-1 (C. elegans Notch) gain-of-function mutants, restoring [CLS]  anchor cell formation and a functional vulva to the former and partly restoring oocyte production to the latter. However, suppressed hermaphrodites are only observed when grown at 25\u00b0, and"}
{"subject": "anchor cell formation", "sub_type": "MPA", "rel": "ThemeOf", "object": "restoring", "obj_type": "PosReg", "file_name": "PubMed-29531012.json", "snippet": " expression, while upregulated during spermatogenesis, also occurs somatically, including in vulva precursor cells. Here, we show that mib-1 mutants suppress both lin-12 and glp-1 (C. elegans Notch) gain-of-function mutants,  [CLS] restoring anchor cell formation [CLS]  and a functional vulva to the former and partly restoring oocyte production to the latter. However, suppressed hermaphrodites are only observed when grown at 25\u00b0, and they are self-sterile."}
{"subject": "functional vulva", "sub_type": "MPA", "rel": "ThemeOf", "object": "restoring", "obj_type": "PosReg", "file_name": "PubMed-29531012.json", "snippet": " expression, while upregulated during spermatogenesis, also occurs somatically, including in vulva precursor cells. Here, we show that mib-1 mutants suppress both lin-12 and glp-1 (C. elegans Notch) gain-of-function mutants,  [CLS] restoring anchor cell formation and a functional vulva [CLS]  to the former and partly restoring oocyte production to the latter. However, suppressed hermaphrodites are only observed when grown at 25\u00b0, and they are self-sterile. This probably explains why"}
{"subject": "Mutations", "sub_type": "Var", "rel": "CauseOf", "object": "activating", "obj_type": "PosReg", "file_name": "PubMed-29544460.json", "snippet": " [CLS] Mutations activating [CLS]  the \u03b1 subunit of heterotrimeric Gs protein are associated with a number of highly specific pathological molecular phenotypes. One of the best characterized is the McCune Albright syndrome. The"}
{"subject": "G\u03b1s", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-29544460.json", "snippet": " toxic adenoma). Typically, most neoplastic lesions, from thyroid to pancreas, remain well differentiated but may be a precursor to aggressive cancer.\nCONCLUSIONS: Here we propose the possibility that gain-of-function  [CLS] mutations of G\u03b1s [CLS]  interfere with signals in the microenvironment of permissive tissues and lead to a transversal neoplastic phenotype."}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "interfere", "obj_type": "NegReg", "file_name": "PubMed-29544460.json", "snippet": " toxic adenoma). Typically, most neoplastic lesions, from thyroid to pancreas, remain well differentiated but may be a precursor to aggressive cancer.\nCONCLUSIONS: Here we propose the possibility that gain-of-function  [CLS] mutations of G\u03b1s interfere [CLS]  with signals in the microenvironment of permissive tissues and lead to a transversal neoplastic phenotype."}
{"subject": "microenvironment of permissive", "sub_type": "MPA", "rel": "ThemeOf", "object": "interfere", "obj_type": "NegReg", "file_name": "PubMed-29544460.json", "snippet": " most neoplastic lesions, from thyroid to pancreas, remain well differentiated but may be a precursor to aggressive cancer.\nCONCLUSIONS: Here we propose the possibility that gain-of-function mutations of G\u03b1s  [CLS] interfere with signals in the microenvironment of permissive [CLS]  tissues and lead to a transversal neoplastic phenotype."}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "lead to", "obj_type": "Reg", "file_name": "PubMed-29544460.json", "snippet": " toxic adenoma). Typically, most neoplastic lesions, from thyroid to pancreas, remain well differentiated but may be a precursor to aggressive cancer.\nCONCLUSIONS: Here we propose the possibility that gain-of-function  [CLS] mutations of G\u03b1s interfere with signals in the microenvironment of permissive tissues and lead to [CLS]  a transversal neoplastic phenotype."}
{"subject": "transversal neoplastic phenotype", "sub_type": "MPA", "rel": "ThemeOf", "object": "lead to", "obj_type": "Reg", "file_name": "PubMed-29544460.json", "snippet": " but may be a precursor to aggressive cancer.\nCONCLUSIONS: Here we propose the possibility that gain-of-function mutations of G\u03b1s interfere with signals in the microenvironment of permissive tissues and  [CLS] lead to a transversal neoplastic phenotype [CLS] ."}
{"subject": "heterotrimeric Gs protein", "sub_type": "Protein", "rel": "ThemeOf", "object": "activating", "obj_type": "PosReg", "file_name": "PubMed-29544460.json", "snippet": " [CLS] activating the \u03b1 subunit of heterotrimeric Gs protein [CLS]  are associated with a number of highly specific pathological molecular phenotypes. One of the best characterized is the McCune Albright syndrome. The disease presents with an increased incidence of"}
{"subject": "McCune Albright syndrome", "sub_type": "Disease", "rel": "ThemeOf", "object": "heterotrimeric Gs protein", "obj_type": "Protein", "file_name": "PubMed-29544460.json", "snippet": " [CLS] heterotrimeric Gs protein are associated with a number of highly specific pathological molecular phenotypes. One of the best characterized is the McCune Albright syndrome [CLS] . The disease presents with an increased incidence of neoplasias in specific tissues.\nMAIN BODY: A similar repertoire of neoplasms can develop whether mutations occur spontaneously in somatic tissues during"}
{"subject": "G\u03b1s", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-29544460.json", "snippet": " occur spontaneously in somatic tissues during fetal development or after birth. Glands are the most \"permissive\" tissues, recently found to include the entire gastrointestinal tract. High frequency of activating  [CLS] G\u03b1s mutations [CLS]  is associated with precise diagnoses (e.g., IPMN, Pyloric gland adenoma, pituitary toxic adenoma). Typically, most neoplastic lesions, from thyroid to pancreas, remain well differentiated but may be a precursor"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "activating", "obj_type": "PosReg", "file_name": "PubMed-29544460.json", "snippet": " mutations occur spontaneously in somatic tissues during fetal development or after birth. Glands are the most \"permissive\" tissues, recently found to include the entire gastrointestinal tract. High frequency of  [CLS] activating G\u03b1s mutations [CLS]  is associated with precise diagnoses (e.g., IPMN, Pyloric gland adenoma, pituitary toxic adenoma). Typically, most neoplastic lesions, from thyroid to pancreas, remain well differentiated but may be a precursor"}
{"subject": "IPMN", "sub_type": "Disease", "rel": "ThemeOf", "object": "activating", "obj_type": "PosReg", "file_name": "PubMed-29544460.json", "snippet": " mutations occur spontaneously in somatic tissues during fetal development or after birth. Glands are the most \"permissive\" tissues, recently found to include the entire gastrointestinal tract. High frequency of  [CLS] activating G\u03b1s mutations is associated with precise diagnoses (e.g., IPMN [CLS] , Pyloric gland adenoma, pituitary toxic adenoma). Typically, most neoplastic lesions, from thyroid to pancreas, remain well differentiated but may be a precursor to aggressive cancer.\nCONCLUSIONS: Here we propose"}
{"subject": "Pyloric gland adenoma", "sub_type": "Disease", "rel": "ThemeOf", "object": "activating", "obj_type": "PosReg", "file_name": "PubMed-29544460.json", "snippet": " mutations occur spontaneously in somatic tissues during fetal development or after birth. Glands are the most \"permissive\" tissues, recently found to include the entire gastrointestinal tract. High frequency of  [CLS] activating G\u03b1s mutations is associated with precise diagnoses (e.g., IPMN, Pyloric gland adenoma [CLS] , pituitary toxic adenoma). Typically, most neoplastic lesions, from thyroid to pancreas, remain well differentiated but may be a precursor to aggressive cancer.\nCONCLUSIONS: Here we propose the possibility that"}
{"subject": "pituitary toxic adenoma", "sub_type": "Disease", "rel": "ThemeOf", "object": "activating", "obj_type": "PosReg", "file_name": "PubMed-29544460.json", "snippet": " mutations occur spontaneously in somatic tissues during fetal development or after birth. Glands are the most \"permissive\" tissues, recently found to include the entire gastrointestinal tract. High frequency of  [CLS] activating G\u03b1s mutations is associated with precise diagnoses (e.g., IPMN, Pyloric gland adenoma, pituitary toxic adenoma [CLS] ). Typically, most neoplastic lesions, from thyroid to pancreas, remain well differentiated but may be a precursor to aggressive cancer.\nCONCLUSIONS: Here we propose the possibility that gain-of-function mutations of"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-29544460.json", "snippet": " pituitary toxic adenoma). Typically, most neoplastic lesions, from thyroid to pancreas, remain well differentiated but may be a precursor to aggressive cancer.\nCONCLUSIONS: Here we propose the possibility that  [CLS] gain-of-function mutations [CLS]  of G\u03b1s interfere with signals in the microenvironment of permissive tissues and lead to a transversal neoplastic phenotype."}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "responsible", "obj_type": "Reg", "file_name": "PubMed-29546444.json", "snippet": " and deficient solar radiation in southwestern China. However, the genetic components of the heavy panicle trait in hybrid rice remain elusive. Here, we report that the combination of loss-of-function  [CLS] mutations in Grain number 1a (Gn1a) and Grain Size 3 (GS3) is responsible [CLS]  for the heavy panicle phenotype of the elite hybrid rice restorer line Shuhui498 (R498). The null gn1a allele is the determinant factor for heavy panicles through increased grain number,"}
{"subject": "heavy panicle phenotype", "sub_type": "MPA", "rel": "ThemeOf", "object": "responsible", "obj_type": "Reg", "file_name": "PubMed-29546444.json", "snippet": " the heavy panicle trait in hybrid rice remain elusive. Here, we report that the combination of loss-of-function mutations in Grain number 1a (Gn1a) and Grain Size 3 (GS3) is  [CLS] responsible for the heavy panicle phenotype [CLS]  of the elite hybrid rice restorer line Shuhui498 (R498). The null gn1a allele is the determinant factor for heavy panicles through increased grain number, while gs3 is associated with"}
{"subject": "GS3", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-29546444.json", "snippet": " and deficient solar radiation in southwestern China. However, the genetic components of the heavy panicle trait in hybrid rice remain elusive. Here, we report that the combination of loss-of-function  [CLS] mutations in Grain number 1a (Gn1a) and Grain Size 3 (GS3 [CLS] ) is responsible for the heavy panicle phenotype of the elite hybrid rice restorer line Shuhui498 (R498). The null gn1a allele is the determinant factor for heavy panicles through increased"}
{"subject": "Gn1a", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-29546444.json", "snippet": " and deficient solar radiation in southwestern China. However, the genetic components of the heavy panicle trait in hybrid rice remain elusive. Here, we report that the combination of loss-of-function  [CLS] mutations in Grain number 1a (Gn1a [CLS] ) and Grain Size 3 (GS3) is responsible for the heavy panicle phenotype of the elite hybrid rice restorer line Shuhui498 (R498). The null gn1a allele is the determinant factor"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-29546444.json", "snippet": " humidity and deficient solar radiation in southwestern China. However, the genetic components of the heavy panicle trait in hybrid rice remain elusive. Here, we report that the combination of  [CLS] loss-of-function mutations [CLS]  in Grain number 1a (Gn1a) and Grain Size 3 (GS3) is responsible for the heavy panicle phenotype of the elite hybrid rice restorer line Shuhui498 (R498). The null gn1a"}
{"subject": "Variants", "sub_type": "Var", "rel": "CauseOf", "object": "association", "obj_type": "Interaction", "file_name": "PubMed-29562163.json", "snippet": " and electronic health records from 46,544 participants in the DiscovEHR human genetics study to identify genetic variants associated with serum levels of alanine aminotransferase (ALT) and aspartate aminotransferase (AST).  [CLS] Variants that were replicated in three additional cohorts (12,527 persons) were evaluated for association [CLS]  with clinical diagnoses of chronic liver disease in DiscovEHR study participants and two independent cohorts (total of 37,173 persons) and with histopathological severity of liver disease in 2391 human"}
{"subject": "nonalcoholic cirrhosis", "sub_type": "Disease", "rel": "ThemeOf", "object": "reduced", "obj_type": "NegReg", "file_name": "PubMed-29562163.json", "snippet": " hepatic lipid droplet protein hydroxysteroid 17-beta dehydrogenase 13, was associated with reduced levels of ALT (P=4.2\u00d710-12) and AST (P=6.2\u00d710-10). Among DiscovEHR study participants, this variant was associated with a  [CLS] reduced risk of alcoholic liver disease (by 42% [95% confidence interval {CI}, 20 to 58] among heterozygotes and by 53% [95% CI, 3 to 77] among homozygotes), nonalcoholic liver disease (by 17% [95% CI, 8 to 25] among heterozygotes and by 30% [95% CI, 13 to 43] among homozygotes), alcoholic cirrhosis (by 42% [95% CI, 14 to 61] among heterozygotes and by 73% [95% CI, 15 to 91] among homozygotes), and nonalcoholic cirrhosis [CLS]  (by 26% [95% CI, 7 to 40] among heterozygotes and by 49% [95% CI, 15 to 69] among homozygotes). Associations were confirmed in two independent cohorts. The rs72613567:TA variant"}
{"subject": "variant", "sub_type": "Var", "rel": "CauseOf", "object": "reduced", "obj_type": "NegReg", "file_name": "PubMed-29562163.json", "snippet": " cirrhosis (by 26% [95% CI, 7 to 40] among heterozygotes and by 49% [95% CI, 15 to 69] among homozygotes). Associations were confirmed in two independent cohorts. The rs72613567:TA  [CLS] variant was associated with a reduced [CLS]  risk of nonalcoholic steatohepatitis, but not steatosis, in human liver samples. The rs72613567:TA variant mitigated liver injury associated with the risk-increasing PNPLA3 p.I148M allele and resulted in an unstable"}
{"subject": "nonalcoholic steatohepatitis", "sub_type": "Disease", "rel": "ThemeOf", "object": "reduced", "obj_type": "NegReg", "file_name": "PubMed-29562163.json", "snippet": " 7 to 40] among heterozygotes and by 49% [95% CI, 15 to 69] among homozygotes). Associations were confirmed in two independent cohorts. The rs72613567:TA variant was associated with a  [CLS] reduced risk of nonalcoholic steatohepatitis [CLS] , but not steatosis, in human liver samples. The rs72613567:TA variant mitigated liver injury associated with the risk-increasing PNPLA3 p.I148M allele and resulted in an unstable and truncated protein with"}
{"subject": "variant", "sub_type": "Var", "rel": "CauseOf", "object": "mitigated", "obj_type": "NegReg", "file_name": "PubMed-29562163.json", "snippet": " homozygotes). Associations were confirmed in two independent cohorts. The rs72613567:TA variant was associated with a reduced risk of nonalcoholic steatohepatitis, but not steatosis, in human liver samples. The rs72613567:TA  [CLS] variant mitigated [CLS]  liver injury associated with the risk-increasing PNPLA3 p.I148M allele and resulted in an unstable and truncated protein with reduced enzymatic activity.\nCONCLUSIONS: A loss-of-function variant in HSD17B13 was associated"}
{"subject": "liver injury", "sub_type": "Disease", "rel": "ThemeOf", "object": "mitigated", "obj_type": "NegReg", "file_name": "PubMed-29562163.json", "snippet": " Associations were confirmed in two independent cohorts. The rs72613567:TA variant was associated with a reduced risk of nonalcoholic steatohepatitis, but not steatosis, in human liver samples. The rs72613567:TA variant  [CLS] mitigated liver injury [CLS]  associated with the risk-increasing PNPLA3 p.I148M allele and resulted in an unstable and truncated protein with reduced enzymatic activity.\nCONCLUSIONS: A loss-of-function variant in HSD17B13 was associated with a"}
{"subject": "variant", "sub_type": "Var", "rel": "CauseOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-29562163.json", "snippet": " liver samples. The rs72613567:TA variant mitigated liver injury associated with the risk-increasing PNPLA3 p.I148M allele and resulted in an unstable and truncated protein with reduced enzymatic activity.\nCONCLUSIONS: A  [CLS] loss-of-function variant [CLS]  in HSD17B13 was associated with a reduced risk of chronic liver disease and of progression from steatosis to steatohepatitis. (Funded by Regeneron Pharmaceuticals and others.)."}
{"subject": "HSD17B13", "sub_type": "Gene", "rel": "ThemeOf", "object": "variant", "obj_type": "Var", "file_name": "PubMed-29562163.json", "snippet": " samples. The rs72613567:TA variant mitigated liver injury associated with the risk-increasing PNPLA3 p.I148M allele and resulted in an unstable and truncated protein with reduced enzymatic activity.\nCONCLUSIONS: A loss-of-function  [CLS] variant in HSD17B13 [CLS]  was associated with a reduced risk of chronic liver disease and of progression from steatosis to steatohepatitis. (Funded by Regeneron Pharmaceuticals and others.)."}
{"subject": "variant", "sub_type": "Var", "rel": "CauseOf", "object": "reduced", "obj_type": "NegReg", "file_name": "PubMed-29562163.json", "snippet": " samples. The rs72613567:TA variant mitigated liver injury associated with the risk-increasing PNPLA3 p.I148M allele and resulted in an unstable and truncated protein with reduced enzymatic activity.\nCONCLUSIONS: A loss-of-function  [CLS] variant in HSD17B13 was associated with a reduced [CLS]  risk of chronic liver disease and of progression from steatosis to steatohepatitis. (Funded by Regeneron Pharmaceuticals and others.)."}
{"subject": "chronic liver disease", "sub_type": "Disease", "rel": "ThemeOf", "object": "reduced", "obj_type": "NegReg", "file_name": "PubMed-29562163.json", "snippet": " associated with the risk-increasing PNPLA3 p.I148M allele and resulted in an unstable and truncated protein with reduced enzymatic activity.\nCONCLUSIONS: A loss-of-function variant in HSD17B13 was associated with a  [CLS] reduced risk of chronic liver disease [CLS]  and of progression from steatosis to steatohepatitis. (Funded by Regeneron Pharmaceuticals and others.)."}
{"subject": "AST", "sub_type": "MPA", "rel": "ThemeOf", "object": "reduced", "obj_type": "NegReg", "file_name": "PubMed-29562163.json", "snippet": " severity of liver disease in 2391 human liver samples.\nRESULTS: A splice variant (rs72613567:TA) in HSD17B13, encoding the hepatic lipid droplet protein hydroxysteroid 17-beta dehydrogenase 13, was associated with  [CLS] reduced levels of ALT (P=4.2\u00d710-12) and AST [CLS]  (P=6.2\u00d710-10). Among DiscovEHR study participants, this variant was associated with a reduced risk of alcoholic liver disease (by 42% [95% confidence interval {CI}, 20 to 58] among heterozygotes and"}
{"subject": "chronic liver disease", "sub_type": "Disease", "rel": "ThemeOf", "object": "association", "obj_type": "Interaction", "file_name": "PubMed-29562163.json", "snippet": " to identify genetic variants associated with serum levels of alanine aminotransferase (ALT) and aspartate aminotransferase (AST). Variants that were replicated in three additional cohorts (12,527 persons) were evaluated for  [CLS] association with clinical diagnoses of chronic liver disease [CLS]  in DiscovEHR study participants and two independent cohorts (total of 37,173 persons) and with histopathological severity of liver disease in 2391 human liver samples.\nRESULTS: A splice variant (rs72613567:TA)"}
{"subject": "splice variant", "sub_type": "Var", "rel": "CauseOf", "object": "reduced", "obj_type": "NegReg", "file_name": "PubMed-29562163.json", "snippet": " chronic liver disease in DiscovEHR study participants and two independent cohorts (total of 37,173 persons) and with histopathological severity of liver disease in 2391 human liver samples.\nRESULTS: A  [CLS] splice variant (rs72613567:TA) in HSD17B13, encoding the hepatic lipid droplet protein hydroxysteroid 17-beta dehydrogenase 13, was associated with reduced [CLS]  levels of ALT (P=4.2\u00d710-12) and AST (P=6.2\u00d710-10). Among DiscovEHR study participants, this variant was associated with a reduced risk of alcoholic liver disease (by 42% [95% confidence interval {CI},"}
{"subject": "HSD17B13", "sub_type": "Gene", "rel": "ThemeOf", "object": "splice variant", "obj_type": "Var", "file_name": "PubMed-29562163.json", "snippet": " chronic liver disease in DiscovEHR study participants and two independent cohorts (total of 37,173 persons) and with histopathological severity of liver disease in 2391 human liver samples.\nRESULTS: A  [CLS] splice variant (rs72613567:TA) in HSD17B13 [CLS] , encoding the hepatic lipid droplet protein hydroxysteroid 17-beta dehydrogenase 13, was associated with reduced levels of ALT (P=4.2\u00d710-12) and AST (P=6.2\u00d710-10). Among DiscovEHR study participants, this variant was associated"}
{"subject": "ALT", "sub_type": "MPA", "rel": "ThemeOf", "object": "reduced", "obj_type": "NegReg", "file_name": "PubMed-29562163.json", "snippet": " severity of liver disease in 2391 human liver samples.\nRESULTS: A splice variant (rs72613567:TA) in HSD17B13, encoding the hepatic lipid droplet protein hydroxysteroid 17-beta dehydrogenase 13, was associated with  [CLS] reduced levels of ALT [CLS]  (P=4.2\u00d710-12) and AST (P=6.2\u00d710-10). Among DiscovEHR study participants, this variant was associated with a reduced risk of alcoholic liver disease (by 42% [95% confidence interval {CI}, 20 to 58]"}
{"subject": "variant", "sub_type": "Var", "rel": "CauseOf", "object": "reduced", "obj_type": "NegReg", "file_name": "PubMed-29562163.json", "snippet": " (rs72613567:TA) in HSD17B13, encoding the hepatic lipid droplet protein hydroxysteroid 17-beta dehydrogenase 13, was associated with reduced levels of ALT (P=4.2\u00d710-12) and AST (P=6.2\u00d710-10). Among DiscovEHR study participants, this  [CLS] variant was associated with a reduced [CLS]  risk of alcoholic liver disease (by 42% [95% confidence interval {CI}, 20 to 58] among heterozygotes and by 53% [95% CI, 3 to 77] among homozygotes), nonalcoholic liver disease"}
{"subject": "alcoholic liver disease", "sub_type": "Disease", "rel": "ThemeOf", "object": "reduced", "obj_type": "NegReg", "file_name": "PubMed-29562163.json", "snippet": " hepatic lipid droplet protein hydroxysteroid 17-beta dehydrogenase 13, was associated with reduced levels of ALT (P=4.2\u00d710-12) and AST (P=6.2\u00d710-10). Among DiscovEHR study participants, this variant was associated with a  [CLS] reduced risk of alcoholic liver disease [CLS]  (by 42% [95% confidence interval {CI}, 20 to 58] among heterozygotes and by 53% [95% CI, 3 to 77] among homozygotes), nonalcoholic liver disease (by 17% [95% CI, 8"}
{"subject": "nonalcoholic liver disease", "sub_type": "Disease", "rel": "ThemeOf", "object": "reduced", "obj_type": "NegReg", "file_name": "PubMed-29562163.json", "snippet": " hepatic lipid droplet protein hydroxysteroid 17-beta dehydrogenase 13, was associated with reduced levels of ALT (P=4.2\u00d710-12) and AST (P=6.2\u00d710-10). Among DiscovEHR study participants, this variant was associated with a  [CLS] reduced risk of alcoholic liver disease (by 42% [95% confidence interval {CI}, 20 to 58] among heterozygotes and by 53% [95% CI, 3 to 77] among homozygotes), nonalcoholic liver disease [CLS]  (by 17% [95% CI, 8 to 25] among heterozygotes and by 30% [95% CI, 13 to 43] among homozygotes), alcoholic cirrhosis (by 42% [95% CI, 14 to 61] among"}
{"subject": "alcoholic cirrhosis", "sub_type": "Disease", "rel": "ThemeOf", "object": "reduced", "obj_type": "NegReg", "file_name": "PubMed-29562163.json", "snippet": " hepatic lipid droplet protein hydroxysteroid 17-beta dehydrogenase 13, was associated with reduced levels of ALT (P=4.2\u00d710-12) and AST (P=6.2\u00d710-10). Among DiscovEHR study participants, this variant was associated with a  [CLS] reduced risk of alcoholic liver disease (by 42% [95% confidence interval {CI}, 20 to 58] among heterozygotes and by 53% [95% CI, 3 to 77] among homozygotes), nonalcoholic liver disease (by 17% [95% CI, 8 to 25] among heterozygotes and by 30% [95% CI, 13 to 43] among homozygotes), alcoholic cirrhosis [CLS]  (by 42% [95% CI, 14 to 61] among heterozygotes and by 73% [95% CI, 15 to 91] among homozygotes), and nonalcoholic cirrhosis (by 26% [95% CI, 7 to 40]"}
{"subject": "CSF3R", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-29572350.json", "snippet": " CSF3R activation.\nGranulocyte colony-stimulating factor (G-CSF or CSF3) and its receptor CSF3R regulate granulopoiesis, neutrophil function, and hematopoietic stem cell mobilization. Recent studies have uncovered an oncogenic role of  [CLS] mutations in the CSF3R [CLS]  gene in many hematologic malignancies. To find additional CSF3R mutations that give rise to cell transformation, we performed a cellular transformation assay in which murine interleukin 3 (IL-3)-dependent Ba/F3"}
{"subject": "missense mutations", "sub_type": "Var", "rel": "CauseOf", "object": "exhibit", "obj_type": "PosReg", "file_name": "PubMed-29572350.json", "snippet": " and ERK activations require CSF3R internalization, whereas STAT5 activation occurred at the cell surface. Cumulatively, we have expanded the regions of the CSF3R extracellular and transmembrane domains in which  [CLS] missense mutations exhibit [CLS]  leukemogenic capacity and have further elucidated the mechanistic underpinnings that underlie altered CSF3R expression, dimerization, and signaling activation."}
{"subject": "leukemogenic", "sub_type": "Disease", "rel": "ThemeOf", "object": "exhibit", "obj_type": "PosReg", "file_name": "PubMed-29572350.json", "snippet": " activations require CSF3R internalization, whereas STAT5 activation occurred at the cell surface. Cumulatively, we have expanded the regions of the CSF3R extracellular and transmembrane domains in which missense mutations  [CLS] exhibit leukemogenic [CLS]  capacity and have further elucidated the mechanistic underpinnings that underlie altered CSF3R expression, dimerization, and signaling activation."}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "hematologic malignancies", "obj_type": "Disease", "file_name": "PubMed-29572350.json", "snippet": " CSF3R activation.\nGranulocyte colony-stimulating factor (G-CSF or CSF3) and its receptor CSF3R regulate granulopoiesis, neutrophil function, and hematopoietic stem cell mobilization. Recent studies have uncovered an oncogenic role of  [CLS] mutations in the CSF3R gene in many hematologic malignancies [CLS] . To find additional CSF3R mutations that give rise to cell transformation, we performed a cellular transformation assay in which murine interleukin 3 (IL-3)-dependent Ba/F3 cells were transduced with WT"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "transform", "obj_type": "Reg", "file_name": "PubMed-29572350.json", "snippet": " WT CSF3R plasmid and screened for spontaneous growth in the absence of IL-3. Any outgrowth clones were sequenced to identify CSF3R mutations with transformation capacity. We identified several novel  [CLS] mutations and determined that they transform [CLS]  cells via four distinct mechanisms: 1) cysteine- and disulfide bond-mediated dimerization (S581C); 2) polar, noncharged amino acid substitution at the transmembrane helix dimer interface at residue Thr-640; 3) increased"}
{"subject": "cells", "sub_type": "CPA", "rel": "ThemeOf", "object": "transform", "obj_type": "Reg", "file_name": "PubMed-29572350.json", "snippet": " for spontaneous growth in the absence of IL-3. Any outgrowth clones were sequenced to identify CSF3R mutations with transformation capacity. We identified several novel mutations and determined that they  [CLS] transform cells [CLS]  via four distinct mechanisms: 1) cysteine- and disulfide bond-mediated dimerization (S581C); 2) polar, noncharged amino acid substitution at the transmembrane helix dimer interface at residue Thr-640; 3) increased internalization"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "cysteine- and disulfide bond-mediated dimerization", "obj_type": "MPA", "file_name": "PubMed-29572350.json", "snippet": " WT CSF3R plasmid and screened for spontaneous growth in the absence of IL-3. Any outgrowth clones were sequenced to identify CSF3R mutations with transformation capacity. We identified several novel  [CLS] mutations and determined that they transform cells via four distinct mechanisms: 1) cysteine- and disulfide bond-mediated dimerization [CLS]  (S581C); 2) polar, noncharged amino acid substitution at the transmembrane helix dimer interface at residue Thr-640; 3) increased internalization by a Glu-524 substitution that mimics a low G-CSF dose;"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "polar, noncharged amino acid substitution", "obj_type": "Var", "file_name": "PubMed-29572350.json", "snippet": " WT CSF3R plasmid and screened for spontaneous growth in the absence of IL-3. Any outgrowth clones were sequenced to identify CSF3R mutations with transformation capacity. We identified several novel  [CLS] mutations and determined that they transform cells via four distinct mechanisms: 1) cysteine- and disulfide bond-mediated dimerization (S581C); 2) polar, noncharged amino acid substitution [CLS]  at the transmembrane helix dimer interface at residue Thr-640; 3) increased internalization by a Glu-524 substitution that mimics a low G-CSF dose; and 4) hydrophobic amino acid substitutions in"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-29572350.json", "snippet": " WT CSF3R plasmid and screened for spontaneous growth in the absence of IL-3. Any outgrowth clones were sequenced to identify CSF3R mutations with transformation capacity. We identified several novel  [CLS] mutations and determined that they transform cells via four distinct mechanisms: 1) cysteine- and disulfide bond-mediated dimerization (S581C); 2) polar, noncharged amino acid substitution at the transmembrane helix dimer interface at residue Thr-640; 3) increased [CLS]  internalization by a Glu-524 substitution that mimics a low G-CSF dose; and 4) hydrophobic amino acid substitutions in the membrane-proximal residues Thr-612, Thr-615, and Thr-618. Furthermore, the change in"}
{"subject": "internalization", "sub_type": "MPA", "rel": "ThemeOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-29572350.json", "snippet": " transform cells via four distinct mechanisms: 1) cysteine- and disulfide bond-mediated dimerization (S581C); 2) polar, noncharged amino acid substitution at the transmembrane helix dimer interface at residue Thr-640; 3)  [CLS] increased internalization [CLS]  by a Glu-524 substitution that mimics a low G-CSF dose; and 4) hydrophobic amino acid substitutions in the membrane-proximal residues Thr-612, Thr-615, and Thr-618. Furthermore, the change in signaling"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "hydrophobic amino acid substitutions", "obj_type": "Var", "file_name": "PubMed-29572350.json", "snippet": " WT CSF3R plasmid and screened for spontaneous growth in the absence of IL-3. Any outgrowth clones were sequenced to identify CSF3R mutations with transformation capacity. We identified several novel  [CLS] mutations and determined that they transform cells via four distinct mechanisms: 1) cysteine- and disulfide bond-mediated dimerization (S581C); 2) polar, noncharged amino acid substitution at the transmembrane helix dimer interface at residue Thr-640; 3) increased internalization by a Glu-524 substitution that mimics a low G-CSF dose; and 4) hydrophobic amino acid substitutions [CLS]  in the membrane-proximal residues Thr-612, Thr-615, and Thr-618. Furthermore, the change in signaling activation was related to an altered CSF3R localization. We also found that CSF3R-induced STAT3 and ERK"}
{"subject": "WNT5A", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-29575631.json", "snippet": " [CLS] WNT5A mutations [CLS]  in an infant with severe and atypical manifestations of Robinow syndrome.\nRobinow syndrome (RS) is a well-recognized Mendelian disorder known to demonstrate both autosomal dominant and autosomal recessive inheritance."}
{"subject": "WNT5A", "sub_type": "Gene", "rel": "ThemeOf", "object": "homozygous frameshifting single nucleotide deletion", "obj_type": "Var", "file_name": "PubMed-29575631.json", "snippet": " inheritance has been associated with mutations in ROR2 while dominant inheritance has been observed for mutations in WNT5A, DVL1, and DVL3. Through trio whole genome sequencing, we identified a  [CLS] homozygous frameshifting single nucleotide deletion in WNT5A [CLS]  in a previously reported, deceased infant with a unique constellation of features comprising a 46,XY disorder of sex development with multiple congenital malformations including congenital diaphragmatic hernia, ambiguous genitalia,"}
{"subject": "homozygous frameshifting single nucleotide deletion", "sub_type": "Var", "rel": "CauseOf", "object": "congenital diaphragmatic hernia", "obj_type": "Disease", "file_name": "PubMed-29575631.json", "snippet": " inheritance has been associated with mutations in ROR2 while dominant inheritance has been observed for mutations in WNT5A, DVL1, and DVL3. Through trio whole genome sequencing, we identified a  [CLS] homozygous frameshifting single nucleotide deletion in WNT5A in a previously reported, deceased infant with a unique constellation of features comprising a 46,XY disorder of sex development with multiple congenital malformations including congenital diaphragmatic hernia [CLS] , ambiguous genitalia, dysmorphic facies, shortened long bones, adactyly, and ventricular septal defect. The parents, who are both heterozygous for the deletion, appear clinically unaffected. In conjunction with published observations"}
{"subject": "homozygous frameshifting single nucleotide deletion", "sub_type": "Var", "rel": "CauseOf", "object": "ambiguous genitalia", "obj_type": "Disease", "file_name": "PubMed-29575631.json", "snippet": " inheritance has been associated with mutations in ROR2 while dominant inheritance has been observed for mutations in WNT5A, DVL1, and DVL3. Through trio whole genome sequencing, we identified a  [CLS] homozygous frameshifting single nucleotide deletion in WNT5A in a previously reported, deceased infant with a unique constellation of features comprising a 46,XY disorder of sex development with multiple congenital malformations including congenital diaphragmatic hernia, ambiguous genitalia [CLS] , dysmorphic facies, shortened long bones, adactyly, and ventricular septal defect. The parents, who are both heterozygous for the deletion, appear clinically unaffected. In conjunction with published observations of Wnt5a"}
{"subject": "homozygous frameshifting single nucleotide deletion", "sub_type": "Var", "rel": "CauseOf", "object": "ventricular septal defect", "obj_type": "Disease", "file_name": "PubMed-29575631.json", "snippet": " inheritance has been associated with mutations in ROR2 while dominant inheritance has been observed for mutations in WNT5A, DVL1, and DVL3. Through trio whole genome sequencing, we identified a  [CLS] homozygous frameshifting single nucleotide deletion in WNT5A in a previously reported, deceased infant with a unique constellation of features comprising a 46,XY disorder of sex development with multiple congenital malformations including congenital diaphragmatic hernia, ambiguous genitalia, dysmorphic facies, shortened long bones, adactyly, and ventricular septal defect [CLS] . The parents, who are both heterozygous for the deletion, appear clinically unaffected. In conjunction with published observations of Wnt5a double knockout mice, we provide evidence for the possibility of"}
{"subject": "homozygous frameshifting single nucleotide deletion", "sub_type": "Var", "rel": "CauseOf", "object": "adactyly", "obj_type": "Disease", "file_name": "PubMed-29575631.json", "snippet": " inheritance has been associated with mutations in ROR2 while dominant inheritance has been observed for mutations in WNT5A, DVL1, and DVL3. Through trio whole genome sequencing, we identified a  [CLS] homozygous frameshifting single nucleotide deletion in WNT5A in a previously reported, deceased infant with a unique constellation of features comprising a 46,XY disorder of sex development with multiple congenital malformations including congenital diaphragmatic hernia, ambiguous genitalia, dysmorphic facies, shortened long bones, adactyly [CLS] , and ventricular septal defect. The parents, who are both heterozygous for the deletion, appear clinically unaffected. In conjunction with published observations of Wnt5a double knockout mice, we provide evidence"}
{"subject": "homozygous frameshifting single nucleotide deletion", "sub_type": "Var", "rel": "CauseOf", "object": "shortened long bones", "obj_type": "Disease", "file_name": "PubMed-29575631.json", "snippet": " inheritance has been associated with mutations in ROR2 while dominant inheritance has been observed for mutations in WNT5A, DVL1, and DVL3. Through trio whole genome sequencing, we identified a  [CLS] homozygous frameshifting single nucleotide deletion in WNT5A in a previously reported, deceased infant with a unique constellation of features comprising a 46,XY disorder of sex development with multiple congenital malformations including congenital diaphragmatic hernia, ambiguous genitalia, dysmorphic facies, shortened long bones [CLS] , adactyly, and ventricular septal defect. The parents, who are both heterozygous for the deletion, appear clinically unaffected. In conjunction with published observations of Wnt5a double knockout mice, we provide"}
{"subject": "homozygous frameshifting single nucleotide deletion", "sub_type": "Var", "rel": "CauseOf", "object": "dysmorphic facies", "obj_type": "Disease", "file_name": "PubMed-29575631.json", "snippet": " inheritance has been associated with mutations in ROR2 while dominant inheritance has been observed for mutations in WNT5A, DVL1, and DVL3. Through trio whole genome sequencing, we identified a  [CLS] homozygous frameshifting single nucleotide deletion in WNT5A in a previously reported, deceased infant with a unique constellation of features comprising a 46,XY disorder of sex development with multiple congenital malformations including congenital diaphragmatic hernia, ambiguous genitalia, dysmorphic facies [CLS] , shortened long bones, adactyly, and ventricular septal defect. The parents, who are both heterozygous for the deletion, appear clinically unaffected. In conjunction with published observations of Wnt5a double knockout"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-29575631.json", "snippet": " [CLS] loss-of-function WNT5A mutations [CLS]  in an infant with severe and atypical manifestations of Robinow syndrome.\nRobinow syndrome (RS) is a well-recognized Mendelian disorder known to demonstrate both autosomal dominant and autosomal recessive inheritance."}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "Robinow syndrome.", "obj_type": "Disease", "file_name": "PubMed-29575631.json", "snippet": " [CLS] mutations in an infant with severe and atypical manifestations of Robinow syndrome. [CLS] \nRobinow syndrome (RS) is a well-recognized Mendelian disorder known to demonstrate both autosomal dominant and autosomal recessive inheritance. Typical manifestations include short stature, characteristic facies, and skeletal anomalies. Recessive"}
{"subject": "SYNGAP1", "sub_type": "Gene", "rel": "CauseOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-29580901.json", "snippet": " [CLS] SYNGAP1 loss-of-function [CLS]  variants are causally associated with intellectual disability, severe epilepsy, autism spectrum disorder and schizophrenia. While there are hundreds of genetic risk factors for neurodevelopmental disorders (NDDs), this gene is"}
{"subject": "variants", "sub_type": "Var", "rel": "ThemeOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-29580901.json", "snippet": " [CLS] loss-of-function variants [CLS]  are causally associated with intellectual disability, severe epilepsy, autism spectrum disorder and schizophrenia. While there are hundreds of genetic risk factors for neurodevelopmental disorders (NDDs), this gene is somewhat"}
{"subject": "intellectual disability", "sub_type": "Disease", "rel": "ThemeOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-29580901.json", "snippet": " [CLS] loss-of-function variants are causally associated with intellectual disability [CLS] , severe epilepsy, autism spectrum disorder and schizophrenia. While there are hundreds of genetic risk factors for neurodevelopmental disorders (NDDs), this gene is somewhat unique because of the frequency and"}
{"subject": "severe epilepsy", "sub_type": "Disease", "rel": "ThemeOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-29580901.json", "snippet": " [CLS] loss-of-function variants are causally associated with intellectual disability, severe epilepsy [CLS] , autism spectrum disorder and schizophrenia. While there are hundreds of genetic risk factors for neurodevelopmental disorders (NDDs), this gene is somewhat unique because of the frequency and penetrance of"}
{"subject": "autism spectrum disorder", "sub_type": "Disease", "rel": "ThemeOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-29580901.json", "snippet": " [CLS] loss-of-function variants are causally associated with intellectual disability, severe epilepsy, autism spectrum disorder [CLS]  and schizophrenia. While there are hundreds of genetic risk factors for neurodevelopmental disorders (NDDs), this gene is somewhat unique because of the frequency and penetrance of loss-of-function variants found"}
{"subject": "schizophrenia", "sub_type": "Disease", "rel": "ThemeOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-29580901.json", "snippet": " [CLS] loss-of-function variants are causally associated with intellectual disability, severe epilepsy, autism spectrum disorder and schizophrenia [CLS] . While there are hundreds of genetic risk factors for neurodevelopmental disorders (NDDs), this gene is somewhat unique because of the frequency and penetrance of loss-of-function variants found in patients"}
{"subject": "PCSK9", "sub_type": "Var", "rel": "CauseOf", "object": "degrading", "obj_type": "NegReg", "file_name": "PubMed-29593095.json", "snippet": " [CLS] PCSK9) plays a central role in cardiovascular disease (CVD) by degrading [CLS]  hepatic low-density lipoprotein receptor (LDLR). As such, loss-of-function (LOF) PCSK9 variants that fail to exit the endoplasmic reticulum (ER) increase hepatic LDLR levels and lower the risk of developing"}
{"subject": "PCSK9", "sub_type": "Gene", "rel": "ThemeOf", "object": "variants", "obj_type": "Var", "file_name": "PubMed-29593095.json", "snippet": " In this study, we investigated whether a variety of LOF PCSK9 variants that are retained in the ER can cause ER stress and hepatic cytotoxicity. Although overexpression of these  [CLS] PCSK9 variants [CLS]  caused an accumulation in the ER of hepatocytes, UPR activation or apoptosis was not observed. Furthermore, ER retention of endogenous PCSK9 via splice switching also failed to induce the"}
{"subject": "variants", "sub_type": "Var", "rel": "CauseOf", "object": "accumulation", "obj_type": "PosReg", "file_name": "PubMed-29593095.json", "snippet": " this study, we investigated whether a variety of LOF PCSK9 variants that are retained in the ER can cause ER stress and hepatic cytotoxicity. Although overexpression of these PCSK9  [CLS] variants caused an accumulation [CLS]  in the ER of hepatocytes, UPR activation or apoptosis was not observed. Furthermore, ER retention of endogenous PCSK9 via splice switching also failed to induce the UPR. Consistent with"}
{"subject": "ER of hepatocytes", "sub_type": "MPA", "rel": "ThemeOf", "object": "accumulation", "obj_type": "PosReg", "file_name": "PubMed-29593095.json", "snippet": " investigated whether a variety of LOF PCSK9 variants that are retained in the ER can cause ER stress and hepatic cytotoxicity. Although overexpression of these PCSK9 variants caused an  [CLS] accumulation in the ER of hepatocytes [CLS] , UPR activation or apoptosis was not observed. Furthermore, ER retention of endogenous PCSK9 via splice switching also failed to induce the UPR. Consistent with these in vitro studies, overexpression"}
{"subject": "overexpression", "sub_type": "PosReg", "rel": "ThemeOf", "object": "variants", "obj_type": "Var", "file_name": "PubMed-29593095.json", "snippet": " protein response (UPR). In this study, we investigated whether a variety of LOF PCSK9 variants that are retained in the ER can cause ER stress and hepatic cytotoxicity. Although  [CLS] overexpression of these PCSK9 variants [CLS]  caused an accumulation in the ER of hepatocytes, UPR activation or apoptosis was not observed. Furthermore, ER retention of endogenous PCSK9 via splice switching also failed to induce the"}
{"subject": "hepatic low-density lipoprotein receptor", "sub_type": "MPA", "rel": "ThemeOf", "object": "degrading", "obj_type": "NegReg", "file_name": "PubMed-29593095.json", "snippet": " unfolded protein response sensor GRP78 and fail to induce endoplasmic reticulum stress when retained.\nThe proprotein convertase subtilisin/kexin type-9 (PCSK9) plays a central role in cardiovascular disease (CVD) by  [CLS] degrading hepatic low-density lipoprotein receptor [CLS]  (LDLR). As such, loss-of-function (LOF) PCSK9 variants that fail to exit the endoplasmic reticulum (ER) increase hepatic LDLR levels and lower the risk of developing CVD. The retention of"}
{"subject": "cardiovascular disease", "sub_type": "Disease", "rel": "ThemeOf", "object": "hepatic low-density lipoprotein receptor", "obj_type": "MPA", "file_name": "PubMed-29593095.json", "snippet": " PCSK9 mutants evade the unfolded protein response sensor GRP78 and fail to induce endoplasmic reticulum stress when retained.\nThe proprotein convertase subtilisin/kexin type-9 (PCSK9) plays a central role in  [CLS] cardiovascular disease (CVD) by degrading hepatic low-density lipoprotein receptor [CLS]  (LDLR). As such, loss-of-function (LOF) PCSK9 variants that fail to exit the endoplasmic reticulum (ER) increase hepatic LDLR levels and lower the risk of developing CVD. The retention of"}
{"subject": "PCSK9", "sub_type": "Gene", "rel": "ThemeOf", "object": "variants", "obj_type": "Var", "file_name": "PubMed-29593095.json", "snippet": " reticulum stress when retained.\nThe proprotein convertase subtilisin/kexin type-9 (PCSK9) plays a central role in cardiovascular disease (CVD) by degrading hepatic low-density lipoprotein receptor (LDLR). As such, loss-of-function (LOF)  [CLS] PCSK9 variants [CLS]  that fail to exit the endoplasmic reticulum (ER) increase hepatic LDLR levels and lower the risk of developing CVD. The retention of misfolded protein in the ER can cause"}
{"subject": "variants", "sub_type": "Var", "rel": "CauseOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-29593095.json", "snippet": " induce endoplasmic reticulum stress when retained.\nThe proprotein convertase subtilisin/kexin type-9 (PCSK9) plays a central role in cardiovascular disease (CVD) by degrading hepatic low-density lipoprotein receptor (LDLR). As such,  [CLS] loss-of-function (LOF) PCSK9 variants [CLS]  that fail to exit the endoplasmic reticulum (ER) increase hepatic LDLR levels and lower the risk of developing CVD. The retention of misfolded protein in the ER can cause"}
{"subject": "variants", "sub_type": "Var", "rel": "CauseOf", "object": "increase", "obj_type": "PosReg", "file_name": "PubMed-29593095.json", "snippet": " stress when retained.\nThe proprotein convertase subtilisin/kexin type-9 (PCSK9) plays a central role in cardiovascular disease (CVD) by degrading hepatic low-density lipoprotein receptor (LDLR). As such, loss-of-function (LOF) PCSK9  [CLS] variants that fail to exit the endoplasmic reticulum (ER) increase [CLS]  hepatic LDLR levels and lower the risk of developing CVD. The retention of misfolded protein in the ER can cause ER stress and activate the unfolded protein response (UPR)."}
{"subject": "hepatic LDLR levels", "sub_type": "MPA", "rel": "ThemeOf", "object": "increase", "obj_type": "PosReg", "file_name": "PubMed-29593095.json", "snippet": " plays a central role in cardiovascular disease (CVD) by degrading hepatic low-density lipoprotein receptor (LDLR). As such, loss-of-function (LOF) PCSK9 variants that fail to exit the endoplasmic reticulum (ER)  [CLS] increase hepatic LDLR levels [CLS]  and lower the risk of developing CVD. The retention of misfolded protein in the ER can cause ER stress and activate the unfolded protein response (UPR). In this study,"}
{"subject": "variants", "sub_type": "Var", "rel": "CauseOf", "object": "lower", "obj_type": "NegReg", "file_name": "PubMed-29593095.json", "snippet": " stress when retained.\nThe proprotein convertase subtilisin/kexin type-9 (PCSK9) plays a central role in cardiovascular disease (CVD) by degrading hepatic low-density lipoprotein receptor (LDLR). As such, loss-of-function (LOF) PCSK9  [CLS] variants that fail to exit the endoplasmic reticulum (ER) increase hepatic LDLR levels and lower [CLS]  the risk of developing CVD. The retention of misfolded protein in the ER can cause ER stress and activate the unfolded protein response (UPR). In this study, we investigated"}
{"subject": "risk of developing CVD", "sub_type": "MPA", "rel": "ThemeOf", "object": "lower", "obj_type": "NegReg", "file_name": "PubMed-29593095.json", "snippet": " cardiovascular disease (CVD) by degrading hepatic low-density lipoprotein receptor (LDLR). As such, loss-of-function (LOF) PCSK9 variants that fail to exit the endoplasmic reticulum (ER) increase hepatic LDLR levels and  [CLS] lower the risk of developing CVD [CLS] . The retention of misfolded protein in the ER can cause ER stress and activate the unfolded protein response (UPR). In this study, we investigated whether a variety of LOF"}
{"subject": "CBL", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutation", "obj_type": "Var", "file_name": "PubMed-29600428.json", "snippet": " [CLS] CBL mutation [CLS]  and MEFV single-nucleotide variant are important genetic predictors of tumor reduction in glucocorticoid-treated patients with chronic myelomonocytic leukemia.\nGlucocorticoid (GC) therapy occasionally relieves tumor-related fever and promotes tumor reduction"}
{"subject": "mutation", "sub_type": "Var", "rel": "CauseOf", "object": "prolonged", "obj_type": "PosReg", "file_name": "PubMed-29600428.json", "snippet": " the myelomonocytic leukemia cell line GDM-1, harboring the CBL mutation, were both more significantly suppressed than non-mutated cells following GC treatment in the presence of GM-CSF. A loss-of-function CBL  [CLS] mutation prolonged [CLS]  STAT5 phosphorylation after GM-CSF stimulation, which was rapidly terminated in both patient samples and GDM-1 cells. In conclusion, GC therapy effectively treats CMML cells harboring the MEFV SNV and"}
{"subject": "STAT5 phosphorylation", "sub_type": "MPA", "rel": "ThemeOf", "object": "prolonged", "obj_type": "PosReg", "file_name": "PubMed-29600428.json", "snippet": " myelomonocytic leukemia cell line GDM-1, harboring the CBL mutation, were both more significantly suppressed than non-mutated cells following GC treatment in the presence of GM-CSF. A loss-of-function CBL mutation  [CLS] prolonged STAT5 phosphorylation [CLS]  after GM-CSF stimulation, which was rapidly terminated in both patient samples and GDM-1 cells. In conclusion, GC therapy effectively treats CMML cells harboring the MEFV SNV and CBL mutation"}
{"subject": "MEFV", "sub_type": "Gene", "rel": "ThemeOf", "object": "single-nucleotide variant", "obj_type": "Var", "file_name": "PubMed-29600428.json", "snippet": " [CLS] MEFV single-nucleotide variant [CLS]  are important genetic predictors of tumor reduction in glucocorticoid-treated patients with chronic myelomonocytic leukemia.\nGlucocorticoid (GC) therapy occasionally relieves tumor-related fever and promotes tumor reduction in patients with chronic"}
{"subject": "single-nucleotide variant", "sub_type": "Var", "rel": "CauseOf", "object": "reduction", "obj_type": "NegReg", "file_name": "PubMed-29600428.json", "snippet": " [CLS] single-nucleotide variant are important genetic predictors of tumor reduction [CLS]  in glucocorticoid-treated patients with chronic myelomonocytic leukemia.\nGlucocorticoid (GC) therapy occasionally relieves tumor-related fever and promotes tumor reduction in patients with chronic myelomonocytic leukemia (CMML). A mutation analysis of"}
{"subject": "mutation", "sub_type": "Var", "rel": "CauseOf", "object": "reduction", "obj_type": "NegReg", "file_name": "PubMed-29600428.json", "snippet": " [CLS] mutation and MEFV single-nucleotide variant are important genetic predictors of tumor reduction [CLS]  in glucocorticoid-treated patients with chronic myelomonocytic leukemia.\nGlucocorticoid (GC) therapy occasionally relieves tumor-related fever and promotes tumor reduction in patients with chronic myelomonocytic leukemia (CMML). A mutation analysis of"}
{"subject": "tumor", "sub_type": "Disease", "rel": "ThemeOf", "object": "reduction", "obj_type": "NegReg", "file_name": "PubMed-29600428.json", "snippet": " [CLS] tumor reduction [CLS]  in glucocorticoid-treated patients with chronic myelomonocytic leukemia.\nGlucocorticoid (GC) therapy occasionally relieves tumor-related fever and promotes tumor reduction in patients with chronic myelomonocytic leukemia (CMML). A mutation analysis of"}
{"subject": "chronic myelomonocytic leukemia", "sub_type": "Disease", "rel": "ThemeOf", "object": "tumor", "obj_type": "Disease", "file_name": "PubMed-29600428.json", "snippet": " [CLS] tumor reduction in glucocorticoid-treated patients with chronic myelomonocytic leukemia [CLS] .\nGlucocorticoid (GC) therapy occasionally relieves tumor-related fever and promotes tumor reduction in patients with chronic myelomonocytic leukemia (CMML). A mutation analysis of 24 patients with CMML revealed the relationship"}
{"subject": "mutation", "sub_type": "Var", "rel": "CauseOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-29600428.json", "snippet": " mutation, and the myelomonocytic leukemia cell line GDM-1, harboring the CBL mutation, were both more significantly suppressed than non-mutated cells following GC treatment in the presence of GM-CSF. A  [CLS] loss-of-function CBL mutation [CLS]  prolonged STAT5 phosphorylation after GM-CSF stimulation, which was rapidly terminated in both patient samples and GDM-1 cells. In conclusion, GC therapy effectively treats CMML cells harboring the MEFV SNV"}
{"subject": "CBL", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutation", "obj_type": "Var", "file_name": "PubMed-29600428.json", "snippet": " and the myelomonocytic leukemia cell line GDM-1, harboring the CBL mutation, were both more significantly suppressed than non-mutated cells following GC treatment in the presence of GM-CSF. A loss-of-function  [CLS] CBL mutation [CLS]  prolonged STAT5 phosphorylation after GM-CSF stimulation, which was rapidly terminated in both patient samples and GDM-1 cells. In conclusion, GC therapy effectively treats CMML cells harboring the MEFV SNV"}
{"subject": "IGF1R", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutation", "obj_type": "Var", "file_name": "PubMed-29621572.json", "snippet": " [CLS] mutation in IGF1R [CLS]  and a crosstalk between IGF1R and Wnt/\u03b2-catenin signaling pathways.\nIGF1R is a ubiquitous receptor tyrosine kinase that plays critical roles in cell proliferation, growth and survival. Clinical studies have"}
{"subject": "mutation", "sub_type": "Var", "rel": "CauseOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-29621572.json", "snippet": " [CLS] loss-of-function mutation [CLS]  in IGF1R and a crosstalk between IGF1R and Wnt/\u03b2-catenin signaling pathways.\nIGF1R is a ubiquitous receptor tyrosine kinase that plays critical roles in cell proliferation, growth and survival. Clinical"}
{"subject": "mutation", "sub_type": "Var", "rel": "CauseOf", "object": "crosstalk", "obj_type": "Reg", "file_name": "PubMed-29621572.json", "snippet": " [CLS] mutation in IGF1R and a crosstalk [CLS]  between IGF1R and Wnt/\u03b2-catenin signaling pathways.\nIGF1R is a ubiquitous receptor tyrosine kinase that plays critical roles in cell proliferation, growth and survival. Clinical studies have demonstrated upregulation of"}
{"subject": "Wnt/\u03b2-catenin signaling pathways", "sub_type": "Pathway", "rel": "ThemeOf", "object": "crosstalk", "obj_type": "Reg", "file_name": "PubMed-29621572.json", "snippet": " [CLS] crosstalk between IGF1R and Wnt/\u03b2-catenin signaling pathways [CLS] .\nIGF1R is a ubiquitous receptor tyrosine kinase that plays critical roles in cell proliferation, growth and survival. Clinical studies have demonstrated upregulation of IGF1R mediated signaling in a number"}
{"subject": "IGF1R", "sub_type": "Gene", "rel": "ThemeOf", "object": "crosstalk", "obj_type": "Reg", "file_name": "PubMed-29621572.json", "snippet": " [CLS] crosstalk between IGF1R [CLS]  and Wnt/\u03b2-catenin signaling pathways.\nIGF1R is a ubiquitous receptor tyrosine kinase that plays critical roles in cell proliferation, growth and survival. Clinical studies have demonstrated upregulation of IGF1R mediated"}
{"subject": "GRN", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutation", "obj_type": "Var", "file_name": "PubMed-29653316.json", "snippet": " [CLS] GRN) null mutation [CLS] , originating from a common founder, in multiple Belgian families with frontotemporal dementia. Here, we used data of a 10-year follow-up study to describe in detail the clinical heterogeneity observed"}
{"subject": "mutation", "sub_type": "Var", "rel": "CauseOf", "object": "reported", "obj_type": "Reg", "file_name": "PubMed-29653316.json", "snippet": " [CLS] reported a granulin (GRN) null mutation [CLS] , originating from a common founder, in multiple Belgian families with frontotemporal dementia. Here, we used data of a 10-year follow-up study to describe in detail the clinical heterogeneity observed"}
{"subject": "frontotemporal dementia", "sub_type": "Disease", "rel": "ThemeOf", "object": "reported", "obj_type": "Reg", "file_name": "PubMed-29653316.json", "snippet": " [CLS] reported a granulin (GRN) null mutation, originating from a common founder, in multiple Belgian families with frontotemporal dementia [CLS] . Here, we used data of a 10-year follow-up study to describe in detail the clinical heterogeneity observed in this extended founder pedigree. We identified 85 patients and 40 unaffected"}
{"subject": "MLKL", "sub_type": "Gene", "rel": "ThemeOf", "object": "variant", "obj_type": "Var", "file_name": "PubMed-29656768.json", "snippet": " [CLS] variant in MLKL [CLS]  confers susceptibility to ApoE \u025b4-negative Alzheimer's disease in Hong Kong Chinese population.\nAlzheimer's disease (AD) is the most common neurodegenerative disorders in the elderly. To identify rare genetic factors"}
{"subject": "variant", "sub_type": "Var", "rel": "CauseOf", "object": "susceptibility", "obj_type": "Reg", "file_name": "PubMed-29656768.json", "snippet": " [CLS] variant in MLKL confers susceptibility [CLS]  to ApoE \u025b4-negative Alzheimer's disease in Hong Kong Chinese population.\nAlzheimer's disease (AD) is the most common neurodegenerative disorders in the elderly. To identify rare genetic factors other than"}
{"subject": "Alzheimer's disease", "sub_type": "Disease", "rel": "ThemeOf", "object": "susceptibility", "obj_type": "Reg", "file_name": "PubMed-29656768.json", "snippet": " [CLS] susceptibility to ApoE \u025b4-negative Alzheimer's disease [CLS]  in Hong Kong Chinese population.\nAlzheimer's disease (AD) is the most common neurodegenerative disorders in the elderly. To identify rare genetic factors other than apolipoprotein E \u025b4 allele (ApoE"}
{"subject": "MLKL", "sub_type": "Gene", "rel": "ThemeOf", "object": "p.Q48X", "obj_type": "Var", "file_name": "PubMed-29656768.json", "snippet": " Among the genes involved in immune function, we identified a rare stop-gain variant (p.Q48X) in mixed lineage kinase domain like pseudokinase (MLKL) gene present exclusively in 6 LOAD cases.  [CLS] MLKL is expressed in neurons, and the its expression levels in the p.Q48X [CLS]  carriers were significantly lower than that in age-matched wild-type controls. The ratio of A\u03b242 to A\u03b240 significantly increased in MLKL knockdown cells compared to scramble controls. MLKL loss-of-function mutation"}
{"subject": "p.Q48X", "sub_type": "Var", "rel": "CauseOf", "object": "lower", "obj_type": "NegReg", "file_name": "PubMed-29656768.json", "snippet": " variant (p.Q48X) in mixed lineage kinase domain like pseudokinase (MLKL) gene present exclusively in 6 LOAD cases. MLKL is expressed in neurons, and the its expression levels in the  [CLS] p.Q48X carriers were significantly lower [CLS]  than that in age-matched wild-type controls. The ratio of A\u03b242 to A\u03b240 significantly increased in MLKL knockdown cells compared to scramble controls. MLKL loss-of-function mutation might contribute to late-onset"}
{"subject": "expression levels", "sub_type": "MPA", "rel": "ThemeOf", "object": "lower", "obj_type": "NegReg", "file_name": "PubMed-29656768.json", "snippet": " identified a rare stop-gain variant (p.Q48X) in mixed lineage kinase domain like pseudokinase (MLKL) gene present exclusively in 6 LOAD cases. MLKL is expressed in neurons, and the its  [CLS] expression levels in the p.Q48X carriers were significantly lower [CLS]  than that in age-matched wild-type controls. The ratio of A\u03b242 to A\u03b240 significantly increased in MLKL knockdown cells compared to scramble controls. MLKL loss-of-function mutation might contribute to late-onset"}
{"subject": "MLKL", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutation", "obj_type": "Var", "file_name": "PubMed-29656768.json", "snippet": " in the p.Q48X carriers were significantly lower than that in age-matched wild-type controls. The ratio of A\u03b242 to A\u03b240 significantly increased in MLKL knockdown cells compared to scramble controls.  [CLS] MLKL loss-of-function mutation [CLS]  might contribute to late-onset ApoE \u025b4-negative AD in the Hong Kong Chinese population."}
{"subject": "mutation", "sub_type": "Var", "rel": "CauseOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-29656768.json", "snippet": " the p.Q48X carriers were significantly lower than that in age-matched wild-type controls. The ratio of A\u03b242 to A\u03b240 significantly increased in MLKL knockdown cells compared to scramble controls. MLKL  [CLS] loss-of-function mutation [CLS]  might contribute to late-onset ApoE \u025b4-negative AD in the Hong Kong Chinese population."}
{"subject": "AD", "sub_type": "Disease", "rel": "ThemeOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-29656768.json", "snippet": " the p.Q48X carriers were significantly lower than that in age-matched wild-type controls. The ratio of A\u03b242 to A\u03b240 significantly increased in MLKL knockdown cells compared to scramble controls. MLKL  [CLS] loss-of-function mutation might contribute to late-onset ApoE \u025b4-negative AD [CLS]  in the Hong Kong Chinese population."}
{"subject": "TRPV1", "sub_type": "Gene", "rel": "ThemeOf", "object": "Leu206Stop", "obj_type": "Var", "file_name": "PubMed-29660342.json", "snippet": " in TRPV1 Leu206Stop mice generated by N-ethyl-N-nitrosourea mutagenesis.\nN-ethyl-N-nitrosourea (ENU) random mutagenesis was used to generate a mouse model for the analysis of the transient receptor potential vanilloid 1 ( [CLS] TRPV1) cation channel. A transversion from T\u2192A in exon 4 led to a Leu206Stop [CLS]  mutation generating a loss-of-function mutant. The TRPV1 agonist capsaicin was used to analyze functional and nociceptive parameters in\u00a0vitro and in\u00a0vivo in TRPV1 Leu206Stop mice and congenic C3HeB/FeJ controls. Capsaicin-induced"}
{"subject": "Leu206Stop", "sub_type": "Var", "rel": "CauseOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-29660342.json", "snippet": " used to generate a mouse model for the analysis of the transient receptor potential vanilloid 1 (TRPV1) cation channel. A transversion from T\u2192A in exon 4 led to a  [CLS] Leu206Stop mutation generating a loss-of-function [CLS]  mutant. The TRPV1 agonist capsaicin was used to analyze functional and nociceptive parameters in\u00a0vitro and in\u00a0vivo in TRPV1 Leu206Stop mice and congenic C3HeB/FeJ controls. Capsaicin-induced [Ca2+]i changes in small"}
{"subject": "TRPV1", "sub_type": "Gene", "rel": "ThemeOf", "object": "Leu206Stop", "obj_type": "Var", "file_name": "PubMed-29660342.json", "snippet": " to analyze functional and nociceptive parameters in\u00a0vitro and in\u00a0vivo in TRPV1 Leu206Stop mice and congenic C3HeB/FeJ controls. Capsaicin-induced [Ca2+]i changes in small diameter DRG neurons were significantly diminished in  [CLS] TRPV1 Leu206Stop [CLS]  mice and administration of capsaicin induced neither hypothermia nor nocifensive behaviour in\u00a0vivo. TRPV1 Leu206Stop mice were tested in the spinal nerve ligation of mononeuropathic pain and developed mechanical hypersensitivity"}
{"subject": "Leu206Stop", "sub_type": "Var", "rel": "CauseOf", "object": "diminished", "obj_type": "NegReg", "file_name": "PubMed-29660342.json", "snippet": " was used to analyze functional and nociceptive parameters in\u00a0vitro and in\u00a0vivo in TRPV1 Leu206Stop mice and congenic C3HeB/FeJ controls. Capsaicin-induced [Ca2+]i changes in small diameter DRG neurons were significantly  [CLS] diminished in TRPV1 Leu206Stop [CLS]  mice and administration of capsaicin induced neither hypothermia nor nocifensive behaviour in\u00a0vivo. TRPV1 Leu206Stop mice were tested in the spinal nerve ligation of mononeuropathic pain and developed mechanical hypersensitivity"}
{"subject": "Capsaicin-induced [Ca2+]i", "sub_type": "MPA", "rel": "ThemeOf", "object": "diminished", "obj_type": "NegReg", "file_name": "PubMed-29660342.json", "snippet": " Leu206Stop mutation generating a loss-of-function mutant. The TRPV1 agonist capsaicin was used to analyze functional and nociceptive parameters in\u00a0vitro and in\u00a0vivo in TRPV1 Leu206Stop mice and congenic C3HeB/FeJ controls.  [CLS] Capsaicin-induced [Ca2+]i changes in small diameter DRG neurons were significantly diminished [CLS]  in TRPV1 Leu206Stop mice and administration of capsaicin induced neither hypothermia nor nocifensive behaviour in\u00a0vivo. TRPV1 Leu206Stop mice were tested in the spinal nerve ligation of mononeuropathic pain and"}
{"subject": "DRG neurons", "sub_type": "CPA", "rel": "ThemeOf", "object": "Capsaicin-induced [Ca2+]i", "obj_type": "MPA", "file_name": "PubMed-29660342.json", "snippet": " Leu206Stop mutation generating a loss-of-function mutant. The TRPV1 agonist capsaicin was used to analyze functional and nociceptive parameters in\u00a0vitro and in\u00a0vivo in TRPV1 Leu206Stop mice and congenic C3HeB/FeJ controls.  [CLS] Capsaicin-induced [Ca2+]i changes in small diameter DRG neurons [CLS]  were significantly diminished in TRPV1 Leu206Stop mice and administration of capsaicin induced neither hypothermia nor nocifensive behaviour in\u00a0vivo. TRPV1 Leu206Stop mice were tested in the spinal nerve ligation of"}
{"subject": "TRPV1", "sub_type": "Gene", "rel": "ThemeOf", "object": "Leu206Stop", "obj_type": "Var", "file_name": "PubMed-29660342.json", "snippet": " spinal nerve ligation of mononeuropathic pain and developed mechanical hypersensitivity two weeks after nerve injury. In the open field test, a significant increase in spontaneous locomotion was detected in  [CLS] TRPV1 Leu206Stop [CLS]  mice as compared to wildtype controls. TRPV1 knockout mice have been reported to carry a similar phenotype regarding capsaicin-evoked responses in\u00a0vitro and in\u00a0vivo. However, in contrast to TRPV1 Leu206Stop"}
{"subject": "Leu206Stop", "sub_type": "Var", "rel": "CauseOf", "object": "increase", "obj_type": "PosReg", "file_name": "PubMed-29660342.json", "snippet": " TRPV1 Leu206Stop mice were tested in the spinal nerve ligation of mononeuropathic pain and developed mechanical hypersensitivity two weeks after nerve injury. In the open field test, a significant  [CLS] increase in spontaneous locomotion was detected in TRPV1 Leu206Stop [CLS]  mice as compared to wildtype controls. TRPV1 knockout mice have been reported to carry a similar phenotype regarding capsaicin-evoked responses in\u00a0vitro and in\u00a0vivo. However, in contrast to TRPV1 Leu206Stop"}
{"subject": "spontaneous locomotion", "sub_type": "CPA", "rel": "ThemeOf", "object": "increase", "obj_type": "PosReg", "file_name": "PubMed-29660342.json", "snippet": " TRPV1 Leu206Stop mice were tested in the spinal nerve ligation of mononeuropathic pain and developed mechanical hypersensitivity two weeks after nerve injury. In the open field test, a significant  [CLS] increase in spontaneous locomotion [CLS]  was detected in TRPV1 Leu206Stop mice as compared to wildtype controls. TRPV1 knockout mice have been reported to carry a similar phenotype regarding capsaicin-evoked responses in\u00a0vitro and in\u00a0vivo. However,"}
{"subject": "TP53", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-29666004.json", "snippet": " [CLS] TP53 gain of function mutations [CLS]  in rapidly progressing solid tumors.\nRecent studies are discovering TP53 mutations with gain of function (GOF) properties that promote tumorigenesis via a variety of mechanisms. To our knowledge, all"}
{"subject": "p.P278S", "sub_type": "Var", "rel": "CauseOf", "object": "GOF", "obj_type": "PosReg", "file_name": "PubMed-29666004.json", "snippet": " with pT3 penile squamous cell carcinoma (allele frequencies 19% and 27%). Immunohistochemistry showed nuclear accumulation of p53. The third patient, a 62-year-old female with metastatic lung adenocarcinoma, had allelic  [CLS] p.P278S (GOF [CLS] ) and p.R283L (non-GOF) variants at frequencies of 61% but with null staining for p53. Germline testing for Patient 1 confirmed wildtype TP53. No other variants were discovered among the"}
{"subject": "metastatic lung adenocarcinoma", "sub_type": "Disease", "rel": "ThemeOf", "object": "GOF", "obj_type": "PosReg", "file_name": "PubMed-29666004.json", "snippet": " and 48%) and a 54-year-old with pT3 penile squamous cell carcinoma (allele frequencies 19% and 27%). Immunohistochemistry showed nuclear accumulation of p53. The third patient, a 62-year-old female with  [CLS] metastatic lung adenocarcinoma, had allelic p.P278S (GOF [CLS] ) and p.R283L (non-GOF) variants at frequencies of 61% but with null staining for p53. Germline testing for Patient 1 confirmed wildtype TP53. No other variants were discovered among the"}
{"subject": "p.R283L", "sub_type": "Var", "rel": "CauseOf", "object": "non-GOF", "obj_type": "Reg", "file_name": "PubMed-29666004.json", "snippet": " squamous cell carcinoma (allele frequencies 19% and 27%). Immunohistochemistry showed nuclear accumulation of p53. The third patient, a 62-year-old female with metastatic lung adenocarcinoma, had allelic p.P278S (GOF) and  [CLS] p.R283L (non-GOF [CLS] ) variants at frequencies of 61% but with null staining for p53. Germline testing for Patient 1 confirmed wildtype TP53. No other variants were discovered among the genes tested in"}
{"subject": "metastatic lung adenocarcinoma", "sub_type": "Disease", "rel": "ThemeOf", "object": "non-GOF", "obj_type": "Reg", "file_name": "PubMed-29666004.json", "snippet": " and 48%) and a 54-year-old with pT3 penile squamous cell carcinoma (allele frequencies 19% and 27%). Immunohistochemistry showed nuclear accumulation of p53. The third patient, a 62-year-old female with  [CLS] metastatic lung adenocarcinoma, had allelic p.P278S (GOF) and p.R283L (non-GOF [CLS] ) variants at frequencies of 61% but with null staining for p53. Germline testing for Patient 1 confirmed wildtype TP53. No other variants were discovered among the genes tested in"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "gain of function", "obj_type": "PosReg", "file_name": "PubMed-29666004.json", "snippet": " [CLS] gain of function mutations [CLS]  in rapidly progressing solid tumors.\nRecent studies are discovering TP53 mutations with gain of function (GOF) properties that promote tumorigenesis via a variety of mechanisms. To our knowledge, all"}
{"subject": "rapidly progressing solid tumors", "sub_type": "Disease", "rel": "ThemeOf", "object": "gain of function", "obj_type": "PosReg", "file_name": "PubMed-29666004.json", "snippet": " [CLS] gain of function mutations in rapidly progressing solid tumors [CLS] .\nRecent studies are discovering TP53 mutations with gain of function (GOF) properties that promote tumorigenesis via a variety of mechanisms. To our knowledge, all reported compound mutations are allelic."}
{"subject": "TP53", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-29666004.json", "snippet": " [CLS] TP53 mutations [CLS]  with gain of function (GOF) properties that promote tumorigenesis via a variety of mechanisms. To our knowledge, all reported compound mutations are allelic. We identified two patients with biallelic"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "gain of function", "obj_type": "PosReg", "file_name": "PubMed-29666004.json", "snippet": " [CLS] mutations with gain of function [CLS]  (GOF) properties that promote tumorigenesis via a variety of mechanisms. To our knowledge, all reported compound mutations are allelic. We identified two patients with biallelic GOF TP53 mutations in"}
{"subject": "tumorigenesis", "sub_type": "CPA", "rel": "ThemeOf", "object": "gain of function", "obj_type": "PosReg", "file_name": "PubMed-29666004.json", "snippet": " [CLS] gain of function (GOF) properties that promote tumorigenesis [CLS]  via a variety of mechanisms. To our knowledge, all reported compound mutations are allelic. We identified two patients with biallelic GOF TP53 mutations in their tumors and a third"}
{"subject": "p.R273H", "sub_type": "Var", "rel": "CauseOf", "object": "GOF", "obj_type": "PosReg", "file_name": "PubMed-29666004.json", "snippet": " variants. The correlation with p53 expression was also examined. Genomic DNA was extracted from formalin-fixed, paraffin-embedded tissue and mutational analysis was performed using Ion AmpliSeq\u2122Cancer HotSpot Panel V2. Biallelic  [CLS] GOF mutations (p.R273H [CLS]  and p.R273C) were identified in a 19-year-old male with glioblastoma (allele frequencies 94% and 48%) and a 54-year-old with pT3 penile squamous cell carcinoma (allele frequencies 19% and 27%)."}
{"subject": "p.R273C", "sub_type": "Var", "rel": "CauseOf", "object": "GOF", "obj_type": "PosReg", "file_name": "PubMed-29666004.json", "snippet": " variants. The correlation with p53 expression was also examined. Genomic DNA was extracted from formalin-fixed, paraffin-embedded tissue and mutational analysis was performed using Ion AmpliSeq\u2122Cancer HotSpot Panel V2. Biallelic  [CLS] GOF mutations (p.R273H and p.R273C [CLS] ) were identified in a 19-year-old male with glioblastoma (allele frequencies 94% and 48%) and a 54-year-old with pT3 penile squamous cell carcinoma (allele frequencies 19% and 27%). Immunohistochemistry showed"}
{"subject": "glioblastoma", "sub_type": "Disease", "rel": "ThemeOf", "object": "GOF", "obj_type": "PosReg", "file_name": "PubMed-29666004.json", "snippet": " variants. The correlation with p53 expression was also examined. Genomic DNA was extracted from formalin-fixed, paraffin-embedded tissue and mutational analysis was performed using Ion AmpliSeq\u2122Cancer HotSpot Panel V2. Biallelic  [CLS] GOF mutations (p.R273H and p.R273C) were identified in a 19-year-old male with glioblastoma [CLS]  (allele frequencies 94% and 48%) and a 54-year-old with pT3 penile squamous cell carcinoma (allele frequencies 19% and 27%). Immunohistochemistry showed nuclear accumulation of p53. The third patient, a"}
{"subject": "CDH1", "sub_type": "Gene", "rel": "ThemeOf", "object": "variants", "obj_type": "Var", "file_name": "PubMed-29706558.json", "snippet": " [CLS] variants in the E-cadherin gene (CDH1 [CLS] ) are strongly associated with the development of hereditary diffuse gastric cancer. There is a paucity of data to guide risk assessment and management of families with hereditary diffuse gastric"}
{"subject": "variants", "sub_type": "Var", "rel": "CauseOf", "object": "associated with", "obj_type": "Reg", "file_name": "PubMed-29706558.json", "snippet": " [CLS] variants in the E-cadherin gene (CDH1) are strongly associated with [CLS]  the development of hereditary diffuse gastric cancer. There is a paucity of data to guide risk assessment and management of families with hereditary diffuse gastric cancer that do not"}
{"subject": "hereditary diffuse gastric cancer", "sub_type": "Disease", "rel": "ThemeOf", "object": "associated with", "obj_type": "Reg", "file_name": "PubMed-29706558.json", "snippet": " and other cancer-predisposing genes in families with hereditary diffuse gastric cancer without CDH1 mutation: a whole-exome sequencing study.\nBACKGROUND: Germline pathogenic variants in the E-cadherin gene (CDH1) are strongly  [CLS] associated with the development of hereditary diffuse gastric cancer [CLS] . There is a paucity of data to guide risk assessment and management of families with hereditary diffuse gastric cancer that do not carry a CDH1 pathogenic variant, making it"}
{"subject": "PALB2", "sub_type": "Gene", "rel": "ThemeOf", "object": "frameshift deletion", "obj_type": "Var", "file_name": "PubMed-29706558.json", "snippet": " were identified in probands from six families with hereditary diffuse gastric cancer; variants were found in genes known to predispose to cancer and in lesser-studied DNA repair genes. A  [CLS] frameshift deletion in PALB2 [CLS]  was found in one member of a family with a history of gastric and breast cancer. Two different MSH2 variants were identified in two unrelated affected individuals, including one"}
{"subject": "frameshift deletion", "sub_type": "Var", "rel": "CauseOf", "object": "found", "obj_type": "Reg", "file_name": "PubMed-29706558.json", "snippet": " were identified in probands from six families with hereditary diffuse gastric cancer; variants were found in genes known to predispose to cancer and in lesser-studied DNA repair genes. A  [CLS] frameshift deletion in PALB2 was found [CLS]  in one member of a family with a history of gastric and breast cancer. Two different MSH2 variants were identified in two unrelated affected individuals, including one frameshift insertion"}
{"subject": "gastric", "sub_type": "Disease", "rel": "ThemeOf", "object": "found", "obj_type": "Reg", "file_name": "PubMed-29706558.json", "snippet": " six families with hereditary diffuse gastric cancer; variants were found in genes known to predispose to cancer and in lesser-studied DNA repair genes. A frameshift deletion in PALB2 was  [CLS] found in one member of a family with a history of gastric [CLS]  and breast cancer. Two different MSH2 variants were identified in two unrelated affected individuals, including one frameshift insertion and one previously described start-codon loss. One family had a unique"}
{"subject": "breast cancer", "sub_type": "Disease", "rel": "ThemeOf", "object": "found", "obj_type": "Reg", "file_name": "PubMed-29706558.json", "snippet": " six families with hereditary diffuse gastric cancer; variants were found in genes known to predispose to cancer and in lesser-studied DNA repair genes. A frameshift deletion in PALB2 was  [CLS] found in one member of a family with a history of gastric and breast cancer [CLS] . Two different MSH2 variants were identified in two unrelated affected individuals, including one frameshift insertion and one previously described start-codon loss. One family had a unique combination of variants"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "Loss of function", "obj_type": "NegReg", "file_name": "PubMed-29726959.json", "snippet": " 4 Receptor Pathway Dysfunction in Obesity: Patient Stratification Aimed at MC4R Agonist Treatment.\nContext: The hypothalamic melanocortin 4 receptor (MC4R) pathway serves a critical role in regulating body weight.  [CLS] Loss of function (LoF) mutations [CLS]  in the MC4R pathway, including mutations in the pro-opiomelanocortin (POMC), prohormone convertase 1 (PCSK1), leptin receptor (LEPR), or MC4R genes, have been shown to cause early-onset severe obesity.\nMethods:"}
{"subject": "POMC", "sub_type": "Gene", "rel": "ThemeOf", "object": "MC4R pathway", "obj_type": "Pathway", "file_name": "PubMed-29726959.json", "snippet": " Stratification Aimed at MC4R Agonist Treatment.\nContext: The hypothalamic melanocortin 4 receptor (MC4R) pathway serves a critical role in regulating body weight. Loss of function (LoF) mutations in the  [CLS] MC4R pathway, including mutations in the pro-opiomelanocortin (POMC [CLS] ), prohormone convertase 1 (PCSK1), leptin receptor (LEPR), or MC4R genes, have been shown to cause early-onset severe obesity.\nMethods: Through a comprehensive epidemiological analysis of known and predicted LoF"}
{"subject": "early-onset severe obesity", "sub_type": "Disease", "rel": "ThemeOf", "object": "Loss of function", "obj_type": "NegReg", "file_name": "PubMed-29726959.json", "snippet": " 4 Receptor Pathway Dysfunction in Obesity: Patient Stratification Aimed at MC4R Agonist Treatment.\nContext: The hypothalamic melanocortin 4 receptor (MC4R) pathway serves a critical role in regulating body weight.  [CLS] Loss of function (LoF) mutations in the MC4R pathway, including mutations in the pro-opiomelanocortin (POMC), prohormone convertase 1 (PCSK1), leptin receptor (LEPR), or MC4R genes, have been shown to cause early-onset severe obesity [CLS] .\nMethods: Through a comprehensive epidemiological analysis of known and predicted LoF variants in the POMC, PCSK1, and LEPR genes, we sought to estimate the number of US individuals with"}
{"subject": "PCSK1", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-29726959.json", "snippet": " in Obesity: Patient Stratification Aimed at MC4R Agonist Treatment.\nContext: The hypothalamic melanocortin 4 receptor (MC4R) pathway serves a critical role in regulating body weight. Loss of function (LoF)  [CLS] mutations in the MC4R pathway, including mutations in the pro-opiomelanocortin (POMC), prohormone convertase 1 (PCSK1 [CLS] ), leptin receptor (LEPR), or MC4R genes, have been shown to cause early-onset severe obesity.\nMethods: Through a comprehensive epidemiological analysis of known and predicted LoF variants in the POMC,"}
{"subject": "LEPR", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-29726959.json", "snippet": " in Obesity: Patient Stratification Aimed at MC4R Agonist Treatment.\nContext: The hypothalamic melanocortin 4 receptor (MC4R) pathway serves a critical role in regulating body weight. Loss of function (LoF)  [CLS] mutations in the MC4R pathway, including mutations in the pro-opiomelanocortin (POMC), prohormone convertase 1 (PCSK1), leptin receptor (LEPR [CLS] ), or MC4R genes, have been shown to cause early-onset severe obesity.\nMethods: Through a comprehensive epidemiological analysis of known and predicted LoF variants in the POMC, PCSK1, and LEPR"}
{"subject": "MC4R", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-29726959.json", "snippet": " in Obesity: Patient Stratification Aimed at MC4R Agonist Treatment.\nContext: The hypothalamic melanocortin 4 receptor (MC4R) pathway serves a critical role in regulating body weight. Loss of function (LoF)  [CLS] mutations in the MC4R pathway, including mutations in the pro-opiomelanocortin (POMC), prohormone convertase 1 (PCSK1), leptin receptor (LEPR), or MC4R [CLS]  genes, have been shown to cause early-onset severe obesity.\nMethods: Through a comprehensive epidemiological analysis of known and predicted LoF variants in the POMC, PCSK1, and LEPR genes, we"}
{"subject": "POMC", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-29726959.json", "snippet": " in Obesity: Patient Stratification Aimed at MC4R Agonist Treatment.\nContext: The hypothalamic melanocortin 4 receptor (MC4R) pathway serves a critical role in regulating body weight. Loss of function (LoF)  [CLS] mutations in the MC4R pathway, including mutations in the pro-opiomelanocortin (POMC [CLS] ), prohormone convertase 1 (PCSK1), leptin receptor (LEPR), or MC4R genes, have been shown to cause early-onset severe obesity.\nMethods: Through a comprehensive epidemiological analysis of known and predicted LoF"}
{"subject": "PCSK1", "sub_type": "Gene", "rel": "ThemeOf", "object": "MC4R pathway", "obj_type": "Pathway", "file_name": "PubMed-29726959.json", "snippet": " Stratification Aimed at MC4R Agonist Treatment.\nContext: The hypothalamic melanocortin 4 receptor (MC4R) pathway serves a critical role in regulating body weight. Loss of function (LoF) mutations in the  [CLS] MC4R pathway, including mutations in the pro-opiomelanocortin (POMC), prohormone convertase 1 (PCSK1 [CLS] ), leptin receptor (LEPR), or MC4R genes, have been shown to cause early-onset severe obesity.\nMethods: Through a comprehensive epidemiological analysis of known and predicted LoF variants in the POMC,"}
{"subject": "LEPR", "sub_type": "Gene", "rel": "ThemeOf", "object": "MC4R pathway", "obj_type": "Pathway", "file_name": "PubMed-29726959.json", "snippet": " Stratification Aimed at MC4R Agonist Treatment.\nContext: The hypothalamic melanocortin 4 receptor (MC4R) pathway serves a critical role in regulating body weight. Loss of function (LoF) mutations in the  [CLS] MC4R pathway, including mutations in the pro-opiomelanocortin (POMC), prohormone convertase 1 (PCSK1), leptin receptor (LEPR [CLS] ), or MC4R genes, have been shown to cause early-onset severe obesity.\nMethods: Through a comprehensive epidemiological analysis of known and predicted LoF variants in the POMC, PCSK1, and LEPR"}
{"subject": "MC4R", "sub_type": "Gene", "rel": "ThemeOf", "object": "MC4R pathway", "obj_type": "Pathway", "file_name": "PubMed-29726959.json", "snippet": " Stratification Aimed at MC4R Agonist Treatment.\nContext: The hypothalamic melanocortin 4 receptor (MC4R) pathway serves a critical role in regulating body weight. Loss of function (LoF) mutations in the  [CLS] MC4R pathway, including mutations in the pro-opiomelanocortin (POMC), prohormone convertase 1 (PCSK1), leptin receptor (LEPR), or MC4R [CLS]  genes, have been shown to cause early-onset severe obesity.\nMethods: Through a comprehensive epidemiological analysis of known and predicted LoF variants in the POMC, PCSK1, and LEPR genes, we"}
{"subject": "C11orf70", "sub_type": "Gene", "rel": "ThemeOf", "object": "Mutations", "obj_type": "Var", "file_name": "PubMed-29727693.json", "snippet": " [CLS] Mutations in C11orf70 [CLS]  Cause Primary Ciliary Dyskinesia with Randomization of Left/Right Body Asymmetry Due to Defects of Outer and Inner Dynein Arms.\nPrimary ciliary dyskinesia (PCD) is characterized by chronic airway disease,"}
{"subject": "respiratory cilia", "sub_type": "CPA", "rel": "ThemeOf", "object": "immotility", "obj_type": "CPA", "file_name": "PubMed-29727693.json", "snippet": " loss-of-function mutations in the open-reading frame C11orf70 in PCD individuals from five distinct families. Transmission electron microscopy analyses and high-resolution immunofluorescence microscopy demonstrate that loss-of-function mutations in C11orf70 cause  [CLS] immotility of respiratory cilia [CLS]  and sperm flagella, respectively, as a result of the loss of axonemal outer (ODAs) and inner dynein arms (IDAs), indicating that C11orf70 is involved in cytoplasmic assembly of dynein"}
{"subject": "sperm flagella", "sub_type": "CPA", "rel": "ThemeOf", "object": "immotility", "obj_type": "CPA", "file_name": "PubMed-29727693.json", "snippet": " loss-of-function mutations in the open-reading frame C11orf70 in PCD individuals from five distinct families. Transmission electron microscopy analyses and high-resolution immunofluorescence microscopy demonstrate that loss-of-function mutations in C11orf70 cause  [CLS] immotility of respiratory cilia and sperm flagella [CLS] , respectively, as a result of the loss of axonemal outer (ODAs) and inner dynein arms (IDAs), indicating that C11orf70 is involved in cytoplasmic assembly of dynein arms. Expression analyses"}
{"subject": "axonemal outer", "sub_type": "Protein", "rel": "ThemeOf", "object": "loss", "obj_type": "NegReg", "file_name": "PubMed-29727693.json", "snippet": " families. Transmission electron microscopy analyses and high-resolution immunofluorescence microscopy demonstrate that loss-of-function mutations in C11orf70 cause immotility of respiratory cilia and sperm flagella, respectively, as a result of the  [CLS] loss of axonemal outer [CLS]  (ODAs) and inner dynein arms (IDAs), indicating that C11orf70 is involved in cytoplasmic assembly of dynein arms. Expression analyses of C11orf70 showed that C11orf70 is expressed in ciliated respiratory"}
{"subject": "inner dynein arms", "sub_type": "Protein", "rel": "ThemeOf", "object": "loss", "obj_type": "NegReg", "file_name": "PubMed-29727693.json", "snippet": " families. Transmission electron microscopy analyses and high-resolution immunofluorescence microscopy demonstrate that loss-of-function mutations in C11orf70 cause immotility of respiratory cilia and sperm flagella, respectively, as a result of the  [CLS] loss of axonemal outer (ODAs) and inner dynein arms [CLS]  (IDAs), indicating that C11orf70 is involved in cytoplasmic assembly of dynein arms. Expression analyses of C11orf70 showed that C11orf70 is expressed in ciliated respiratory cells and that the expression"}
{"subject": "loss", "sub_type": "NegReg", "rel": "CauseOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-29727693.json", "snippet": " and sperm flagella. We identified loss-of-function mutations in the open-reading frame C11orf70 in PCD individuals from five distinct families. Transmission electron microscopy analyses and high-resolution immunofluorescence microscopy demonstrate that  [CLS] loss-of-function mutations in C11orf70 cause immotility of respiratory cilia and sperm flagella, respectively, as a result of the loss [CLS]  of axonemal outer (ODAs) and inner dynein arms (IDAs), indicating that C11orf70 is involved in cytoplasmic assembly of dynein arms. Expression analyses of C11orf70 showed that C11orf70 is expressed"}
{"subject": "mutations", "sub_type": "Var", "rel": "ThemeOf", "object": "loss", "obj_type": "NegReg", "file_name": "PubMed-29727693.json", "snippet": " sperm flagella. We identified loss-of-function mutations in the open-reading frame C11orf70 in PCD individuals from five distinct families. Transmission electron microscopy analyses and high-resolution immunofluorescence microscopy demonstrate that loss-of-function  [CLS] mutations in C11orf70 cause immotility of respiratory cilia and sperm flagella, respectively, as a result of the loss [CLS]  of axonemal outer (ODAs) and inner dynein arms (IDAs), indicating that C11orf70 is involved in cytoplasmic assembly of dynein arms. Expression analyses of C11orf70 showed that C11orf70 is expressed"}
{"subject": "Primary Ciliary Dyskinesia", "sub_type": "Disease", "rel": "ThemeOf", "object": "Cause", "obj_type": "Reg", "file_name": "PubMed-29727693.json", "snippet": " [CLS] Cause Primary Ciliary Dyskinesia [CLS]  with Randomization of Left/Right Body Asymmetry Due to Defects of Outer and Inner Dynein Arms.\nPrimary ciliary dyskinesia (PCD) is characterized by chronic airway disease, male infertility, and randomization"}
{"subject": "Mutations", "sub_type": "Var", "rel": "CauseOf", "object": "Defects", "obj_type": "NegReg", "file_name": "PubMed-29727693.json", "snippet": " [CLS] Mutations in C11orf70 Cause Primary Ciliary Dyskinesia with Randomization of Left/Right Body Asymmetry Due to Defects [CLS]  of Outer and Inner Dynein Arms.\nPrimary ciliary dyskinesia (PCD) is characterized by chronic airway disease, male infertility, and randomization of the left/right body axis as a result of"}
{"subject": "Outer and Inner Dynein Arms", "sub_type": "Protein", "rel": "ThemeOf", "object": "Defects", "obj_type": "NegReg", "file_name": "PubMed-29727693.json", "snippet": " [CLS] Defects of Outer and Inner Dynein Arms [CLS] .\nPrimary ciliary dyskinesia (PCD) is characterized by chronic airway disease, male infertility, and randomization of the left/right body axis as a result of defects of motile cilia and sperm"}
{"subject": "Defects", "sub_type": "NegReg", "rel": "CauseOf", "object": "Cause", "obj_type": "Reg", "file_name": "PubMed-29727693.json", "snippet": " [CLS] Cause Primary Ciliary Dyskinesia with Randomization of Left/Right Body Asymmetry Due to Defects [CLS]  of Outer and Inner Dynein Arms.\nPrimary ciliary dyskinesia (PCD) is characterized by chronic airway disease, male infertility, and randomization of the left/right body axis as a result of"}
{"subject": "C11orf70", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-29727693.json", "snippet": " sperm flagella. We identified loss-of-function mutations in the open-reading frame C11orf70 in PCD individuals from five distinct families. Transmission electron microscopy analyses and high-resolution immunofluorescence microscopy demonstrate that loss-of-function  [CLS] mutations in C11orf70 [CLS]  cause immotility of respiratory cilia and sperm flagella, respectively, as a result of the loss of axonemal outer (ODAs) and inner dynein arms (IDAs), indicating that C11orf70 is involved"}
{"subject": "immotility", "sub_type": "CPA", "rel": "ThemeOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-29727693.json", "snippet": " and sperm flagella. We identified loss-of-function mutations in the open-reading frame C11orf70 in PCD individuals from five distinct families. Transmission electron microscopy analyses and high-resolution immunofluorescence microscopy demonstrate that  [CLS] loss-of-function mutations in C11orf70 cause immotility [CLS]  of respiratory cilia and sperm flagella, respectively, as a result of the loss of axonemal outer (ODAs) and inner dynein arms (IDAs), indicating that C11orf70 is involved in cytoplasmic"}
{"subject": "MAP1B", "sub_type": "Gene", "rel": "ThemeOf", "object": "variants", "obj_type": "Var", "file_name": "PubMed-29738522.json", "snippet": " [CLS] variants in MAP1B [CLS]  in periventricular nodular heterotopia.\nPeriventricular nodular heterotopia (PVNH) is a malformation of cortical development commonly associated with epilepsy. We exome sequenced 202 individuals with sporadic PVNH to identify novel"}
{"subject": "MAP1B", "sub_type": "Gene", "rel": "ThemeOf", "object": "variants", "obj_type": "Var", "file_name": "PubMed-29738522.json", "snippet": " genes yet to be associated with the condition. Using a gene-level collapsing analysis comparing cases and controls, we identified a genome-wide significant signal driven by four ultra-rare loss-of-function heterozygous  [CLS] variants in MAP1B [CLS] , including one de novo variant. In at least one instance, the MAP1B variant was inherited from a parent with previously undiagnosed PVNH. The PVNH was frontally predominant and associated"}
{"subject": "variants", "sub_type": "Var", "rel": "CauseOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-29738522.json", "snippet": " alleles in genes yet to be associated with the condition. Using a gene-level collapsing analysis comparing cases and controls, we identified a genome-wide significant signal driven by four ultra-rare  [CLS] loss-of-function heterozygous variants [CLS]  in MAP1B, including one de novo variant. In at least one instance, the MAP1B variant was inherited from a parent with previously undiagnosed PVNH. The PVNH was frontally predominant"}
{"subject": "MAP1B", "sub_type": "Gene", "rel": "ThemeOf", "object": "variant", "obj_type": "Var", "file_name": "PubMed-29738522.json", "snippet": " cases and controls, we identified a genome-wide significant signal driven by four ultra-rare loss-of-function heterozygous variants in MAP1B, including one de novo variant. In at least one instance, the  [CLS] MAP1B variant [CLS]  was inherited from a parent with previously undiagnosed PVNH. The PVNH was frontally predominant and associated with perisylvian polymicrogyria. These results implicate MAP1B in PVNH. More broadly, our findings"}
{"subject": "variant", "sub_type": "Var", "rel": "CauseOf", "object": "inherited from", "obj_type": "Reg", "file_name": "PubMed-29738522.json", "snippet": " and controls, we identified a genome-wide significant signal driven by four ultra-rare loss-of-function heterozygous variants in MAP1B, including one de novo variant. In at least one instance, the MAP1B  [CLS] variant was inherited from [CLS]  a parent with previously undiagnosed PVNH. The PVNH was frontally predominant and associated with perisylvian polymicrogyria. These results implicate MAP1B in PVNH. More broadly, our findings suggest that detrimental"}
{"subject": "PVNH", "sub_type": "Disease", "rel": "ThemeOf", "object": "inherited from", "obj_type": "Reg", "file_name": "PubMed-29738522.json", "snippet": " we identified a genome-wide significant signal driven by four ultra-rare loss-of-function heterozygous variants in MAP1B, including one de novo variant. In at least one instance, the MAP1B variant was  [CLS] inherited from a parent with previously undiagnosed PVNH [CLS] . The PVNH was frontally predominant and associated with perisylvian polymicrogyria. These results implicate MAP1B in PVNH. More broadly, our findings suggest that detrimental mutations likely arising in immediately preceding"}
{"subject": "variant", "sub_type": "Var", "rel": "CauseOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-29844158.json", "snippet": " [CLS] gain-of-function variant [CLS]  in Alzheimer's disease displays enhanced catalysis by a mechanism that evades down-regulation.\nConventional protein kinase C (PKC) family members are reversibly activated by binding to the second messengers Ca2+"}
{"subject": "signaling", "sub_type": "MPA", "rel": "ThemeOf", "object": "enhances", "obj_type": "PosReg", "file_name": "PubMed-29844158.json", "snippet": " protein destabilization, is one of many mechanisms by which PKC function is lost in cancer. Here, we address how a gain-of-function germline mutation in PKC\u03b1 in Alzheimer's disease (AD)  [CLS] enhances signaling [CLS]  without increasing vulnerability to down-regulation. Biochemical analyses of purified protein demonstrate that this mutation results in an \u223c30% increase in the catalytic rate of the activated enzyme, with no"}
{"subject": "mutation", "sub_type": "Var", "rel": "CauseOf", "object": "increase", "obj_type": "PosReg", "file_name": "PubMed-29844158.json", "snippet": " Here, we address how a gain-of-function germline mutation in PKC\u03b1 in Alzheimer's disease (AD) enhances signaling without increasing vulnerability to down-regulation. Biochemical analyses of purified protein demonstrate that this  [CLS] mutation results in an \u223c30% increase [CLS]  in the catalytic rate of the activated enzyme, with no changes in the concentrations of Ca2+ or lipid required for half-maximal activation. Molecular dynamics simulations reveal that this mutation"}
{"subject": "catalytic", "sub_type": "MPA", "rel": "ThemeOf", "object": "increase", "obj_type": "PosReg", "file_name": "PubMed-29844158.json", "snippet": " gain-of-function germline mutation in PKC\u03b1 in Alzheimer's disease (AD) enhances signaling without increasing vulnerability to down-regulation. Biochemical analyses of purified protein demonstrate that this mutation results in an \u223c30%  [CLS] increase in the catalytic [CLS]  rate of the activated enzyme, with no changes in the concentrations of Ca2+ or lipid required for half-maximal activation. Molecular dynamics simulations reveal that this mutation has both localized"}
{"subject": "mutation", "sub_type": "Var", "rel": "CauseOf", "object": "decreasing", "obj_type": "NegReg", "file_name": "PubMed-29844158.json", "snippet": " increase in the catalytic rate of the activated enzyme, with no changes in the concentrations of Ca2+ or lipid required for half-maximal activation. Molecular dynamics simulations reveal that this  [CLS] mutation has both localized and allosteric effects, most notably decreasing [CLS]  the dynamics of the C-helix, a key determinant in the catalytic turnover of kinases. Consistent with this mutation not altering autoinhibitory constraints, live-cell imaging studies reveal that the basal"}
{"subject": "dynamics of the C-helix", "sub_type": "MPA", "rel": "ThemeOf", "object": "decreasing", "obj_type": "NegReg", "file_name": "PubMed-29844158.json", "snippet": " with no changes in the concentrations of Ca2+ or lipid required for half-maximal activation. Molecular dynamics simulations reveal that this mutation has both localized and allosteric effects, most notably  [CLS] decreasing the dynamics of the C-helix [CLS] , a key determinant in the catalytic turnover of kinases. Consistent with this mutation not altering autoinhibitory constraints, live-cell imaging studies reveal that the basal signaling output of PKC\u03b1-M489V is"}
{"subject": "enzyme", "sub_type": "Enzyme", "rel": "ThemeOf", "object": "mutant", "obj_type": "Var", "file_name": "PubMed-29844158.json", "snippet": " in the catalytic turnover of kinases. Consistent with this mutation not altering autoinhibitory constraints, live-cell imaging studies reveal that the basal signaling output of PKC\u03b1-M489V is unchanged. However, the  [CLS] mutant enzyme [CLS]  in cells displays increased sensitivity to an inhibitor that is ineffective toward scaffolded PKC, suggesting the altered dynamics of the kinase domain may influence protein interactions. Finally, we show"}
{"subject": "mutant", "sub_type": "Var", "rel": "CauseOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-29844158.json", "snippet": " in the catalytic turnover of kinases. Consistent with this mutation not altering autoinhibitory constraints, live-cell imaging studies reveal that the basal signaling output of PKC\u03b1-M489V is unchanged. However, the  [CLS] mutant enzyme in cells displays increased [CLS]  sensitivity to an inhibitor that is ineffective toward scaffolded PKC, suggesting the altered dynamics of the kinase domain may influence protein interactions. Finally, we show that phosphorylation of a"}
{"subject": "sensitivity", "sub_type": "MPA", "rel": "ThemeOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-29844158.json", "snippet": " kinases. Consistent with this mutation not altering autoinhibitory constraints, live-cell imaging studies reveal that the basal signaling output of PKC\u03b1-M489V is unchanged. However, the mutant enzyme in cells displays  [CLS] increased sensitivity [CLS]  to an inhibitor that is ineffective toward scaffolded PKC, suggesting the altered dynamics of the kinase domain may influence protein interactions. Finally, we show that phosphorylation of a key"}
{"subject": "protein", "sub_type": "Protein", "rel": "ThemeOf", "object": "interactions", "obj_type": "Interaction", "file_name": "PubMed-29844158.json", "snippet": " unchanged. However, the mutant enzyme in cells displays increased sensitivity to an inhibitor that is ineffective toward scaffolded PKC, suggesting the altered dynamics of the kinase domain may influence  [CLS] protein interactions [CLS] . Finally, we show that phosphorylation of a key PKC substrate, myristoylated alanine-rich C-kinase substrate, is increased in brains of CRISPR-Cas9 genome-edited mice containing the PKC\u03b1-M489V mutation. Our results unveil"}
{"subject": "interactions", "sub_type": "Interaction", "rel": "ThemeOf", "object": "influence", "obj_type": "Reg", "file_name": "PubMed-29844158.json", "snippet": " is unchanged. However, the mutant enzyme in cells displays increased sensitivity to an inhibitor that is ineffective toward scaffolded PKC, suggesting the altered dynamics of the kinase domain may  [CLS] influence protein interactions [CLS] . Finally, we show that phosphorylation of a key PKC substrate, myristoylated alanine-rich C-kinase substrate, is increased in brains of CRISPR-Cas9 genome-edited mice containing the PKC\u03b1-M489V mutation. Our results unveil"}
{"subject": "Alzheimer's disease", "sub_type": "Disease", "rel": "ThemeOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-29844158.json", "snippet": " [CLS] gain-of-function variant in Alzheimer's disease [CLS]  displays enhanced catalysis by a mechanism that evades down-regulation.\nConventional protein kinase C (PKC) family members are reversibly activated by binding to the second messengers Ca2+ and diacylglycerol, events"}
{"subject": "increased", "sub_type": "PosReg", "rel": "CauseOf", "object": "influence", "obj_type": "Reg", "file_name": "PubMed-29844158.json", "snippet": " kinases. Consistent with this mutation not altering autoinhibitory constraints, live-cell imaging studies reveal that the basal signaling output of PKC\u03b1-M489V is unchanged. However, the mutant enzyme in cells displays  [CLS] increased sensitivity to an inhibitor that is ineffective toward scaffolded PKC, suggesting the altered dynamics of the kinase domain may influence [CLS]  protein interactions. Finally, we show that phosphorylation of a key PKC substrate, myristoylated alanine-rich C-kinase substrate, is increased in brains of CRISPR-Cas9 genome-edited mice containing the PKC\u03b1-M489V mutation. Our"}
{"subject": "PKC\u03b1", "sub_type": "Enzyme", "rel": "ThemeOf", "object": "M489V mutation", "obj_type": "Var", "file_name": "PubMed-29844158.json", "snippet": " domain may influence protein interactions. Finally, we show that phosphorylation of a key PKC substrate, myristoylated alanine-rich C-kinase substrate, is increased in brains of CRISPR-Cas9 genome-edited mice containing the  [CLS] PKC\u03b1-M489V mutation [CLS] . Our results unveil how an AD-associated mutation in PKC\u03b1 permits enhanced agonist-dependent signaling via a mechanism that evades the cell's homeostatic down-regulation of constitutively active PKC\u03b1."}
{"subject": "M489V mutation", "sub_type": "Var", "rel": "CauseOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-29844158.json", "snippet": " scaffolded PKC, suggesting the altered dynamics of the kinase domain may influence protein interactions. Finally, we show that phosphorylation of a key PKC substrate, myristoylated alanine-rich C-kinase substrate, is  [CLS] increased in brains of CRISPR-Cas9 genome-edited mice containing the PKC\u03b1-M489V mutation [CLS] . Our results unveil how an AD-associated mutation in PKC\u03b1 permits enhanced agonist-dependent signaling via a mechanism that evades the cell's homeostatic down-regulation of constitutively active PKC\u03b1."}
{"subject": "phosphorylation", "sub_type": "MPA", "rel": "ThemeOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-29844158.json", "snippet": " cells displays increased sensitivity to an inhibitor that is ineffective toward scaffolded PKC, suggesting the altered dynamics of the kinase domain may influence protein interactions. Finally, we show that  [CLS] phosphorylation of a key PKC substrate, myristoylated alanine-rich C-kinase substrate, is increased [CLS]  in brains of CRISPR-Cas9 genome-edited mice containing the PKC\u03b1-M489V mutation. Our results unveil how an AD-associated mutation in PKC\u03b1 permits enhanced agonist-dependent signaling via a mechanism that evades the"}
{"subject": "myristoylated alanine-rich C-kinase substrate", "sub_type": "MPA", "rel": "ThemeOf", "object": "phosphorylation", "obj_type": "MPA", "file_name": "PubMed-29844158.json", "snippet": " cells displays increased sensitivity to an inhibitor that is ineffective toward scaffolded PKC, suggesting the altered dynamics of the kinase domain may influence protein interactions. Finally, we show that  [CLS] phosphorylation of a key PKC substrate, myristoylated alanine-rich C-kinase substrate [CLS] , is increased in brains of CRISPR-Cas9 genome-edited mice containing the PKC\u03b1-M489V mutation. Our results unveil how an AD-associated mutation in PKC\u03b1 permits enhanced agonist-dependent signaling via a mechanism that"}
{"subject": "mutation", "sub_type": "Var", "rel": "CauseOf", "object": "associated", "obj_type": "Reg", "file_name": "PubMed-29844158.json", "snippet": " show that phosphorylation of a key PKC substrate, myristoylated alanine-rich C-kinase substrate, is increased in brains of CRISPR-Cas9 genome-edited mice containing the PKC\u03b1-M489V mutation. Our results unveil how an AD- [CLS] associated mutation [CLS]  in PKC\u03b1 permits enhanced agonist-dependent signaling via a mechanism that evades the cell's homeostatic down-regulation of constitutively active PKC\u03b1."}
{"subject": "AD", "sub_type": "Disease", "rel": "ThemeOf", "object": "associated", "obj_type": "Reg", "file_name": "PubMed-29844158.json", "snippet": " show that phosphorylation of a key PKC substrate, myristoylated alanine-rich C-kinase substrate, is increased in brains of CRISPR-Cas9 genome-edited mice containing the PKC\u03b1-M489V mutation. Our results unveil how an  [CLS] AD-associated [CLS]  mutation in PKC\u03b1 permits enhanced agonist-dependent signaling via a mechanism that evades the cell's homeostatic down-regulation of constitutively active PKC\u03b1."}
{"subject": "PKC\u03b1", "sub_type": "Enzyme", "rel": "ThemeOf", "object": "mutation", "obj_type": "Var", "file_name": "PubMed-29844158.json", "snippet": " that phosphorylation of a key PKC substrate, myristoylated alanine-rich C-kinase substrate, is increased in brains of CRISPR-Cas9 genome-edited mice containing the PKC\u03b1-M489V mutation. Our results unveil how an AD-associated  [CLS] mutation in PKC\u03b1 [CLS]  permits enhanced agonist-dependent signaling via a mechanism that evades the cell's homeostatic down-regulation of constitutively active PKC\u03b1."}
{"subject": "mutation", "sub_type": "Var", "rel": "CauseOf", "object": "evades", "obj_type": "NegReg", "file_name": "PubMed-29844158.json", "snippet": " that phosphorylation of a key PKC substrate, myristoylated alanine-rich C-kinase substrate, is increased in brains of CRISPR-Cas9 genome-edited mice containing the PKC\u03b1-M489V mutation. Our results unveil how an AD-associated  [CLS] mutation in PKC\u03b1 permits enhanced agonist-dependent signaling via a mechanism that evades [CLS]  the cell's homeostatic down-regulation of constitutively active PKC\u03b1."}
{"subject": "homeostatic down-regulation", "sub_type": "MPA", "rel": "ThemeOf", "object": "evades", "obj_type": "NegReg", "file_name": "PubMed-29844158.json", "snippet": " is increased in brains of CRISPR-Cas9 genome-edited mice containing the PKC\u03b1-M489V mutation. Our results unveil how an AD-associated mutation in PKC\u03b1 permits enhanced agonist-dependent signaling via a mechanism that  [CLS] evades the cell's homeostatic down-regulation [CLS]  of constitutively active PKC\u03b1."}
{"subject": "Protein kinase C\u03b1", "sub_type": "Enzyme", "rel": "ThemeOf", "object": "variant", "obj_type": "Var", "file_name": "PubMed-29844158.json", "snippet": " [CLS] Protein kinase C\u03b1 gain-of-function variant [CLS]  in Alzheimer's disease displays enhanced catalysis by a mechanism that evades down-regulation.\nConventional protein kinase C (PKC) family members are reversibly activated by binding to the second messengers Ca2+"}
{"subject": "constitutively active PKC\u03b1", "sub_type": "Enzyme", "rel": "ThemeOf", "object": "homeostatic down-regulation", "obj_type": "MPA", "file_name": "PubMed-29844158.json", "snippet": " brains of CRISPR-Cas9 genome-edited mice containing the PKC\u03b1-M489V mutation. Our results unveil how an AD-associated mutation in PKC\u03b1 permits enhanced agonist-dependent signaling via a mechanism that evades the cell's  [CLS] homeostatic down-regulation of constitutively active PKC\u03b1 [CLS] ."}
{"subject": "evades", "sub_type": "NegReg", "rel": "CauseOf", "object": "enhanced", "obj_type": "PosReg", "file_name": "PubMed-29844158.json", "snippet": " key PKC substrate, myristoylated alanine-rich C-kinase substrate, is increased in brains of CRISPR-Cas9 genome-edited mice containing the PKC\u03b1-M489V mutation. Our results unveil how an AD-associated mutation in PKC\u03b1 permits  [CLS] enhanced agonist-dependent signaling via a mechanism that evades [CLS]  the cell's homeostatic down-regulation of constitutively active PKC\u03b1."}
{"subject": "agonist-dependent signaling", "sub_type": "MPA", "rel": "ThemeOf", "object": "enhanced", "obj_type": "PosReg", "file_name": "PubMed-29844158.json", "snippet": " key PKC substrate, myristoylated alanine-rich C-kinase substrate, is increased in brains of CRISPR-Cas9 genome-edited mice containing the PKC\u03b1-M489V mutation. Our results unveil how an AD-associated mutation in PKC\u03b1 permits  [CLS] enhanced agonist-dependent signaling [CLS]  via a mechanism that evades the cell's homeostatic down-regulation of constitutively active PKC\u03b1."}
{"subject": "variant", "sub_type": "Var", "rel": "CauseOf", "object": "enhanced", "obj_type": "PosReg", "file_name": "PubMed-29844158.json", "snippet": " [CLS] variant in Alzheimer's disease displays enhanced [CLS]  catalysis by a mechanism that evades down-regulation.\nConventional protein kinase C (PKC) family members are reversibly activated by binding to the second messengers Ca2+ and diacylglycerol, events that break"}
{"subject": "catalysis", "sub_type": "MPA", "rel": "ThemeOf", "object": "enhanced", "obj_type": "PosReg", "file_name": "PubMed-29844158.json", "snippet": " [CLS] enhanced catalysis [CLS]  by a mechanism that evades down-regulation.\nConventional protein kinase C (PKC) family members are reversibly activated by binding to the second messengers Ca2+ and diacylglycerol, events that break autoinhibitory"}
{"subject": "germline mutation", "sub_type": "Var", "rel": "CauseOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-29844158.json", "snippet": " but degradation-sensitive, conformation. Perturbing these autoinhibitory constraints, resulting in protein destabilization, is one of many mechanisms by which PKC function is lost in cancer. Here, we address how a  [CLS] gain-of-function germline mutation [CLS]  in PKC\u03b1 in Alzheimer's disease (AD) enhances signaling without increasing vulnerability to down-regulation. Biochemical analyses of purified protein demonstrate that this mutation results in an \u223c30% increase in the"}
{"subject": "PKC\u03b1", "sub_type": "Enzyme", "rel": "ThemeOf", "object": "germline mutation", "obj_type": "Var", "file_name": "PubMed-29844158.json", "snippet": " degradation-sensitive, conformation. Perturbing these autoinhibitory constraints, resulting in protein destabilization, is one of many mechanisms by which PKC function is lost in cancer. Here, we address how a gain-of-function  [CLS] germline mutation in PKC\u03b1 [CLS]  in Alzheimer's disease (AD) enhances signaling without increasing vulnerability to down-regulation. Biochemical analyses of purified protein demonstrate that this mutation results in an \u223c30% increase in the catalytic rate"}
{"subject": "Alzheimer's disease", "sub_type": "Disease", "rel": "ThemeOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-29844158.json", "snippet": " but degradation-sensitive, conformation. Perturbing these autoinhibitory constraints, resulting in protein destabilization, is one of many mechanisms by which PKC function is lost in cancer. Here, we address how a  [CLS] gain-of-function germline mutation in PKC\u03b1 in Alzheimer's disease [CLS]  (AD) enhances signaling without increasing vulnerability to down-regulation. Biochemical analyses of purified protein demonstrate that this mutation results in an \u223c30% increase in the catalytic rate of the activated"}
{"subject": "gain-of-function", "sub_type": "PosReg", "rel": "CauseOf", "object": "enhances", "obj_type": "PosReg", "file_name": "PubMed-29844158.json", "snippet": " but degradation-sensitive, conformation. Perturbing these autoinhibitory constraints, resulting in protein destabilization, is one of many mechanisms by which PKC function is lost in cancer. Here, we address how a  [CLS] gain-of-function germline mutation in PKC\u03b1 in Alzheimer's disease (AD) enhances [CLS]  signaling without increasing vulnerability to down-regulation. Biochemical analyses of purified protein demonstrate that this mutation results in an \u223c30% increase in the catalytic rate of the activated enzyme, with"}
{"subject": "KCNJ6", "sub_type": "Gene", "rel": "ThemeOf", "object": "Mutation", "obj_type": "Var", "file_name": "PubMed-29852244.json", "snippet": " [CLS] KCNJ6 Mutation [CLS]  in a Severe Hyperkinetic Movement Disorder Phenotype.\nHere, we describe a fourth case of a human with a de novo KCNJ6 (GIRK2) mutation, who presented with clinical findings of"}
{"subject": "GIRK2", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutant", "obj_type": "Var", "file_name": "PubMed-29852244.json", "snippet": " novo variant in the KCNJ6 (c.512T>G, p.Leu171Arg). We conducted in vitro functional studies to determine if this Leu-to-Arg mutation alters the function of GIRK2 channels. Heterologous expression of the  [CLS] mutant GIRK2 [CLS]  channel alone produced an aberrant basal inward current that lacked G protein activation, lost K+ selectivity and gained Ca2+ permeability. Notably, the inward current was inhibited by the Na+"}
{"subject": "mutant", "sub_type": "Var", "rel": "CauseOf", "object": "produced", "obj_type": "PosReg", "file_name": "PubMed-29852244.json", "snippet": " novo variant in the KCNJ6 (c.512T>G, p.Leu171Arg). We conducted in vitro functional studies to determine if this Leu-to-Arg mutation alters the function of GIRK2 channels. Heterologous expression of the  [CLS] mutant GIRK2 channel alone produced [CLS]  an aberrant basal inward current that lacked G protein activation, lost K+ selectivity and gained Ca2+ permeability. Notably, the inward current was inhibited by the Na+ channel blocker QX-314,"}
{"subject": "basal inward current", "sub_type": "MPA", "rel": "ThemeOf", "object": "produced", "obj_type": "PosReg", "file_name": "PubMed-29852244.json", "snippet": " KCNJ6 (c.512T>G, p.Leu171Arg). We conducted in vitro functional studies to determine if this Leu-to-Arg mutation alters the function of GIRK2 channels. Heterologous expression of the mutant GIRK2 channel alone  [CLS] produced an aberrant basal inward current [CLS]  that lacked G protein activation, lost K+ selectivity and gained Ca2+ permeability. Notably, the inward current was inhibited by the Na+ channel blocker QX-314, similar to the previously reported"}
{"subject": "produced", "sub_type": "PosReg", "rel": "CauseOf", "object": "lacked", "obj_type": "NegReg", "file_name": "PubMed-29852244.json", "snippet": " KCNJ6 (c.512T>G, p.Leu171Arg). We conducted in vitro functional studies to determine if this Leu-to-Arg mutation alters the function of GIRK2 channels. Heterologous expression of the mutant GIRK2 channel alone  [CLS] produced an aberrant basal inward current that lacked [CLS]  G protein activation, lost K+ selectivity and gained Ca2+ permeability. Notably, the inward current was inhibited by the Na+ channel blocker QX-314, similar to the previously reported weaver mutation"}
{"subject": "G protein", "sub_type": "Protein", "rel": "ThemeOf", "object": "activation", "obj_type": "MPA", "file_name": "PubMed-29852244.json", "snippet": " studies to determine if this Leu-to-Arg mutation alters the function of GIRK2 channels. Heterologous expression of the mutant GIRK2 channel alone produced an aberrant basal inward current that lacked  [CLS] G protein activation [CLS] , lost K+ selectivity and gained Ca2+ permeability. Notably, the inward current was inhibited by the Na+ channel blocker QX-314, similar to the previously reported weaver mutation in murine GIRK2."}
{"subject": "activation", "sub_type": "MPA", "rel": "ThemeOf", "object": "lacked", "obj_type": "NegReg", "file_name": "PubMed-29852244.json", "snippet": " functional studies to determine if this Leu-to-Arg mutation alters the function of GIRK2 channels. Heterologous expression of the mutant GIRK2 channel alone produced an aberrant basal inward current that  [CLS] lacked G protein activation [CLS] , lost K+ selectivity and gained Ca2+ permeability. Notably, the inward current was inhibited by the Na+ channel blocker QX-314, similar to the previously reported weaver mutation in murine GIRK2."}
{"subject": "produced", "sub_type": "PosReg", "rel": "CauseOf", "object": "lost", "obj_type": "NegReg", "file_name": "PubMed-29852244.json", "snippet": " KCNJ6 (c.512T>G, p.Leu171Arg). We conducted in vitro functional studies to determine if this Leu-to-Arg mutation alters the function of GIRK2 channels. Heterologous expression of the mutant GIRK2 channel alone  [CLS] produced an aberrant basal inward current that lacked G protein activation, lost [CLS]  K+ selectivity and gained Ca2+ permeability. Notably, the inward current was inhibited by the Na+ channel blocker QX-314, similar to the previously reported weaver mutation in murine GIRK2. Expression"}
{"subject": "K+ selectivity", "sub_type": "MPA", "rel": "ThemeOf", "object": "lost", "obj_type": "NegReg", "file_name": "PubMed-29852244.json", "snippet": " if this Leu-to-Arg mutation alters the function of GIRK2 channels. Heterologous expression of the mutant GIRK2 channel alone produced an aberrant basal inward current that lacked G protein activation,  [CLS] lost K+ selectivity [CLS]  and gained Ca2+ permeability. Notably, the inward current was inhibited by the Na+ channel blocker QX-314, similar to the previously reported weaver mutation in murine GIRK2. Expression of a"}
{"subject": "produced", "sub_type": "PosReg", "rel": "CauseOf", "object": "gained", "obj_type": "PosReg", "file_name": "PubMed-29852244.json", "snippet": " KCNJ6 (c.512T>G, p.Leu171Arg). We conducted in vitro functional studies to determine if this Leu-to-Arg mutation alters the function of GIRK2 channels. Heterologous expression of the mutant GIRK2 channel alone  [CLS] produced an aberrant basal inward current that lacked G protein activation, lost K+ selectivity and gained [CLS]  Ca2+ permeability. Notably, the inward current was inhibited by the Na+ channel blocker QX-314, similar to the previously reported weaver mutation in murine GIRK2. Expression of a tandem dimer"}
{"subject": "Ca2+ permeability", "sub_type": "MPA", "rel": "ThemeOf", "object": "gained", "obj_type": "PosReg", "file_name": "PubMed-29852244.json", "snippet": " alters the function of GIRK2 channels. Heterologous expression of the mutant GIRK2 channel alone produced an aberrant basal inward current that lacked G protein activation, lost K+ selectivity and  [CLS] gained Ca2+ permeability [CLS] . Notably, the inward current was inhibited by the Na+ channel blocker QX-314, similar to the previously reported weaver mutation in murine GIRK2. Expression of a tandem dimer containing GIRK1"}
{"subject": "Mutation", "sub_type": "Var", "rel": "CauseOf", "object": "Gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-29852244.json", "snippet": " [CLS] Gain-of-function KCNJ6 Mutation [CLS]  in a Severe Hyperkinetic Movement Disorder Phenotype.\nHere, we describe a fourth case of a human with a de novo KCNJ6 (GIRK2) mutation, who presented with clinical findings of"}
{"subject": "GIRK2", "sub_type": "Gene", "rel": "ThemeOf", "object": "p.Leu171Arg", "obj_type": "Var", "file_name": "PubMed-29852244.json", "snippet": " reported weaver mutation in murine GIRK2. Expression of a tandem dimer containing GIRK1 and GIRK2(p.Leu171Arg) did not lead to any currents, suggesting heterotetramers are not functional. In neurons expressing  [CLS] p.Leu171Arg GIRK2 [CLS]  channels, these changes in channel properties would be expected to generate a sustained depolarization, instead of the normal G protein-gated inhibitory response, which could be mitigated by expression of"}
{"subject": "p.Leu171Arg", "sub_type": "Var", "rel": "CauseOf", "object": "depolarization", "obj_type": "NegReg", "file_name": "PubMed-29852244.json", "snippet": " reported weaver mutation in murine GIRK2. Expression of a tandem dimer containing GIRK1 and GIRK2(p.Leu171Arg) did not lead to any currents, suggesting heterotetramers are not functional. In neurons expressing  [CLS] p.Leu171Arg GIRK2 channels, these changes in channel properties would be expected to generate a sustained depolarization [CLS] , instead of the normal G protein-gated inhibitory response, which could be mitigated by expression of other GIRK subunits. The identification of the p.Leu171Arg GIRK2 mutation potentially expands the Keppen-Lubinsky"}
{"subject": "G protein-gated inhibitory response", "sub_type": "MPA", "rel": "ThemeOf", "object": "depolarization", "obj_type": "NegReg", "file_name": "PubMed-29852244.json", "snippet": " did not lead to any currents, suggesting heterotetramers are not functional. In neurons expressing p.Leu171Arg GIRK2 channels, these changes in channel properties would be expected to generate a sustained  [CLS] depolarization, instead of the normal G protein-gated inhibitory response [CLS] , which could be mitigated by expression of other GIRK subunits. The identification of the p.Leu171Arg GIRK2 mutation potentially expands the Keppen-Lubinsky syndrome phenotype to include severe dystonia and ballismus."}
{"subject": "Severe Hyperkinetic Movement Disorder", "sub_type": "Disease", "rel": "ThemeOf", "object": "Gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-29852244.json", "snippet": " [CLS] Gain-of-function KCNJ6 Mutation in a Severe Hyperkinetic Movement Disorder [CLS]  Phenotype.\nHere, we describe a fourth case of a human with a de novo KCNJ6 (GIRK2) mutation, who presented with clinical findings of severe hyperkinetic movement disorder and developmental"}
{"subject": "KCNJ6", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutation", "obj_type": "Var", "file_name": "PubMed-29852244.json", "snippet": " [CLS] KCNJ6 (GIRK2) mutation [CLS] , who presented with clinical findings of severe hyperkinetic movement disorder and developmental delay, similar to the Keppen-Lubinsky syndrome but without lipodystrophy. Whole-exome sequencing of the patient's DNA revealed a"}
{"subject": "mutation", "sub_type": "Var", "rel": "CauseOf", "object": "presented", "obj_type": "Reg", "file_name": "PubMed-29852244.json", "snippet": " [CLS] mutation, who presented [CLS]  with clinical findings of severe hyperkinetic movement disorder and developmental delay, similar to the Keppen-Lubinsky syndrome but without lipodystrophy. Whole-exome sequencing of the patient's DNA revealed a heterozygous de"}
{"subject": "severe hyperkinetic movement disorder", "sub_type": "Disease", "rel": "ThemeOf", "object": "presented", "obj_type": "Reg", "file_name": "PubMed-29852244.json", "snippet": " [CLS] presented with clinical findings of severe hyperkinetic movement disorder [CLS]  and developmental delay, similar to the Keppen-Lubinsky syndrome but without lipodystrophy. Whole-exome sequencing of the patient's DNA revealed a heterozygous de novo variant in the KCNJ6 (c.512T>G, p.Leu171Arg). We"}
{"subject": "developmental delay", "sub_type": "CPA", "rel": "ThemeOf", "object": "presented", "obj_type": "Reg", "file_name": "PubMed-29852244.json", "snippet": " [CLS] presented with clinical findings of severe hyperkinetic movement disorder and developmental delay [CLS] , similar to the Keppen-Lubinsky syndrome but without lipodystrophy. Whole-exome sequencing of the patient's DNA revealed a heterozygous de novo variant in the KCNJ6 (c.512T>G, p.Leu171Arg). We conducted in vitro"}
{"subject": "KCNJ6", "sub_type": "Gene", "rel": "ThemeOf", "object": "c.512T>G", "obj_type": "Var", "file_name": "PubMed-29852244.json", "snippet": " severe hyperkinetic movement disorder and developmental delay, similar to the Keppen-Lubinsky syndrome but without lipodystrophy. Whole-exome sequencing of the patient's DNA revealed a heterozygous de novo variant in the  [CLS] KCNJ6 (c.512T>G [CLS] , p.Leu171Arg). We conducted in vitro functional studies to determine if this Leu-to-Arg mutation alters the function of GIRK2 channels. Heterologous expression of the mutant GIRK2 channel alone produced an"}
{"subject": "KCNJ6", "sub_type": "Gene", "rel": "ThemeOf", "object": "p.Leu171Arg", "obj_type": "Var", "file_name": "PubMed-29852244.json", "snippet": " severe hyperkinetic movement disorder and developmental delay, similar to the Keppen-Lubinsky syndrome but without lipodystrophy. Whole-exome sequencing of the patient's DNA revealed a heterozygous de novo variant in the  [CLS] KCNJ6 (c.512T>G, p.Leu171Arg [CLS] ). We conducted in vitro functional studies to determine if this Leu-to-Arg mutation alters the function of GIRK2 channels. Heterologous expression of the mutant GIRK2 channel alone produced an aberrant"}
{"subject": "Variants", "sub_type": "Var", "rel": "CauseOf", "object": "Loss-of-Function", "obj_type": "NegReg", "file_name": "PubMed-29861108.json", "snippet": " [CLS] Loss-of-Function Variants [CLS]  in TLK2: Clinical and Genotype-Phenotype Evaluation of a Distinct Neurodevelopmental Disorder.\nNext-generation sequencing is a powerful tool for the discovery of genes related to neurodevelopmental disorders (NDDs). Here, we"}
{"subject": "TLK2", "sub_type": "Gene", "rel": "ThemeOf", "object": "Variants", "obj_type": "Var", "file_name": "PubMed-29861108.json", "snippet": " [CLS] Variants in TLK2 [CLS] : Clinical and Genotype-Phenotype Evaluation of a Distinct Neurodevelopmental Disorder.\nNext-generation sequencing is a powerful tool for the discovery of genes related to neurodevelopmental disorders (NDDs). Here, we report the"}
{"subject": "Distinct Neurodevelopmental Disorder", "sub_type": "Disease", "rel": "ThemeOf", "object": "Loss-of-Function", "obj_type": "NegReg", "file_name": "PubMed-29861108.json", "snippet": " [CLS] Loss-of-Function Variants in TLK2: Clinical and Genotype-Phenotype Evaluation of a Distinct Neurodevelopmental Disorder [CLS] .\nNext-generation sequencing is a powerful tool for the discovery of genes related to neurodevelopmental disorders (NDDs). Here, we report the identification of a distinct syndrome due to de novo"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "cases", "obj_type": "Reg", "file_name": "PubMed-29889573.json", "snippet": " acrosomal glycoprotein that is synthesized during spermatogenesis. It is overexpressed in tumors and has anti-inflammatory properties. The protein may be cleaved into granulins which display pro-inflammatory properties. In 2006,  [CLS] mutations in progranulin gene (GRN) that cause haploinsufficiency were found in familial cases [CLS]  of frontotemporal dementia (FTD). Patients with null mutations in GRN display very low-plasma PGRN levels; this analysis is useful for identifying mutation carriers, independent of the clinical presentation, and"}
{"subject": "frontotemporal dementia", "sub_type": "Disease", "rel": "ThemeOf", "object": "cases", "obj_type": "Reg", "file_name": "PubMed-29889573.json", "snippet": " and has anti-inflammatory properties. The protein may be cleaved into granulins which display pro-inflammatory properties. In 2006, mutations in progranulin gene (GRN) that cause haploinsufficiency were found in familial  [CLS] cases of frontotemporal dementia [CLS]  (FTD). Patients with null mutations in GRN display very low-plasma PGRN levels; this analysis is useful for identifying mutation carriers, independent of the clinical presentation, and in those before"}
{"subject": "GRN", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-29889573.json", "snippet": " acrosomal glycoprotein that is synthesized during spermatogenesis. It is overexpressed in tumors and has anti-inflammatory properties. The protein may be cleaved into granulins which display pro-inflammatory properties. In 2006,  [CLS] mutations in progranulin gene (GRN [CLS] ) that cause haploinsufficiency were found in familial cases of frontotemporal dementia (FTD). Patients with null mutations in GRN display very low-plasma PGRN levels; this analysis is useful for identifying"}
{"subject": "Sik3", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutation", "obj_type": "Var", "file_name": "PubMed-29899451.json", "snippet": " the sleep-deprived and Sleepy mouse models of increased sleep need. Sleep deprivation induces cumulative phosphorylation of the brain proteome, which dissipates during sleep. Sleepy mice, owing to a gain-of-function  [CLS] mutation in the Sik3 [CLS]  gene 12 , have a constitutively high sleep need despite increased sleep amount. The brain proteome of these mice exhibits hyperphosphorylation, similar to that seen in the brain of"}
{"subject": "SNIPPs", "sub_type": "Protein", "rel": "ThemeOf", "object": "phosphorylates", "obj_type": "MPA", "file_name": "PubMed-29899451.json", "snippet": " the two models identifies 80 mostly synaptic sleep-need-index phosphoproteins (SNIPPs), in which phosphorylation states closely parallel changes of sleep need. SLEEPY, the mutant SIK3 protein, preferentially associates with and  [CLS] phosphorylates SNIPPs [CLS] . Inhibition of SIK3 activity reduces phosphorylation of SNIPPs and slow wave activity during non-rapid-eye-movement sleep, the best known measurable index of sleep need, in both Sleepy mice and sleep-deprived"}
{"subject": "mutation", "sub_type": "Var", "rel": "CauseOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-29899451.json", "snippet": " of the sleep-deprived and Sleepy mouse models of increased sleep need. Sleep deprivation induces cumulative phosphorylation of the brain proteome, which dissipates during sleep. Sleepy mice, owing to a  [CLS] gain-of-function mutation [CLS]  in the Sik3 gene 12 , have a constitutively high sleep need despite increased sleep amount. The brain proteome of these mice exhibits hyperphosphorylation, similar to that seen in"}
{"subject": "hyperphosphorylation", "sub_type": "MPA", "rel": "ThemeOf", "object": "brain proteome", "obj_type": "Protein", "file_name": "PubMed-29899451.json", "snippet": " proteome, which dissipates during sleep. Sleepy mice, owing to a gain-of-function mutation in the Sik3 gene 12 , have a constitutively high sleep need despite increased sleep amount. The  [CLS] brain proteome of these mice exhibits hyperphosphorylation [CLS] , similar to that seen in the brain of sleep-deprived mice. Comparison of the two models identifies 80 mostly synaptic sleep-need-index phosphoproteins (SNIPPs), in which phosphorylation states closely parallel changes"}
{"subject": "brain proteome", "sub_type": "Protein", "rel": "CauseOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-29899451.json", "snippet": " of the sleep-deprived and Sleepy mouse models of increased sleep need. Sleep deprivation induces cumulative phosphorylation of the brain proteome, which dissipates during sleep. Sleepy mice, owing to a  [CLS] gain-of-function mutation in the Sik3 gene 12 , have a constitutively high sleep need despite increased sleep amount. The brain proteome [CLS]  of these mice exhibits hyperphosphorylation, similar to that seen in the brain of sleep-deprived mice. Comparison of the two models identifies 80 mostly synaptic sleep-need-index phosphoproteins (SNIPPs), in which"}
{"subject": "SIK3", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutant", "obj_type": "Var", "file_name": "PubMed-29899451.json", "snippet": " the brain of sleep-deprived mice. Comparison of the two models identifies 80 mostly synaptic sleep-need-index phosphoproteins (SNIPPs), in which phosphorylation states closely parallel changes of sleep need. SLEEPY, the  [CLS] mutant SIK3 [CLS]  protein, preferentially associates with and phosphorylates SNIPPs. Inhibition of SIK3 activity reduces phosphorylation of SNIPPs and slow wave activity during non-rapid-eye-movement sleep, the best known measurable index of sleep"}
{"subject": "protein", "sub_type": "Protein", "rel": "ThemeOf", "object": "SIK3", "obj_type": "Gene", "file_name": "PubMed-29899451.json", "snippet": " brain of sleep-deprived mice. Comparison of the two models identifies 80 mostly synaptic sleep-need-index phosphoproteins (SNIPPs), in which phosphorylation states closely parallel changes of sleep need. SLEEPY, the mutant  [CLS] SIK3 protein [CLS] , preferentially associates with and phosphorylates SNIPPs. Inhibition of SIK3 activity reduces phosphorylation of SNIPPs and slow wave activity during non-rapid-eye-movement sleep, the best known measurable index of sleep need,"}
{"subject": "mutant", "sub_type": "Var", "rel": "CauseOf", "object": "preferentially", "obj_type": "PosReg", "file_name": "PubMed-29899451.json", "snippet": " the brain of sleep-deprived mice. Comparison of the two models identifies 80 mostly synaptic sleep-need-index phosphoproteins (SNIPPs), in which phosphorylation states closely parallel changes of sleep need. SLEEPY, the  [CLS] mutant SIK3 protein, preferentially [CLS]  associates with and phosphorylates SNIPPs. Inhibition of SIK3 activity reduces phosphorylation of SNIPPs and slow wave activity during non-rapid-eye-movement sleep, the best known measurable index of sleep need, in"}
{"subject": "associates with", "sub_type": "Interaction", "rel": "ThemeOf", "object": "preferentially", "obj_type": "PosReg", "file_name": "PubMed-29899451.json", "snippet": " sleep-deprived mice. Comparison of the two models identifies 80 mostly synaptic sleep-need-index phosphoproteins (SNIPPs), in which phosphorylation states closely parallel changes of sleep need. SLEEPY, the mutant SIK3 protein,  [CLS] preferentially associates with [CLS]  and phosphorylates SNIPPs. Inhibition of SIK3 activity reduces phosphorylation of SNIPPs and slow wave activity during non-rapid-eye-movement sleep, the best known measurable index of sleep need, in both Sleepy"}
{"subject": "phosphorylates", "sub_type": "MPA", "rel": "ThemeOf", "object": "associates with", "obj_type": "Interaction", "file_name": "PubMed-29899451.json", "snippet": " mice. Comparison of the two models identifies 80 mostly synaptic sleep-need-index phosphoproteins (SNIPPs), in which phosphorylation states closely parallel changes of sleep need. SLEEPY, the mutant SIK3 protein, preferentially  [CLS] associates with and phosphorylates [CLS]  SNIPPs. Inhibition of SIK3 activity reduces phosphorylation of SNIPPs and slow wave activity during non-rapid-eye-movement sleep, the best known measurable index of sleep need, in both Sleepy mice and"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "loss of function", "obj_type": "NegReg", "file_name": "PubMed-29912901.json", "snippet": " tumour that arises as a consequence of somatic and rare germline mutations, the characterisation of which has refined our understanding of nephrogenesis and carcinogenesis. Here we report that germline  [CLS] loss of function mutations [CLS]  in TRIM28 predispose children to Wilms tumour. Loss of function of this transcriptional co-repressor, which has a role in nephrogenesis, has not previously been associated with cancer. Inactivation of"}
{"subject": "Wilms tumour", "sub_type": "Disease", "rel": "ThemeOf", "object": "loss of function", "obj_type": "NegReg", "file_name": "PubMed-29912901.json", "snippet": " tumour that arises as a consequence of somatic and rare germline mutations, the characterisation of which has refined our understanding of nephrogenesis and carcinogenesis. Here we report that germline  [CLS] loss of function mutations in TRIM28 predispose children to Wilms tumour [CLS] . Loss of function of this transcriptional co-repressor, which has a role in nephrogenesis, has not previously been associated with cancer. Inactivation of TRIM28, either germline or somatic, occurred through"}
{"subject": "TRIM28", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-29912901.json", "snippet": " as a consequence of somatic and rare germline mutations, the characterisation of which has refined our understanding of nephrogenesis and carcinogenesis. Here we report that germline loss of function  [CLS] mutations in TRIM28 [CLS]  predispose children to Wilms tumour. Loss of function of this transcriptional co-repressor, which has a role in nephrogenesis, has not previously been associated with cancer. Inactivation of TRIM28, either"}
{"subject": "loss of heterozygosity", "sub_type": "Var", "rel": "CauseOf", "object": "Inactivation", "obj_type": "NegReg", "file_name": "PubMed-29912901.json", "snippet": " function mutations in TRIM28 predispose children to Wilms tumour. Loss of function of this transcriptional co-repressor, which has a role in nephrogenesis, has not previously been associated with cancer.  [CLS] Inactivation of TRIM28, either germline or somatic, occurred through inactivating mutations, loss of heterozygosity [CLS]  or epigenetic silencing. TRIM28-mutated tumours had a monomorphic epithelial histology that is uncommon for Wilms tumour. Critically, these tumours were negative for TRIM28 immunohistochemical staining whereas the epithelial component"}
{"subject": "inactivating mutations", "sub_type": "Var", "rel": "CauseOf", "object": "Inactivation", "obj_type": "NegReg", "file_name": "PubMed-29912901.json", "snippet": " function mutations in TRIM28 predispose children to Wilms tumour. Loss of function of this transcriptional co-repressor, which has a role in nephrogenesis, has not previously been associated with cancer.  [CLS] Inactivation of TRIM28, either germline or somatic, occurred through inactivating mutations [CLS] , loss of heterozygosity or epigenetic silencing. TRIM28-mutated tumours had a monomorphic epithelial histology that is uncommon for Wilms tumour. Critically, these tumours were negative for TRIM28 immunohistochemical staining whereas"}
{"subject": "epigenetic silencing", "sub_type": "Var", "rel": "CauseOf", "object": "Inactivation", "obj_type": "NegReg", "file_name": "PubMed-29912901.json", "snippet": " function mutations in TRIM28 predispose children to Wilms tumour. Loss of function of this transcriptional co-repressor, which has a role in nephrogenesis, has not previously been associated with cancer.  [CLS] Inactivation of TRIM28, either germline or somatic, occurred through inactivating mutations, loss of heterozygosity or epigenetic silencing [CLS] . TRIM28-mutated tumours had a monomorphic epithelial histology that is uncommon for Wilms tumour. Critically, these tumours were negative for TRIM28 immunohistochemical staining whereas the epithelial component in normal tissue"}
{"subject": "TRIM28", "sub_type": "Gene", "rel": "ThemeOf", "object": "Inactivation", "obj_type": "NegReg", "file_name": "PubMed-29912901.json", "snippet": " function mutations in TRIM28 predispose children to Wilms tumour. Loss of function of this transcriptional co-repressor, which has a role in nephrogenesis, has not previously been associated with cancer.  [CLS] Inactivation of TRIM28 [CLS] , either germline or somatic, occurred through inactivating mutations, loss of heterozygosity or epigenetic silencing. TRIM28-mutated tumours had a monomorphic epithelial histology that is uncommon for Wilms tumour. Critically, these"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "loss of function", "obj_type": "NegReg", "file_name": "PubMed-29935645.json", "snippet": " [CLS] loss of function mutations [CLS] .\nOBJECTIVE: To study the functional properties of six novel missense mutations of the NR5A1 gene encoding the steroidogenic factor 1 (SF-1) identified in six patients with 46,XY disorders of"}
{"subject": "p.Q460R", "sub_type": "Var", "rel": "CauseOf", "object": "identified in", "obj_type": "Reg", "file_name": "PubMed-29935645.json", "snippet": " analysis to identify the mutations or deletions/duplications of the NR5A1 gene. Functional studies by transactivation assays to predict the impact of mutations on molecular function.\nRESULT(S): NR5A1 exons sequencing  [CLS] identified in six 46,XY DSD patients six novel mutations: p.T40R, p.T47C, p.G328W, p.A351E, p.R427W, and p.Q460R [CLS] . Five missense variants were heterozygous, and one was homozygous (p.R427W). Functional analysis revealed a significant loss of DNA-binding and transactivation ability for all variants, except for p.Q460R, which showed"}
{"subject": "p.T40R", "sub_type": "Var", "rel": "CauseOf", "object": "identified in", "obj_type": "Reg", "file_name": "PubMed-29935645.json", "snippet": " analysis to identify the mutations or deletions/duplications of the NR5A1 gene. Functional studies by transactivation assays to predict the impact of mutations on molecular function.\nRESULT(S): NR5A1 exons sequencing  [CLS] identified in six 46,XY DSD patients six novel mutations: p.T40R [CLS] , p.T47C, p.G328W, p.A351E, p.R427W, and p.Q460R. Five missense variants were heterozygous, and one was homozygous (p.R427W). Functional analysis revealed a significant loss of DNA-binding and transactivation ability for all"}
{"subject": "p.R427W", "sub_type": "Var", "rel": "CauseOf", "object": "identified in", "obj_type": "Reg", "file_name": "PubMed-29935645.json", "snippet": " analysis to identify the mutations or deletions/duplications of the NR5A1 gene. Functional studies by transactivation assays to predict the impact of mutations on molecular function.\nRESULT(S): NR5A1 exons sequencing  [CLS] identified in six 46,XY DSD patients six novel mutations: p.T40R, p.T47C, p.G328W, p.A351E, p.R427W [CLS] , and p.Q460R. Five missense variants were heterozygous, and one was homozygous (p.R427W). Functional analysis revealed a significant loss of DNA-binding and transactivation ability for all variants, except for p.Q460R,"}
{"subject": "p.A351E", "sub_type": "Var", "rel": "CauseOf", "object": "identified in", "obj_type": "Reg", "file_name": "PubMed-29935645.json", "snippet": " analysis to identify the mutations or deletions/duplications of the NR5A1 gene. Functional studies by transactivation assays to predict the impact of mutations on molecular function.\nRESULT(S): NR5A1 exons sequencing  [CLS] identified in six 46,XY DSD patients six novel mutations: p.T40R, p.T47C, p.G328W, p.A351E [CLS] , p.R427W, and p.Q460R. Five missense variants were heterozygous, and one was homozygous (p.R427W). Functional analysis revealed a significant loss of DNA-binding and transactivation ability for all variants, except for"}
{"subject": "p.G328W", "sub_type": "Var", "rel": "CauseOf", "object": "identified in", "obj_type": "Reg", "file_name": "PubMed-29935645.json", "snippet": " analysis to identify the mutations or deletions/duplications of the NR5A1 gene. Functional studies by transactivation assays to predict the impact of mutations on molecular function.\nRESULT(S): NR5A1 exons sequencing  [CLS] identified in six 46,XY DSD patients six novel mutations: p.T40R, p.T47C, p.G328W [CLS] , p.A351E, p.R427W, and p.Q460R. Five missense variants were heterozygous, and one was homozygous (p.R427W). Functional analysis revealed a significant loss of DNA-binding and transactivation ability for all variants, except"}
{"subject": "p.T47C", "sub_type": "Var", "rel": "CauseOf", "object": "identified in", "obj_type": "Reg", "file_name": "PubMed-29935645.json", "snippet": " analysis to identify the mutations or deletions/duplications of the NR5A1 gene. Functional studies by transactivation assays to predict the impact of mutations on molecular function.\nRESULT(S): NR5A1 exons sequencing  [CLS] identified in six 46,XY DSD patients six novel mutations: p.T40R, p.T47C [CLS] , p.G328W, p.A351E, p.R427W, and p.Q460R. Five missense variants were heterozygous, and one was homozygous (p.R427W). Functional analysis revealed a significant loss of DNA-binding and transactivation ability for all variants,"}
{"subject": "p.R427W", "sub_type": "Var", "rel": "CauseOf", "object": "loss", "obj_type": "NegReg", "file_name": "PubMed-29935645.json", "snippet": " by transactivation assays to predict the impact of mutations on molecular function.\nRESULT(S): NR5A1 exons sequencing identified in six 46,XY DSD patients six novel mutations: p.T40R, p.T47C, p.G328W, p.A351E,  [CLS] p.R427W, and p.Q460R. Five missense variants were heterozygous, and one was homozygous (p.R427W). Functional analysis revealed a significant loss [CLS]  of DNA-binding and transactivation ability for all variants, except for p.Q460R, which showed a modest reduced activity compared with that of the wild-type protein. Phenotypes associated with these mutations"}
{"subject": "46,XY DSD", "sub_type": "Disease", "rel": "ThemeOf", "object": "identified in", "obj_type": "Reg", "file_name": "PubMed-29935645.json", "snippet": " analysis to identify the mutations or deletions/duplications of the NR5A1 gene. Functional studies by transactivation assays to predict the impact of mutations on molecular function.\nRESULT(S): NR5A1 exons sequencing  [CLS] identified in six 46,XY DSD [CLS]  patients six novel mutations: p.T40R, p.T47C, p.G328W, p.A351E, p.R427W, and p.Q460R. Five missense variants were heterozygous, and one was homozygous (p.R427W). Functional analysis revealed a significant loss of DNA-binding"}
{"subject": "p.A351E", "sub_type": "Var", "rel": "CauseOf", "object": "loss", "obj_type": "NegReg", "file_name": "PubMed-29935645.json", "snippet": " studies by transactivation assays to predict the impact of mutations on molecular function.\nRESULT(S): NR5A1 exons sequencing identified in six 46,XY DSD patients six novel mutations: p.T40R, p.T47C, p.G328W,  [CLS] p.A351E, p.R427W, and p.Q460R. Five missense variants were heterozygous, and one was homozygous (p.R427W). Functional analysis revealed a significant loss [CLS]  of DNA-binding and transactivation ability for all variants, except for p.Q460R, which showed a modest reduced activity compared with that of the wild-type protein. Phenotypes associated with these mutations"}
{"subject": "p.G328W", "sub_type": "Var", "rel": "CauseOf", "object": "loss", "obj_type": "NegReg", "file_name": "PubMed-29935645.json", "snippet": " Functional studies by transactivation assays to predict the impact of mutations on molecular function.\nRESULT(S): NR5A1 exons sequencing identified in six 46,XY DSD patients six novel mutations: p.T40R, p.T47C,  [CLS] p.G328W, p.A351E, p.R427W, and p.Q460R. Five missense variants were heterozygous, and one was homozygous (p.R427W). Functional analysis revealed a significant loss [CLS]  of DNA-binding and transactivation ability for all variants, except for p.Q460R, which showed a modest reduced activity compared with that of the wild-type protein. Phenotypes associated with these mutations"}
{"subject": "NR5A1", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-29935645.json", "snippet": " [CLS] NR5A1 gene in 46,XY disorders of sex development: identification of six novel loss of function mutations [CLS] .\nOBJECTIVE: To study the functional properties of six novel missense mutations of the NR5A1 gene encoding the steroidogenic factor 1 (SF-1) identified in six patients with 46,XY disorders of"}
{"subject": "p.T47C", "sub_type": "Var", "rel": "CauseOf", "object": "loss", "obj_type": "NegReg", "file_name": "PubMed-29935645.json", "snippet": " gene. Functional studies by transactivation assays to predict the impact of mutations on molecular function.\nRESULT(S): NR5A1 exons sequencing identified in six 46,XY DSD patients six novel mutations: p.T40R,  [CLS] p.T47C, p.G328W, p.A351E, p.R427W, and p.Q460R. Five missense variants were heterozygous, and one was homozygous (p.R427W). Functional analysis revealed a significant loss [CLS]  of DNA-binding and transactivation ability for all variants, except for p.Q460R, which showed a modest reduced activity compared with that of the wild-type protein. Phenotypes associated with these mutations"}
{"subject": "p.T40R", "sub_type": "Var", "rel": "CauseOf", "object": "loss", "obj_type": "NegReg", "file_name": "PubMed-29935645.json", "snippet": " NR5A1 gene. Functional studies by transactivation assays to predict the impact of mutations on molecular function.\nRESULT(S): NR5A1 exons sequencing identified in six 46,XY DSD patients six novel mutations:  [CLS] p.T40R, p.T47C, p.G328W, p.A351E, p.R427W, and p.Q460R. Five missense variants were heterozygous, and one was homozygous (p.R427W). Functional analysis revealed a significant loss [CLS]  of DNA-binding and transactivation ability for all variants, except for p.Q460R, which showed a modest reduced activity compared with that of the wild-type protein. Phenotypes associated with these mutations"}
{"subject": "DNA-binding", "sub_type": "Interaction", "rel": "ThemeOf", "object": "loss", "obj_type": "NegReg", "file_name": "PubMed-29935645.json", "snippet": " six 46,XY DSD patients six novel mutations: p.T40R, p.T47C, p.G328W, p.A351E, p.R427W, and p.Q460R. Five missense variants were heterozygous, and one was homozygous (p.R427W). Functional analysis revealed a significant  [CLS] loss of DNA-binding [CLS]  and transactivation ability for all variants, except for p.Q460R, which showed a modest reduced activity compared with that of the wild-type protein. Phenotypes associated with these mutations varied from"}
{"subject": "transactivation", "sub_type": "MPA", "rel": "ThemeOf", "object": "loss", "obj_type": "NegReg", "file_name": "PubMed-29935645.json", "snippet": " six 46,XY DSD patients six novel mutations: p.T40R, p.T47C, p.G328W, p.A351E, p.R427W, and p.Q460R. Five missense variants were heterozygous, and one was homozygous (p.R427W). Functional analysis revealed a significant  [CLS] loss of DNA-binding and transactivation [CLS]  ability for all variants, except for p.Q460R, which showed a modest reduced activity compared with that of the wild-type protein. Phenotypes associated with these mutations varied from males with"}
{"subject": "NR5A1", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-29935645.json", "snippet": " these mutations varied from males with spontaneous puberty, substantial T production, and possible fertility, to females with and without m\u00fcllerian structures and primary amenorrhea.\nCONCLUSION(S): We describe six novel  [CLS] mutations in NR5A1 [CLS]  gene and showed that they might affect protein structure, therefore compromising seriously the SF-1 role in regulating gonadal development. Clinically, we suggest that NR5A1 analysis should be performed whenever"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "affect", "obj_type": "Reg", "file_name": "PubMed-29935645.json", "snippet": " these mutations varied from males with spontaneous puberty, substantial T production, and possible fertility, to females with and without m\u00fcllerian structures and primary amenorrhea.\nCONCLUSION(S): We describe six novel  [CLS] mutations in NR5A1 gene and showed that they might affect [CLS]  protein structure, therefore compromising seriously the SF-1 role in regulating gonadal development. Clinically, we suggest that NR5A1 analysis should be performed whenever atypical sex organs are evidenced or there"}
{"subject": "protein structure", "sub_type": "MPA", "rel": "ThemeOf", "object": "affect", "obj_type": "Reg", "file_name": "PubMed-29935645.json", "snippet": " T production, and possible fertility, to females with and without m\u00fcllerian structures and primary amenorrhea.\nCONCLUSION(S): We describe six novel mutations in NR5A1 gene and showed that they might  [CLS] affect protein structure [CLS] , therefore compromising seriously the SF-1 role in regulating gonadal development. Clinically, we suggest that NR5A1 analysis should be performed whenever atypical sex organs are evidenced or there is an"}
{"subject": "affect", "sub_type": "Reg", "rel": "CauseOf", "object": "compromising", "obj_type": "NegReg", "file_name": "PubMed-29935645.json", "snippet": " T production, and possible fertility, to females with and without m\u00fcllerian structures and primary amenorrhea.\nCONCLUSION(S): We describe six novel mutations in NR5A1 gene and showed that they might  [CLS] affect protein structure, therefore compromising [CLS]  seriously the SF-1 role in regulating gonadal development. Clinically, we suggest that NR5A1 analysis should be performed whenever atypical sex organs are evidenced or there is an abnormal sexual"}
{"subject": "SF-1", "sub_type": "MPA", "rel": "ThemeOf", "object": "compromising", "obj_type": "NegReg", "file_name": "PubMed-29935645.json", "snippet": " fertility, to females with and without m\u00fcllerian structures and primary amenorrhea.\nCONCLUSION(S): We describe six novel mutations in NR5A1 gene and showed that they might affect protein structure, therefore  [CLS] compromising seriously the SF-1 [CLS]  role in regulating gonadal development. Clinically, we suggest that NR5A1 analysis should be performed whenever atypical sex organs are evidenced or there is an abnormal sexual development, to have"}
{"subject": "gonadal development", "sub_type": "CPA", "rel": "ThemeOf", "object": "compromising", "obj_type": "NegReg", "file_name": "PubMed-29935645.json", "snippet": " fertility, to females with and without m\u00fcllerian structures and primary amenorrhea.\nCONCLUSION(S): We describe six novel mutations in NR5A1 gene and showed that they might affect protein structure, therefore  [CLS] compromising seriously the SF-1 role in regulating gonadal development [CLS] . Clinically, we suggest that NR5A1 analysis should be performed whenever atypical sex organs are evidenced or there is an abnormal sexual development, to have proper diagnosis and better management"}
{"subject": "46,XY disorders of sex development", "sub_type": "Disease", "rel": "ThemeOf", "object": "loss of function", "obj_type": "NegReg", "file_name": "PubMed-29935645.json", "snippet": " [CLS] 46,XY disorders of sex development: identification of six novel loss of function [CLS]  mutations.\nOBJECTIVE: To study the functional properties of six novel missense mutations of the NR5A1 gene encoding the steroidogenic factor 1 (SF-1) identified in six patients with 46,XY disorders"}
{"subject": "NR5A1", "sub_type": "Gene", "rel": "ThemeOf", "object": "p.T40R", "obj_type": "Var", "file_name": "PubMed-29935645.json", "snippet": " ligation-dependent probe amplification analysis to identify the mutations or deletions/duplications of the NR5A1 gene. Functional studies by transactivation assays to predict the impact of mutations on molecular function.\nRESULT(S):  [CLS] NR5A1 exons sequencing identified in six 46,XY DSD patients six novel mutations: p.T40R [CLS] , p.T47C, p.G328W, p.A351E, p.R427W, and p.Q460R. Five missense variants were heterozygous, and one was homozygous (p.R427W). Functional analysis revealed a significant loss of DNA-binding and transactivation ability for all"}
{"subject": "NR5A1", "sub_type": "Gene", "rel": "ThemeOf", "object": "p.Q460R", "obj_type": "Var", "file_name": "PubMed-29935645.json", "snippet": " ligation-dependent probe amplification analysis to identify the mutations or deletions/duplications of the NR5A1 gene. Functional studies by transactivation assays to predict the impact of mutations on molecular function.\nRESULT(S):  [CLS] NR5A1 exons sequencing identified in six 46,XY DSD patients six novel mutations: p.T40R, p.T47C, p.G328W, p.A351E, p.R427W, and p.Q460R [CLS] . Five missense variants were heterozygous, and one was homozygous (p.R427W). Functional analysis revealed a significant loss of DNA-binding and transactivation ability for all variants, except for p.Q460R, which showed"}
{"subject": "NR5A1", "sub_type": "Gene", "rel": "ThemeOf", "object": "p.R427W", "obj_type": "Var", "file_name": "PubMed-29935645.json", "snippet": " ligation-dependent probe amplification analysis to identify the mutations or deletions/duplications of the NR5A1 gene. Functional studies by transactivation assays to predict the impact of mutations on molecular function.\nRESULT(S):  [CLS] NR5A1 exons sequencing identified in six 46,XY DSD patients six novel mutations: p.T40R, p.T47C, p.G328W, p.A351E, p.R427W [CLS] , and p.Q460R. Five missense variants were heterozygous, and one was homozygous (p.R427W). Functional analysis revealed a significant loss of DNA-binding and transactivation ability for all variants, except for p.Q460R,"}
{"subject": "NR5A1", "sub_type": "Gene", "rel": "ThemeOf", "object": "p.A351E", "obj_type": "Var", "file_name": "PubMed-29935645.json", "snippet": " ligation-dependent probe amplification analysis to identify the mutations or deletions/duplications of the NR5A1 gene. Functional studies by transactivation assays to predict the impact of mutations on molecular function.\nRESULT(S):  [CLS] NR5A1 exons sequencing identified in six 46,XY DSD patients six novel mutations: p.T40R, p.T47C, p.G328W, p.A351E [CLS] , p.R427W, and p.Q460R. Five missense variants were heterozygous, and one was homozygous (p.R427W). Functional analysis revealed a significant loss of DNA-binding and transactivation ability for all variants, except for"}
{"subject": "NR5A1", "sub_type": "Gene", "rel": "ThemeOf", "object": "p.G328W", "obj_type": "Var", "file_name": "PubMed-29935645.json", "snippet": " ligation-dependent probe amplification analysis to identify the mutations or deletions/duplications of the NR5A1 gene. Functional studies by transactivation assays to predict the impact of mutations on molecular function.\nRESULT(S):  [CLS] NR5A1 exons sequencing identified in six 46,XY DSD patients six novel mutations: p.T40R, p.T47C, p.G328W [CLS] , p.A351E, p.R427W, and p.Q460R. Five missense variants were heterozygous, and one was homozygous (p.R427W). Functional analysis revealed a significant loss of DNA-binding and transactivation ability for all variants, except"}
{"subject": "NR5A1", "sub_type": "Gene", "rel": "ThemeOf", "object": "p.T47C", "obj_type": "Var", "file_name": "PubMed-29935645.json", "snippet": " ligation-dependent probe amplification analysis to identify the mutations or deletions/duplications of the NR5A1 gene. Functional studies by transactivation assays to predict the impact of mutations on molecular function.\nRESULT(S):  [CLS] NR5A1 exons sequencing identified in six 46,XY DSD patients six novel mutations: p.T40R, p.T47C [CLS] , p.G328W, p.A351E, p.R427W, and p.Q460R. Five missense variants were heterozygous, and one was homozygous (p.R427W). Functional analysis revealed a significant loss of DNA-binding and transactivation ability for all variants,"}
{"subject": "Substitution", "sub_type": "Var", "rel": "CauseOf", "object": "loss", "obj_type": "NegReg", "file_name": "PubMed-29941455.json", "snippet": " the two-electrode voltage clamp technique in Xenopus oocytes, and interpreting changes in receptor parameters by using currently available structural information on the open and closed states of the GlyR.  [CLS] Substitution of six of the eight Phe residues in the ECD with Ala resulted in loss [CLS]  of function or significantly increased the EC50 and also altered the maximal response to the partial GlyR agonist taurine compared with glycine in those receptor variants that were functional."}
{"subject": "function", "sub_type": "MPA", "rel": "ThemeOf", "object": "loss", "obj_type": "NegReg", "file_name": "PubMed-29941455.json", "snippet": " using currently available structural information on the open and closed states of the GlyR. Substitution of six of the eight Phe residues in the ECD with Ala resulted in  [CLS] loss of function [CLS]  or significantly increased the EC50 and also altered the maximal response to the partial GlyR agonist taurine compared with glycine in those receptor variants that were functional. Substitutions with"}
{"subject": "Substitution", "sub_type": "Var", "rel": "CauseOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-29941455.json", "snippet": " the two-electrode voltage clamp technique in Xenopus oocytes, and interpreting changes in receptor parameters by using currently available structural information on the open and closed states of the GlyR.  [CLS] Substitution of six of the eight Phe residues in the ECD with Ala resulted in loss of function or significantly increased [CLS]  the EC50 and also altered the maximal response to the partial GlyR agonist taurine compared with glycine in those receptor variants that were functional. Substitutions with other amino acids,"}
{"subject": "EC50", "sub_type": "MPA", "rel": "ThemeOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-29941455.json", "snippet": " on the open and closed states of the GlyR. Substitution of six of the eight Phe residues in the ECD with Ala resulted in loss of function or significantly  [CLS] increased the EC50 [CLS]  and also altered the maximal response to the partial GlyR agonist taurine compared with glycine in those receptor variants that were functional. Substitutions with other amino acids, combined with"}
{"subject": "Substitution", "sub_type": "Var", "rel": "CauseOf", "object": "altered", "obj_type": "Reg", "file_name": "PubMed-29941455.json", "snippet": " the two-electrode voltage clamp technique in Xenopus oocytes, and interpreting changes in receptor parameters by using currently available structural information on the open and closed states of the GlyR.  [CLS] Substitution of six of the eight Phe residues in the ECD with Ala resulted in loss of function or significantly increased the EC50 and also altered [CLS]  the maximal response to the partial GlyR agonist taurine compared with glycine in those receptor variants that were functional. Substitutions with other amino acids, combined with examination of nearby"}
{"subject": "maximal response to the partial GlyR agonist taurine", "sub_type": "MPA", "rel": "ThemeOf", "object": "altered", "obj_type": "Reg", "file_name": "PubMed-29941455.json", "snippet": " states of the GlyR. Substitution of six of the eight Phe residues in the ECD with Ala resulted in loss of function or significantly increased the EC50 and also  [CLS] altered the maximal response to the partial GlyR agonist taurine [CLS]  compared with glycine in those receptor variants that were functional. Substitutions with other amino acids, combined with examination of nearby residues that could potentially interact with these Phe residues,"}
{"subject": "mutants", "sub_type": "Var", "rel": "CauseOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-29969449.json", "snippet": " the importance of the RES complex for vertebrate splicing, the intronic features associated with its activity, and its role in development are unknown. In this study, we have generated  [CLS] loss-of-function mutants [CLS]  for the three components of the RES complex in zebrafish and showed that they are required during early development. The mutants showed a marked neural phenotype with increased cell"}
{"subject": "intron splicing", "sub_type": "MPA", "rel": "ThemeOf", "object": "defect", "obj_type": "NegReg", "file_name": "PubMed-29969449.json", "snippet": " marked neural phenotype with increased cell death in the brain and a decrease in differentiated neurons. Transcriptomic analysis of bud13, snip1 (pml1) and rbmx2 (snu17) mutants revealed a global  [CLS] defect in intron splicing [CLS] , with strong mis-splicing of a subset of introns. We found these RES-dependent introns were short, rich in GC and flanked by GC depleted exons, all of which are features"}
{"subject": "mis-splicing of a subset of introns", "sub_type": "MPA", "rel": "ThemeOf", "object": "intron splicing", "obj_type": "MPA", "file_name": "PubMed-29969449.json", "snippet": " phenotype with increased cell death in the brain and a decrease in differentiated neurons. Transcriptomic analysis of bud13, snip1 (pml1) and rbmx2 (snu17) mutants revealed a global defect in  [CLS] intron splicing, with strong mis-splicing of a subset of introns [CLS] . We found these RES-dependent introns were short, rich in GC and flanked by GC depleted exons, all of which are features associated with intron definition. Using these features, we"}
{"subject": "loss-of-function", "sub_type": "NegReg", "rel": "CauseOf", "object": "decrease", "obj_type": "NegReg", "file_name": "PubMed-29969449.json", "snippet": " the importance of the RES complex for vertebrate splicing, the intronic features associated with its activity, and its role in development are unknown. In this study, we have generated  [CLS] loss-of-function mutants for the three components of the RES complex in zebrafish and showed that they are required during early development. The mutants showed a marked neural phenotype with increased cell death in the brain and a decrease [CLS]  in differentiated neurons. Transcriptomic analysis of bud13, snip1 (pml1) and rbmx2 (snu17) mutants revealed a global defect in intron splicing, with strong mis-splicing of a subset of introns. We"}
{"subject": "differentiated neurons", "sub_type": "CPA", "rel": "ThemeOf", "object": "decrease", "obj_type": "NegReg", "file_name": "PubMed-29969449.json", "snippet": " RES complex in zebrafish and showed that they are required during early development. The mutants showed a marked neural phenotype with increased cell death in the brain and a  [CLS] decrease in differentiated neurons [CLS] . Transcriptomic analysis of bud13, snip1 (pml1) and rbmx2 (snu17) mutants revealed a global defect in intron splicing, with strong mis-splicing of a subset of introns. We found these RES-dependent"}
{"subject": "rbmx2", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutants", "obj_type": "Var", "file_name": "PubMed-29969449.json", "snippet": " early development. The mutants showed a marked neural phenotype with increased cell death in the brain and a decrease in differentiated neurons. Transcriptomic analysis of bud13, snip1 (pml1) and  [CLS] rbmx2 (snu17) mutants [CLS]  revealed a global defect in intron splicing, with strong mis-splicing of a subset of introns. We found these RES-dependent introns were short, rich in GC and flanked by GC"}
{"subject": "snip1", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutants", "obj_type": "Var", "file_name": "PubMed-29969449.json", "snippet": " are required during early development. The mutants showed a marked neural phenotype with increased cell death in the brain and a decrease in differentiated neurons. Transcriptomic analysis of bud13,  [CLS] snip1 (pml1) and rbmx2 (snu17) mutants [CLS]  revealed a global defect in intron splicing, with strong mis-splicing of a subset of introns. We found these RES-dependent introns were short, rich in GC and flanked by GC"}
{"subject": "bud13", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutants", "obj_type": "Var", "file_name": "PubMed-29969449.json", "snippet": " they are required during early development. The mutants showed a marked neural phenotype with increased cell death in the brain and a decrease in differentiated neurons. Transcriptomic analysis of  [CLS] bud13, snip1 (pml1) and rbmx2 (snu17) mutants [CLS]  revealed a global defect in intron splicing, with strong mis-splicing of a subset of introns. We found these RES-dependent introns were short, rich in GC and flanked by GC"}
{"subject": "mutants", "sub_type": "Var", "rel": "CauseOf", "object": "defect", "obj_type": "NegReg", "file_name": "PubMed-29969449.json", "snippet": " The mutants showed a marked neural phenotype with increased cell death in the brain and a decrease in differentiated neurons. Transcriptomic analysis of bud13, snip1 (pml1) and rbmx2 (snu17)  [CLS] mutants revealed a global defect [CLS]  in intron splicing, with strong mis-splicing of a subset of introns. We found these RES-dependent introns were short, rich in GC and flanked by GC depleted exons, all of"}
{"subject": "p53", "sub_type": "Gene", "rel": "ThemeOf", "object": "Mutant", "obj_type": "Var", "file_name": "PubMed-29970031.json", "snippet": " [CLS] Mutant p53 [CLS]  gain of function induces HER2 over-expression in cancer cells.\nBACKGROUND: HER2 over-expression is related with a poor prognosis in patients with invasive breast cancer tumors. Clinical associations have reported"}
{"subject": "mtp53", "sub_type": "Var", "rel": "CauseOf", "object": "Higher", "obj_type": "PosReg", "file_name": "PubMed-29970031.json", "snippet": " have been evaluated after inducing or silencing of p53 mutants' expression in cell lines. Finally, we evaluated the interaction of the p53 mutants over the HER2 receptor promoter.\nRESULTS:  [CLS] Higher HER2 expression in cell lines harboring endogenous mtp53 [CLS]  compared with wt or null expression of p53 cell lines. Transfection of p53 mutants (R248Q and R273C) in cell lines increased the expression of HER2. Silencing of p53 mutants,"}
{"subject": "HER2", "sub_type": "Protein", "rel": "ThemeOf", "object": "expression", "obj_type": "MPA", "file_name": "PubMed-29970031.json", "snippet": " been evaluated after inducing or silencing of p53 mutants' expression in cell lines. Finally, we evaluated the interaction of the p53 mutants over the HER2 receptor promoter.\nRESULTS: Higher  [CLS] HER2 expression [CLS]  in cell lines harboring endogenous mtp53 compared with wt or null expression of p53 cell lines. Transfection of p53 mutants (R248Q and R273C) in cell lines increased the expression"}
{"subject": "expression", "sub_type": "MPA", "rel": "ThemeOf", "object": "Higher", "obj_type": "PosReg", "file_name": "PubMed-29970031.json", "snippet": " have been evaluated after inducing or silencing of p53 mutants' expression in cell lines. Finally, we evaluated the interaction of the p53 mutants over the HER2 receptor promoter.\nRESULTS:  [CLS] Higher HER2 expression [CLS]  in cell lines harboring endogenous mtp53 compared with wt or null expression of p53 cell lines. Transfection of p53 mutants (R248Q and R273C) in cell lines increased the expression"}
{"subject": "p53", "sub_type": "Gene", "rel": "ThemeOf", "object": "R248Q", "obj_type": "Var", "file_name": "PubMed-29970031.json", "snippet": " p53 mutants over the HER2 receptor promoter.\nRESULTS: Higher HER2 expression in cell lines harboring endogenous mtp53 compared with wt or null expression of p53 cell lines. Transfection of  [CLS] p53 mutants (R248Q [CLS]  and R273C) in cell lines increased the expression of HER2. Silencing of p53 mutants, decrease HER2 expression. The p53 mutants R248Q and R273C significantly increase the luciferase activity on"}
{"subject": "p53", "sub_type": "Gene", "rel": "ThemeOf", "object": "R273C", "obj_type": "Var", "file_name": "PubMed-29970031.json", "snippet": " p53 mutants over the HER2 receptor promoter.\nRESULTS: Higher HER2 expression in cell lines harboring endogenous mtp53 compared with wt or null expression of p53 cell lines. Transfection of  [CLS] p53 mutants (R248Q and R273C [CLS] ) in cell lines increased the expression of HER2. Silencing of p53 mutants, decrease HER2 expression. The p53 mutants R248Q and R273C significantly increase the luciferase activity on the HER2"}
{"subject": "R273C", "sub_type": "Var", "rel": "CauseOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-29970031.json", "snippet": " HER2 receptor promoter.\nRESULTS: Higher HER2 expression in cell lines harboring endogenous mtp53 compared with wt or null expression of p53 cell lines. Transfection of p53 mutants (R248Q and  [CLS] R273C) in cell lines increased [CLS]  the expression of HER2. Silencing of p53 mutants, decrease HER2 expression. The p53 mutants R248Q and R273C significantly increase the luciferase activity on the HER2 promoter, and both mutants"}
{"subject": "R248Q", "sub_type": "Var", "rel": "CauseOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-29970031.json", "snippet": " over the HER2 receptor promoter.\nRESULTS: Higher HER2 expression in cell lines harboring endogenous mtp53 compared with wt or null expression of p53 cell lines. Transfection of p53 mutants ( [CLS] R248Q and R273C) in cell lines increased [CLS]  the expression of HER2. Silencing of p53 mutants, decrease HER2 expression. The p53 mutants R248Q and R273C significantly increase the luciferase activity on the HER2 promoter, and both mutants"}
{"subject": "HER2", "sub_type": "Protein", "rel": "ThemeOf", "object": "expression", "obj_type": "MPA", "file_name": "PubMed-29970031.json", "snippet": " expression in cell lines harboring endogenous mtp53 compared with wt or null expression of p53 cell lines. Transfection of p53 mutants (R248Q and R273C) in cell lines increased the  [CLS] expression of HER2 [CLS] . Silencing of p53 mutants, decrease HER2 expression. The p53 mutants R248Q and R273C significantly increase the luciferase activity on the HER2 promoter, and both mutants also promote acetylation of"}
{"subject": "expression", "sub_type": "MPA", "rel": "ThemeOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-29970031.json", "snippet": " Higher HER2 expression in cell lines harboring endogenous mtp53 compared with wt or null expression of p53 cell lines. Transfection of p53 mutants (R248Q and R273C) in cell lines  [CLS] increased the expression [CLS]  of HER2. Silencing of p53 mutants, decrease HER2 expression. The p53 mutants R248Q and R273C significantly increase the luciferase activity on the HER2 promoter, and both mutants also promote"}
{"subject": "p53", "sub_type": "Gene", "rel": "ThemeOf", "object": "R248Q", "obj_type": "Var", "file_name": "PubMed-29970031.json", "snippet": " null expression of p53 cell lines. Transfection of p53 mutants (R248Q and R273C) in cell lines increased the expression of HER2. Silencing of p53 mutants, decrease HER2 expression. The  [CLS] p53 mutants R248Q [CLS]  and R273C significantly increase the luciferase activity on the HER2 promoter, and both mutants also promote acetylation of H3 and H4 histones binding in it.\nCONCLUSIONS: These findings show"}
{"subject": "Mutant", "sub_type": "Var", "rel": "CauseOf", "object": "gain of function", "obj_type": "PosReg", "file_name": "PubMed-29970031.json", "snippet": " [CLS] Mutant p53 gain of function [CLS]  induces HER2 over-expression in cancer cells.\nBACKGROUND: HER2 over-expression is related with a poor prognosis in patients with invasive breast cancer tumors. Clinical associations have reported that somatic mutations"}
{"subject": "p53", "sub_type": "Gene", "rel": "ThemeOf", "object": "R273C", "obj_type": "Var", "file_name": "PubMed-29970031.json", "snippet": " null expression of p53 cell lines. Transfection of p53 mutants (R248Q and R273C) in cell lines increased the expression of HER2. Silencing of p53 mutants, decrease HER2 expression. The  [CLS] p53 mutants R248Q and R273C [CLS]  significantly increase the luciferase activity on the HER2 promoter, and both mutants also promote acetylation of H3 and H4 histones binding in it.\nCONCLUSIONS: These findings show for the"}
{"subject": "R248Q", "sub_type": "Var", "rel": "CauseOf", "object": "increase", "obj_type": "PosReg", "file_name": "PubMed-29970031.json", "snippet": " of p53 cell lines. Transfection of p53 mutants (R248Q and R273C) in cell lines increased the expression of HER2. Silencing of p53 mutants, decrease HER2 expression. The p53 mutants  [CLS] R248Q and R273C significantly increase [CLS]  the luciferase activity on the HER2 promoter, and both mutants also promote acetylation of H3 and H4 histones binding in it.\nCONCLUSIONS: These findings show for the first time"}
{"subject": "R273C", "sub_type": "Var", "rel": "CauseOf", "object": "increase", "obj_type": "PosReg", "file_name": "PubMed-29970031.json", "snippet": " cell lines. Transfection of p53 mutants (R248Q and R273C) in cell lines increased the expression of HER2. Silencing of p53 mutants, decrease HER2 expression. The p53 mutants R248Q and  [CLS] R273C significantly increase [CLS]  the luciferase activity on the HER2 promoter, and both mutants also promote acetylation of H3 and H4 histones binding in it.\nCONCLUSIONS: These findings show for the first time"}
{"subject": "luciferase", "sub_type": "Enzyme", "rel": "ThemeOf", "object": "activity", "obj_type": "MPA", "file_name": "PubMed-29970031.json", "snippet": " p53 mutants (R248Q and R273C) in cell lines increased the expression of HER2. Silencing of p53 mutants, decrease HER2 expression. The p53 mutants R248Q and R273C significantly increase the  [CLS] luciferase activity [CLS]  on the HER2 promoter, and both mutants also promote acetylation of H3 and H4 histones binding in it.\nCONCLUSIONS: These findings show for the first time that p53 mutants"}
{"subject": "activity", "sub_type": "MPA", "rel": "ThemeOf", "object": "increase", "obj_type": "PosReg", "file_name": "PubMed-29970031.json", "snippet": " Transfection of p53 mutants (R248Q and R273C) in cell lines increased the expression of HER2. Silencing of p53 mutants, decrease HER2 expression. The p53 mutants R248Q and R273C significantly  [CLS] increase the luciferase activity [CLS]  on the HER2 promoter, and both mutants also promote acetylation of H3 and H4 histones binding in it.\nCONCLUSIONS: These findings show for the first time that p53 mutants"}
{"subject": "H3", "sub_type": "Protein", "rel": "ThemeOf", "object": "binding", "obj_type": "Interaction", "file_name": "PubMed-29970031.json", "snippet": " Silencing of p53 mutants, decrease HER2 expression. The p53 mutants R248Q and R273C significantly increase the luciferase activity on the HER2 promoter, and both mutants also promote acetylation of  [CLS] H3 and H4 histones binding [CLS]  in it.\nCONCLUSIONS: These findings show for the first time that p53 mutants induce over-expression of HER2 at transcriptional level of the HER2 protein. Our results could have clinical"}
{"subject": "H4 histones", "sub_type": "Protein", "rel": "ThemeOf", "object": "binding", "obj_type": "Interaction", "file_name": "PubMed-29970031.json", "snippet": " p53 mutants, decrease HER2 expression. The p53 mutants R248Q and R273C significantly increase the luciferase activity on the HER2 promoter, and both mutants also promote acetylation of H3 and  [CLS] H4 histones binding [CLS]  in it.\nCONCLUSIONS: These findings show for the first time that p53 mutants induce over-expression of HER2 at transcriptional level of the HER2 protein. Our results could have clinical"}
{"subject": "binding", "sub_type": "Interaction", "rel": "ThemeOf", "object": "acetylation", "obj_type": "MPA", "file_name": "PubMed-29970031.json", "snippet": " of HER2. Silencing of p53 mutants, decrease HER2 expression. The p53 mutants R248Q and R273C significantly increase the luciferase activity on the HER2 promoter, and both mutants also promote  [CLS] acetylation of H3 and H4 histones binding [CLS]  in it.\nCONCLUSIONS: These findings show for the first time that p53 mutants induce over-expression of HER2 at transcriptional level of the HER2 protein. Our results could have clinical"}
{"subject": "acetylation", "sub_type": "MPA", "rel": "ThemeOf", "object": "promote", "obj_type": "PosReg", "file_name": "PubMed-29970031.json", "snippet": " expression of HER2. Silencing of p53 mutants, decrease HER2 expression. The p53 mutants R248Q and R273C significantly increase the luciferase activity on the HER2 promoter, and both mutants also  [CLS] promote acetylation [CLS]  of H3 and H4 histones binding in it.\nCONCLUSIONS: These findings show for the first time that p53 mutants induce over-expression of HER2 at transcriptional level of the HER2"}
{"subject": "R248Q", "sub_type": "Var", "rel": "CauseOf", "object": "promote", "obj_type": "PosReg", "file_name": "PubMed-29970031.json", "snippet": " of p53 cell lines. Transfection of p53 mutants (R248Q and R273C) in cell lines increased the expression of HER2. Silencing of p53 mutants, decrease HER2 expression. The p53 mutants  [CLS] R248Q and R273C significantly increase the luciferase activity on the HER2 promoter, and both mutants also promote [CLS]  acetylation of H3 and H4 histones binding in it.\nCONCLUSIONS: These findings show for the first time that p53 mutants induce over-expression of HER2 at transcriptional level of the"}
{"subject": "gain of function", "sub_type": "PosReg", "rel": "CauseOf", "object": "induces", "obj_type": "Reg", "file_name": "PubMed-29970031.json", "snippet": " [CLS] gain of function induces [CLS]  HER2 over-expression in cancer cells.\nBACKGROUND: HER2 over-expression is related with a poor prognosis in patients with invasive breast cancer tumors. Clinical associations have reported that somatic mutations of"}
{"subject": "R273C", "sub_type": "Var", "rel": "CauseOf", "object": "promote", "obj_type": "PosReg", "file_name": "PubMed-29970031.json", "snippet": " cell lines. Transfection of p53 mutants (R248Q and R273C) in cell lines increased the expression of HER2. Silencing of p53 mutants, decrease HER2 expression. The p53 mutants R248Q and  [CLS] R273C significantly increase the luciferase activity on the HER2 promoter, and both mutants also promote [CLS]  acetylation of H3 and H4 histones binding in it.\nCONCLUSIONS: These findings show for the first time that p53 mutants induce over-expression of HER2 at transcriptional level of the"}
{"subject": "HER2", "sub_type": "Protein", "rel": "ThemeOf", "object": "over-expression", "obj_type": "MPA", "file_name": "PubMed-29970031.json", "snippet": " [CLS] HER2 over-expression [CLS]  in cancer cells.\nBACKGROUND: HER2 over-expression is related with a poor prognosis in patients with invasive breast cancer tumors. Clinical associations have reported that somatic mutations of p53 more"}
{"subject": "over-expression", "sub_type": "MPA", "rel": "ThemeOf", "object": "induces", "obj_type": "Reg", "file_name": "PubMed-29970031.json", "snippet": " [CLS] induces HER2 over-expression [CLS]  in cancer cells.\nBACKGROUND: HER2 over-expression is related with a poor prognosis in patients with invasive breast cancer tumors. Clinical associations have reported that somatic mutations of p53 more"}
{"subject": "p53", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutants", "obj_type": "Var", "file_name": "PubMed-29970031.json", "snippet": " luciferase activity on the HER2 promoter, and both mutants also promote acetylation of H3 and H4 histones binding in it.\nCONCLUSIONS: These findings show for the first time that  [CLS] p53 mutants [CLS]  induce over-expression of HER2 at transcriptional level of the HER2 protein. Our results could have clinical implications in breast cancer and other types of cancer where HER2 is over-expressed"}
{"subject": "mutants", "sub_type": "Var", "rel": "CauseOf", "object": "induce", "obj_type": "Reg", "file_name": "PubMed-29970031.json", "snippet": " activity on the HER2 promoter, and both mutants also promote acetylation of H3 and H4 histones binding in it.\nCONCLUSIONS: These findings show for the first time that p53  [CLS] mutants induce [CLS]  over-expression of HER2 at transcriptional level of the HER2 protein. Our results could have clinical implications in breast cancer and other types of cancer where HER2 is over-expressed and"}
{"subject": "HER2", "sub_type": "Protein", "rel": "ThemeOf", "object": "over-expression", "obj_type": "MPA", "file_name": "PubMed-29970031.json", "snippet": " the HER2 promoter, and both mutants also promote acetylation of H3 and H4 histones binding in it.\nCONCLUSIONS: These findings show for the first time that p53 mutants induce  [CLS] over-expression of HER2 [CLS]  at transcriptional level of the HER2 protein. Our results could have clinical implications in breast cancer and other types of cancer where HER2 is over-expressed and used as a"}
{"subject": "over-expression", "sub_type": "MPA", "rel": "ThemeOf", "object": "induce", "obj_type": "Reg", "file_name": "PubMed-29970031.json", "snippet": " on the HER2 promoter, and both mutants also promote acetylation of H3 and H4 histones binding in it.\nCONCLUSIONS: These findings show for the first time that p53 mutants  [CLS] induce over-expression [CLS]  of HER2 at transcriptional level of the HER2 protein. Our results could have clinical implications in breast cancer and other types of cancer where HER2 is over-expressed and used"}
{"subject": "SLC30A8", "sub_type": "Gene", "rel": "ThemeOf", "object": "R138X", "obj_type": "Var", "file_name": "PubMed-30038024.json", "snippet": " [CLS] SLC30A8 R138X [CLS]  loss-of-function mutation have increased insulin secretory capacity.\nSLC30A8 encodes a zinc transporter that is primarily expressed in the pancreatic islets of Langerhans. In \u03b2-cells it transports zinc into insulin-containing"}
{"subject": "secrete insulin", "sub_type": "MPA", "rel": "ThemeOf", "object": "increasing", "obj_type": "PosReg", "file_name": "PubMed-30038024.json", "snippet": " secretion. This effect was not associated with enhanced \u03b2-cell proliferation or mass. Our data suggest that the SLC30A8 R138X LOF mutation may exert beneficial effects on glucose metabolism by  [CLS] increasing the capacity of \u03b2-cells to secrete insulin [CLS]  under hyperglycemic conditions."}
{"subject": "increasing", "sub_type": "PosReg", "rel": "CauseOf", "object": "beneficial effects", "obj_type": "PosReg", "file_name": "PubMed-30038024.json", "snippet": " showed a 50% increase in insulin secretion. This effect was not associated with enhanced \u03b2-cell proliferation or mass. Our data suggest that the SLC30A8 R138X LOF mutation may exert  [CLS] beneficial effects on glucose metabolism by increasing [CLS]  the capacity of \u03b2-cells to secrete insulin under hyperglycemic conditions."}
{"subject": "glucose metabolism", "sub_type": "MPA", "rel": "ThemeOf", "object": "beneficial effects", "obj_type": "PosReg", "file_name": "PubMed-30038024.json", "snippet": " showed a 50% increase in insulin secretion. This effect was not associated with enhanced \u03b2-cell proliferation or mass. Our data suggest that the SLC30A8 R138X LOF mutation may exert  [CLS] beneficial effects on glucose metabolism [CLS]  by increasing the capacity of \u03b2-cells to secrete insulin under hyperglycemic conditions."}
{"subject": "R138X", "sub_type": "Var", "rel": "CauseOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-30038024.json", "snippet": " [CLS] R138X loss-of-function [CLS]  mutation have increased insulin secretory capacity.\nSLC30A8 encodes a zinc transporter that is primarily expressed in the pancreatic islets of Langerhans. In \u03b2-cells it transports zinc into insulin-containing secretory"}
{"subject": "loss-of-function", "sub_type": "NegReg", "rel": "CauseOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-30038024.json", "snippet": " [CLS] loss-of-function mutation have increased [CLS]  insulin secretory capacity.\nSLC30A8 encodes a zinc transporter that is primarily expressed in the pancreatic islets of Langerhans. In \u03b2-cells it transports zinc into insulin-containing secretory granules. Loss-of-function (LOF)"}
{"subject": "insulin secretory capacity", "sub_type": "MPA", "rel": "ThemeOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-30038024.json", "snippet": " [CLS] increased insulin secretory capacity [CLS] .\nSLC30A8 encodes a zinc transporter that is primarily expressed in the pancreatic islets of Langerhans. In \u03b2-cells it transports zinc into insulin-containing secretory granules. Loss-of-function (LOF) mutations in SLC30A8"}
{"subject": "R138X", "sub_type": "Var", "rel": "CauseOf", "object": "increase", "obj_type": "PosReg", "file_name": "PubMed-30038024.json", "snippet": " mutations for SLC30A8, R138X. The R138X mice had normal body weight, glucose tolerance, and pancreatic \u03b2-cell mass. Interestingly, in hyperglycemic conditions induced by the insulin receptor antagonist S961, the  [CLS] R138X mice showed a 50% increase [CLS]  in insulin secretion. This effect was not associated with enhanced \u03b2-cell proliferation or mass. Our data suggest that the SLC30A8 R138X LOF mutation may exert beneficial effects on glucose"}
{"subject": "insulin secretion", "sub_type": "MPA", "rel": "ThemeOf", "object": "increase", "obj_type": "PosReg", "file_name": "PubMed-30038024.json", "snippet": " R138X mice had normal body weight, glucose tolerance, and pancreatic \u03b2-cell mass. Interestingly, in hyperglycemic conditions induced by the insulin receptor antagonist S961, the R138X mice showed a 50%  [CLS] increase in insulin secretion [CLS] . This effect was not associated with enhanced \u03b2-cell proliferation or mass. Our data suggest that the SLC30A8 R138X LOF mutation may exert beneficial effects on glucose metabolism by increasing"}
{"subject": "SLC30A8", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutation", "obj_type": "Var", "file_name": "PubMed-30038024.json", "snippet": " receptor antagonist S961, the R138X mice showed a 50% increase in insulin secretion. This effect was not associated with enhanced \u03b2-cell proliferation or mass. Our data suggest that the  [CLS] SLC30A8 R138X LOF mutation [CLS]  may exert beneficial effects on glucose metabolism by increasing the capacity of \u03b2-cells to secrete insulin under hyperglycemic conditions."}
{"subject": "mutation", "sub_type": "Var", "rel": "CauseOf", "object": "LOF", "obj_type": "NegReg", "file_name": "PubMed-30038024.json", "snippet": " S961, the R138X mice showed a 50% increase in insulin secretion. This effect was not associated with enhanced \u03b2-cell proliferation or mass. Our data suggest that the SLC30A8 R138X  [CLS] LOF mutation [CLS]  may exert beneficial effects on glucose metabolism by increasing the capacity of \u03b2-cells to secrete insulin under hyperglycemic conditions."}
{"subject": "LOF", "sub_type": "NegReg", "rel": "CauseOf", "object": "increasing", "obj_type": "PosReg", "file_name": "PubMed-30038024.json", "snippet": " S961, the R138X mice showed a 50% increase in insulin secretion. This effect was not associated with enhanced \u03b2-cell proliferation or mass. Our data suggest that the SLC30A8 R138X  [CLS] LOF mutation may exert beneficial effects on glucose metabolism by increasing [CLS]  the capacity of \u03b2-cells to secrete insulin under hyperglycemic conditions."}
{"subject": "NOTCH3", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations in exon 33", "obj_type": "Var", "file_name": "PubMed-30042232.json", "snippet": " [CLS] mutations in exon 33 of NOTCH3 [CLS]  leading to a truncated protein lacking sequences for NOTCH3 degradation and presumably causing NOTCH3 gain of function. To create a mouse model reproducing human LMS-associated mutations, we utilized CRISPR/Cas9"}
{"subject": "osteoblast proliferation", "sub_type": "CPA", "rel": "ThemeOf", "object": "increase", "obj_type": "PosReg", "file_name": "PubMed-30042232.json", "snippet": " Cultures of bone marrow-derived macrophages from Notch3tm1.1Ecan mice revealed increased osteoclast formation, particularly in cocultures with osteoblasts from Notch3tm1.1Ecan mice. In conclusion, the Notch3tm1.1Ecan mutation causes osteopenia despite an  [CLS] increase in osteoblast proliferation [CLS]  and function and is associated with enhanced Tnfsf11 expression in osteoblasts and osteocytes."}
{"subject": "function", "sub_type": "CPA", "rel": "ThemeOf", "object": "increase", "obj_type": "PosReg", "file_name": "PubMed-30042232.json", "snippet": " Cultures of bone marrow-derived macrophages from Notch3tm1.1Ecan mice revealed increased osteoclast formation, particularly in cocultures with osteoblasts from Notch3tm1.1Ecan mice. In conclusion, the Notch3tm1.1Ecan mutation causes osteopenia despite an  [CLS] increase in osteoblast proliferation and function [CLS]  and is associated with enhanced Tnfsf11 expression in osteoblasts and osteocytes."}
{"subject": "Notch3tm1.1Ecan mutation", "sub_type": "Var", "rel": "CauseOf", "object": "enhanced", "obj_type": "PosReg", "file_name": "PubMed-30042232.json", "snippet": " in osteocyte-rich femora from Notch3tm1.1Ecan mice. Cultures of bone marrow-derived macrophages from Notch3tm1.1Ecan mice revealed increased osteoclast formation, particularly in cocultures with osteoblasts from Notch3tm1.1Ecan mice. In conclusion, the  [CLS] Notch3tm1.1Ecan mutation causes osteopenia despite an increase in osteoblast proliferation and function and is associated with enhanced [CLS]  Tnfsf11 expression in osteoblasts and osteocytes."}
{"subject": "Tnfsf11", "sub_type": "Gene", "rel": "ThemeOf", "object": "expression", "obj_type": "MPA", "file_name": "PubMed-30042232.json", "snippet": " formation, particularly in cocultures with osteoblasts from Notch3tm1.1Ecan mice. In conclusion, the Notch3tm1.1Ecan mutation causes osteopenia despite an increase in osteoblast proliferation and function and is associated with enhanced  [CLS] Tnfsf11 expression [CLS]  in osteoblasts and osteocytes."}
{"subject": "expression", "sub_type": "MPA", "rel": "ThemeOf", "object": "enhanced", "obj_type": "PosReg", "file_name": "PubMed-30042232.json", "snippet": " osteoclast formation, particularly in cocultures with osteoblasts from Notch3tm1.1Ecan mice. In conclusion, the Notch3tm1.1Ecan mutation causes osteopenia despite an increase in osteoblast proliferation and function and is associated with  [CLS] enhanced Tnfsf11 expression [CLS]  in osteoblasts and osteocytes."}
{"subject": "Notch3tm1.1Ecan", "sub_type": "Var", "rel": "CauseOf", "object": "osteopenia", "obj_type": "NegReg", "file_name": "PubMed-30042232.json", "snippet": " utilized CRISPR/Cas9 to introduce a tandem termination codon at bases 6691-6696 (ACCAAG\u2192TAATGA) and verified this mutation (Notch3tm1.1Ecan ) by DNA sequencing of F1 mice. One-month-old male and female heterozygous  [CLS] Notch3tm1.1Ecan mice had cancellous and cortical bone osteopenia [CLS]  but exhibited no obvious neurological alterations, and histopathology of multiple organs revealed no abnormalities. Microcomputed tomography of these mutants revealed a 35-60% decrease in cancellous bone volume associated with"}
{"subject": "cancellous and cortical bone", "sub_type": "CPA", "rel": "ThemeOf", "object": "osteopenia", "obj_type": "NegReg", "file_name": "PubMed-30042232.json", "snippet": " introduce a tandem termination codon at bases 6691-6696 (ACCAAG\u2192TAATGA) and verified this mutation (Notch3tm1.1Ecan ) by DNA sequencing of F1 mice. One-month-old male and female heterozygous Notch3tm1.1Ecan mice had  [CLS] cancellous and cortical bone osteopenia [CLS]  but exhibited no obvious neurological alterations, and histopathology of multiple organs revealed no abnormalities. Microcomputed tomography of these mutants revealed a 35-60% decrease in cancellous bone volume associated with"}
{"subject": "mutants", "sub_type": "Var", "rel": "CauseOf", "object": "reduction", "obj_type": "NegReg", "file_name": "PubMed-30042232.json", "snippet": " and female heterozygous Notch3tm1.1Ecan mice had cancellous and cortical bone osteopenia but exhibited no obvious neurological alterations, and histopathology of multiple organs revealed no abnormalities. Microcomputed tomography of these  [CLS] mutants revealed a 35-60% decrease in cancellous bone volume associated with a reduction [CLS]  in trabecular number and decreased connectivity. During maturation, cancellous and cortical bones were restored in female but not in male mice, which exhibited cancellous bone osteopenia at 4 months."}
{"subject": "trabecular number", "sub_type": "CPA", "rel": "ThemeOf", "object": "reduction", "obj_type": "NegReg", "file_name": "PubMed-30042232.json", "snippet": " exhibited no obvious neurological alterations, and histopathology of multiple organs revealed no abnormalities. Microcomputed tomography of these mutants revealed a 35-60% decrease in cancellous bone volume associated with a  [CLS] reduction in trabecular number [CLS]  and decreased connectivity. During maturation, cancellous and cortical bones were restored in female but not in male mice, which exhibited cancellous bone osteopenia at 4 months. Cancellous bone histomorphometry"}
{"subject": "mutants", "sub_type": "Var", "rel": "CauseOf", "object": "decreased", "obj_type": "NegReg", "file_name": "PubMed-30042232.json", "snippet": " and female heterozygous Notch3tm1.1Ecan mice had cancellous and cortical bone osteopenia but exhibited no obvious neurological alterations, and histopathology of multiple organs revealed no abnormalities. Microcomputed tomography of these  [CLS] mutants revealed a 35-60% decrease in cancellous bone volume associated with a reduction in trabecular number and decreased [CLS]  connectivity. During maturation, cancellous and cortical bones were restored in female but not in male mice, which exhibited cancellous bone osteopenia at 4 months. Cancellous bone histomorphometry revealed increased"}
{"subject": "mutations in exon 33", "sub_type": "Var", "rel": "CauseOf", "object": "truncated", "obj_type": "MPA", "file_name": "PubMed-30042232.json", "snippet": " [CLS] mutations in exon 33 of NOTCH3 leading to a truncated [CLS]  protein lacking sequences for NOTCH3 degradation and presumably causing NOTCH3 gain of function. To create a mouse model reproducing human LMS-associated mutations, we utilized CRISPR/Cas9 to introduce a tandem"}
{"subject": "connectivity", "sub_type": "CPA", "rel": "ThemeOf", "object": "decreased", "obj_type": "NegReg", "file_name": "PubMed-30042232.json", "snippet": " and histopathology of multiple organs revealed no abnormalities. Microcomputed tomography of these mutants revealed a 35-60% decrease in cancellous bone volume associated with a reduction in trabecular number and  [CLS] decreased connectivity [CLS] . During maturation, cancellous and cortical bones were restored in female but not in male mice, which exhibited cancellous bone osteopenia at 4 months. Cancellous bone histomorphometry revealed increased osteoblast"}
{"subject": "cancellous bone volume", "sub_type": "CPA", "rel": "ThemeOf", "object": "decrease", "obj_type": "NegReg", "file_name": "PubMed-30042232.json", "snippet": " mice had cancellous and cortical bone osteopenia but exhibited no obvious neurological alterations, and histopathology of multiple organs revealed no abnormalities. Microcomputed tomography of these mutants revealed a 35-60%  [CLS] decrease in cancellous bone volume [CLS]  associated with a reduction in trabecular number and decreased connectivity. During maturation, cancellous and cortical bones were restored in female but not in male mice, which exhibited cancellous bone"}
{"subject": "reduction", "sub_type": "NegReg", "rel": "CauseOf", "object": "decrease", "obj_type": "NegReg", "file_name": "PubMed-30042232.json", "snippet": " mice had cancellous and cortical bone osteopenia but exhibited no obvious neurological alterations, and histopathology of multiple organs revealed no abnormalities. Microcomputed tomography of these mutants revealed a 35-60%  [CLS] decrease in cancellous bone volume associated with a reduction [CLS]  in trabecular number and decreased connectivity. During maturation, cancellous and cortical bones were restored in female but not in male mice, which exhibited cancellous bone osteopenia at 4 months."}
{"subject": "decreased", "sub_type": "NegReg", "rel": "CauseOf", "object": "decrease", "obj_type": "NegReg", "file_name": "PubMed-30042232.json", "snippet": " mice had cancellous and cortical bone osteopenia but exhibited no obvious neurological alterations, and histopathology of multiple organs revealed no abnormalities. Microcomputed tomography of these mutants revealed a 35-60%  [CLS] decrease in cancellous bone volume associated with a reduction in trabecular number and decreased [CLS]  connectivity. During maturation, cancellous and cortical bones were restored in female but not in male mice, which exhibited cancellous bone osteopenia at 4 months. Cancellous bone histomorphometry revealed increased"}
{"subject": "calvarial osteoblasts", "sub_type": "CPA", "rel": "ThemeOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-30042232.json", "snippet": " which exhibited cancellous bone osteopenia at 4 months. Cancellous bone histomorphometry revealed increased osteoblast and osteocyte numbers and a modest increase in osteoclast surface and bone formation rate. Notch3tm1.1Ecan  [CLS] calvarial osteoblasts had increased [CLS]  proliferation and increased bone \u03b3-carboxyglutamate protein (Bglap) and TNF superfamily member 11 (Tnfsf11) mRNA levels and lower Tnfrsf11b levels. Tnfsf11 mRNA was increased in osteocyte-rich femora from Notch3tm1.1Ecan mice."}
{"subject": "Notch3tm1.1Ecan", "sub_type": "Var", "rel": "CauseOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-30042232.json", "snippet": " mice, which exhibited cancellous bone osteopenia at 4 months. Cancellous bone histomorphometry revealed increased osteoblast and osteocyte numbers and a modest increase in osteoclast surface and bone formation rate.  [CLS] Notch3tm1.1Ecan calvarial osteoblasts had increased [CLS]  proliferation and increased bone \u03b3-carboxyglutamate protein (Bglap) and TNF superfamily member 11 (Tnfsf11) mRNA levels and lower Tnfrsf11b levels. Tnfsf11 mRNA was increased in osteocyte-rich femora from Notch3tm1.1Ecan mice."}
{"subject": "Notch3tm1.1Ecan", "sub_type": "Var", "rel": "CauseOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-30042232.json", "snippet": " mice, which exhibited cancellous bone osteopenia at 4 months. Cancellous bone histomorphometry revealed increased osteoblast and osteocyte numbers and a modest increase in osteoclast surface and bone formation rate.  [CLS] Notch3tm1.1Ecan calvarial osteoblasts had increased proliferation and increased [CLS]  bone \u03b3-carboxyglutamate protein (Bglap) and TNF superfamily member 11 (Tnfsf11) mRNA levels and lower Tnfrsf11b levels. Tnfsf11 mRNA was increased in osteocyte-rich femora from Notch3tm1.1Ecan mice. Cultures of bone"}
{"subject": "protein", "sub_type": "Protein", "rel": "ThemeOf", "object": "truncated", "obj_type": "MPA", "file_name": "PubMed-30042232.json", "snippet": " mice.\nLateral meningocele syndrome (LMS) is a rare genetic disorder characterized by neurological complications and osteoporosis. LMS is associated with mutations in exon 33 of NOTCH3 leading to a  [CLS] truncated protein [CLS]  lacking sequences for NOTCH3 degradation and presumably causing NOTCH3 gain of function. To create a mouse model reproducing human LMS-associated mutations, we utilized CRISPR/Cas9 to introduce a tandem termination"}
{"subject": "bone \u03b3-carboxyglutamate protein (Bglap)", "sub_type": "Protein", "rel": "ThemeOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-30042232.json", "snippet": " 4 months. Cancellous bone histomorphometry revealed increased osteoblast and osteocyte numbers and a modest increase in osteoclast surface and bone formation rate. Notch3tm1.1Ecan calvarial osteoblasts had increased proliferation and  [CLS] increased bone \u03b3-carboxyglutamate protein (Bglap) [CLS]  and TNF superfamily member 11 (Tnfsf11) mRNA levels and lower Tnfrsf11b levels. Tnfsf11 mRNA was increased in osteocyte-rich femora from Notch3tm1.1Ecan mice. Cultures of bone marrow-derived macrophages from Notch3tm1.1Ecan"}
{"subject": "TNF superfamily member 11 (Tnfsf11)", "sub_type": "Gene", "rel": "ThemeOf", "object": "mRNA levels", "obj_type": "MPA", "file_name": "PubMed-30042232.json", "snippet": " increased osteoblast and osteocyte numbers and a modest increase in osteoclast surface and bone formation rate. Notch3tm1.1Ecan calvarial osteoblasts had increased proliferation and increased bone \u03b3-carboxyglutamate protein (Bglap) and  [CLS] TNF superfamily member 11 (Tnfsf11) mRNA levels [CLS]  and lower Tnfrsf11b levels. Tnfsf11 mRNA was increased in osteocyte-rich femora from Notch3tm1.1Ecan mice. Cultures of bone marrow-derived macrophages from Notch3tm1.1Ecan mice revealed increased osteoclast formation, particularly in cocultures"}
{"subject": "mRNA levels", "sub_type": "MPA", "rel": "ThemeOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-30042232.json", "snippet": " 4 months. Cancellous bone histomorphometry revealed increased osteoblast and osteocyte numbers and a modest increase in osteoclast surface and bone formation rate. Notch3tm1.1Ecan calvarial osteoblasts had increased proliferation and  [CLS] increased bone \u03b3-carboxyglutamate protein (Bglap) and TNF superfamily member 11 (Tnfsf11) mRNA levels [CLS]  and lower Tnfrsf11b levels. Tnfsf11 mRNA was increased in osteocyte-rich femora from Notch3tm1.1Ecan mice. Cultures of bone marrow-derived macrophages from Notch3tm1.1Ecan mice revealed increased osteoclast formation, particularly in cocultures"}
{"subject": "Notch3tm1.1Ecan", "sub_type": "Var", "rel": "CauseOf", "object": "lower", "obj_type": "NegReg", "file_name": "PubMed-30042232.json", "snippet": " mice, which exhibited cancellous bone osteopenia at 4 months. Cancellous bone histomorphometry revealed increased osteoblast and osteocyte numbers and a modest increase in osteoclast surface and bone formation rate.  [CLS] Notch3tm1.1Ecan calvarial osteoblasts had increased proliferation and increased bone \u03b3-carboxyglutamate protein (Bglap) and TNF superfamily member 11 (Tnfsf11) mRNA levels and lower [CLS]  Tnfrsf11b levels. Tnfsf11 mRNA was increased in osteocyte-rich femora from Notch3tm1.1Ecan mice. Cultures of bone marrow-derived macrophages from Notch3tm1.1Ecan mice revealed increased osteoclast formation, particularly in cocultures with osteoblasts"}
{"subject": "Tnfrsf11b levels", "sub_type": "MPA", "rel": "ThemeOf", "object": "lower", "obj_type": "NegReg", "file_name": "PubMed-30042232.json", "snippet": " increase in osteoclast surface and bone formation rate. Notch3tm1.1Ecan calvarial osteoblasts had increased proliferation and increased bone \u03b3-carboxyglutamate protein (Bglap) and TNF superfamily member 11 (Tnfsf11) mRNA levels and  [CLS] lower Tnfrsf11b levels [CLS] . Tnfsf11 mRNA was increased in osteocyte-rich femora from Notch3tm1.1Ecan mice. Cultures of bone marrow-derived macrophages from Notch3tm1.1Ecan mice revealed increased osteoclast formation, particularly in cocultures with osteoblasts from Notch3tm1.1Ecan"}
{"subject": "truncated", "sub_type": "MPA", "rel": "CauseOf", "object": "lacking", "obj_type": "NegReg", "file_name": "PubMed-30042232.json", "snippet": " mice.\nLateral meningocele syndrome (LMS) is a rare genetic disorder characterized by neurological complications and osteoporosis. LMS is associated with mutations in exon 33 of NOTCH3 leading to a  [CLS] truncated protein lacking [CLS]  sequences for NOTCH3 degradation and presumably causing NOTCH3 gain of function. To create a mouse model reproducing human LMS-associated mutations, we utilized CRISPR/Cas9 to introduce a tandem termination codon"}
{"subject": "sequences for NOTCH3 degradation", "sub_type": "MPA", "rel": "ThemeOf", "object": "lacking", "obj_type": "NegReg", "file_name": "PubMed-30042232.json", "snippet": " meningocele syndrome (LMS) is a rare genetic disorder characterized by neurological complications and osteoporosis. LMS is associated with mutations in exon 33 of NOTCH3 leading to a truncated protein  [CLS] lacking sequences for NOTCH3 degradation [CLS]  and presumably causing NOTCH3 gain of function. To create a mouse model reproducing human LMS-associated mutations, we utilized CRISPR/Cas9 to introduce a tandem termination codon at bases 6691-6696 (ACCAAG\u2192TAATGA)"}
{"subject": "mutations in exon 33", "sub_type": "Var", "rel": "CauseOf", "object": "gain of function", "obj_type": "PosReg", "file_name": "PubMed-30042232.json", "snippet": " [CLS] mutations in exon 33 of NOTCH3 leading to a truncated protein lacking sequences for NOTCH3 degradation and presumably causing NOTCH3 gain of function [CLS] . To create a mouse model reproducing human LMS-associated mutations, we utilized CRISPR/Cas9 to introduce a tandem termination codon at bases 6691-6696 (ACCAAG\u2192TAATGA) and verified this mutation (Notch3tm1.1Ecan ) by"}
{"subject": "NOTCH3", "sub_type": "Gene", "rel": "ThemeOf", "object": "gain of function", "obj_type": "PosReg", "file_name": "PubMed-30042232.json", "snippet": " characterized by neurological complications and osteoporosis. LMS is associated with mutations in exon 33 of NOTCH3 leading to a truncated protein lacking sequences for NOTCH3 degradation and presumably causing  [CLS] NOTCH3 gain of function [CLS] . To create a mouse model reproducing human LMS-associated mutations, we utilized CRISPR/Cas9 to introduce a tandem termination codon at bases 6691-6696 (ACCAAG\u2192TAATGA) and verified this mutation (Notch3tm1.1Ecan ) by"}
{"subject": "Notch3tm1.1Ecan mutation", "sub_type": "Var", "rel": "CauseOf", "object": "osteopenia", "obj_type": "Disease", "file_name": "PubMed-30042232.json", "snippet": " in osteocyte-rich femora from Notch3tm1.1Ecan mice. Cultures of bone marrow-derived macrophages from Notch3tm1.1Ecan mice revealed increased osteoclast formation, particularly in cocultures with osteoblasts from Notch3tm1.1Ecan mice. In conclusion, the  [CLS] Notch3tm1.1Ecan mutation causes osteopenia [CLS]  despite an increase in osteoblast proliferation and function and is associated with enhanced Tnfsf11 expression in osteoblasts and osteocytes."}
{"subject": "Notch3tm1.1Ecan mutation", "sub_type": "Var", "rel": "CauseOf", "object": "increase", "obj_type": "PosReg", "file_name": "PubMed-30042232.json", "snippet": " in osteocyte-rich femora from Notch3tm1.1Ecan mice. Cultures of bone marrow-derived macrophages from Notch3tm1.1Ecan mice revealed increased osteoclast formation, particularly in cocultures with osteoblasts from Notch3tm1.1Ecan mice. In conclusion, the  [CLS] Notch3tm1.1Ecan mutation causes osteopenia despite an increase [CLS]  in osteoblast proliferation and function and is associated with enhanced Tnfsf11 expression in osteoblasts and osteocytes."}
{"subject": "ABCC8", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-30068891.json", "snippet": " [CLS] ABCC8) mutations [CLS]  are known to cause neonatal diabetes mellitus and maturity-onset diabetes in the young. However, the intrafamilial heterogeneous nature of diabetes caused by the ABCC8 mutation is not fully understood"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "Gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-30068891.json", "snippet": " [CLS] Gain-of-function ATP-binding cassette subfamily C member 8 (ABCC8) mutations [CLS]  are known to cause neonatal diabetes mellitus and maturity-onset diabetes in the young. However, the intrafamilial heterogeneous nature of diabetes caused by the ABCC8 mutation is not fully understood"}
{"subject": "Gain-of-function", "sub_type": "PosReg", "rel": "CauseOf", "object": "cause", "obj_type": "Reg", "file_name": "PubMed-30068891.json", "snippet": " [CLS] Gain-of-function ATP-binding cassette subfamily C member 8 (ABCC8) mutations are known to cause [CLS]  neonatal diabetes mellitus and maturity-onset diabetes in the young. However, the intrafamilial heterogeneous nature of diabetes caused by the ABCC8 mutation is not fully understood to date. To clarify"}
{"subject": "neonatal diabetes mellitus", "sub_type": "Disease", "rel": "ThemeOf", "object": "cause", "obj_type": "Reg", "file_name": "PubMed-30068891.json", "snippet": " in a family with a gain-of-function mutation in the ATP-binding cassette subfamily C member 8 (ABCC8) gene.\nGain-of-function ATP-binding cassette subfamily C member 8 (ABCC8) mutations are known to  [CLS] cause neonatal diabetes mellitus [CLS]  and maturity-onset diabetes in the young. However, the intrafamilial heterogeneous nature of diabetes caused by the ABCC8 mutation is not fully understood to date. To clarify the intrafamilial heterogeneous"}
{"subject": "maturity-onset diabetes", "sub_type": "Disease", "rel": "ThemeOf", "object": "cause", "obj_type": "Reg", "file_name": "PubMed-30068891.json", "snippet": " in a family with a gain-of-function mutation in the ATP-binding cassette subfamily C member 8 (ABCC8) gene.\nGain-of-function ATP-binding cassette subfamily C member 8 (ABCC8) mutations are known to  [CLS] cause neonatal diabetes mellitus and maturity-onset diabetes [CLS]  in the young. However, the intrafamilial heterogeneous nature of diabetes caused by the ABCC8 mutation is not fully understood to date. To clarify the intrafamilial heterogeneous nature of monogenetic"}
{"subject": "ABCC8", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutation", "obj_type": "Var", "file_name": "PubMed-30068891.json", "snippet": " [CLS] mutation in the ATP-binding cassette subfamily C member 8 (ABCC8 [CLS] ) gene.\nGain-of-function ATP-binding cassette subfamily C member 8 (ABCC8) mutations are known to cause neonatal diabetes mellitus and maturity-onset diabetes in the young. However, the intrafamilial heterogeneous nature of"}
{"subject": "mutation", "sub_type": "Var", "rel": "CauseOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-30068891.json", "snippet": " [CLS] gain-of-function mutation [CLS]  in the ATP-binding cassette subfamily C member 8 (ABCC8) gene.\nGain-of-function ATP-binding cassette subfamily C member 8 (ABCC8) mutations are known to cause neonatal diabetes mellitus and maturity-onset diabetes"}
{"subject": "diabetes", "sub_type": "Disease", "rel": "ThemeOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-30068891.json", "snippet": " [CLS] diabetes in a family with a gain-of-function [CLS]  mutation in the ATP-binding cassette subfamily C member 8 (ABCC8) gene.\nGain-of-function ATP-binding cassette subfamily C member 8 (ABCC8) mutations are known to cause neonatal diabetes mellitus and maturity-onset"}
{"subject": "ERBB2", "sub_type": "Gene", "rel": "ThemeOf", "object": "point mutations", "obj_type": "Var", "file_name": "PubMed-30094493.json", "snippet": " [CLS] point mutations of the human epidermal growth factor receptor 2 (HER2) gene (ERBB2 [CLS] ) have been shown to activate the corresponding signaling pathway in breast cancer. The prevalence of ERBB2/HER2 mutation in bone metastasis of breast cancer and the associated phenotype are not"}
{"subject": "point mutations", "sub_type": "Var", "rel": "CauseOf", "object": "activate", "obj_type": "PosReg", "file_name": "PubMed-30094493.json", "snippet": " [CLS] point mutations of the human epidermal growth factor receptor 2 (HER2) gene (ERBB2) have been shown to activate [CLS]  the corresponding signaling pathway in breast cancer. The prevalence of ERBB2/HER2 mutation in bone metastasis of breast cancer and the associated phenotype are not known. In this study, bone"}
{"subject": "signaling pathway", "sub_type": "Pathway", "rel": "ThemeOf", "object": "activate", "obj_type": "PosReg", "file_name": "PubMed-30094493.json", "snippet": " gene mutation in bone metastases from breast cancer.\nIn addition to amplification, point mutations of the human epidermal growth factor receptor 2 (HER2) gene (ERBB2) have been shown to  [CLS] activate the corresponding signaling pathway [CLS]  in breast cancer. The prevalence of ERBB2/HER2 mutation in bone metastasis of breast cancer and the associated phenotype are not known. In this study, bone metastases from breast cancer"}
{"subject": "breast cancer", "sub_type": "Disease", "rel": "ThemeOf", "object": "signaling pathway", "obj_type": "Pathway", "file_name": "PubMed-30094493.json", "snippet": " bone metastases from breast cancer.\nIn addition to amplification, point mutations of the human epidermal growth factor receptor 2 (HER2) gene (ERBB2) have been shown to activate the corresponding  [CLS] signaling pathway in breast cancer [CLS] . The prevalence of ERBB2/HER2 mutation in bone metastasis of breast cancer and the associated phenotype are not known. In this study, bone metastases from breast cancer patients (n\u2009=\u2009231) were"}
{"subject": "mutation", "sub_type": "Var", "rel": "CauseOf", "object": "activating", "obj_type": "PosReg", "file_name": "PubMed-30094493.json", "snippet": " all mutated cases. Among the 14% of metastatic luminal cancers with estrogen receptor gene (ESR1) mutation, conveying resistance against aromatase inhibitors, no concomitant ERBB2/HER2 mutation occurred. We conclude that  [CLS] activating HER2 mutation [CLS]  is present in about 3% of bone metastases from breast cancers, with significantly higher rates in the pleomorphic subtype of lobular cancer. Since mutated cases appear to be HER2-negative"}
{"subject": "activating", "sub_type": "PosReg", "rel": "CauseOf", "object": "higher rates", "obj_type": "PosReg", "file_name": "PubMed-30094493.json", "snippet": " all mutated cases. Among the 14% of metastatic luminal cancers with estrogen receptor gene (ESR1) mutation, conveying resistance against aromatase inhibitors, no concomitant ERBB2/HER2 mutation occurred. We conclude that  [CLS] activating HER2 mutation is present in about 3% of bone metastases from breast cancers, with significantly higher rates [CLS]  in the pleomorphic subtype of lobular cancer. Since mutated cases appear to be HER2-negative by conventional testing, the opportunity for specific anti-HER2 therapy may be missed."}
{"subject": "breast cancers", "sub_type": "Disease", "rel": "ThemeOf", "object": "bone metastases", "obj_type": "CPA", "file_name": "PubMed-30094493.json", "snippet": " cancers with estrogen receptor gene (ESR1) mutation, conveying resistance against aromatase inhibitors, no concomitant ERBB2/HER2 mutation occurred. We conclude that activating HER2 mutation is present in about 3% of  [CLS] bone metastases from breast cancers [CLS] , with significantly higher rates in the pleomorphic subtype of lobular cancer. Since mutated cases appear to be HER2-negative by conventional testing, the opportunity for specific anti-HER2 therapy may be"}
{"subject": "bone metastases", "sub_type": "CPA", "rel": "ThemeOf", "object": "higher rates", "obj_type": "PosReg", "file_name": "PubMed-30094493.json", "snippet": " cancers with estrogen receptor gene (ESR1) mutation, conveying resistance against aromatase inhibitors, no concomitant ERBB2/HER2 mutation occurred. We conclude that activating HER2 mutation is present in about 3% of  [CLS] bone metastases from breast cancers, with significantly higher rates [CLS]  in the pleomorphic subtype of lobular cancer. Since mutated cases appear to be HER2-negative by conventional testing, the opportunity for specific anti-HER2 therapy may be missed."}
{"subject": "HER2", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutation", "obj_type": "Var", "file_name": "PubMed-30094493.json", "snippet": " mutated cases. Among the 14% of metastatic luminal cancers with estrogen receptor gene (ESR1) mutation, conveying resistance against aromatase inhibitors, no concomitant ERBB2/HER2 mutation occurred. We conclude that activating  [CLS] HER2 mutation [CLS]  is present in about 3% of bone metastases from breast cancers, with significantly higher rates in the pleomorphic subtype of lobular cancer. Since mutated cases appear to be HER2-negative"}
{"subject": "PINK1", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutant", "obj_type": "Var", "file_name": "PubMed-30185553.json", "snippet": " (ER) to mitochondria through the ER-mitochondria contact site (ERMCS) critically regulates mitochondrial Ca2+ (mito-Ca2+) homeostasis in dopaminergic (DA) neurons, and that the PD-associated PINK1 protein modulates this process. In  [CLS] PINK1 mutant [CLS]  DA neurons, the ERMCS is strengthened and mito-Ca2+ level is elevated, resulting in mitochondrial enlargement and neuronal death. Miro, a well-characterized component of the mitochondrial trafficking machinery, mediates the"}
{"subject": "mutant", "sub_type": "Var", "rel": "CauseOf", "object": "strengthened", "obj_type": "PosReg", "file_name": "PubMed-30185553.json", "snippet": " to mitochondria through the ER-mitochondria contact site (ERMCS) critically regulates mitochondrial Ca2+ (mito-Ca2+) homeostasis in dopaminergic (DA) neurons, and that the PD-associated PINK1 protein modulates this process. In PINK1  [CLS] mutant DA neurons, the ERMCS is strengthened [CLS]  and mito-Ca2+ level is elevated, resulting in mitochondrial enlargement and neuronal death. Miro, a well-characterized component of the mitochondrial trafficking machinery, mediates the effects of PINK1 on mito-Ca2+ and"}
{"subject": "mutant", "sub_type": "Var", "rel": "CauseOf", "object": "elevated", "obj_type": "PosReg", "file_name": "PubMed-30185553.json", "snippet": " to mitochondria through the ER-mitochondria contact site (ERMCS) critically regulates mitochondrial Ca2+ (mito-Ca2+) homeostasis in dopaminergic (DA) neurons, and that the PD-associated PINK1 protein modulates this process. In PINK1  [CLS] mutant DA neurons, the ERMCS is strengthened and mito-Ca2+ level is elevated [CLS] , resulting in mitochondrial enlargement and neuronal death. Miro, a well-characterized component of the mitochondrial trafficking machinery, mediates the effects of PINK1 on mito-Ca2+ and mitochondrial morphology, apparently in a"}
{"subject": "elevated", "sub_type": "PosReg", "rel": "CauseOf", "object": "enlargement", "obj_type": "PosReg", "file_name": "PubMed-30185553.json", "snippet": " Ca2+ (mito-Ca2+) homeostasis in dopaminergic (DA) neurons, and that the PD-associated PINK1 protein modulates this process. In PINK1 mutant DA neurons, the ERMCS is strengthened and mito-Ca2+ level is  [CLS] elevated, resulting in mitochondrial enlargement [CLS]  and neuronal death. Miro, a well-characterized component of the mitochondrial trafficking machinery, mediates the effects of PINK1 on mito-Ca2+ and mitochondrial morphology, apparently in a transport-independent manner. Miro overexpression"}
{"subject": "ERMCS", "sub_type": "MPA", "rel": "ThemeOf", "object": "strengthened", "obj_type": "PosReg", "file_name": "PubMed-30185553.json", "snippet": " ER-mitochondria contact site (ERMCS) critically regulates mitochondrial Ca2+ (mito-Ca2+) homeostasis in dopaminergic (DA) neurons, and that the PD-associated PINK1 protein modulates this process. In PINK1 mutant DA neurons, the  [CLS] ERMCS is strengthened [CLS]  and mito-Ca2+ level is elevated, resulting in mitochondrial enlargement and neuronal death. Miro, a well-characterized component of the mitochondrial trafficking machinery, mediates the effects of PINK1 on mito-Ca2+ and"}
{"subject": "mito-Ca2+ level", "sub_type": "MPA", "rel": "ThemeOf", "object": "elevated", "obj_type": "PosReg", "file_name": "PubMed-30185553.json", "snippet": " critically regulates mitochondrial Ca2+ (mito-Ca2+) homeostasis in dopaminergic (DA) neurons, and that the PD-associated PINK1 protein modulates this process. In PINK1 mutant DA neurons, the ERMCS is strengthened and  [CLS] mito-Ca2+ level is elevated [CLS] , resulting in mitochondrial enlargement and neuronal death. Miro, a well-characterized component of the mitochondrial trafficking machinery, mediates the effects of PINK1 on mito-Ca2+ and mitochondrial morphology, apparently in a"}
{"subject": "mitochondrial", "sub_type": "MPA", "rel": "ThemeOf", "object": "enlargement", "obj_type": "PosReg", "file_name": "PubMed-30185553.json", "snippet": " in dopaminergic (DA) neurons, and that the PD-associated PINK1 protein modulates this process. In PINK1 mutant DA neurons, the ERMCS is strengthened and mito-Ca2+ level is elevated, resulting in  [CLS] mitochondrial enlargement [CLS]  and neuronal death. Miro, a well-characterized component of the mitochondrial trafficking machinery, mediates the effects of PINK1 on mito-Ca2+ and mitochondrial morphology, apparently in a transport-independent manner. Miro overexpression"}
{"subject": "STAT1", "sub_type": "Gene", "rel": "ThemeOf", "object": "Variant", "obj_type": "Var", "file_name": "PubMed-30187709.json", "snippet": " [CLS] STAT1 Gain-of-Function Variant [CLS] : First Case in Korea.\nBronchiectasis is a chronic disease characterized by airway infection and inflammation, leading to permanent dilation of the bronchi. Evaluation of underlying etiology is important in"}
{"subject": "c.800C>T", "sub_type": "Var", "rel": "CauseOf", "object": "revealed", "obj_type": "Reg", "file_name": "PubMed-30187709.json", "snippet": " who carried a pathogenic variant of the STAT1 gene. The 24-year-old female presented with recurrent respiratory bacterial and nontuberculous mycobacterial infections complicated by severe bronchiectasis and CMC. Whole-exome sequencing  [CLS] revealed a c.800C>T [CLS]  (p.Ala267Val) heterozygous mutation in the STAT1 gene. Further analysis by Sanger sequencing of STAT1 from the patient and her parents revealed the patient had a de novo occurrence of"}
{"subject": "respiratory bacterial and nontuberculous mycobacterial infections", "sub_type": "Disease", "rel": "ThemeOf", "object": "revealed", "obj_type": "Reg", "file_name": "PubMed-30187709.json", "snippet": " we report on a patient with CMC and bronchiectasis with various types of infections who carried a pathogenic variant of the STAT1 gene. The 24-year-old female presented with recurrent  [CLS] respiratory bacterial and nontuberculous mycobacterial infections complicated by severe bronchiectasis and CMC. Whole-exome sequencing revealed [CLS]  a c.800C>T (p.Ala267Val) heterozygous mutation in the STAT1 gene. Further analysis by Sanger sequencing of STAT1 from the patient and her parents revealed the patient had a de novo"}
{"subject": "bronchiectasis", "sub_type": "Disease", "rel": "ThemeOf", "object": "revealed", "obj_type": "Reg", "file_name": "PubMed-30187709.json", "snippet": " with various types of infections who carried a pathogenic variant of the STAT1 gene. The 24-year-old female presented with recurrent respiratory bacterial and nontuberculous mycobacterial infections complicated by severe  [CLS] bronchiectasis and CMC. Whole-exome sequencing revealed [CLS]  a c.800C>T (p.Ala267Val) heterozygous mutation in the STAT1 gene. Further analysis by Sanger sequencing of STAT1 from the patient and her parents revealed the patient had a de novo"}
{"subject": "CMC", "sub_type": "Disease", "rel": "ThemeOf", "object": "revealed", "obj_type": "Reg", "file_name": "PubMed-30187709.json", "snippet": " types of infections who carried a pathogenic variant of the STAT1 gene. The 24-year-old female presented with recurrent respiratory bacterial and nontuberculous mycobacterial infections complicated by severe bronchiectasis and  [CLS] CMC. Whole-exome sequencing revealed [CLS]  a c.800C>T (p.Ala267Val) heterozygous mutation in the STAT1 gene. Further analysis by Sanger sequencing of STAT1 from the patient and her parents revealed the patient had a de novo"}
{"subject": "STAT1", "sub_type": "Gene", "rel": "ThemeOf", "object": "alleles", "obj_type": "Var", "file_name": "PubMed-30187709.json", "snippet": " caused by unusual pathogens. The signal transducer and activator of transcription 1 (STAT1) protein plays a key role in STAT signaling and immune system regulation. Heterozygotes for gain-of-function (GOF)  [CLS] alleles of the STAT1 [CLS]  gene usually display autosomal dominant chronic mucocutaneous candidiasis (CMC) and a wide range of clinical features, such as bronchiectasis. Here, we report on a patient with CMC and bronchiectasis"}
{"subject": "alleles", "sub_type": "Var", "rel": "CauseOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-30187709.json", "snippet": " recurrent infections caused by unusual pathogens. The signal transducer and activator of transcription 1 (STAT1) protein plays a key role in STAT signaling and immune system regulation. Heterozygotes for  [CLS] gain-of-function (GOF) alleles [CLS]  of the STAT1 gene usually display autosomal dominant chronic mucocutaneous candidiasis (CMC) and a wide range of clinical features, such as bronchiectasis. Here, we report on a patient with"}
{"subject": "autosomal dominant chronic mucocutaneous candidiasis", "sub_type": "Disease", "rel": "ThemeOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-30187709.json", "snippet": " recurrent infections caused by unusual pathogens. The signal transducer and activator of transcription 1 (STAT1) protein plays a key role in STAT signaling and immune system regulation. Heterozygotes for  [CLS] gain-of-function (GOF) alleles of the STAT1 gene usually display autosomal dominant chronic mucocutaneous candidiasis [CLS]  (CMC) and a wide range of clinical features, such as bronchiectasis. Here, we report on a patient with CMC and bronchiectasis with various types of infections who carried a"}
{"subject": "bronchiectasis", "sub_type": "Disease", "rel": "ThemeOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-30187709.json", "snippet": " recurrent infections caused by unusual pathogens. The signal transducer and activator of transcription 1 (STAT1) protein plays a key role in STAT signaling and immune system regulation. Heterozygotes for  [CLS] gain-of-function (GOF) alleles of the STAT1 gene usually display autosomal dominant chronic mucocutaneous candidiasis (CMC) and a wide range of clinical features, such as bronchiectasis [CLS] . Here, we report on a patient with CMC and bronchiectasis with various types of infections who carried a pathogenic variant of the STAT1 gene. The 24-year-old female presented with"}
{"subject": "Variant", "sub_type": "Var", "rel": "CauseOf", "object": "Gain-of-Function", "obj_type": "PosReg", "file_name": "PubMed-30187709.json", "snippet": " [CLS] Gain-of-Function Variant [CLS] : First Case in Korea.\nBronchiectasis is a chronic disease characterized by airway infection and inflammation, leading to permanent dilation of the bronchi. Evaluation of underlying etiology is important in"}
{"subject": "Bronchiectasis", "sub_type": "Disease", "rel": "ThemeOf", "object": "Gain-of-Function", "obj_type": "PosReg", "file_name": "PubMed-30187709.json", "snippet": " [CLS] Bronchiectasis and Recurrent Respiratory Infections with a De Novo STAT1 Gain-of-Function [CLS]  Variant: First Case in Korea.\nBronchiectasis is a chronic disease characterized by airway infection and inflammation, leading to permanent dilation of the bronchi. Evaluation of underlying etiology is important"}
{"subject": "Recurrent Respiratory Infections", "sub_type": "Disease", "rel": "ThemeOf", "object": "Gain-of-Function", "obj_type": "PosReg", "file_name": "PubMed-30187709.json", "snippet": " [CLS] Recurrent Respiratory Infections with a De Novo STAT1 Gain-of-Function [CLS]  Variant: First Case in Korea.\nBronchiectasis is a chronic disease characterized by airway infection and inflammation, leading to permanent dilation of the bronchi. Evaluation of underlying etiology is important"}
{"subject": "STAT1", "sub_type": "Gene", "rel": "ThemeOf", "object": "c.800C>T", "obj_type": "Var", "file_name": "PubMed-30187709.json", "snippet": " a pathogenic variant of the STAT1 gene. The 24-year-old female presented with recurrent respiratory bacterial and nontuberculous mycobacterial infections complicated by severe bronchiectasis and CMC. Whole-exome sequencing revealed a  [CLS] c.800C>T (p.Ala267Val) heterozygous mutation in the STAT1 [CLS]  gene. Further analysis by Sanger sequencing of STAT1 from the patient and her parents revealed the patient had a de novo occurrence of the variant. This is the first"}
{"subject": "SOD1", "sub_type": "Gene", "rel": "ThemeOf", "object": "Mutations", "obj_type": "Var", "file_name": "PubMed-30296255.json", "snippet": " [CLS] Mutations in Cu/Zn superoxide dismutase 1 (SOD1 [CLS] ) lead to Amyotrophic Lateral Sclerosis (ALS), a neurodegenerative disease that disproportionately affects glutamatergic and cholinergic motor neurons. Previous work with SOD1 overexpression models supports a role for SOD1 toxic"}
{"subject": "Mutations", "sub_type": "Var", "rel": "CauseOf", "object": "lead to", "obj_type": "Reg", "file_name": "PubMed-30296255.json", "snippet": " [CLS] Mutations in Cu/Zn superoxide dismutase 1 (SOD1) lead to [CLS]  Amyotrophic Lateral Sclerosis (ALS), a neurodegenerative disease that disproportionately affects glutamatergic and cholinergic motor neurons. Previous work with SOD1 overexpression models supports a role for SOD1 toxic gain of"}
{"subject": "Amyotrophic Lateral Sclerosis", "sub_type": "Disease", "rel": "ThemeOf", "object": "lead to", "obj_type": "Reg", "file_name": "PubMed-30296255.json", "snippet": " copy/knock-in models of ALS SOD1 in C. elegans suggest loss and gain of function have different contributions to cholinergic and glutamatergic neurodegeneration.\nMutations in Cu/Zn superoxide dismutase 1 (SOD1)  [CLS] lead to Amyotrophic Lateral Sclerosis [CLS]  (ALS), a neurodegenerative disease that disproportionately affects glutamatergic and cholinergic motor neurons. Previous work with SOD1 overexpression models supports a role for SOD1 toxic gain of function in ALS"}
{"subject": "CYBC1", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutation", "obj_type": "Var", "file_name": "PubMed-30361506.json", "snippet": " [CLS] mutation leading to CYBC1 [CLS]  deficiency causes chronic granulomatous disease.\nMutations in genes encoding subunits of the phagocyte NADPH oxidase complex are recognized to cause chronic granulomatous disease (CGD), a severe primary immunodeficiency. Here"}
{"subject": "chronic granulomatous disease", "sub_type": "Disease", "rel": "ThemeOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-30361506.json", "snippet": " [CLS] loss-of-function mutation leading to CYBC1 deficiency causes chronic granulomatous disease [CLS] .\nMutations in genes encoding subunits of the phagocyte NADPH oxidase complex are recognized to cause chronic granulomatous disease (CGD), a severe primary immunodeficiency. Here we describe how deficiency of"}
{"subject": "CYBC1", "sub_type": "Gene", "rel": "ThemeOf", "object": "p.Tyr2Ter", "obj_type": "Var", "file_name": "PubMed-30361506.json", "snippet": " in humans (C17orf62), leads to reduced expression of NADPH oxidase's main subunit (gp91phox) and results in CGD. Analyzing two brothers diagnosed with CGD we identify a homozygous loss-of-function mutation,  [CLS] p.Tyr2Ter, in CYBC1 [CLS] . Imputation of p.Tyr2Ter into 155K chip-genotyped Icelanders reveals six additional homozygotes, all with signs of CGD, manifesting as colitis, rare infections, or a severely impaired PMA-induced neutrophil oxidative burst."}
{"subject": "p.Tyr2Ter", "sub_type": "Var", "rel": "CauseOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-30361506.json", "snippet": " uncharacterized protein in humans (C17orf62), leads to reduced expression of NADPH oxidase's main subunit (gp91phox) and results in CGD. Analyzing two brothers diagnosed with CGD we identify a homozygous  [CLS] loss-of-function mutation, p.Tyr2Ter [CLS] , in CYBC1. Imputation of p.Tyr2Ter into 155K chip-genotyped Icelanders reveals six additional homozygotes, all with signs of CGD, manifesting as colitis, rare infections, or a severely impaired PMA-induced neutrophil"}
{"subject": "p.Tyr2Ter", "sub_type": "Var", "rel": "CauseOf", "object": "associates with", "obj_type": "Reg", "file_name": "PubMed-30361506.json", "snippet": " p.Tyr2Ter into 155K chip-genotyped Icelanders reveals six additional homozygotes, all with signs of CGD, manifesting as colitis, rare infections, or a severely impaired PMA-induced neutrophil oxidative burst. Homozygosity for  [CLS] p.Tyr2Ter consequently associates with [CLS]  inflammatory bowel disease (IBD) in Iceland (P\u2009=\u20098.3\u2009\u00d7\u200910-8; OR\u2009=\u200967.6), as well as reduced height (P\u2009=\u20093.3\u2009\u00d7\u200910-4; -8.5\u2009cm). Overall, we find that CYBC1 deficiency results in CGD characterized by colitis and a"}
{"subject": "inflammatory bowel disease", "sub_type": "Disease", "rel": "ThemeOf", "object": "associates with", "obj_type": "Reg", "file_name": "PubMed-30361506.json", "snippet": " 155K chip-genotyped Icelanders reveals six additional homozygotes, all with signs of CGD, manifesting as colitis, rare infections, or a severely impaired PMA-induced neutrophil oxidative burst. Homozygosity for p.Tyr2Ter consequently  [CLS] associates with inflammatory bowel disease [CLS]  (IBD) in Iceland (P\u2009=\u20098.3\u2009\u00d7\u200910-8; OR\u2009=\u200967.6), as well as reduced height (P\u2009=\u20093.3\u2009\u00d7\u200910-4; -8.5\u2009cm). Overall, we find that CYBC1 deficiency results in CGD characterized by colitis and a distinct profile of"}
{"subject": "mutation", "sub_type": "Var", "rel": "CauseOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-30361506.json", "snippet": " [CLS] loss-of-function mutation [CLS]  leading to CYBC1 deficiency causes chronic granulomatous disease.\nMutations in genes encoding subunits of the phagocyte NADPH oxidase complex are recognized to cause chronic granulomatous disease (CGD), a severe"}
{"subject": "Mutations", "sub_type": "Var", "rel": "CauseOf", "object": "cause", "obj_type": "Reg", "file_name": "PubMed-30361506.json", "snippet": " [CLS] Mutations in genes encoding subunits of the phagocyte NADPH oxidase complex are recognized to cause [CLS]  chronic granulomatous disease (CGD), a severe primary immunodeficiency. Here we describe how deficiency of CYBC1, a previously uncharacterized protein in humans (C17orf62), leads to reduced expression of NADPH oxidase's"}
{"subject": "chronic granulomatous disease", "sub_type": "Disease", "rel": "ThemeOf", "object": "cause", "obj_type": "Reg", "file_name": "PubMed-30361506.json", "snippet": " [CLS] cause chronic granulomatous disease [CLS]  (CGD), a severe primary immunodeficiency. Here we describe how deficiency of CYBC1, a previously uncharacterized protein in humans (C17orf62), leads to reduced expression of NADPH oxidase's main subunit (gp91phox)"}
{"subject": "single amino acid mutation", "sub_type": "Var", "rel": "CauseOf", "object": "conformational change", "obj_type": "MPA", "file_name": "PubMed-30388729.json", "snippet": " the predicted three-dimensional ZEP structure of zea1, we observed a conformational change on the substrate-binding site in the ZEP. A comparative analysis of the ZEP structures suggested that the  [CLS] conformational change induced by a single amino acid mutation [CLS]  might impact the interaction between the substrate and substrate-binding site, resulting in loss of zeaxanthin epoxidase function."}
{"subject": "glycine to aspartate in a highly conserved region in the catalytic domain", "sub_type": "MPA", "rel": "ThemeOf", "object": "change", "obj_type": "Reg", "file_name": "PubMed-30388729.json", "snippet": " the mutant. We found that the zea1 mutant has a point mutation of the 1337th nucleotide of the ZEP sequence (a change from guanine to adenine), resulting in a  [CLS] change of glycine to aspartate in a highly conserved region in the catalytic domain [CLS] . Similar expression levels of ZEP mRNA and protein in both wild-type and zea1 were confirmed by using qRT-PCR and western blot analysis, respectively. Additionally, the enzyme activity analysis of"}
{"subject": "ZEP", "sub_type": "Enzyme", "rel": "ThemeOf", "object": "conformational change", "obj_type": "MPA", "file_name": "PubMed-30388729.json", "snippet": " the levels of cofactors. From the predicted three-dimensional ZEP structure of zea1, we observed a conformational change on the substrate-binding site in the ZEP. A comparative analysis of the  [CLS] ZEP structures suggested that the conformational change [CLS]  induced by a single amino acid mutation might impact the interaction between the substrate and substrate-binding site, resulting in loss of zeaxanthin epoxidase function."}
{"subject": "conformational change", "sub_type": "MPA", "rel": "CauseOf", "object": "impact", "obj_type": "NegReg", "file_name": "PubMed-30388729.json", "snippet": " the predicted three-dimensional ZEP structure of zea1, we observed a conformational change on the substrate-binding site in the ZEP. A comparative analysis of the ZEP structures suggested that the  [CLS] conformational change induced by a single amino acid mutation might impact [CLS]  the interaction between the substrate and substrate-binding site, resulting in loss of zeaxanthin epoxidase function."}
{"subject": "interaction between the substrate and substrate-binding site", "sub_type": "Interaction", "rel": "ThemeOf", "object": "impact", "obj_type": "NegReg", "file_name": "PubMed-30388729.json", "snippet": " conformational change on the substrate-binding site in the ZEP. A comparative analysis of the ZEP structures suggested that the conformational change induced by a single amino acid mutation might  [CLS] impact the interaction between the substrate and substrate-binding site [CLS] , resulting in loss of zeaxanthin epoxidase function."}
{"subject": "impact", "sub_type": "NegReg", "rel": "CauseOf", "object": "loss", "obj_type": "NegReg", "file_name": "PubMed-30388729.json", "snippet": " conformational change on the substrate-binding site in the ZEP. A comparative analysis of the ZEP structures suggested that the conformational change induced by a single amino acid mutation might  [CLS] impact the interaction between the substrate and substrate-binding site, resulting in loss [CLS]  of zeaxanthin epoxidase function."}
{"subject": "zeaxanthin epoxidase", "sub_type": "Enzyme", "rel": "ThemeOf", "object": "function", "obj_type": "MPA", "file_name": "PubMed-30388729.json", "snippet": " the ZEP structures suggested that the conformational change induced by a single amino acid mutation might impact the interaction between the substrate and substrate-binding site, resulting in loss of  [CLS] zeaxanthin epoxidase function [CLS] ."}
{"subject": "function", "sub_type": "MPA", "rel": "ThemeOf", "object": "loss", "obj_type": "NegReg", "file_name": "PubMed-30388729.json", "snippet": " analysis of the ZEP structures suggested that the conformational change induced by a single amino acid mutation might impact the interaction between the substrate and substrate-binding site, resulting in  [CLS] loss of zeaxanthin epoxidase function [CLS] ."}
{"subject": "ZEP", "sub_type": "Gene", "rel": "ThemeOf", "object": "point mutation", "obj_type": "Var", "file_name": "PubMed-30388729.json", "snippet": " related to zeaxanthin epoxidase (ZEP). In this study, we isolated the ZEP gene from both wild-type D. tertiolecta and the mutant. We found that the zea1 mutant has a  [CLS] point mutation of the 1337th nucleotide of the ZEP [CLS]  sequence (a change from guanine to adenine), resulting in a change of glycine to aspartate in a highly conserved region in the catalytic domain. Similar expression levels of ZEP"}
{"subject": "point mutation", "sub_type": "Var", "rel": "CauseOf", "object": "change", "obj_type": "Reg", "file_name": "PubMed-30388729.json", "snippet": " related to zeaxanthin epoxidase (ZEP). In this study, we isolated the ZEP gene from both wild-type D. tertiolecta and the mutant. We found that the zea1 mutant has a  [CLS] point mutation of the 1337th nucleotide of the ZEP sequence (a change from guanine to adenine), resulting in a change [CLS]  of glycine to aspartate in a highly conserved region in the catalytic domain. Similar expression levels of ZEP mRNA and protein in both wild-type and zea1 were confirmed by"}
{"subject": "LZTR1", "sub_type": "Gene", "rel": "ThemeOf", "object": "inactivation", "obj_type": "Var", "file_name": "PubMed-30442766.json", "snippet": " [CLS] inactivation of the cullin 3 adapter protein-encoding leucine zipper-like transcription regulator 1 (LZTR1 [CLS] ) gene led to enhanced mitogen-activated protein kinase (MAPK) pathway activity and reduced sensitivity to tyrosine kinase inhibitors. Knockdown of the Drosophila LZTR1 ortholog CG3711 resulted in a Ras-dependent gain-of-function"}
{"subject": "Inactivation", "sub_type": "Var", "rel": "CauseOf", "object": "enhanced", "obj_type": "PosReg", "file_name": "PubMed-30442766.json", "snippet": " and reduced sensitivity to tyrosine kinase inhibitors. Knockdown of the Drosophila LZTR1 ortholog CG3711 resulted in a Ras-dependent gain-of-function phenotype. Endogenous human LZTR1 associates with the main RAS isoforms.  [CLS] Inactivation of LZTR1 led to decreased ubiquitination and enhanced [CLS]  plasma membrane localization of endogenous KRAS (V-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog). We propose that LZTR1 acts as a conserved regulator of RAS ubiquitination and MAPK pathway activation."}
{"subject": "plasma membrane localization", "sub_type": "MPA", "rel": "ThemeOf", "object": "enhanced", "obj_type": "PosReg", "file_name": "PubMed-30442766.json", "snippet": " of the Drosophila LZTR1 ortholog CG3711 resulted in a Ras-dependent gain-of-function phenotype. Endogenous human LZTR1 associates with the main RAS isoforms. Inactivation of LZTR1 led to decreased ubiquitination and  [CLS] enhanced plasma membrane localization [CLS]  of endogenous KRAS (V-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog). We propose that LZTR1 acts as a conserved regulator of RAS ubiquitination and MAPK pathway activation. Because LZTR1 disease"}
{"subject": "inactivation", "sub_type": "Var", "rel": "CauseOf", "object": "enhanced", "obj_type": "PosReg", "file_name": "PubMed-30442766.json", "snippet": " [CLS] inactivation of the cullin 3 adapter protein-encoding leucine zipper-like transcription regulator 1 (LZTR1) gene led to enhanced [CLS]  mitogen-activated protein kinase (MAPK) pathway activity and reduced sensitivity to tyrosine kinase inhibitors. Knockdown of the Drosophila LZTR1 ortholog CG3711 resulted in a Ras-dependent gain-of-function phenotype. Endogenous human LZTR1"}
{"subject": "activity", "sub_type": "MPA", "rel": "ThemeOf", "object": "enhanced", "obj_type": "PosReg", "file_name": "PubMed-30442766.json", "snippet": " genetic screens aimed at understanding drug resistance mechanisms in chronic myeloid leukemia cells, inactivation of the cullin 3 adapter protein-encoding leucine zipper-like transcription regulator 1 (LZTR1) gene led to  [CLS] enhanced mitogen-activated protein kinase (MAPK) pathway activity [CLS]  and reduced sensitivity to tyrosine kinase inhibitors. Knockdown of the Drosophila LZTR1 ortholog CG3711 resulted in a Ras-dependent gain-of-function phenotype. Endogenous human LZTR1 associates with the main RAS isoforms."}
{"subject": "mitogen-activated protein kinase (MAPK) pathway", "sub_type": "Pathway", "rel": "ThemeOf", "object": "activity", "obj_type": "MPA", "file_name": "PubMed-30442766.json", "snippet": " screens aimed at understanding drug resistance mechanisms in chronic myeloid leukemia cells, inactivation of the cullin 3 adapter protein-encoding leucine zipper-like transcription regulator 1 (LZTR1) gene led to enhanced  [CLS] mitogen-activated protein kinase (MAPK) pathway activity [CLS]  and reduced sensitivity to tyrosine kinase inhibitors. Knockdown of the Drosophila LZTR1 ortholog CG3711 resulted in a Ras-dependent gain-of-function phenotype. Endogenous human LZTR1 associates with the main RAS isoforms."}
{"subject": "inactivation", "sub_type": "Var", "rel": "CauseOf", "object": "reduced", "obj_type": "NegReg", "file_name": "PubMed-30442766.json", "snippet": " [CLS] inactivation of the cullin 3 adapter protein-encoding leucine zipper-like transcription regulator 1 (LZTR1) gene led to enhanced mitogen-activated protein kinase (MAPK) pathway activity and reduced [CLS]  sensitivity to tyrosine kinase inhibitors. Knockdown of the Drosophila LZTR1 ortholog CG3711 resulted in a Ras-dependent gain-of-function phenotype. Endogenous human LZTR1 associates with the main RAS isoforms. Inactivation of"}
{"subject": "sensitivity to tyrosine kinase inhibitors", "sub_type": "MPA", "rel": "ThemeOf", "object": "reduced", "obj_type": "NegReg", "file_name": "PubMed-30442766.json", "snippet": " in chronic myeloid leukemia cells, inactivation of the cullin 3 adapter protein-encoding leucine zipper-like transcription regulator 1 (LZTR1) gene led to enhanced mitogen-activated protein kinase (MAPK) pathway activity and  [CLS] reduced sensitivity to tyrosine kinase inhibitors [CLS] . Knockdown of the Drosophila LZTR1 ortholog CG3711 resulted in a Ras-dependent gain-of-function phenotype. Endogenous human LZTR1 associates with the main RAS isoforms. Inactivation of LZTR1 led to decreased ubiquitination"}
{"subject": "LZTR1", "sub_type": "Gene", "rel": "ThemeOf", "object": "Inactivation", "obj_type": "Var", "file_name": "PubMed-30442766.json", "snippet": " and reduced sensitivity to tyrosine kinase inhibitors. Knockdown of the Drosophila LZTR1 ortholog CG3711 resulted in a Ras-dependent gain-of-function phenotype. Endogenous human LZTR1 associates with the main RAS isoforms.  [CLS] Inactivation of LZTR1 [CLS]  led to decreased ubiquitination and enhanced plasma membrane localization of endogenous KRAS (V-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog). We propose that LZTR1 acts as a conserved regulator of"}
{"subject": "Inactivation", "sub_type": "Var", "rel": "CauseOf", "object": "decreased", "obj_type": "NegReg", "file_name": "PubMed-30442766.json", "snippet": " and reduced sensitivity to tyrosine kinase inhibitors. Knockdown of the Drosophila LZTR1 ortholog CG3711 resulted in a Ras-dependent gain-of-function phenotype. Endogenous human LZTR1 associates with the main RAS isoforms.  [CLS] Inactivation of LZTR1 led to decreased [CLS]  ubiquitination and enhanced plasma membrane localization of endogenous KRAS (V-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog). We propose that LZTR1 acts as a conserved regulator of RAS ubiquitination and"}
{"subject": "ubiquitination", "sub_type": "MPA", "rel": "ThemeOf", "object": "decreased", "obj_type": "NegReg", "file_name": "PubMed-30442766.json", "snippet": " kinase inhibitors. Knockdown of the Drosophila LZTR1 ortholog CG3711 resulted in a Ras-dependent gain-of-function phenotype. Endogenous human LZTR1 associates with the main RAS isoforms. Inactivation of LZTR1 led to  [CLS] decreased ubiquitination [CLS]  and enhanced plasma membrane localization of endogenous KRAS (V-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog). We propose that LZTR1 acts as a conserved regulator of RAS ubiquitination and MAPK"}
{"subject": "TTN", "sub_type": "Gene", "rel": "ThemeOf", "object": "variant", "obj_type": "Var", "file_name": "PubMed-30535219.json", "snippet": " in 2.1% of case participants compared with 1.1% in control participants (odds ratio [OR], 1.76 [95% CI, 1.04-2.97]). The proportion of individuals with early-onset AF who carried a LOF  [CLS] variant in TTN [CLS]  increased with an earlier age of AF onset (P value for trend, 4.92\u2009\u00d7\u200910-4), and 6.5% of individuals with AF onset prior to age 30 carried a TTN LOF variant"}
{"subject": "variant", "sub_type": "Var", "rel": "CauseOf", "object": "LOF", "obj_type": "PosReg", "file_name": "PubMed-30535219.json", "snippet": " present in 2.1% of case participants compared with 1.1% in control participants (odds ratio [OR], 1.76 [95% CI, 1.04-2.97]). The proportion of individuals with early-onset AF who carried a  [CLS] LOF variant [CLS]  in TTN increased with an earlier age of AF onset (P value for trend, 4.92\u2009\u00d7\u200910-4), and 6.5% of individuals with AF onset prior to age 30 carried a TTN"}
{"subject": "LOF", "sub_type": "PosReg", "rel": "CauseOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-30535219.json", "snippet": " present in 2.1% of case participants compared with 1.1% in control participants (odds ratio [OR], 1.76 [95% CI, 1.04-2.97]). The proportion of individuals with early-onset AF who carried a  [CLS] LOF variant in TTN increased [CLS]  with an earlier age of AF onset (P value for trend, 4.92\u2009\u00d7\u200910-4), and 6.5% of individuals with AF onset prior to age 30 carried a TTN LOF variant (OR,"}
{"subject": "early-onset AF", "sub_type": "Disease", "rel": "ThemeOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-30535219.json", "snippet": " the sarcomeric protein titin, was present in 2.1% of case participants compared with 1.1% in control participants (odds ratio [OR], 1.76 [95% CI, 1.04-2.97]). The proportion of individuals with  [CLS] early-onset AF who carried a LOF variant in TTN increased [CLS]  with an earlier age of AF onset (P value for trend, 4.92\u2009\u00d7\u200910-4), and 6.5% of individuals with AF onset prior to age 30 carried a TTN LOF variant (OR,"}
{"subject": "TTN", "sub_type": "Gene", "rel": "ThemeOf", "object": "variant", "obj_type": "Var", "file_name": "PubMed-30535219.json", "snippet": " early-onset AF (cases) and 41\u202f200 control participants (OR, 2.16 [95% CI, 1.19-3.92]; P\u2009=\u2009.01).\nConclusions and Relevance: In a case-control study, there was a statistically significant association between an LOF  [CLS] variant in the TTN [CLS]  gene and early-onset AF, with the variant present in a small percentage of participants with early-onset AF (the case group). Further research is necessary to understand whether this is"}
{"subject": "variant", "sub_type": "Var", "rel": "CauseOf", "object": "LOF", "obj_type": "NegReg", "file_name": "PubMed-30535219.json", "snippet": " with early-onset AF (cases) and 41\u202f200 control participants (OR, 2.16 [95% CI, 1.19-3.92]; P\u2009=\u2009.01).\nConclusions and Relevance: In a case-control study, there was a statistically significant association between an  [CLS] LOF variant [CLS]  in the TTN gene and early-onset AF, with the variant present in a small percentage of participants with early-onset AF (the case group). Further research is necessary to understand"}
{"subject": "LOF", "sub_type": "NegReg", "rel": "CauseOf", "object": "significant association", "obj_type": "Reg", "file_name": "PubMed-30535219.json", "snippet": " study of 1582 patients with early-onset AF (cases) and 41\u202f200 control participants (OR, 2.16 [95% CI, 1.19-3.92]; P\u2009=\u2009.01).\nConclusions and Relevance: In a case-control study, there was a statistically  [CLS] significant association between an LOF [CLS]  variant in the TTN gene and early-onset AF, with the variant present in a small percentage of participants with early-onset AF (the case group). Further research is necessary to"}
{"subject": "early-onset AF", "sub_type": "Disease", "rel": "ThemeOf", "object": "significant association", "obj_type": "Reg", "file_name": "PubMed-30535219.json", "snippet": " study of 1582 patients with early-onset AF (cases) and 41\u202f200 control participants (OR, 2.16 [95% CI, 1.19-3.92]; P\u2009=\u2009.01).\nConclusions and Relevance: In a case-control study, there was a statistically  [CLS] significant association between an LOF variant in the TTN gene and early-onset AF [CLS] , with the variant present in a small percentage of participants with early-onset AF (the case group). Further research is necessary to understand whether this is a causal relationship."}
{"subject": "RIG-I", "sub_type": "Gene", "rel": "ThemeOf", "object": "C268F", "obj_type": "Var", "file_name": "PubMed-30560918.json", "snippet": " checkpoints that compromise discrimination against self RNA during RIG-I mediated autoimmunity.\nRetinoic acid inducible gene-I (RIG-I) ensures immune surveillance of viral RNAs bearing a 5'-triphosphate (5'ppp) moiety. Mutations in  [CLS] RIG-I (C268F [CLS]  and E373A) lead to impaired ATPase activity, thereby driving hyperactive signaling associated with autoimmune diseases. Here we report, using hydrogen/deuterium exchange, mechanistic models for dysregulated RIG-I proofreading that ultimately"}
{"subject": "H830A mutation", "sub_type": "Var", "rel": "CauseOf", "object": "restores", "obj_type": "PosReg", "file_name": "PubMed-30560918.json", "snippet": " 7-methylguanosine and N1-2'-O-methylation (Cap1) on the 5' end. Cap1-RNA compromises its ability to stabilize RIG-I helicase and blunts caspase activation and recruitment domains (CARD) partial opening by threefold. RIG-I  [CLS] H830A mutation restores [CLS]  Cap1-helicase engagement as well as CARDs partial opening event to a level comparable to that of 5'ppp. However, E373A RIG-I locks the receptor in an ATP-bound state, resulting in"}
{"subject": "Cap1-helicase", "sub_type": "Protein", "rel": "ThemeOf", "object": "engagement", "obj_type": "MPA", "file_name": "PubMed-30560918.json", "snippet": " (Cap1) on the 5' end. Cap1-RNA compromises its ability to stabilize RIG-I helicase and blunts caspase activation and recruitment domains (CARD) partial opening by threefold. RIG-I H830A mutation restores  [CLS] Cap1-helicase engagement [CLS]  as well as CARDs partial opening event to a level comparable to that of 5'ppp. However, E373A RIG-I locks the receptor in an ATP-bound state, resulting in enhanced Cap1-helicase"}
{"subject": "engagement", "sub_type": "MPA", "rel": "ThemeOf", "object": "restores", "obj_type": "PosReg", "file_name": "PubMed-30560918.json", "snippet": " N1-2'-O-methylation (Cap1) on the 5' end. Cap1-RNA compromises its ability to stabilize RIG-I helicase and blunts caspase activation and recruitment domains (CARD) partial opening by threefold. RIG-I H830A mutation  [CLS] restores Cap1-helicase engagement [CLS]  as well as CARDs partial opening event to a level comparable to that of 5'ppp. However, E373A RIG-I locks the receptor in an ATP-bound state, resulting in enhanced Cap1-helicase"}
{"subject": "CARDs partial opening event", "sub_type": "MPA", "rel": "ThemeOf", "object": "restores", "obj_type": "PosReg", "file_name": "PubMed-30560918.json", "snippet": " N1-2'-O-methylation (Cap1) on the 5' end. Cap1-RNA compromises its ability to stabilize RIG-I helicase and blunts caspase activation and recruitment domains (CARD) partial opening by threefold. RIG-I H830A mutation  [CLS] restores Cap1-helicase engagement as well as CARDs partial opening event [CLS]  to a level comparable to that of 5'ppp. However, E373A RIG-I locks the receptor in an ATP-bound state, resulting in enhanced Cap1-helicase engagement and a sequential CARDs stimulation. C268F"}
{"subject": "RIG-I", "sub_type": "Gene", "rel": "ThemeOf", "object": "E373A", "obj_type": "Var", "file_name": "PubMed-30560918.json", "snippet": " recruitment domains (CARD) partial opening by threefold. RIG-I H830A mutation restores Cap1-helicase engagement as well as CARDs partial opening event to a level comparable to that of 5'ppp. However,  [CLS] E373A RIG-I [CLS]  locks the receptor in an ATP-bound state, resulting in enhanced Cap1-helicase engagement and a sequential CARDs stimulation. C268F mutation renders a more tethered ring architecture and results in constitutive"}
{"subject": "E373A", "sub_type": "Var", "rel": "CauseOf", "object": "enhanced", "obj_type": "PosReg", "file_name": "PubMed-30560918.json", "snippet": " recruitment domains (CARD) partial opening by threefold. RIG-I H830A mutation restores Cap1-helicase engagement as well as CARDs partial opening event to a level comparable to that of 5'ppp. However,  [CLS] E373A RIG-I locks the receptor in an ATP-bound state, resulting in enhanced [CLS]  Cap1-helicase engagement and a sequential CARDs stimulation. C268F mutation renders a more tethered ring architecture and results in constitutive CARDs signaling in an ATP-independent manner."}
{"subject": "Cap1-helicase", "sub_type": "Protein", "rel": "ThemeOf", "object": "engagement", "obj_type": "MPA", "file_name": "PubMed-30560918.json", "snippet": " engagement as well as CARDs partial opening event to a level comparable to that of 5'ppp. However, E373A RIG-I locks the receptor in an ATP-bound state, resulting in enhanced  [CLS] Cap1-helicase engagement [CLS]  and a sequential CARDs stimulation. C268F mutation renders a more tethered ring architecture and results in constitutive CARDs signaling in an ATP-independent manner."}
{"subject": "engagement", "sub_type": "MPA", "rel": "ThemeOf", "object": "enhanced", "obj_type": "PosReg", "file_name": "PubMed-30560918.json", "snippet": " Cap1-helicase engagement as well as CARDs partial opening event to a level comparable to that of 5'ppp. However, E373A RIG-I locks the receptor in an ATP-bound state, resulting in  [CLS] enhanced Cap1-helicase engagement [CLS]  and a sequential CARDs stimulation. C268F mutation renders a more tethered ring architecture and results in constitutive CARDs signaling in an ATP-independent manner."}
{"subject": "sequential CARDs stimulation", "sub_type": "MPA", "rel": "ThemeOf", "object": "enhanced", "obj_type": "PosReg", "file_name": "PubMed-30560918.json", "snippet": " Cap1-helicase engagement as well as CARDs partial opening event to a level comparable to that of 5'ppp. However, E373A RIG-I locks the receptor in an ATP-bound state, resulting in  [CLS] enhanced Cap1-helicase engagement and a sequential CARDs stimulation [CLS] . C268F mutation renders a more tethered ring architecture and results in constitutive CARDs signaling in an ATP-independent manner."}
{"subject": "C268F mutation", "sub_type": "Var", "rel": "CauseOf", "object": "more", "obj_type": "PosReg", "file_name": "PubMed-30560918.json", "snippet": " event to a level comparable to that of 5'ppp. However, E373A RIG-I locks the receptor in an ATP-bound state, resulting in enhanced Cap1-helicase engagement and a sequential CARDs stimulation.  [CLS] C268F mutation renders a more [CLS]  tethered ring architecture and results in constitutive CARDs signaling in an ATP-independent manner."}
{"subject": "RIG-I", "sub_type": "Gene", "rel": "ThemeOf", "object": "E373A", "obj_type": "Var", "file_name": "PubMed-30560918.json", "snippet": " checkpoints that compromise discrimination against self RNA during RIG-I mediated autoimmunity.\nRetinoic acid inducible gene-I (RIG-I) ensures immune surveillance of viral RNAs bearing a 5'-triphosphate (5'ppp) moiety. Mutations in  [CLS] RIG-I (C268F and E373A [CLS] ) lead to impaired ATPase activity, thereby driving hyperactive signaling associated with autoimmune diseases. Here we report, using hydrogen/deuterium exchange, mechanistic models for dysregulated RIG-I proofreading that ultimately result in"}
{"subject": "tethered ring architecture", "sub_type": "MPA", "rel": "ThemeOf", "object": "more", "obj_type": "PosReg", "file_name": "PubMed-30560918.json", "snippet": " comparable to that of 5'ppp. However, E373A RIG-I locks the receptor in an ATP-bound state, resulting in enhanced Cap1-helicase engagement and a sequential CARDs stimulation. C268F mutation renders a  [CLS] more tethered ring architecture [CLS]  and results in constitutive CARDs signaling in an ATP-independent manner."}
{"subject": "C268F mutation", "sub_type": "Var", "rel": "CauseOf", "object": "results in", "obj_type": "Reg", "file_name": "PubMed-30560918.json", "snippet": " event to a level comparable to that of 5'ppp. However, E373A RIG-I locks the receptor in an ATP-bound state, resulting in enhanced Cap1-helicase engagement and a sequential CARDs stimulation.  [CLS] C268F mutation renders a more tethered ring architecture and results in [CLS]  constitutive CARDs signaling in an ATP-independent manner."}
{"subject": "constitutive CARDs signaling", "sub_type": "MPA", "rel": "ThemeOf", "object": "results in", "obj_type": "Reg", "file_name": "PubMed-30560918.json", "snippet": " However, E373A RIG-I locks the receptor in an ATP-bound state, resulting in enhanced Cap1-helicase engagement and a sequential CARDs stimulation. C268F mutation renders a more tethered ring architecture and  [CLS] results in constitutive CARDs signaling [CLS]  in an ATP-independent manner."}
{"subject": "C268F", "sub_type": "Var", "rel": "CauseOf", "object": "impaired", "obj_type": "NegReg", "file_name": "PubMed-30560918.json", "snippet": " that compromise discrimination against self RNA during RIG-I mediated autoimmunity.\nRetinoic acid inducible gene-I (RIG-I) ensures immune surveillance of viral RNAs bearing a 5'-triphosphate (5'ppp) moiety. Mutations in RIG-I ( [CLS] C268F and E373A) lead to impaired [CLS]  ATPase activity, thereby driving hyperactive signaling associated with autoimmune diseases. Here we report, using hydrogen/deuterium exchange, mechanistic models for dysregulated RIG-I proofreading that ultimately result in the improper recognition"}
{"subject": "E373A", "sub_type": "Var", "rel": "CauseOf", "object": "impaired", "obj_type": "NegReg", "file_name": "PubMed-30560918.json", "snippet": " discrimination against self RNA during RIG-I mediated autoimmunity.\nRetinoic acid inducible gene-I (RIG-I) ensures immune surveillance of viral RNAs bearing a 5'-triphosphate (5'ppp) moiety. Mutations in RIG-I (C268F and  [CLS] E373A) lead to impaired [CLS]  ATPase activity, thereby driving hyperactive signaling associated with autoimmune diseases. Here we report, using hydrogen/deuterium exchange, mechanistic models for dysregulated RIG-I proofreading that ultimately result in the improper recognition"}
{"subject": "ATPase", "sub_type": "Protein", "rel": "ThemeOf", "object": "activity", "obj_type": "MPA", "file_name": "PubMed-30560918.json", "snippet": " during RIG-I mediated autoimmunity.\nRetinoic acid inducible gene-I (RIG-I) ensures immune surveillance of viral RNAs bearing a 5'-triphosphate (5'ppp) moiety. Mutations in RIG-I (C268F and E373A) lead to impaired  [CLS] ATPase activity [CLS] , thereby driving hyperactive signaling associated with autoimmune diseases. Here we report, using hydrogen/deuterium exchange, mechanistic models for dysregulated RIG-I proofreading that ultimately result in the improper recognition of cellular"}
{"subject": "activity", "sub_type": "MPA", "rel": "ThemeOf", "object": "impaired", "obj_type": "NegReg", "file_name": "PubMed-30560918.json", "snippet": " RNA during RIG-I mediated autoimmunity.\nRetinoic acid inducible gene-I (RIG-I) ensures immune surveillance of viral RNAs bearing a 5'-triphosphate (5'ppp) moiety. Mutations in RIG-I (C268F and E373A) lead to  [CLS] impaired ATPase activity [CLS] , thereby driving hyperactive signaling associated with autoimmune diseases. Here we report, using hydrogen/deuterium exchange, mechanistic models for dysregulated RIG-I proofreading that ultimately result in the improper recognition of cellular"}
{"subject": "impaired", "sub_type": "NegReg", "rel": "CauseOf", "object": "hyperactive", "obj_type": "PosReg", "file_name": "PubMed-30560918.json", "snippet": " RNA during RIG-I mediated autoimmunity.\nRetinoic acid inducible gene-I (RIG-I) ensures immune surveillance of viral RNAs bearing a 5'-triphosphate (5'ppp) moiety. Mutations in RIG-I (C268F and E373A) lead to  [CLS] impaired ATPase activity, thereby driving hyperactive [CLS]  signaling associated with autoimmune diseases. Here we report, using hydrogen/deuterium exchange, mechanistic models for dysregulated RIG-I proofreading that ultimately result in the improper recognition of cellular RNAs bearing 7-methylguanosine"}
{"subject": "signaling", "sub_type": "MPA", "rel": "ThemeOf", "object": "hyperactive", "obj_type": "PosReg", "file_name": "PubMed-30560918.json", "snippet": "\nRetinoic acid inducible gene-I (RIG-I) ensures immune surveillance of viral RNAs bearing a 5'-triphosphate (5'ppp) moiety. Mutations in RIG-I (C268F and E373A) lead to impaired ATPase activity, thereby driving  [CLS] hyperactive signaling [CLS]  associated with autoimmune diseases. Here we report, using hydrogen/deuterium exchange, mechanistic models for dysregulated RIG-I proofreading that ultimately result in the improper recognition of cellular RNAs bearing 7-methylguanosine and"}
{"subject": "RIG-I", "sub_type": "Gene", "rel": "ThemeOf", "object": "H830A mutation", "obj_type": "Var", "file_name": "PubMed-30560918.json", "snippet": " bearing 7-methylguanosine and N1-2'-O-methylation (Cap1) on the 5' end. Cap1-RNA compromises its ability to stabilize RIG-I helicase and blunts caspase activation and recruitment domains (CARD) partial opening by threefold.  [CLS] RIG-I H830A mutation [CLS]  restores Cap1-helicase engagement as well as CARDs partial opening event to a level comparable to that of 5'ppp. However, E373A RIG-I locks the receptor in an ATP-bound state, resulting"}
{"subject": "PRLR", "sub_type": "Gene", "rel": "ThemeOf", "object": "variants", "obj_type": "Var", "file_name": "PubMed-30575453.json", "snippet": " 35-year-old woman who presented with idiopathic hyperprolactinemia that was associated with a complete lack of lactation after each of her two deliveries. She is a compound heterozygote for loss-of-function  [CLS] variants of PRLR [CLS] . Her unaffected parents are heterozygotes. These findings are consistent with previous work showing that mice deficient in functional Prlr do not lactate."}
{"subject": "variants", "sub_type": "Var", "rel": "CauseOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-30575453.json", "snippet": " a 35-year-old woman who presented with idiopathic hyperprolactinemia that was associated with a complete lack of lactation after each of her two deliveries. She is a compound heterozygote for  [CLS] loss-of-function variants [CLS]  of PRLR. Her unaffected parents are heterozygotes. These findings are consistent with previous work showing that mice deficient in functional Prlr do not lactate."}
{"subject": "loss-of-function", "sub_type": "NegReg", "rel": "CauseOf", "object": "not", "obj_type": "NegReg", "file_name": "PubMed-30575453.json", "snippet": " a 35-year-old woman who presented with idiopathic hyperprolactinemia that was associated with a complete lack of lactation after each of her two deliveries. She is a compound heterozygote for  [CLS] loss-of-function variants of PRLR. Her unaffected parents are heterozygotes. These findings are consistent with previous work showing that mice deficient in functional Prlr do not [CLS]  lactate."}
{"subject": "lactate", "sub_type": "CPA", "rel": "ThemeOf", "object": "not", "obj_type": "NegReg", "file_name": "PubMed-30575453.json", "snippet": " is a compound heterozygote for loss-of-function variants of PRLR. Her unaffected parents are heterozygotes. These findings are consistent with previous work showing that mice deficient in functional Prlr do  [CLS] not lactate [CLS] ."}
{"subject": "not", "sub_type": "NegReg", "rel": "CauseOf", "object": "hyperprolactinemia", "obj_type": "Disease", "file_name": "PubMed-30575453.json", "snippet": " PRLR) was reported previously in a woman with persistent postpartum galactorrhea; however, this paradoxical phenotype is not completely understood. Here we describe a 35-year-old woman who presented with idiopathic  [CLS] hyperprolactinemia that was associated with a complete lack of lactation after each of her two deliveries. She is a compound heterozygote for loss-of-function variants of PRLR. Her unaffected parents are heterozygotes. These findings are consistent with previous work showing that mice deficient in functional Prlr do not [CLS]  lactate."}
{"subject": "Cd tolerance", "sub_type": "CPA", "rel": "ThemeOf", "object": "Enhanced", "obj_type": "PosReg", "file_name": "PubMed-30617455.json", "snippet": " of the WRKY transcription factor WRKY12 in the regulation of Cd tolerance by repressing the expression of PC synthesis-related genes. The expression of WRKY12 was inhibited by Cd stress.  [CLS] Enhanced Cd tolerance [CLS]  was observed in the WRKY12 loss-of-function mutants, whereas increased Cd sensitivity was found in the WRKY12-overexpressing plants. Overexpression and loss-of-function of WRKY12 were associated respectively with increased and decreased"}
{"subject": "GSH1", "sub_type": "Gene", "rel": "ThemeOf", "object": "expression", "obj_type": "MPA", "file_name": "PubMed-30617455.json", "snippet": " whereas increased Cd sensitivity was found in the WRKY12-overexpressing plants. Overexpression and loss-of-function of WRKY12 were associated respectively with increased and decreased Cd accumulation by repressing or releasing the  [CLS] expression of the genes involved in the PC synthesis pathway. Transient expression assay showed that WRKY12 repressed the expression of GSH1 [CLS] , GSH2, PCS1, and PCS2. Further analysis indicated that WRKY12 could directly bind to the W-box of the promoter in GSH1 but not in GSH2, PCS1, and PCS2 in vivo."}
{"subject": "GSH2", "sub_type": "Gene", "rel": "ThemeOf", "object": "expression", "obj_type": "MPA", "file_name": "PubMed-30617455.json", "snippet": " whereas increased Cd sensitivity was found in the WRKY12-overexpressing plants. Overexpression and loss-of-function of WRKY12 were associated respectively with increased and decreased Cd accumulation by repressing or releasing the  [CLS] expression of the genes involved in the PC synthesis pathway. Transient expression assay showed that WRKY12 repressed the expression of GSH1, GSH2 [CLS] , PCS1, and PCS2. Further analysis indicated that WRKY12 could directly bind to the W-box of the promoter in GSH1 but not in GSH2, PCS1, and PCS2 in vivo. Together,"}
{"subject": "PCS1", "sub_type": "Gene", "rel": "ThemeOf", "object": "expression", "obj_type": "MPA", "file_name": "PubMed-30617455.json", "snippet": " whereas increased Cd sensitivity was found in the WRKY12-overexpressing plants. Overexpression and loss-of-function of WRKY12 were associated respectively with increased and decreased Cd accumulation by repressing or releasing the  [CLS] expression of the genes involved in the PC synthesis pathway. Transient expression assay showed that WRKY12 repressed the expression of GSH1, GSH2, PCS1 [CLS] , and PCS2. Further analysis indicated that WRKY12 could directly bind to the W-box of the promoter in GSH1 but not in GSH2, PCS1, and PCS2 in vivo. Together, our"}
{"subject": "PCS2", "sub_type": "Gene", "rel": "ThemeOf", "object": "expression", "obj_type": "MPA", "file_name": "PubMed-30617455.json", "snippet": " whereas increased Cd sensitivity was found in the WRKY12-overexpressing plants. Overexpression and loss-of-function of WRKY12 were associated respectively with increased and decreased Cd accumulation by repressing or releasing the  [CLS] expression of the genes involved in the PC synthesis pathway. Transient expression assay showed that WRKY12 repressed the expression of GSH1, GSH2, PCS1, and PCS2 [CLS] . Further analysis indicated that WRKY12 could directly bind to the W-box of the promoter in GSH1 but not in GSH2, PCS1, and PCS2 in vivo. Together, our results suggest"}
{"subject": "WRKY12", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutants", "obj_type": "Var", "file_name": "PubMed-30617455.json", "snippet": " the regulation of Cd tolerance by repressing the expression of PC synthesis-related genes. The expression of WRKY12 was inhibited by Cd stress. Enhanced Cd tolerance was observed in the  [CLS] WRKY12 loss-of-function mutants [CLS] , whereas increased Cd sensitivity was found in the WRKY12-overexpressing plants. Overexpression and loss-of-function of WRKY12 were associated respectively with increased and decreased Cd accumulation by repressing or releasing the"}
{"subject": "mutants", "sub_type": "Var", "rel": "CauseOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-30617455.json", "snippet": " regulation of Cd tolerance by repressing the expression of PC synthesis-related genes. The expression of WRKY12 was inhibited by Cd stress. Enhanced Cd tolerance was observed in the WRKY12  [CLS] loss-of-function mutants [CLS] , whereas increased Cd sensitivity was found in the WRKY12-overexpressing plants. Overexpression and loss-of-function of WRKY12 were associated respectively with increased and decreased Cd accumulation by repressing or releasing the"}
{"subject": "loss-of-function", "sub_type": "NegReg", "rel": "CauseOf", "object": "Enhanced", "obj_type": "PosReg", "file_name": "PubMed-30617455.json", "snippet": " of the WRKY transcription factor WRKY12 in the regulation of Cd tolerance by repressing the expression of PC synthesis-related genes. The expression of WRKY12 was inhibited by Cd stress.  [CLS] Enhanced Cd tolerance was observed in the WRKY12 loss-of-function [CLS]  mutants, whereas increased Cd sensitivity was found in the WRKY12-overexpressing plants. Overexpression and loss-of-function of WRKY12 were associated respectively with increased and decreased Cd accumulation by repressing or releasing"}
{"subject": "WRKY12", "sub_type": "Gene", "rel": "ThemeOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-30617455.json", "snippet": " of WRKY12 was inhibited by Cd stress. Enhanced Cd tolerance was observed in the WRKY12 loss-of-function mutants, whereas increased Cd sensitivity was found in the WRKY12-overexpressing plants. Overexpression and  [CLS] loss-of-function of WRKY12 [CLS]  were associated respectively with increased and decreased Cd accumulation by repressing or releasing the expression of the genes involved in the PC synthesis pathway. Transient expression assay showed that"}
{"subject": "loss-of-function", "sub_type": "NegReg", "rel": "CauseOf", "object": "releasing", "obj_type": "PosReg", "file_name": "PubMed-30617455.json", "snippet": " of WRKY12 was inhibited by Cd stress. Enhanced Cd tolerance was observed in the WRKY12 loss-of-function mutants, whereas increased Cd sensitivity was found in the WRKY12-overexpressing plants. Overexpression and  [CLS] loss-of-function of WRKY12 were associated respectively with increased and decreased Cd accumulation by repressing or releasing [CLS]  the expression of the genes involved in the PC synthesis pathway. Transient expression assay showed that WRKY12 repressed the expression of GSH1, GSH2, PCS1, and PCS2. Further analysis indicated"}
{"subject": "expression", "sub_type": "MPA", "rel": "ThemeOf", "object": "releasing", "obj_type": "PosReg", "file_name": "PubMed-30617455.json", "snippet": " loss-of-function mutants, whereas increased Cd sensitivity was found in the WRKY12-overexpressing plants. Overexpression and loss-of-function of WRKY12 were associated respectively with increased and decreased Cd accumulation by repressing or  [CLS] releasing the expression [CLS]  of the genes involved in the PC synthesis pathway. Transient expression assay showed that WRKY12 repressed the expression of GSH1, GSH2, PCS1, and PCS2. Further analysis indicated that WRKY12"}
{"subject": "releasing", "sub_type": "PosReg", "rel": "CauseOf", "object": "decreased", "obj_type": "NegReg", "file_name": "PubMed-30617455.json", "snippet": " tolerance was observed in the WRKY12 loss-of-function mutants, whereas increased Cd sensitivity was found in the WRKY12-overexpressing plants. Overexpression and loss-of-function of WRKY12 were associated respectively with increased and  [CLS] decreased Cd accumulation by repressing or releasing [CLS]  the expression of the genes involved in the PC synthesis pathway. Transient expression assay showed that WRKY12 repressed the expression of GSH1, GSH2, PCS1, and PCS2. Further analysis indicated"}
{"subject": "Cd accumulation", "sub_type": "CPA", "rel": "ThemeOf", "object": "decreased", "obj_type": "NegReg", "file_name": "PubMed-30617455.json", "snippet": " tolerance was observed in the WRKY12 loss-of-function mutants, whereas increased Cd sensitivity was found in the WRKY12-overexpressing plants. Overexpression and loss-of-function of WRKY12 were associated respectively with increased and  [CLS] decreased Cd accumulation [CLS]  by repressing or releasing the expression of the genes involved in the PC synthesis pathway. Transient expression assay showed that WRKY12 repressed the expression of GSH1, GSH2, PCS1, and"}
{"subject": "QRICH2", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-30683861.json", "snippet": " [CLS] mutations in QRICH2 [CLS]  cause male infertility with multiple morphological abnormalities of the sperm flagella.\nAberrant sperm flagella impair sperm motility and cause male infertility, yet the genes which have been identified in"}
{"subject": "male infertility", "sub_type": "Disease", "rel": "ThemeOf", "object": "cause", "obj_type": "Reg", "file_name": "PubMed-30683861.json", "snippet": " [CLS] cause male infertility [CLS] , yet the genes which have been identified in multiple morphological abnormalities of the flagella (MMAF) can only explain the pathogenic mechanisms of MMAF in a small number of cases."}
{"subject": "QRICH2", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-30683861.json", "snippet": " experiments indicate that QRICH2 is involved in sperm flagellar development through stabilizing and enhancing the expression of proteins related to flagellar development. Our findings strongly suggest that the genetic  [CLS] mutations of human QRICH2 [CLS]  can lead to male infertility with MMAF and that QRICH2 is essential for sperm flagellar formation."}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "lead to", "obj_type": "Reg", "file_name": "PubMed-30683861.json", "snippet": " experiments indicate that QRICH2 is involved in sperm flagellar development through stabilizing and enhancing the expression of proteins related to flagellar development. Our findings strongly suggest that the genetic  [CLS] mutations of human QRICH2 can lead to [CLS]  male infertility with MMAF and that QRICH2 is essential for sperm flagellar formation."}
{"subject": "male infertility", "sub_type": "Disease", "rel": "ThemeOf", "object": "lead to", "obj_type": "Reg", "file_name": "PubMed-30683861.json", "snippet": " involved in sperm flagellar development through stabilizing and enhancing the expression of proteins related to flagellar development. Our findings strongly suggest that the genetic mutations of human QRICH2 can  [CLS] lead to male infertility [CLS]  with MMAF and that QRICH2 is essential for sperm flagellar formation."}
{"subject": "MMAF", "sub_type": "CPA", "rel": "ThemeOf", "object": "lead to", "obj_type": "Reg", "file_name": "PubMed-30683861.json", "snippet": " involved in sperm flagellar development through stabilizing and enhancing the expression of proteins related to flagellar development. Our findings strongly suggest that the genetic mutations of human QRICH2 can  [CLS] lead to male infertility with MMAF [CLS]  and that QRICH2 is essential for sperm flagellar formation."}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "Loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-30683861.json", "snippet": " [CLS] Loss-of-function mutations [CLS]  in QRICH2 cause male infertility with multiple morphological abnormalities of the sperm flagella.\nAberrant sperm flagella impair sperm motility and cause male infertility, yet the genes which have been"}
{"subject": "Loss-of-function", "sub_type": "NegReg", "rel": "CauseOf", "object": "cause", "obj_type": "Reg", "file_name": "PubMed-30683861.json", "snippet": " [CLS] Loss-of-function mutations in QRICH2 cause [CLS]  male infertility with multiple morphological abnormalities of the sperm flagella.\nAberrant sperm flagella impair sperm motility and cause male infertility, yet the genes which have been identified in multiple"}
{"subject": "male infertility", "sub_type": "Disease", "rel": "ThemeOf", "object": "cause", "obj_type": "Reg", "file_name": "PubMed-30683861.json", "snippet": " [CLS] cause male infertility [CLS]  with multiple morphological abnormalities of the sperm flagella.\nAberrant sperm flagella impair sperm motility and cause male infertility, yet the genes which have been identified in multiple morphological abnormalities"}
{"subject": "sperm flagella", "sub_type": "CPA", "rel": "ThemeOf", "object": "Aberrant", "obj_type": "Var", "file_name": "PubMed-30683861.json", "snippet": " [CLS] Aberrant sperm flagella [CLS]  impair sperm motility and cause male infertility, yet the genes which have been identified in multiple morphological abnormalities of the flagella (MMAF) can only explain the pathogenic mechanisms of"}
{"subject": "Aberrant", "sub_type": "Var", "rel": "CauseOf", "object": "impair", "obj_type": "NegReg", "file_name": "PubMed-30683861.json", "snippet": " [CLS] Aberrant sperm flagella impair [CLS]  sperm motility and cause male infertility, yet the genes which have been identified in multiple morphological abnormalities of the flagella (MMAF) can only explain the pathogenic mechanisms of MMAF"}
{"subject": "sperm motility", "sub_type": "CPA", "rel": "ThemeOf", "object": "impair", "obj_type": "NegReg", "file_name": "PubMed-30683861.json", "snippet": " [CLS] impair sperm motility [CLS]  and cause male infertility, yet the genes which have been identified in multiple morphological abnormalities of the flagella (MMAF) can only explain the pathogenic mechanisms of MMAF in a"}
{"subject": "impair", "sub_type": "NegReg", "rel": "CauseOf", "object": "cause", "obj_type": "Reg", "file_name": "PubMed-30683861.json", "snippet": " [CLS] impair sperm motility and cause [CLS]  male infertility, yet the genes which have been identified in multiple morphological abnormalities of the flagella (MMAF) can only explain the pathogenic mechanisms of MMAF in a small number"}
